FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Melo, A
   Tavares, JD
   Costa, MD
   de Aguiar, RS
   Malinger, G
   Melo, FD
   da-Silva, MB
   Schamber-Reis, BLF
   Gama, G
   Tanuri, A
   Chimelli, L
   Oliveira-Szejnfeld, P
   de Amorim, MMR
AF Melo, Adriana
   de Sales Tavares, Jousilene
   de Assis Costa, Marianny
   Santana de Aguiar, Renato
   Malinger, Gustavo
   de Oliveira Melo, Fabiana
   Balbino da-Silva, Mariana
   Luiz Fonseca Schamber-Reis, Bruno
   Gama, Gabriela
   Tanuri, Amilcar
   Chimelli, Leila
   Oliveira-Szejnfeld, Patricia
   M. Ramos de Amorim, Melania
TI Obstetric and perinatal outcomes in cases of congenital Zika syndrome
SO PRENATAL DIAGNOSIS
LA English
DT Article; Early Access
ID VIRUS-INFECTION; INFANTS; BRAZIL; RISK
AB Objective To describe obstetric and perinatal outcomes in cases of congenital Zika syndrome (CZS).
   Methods A dual prospective and retrospective cohort study involving 102 pairs of mothers and fetuses/children with CZS whose infection was confirmed by testing for the Zika virus in amniotic fluid, umbilical cord blood, and fragments from the placenta of the newborn infant (confirmed CZS), or by intrauterine imaging tests (neurosonography), and/or postnatal computed tomography (presumed CZS).
   Results Suspicion of CZS was investigated by ultrasonography during pregnancy in 52.9% of cases. The principal prenatal imaging findings were ventriculomegaly (43.1%) and microcephaly (42.2%). Median gestational age at delivery was 39 weeks, with 15.7% being premature. Mean head circumference at birth was 30.0 +/- 2.3 cm, with 66% of cases being classified as having microcephaly. Arthrogryposis was found in 10 cases (9.8%). There were no fetal deaths; however, nine neonatal deaths were recorded, and three autopsies were performed.
   Conclusion Neonatal mortality was high, almost 10%. Regarding the abnormalities of CZS, microcephaly, although common, was not present in all cases and intracranial findings need to be taken into consideration for diagnosis. Therefore, ultrasound screening during pregnancy should be systematized and expanded in endemic zones.
C1 [Melo, Adriana; de Sales Tavares, Jousilene; de Oliveira Melo, Fabiana; Balbino da-Silva, Mariana; Gama, Gabriela; M. Ramos de Amorim, Melania] Inst Pesquisa Prof Amorim Neto IPESQ, Campina Grande, Paraiba, Brazil.
   [Melo, Adriana; de Assis Costa, Marianny; Luiz Fonseca Schamber-Reis, Bruno; Gama, Gabriela] UNIFACISA, Campina Grande, Paraiba, Brazil.
   [Melo, Adriana; M. Ramos de Amorim, Melania] Fed Univ Campina Grande UFCG, Campina Grande, Paraiba, Brazil.
   [Santana de Aguiar, Renato; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [Malinger, Gustavo] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Lis Matern Hosp, Tel Aviv, Israel.
   [Malinger, Gustavo] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.
   [Chimelli, Leila] Inst Estadual Cerebro Paulo Niemeyer, Rio De Janeiro, Brazil.
   [Oliveira-Szejnfeld, Patricia] Univ Fed Sao Paulo, Sao Paulo, Brazil.
   [Oliveira-Szejnfeld, Patricia] Inst DOr Pesquisa IDOR, Rio De Janeiro, Brazil.
   [M. Ramos de Amorim, Melania] Inst Med Integral Prof Fernando Figueira IMIP, Recife, PE, Brazil.
RP Melo, A (corresponding author), Inst Pesquisa Prof Joaquim Amorim Neto, Rua Salvino de Oliveira Neto 87, BR-58402040 Campina Grande, Paraiba, Brazil.
EM asomelo@gmail.com
RI Amorim, Melania/C-5807-2013
OI Amorim, Melania/0000-0003-1047-2514
FU Coordination for the Improvement of Higher Education Personnel
   (CAPES)CAPES; Ministry of Education (MEC)Spanish Government; National
   Council for Scientific and Technological Development (CNPq)National
   Council for Scientific and Technological Development (CNPq); Ministry of
   HealthMinistry of Health - Turkey [443372/2016-0, 425136/2016-7,
   440488/2016-8, 428837/2016-6]; Ministry of Science, Technology and
   Innovation (MCTI); Department of Science and Technology
   (Decit)Department of Science & Technology (India); Secretariat of
   Science, Technology and Strategic Supplies (SCTIE)
FX Coordination for the Improvement of Higher Education Personnel (CAPES);
   Ministry of Education (MEC); National Council for Scientific and
   Technological Development (CNPq); Ministry of Health (grants
   443372/2016-0, 425136/2016-7, 440488/2016-8 and 428837/2016-6).;
   Ministry of Science, Technology and Innovation (MCTI); and Department of
   Science and Technology (Decit); Secretariat of Science, Technology and
   Strategic Supplies (SCTIE)
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil MdS., 2018, MONITORAMENTO INTEGR
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Farinelli EC, 2018, ACTA TROP, V180, P47, DOI 10.1016/j.actatropica.2018.01.005
   Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Levine D, 2017, RADIOLOGY, V285, P744, DOI 10.1148/radiol.2017171238
   Malinger G, 2019, ULTRASOUND OBST GYN, V53, P436, DOI 10.1002/uog.20199
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Pessoa A, 2018, PEDIATRICS, V141, pS167, DOI 10.1542/peds.2017-2038F
   Pomar L, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4431
   Sassetti M, 2018, T ROY SOC TROP MED H, V112, P458, DOI 10.1093/trstmh/try074
   Schaub B, 2017, LANCET CHILD ADOLESC, V1, P45, DOI 10.1016/S2352-4642(17)30001-9
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
NR 20
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0197-3851
EI 1097-0223
J9 PRENATAL DIAG
JI Prenat. Diagn.
DI 10.1002/pd.5831
EA OCT 2020
PG 9
WC Genetics & Heredity; Obstetrics & Gynecology
SC Genetics & Heredity; Obstetrics & Gynecology
GA OJ1MK
UT WOS:000583731500001
PM 32939752
DA 2020-12-08
ER

PT J
AU Ogino, LL
   Lamback, EB
   Guterres, A
   Lima, CHD
   Henriques, DG
   Barbosa, MA
   Silva, DA
   Camacho, AHD
   Chimelli, L
   Kasuki, L
   Gadelha, MR
AF Ogino, Liana Lumi
   Lamback, Elisa Baranski
   Guterres, Alexandro
   de Azeredo Lima, Carlos Henrique
   Henriques, Daniel Gomes
   Barbosa, Monique Alvares
   Silva, Debora Aparecida
   da Silva Camacho, Aline Helen
   Chimelli, Leila
   Kasuki, Leandro
   Gadelha, Monica R.
TI Telomerase expression in clinically non-functioning pituitary adenomas
SO ENDOCRINE
LA English
DT Article; Early Access
DE Non-functioning pituitary adenomas; Telomerase; Tumorigenesis; Pituitary
   tumor
ID 2ND BRAIN-TUMOR; CONSERVATIVE SURGERY; RADIATION-THERAPY;
   REVERSE-TRANSCRIPTASE; RADIOTHERAPY; CLASSIFICATION; CANCER; LENGTH;
   HTERT; PROLIFERATION
AB Purpose Non-functioning pituitary adenomas (NFPA) are benign tumors, however, some are agressive. We aimed to assess if human telomerase reverse transcriptase (hTERT) is present in NFPA and if it can be used as a marker of aggressiveness and proliferation. Methods Consecutive patients operated for NFPA whose fresh frozen tumors were available were included. We analyzed tumor's aggressiveness (based on radiological progression) and proliferation (based on Ki-67), as well as hTERT mRNA by quantitative real-time polymerase chain reaction (RT-qPCR). Results We included 109 samples from 86 patients followed for a median period of 60 months (5-120 months). Aggressive tumors were present in 66% cases and proliferative tumors in 47.7%. Seven (6.4%) samples expressed hTERT: 3 (42.8%) had aggressive and proliferative tumors, 2 (28.6%) only exhibited aggressiveness and the remaining 2 (28.6%) only proliferation. From the aggressive and proliferative tumors, 14% and 16%, respectively, expressed hTERT. From the non-aggressive and non-proliferative tumors, 9% and 6%, respectively, expressed hTERT. Conclusion hTERT expression is present in a minority of NFPA and does not seem to be related to aggressiveness or proliferation in NFPA.
C1 [Ogino, Liana Lumi; Guterres, Alexandro; de Azeredo Lima, Carlos Henrique; Silva, Debora Aparecida; da Silva Camacho, Aline Helen; Chimelli, Leila; Gadelha, Monica R.] Inst Estadual Cerebro Paulo Niemeyer, Neuropathol & Mol Genet Lab, Rio De Janeiro, Brazil.
   [Lamback, Elisa Baranski; Henriques, Daniel Gomes; Kasuki, Leandro; Gadelha, Monica R.] Univ Fed Rio de Janeiro, Med Sch, Neuroendocrinol Res Ctr, Endocrinol Div, Rio De Janeiro, Brazil.
   [Lamback, Elisa Baranski; Henriques, Daniel Gomes; Kasuki, Leandro; Gadelha, Monica R.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil.
   [Barbosa, Monique Alvares] Inst Estadual Cerebro Paulo Niemeyer, Radiol Div, Rio De Janeiro, Brazil.
   [da Silva Camacho, Aline Helen] Inst Nacl Canc, Pathol Div, Rio De Janeiro, Brazil.
   [Kasuki, Leandro; Gadelha, Monica R.] Inst Estadual Cerebro Paulo Niemeyer, Neuroendocrinol Div, Rio De Janeiro, Brazil.
   [Kasuki, Leandro] Hosp Fed Bonsucesso, Endocrinol Div, Rio De Janeiro, Brazil.
RP Gadelha, MR (corresponding author), Inst Estadual Cerebro Paulo Niemeyer, Neuropathol & Mol Genet Lab, Rio De Janeiro, Brazil.; Gadelha, MR (corresponding author), Univ Fed Rio de Janeiro, Med Sch, Neuroendocrinol Res Ctr, Endocrinol Div, Rio De Janeiro, Brazil.; Gadelha, MR (corresponding author), Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil.; Gadelha, MR (corresponding author), Inst Estadual Cerebro Paulo Niemeyer, Neuroendocrinol Div, Rio De Janeiro, Brazil.
EM mgadelha@hucff.ufrj.br
CR ALMEFTY O, 1990, J NEUROSURG, V73, P502, DOI 10.3171/jns.1990.73.4.0502
   Asa SL, 2002, NAT REV CANCER, V2, P836, DOI 10.1038/nrc926
   Blasco MA, 2003, EUR J CELL BIOL, V82, P441, DOI 10.1078/0171-9335-00335
   Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349
   Boresowicz J, 2018, NEUROENDOCRINOL LETT, V39, P49
   BRADA M, 1993, CLIN ENDOCRINOL, V38, P571, DOI 10.1111/j.1365-2265.1993.tb02137.x
   BRADA M, 1992, BRIT MED J, V304, P1343, DOI 10.1136/bmj.304.6838.1343
   Chen Y, 2012, NEUROENDOCRINOLOGY, V96, P333, DOI 10.1159/000339823
   Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083
   COMTOIS R, 1991, CANCER, V68, P860, DOI 10.1002/1097-0142(19910815)68:4<860::AID-CNCR2820680431>3.0.CO;2-4
   Verdolin AD, 2020, ENDOCRINE, V68, P174, DOI 10.1007/s12020-019-02149-8
   Dekkers OM, 2006, J CLIN ENDOCR METAB, V91, P1796, DOI 10.1210/jc.2005-2552
   DeMasters BKK, 1997, AM J CLIN PATHOL, V107, P548
   Freda PU, 1999, J CLIN ENDOCR METAB, V84, P3859, DOI 10.1210/jc.84.11.3859
   Gittoes NJL, 1998, CLIN ENDOCRINOL, V48, P331
   Hahn CA, 2009, INT J RADIAT ONCOL, V73, P1082, DOI 10.1016/j.ijrobp.2008.05.061
   Harada K, 2000, SURG NEUROL, V53, P267, DOI 10.1016/S0090-3019(00)00181-6
   Hiraga S, 1998, CANCER RES, V58, P2117
   Hirose M, 1998, CLIN CHEM, V44, P2446
   Hiyama E, 2001, NEOPLASIA, V3, P17, DOI 10.1038/sj.neo.7900134
   Holt SE, 1999, J CELL PHYSIOL, V180, P10, DOI 10.1002/(SICI)1097-4652(199907)180:1<10::AID-JCP2>3.0.CO;2-D
   Hu LH, 2004, WORLD J GASTROENTERO, V10, P3514
   KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428
   Kong WM, 2015, J CANCER, V6, P1337, DOI 10.7150/jca.13054
   Kovacs K, 2001, J NEURO-ONCOL, V54, P121, DOI 10.1023/A:1012945129981
   Lamback EB, 2020, ENDOCRINE, V70, P380, DOI 10.1007/s12020-020-02402-5
   Martins CS, 2015, J ENDOCRINOL INVEST, V38, P1243, DOI 10.1007/s40618-015-0298-3
   McCord MW, 1997, INT J RADIAT ONCOL, V39, P437, DOI 10.1016/S0360-3016(97)00335-0
   Melmed S, 2003, J CLIN INVEST, V112, P1603, DOI 10.1172/JCI20401
   Mete O, 2017, ENDOCR PATHOL, V28, P228, DOI 10.1007/s12022-017-9498-z
   Minniti G, 2005, J CLIN ENDOCR METAB, V90, P800, DOI 10.1210/jc.2004-1152
   Nomikos P, 2004, ACTA NEUROCHIR, V146, P27, DOI 10.1007/s00701-003-0174-3
   Normann KR, 2016, MOL CELL ENDOCRINOL, V437, P183, DOI 10.1016/j.mce.2016.08.030
   Ortiz-Plata A, 2007, J NEURO-ONCOL, V84, P159, DOI 10.1007/s11060-007-9365-8
   Ratnasingam J, 2017, CLIN ENDOCRINOL, V87, P717, DOI 10.1111/cen.13402
   Raverot G, 2018, EUR J ENDOCRINOL, V178, pG1, DOI 10.1530/EJE-17-0796
   Raverot G, 2012, CLIN ENDOCRINOL, V76, P769, DOI 10.1111/j.1365-2265.2012.04381.x
   Rush S, 1997, INT J RADIAT ONCOL, V37, P1031, DOI 10.1016/S0360-3016(96)00586-X
   Scheithauer BW, 2006, NEUROSURGERY, V59, P341, DOI 10.1227/01.NEU.0000223437.51435.6E
   SCHEITHAUER BW, 1986, J NEUROSURG, V65, P733, DOI 10.3171/jns.1986.65.6.0733
   Shay JW, 2016, CANCER DISCOV, V6, P584, DOI 10.1158/2159-8290.CD-16-0062
   Shay JW, 2011, SEMIN CANCER BIOL, V21, P349, DOI 10.1016/j.semcancer.2011.10.001
   Soto-Ares G, 2002, EUR J ENDOCRINOL, V146, P179, DOI 10.1530/eje.0.1460179
   Tortosa F, 2018, REV CLIN ESP, V218, P128, DOI 10.1016/j.rce.2017.12.002
   Toshikuni N, 2000, BRIT J CANCER, V82, P833, DOI 10.1054/bjoc.1999.1008
   Trouillas J, 2013, ACTA NEUROPATHOL, V126, P123, DOI 10.1007/s00401-013-1084-y
   TSANG RW, 1993, CANCER-AM CANCER SOC, V72, P2227, DOI 10.1002/1097-0142(19931001)72:7<2227::AID-CNCR2820720727>3.0.CO;2-I
   Vasef MA, 1999, AM J CLIN PATHOL, V112, pS68
   Wang ZL, 2002, UROL ONCOL, V7, P199, DOI 10.1016/S1078-1439(02)00191-6
   Wichers-Rother M, 2004, EXP CLIN ENDOCR DIAB, V112, P323, DOI 10.1055/s-2004-820914
   Woollons AC, 2000, CLIN ENDOCRINOL, V53, P713, DOI 10.1046/j.1365-2265.2000.01153.x
   Yoshino A, 2003, J NEURO-ONCOL, V63, P155, DOI 10.1023/A:1023935621976
   Yuan XT, 2019, ONCOGENE, V38, P6172, DOI 10.1038/s41388-019-0872-9
NR 53
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1355-008X
EI 1559-0100
J9 ENDOCRINE
JI Endocrine
DI 10.1007/s12020-020-02524-w
EA OCT 2020
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA OG0AZ
UT WOS:000581559700001
PM 33090306
DA 2020-12-08
ER

PT J
AU Lamback, EB
   Guterres, A
   Barbosa, MA
   Lima, CHD
   Silva, DA
   Camacho, AHD
   Chimelli, L
   Kasuki, L
   Gadelha, MNR
AF Lamback, Elisa B.
   Guterres, Alexandro
   Barbosa, Monique Alvares
   Lima, Carlos Henrique de Azeredo
   Silva, Debora Aparecida
   Camacho, Aline Helen da Silva
   Chimelli, Leila
   Kasuki, Leandro
   Gadelha, Monica R.
TI Cyclin A in nonfunctioning pituitary adenomas
SO ENDOCRINE
LA English
DT Article
DE Nonfunctioning pituitary adenomas; Cyclin A; Tumorigenesis;
   Proliferation; Invasion
ID TRANSCRIPTION FACTORS; GENE-EXPRESSION; B1 PROTEINS; CLASSIFICATION;
   OVEREXPRESSION; DIAGNOSIS; TUMORS; PATHOGENESIS
AB Purpose Assess cyclin A in nonfunctioning pituitary adenomas (NFPA) and compare its expression in non-invasive and non-proliferative tumors with invasive and proliferative tumors (12x higher risk of recurrence). Methods Quantitative real time polymerase chain reaction to analyze cyclin A using normal pituitary gland as reference. Fold change (FC) > 1 was considered as increased. Tumor invasion was based on Knosp criteria (grades 3-4 considered invasive) and proliferation on the presence of at least two of three criteria: Ki-67 >= 3%; mitoses > 2/10; positive p53. Both groups were compared with Mann-Whitney test consideringpvalue < 0.05 as statistically significant. Results Thirty-one patients with NFPA were included. Tumors were mainly of gonadotrophic origin (74.2%), followed by corticotrophic (19.4%) and lactotrophic (3.2%) origins and null-cell adenomas (3.2%). Median tumor diameter was 3.5 cm (1.8-8.0) and Ki-67 was 3.0% (0.3-11%). Sixteen patients had tumors classified as non-invasive and non-proliferative and 15 as invasive and proliferative. Median FC was 0.31 in all tumors (0.13-1.94). Cyclin A was not related to invasion or proliferation (FC 0.41 in non-invasive and non-proliferative tumors and FC 0.30 in invasive and proliferative tumors;p = 0.968). Four (12.9%) patients had tumors that exhibited increased cyclin A [median FC of 1.04 (1.02-1.94)]-three of gonadotrophic origin and one null-cell adenoma, with two tumors classified as non-invasive and non-proliferative and two tumors classified as invasive and proliferative. Median tumor diameter in these samples was 3.4 cm (2.4-3.6) and Ki-67 was 5.1% (2-11%). Conclusions Cyclin A was increased in a minority of NFPA and does not seem to be related to invasion or proliferation.
C1 [Lamback, Elisa B.; Kasuki, Leandro; Gadelha, Monica R.] Univ Fed Rio de Janeiro, Endocrinol Div, Neuroendocrinol Res Ctr, Med Sch, Rio De Janeiro, Brazil.
   [Lamback, Elisa B.; Kasuki, Leandro; Gadelha, Monica R.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil.
   [Guterres, Alexandro; Lima, Carlos Henrique de Azeredo; Silva, Debora Aparecida; Camacho, Aline Helen da Silva; Chimelli, Leila; Gadelha, Monica R.] Inst Estadual Cerebro Paulo Niemeyer, Neuropathol & Mol Genet Lab, Rio De Janeiro, Brazil.
   [Barbosa, Monique Alvares] Inst Estadual Cerebro Paulo Niemeyer, Radiol Div, Rio De Janeiro, Brazil.
   [Camacho, Aline Helen da Silva] Inst Nacl Canc, Pathol Div, Rio De Janeiro, Brazil.
   [Kasuki, Leandro; Gadelha, Monica R.] Inst Estadual Cerebro Paulo Niemeyer, Neuroendocrinol Div, Rio De Janeiro, Brazil.
   [Kasuki, Leandro] Hosp Fed Bonsucesso, Endocrinol Div, Rio De Janeiro, Brazil.
RP Gadelha, MR (corresponding author), Univ Fed Rio de Janeiro, Endocrinol Div, Neuroendocrinol Res Ctr, Med Sch, Rio De Janeiro, Brazil.; Gadelha, MR (corresponding author), Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil.; Gadelha, MR (corresponding author), Inst Estadual Cerebro Paulo Niemeyer, Neuropathol & Mol Genet Lab, Rio De Janeiro, Brazil.; Gadelha, MR (corresponding author), Inst Estadual Cerebro Paulo Niemeyer, Neuroendocrinol Div, Rio De Janeiro, Brazil.
EM mgadelha@hucff.ufrj.br
RI Guterres, Alexandro/B-4881-2014
OI Guterres, Alexandro/0000-0001-8323-1477
CR Allan K, 2000, ARCH PATHOL LAB MED, V124, P216
   Anderson JR, 1999, J NEUROL NEUROSUR PS, V66, P703, DOI 10.1136/jnnp.66.6.703
   Boelaert K, 2001, EUR J ENDOCRINOL, V144, P569, DOI 10.1530/eje.0.1440569
   Buurman H, 2006, EUR J ENDOCRINOL, V154, P753, DOI 10.1530/eje.1.02107
   Chen Y, 2012, NEUROENDOCRINOLOGY, V96, P333, DOI 10.1159/000339823
   Verdolin AD, 2020, ENDOCRINE, V68, P174, DOI 10.1007/s12020-019-02149-8
   DESDOUETS C, 1995, MOL CELL BIOL, V15, P3301
   Diederichs S, 2004, J BIOL CHEM, V279, P33727, DOI 10.1074/jbc.M401708200
   Torregrosa-Quesada ME, 2019, CANCERS, V11, DOI 10.3390/cancers11121990
   Furihata M, 1996, CLIN CANCER RES, V2, P1781
   Gadelha MR, 2013, FRONT HORM RES, V41, P111, DOI 10.1159/000345673
   Greenman Y, 2009, BEST PRACT RES CL EN, V23, P625, DOI 10.1016/j.beem.2009.05.005
   HENGLEIN B, 1994, P NATL ACAD SCI USA, V91, P5490, DOI 10.1073/pnas.91.12.5490
   Hibberts NA, 1999, CLIN CANCER RES, V5, P2133
   Jordan S, 2000, EUR J ENDOCRINOL, V143, pR1, DOI 10.1530/eje.0.143R001
   Kalaszczynska I, 2009, CELL, V138, P352, DOI 10.1016/j.cell.2009.04.062
   Kasuki L, 2020, REV ENDOCR METAB DIS, V21, P203, DOI 10.1007/s11154-019-09531-x
   KNOSP E, 1993, NEUROSURGERY, V33, P610, DOI 10.1227/00006123-199310000-00008
   Kushner J, 1999, J ORAL PATHOL MED, V28, P77
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lloyd RV, 2017, WHO CLASSIFICATION T
   Lopes MBS, 2017, ACTA NEUROPATHOL, V134, P521, DOI 10.1007/s00401-017-1769-8
   Loukil Abdelhalim, 2015, World J Biol Chem, V6, P346, DOI 10.4331/wjbc.v6.i4.346
   LUNDIN P, 1992, J COMPUT ASSIST TOMO, V16, P519, DOI 10.1097/00004728-199207000-00004
   Mashal RD, 1996, CANCER RES, V56, P4159
   Melmed S, 2015, ENDOCRIN METAB CLIN, V44, P1, DOI 10.1016/j.ecl.2014.11.004
   Melmed S, 2011, NAT REV ENDOCRINOL, V7, P257, DOI 10.1038/nrendo.2011.40
   Melmed S, 2011, J CLIN ENDOCR METAB, V96, P273, DOI 10.1210/jc.2010-1692
   Miao C, 2015, ONCOL LETT, V10, P1716, DOI 10.3892/ol.2015.3474
   Musat M, 2004, FRONT HORM RES, V32, P34
   Nakabayashi H, 2001, J HISTOCHEM CYTOCHEM, V49, P1193, DOI 10.1177/002215540104900916
   Neto LV, 2016, ARCH ENDOCRIN METAB, V60, P374, DOI 10.1590/2359-3997000000179
   Nieman LK, 2008, J CLIN ENDOCR METAB, V93, P1526, DOI 10.1210/jc.2008-0125
   Nishioka H, 2015, ENDOCR PATHOL, V26, P349, DOI 10.1007/s12022-015-9398-z
   Normann KR, 2016, MOL CELL ENDOCRINOL, V437, P183, DOI 10.1016/j.mce.2016.08.030
   O'Hurley G, 2014, MOL ONCOL, V8, P783, DOI 10.1016/j.molonc.2014.03.008
   Olsson DS, 2017, ENDOCRINE, V56, P1, DOI 10.1007/s12020-016-1211-3
   Quereda V, 2009, J MOL ENDOCRINOL, V42, P75, DOI 10.1677/JME-08-0146
   Ramirez C, 2012, J CLIN ENDOCR METAB, V97, P1745, DOI 10.1210/jc.2011-3163
   ROSENBERG AR, 1995, ONCOGENE, V10, P1501
   Saeger W, 2007, EUR J ENDOCRINOL, V156, P203, DOI 10.1530/eje.1.02326
   SCHEITHAUER BW, 1986, J NEUROSURG, V65, P733, DOI 10.3171/jns.1986.65.6.0733
   Sinn HP, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3111-1
   Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X
   Traganos F, 2004, CELL CYCLE, V3, P32
   Trouillas J, 2013, ACTA NEUROPATHOL, V126, P123, DOI 10.1007/s00401-013-1084-y
   Turner HE, 2000, CLIN ENDOCRINOL, V53, P337
   Wildemberg LE, 2018, PITUITARY, V21, P138, DOI 10.1007/s11102-018-0870-x
   Yam CH, 2002, CELL MOL LIFE SCI, V59, P1317, DOI 10.1007/s00018-002-8510-y
   Yu R, 2010, PROG BRAIN RES, V182, P207, DOI 10.1016/S0079-6123(10)82009-6
   Zahr Roula, 2018, Eur Endocrinol, V14, P57, DOI 10.17925/EE.2018.14.2.57
NR 51
TC 1
Z9 1
U1 2
U2 2
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1355-008X
EI 1559-0100
J9 ENDOCRINE
JI Endocrine
PD NOV
PY 2020
VL 70
IS 2
BP 380
EP 387
DI 10.1007/s12020-020-02402-5
EA JUL 2020
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA OF2GO
UT WOS:000545176100002
PM 32621052
DA 2020-12-08
ER

PT J
AU Aguiar, RS
   Pohl, F
   Morais, GL
   Nogueira, FCS
   de Carvalho, JB
   Guida, L
   Arge, LWP
   Melo, A
   Moreira, MEL
   Cunha, DP
   Gomes, L
   Portari, EA
   Velasquez, E
   Melani, RD
   Pezzuto, P
   de Castro, FL
   Geddes, VEV
   Gerber, AL
   Azevedo, GS
   Schamber-Reis, BL
   Goncalves, AL
   Junqueira-de-Azevedo, I
   Nishiyama, MY
   Ho, P
   Schanoski, A
   Schuch, V
   Tanuri, A
   Chimelli, L
   Vasconcelos, ZFM
   Domont, GB
   Vasconcelos, ATR
   Nakaya, HI
AF Aguiar, Renato S.
   Pohl, Fabio
   Morais, Guilherme L.
   Nogueira, Fabio C. S.
   de Carvalho, Joseane B.
   Guida, Leticia
   Arge, Luis W. P.
   Melo, Adriana
   Moreira, Maria E. L.
   Cunha, Daniela P.
   Gomes, Leonardo
   Portari, Elyzabeth A.
   Velasquez, Erika
   Melani, Rafael D.
   Pezzuto, Paula
   de Castro, Fernanda L.
   Geddes, Victor E. V.
   Gerber, Alexandra L.
   Azevedo, Girlene S.
   Schamber-Reis, Bruno L.
   Goncalves, Alessandro L.
   Junqueira-de-Azevedo, Inacio
   Nishiyama Jr, Milton Y.
   Ho, Paulo
   Schanoski, Alessandra
   Schuch, Viviane
   Tanuri, Amilcar
   Chimelli, Leila
   Vasconcelos, Zilton F. M.
   Domont, Gilberto B.
   Vasconcelos, Ana T. R.
   Nakaya, Helder, I
TI Molecular alterations in the extracellular matrix in the brains of
   newborns with congenital Zika syndrome
SO SCIENCE SIGNALING
LA English
DT Article
ID VIRUS-INFECTION; RNA-SEQ; COLLAGEN; MUTATIONS; DATABASE; VISUALIZATION;
   POLYMORPHISM; DISRUPTION; PROTEINS; REGIONS
AB Zika virus (ZIKV) infection during pregnancy can cause a set of severe abnormalities in the fetus known as congenital Zika syndrome (CZS). Experiments with animal models and in vitro systems have substantially contributed to our understanding of the pathophysiology of ZIKV infection. Here, to investigate the molecular basis of CZS in humans, we used a systems biology approach to integrate transcriptomic, proteomic, and genomic data from the postmortem brains of neonates with CZS. We observed that collagens were greatly reduced in expression in CZS brains at both the RNA and protein levels and that neonates with CZS had several single-nucleotide polymorphisms in collagen-encoding genes that are associated with osteogenesis imperfecta and arthrogryposis. These findings were validated by immunohistochemistry and comparative analysis of collagen abundance in ZIKV-infected and uninfected samples. In addition, we showed a ZIKV-dependent increase in the expression of cell adhesion factors that are essential for neurite outgrowth and axon guidance, findings that are consistent with the neuronal migration defects observed in CZS. Together, these findings provide insights into the underlying molecular alterations in the ZIKV-infected brain and reveal host genes associated with CZS susceptibility.
C1 [Aguiar, Renato S.; Pezzuto, Paula; de Castro, Fernanda L.; Geddes, Victor E. V.; Goncalves, Alessandro L.; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [Aguiar, Renato S.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil.
   [Pohl, Fabio; Schuch, Viviane; Nakaya, Helder, I] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.
   [Morais, Guilherme L.; de Carvalho, Joseane B.; Arge, Luis W. P.; Gerber, Alexandra L.; Vasconcelos, Ana T. R.] LNCC MCTI, Natl Lab Sci Computat, Petropolis, RJ, Brazil.
   [Nogueira, Fabio C. S.; Velasquez, Erika; Melani, Rafael D.; Domont, Gilberto B.] Univ Fed Rio de Janeiro, Inst Chem, Dept Biochem, Prote Unit, Rio De Janeiro, Brazil.
   [Nogueira, Fabio C. S.] Univ Fed Rio de Janeiro, Inst Chem, LADETEC, Lab Prote, Rio De Janeiro, Brazil.
   [Guida, Leticia; Moreira, Maria E. L.; Cunha, Daniela P.; Gomes, Leonardo; Portari, Elyzabeth A.; Vasconcelos, Zilton F. M.] Fiocruz MS, Fernandes Figueira Inst, Rio De Janeiro, Brazil.
   [Melo, Adriana; Azevedo, Girlene S.] Inst Pesquisa Prof Amorim Neto, Campina Grande, Paraiba, Brazil.
   [Schamber-Reis, Bruno L.] Ctr Univ UniFacisa, Nucleo Genet Med, Fac Ciencias Med Campina Grande, Campina Grande, Paraiba, Brazil.
   [Junqueira-de-Azevedo, Inacio; Nishiyama Jr, Milton Y.] Butantan Inst, Special Lab Appl Toxinol, Sao Paulo, Brazil.
   [Ho, Paulo; Schanoski, Alessandra] Butantan Inst, Bacteriol Lab, Sao Paulo, Brazil.
   [Chimelli, Leila] Inst Estadual Cerebro, Lab Neuropatol, Rio De Janeiro, Brazil.
   [Nakaya, Helder, I] Univ Sao Paulo, Sci Platform Pasteur, Sao Paulo, Brazil.
RP Nakaya, HI (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.; Vasconcelos, ATR (corresponding author), LNCC MCTI, Natl Lab Sci Computat, Petropolis, RJ, Brazil.; Domont, GB (corresponding author), Univ Fed Rio de Janeiro, Inst Chem, Dept Biochem, Prote Unit, Rio De Janeiro, Brazil.; Vasconcelos, ZFM (corresponding author), Fiocruz MS, Fernandes Figueira Inst, Rio De Janeiro, Brazil.; Chimelli, L (corresponding author), Inst Estadual Cerebro, Lab Neuropatol, Rio De Janeiro, Brazil.; Nakaya, HI (corresponding author), Univ Sao Paulo, Sci Platform Pasteur, Sao Paulo, Brazil.
EM chimelli@hucff.ufrj.br; zilton.vasconcelos@iff.fiocruz.br;
   gilbertodomont@gmail.com; atrv@lncc.br; hnakaya@usp.br
RI NOGUEIRA, FABIO CESAR SOUSA/G-9580-2011; Junior, Milton Y
   Nishiyama/H-4002-2013; Center of Toxins, Immune-response/J-5731-2015;
   Junqueira-de-Azevedo, Inacio L. M./H-5239-2011; Nakaya,
   Helder/AAF-1738-2020; Nakaya, Helder I/A-1397-2010; Aguiar,
   Renato/G-3542-2015
OI NOGUEIRA, FABIO CESAR SOUSA/0000-0001-5507-7142; Junior, Milton Y
   Nishiyama/0000-0002-2410-0562; Junqueira-de-Azevedo, Inacio L.
   M./0000-0003-4491-0180; Nakaya, Helder/0000-0001-5297-9108; Nakaya,
   Helder I/0000-0001-5297-9108; Geddes, Victor/0000-0002-0723-3873;
   /0000-0002-2034-0294; Guida, Leticia/0000-0003-3543-1532; Arge, Luis
   Willian Pacheco/0000-0002-0109-4809; Pohl, Fabio/0000-0003-1695-4936;
   Aguiar, Renato/0000-0001-5180-3717
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [440900/2016-6, 313662/2017-7, 440613/2016-7, 303170/2017-4]; CAPESCAPES
   [88881.130757/2016-01, 001, 88887.130697]; FINEPCiencia Tecnologia e
   Inovacao (FINEP) [01.16.0078.00]; Sao Paulo Research Foundation
   (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2017/50137-3, 2012/19278-6, 2018/14933-2, 2018/21934-5, 2013/08216-2];
   FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [E-26/202.650/2018, 26/202.903/20]
FX This research was supported by CNPq (grant no. 440900/2016-6), CAPES
   (grant no. 88881.130757/2016-01), and FINEP (grant no. 01.16.0078.00).
   H.I.N. is supported by CNPq (313662/2017-7) and the Sao Paulo Research
   Foundation (FAPESP; grants 2017/50137-3, 2012/19278-6, 2018/14933-2,
   2018/21934-5, and 2013/08216-2). F.L.d.C., V.E.V.G., J.B.C., and
   L.W.P.A. are funded by CAPES (grant 001). G.B.D. has financial support
   from grants 88887.130697 (CAPES) and 440613/2016-7 (CNPq). F.C.S.N. is
   supported by FAPERJ (E-26/202.650/2018). A.T.R.V. is supported by CNPq
   (303170/2017-4) and FAPERJ (26/202.903/20).
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Andersen LL, 2015, J EXP MED, V212, P1371, DOI 10.1084/jem.20142274
   Baeten KM, 2011, DEV NEUROBIOL, V71, P1018, DOI 10.1002/dneu.20954
   Bateman JF, 2009, NAT REV GENET, V10, P173, DOI 10.1038/nrg2520
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Buxbaum JD, 2008, MOL PSYCHIATR, V13, P162, DOI 10.1038/sj.mp.4001991
   Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128
   Chen Q, 2018, MBIO, V9, DOI 10.1128/mBio.01683-18
   Chen Y, 2017, INT J CLIN EXP MED, V10, P14904
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020
   Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695
   Cingolani Pablo, 2012, Frontiers in Genetics, V3, P35, DOI 10.3389/fgene.2012.00035
   Conde JN, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00213
   Costa VV, 2017, MBIO, V8, DOI [10.1128/mBio.00350-17, 10.1128/mbio.00350-17]
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Deckx S, 2016, FASEB J, V30, P2651, DOI 10.1096/fj.201500096R
   DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806
   Dittrich R, 2007, NEUROLOGY, V68, P2120, DOI 10.1212/01.wnl.0000264892.92538.a9
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faqeih E, 2009, AM J MED GENET A, V149A, P461, DOI 10.1002/ajmg.a.32653
   Fernandez-Calle R, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0823-8
   Ferraris P, 2019, EMERG MICROBES INFEC, V8, P1003, DOI 10.1080/22221751.2019.1637283
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Gorshkov V, 2015, ANAL CHEM, V87, P6319, DOI 10.1021/acs.analchem.5b01166
   Gratton R, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051048
   Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HIPC-CHI Signatures Project Team; HIPC-I Consortium, 2017, SCI IMMUNOL, V2
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kozak RA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100297
   Krow-Lucal ER, 2018, LANCET CHILD ADOLESC, V2, P204, DOI 10.1016/S2352-4642(18)30020-8
   Kuboyama K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048797
   Kuo DS, 2012, HUM MOL GENET, V21, pR97, DOI 10.1093/hmg/dds346
   Kwissa M, 2014, CELL HOST MICROBE, V16, P115, DOI 10.1016/j.chom.2014.06.001
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Larroche J.-C., 1977, DEV PATHOLOGY NEONAT, Vxviii
   Lex A, 2014, IEEE T VIS COMPUT GR, V20, P1983, DOI 10.1109/TVCG.2014.2346248
   Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630
   Liu XM, 2016, HUM MUTAT, V37, P235, DOI 10.1002/humu.22932
   Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Mala JGS, 2010, LIFE SCI, V87, P579, DOI 10.1016/j.lfs.2010.09.024
   Mammoto T, 2013, AM J PATHOL, V183, P1293, DOI 10.1016/j.ajpath.2013.06.026
   Maness PF, 2007, NAT NEUROSCI, V10, P263, DOI 10.1038/nn0207-263b
   Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Nadarajah B, 2003, CEREB CORTEX, V13, P607, DOI 10.1093/cercor/13.6.607
   Nakaya HI, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0146
   Naslavsky MS, 2017, HUM MUTAT, V38, P751, DOI 10.1002/humu.23220
   Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407
   Ogus AC, 2004, EUR RESPIR J, V23, P219, DOI 10.1183/09031936.03.00061703
   Pariser H, 2005, BIOCHEM BIOPH RES CO, V332, P664, DOI 10.1016/j.bbrc.2005.05.007
   Plotkin Horacio, 2004, BMC Pediatr, V4, P16, DOI 10.1186/1471-2431-4-16
   Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754
   Robinson KA, 2017, MATRIX BIOL, V64, P81, DOI 10.1016/j.matbio.2017.08.004
   Sakurai T, 1997, J CELL BIOL, V136, P907, DOI 10.1083/jcb.136.4.907
   Schiela B, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02177
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Schroder NWJ, 2005, J IMMUNOL, V175, P2534, DOI 10.4049/jimmunol.175.4.2534
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308
   Shin J, 2015, CELL STEM CELL, V17, P360, DOI 10.1016/j.stem.2015.07.013
   Siqueira WL, 2016, BRAZ ORAL RES, V30, DOI 10.1590/1807-3107BOR-2016.vol30.0046
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Teichmann SA, 2000, J MOL BIOL, V296, P1367, DOI 10.1006/jmbi.1999.3497
   Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]
   Useche YM, 2019, J INFECT PUBLIC HEAL, V12, P43, DOI 10.1016/j.jiph.2018.08.009
   Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]
   van der Velde KJ, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1141-7
   Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Weng YC, 2012, ANN NEUROL, V71, P470, DOI 10.1002/ana.22682
   Wojtas AM, 2017, P NATL ACAD SCI USA, V114, pE6962, DOI 10.1073/pnas.1701137114
   Xia JG, 2014, NUCLEIC ACIDS RES, V42, pW167, DOI 10.1093/nar/gku443
   Zhu Zhe, 2017, J Exp Med, V214, P3145, DOI 10.1084/jem.2017109309122017c
   Zou YQ, 2014, HUM MOL GENET, V23, P2339, DOI 10.1093/hmg/ddt627
NR 86
TC 1
Z9 1
U1 0
U2 0
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1945-0877
EI 1937-9145
J9 SCI SIGNAL
JI Sci. Signal.
PD JUN 9
PY 2020
VL 13
IS 635
AR eaay6736
DI 10.1126/scisignal.aay6736
PG 13
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA LY4UD
UT WOS:000540523900001
PM 32518143
DA 2020-12-08
ER

PT J
AU Kasuki, L
   Antunes, X
   Coelho, MCA
   Lamback, EB
   Galvao, S
   Camacho, AHS
   Chimelli, L
   Ventura, N
   Gadelha, MR
AF Kasuki, Leandro
   Antunes, Ximene
   Coelho, Maria Caroline Alves
   Lamback, Elisa Baranski
   Galvao, Sarah
   Silva Camacho, Aline Helen
   Chimelli, Leila
   Ventura, Nina
   Gadelha, Monica R.
TI Accuracy of microcystic aspect on T2-weighted MRI for the diagnosis of
   silent corticotroph adenomas
SO CLINICAL ENDOCRINOLOGY
LA English
DT Article
DE aggressiveness; microcystic pattern; nonfunctioning pituitary adenomas;
   silent corticotropinoma
ID PITUITARY; CLASSIFICATION; TUMORS
AB Introduction A single study suggested that silent corticotropinomas (SCAs) have a different imaging phenotype, with microcystic aspect on T2-weighted sequence of magnetic resonance imaging (T2-MRI). This study only analysed manifest and silent corticotropinomas and nonfunctioning gonadotroph adenomas. Therefore, the prevalence of microcystic patterns of other tumours is not known. Aim To analyse frequency of microcystic patterns on T2-MRI in all subtypes of pituitary adenomas and determine accuracy of this radiological finding for diagnosing SCA. Methods Consecutive pituitary adenoma patients who underwent surgery between 2013 and 2016 at a single centre were included. T2-MRIs were evaluated by a radiologist and an endocrinologist blinded to histological diagnosis. Results A total of 143 patients (52% female) with median age of 49 years (14-80) were included. Clinically, there were 90 nonfunctioning pituitary adenomas (NFPAs), 32 somatotropinomas, 13 corticotropinomas, five prolactinomas and three TSH-secreting adenomas. Of the patients with NFPA, 12 (13%) were SCAs, 73 (79%) were gonadotropinomas and five (6%) were positive for prolactin (three) or TSH (two). A microcystic pattern was observed in 16 tumours (11%): one somatotropinoma, one corticotropinoma, seven SCAs and seven gonadotropinomas, and in no prolactinomas or TSH-secreting adenomas. It was more common in SCAs than in other tumours (58.3% vs 6.9%, respectively, P < .001) and had a sensitivity of 58%, a specificity of 93% and an accuracy of 90% to define an SCA. Conclusion Microcystic aspect on T2-MRI is able to define SCA with a good accuracy and can be a useful tool, considering the more aggressive behaviour of these tumours.
C1 [Kasuki, Leandro; Antunes, Ximene; Coelho, Maria Caroline Alves; Lamback, Elisa Baranski; Galvao, Sarah; Gadelha, Monica R.] Univ Fed Rio de Janeiro, Neuroendocrinol Res Ctr, Endocrinol Sect, Sch Med, Rio De Janeiro, Brazil.
   [Kasuki, Leandro; Antunes, Ximene; Coelho, Maria Caroline Alves; Lamback, Elisa Baranski; Galvao, Sarah; Gadelha, Monica R.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil.
   [Kasuki, Leandro; Gadelha, Monica R.] Inst Estadual Cerebro Paulo Niemeyer, Neuroendocrinol Unit, Secretaria Estadual Saude, Rio De Janeiro, Brazil.
   [Kasuki, Leandro] Hosp Fed Bonsucesso, Endocrine Sect, Rio De Janeiro, Brazil.
   [Silva Camacho, Aline Helen; Chimelli, Leila; Gadelha, Monica R.] Inst Estadual Cerebro Paulo Niemeyer, Neuropathol & Mol Genet Lab, Secretaria Estadual Saude, Rio De Janeiro, Brazil.
   [Ventura, Nina] Inst Estadual Cerebro Paulo Niemeyer, Radiol Unit, Secretaria Estadual Saude, Rio De Janeiro, Brazil.
RP Gadelha, MR (corresponding author), Rua Prof Rodolpho Paulo Rocco 255,9 Andar, BR-21941913 Rio De Janeiro, Brazil.
EM mgadelha@hucff.ufrj.br
OI Gadelha, Monica/0000-0002-9250-3558
CR Antunes X, 2018, ENDOCRINE, V60, P415, DOI 10.1007/s12020-018-1590-8
   Ben-Shlomo A, 2018, PITUITARY, V21, P183, DOI 10.1007/s11102-018-0864-8
   Bradley KJ, 2003, CLIN ENDOCRINOL, V58, P59, DOI 10.1046/j.1365-2265.2003.01674.x
   Cazabat L, 2014, CLIN ENDOCRINOL, V81, P566, DOI 10.1111/cen.12443
   Cho HY, 2010, CLIN ENDOCRINOL, V72, P648, DOI 10.1111/j.1365-2265.2009.03673.x
   Cooper O, 2015, PITUITARY, V18, P225, DOI 10.1007/s11102-014-0624-3
   Cooper Odelia, 2010, Hormones & Cancer, V1, P80, DOI 10.1007/s12672-010-0014-x
   Drummond J, 2019, J CLIN ENDOCR METAB, V104, P2473, DOI 10.1210/jc.2018-00688
   Fountas A, 2019, J CLIN ENDOCR METAB, V104, P1039, DOI 10.1210/jc.2018-01956
   Inoshita N, 2018, BRAIN TUMOR PATHOL, V35, P51, DOI 10.1007/s10014-018-0314-3
   Jahangiri A, 2013, NEUROSURGERY, V73, P8, DOI 10.1227/01.neu.0000429858.96652.1e
   Katznelson L, 2014, J CLIN ENDOCR METAB, V99, P3933, DOI 10.1210/jc.2014-2700
   Manojlovic-Gacic E, 2018, PITUITARY, V21, P119, DOI 10.1007/s11102-017-0855-1
   Melmed S, 2011, J CLIN ENDOCR METAB, V96, P273, DOI 10.1210/jc.2010-1692
   Nieman LK, 2008, J CLIN ENDOCR METAB, V93, P1526, DOI 10.1210/jc.2008-0125
   Ntali G, 2018, PITUITARY, V21, P111, DOI 10.1007/s11102-018-0869-3
   Raverot G, 2010, EUR J ENDOCRINOL, V163, P35, DOI 10.1530/EJE-10-0076
   Saeger W, 2007, EUR J ENDOCRINOL, V156, P203, DOI 10.1530/eje.1.02326
NR 18
TC 2
Z9 2
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0300-0664
EI 1365-2265
J9 CLIN ENDOCRINOL
JI Clin. Endocrinol.
PD FEB
PY 2020
VL 92
IS 2
BP 145
EP 149
DI 10.1111/cen.14133
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA KB7SX
UT WOS:000506691500007
PM 31773787
DA 2020-12-08
ER

PT J
AU Ledur, PF
   Karmirian, K
   Pedrosa, CDG
   Souza, LRQ
   Assis-de-Lemos, G
   Martins, TM
   Ferreira, JDCG
   Reis, GFD
   Silva, ES
   Silva, D
   Salerno, JA
   Ornelas, IM
   Devalle, S
   da Costa, RFM
   Goto-Silva, L
   Higa, LM
   Melo, A
   Tanuri, A
   Chimelli, L
   Murata, MM
   Garcez, PP
   Filippi-Chiela, EC
   Galina, A
   Borges, HL
   Rehen, SK
AF Ledur, Pitia Flores
   Karmirian, Karina
   Gouveia Pedrosa, Carolina da Silva
   Quintino Souza, Leticia Rocha
   Assis-de-Lemos, Gabriela
   Martins, Thiago Martino
   Cavalheiro Gomes Ferreira, Jessica de Cassia
   de Azevedo Reis, Gabriel Ferreira
   Silva, Eduardo Santos
   Silva, Debora
   Salerno, Jose Alexandre
   Ornelas, Isis Moraes
   Devalle, Sylvie
   Madeiro da Costa, Rodrigo Furtado
   Goto-Silva, Livia
   Higa, Luiza Mendonca
   Melo, Adriana
   Tanuri, Amilcar
   Chimelli, Leila
   Murata, Marcos Massao
   Garcez, Patricia Pestana
   Filippi-Chiela, Eduardo Cremonese
   Galina, Antonio
   Borges, Helena Lobo
   Rehen, Stevens Kastrup
TI Zika virus infection leads to mitochondrial failure, oxidative stress
   and DNA damage in human iPSC-derived astrocytes
SO SCIENTIFIC REPORTS
LA English
DT Article
ID UNFOLDED PROTEIN RESPONSE; ENDOTHELIAL-CELLS; BREAK REPAIR; STEM-CELLS;
   BRAIN; GENERATION; DYSFUNCTION; ORGANOIDS; GROWTH
AB Zika virus (ZIKV) has been extensively studied since it was linked to congenital malformations, and recent research has revealed that astrocytes are targets of ZIKV. However, the consequences of ZIKV infection, especially to this cell type, remain largely unknown, particularly considering integrative studies aiming to understand the crosstalk among key cellular mechanisms and fates involved in the neurotoxicity of the virus. Here, the consequences of ZIKV infection in iPSC-derived astrocytes are presented. Our results show ROS imbalance, mitochondrial defects and DNA breakage, which have been previously linked to neurological disorders. We have also detected glial reactivity, also present in mice and in post-mortem brains from infected neonates from the Northeast of Brazil. Given the role of glia in the developing brain, these findings may help to explain the observed effects in congenital Zika syndrome related to neuronal loss and motor deficit.
C1 [Ledur, Pitia Flores; Karmirian, Karina; Gouveia Pedrosa, Carolina da Silva; Quintino Souza, Leticia Rocha; Salerno, Jose Alexandre; Ornelas, Isis Moraes; Devalle, Sylvie; Madeiro da Costa, Rodrigo Furtado; Goto-Silva, Livia; Rehen, Stevens Kastrup] DOr Inst Res & Educ, Rio De Janeiro, Brazil.
   [Karmirian, Karina; Martins, Thiago Martino; Cavalheiro Gomes Ferreira, Jessica de Cassia; Salerno, Jose Alexandre; Garcez, Patricia Pestana; Borges, Helena Lobo; Rehen, Stevens Kastrup] Fed Univ Rio de Janeiro UFRJ, Inst Biomed Sci, Rio De Janeiro, RJ, Brazil.
   [Assis-de-Lemos, Gabriela; Galina, Antonio] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo De Meis, Rio De Janeiro, RJ, Brazil.
   [de Azevedo Reis, Gabriel Ferreira; Silva, Eduardo Santos; Murata, Marcos Massao] State Univ Rio de Janeiro UERJ, Dept Biophys & Biometr, Insitute Biol, Rio De Janeiro, RJ, Brazil.
   [Silva, Debora; Chimelli, Leila] State Inst Brain Paulo Niemeyer, Lab Neuropathol, Rio De Janeiro, RJ, Brazil.
   [Higa, Luiza Mendonca; Tanuri, Amilcar] Fed Univ Rio de Janeiro UFRJ, Inst Biol, Rio De Janeiro, RJ, Brazil.
   [Filippi-Chiela, Eduardo Cremonese] Fed Univ Rio Grande do Sul UFRGS, Inst Hlth Sci, Porto Alegre, RS, Brazil.
   [Melo, Adriana] Res Inst Prof Joaquim Amorim Neto IPESQ, Campina Grande, Paraiba, Brazil.
RP Rehen, SK (corresponding author), DOr Inst Res & Educ, Rio De Janeiro, Brazil.; Rehen, SK (corresponding author), Fed Univ Rio de Janeiro UFRJ, Inst Biomed Sci, Rio De Janeiro, RJ, Brazil.
EM srehen@lance-ufrj.org
RI Higa, Luiza/W-2698-2019; Borges, Helena/W-7533-2019; de Lemos, Gabriela
   A/C-1743-2019; Borges, Helena L/E-5044-2013; Filippi-Chiela,
   Eduardo/F-1959-2014; Rehen, Stevens K/J-5874-2012; Borges,
   Helena/AAG-3701-2020; Garcez, Patricia/F-8026-2012
OI Borges, Helena/0000-0003-2866-4223; de Lemos, Gabriela
   A/0000-0002-2804-3163; Borges, Helena L/0000-0003-2866-4223;
   Filippi-Chiela, Eduardo/0000-0001-8192-3779; Rehen, Stevens
   K/0000-0003-4216-9501; Garcez, Patricia/0000-0002-9107-1335; Salerno,
   Jose Alexandre/0000-0003-0511-7083
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [440909/2016-3, 441096/2016-6]; CAPESCAPES [440909/2016-3,
   88887.116625/2016-01]; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [E-26/201.340/2016,
   E-26/201.319/2016]; FINEPCiencia Tecnologia e Inovacao (FINEP)
   [01.08.0657.00, 01.12.0161.00]; BNDES [10.2.0051.1]; D'Or Institute for
   Research and Education
FX This project was supported by grants from CNPq (grant numbers
   440909/2016-3 and 441096/2016-6), CAPES (grant numbers
   88887.116625/2016-01 and 440909/2016-3), FAPERJ (grant numbers
   E-26/201.340/2016 and E-26/201.319/2016), FINEP (grant numbers
   01.08.0657.00 and 01.12.0161.00) and BNDES (grant number 10.2.0051.1),
   in addition to intramural grants from D'Or Institute for Research and
   Education. We thank Ismael Carlos da Silva Gomes, Marcelo do Nascimento
   Costa, Gabriela Lopes Vitoria and Severino Galdino from D'Or Institute
   for Research and Education for technical support, and Daniel Cadilhe,
   Pablo Trindade, Pablo Leal Cardozo and Erick Correia Loiola for
   scientific discussions and input.
CR Bender C., 2012, ASTROCYTES STRUCTURE, P109, DOI 10.13140/2.1.4745.8243
   Bhat AH, 2015, BIOMED PHARMACOTHER, V74, P101, DOI 10.1016/j.biopha.2015.07.025
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Casas BS, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0095-9
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chandler AL, 2012, BIRTH DEFECTS RES A, V94, P864, DOI 10.1002/bdra.23068
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Souza IND, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2749
   Desler Claus, 2012, J Aging Res, V2012, P192503, DOI 10.1155/2012/192503
   Devhare P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.517
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Filippi-Chiela EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042522
   Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gladwyn-Ng I, 2018, NAT NEUROSCI, V21, P63, DOI 10.1038/s41593-017-0038-4
   Gnaiger E, 2012, MITOCHONDRIAL PATHWA
   Gullberg RC, 2015, VIROLOGY, V475, P219, DOI 10.1016/j.virol.2014.10.037
   Guo CY, 2013, NEURAL REGEN RES, V8, P2003, DOI 10.3969/j.issn.1673-5374.2013.21.009
   Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015
   Jheng JR, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00388
   Jorgacevski J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44559-8
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kuo LJ, 2008, IN VIVO, V22, P305
   Lambrus BG, 2016, J CELL BIOL, V214, P143, DOI 10.1083/jcb.201604054
   Li G, 2017, P NATL ACAD SCI USA, V114, pE376, DOI 10.1073/pnas.1619735114
   Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006
   Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Madigan CA, 2017, CELL, V170, P973, DOI 10.1016/j.cell.2017.07.030
   Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018
   Medvedev R, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9012580
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112
   Morgan WF, 1998, MUTAT RES-FUND MOL M, V404, P125, DOI 10.1016/S0027-5107(98)00104-3
   Mulkey SB, 2020, JAMA PEDIATR, V174, P269, DOI 10.1001/jamapediatrics.2019.5204
   Nakamura AJ, 2010, CELL CYCLE, V9, P389, DOI 10.4161/cc.9.2.10475
   Nigg EA, 2018, NAT REV MOL CELL BIO, V19, P297, DOI 10.1038/nrm.2017.127
   O'Driscoll M, 2008, DNA REPAIR, V7, P1039, DOI 10.1016/j.dnarep.2008.03.018
   Offerdahl DK, 2017, VIROLOGY, V501, P54, DOI 10.1016/j.virol.2016.11.002
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Ouyang YB, 2011, MITOCHONDRION, V11, P279, DOI 10.1016/j.mito.2010.10.007
   Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719
   Phatnani H, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020628
   Potokar M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030691
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Reemst K, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3339/fnhum.2016.00566
   Reid CR, 2015, VIRUSES-BASEL, V7, P4385, DOI 10.3390/v7082825
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Ryan EL, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010002
   Schneider L, 2012, CELL DEATH DIFFER, V19, P582, DOI 10.1038/cdd.2011.129
   Schreiner B, 2015, CELL REP, V12, P1377, DOI 10.1016/j.celrep.2015.07.051
   Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870
   Sher AA, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00596
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Sochacki J, 2016, STEM CELL RES, V17, P107, DOI 10.1016/j.scr.2016.05.018
   Sochacki J, 2016, STEM CELL RES, V17, P97, DOI 10.1016/j.scr.2016.05.017
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Stefanik M, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0407-2
   Trindade P., 2019, BIORXIV, P1, DOI [10.1101/722017, DOI 10.1101/722017]
   van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049
   Vitale I, 2011, CELL DEATH DIFFER, V18, P1403, DOI 10.1038/cdd.2010.145
   Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115
   Wang J, 2018, BIOCHEM BIOPH RES CO, V497, P619, DOI 10.1016/j.bbrc.2018.02.118
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wu JX, 2010, PROTEIN CELL, V1, P117, DOI 10.1007/s13238-010-0010-5
   Yan YP, 2013, STEM CELL TRANSL MED, V2, P1022, DOI [10.5966/sctm.2013-0080erratum, 10.5966/sctm.2013-0080]
   Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06
   Zhang XP, 2009, P NATL ACAD SCI USA, V106, P12245, DOI 10.1073/pnas.0813088106
   Zody MC, 2006, NATURE, V440, P1045, DOI 10.1038/nature04689
NR 86
TC 5
Z9 5
U1 1
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 27
PY 2020
VL 10
IS 1
AR 1218
DI 10.1038/s41598-020-57914-x
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LY2JT
UT WOS:000540347100001
PM 31988337
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Barbeito-Andres, J
   Pezzuto, P
   Higa, LM
   Dias, AA
   Vasconcelos, JM
   Santos, TMP
   Ferreira, JCCG
   Ferreira, RO
   Dutra, FF
   Rossi, AD
   Barbosa, RV
   Amorim, CKN
   De Souza, MPC
   Chimelli, L
   Aguiar, RS
   Gonzalez, PN
   Lara, FA
   Castro, MC
   Molnar, Z
   Lopes, RT
   Bozza, MT
   Vianez, JLSG
   Barbeito, CG
   Cuervo, P
   Bellio, M
   Tanuri, A
   Garcez, PP
AF Barbeito-Andres, J.
   Pezzuto, P.
   Higa, L. M.
   Dias, A. A.
   Vasconcelos, J. M.
   Santos, T. M. P.
   Ferreira, J. C. C. G.
   Ferreira, R. O.
   Dutra, F. F.
   Rossi, A. D.
   Barbosa, R., V
   Amorim, C. K. N.
   De Souza, M. P. C.
   Chimelli, L.
   Aguiar, R. S.
   Gonzalez, P. N.
   Lara, F. A.
   Castro, M. C.
   Molnar, Z.
   Lopes, R. T.
   Bozza, M. T.
   Vianez, J. L. S. G.
   Barbeito, C. G.
   Cuervo, P.
   Bellio, M.
   Tanuri, A.
   Garcez, P. P.
TI Congenital Zika syndrome is associated with maternal protein
   malnutrition
SO SCIENCE ADVANCES
LA English
DT Article
ID INFECTION; NUTRITION; GROWTH; MODEL; MICE
AB Zika virus (ZIKV) infection during pregnancy is associated with a spectrum of developmental impairments known as congenital Zika syndrome (CZS). The prevalence of this syndrome varies across ZIKV endemic regions, suggesting that its occurrence could depend on cofactors. Here, we evaluate the relevance of protein malnutrition for the emergence of CZS. Epidemiological data from the ZIKV outbreak in the Americas suggest a relationship between undernutrition and cases of microcephaly. To experimentally examine this relationship, we use immunocompetent pregnant mice, which were subjected to protein malnutrition and infected with a Brazilian ZIKV strain. We found that the combination of protein restriction and ZIKV infection leads to severe alterations of placental structure and embryonic body growth, with offspring displaying a reduction in neurogenesis and postnatal brain size. RNA-seq analysis reveals gene expression deregulation required for brain development in infected low-protein progeny. These results suggest that maternal protein malnutrition increases susceptibility to CZS.
C1 [Barbeito-Andres, J.; Ferreira, J. C. C. G.; Ferreira, R. O.; Garcez, P. P.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Barbeito-Andres, J.; Gonzalez, P. N.] Consejo Nacl Invest Cient & Tecn, Inst Studies Neurosci & Complex Syst ENyS, Buenos Aires, DF, Argentina.
   [Pezzuto, P.; Higa, L. M.; Rossi, A. D.; Aguiar, R. S.; Tanuri, A.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [Dias, A. A.; Dutra, F. F.; Bozza, M. T.; Bellio, M.] Univ Fed Rio de Janeiro, Microbiol Inst Paulo de Goes, Rio De Janeiro, Brazil.
   [Vasconcelos, J. M.] Fed Univ Para, Biol Sci Inst, Belem, Para, Brazil.
   [Santos, T. M. P.; Lopes, R. T.] Univ Fed Rio de Janeiro, Nucl Instrumentat Lab, Rio De Janeiro, Brazil.
   [Barbosa, R., V] CENABIO Natl Ctr Struct Biol & Bioimaging, Rio De Janeiro, Brazil.
   [Amorim, C. K. N.; De Souza, M. P. C.; Vianez, J. L. S. G.] Evandro Chagas Inst, Technol Innovat Ctr, Ananindeua, Brazil.
   [Chimelli, L.] State Inst Brain Paulo Niemeyer, Rio De Janeiro, Brazil.
   [Lara, F. A.; Cuervo, P.] Fiocruz MS, Oswaldo Cruz Inst, Rio De Janeiro, Brazil.
   [Castro, M. C.] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA.
   [Molnar, Z.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.
   [Barbeito, C. G.] Natl Univ La Plata, Fac Vet Sci, Buenos Aires, DF, Argentina.
RP Garcez, PP (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
EM ppgarcez@icb.ufrj.br
RI Aguiar, Renato S/G-3542-2015; Rossi, Atila Duque/AAV-6079-2020; Cuervo,
   Patricia/Y-6048-2019; Higa, Luiza/W-2698-2019; Barbeito,
   Claudio/AAM-5227-2020; Ferreira, Raiane/AAZ-5987-2020; BELLIO,
   MARIA/N-8525-2018; Garcez, Patricia/F-8026-2012
OI Aguiar, Renato S/0000-0001-5180-3717; Rossi, Atila
   Duque/0000-0001-6235-8807; Cuervo, Patricia/0000-0002-6245-4185;
   Barbeito, Claudio/0000-0001-9459-138X; BELLIO,
   MARIA/0000-0002-3360-2740; Molnar, Zoltan/0000-0002-6852-6004; Alves
   Dias, Andre/0000-0002-6437-2773; Garcez, Patricia/0000-0002-9107-1335
FU MRC Zika Rapid Response Grant [MC_PC_15102]; FAPERJCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E_03/2017E_03/2017]; Brazilian Ministry of Health [DSAST/SVS
   25380.001612/2017-70]; AAPA Professional Development Grant
FX This work was funded by the MRC Zika Rapid Response Grant (MC_PC_15102),
   FAPERJ (E_03/2017E_03/2017), the Brazilian Ministry of Health (DSAST/SVS
   25380.001612/2017-70), and the AAPA Professional Development Grant.
CR Barbeito-Andres J, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006592
   CAIRESJUNIOR LC, 2018, NAT COMM, V0009
   Carvalho-Sauer R, 2019, INT J INFECT DIS, V82, P44, DOI 10.1016/j.ijid.2019.02.040
   CHANDRA RK, 1992, J NUTR, V122, P754, DOI 10.1093/jn/122.suppl_3.754
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   de Souza WV, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5039-z
   Dobin A., 2015, CURRENT PROTOCOLS BI
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gonzalez PN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152227
   Hedrich A, 2007, VER SALUS GAURAUPUA, V1, P139
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Institute of Medicine Food and Nutrition Board., 2005, DIETARY REFERENCE IN
   Instituto Brasileiro de Geografia e Estatistica, 2015, IND SOC POP BRAS
   Katona P, 2008, CLIN INFECT DIS, V46, P1582, DOI 10.1086/587658
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Losada-Barragan M, 2017, SCI REP-UK, V7, DOI 10.1038/srep45991
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Luo HC, 2017, ONCOTARGET, V8, P81295, DOI 10.18632/oncotarget.18333
   Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mourao Junior C. A., 2016, REV EXTENDERE, V4, P85
   Moussaud S, 2010, J NEUROSCI METH, V187, P243, DOI 10.1016/j.jneumeth.2010.01.017
   Naylor C, 2016, TRENDS MOL MED, V22, P88, DOI 10.1016/j.molmed.2015.12.001
   Paul AM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02028
   Prata-Barbos A, 2019, J PEDIAT-BRAZIL, V95, pS30, DOI 10.1016/j.jped.2018.10.016
   R Foundation for Statistical Computing, 2013, LANG ENV STAT COMP
   Rathore APS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav3208
   REVILLARD JP, 1990, FOOD ADDIT CONTAM, V7, pS82, DOI 10.1080/02652039009373853
   Rogers I, 1998, EUR J CLIN NUTR, V52, P246, DOI 10.1038/sj.ejcn.1600543
   Rosen S., 2008, FOOD SECURITY ASSESS
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Schmidt CO, 2008, INT J PUBLIC HEALTH, V53, P165, DOI 10.1007/s00038-008-7068-3
   Silva Gomes V. T., 2015, REV INTERDISCIP, V8, P127
   Szaba FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006994
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4
   Weger-Lucarelli J, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006247
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xavier-Neto J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005363
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
NR 47
TC 4
Z9 4
U1 1
U2 2
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 2375-2548
J9 SCI ADV
JI Sci. Adv.
PD JAN
PY 2020
VL 6
IS 2
AR eaaw6284
DI 10.1126/sciadv.aaw6284
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA KD0JH
UT WOS:000507557500004
PM 31950075
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Verdolin, AD
   Lamback, EB
   Ventura, N
   Guasti, A
   Pereira, PJD
   Gadelha, MR
   Chimelli, L
AF de Almeida Verdolin, Annelise
   Lamback, Elisa Baranski
   Ventura, Nina
   Guasti, Andre
   da Mata Pereira, Paulo Jose
   Gadelha, Monica R.
   Chimelli, Leila
TI Collision sellar lesions: coexistence of pituitary adenoma and Rathke
   cleft cyst-a single-center experience
SO ENDOCRINE
LA English
DT Article
DE Pituitary adenoma; Rathke cleft cyst; Collision sellar lesions; Cystic
   sellar lesions; Cholesterol crystals
ID REGION; TUMOR
AB Purpose Collision sellar lesions represent the coexistence of distinct histopathological lesions found in the sella turcica. They are uncommon entities and have mainly been reported as pituitary adenoma (PA) associated to Rathke cleft cyst (RCC). Pre- and perioperative diagnosis is difficult, since most of the cases appear clinically, radiologically, and macroscopically as solitary cystic sellar lesion. Methods A retrospective study of histological reports from patients operated for PA from 2013 to 2018 in a single neurosurgery reference center was performed. Patients who also exhibited RCC in the histological sections were included. Clinical and biochemical data were collected from medical files. MRI scans and histopathological slides were also reviewed. Results Among 554 PA, five patients (0.9%) presented the association of PA and RCC. At diagnosis, patients had median age of 60 years (33-78) with, at least, one pituitary dysfunction, and visual field loss and/or headache. There was a female predominance (n = 3). All patients had nonfunctioning PA. MRI studies showed a predominantly cystic lesion and were unable to distinguish both lesions. The definitive diagnosis was made by histopathology. Conclusion The association of PA and RCC is extremely rare. On MRI, they appear as a solid-cystic or cystic sellar tumors. RCC can rupture causing granulomatous reaction with cholesterol crystal formation, which can be mistaken for craniopharyngiomas during surgery. Therefore, collision sellar lesion must be included in the differential diagnosis of cystic sellar lesions. The definitive diagnosis is made by histological study.
C1 [de Almeida Verdolin, Annelise] Inst Nacl Canc, Div Pathol, Rio De Janeiro, Brazil.
   [Lamback, Elisa Baranski; Gadelha, Monica R.] Univ Fed Rio de Janeiro, Sch Med, Div Endocrinol, Neuroendocrinol Res Ctr, Rio De Janeiro, Brazil.
   [Lamback, Elisa Baranski; Gadelha, Monica R.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil.
   [Ventura, Nina] Inst Estadual Cerebro Paulo Niemeyer, Div Radiol, Rio De Janeiro, Brazil.
   [Guasti, Andre; da Mata Pereira, Paulo Jose] Inst Estadual Cerebro Paulo Niemeyer, Neurosurg Div, Rio De Janeiro, Brazil.
   [Gadelha, Monica R.] Inst Estadual Cerebro Paulo Niemeyer, Neuroendocrinol Div, Rio De Janeiro, Brazil.
   [Gadelha, Monica R.; Chimelli, Leila] Inst Estadual Cerebro Paulo Niemeyer, Neuropathol & Mol Genet Lab, Rua Resende 156 Ctr, BR-20231092 Rio De Janeiro, Brazil.
RP Chimelli, L (corresponding author), Inst Estadual Cerebro Paulo Niemeyer, Neuropathol & Mol Genet Lab, Rua Resende 156 Ctr, BR-20231092 Rio De Janeiro, Brazil.
EM leila.chimelli@gmail.com
CR Amano K, 2013, BRAIN TUMOR PATHOL, V30, P233, DOI 10.1007/s10014-012-0130-0
   Andrysiak-Mamos E, 2018, ENDOKRYNOL POL, V69, P212, DOI 10.5603/EP.2018.0023
   Babu Ranjith, 2013, Asian J Neurosurg, V8, P183, DOI 10.4103/1793-5482.125662
   Bader Lucas J, 2004, Pituitary, V7, P39, DOI 10.1023/B:PITU.0000044632.15978.44
   Bresson D, 2016, OTOLARYNG CLIN N AM, V49, P63, DOI 10.1016/j.otc.2015.09.004
   Byun WM, 2000, AM J NEURORADIOL, V21, P485
   Gessler Florian, 2011, Skull Base Rep, V1, P99, DOI 10.1055/s-0031-1280737
   GIUFFRE R, 1968, NEUROCHIRURGIA, V11, P81
   HIYAMA H, 1986, Neurological Surgery, V14, P435
   IKEDA H, 1987, Neurological Surgery, V15, P999
   Jagtap Varsha S, 2018, J Assoc Physicians India, V66, P42
   Karavitaki N, 2008, PITUITARY, V11, P317, DOI 10.1007/s11102-007-0070-6
   Kleinschmidt-DeMasters BK, 2015, ARCH PATHOL LAB MED, V139, P356, DOI 10.5858/arpa.2014-0020-OA
   Koutourousiou M, 2010, PITUITARY, V13, P8, DOI 10.1007/s11102-009-0190-2
   KURISAKA M, 1982, Neurologia Medico-Chirurgica, V22, P453, DOI 10.2176/nmc.22.453
   Li GH, 2018, MOL CLIN ONCOL, V8, P445, DOI 10.3892/mco.2018.1547
   MATSUMORI K, 1984, Neurological Surgery, V12, P833
   MESSIMY R, 1955, Rev Neurol (Paris), V92, P235
   Miyagi Atsushi, 1993, Neurologia Medico-Chirurgica, V33, P643, DOI 10.2176/nmc.33.643
   NAKASU S, 1989, SURG NEUROL, V31, P41, DOI 10.1016/0090-3019(89)90216-4
   NISHIO S, 1995, BRIT J NEUROSURG, V9, P51, DOI 10.1080/02688699550041755
   NISHIO S, 1987, NEUROSURGERY, V21, P371, DOI 10.1227/00006123-198709000-00016
   Noh SJ, 2007, ACTA NEUROCHIR, V149, P1223, DOI 10.1007/s00701-007-1295-x
   PEARL GS, 1981, AM J SURG PATHOL, V5, P85, DOI 10.1097/00000478-198101000-00012
   Rahmani R, 2015, J NEUROSURG, V122, P812, DOI 10.3171/2014.12.JNS14542
   Saeger W, 2007, PATHOL RES PRACT, V203, P221, DOI 10.1016/j.prp.2006.12.011
   SHUANGSHOTI S, 1970, ARCH PATHOL, V90, P444
   Sumida M, 2001, NEURORADIOLOGY, V43, P755, DOI 10.1007/s002340100559
   SWANSON SE, 1985, NEUROSURGERY, V17, P657, DOI 10.1227/00006123-198510000-00022
   Tamura R, 2015, CASE REP NEUROL MED, DOI 10.1155/2015/948025
   TROKOUDES KM, 1978, JAMA-J AM MED ASSOC, V240, P471, DOI 10.1001/jama.240.5.471
   Vancura RW, 2006, ARCH PATHOL LAB MED, V130, P403
   Yokoyama S, 1998, ENDOCR PATHOL, V9, P91, DOI 10.1007/BF02739956
   Zhou PZ, 2012, NEUROL INDIA, V60, P665, DOI 10.4103/0028-3886.105217
NR 34
TC 3
Z9 3
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1355-008X
EI 1559-0100
J9 ENDOCRINE
JI Endocrine
PD APR
PY 2020
VL 68
IS 1
BP 174
EP 181
DI 10.1007/s12020-019-02149-8
EA DEC 2019
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA LE6CS
UT WOS:000500614900001
PM 31802354
DA 2020-12-08
ER

PT J
AU Souza, INDO
   Frost, P
   Franca, J
   Nascimento-Viana, J
   Neris, R
   Nogueira, C
   Neves, G
   Chimelli, L
   De-Felice, F
   Ferreira, S
   Assuncao-Miranda, I
   Figueiredo, C
   Poian, AD
   Clarke, J
AF Souza, I. N. D. O.
   Frost, P.
   Franca, J.
   Nascimento-Viana, J.
   Neris, R.
   Nogueira, C.
   Neves, G.
   Chimelli, L.
   De-Felice, F.
   Ferreira, S.
   Assuncao-Miranda, I.
   Figueiredo, C.
   Poian, A. D.
   Clarke, J.
TI Acute and chronic neurological consequences of neonatal zika virus
   infection in mice
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
CT Joint Meeting of the International-Society-for-Neurochemistry and
   American-Society-for-Neurochemistry (ISN-ASN)
CY AUG 04-08, 2019
CL Montreal, CANADA
SP Int Soc Neurochemistry, Amer Soc Neurochemistry
C1 [Souza, I. N. D. O.; Frost, P.; Nascimento-Viana, J.; Nogueira, C.; Figueiredo, C.; Clarke, J.] Univ Fed Rio de Janeiro, Fac Pharm, Rio De Janeiro, Brazil.
   [Frost, P.; Franca, J.; Neves, G.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Neris, R.; Assuncao-Miranda, I.] Univ Fed Rio de Janeiro, Inst Microbiol, Rio De Janeiro, Brazil.
   [Chimelli, L.] State Inst Brain, Neuropathol Lab, Rio De Janeiro, Brazil.
   [De-Felice, F.; Ferreira, S.; Poian, A. D.] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, Brazil.
   [De-Felice, F.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.
   [Ferreira, S.] Univ Fed Rio de Janeiro, Inst Biophys, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD JUL
PY 2019
VL 150
SU 1
SI SI
MA MTU05-06
BP 105
EP 105
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA IN4IY
UT WOS:000478639800238
DA 2020-12-08
ER

PT J
AU Azevedo, EP
   Guimaraes-Costa, AB
   Bandeira-Melo, C
   Chimelli, L
   Waddington-Cruz, M
   Saraiva, EM
   Palhano, FL
   Foguel, D
AF Azevedo, Estefania P.
   Guimaraes-Costa, Anderson B.
   Bandeira-Melo, Christianne
   Chimelli, Leila
   Waddington-Cruz, Marcia
   Saraiva, Elvira M.
   Palhano, Fernando L.
   Foguel, Debora
TI Inflammatory profiling of patients with familial amyloid polyneuropathy
SO BMC NEUROLOGY
LA English
DT Article
DE Amyloid; Transthyretin; Biomarkers; Cytokines; Familial amyloid
   polyneuropathy
ID TRANSTHYRETIN AMYLOIDOSIS; MOUSE MODEL; EXPRESSION; VAL30MET; RELEASE;
   STRESS; TARGET
AB BackgroundFamilial amyloid polyneuropathy (FAP) or ATTRv (amyloid TTR variant) amyloidosis is a fatal hereditary disease characterized by the deposition of amyloid fibrils composed of transthyretin (TTR). The current diagnosis of ATTRv relies on genetic identification of TTR mutations and on Congo Red-positive amyloid deposits, which are absent in most ATTRv patients that are asymptomatic or early symptomatic, supporting the need for novel biomarkers to identify patients in earlier disease phases allowing disease control.MethodsIn an effort to search for new markers for ATTRv, our group searched for nine inflammation markers in ATTRv serum from a cohort of 28 Brazilian ATTRv patients.ResultsWe found that the levels of six markerswere increased (TNF-, IL-1, IL-8, IL-33, IFN- and IL-10), one had decreased levels (IL-12) and two of them were unchanged (IL-6 and cortisol). Interestingly, asymptomatic patients already presented high levels of IL-33, IL-1 and IL-10, suggesting that inflammation may take place before fibril deposition.ConclusionsOur findings shed light on a new, previously unidentified aspect of ATTRv, which might help define new criteria for disease management, as well as provide additional understanding of ATTRv aggressiveness.
C1 [Azevedo, Estefania P.; Palhano, Fernando L.; Foguel, Debora] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Rio De Janeiro, Brazil.
   [Guimaraes-Costa, Anderson B.; Saraiva, Elvira M.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Rio De Janeiro, Brazil.
   [Bandeira-Melo, Christianne] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.
   [Chimelli, Leila] Univ Fed Rio de Janeiro, Serv Anat Patol, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil.
   [Waddington-Cruz, Marcia] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Serv Neurol, Rio De Janeiro, Brazil.
RP Foguel, D (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Rio De Janeiro, Brazil.
EM estefania@bioqmed.ufrj.br; foguel@bioqmed.ufrj.br
RI de Melo, Christianne Bandeira/B-7724-2009; Costa, Anderson G.
   B./K-1059-2012
OI de Melo, Christianne Bandeira/0000-0003-3305-3865; Costa, Anderson G.
   B./0000-0003-4582-1980
FU Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES)CAPES; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq)
FX We also thank the funding agencies Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPq). Funding Agencies had
   no role in the design of the study; collection, analysis, and
   interpretation of data; and in writing the manuscript.
CR Azevedo EPC, 2012, J BIOL CHEM, V287, P37206, DOI 10.1074/jbc.M112.369942
   Azevedo EPC, 2011, BIOCHEMISTRY-US, V50, P11070, DOI 10.1021/bi201365r
   Benson MD, 2013, MUSCLE NERVE, V47, P157, DOI 10.1002/mus.23521
   Buxbaum JN, 2012, FASEB J, V26, P2283, DOI 10.1096/fj.11-189571
   Cai DS, 2011, ANN NY ACAD SCI, V1243, pE1, DOI 10.1111/j.1749-6632.2011.06388.x
   Coelho Teresa, 1993, Journal of Rheumatology, V20, P179
   Coelho T, 2013, J NEUROL, V260, P2802, DOI 10.1007/s00415-013-7051-7
   Coutinho P, 1980, AMYLOID AMYLOIDOSIS, P88
   Dohrn MF, 2013, J NEUROL, V260, P3093, DOI 10.1007/s00415-013-7124-7
   Eskan MA, 2008, INFECT IMMUN, V76, P2080, DOI 10.1128/IAI.01428-07
   Ethuin F, 2001, J LEUKOCYTE BIOL, V70, P439
   Gertz MA, 2015, J AM COLL CARDIOL, V66, P2451, DOI 10.1016/j.jacc.2015.09.075
   Goncalves NP, 2014, AMYLOID, V21, P175, DOI 10.3109/13506129.2014.927759
   Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107
   Helk E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003096
   Hund E, 2012, APPL CLIN GENET, V5, P37, DOI 10.2147/TACG.S19903
   King Shirley L, 2002, Biol Res Nurs, V4, P92, DOI 10.1177/1099800402238334
   Koike H, 2008, J NEUROL NEUROSUR PS, V79, P1171, DOI 10.1136/jnnp.2007.135681
   Koike H, 2002, ARCH NEUROL-CHICAGO, V59, P1771, DOI 10.1001/archneur.59.11.1771
   Koike H, 2012, J NEUROL NEUROSUR PS, V83, P152, DOI 10.1136/jnnp-2011-301299
   Kurian SM, 2016, THERANOSTICS, V6, P1792, DOI 10.7150/thno.14584
   Liaskou E, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/949157
   Llado L, 2010, LIVER TRANSPLANT, V16, P1386, DOI 10.1002/lt.22174
   Lopes A, 2018, J COMMUN GENET, V9, P93, DOI 10.1007/s12687-017-0338-0
   Malireddi RKS, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00077
   Mathey EK, 1999, J NEUROL SCI, V163, P47, DOI 10.1016/S0022-510X(99)00009-X
   Nunes AF, 2005, FASEB J, V19, P166, DOI 10.1096/fj.05-4106fje
   Oishi Y, 2017, CELL METAB, V25, P412, DOI 10.1016/j.cmet.2016.11.009
   Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312
   Plante-Bordeneuve V, 2011, LANCET NEUROL, V10, P1086, DOI 10.1016/S1474-4422(11)70246-0
   Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101
   Saporta MAC, 2009, EUR J NEUROL, V16, P337, DOI 10.1111/j.1468-1331.2008.02429.x
   Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034
   Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018
   Sequeiros J, 1991, AMYLOID AMYLOIDOSIS
   Singer M, 2004, J IMMUNOL, V173, P4197, DOI 10.4049/jimmunol.173.6.4197
   Sousa MM, 2001, J NEUROSCI, V21, P7576
   Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664
   Verri WA, 2010, ANN RHEUM DIS, V69, P1697, DOI 10.1136/ard.2009.122655
   Wu Y, 2013, J ENDOCRINOL, V219, P195, DOI 10.1530/JOE-13-0160
   Zhang XQ, 2014, WORLD J GASTROENTERO, V20, P1768, DOI 10.3748/wjg.v20.i7.1768
NR 41
TC 2
Z9 2
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2377
J9 BMC NEUROL
JI BMC Neurol.
PD JUN 28
PY 2019
VL 19
AR 146
DI 10.1186/s12883-019-1369-4
PG 7
WC Clinical Neurology
SC Neurosciences & Neurology
GA IF5UO
UT WOS:000473148100002
PM 31253122
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Alves-Leon, SV
   Lima, MD
   Nunes, PCG
   Chimelli, LMC
   Rabelo, K
   Nogueira, RMR
   de Bruycker-Nogueira, F
   de Azeredo, EL
   Bahia, PR
   Lopes, FCR
   de Souza, JPBM
   Fontes-Dantas, FL
   Paes, MV
   Lemos, ERS
   Santos, FB
AF Alves-Leon, Soniza Vieira
   Lima, Monique da Rocha
   Guerra Nunes, Priscila Conrado
   Cardao Chimelli, Leila Maria
   Rabelo, Kissila
   Ribeiro Nogueira, Rita Maria
   de Bruycker-Nogueira, Fernanda
   de Azeredo, Elzinandes Leal
   Bahia, Paulo Roberto
   Rueda Lopes, Fernanda Cristina
   Barreto Marcondes de Souza, Jorge P.
   Fontes-Dantas, Fabricia Lima
   Paes, Marciano Viana
   Lemos, Elba R. S.
   Santos, Flavia Barreto
TI Zika virus found in brain tissue of a multiple sclerosis patient
   undergoing an acute disseminated encephalomyelitis-like episode
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Article
DE Multiple sclerosis; Zika virus; acute disseminated encephalomyelitis;
   differential diagnosis; immunotherapy
AB Background: A range of different neurological manifestations has been reported in fetuses and adults after Zika virus (ZIKV) infection.
   Objective: We describe a detection of the ZIKV in the brain tissue from a multiple sclerosis (MS) patient with acute disseminated encephalomyelitis (ADEM)-like event in Rio de Janeiro, Brazil.
   Methods: Biological samples collected during the hospitalization were tested by serology and molecular diagnostic for various infectious agents. Histopathological analysis was performed using the anti-flavivirus group 4G2 monoclonal antibody, anti-ZIKV non-structural 1 (NS1) monoclonal antibody, and anti-CD4, CD8, and CD11b antibodies.
   Results: Anti-ZIKV IgM and IgG antibodies were positive in the serum and urine. A brain biopsy showed ZIKV protein in brain cells and T CD8 infiltration in brain tissue.
   Conclusion: Our data describe the coexistence of a recent central nervous system (CNS) ZIKV infection accompanied by a severe ADEM-like syndrome outcome in a patient with clinical history of MS. A de novo immune response concomitant with ZIKV infection might be involved in the mechanism of the ADEM-like syndrome and response to immunotherapy. The present report reinforces the importance of providing the differential diagnosis of acute episodes of MS exacerbation in an environment prone to ZIKV expression.
C1 [Alves-Leon, Soniza Vieira; Bahia, Paulo Roberto; Rueda Lopes, Fernanda Cristina] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, SNC, Ctr Referencia & Pesquisa Esclerose Multipla & Ou, Rio De Janeiro, Brazil.
   [Alves-Leon, Soniza Vieira; Barreto Marcondes de Souza, Jorge P.; Fontes-Dantas, Fabricia Lima] Univ Fed Estado Rio de Janeiro UNIRIO, Programa Posgrad Neurol, Rio De Janeiro, Brazil.
   [Lima, Monique da Rocha; Guerra Nunes, Priscila Conrado; de Bruycker-Nogueira, Fernanda; de Azeredo, Elzinandes Leal; Santos, Flavia Barreto] Fundacao Oswaldo Cruz FIOCRUZ, Inst Oswaldo Cruz, Lab Imunol Viral, Rio De Janeiro, Brazil.
   [Cardao Chimelli, Leila Maria] Inst Estadual Cerebro Paulo Niemeyer, Lab Neuropatol, Rio De Janeiro, Brazil.
   [Rabelo, Kissila] Univ Estado Rio de Janeiro UNIRIO, Lab Ultraestrutura & Biol Tecidual, Rio De Janeiro, Brazil.
   [Ribeiro Nogueira, Rita Maria] Fundacao Oswaldo Cruz FIOCRUZ, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Paes, Marciano Viana] Fundacao Oswaldo Cruz FIOCRUZ, Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, Rio De Janeiro, Brazil.
   [Lemos, Elba R. S.] Fundacao Oswaldo Cruz FIOCRUZ, Inst Oswaldo Cruz, Lab Hantaviroses & Rickettsioses, Rio De Janeiro, Brazil.
RP Alves-Leon, SV (corresponding author), Neurol Dept, Rua Mariz & Barros 775, BR-20270901 Rio De Janeiro, RJ, Brazil.
EM sonizavleon@globo.com
RI Fontes-Dantas, Fabricia Lima/Y-1330-2019; Leon, Soniza V
   Alves/J-7786-2012; Fontes, Fabricia Lima/K-1998-2015
OI Fontes-Dantas, Fabricia Lima/0000-0002-5201-0927; Fontes, Fabricia
   Lima/0000-0002-5201-0927; Rabelo, Kissila/0000-0001-7579-7788; Paes,
   Marciano/0000-0002-2266-2801; Santos, Flavia/0000-0002-1309-5366
FU Brazilian National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordination for the Improvement of Higher Education Personnel
   (CAPES)CAPES; Department of Science and Technology (DECIT)Department of
   Science & Technology (India) [14/2016]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: Brazilian
   National Council for Scientific and Technological Development (CNPq),
   Coordination for the Improvement of Higher Education Personnel (CAPES),
   and Department of Science and Technology (DECIT No. 14/2016).
CR Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Das Sarma J, 2014, J NEUROVIROL, V20, P122, DOI 10.1007/s13365-013-0188-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Lassmann H, 2010, BRAIN, V133, P317, DOI 10.1093/brain/awp342
   McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tsai TT, 2016, SCI REP-UK, V6, DOI 10.1038/srep27670
NR 10
TC 2
Z9 2
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
EI 1477-0970
J9 MULT SCLER J
JI Mult. Scler. J.
PD MAR
PY 2019
VL 25
IS 3
BP 427
EP 430
DI 10.1177/1352458518781992
PG 4
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA HO1ST
UT WOS:000460691800018
PM 30226115
DA 2020-12-08
ER

PT J
AU Coelho, MCA
   Vasquez, ML
   Wildemberg, LE
   Vazquez-Borrego, MC
   Bitana, L
   Camacho, AHD
   Silva, D
   Ogino, LL
   Ventura, N
   Sanchez-Sanchez, R
   Chimelli, L
   Kasuki, L
   Luque, RM
   Gadelha, MR
AF Alves Coelho, Maria Caroline
   Vasquez, Marina Lipkin
   Wildemberg, Luiz Eduardo
   Vazquez-Borrego, Mari C.
   Bitana, Luciana
   da Silva Camacho, Aline Helen
   Silva, Debora
   Ogino, Liana Lumi
   Ventura, Nina
   Sanchez-Sanchez, Rafael
   Chimelli, Leila
   Kasuki, Leandro
   Luque, Raul M.
   Gadelha, Monica R.
TI Clinical significance of filamin A in patients with acromegaly and its
   association with somatostatin and dopamine receptor profiles
SO SCIENTIFIC REPORTS
LA English
DT Article
ID GENE-EXPRESSION LEVELS; QUANTITATIVE-ANALYSIS; BIOCHEMICAL RESPONSE;
   PROSTATE-CANCER; OCTREOTIDE LAR; PITUITARY; SOMATOTROPINOMAS; ANALOGS;
   SSTR2; PASIREOTIDE
AB Filamin-A (FLNA) plays a crucial role in somatostatin receptor (sst) subtype-2 signaling in somatotropinomas. Our objective was to investigate the in vivo association between FLNA and sst2 expression, sst5 expression, dopamine receptor subtype-2 (D2) expression, somatostatin receptor ligand (SRL) responsiveness and tumor invasiveness in somatotropinomas. Quantitative real-time PCR was used to evaluate the absolute mRNA copy numbers of FLNA/sst2/sst5/D2 in 96 somatotropinomas. FLNA, sst2 and sst5 protein expression levels were also evaluated using immunohistochemistry. The Knosp-Steiner criteria were used to evaluate tumor invasiveness. Median FLNA, sst2, sst5 and D2 copy numbers were 4,244, 731, 156 and 3,989, respectively. Thirty-one of the 35 available tumors (89%) were immune positive for FLNA in the cytoplasm and membrane but not in the nucleus. FLNA and sst5 expression were positively correlated at the mRNA and protein levels (p < 0.001 and p = 0.033, respectively). FLNA was positively correlated with sst2 mRNA in patients who were responsive to SRL (p = 0.014, R = 0.659). No association was found between FLNA and tumor invasiveness. Our findings show that in somatotropinomas FLNA expression positively correlated with in vivo sst5 and D2 expression. Notably, FLNA was only correlated with sst2 in patients who were controlled with SRL. FLNA was not associated with tumor invasiveness.
C1 [Alves Coelho, Maria Caroline; Wildemberg, Luiz Eduardo; Kasuki, Leandro; Gadelha, Monica R.] Univ Fed Rio de Janeiro, Sch Med, Div Endocrinol, Neuroendocrinol Res Ctr, Rio De Janeiro, Brazil.
   [Alves Coelho, Maria Caroline; Wildemberg, Luiz Eduardo; Kasuki, Leandro; Gadelha, Monica R.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil.
   [Alves Coelho, Maria Caroline] Univ Estado Rio De Janeiro, Hosp Univ Pedro Ernesto, Div Endocrine, Rio De Janeiro, Brazil.
   [Alves Coelho, Maria Caroline] Inst Estadual Diabet & Endocrinol Luiz Capriglion, Div Endocrine, Rio De Janeiro, Brazil.
   [Vasquez, Marina Lipkin; Bitana, Luciana; da Silva Camacho, Aline Helen; Silva, Debora; Ogino, Liana Lumi; Chimelli, Leila; Gadelha, Monica R.] Inst Estadual Cerebro Paulo Niemeyer, Neuropathol & Mol Genet Lab, Rio De Janeiro, Brazil.
   [Wildemberg, Luiz Eduardo; Kasuki, Leandro; Gadelha, Monica R.] Inst Estadual Cerebro Paulo Niemeyer, Neuroendocrinol Div, Rio De Janeiro, Brazil.
   [Vazquez-Borrego, Mari C.; Sanchez-Sanchez, Rafael; Luque, Raul M.] Maimonides Inst Biomed Res Cordoba IMIBIC, Cordoba, Spain.
   [Vazquez-Borrego, Mari C.; Luque, Raul M.] Univ Cordoba, Dept Cell Biol Physiol & Immunol, Cordoba, Spain.
   [Vazquez-Borrego, Mari C.; Sanchez-Sanchez, Rafael; Luque, Raul M.] Hosp Univ Reina Sofia, Cordoba, Spain.
   [da Silva Camacho, Aline Helen] Inst Nacl Canc, Div Pathol, Rio De Janeiro, Brazil.
   [Ventura, Nina] Inst Estadual Cerebro Paulo Niemeyer, Div Radiol, Rio De Janeiro, Brazil.
   [Sanchez-Sanchez, Rafael] Reina Sofia Univ Hosp, Pathol Serv, Cordoba, Spain.
   [Kasuki, Leandro] Hosp Fed Bonsucesso, Div Endocrine, Rio De Janeiro, Brazil.
   [Luque, Raul M.] CIBER Fisiopatol Obes & Nutr CIBERobn, Madrid, Spain.
RP Gadelha, MR (corresponding author), Univ Fed Rio de Janeiro, Sch Med, Div Endocrinol, Neuroendocrinol Res Ctr, Rio De Janeiro, Brazil.; Gadelha, MR (corresponding author), Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil.; Gadelha, MR (corresponding author), Inst Estadual Cerebro Paulo Niemeyer, Neuropathol & Mol Genet Lab, Rio De Janeiro, Brazil.; Gadelha, MR (corresponding author), Inst Estadual Cerebro Paulo Niemeyer, Neuroendocrinol Div, Rio De Janeiro, Brazil.
EM mgadelha@hucff.ufrj.br
RI wildemberg, luiz/S-4712-2017; Kasui, Leandro/R-8117-2019
OI Luque, Raul M./0000-0002-7585-1913; Vazquez-Borrego, Mari
   C./0000-0001-7256-8111; Sanchez-Sanchez, Rafael/0000-0002-9821-0211
FU Junta de AndaluciaJunta de Andalucia [CTS-1406, BIO-0139]; Instituto de
   Salud Carlos III - European Union (ERDF/ESF, "Investing in your future")
   [PI16/00264]; CIBERobn
FX This work was funded by the following grants: Junta de Andalucia
   (CTS-1406, BIO-0139); Instituto de Salud Carlos III, co-funded by
   European Union (ERDF/ESF, "Investing in your future"; PI16/00264) and
   CIBERobn. CIBER is an initiative of Instituto de Salud Carlos III,
   Ministerio de Sanidad, Servicios Sociales e Igualdad, Spain.
CR Baldassarre M, 2012, J CELL SCI, V125, P3858, DOI 10.1242/jcs.104018
   Bedolla RG, 2009, CLIN CANCER RES, V15, P788, DOI 10.1158/1078-0432.CCR-08-1402
   Casar-Borota O, 2013, J CLIN ENDOCR METAB, V98, pE1730, DOI 10.1210/jc.2013-2145
   Coelho M. C. A., 2018, J CELL MOL MED
   Colao A, 2016, PITUITARY, V19, P235, DOI 10.1007/s11102-015-0684-z
   Cordoba-Chacon J, 2010, CELL MOL LIFE SCI, V67, P1147, DOI 10.1007/s00018-009-0240-y
   Franck S.E., 2016, NEUROENDOCRINOLOGY
   Gadelha MR, 2017, PITUITARY, V20, P100, DOI 10.1007/s11102-017-0791-0
   Gadelha MR, 2013, TRENDS ENDOCRIN MET, V24, P238, DOI 10.1016/j.tem.2012.11.007
   Gatto F, 2017, J CLIN ENDOCR METAB, V102, P2009, DOI 10.1210/jc.2017-00135
   Gatto F, 2013, J CLIN ENDOCR METAB, V98, pE66, DOI 10.1210/jc.2012-2609
   Gawecka JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011269
   Hormaechea-Agulla D, 2016, CANCER LETT, V383, P125, DOI 10.1016/j.canlet.2016.09.022
   Iacovazzo D, 2016, EUR J ENDOCRINOL, V174, P241, DOI 10.1530/EJE-15-0832
   Jiang X, 2013, INT J BIOL SCI, V9, P67, DOI 10.7150/ijbs.5577
   Kasuki L, 2013, EUR J ENDOCRINOL, V169, P217, DOI 10.1530/EJE-13-0349
   Kasuki L, 2012, ARQ BRAS ENDOCRINOL, V56, P501, DOI 10.1590/S0004-27302012000800007
   Katznelson L, 2014, J CLIN ENDOCR METAB, V99, P3933, DOI 10.1210/jc.2014-2700
   Kim H, 2011, FEBS LETT, V585, P18, DOI 10.1016/j.febslet.2010.11.033
   Li M, 2000, MOL PHARMACOL, V57, P446
   Lin RW, 2001, P NATL ACAD SCI USA, V98, P5258, DOI 10.1073/pnas.011538198
   Micko ASG, 2015, J NEUROSURG, V122, P803, DOI 10.3171/2014.12.JNS141083
   Mingione A, 2017, J MOL ENDOCRINOL, V58, P91, DOI 10.1530/JME-16-0184
   Peverelli E, 2018, INT J CANCER, V142, P1842, DOI 10.1002/ijc.31205
   Peverelli E, 2014, HORM METAB RES, V46, P845, DOI 10.1055/s-0034-1384520
   Peverelli E, 2014, ENDOCRINOLOGY, V155, P2932, DOI 10.1210/en.2014-1063
   Peverelli E, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00187
   Peverelli E, 2012, J CLIN ENDOCR METAB, V97, P967, DOI 10.1210/jc.2011-2902
   Peverelli E, 2009, ENDOCRINOLOGY, V150, P3169, DOI 10.1210/en.2008-1785
   Sandret L, 2011, J CLIN ENDOCR METAB, V96, P1327, DOI 10.1210/jc.2010-2443
   Shimon I, 1997, J CLIN INVEST, V99, P789, DOI 10.1172/JCI119225
   Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082
   Taboada GF, 2008, EUR J ENDOCRINOL, V158, P295, DOI 10.1530/EJE-07-0562
   Taboada GF, 2007, EUR J ENDOCRINOL, V156, P65, DOI 10.1530/eje.1.02313
   van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6
   Vitali E, 2017, ONCOTARGET, V8, P77330, DOI 10.18632/oncotarget.20473
   Vitali E, 2016, ENDOCR-RELAT CANCER, V23, P181, DOI 10.1530/ERC-15-0358
   Wildemberg LEA, 2013, J ENDOCRINOL INVEST, V36, P38, DOI 10.3275/8305
   Xu YJ, 2010, J EXP MED, V207, P2421, DOI 10.1084/jem.20100433
   Zheng M, 2016, BBA-MOL CELL RES, V1863, P2072, DOI 10.1016/j.bbamcr.2016.05.010
   Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001
NR 41
TC 4
Z9 4
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 4
PY 2019
VL 9
AR 1122
DI 10.1038/s41598-018-37692-3
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HK0UA
UT WOS:000457616300011
PM 30718563
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Matias, D
   Dubois, LG
   Pontes, B
   Rosario, L
   Ferrer, VP
   Balca-Silva, J
   Fonseca, ACC
   Macharia, LW
   Romao, L
   Spohr, TCLDE
   Chimelli, L
   Niemeyer, P
   Lopes, MC
   Abreu, JG
   Lima, FRS
   Moura-Neto, V
AF Matias, Diana
   Dubois, Luiz Gustavo
   Pontes, Bruno
   Rosario, Luciane
   Ferrer, Valeria Pereira
   Balca-Silva, Joana
   Carvalho Fonseca, Anna Carolina
   Macharia, Lucy Wanjiku
   Romao, Luciana
   de Sampaio e Spohr, Tania Cristina Leite
   Chimelli, Leila
   Niemeyer Filho, Paulo
   Lopes, Maria Celeste
   Abreu, Jose Garcia
   Souza Lima, Flavia Regina
   Moura-Neto, Vivaldo
TI GBM-Derived Wnt3a Induces M2-Like Phenotype in Microglial Cells Through
   Wnt/beta-Catenin Signaling
SO MOLECULAR NEUROBIOLOGY
LA English
DT Article
DE Glioblastoma; Microglia; Wnt/beta-catenin pathway; Wnt3a; M2-like
   phenotype
ID STRESS-INDUCIBLE PROTEIN-1; HUMAN GLIOBLASTOMA CELLS; CANCER STEM-CELLS;
   GLIOMA; ACTIVATION; PROGRESSION; MODULATION; EXPRESSION; MIGRATION;
   RELEASE
AB Glioblastoma is an extremely aggressive and deadly brain tumor known for its striking cellular heterogeneity and capability to communicate with microenvironment components, such as microglia. Microglia-glioblastoma interaction contributes to an increase in tumor invasiveness, and Wnt signaling pathway is one of the main cascades related to tumor progression through changes in cell migration and invasion. However, very little is known about the role of canonical Wnt signaling during microglia-glioblastoma crosstalk. Here, we show for the first time that Wnt3a is one of the factors that regulate interactions between microglia and glioblastoma cells. Wnt3a activates the Wnt/-catenin signaling of both glioblastoma and microglial cells. Glioblastoma-conditioned medium not only induces nuclear translocation of microglial -catenin but also increases microglia viability and proliferation as well as Wnt3a, cyclin-D1, and c-myc expression. Moreover, glioblastoma-derived Wnt3a increases microglial ARG-1 and STI1 expression, followed by an upregulation of IL-10 mRNA levels, and a decrease in IL1 gene expression. The presence of Wnt3a in microglia-glioblastoma co-cultures increases the formation of membrane nanotubes accompanied by changes in migration capability. In vivo, tumors formed from Wnt3a-stimulated glioblastoma cells presented greater microglial infiltration and more aggressive characteristics such as growth rate than untreated tumors. Thus, we propose that Wnt3a belongs to the arsenal of factors capable of stimulating the induction of M2-like phenotype on microglial cells, which contributes to the poor prognostic of glioblastoma, reinforcing that Wnt/-catenin pathway can be a potential therapeutic target to attenuate glioblastoma progression.
C1 [Matias, Diana; Dubois, Luiz Gustavo; Rosario, Luciane; Ferrer, Valeria Pereira; Balca-Silva, Joana; Macharia, Lucy Wanjiku; de Sampaio e Spohr, Tania Cristina Leite; Chimelli, Leila; Niemeyer Filho, Paulo; Moura-Neto, Vivaldo] Inst Estadual Cerebro Paulo Niemeyer, Lab Biomed Cerebro, Secretaria Saude Estado Rio Janeiro, Rua Resende 156, BR-20231092 Rio De Janeiro, Brazil.
   [Matias, Diana; Dubois, Luiz Gustavo; Pontes, Bruno; Carvalho Fonseca, Anna Carolina; Romao, Luciana; Abreu, Jose Garcia; Souza Lima, Flavia Regina] Univ Fed Rio de Janeiro, ICB, BR-21941902 Rio de Janeiro, Brazil.
   [Balca-Silva, Joana; Lopes, Maria Celeste] Ctr Neurociencias & Biol Celular, Coimbra, Portugal.
   [Balca-Silva, Joana; Lopes, Maria Celeste] Inst Biomed Imagem & Ciencias Vida CNC IBILI, Coimbra, Portugal.
   [Balca-Silva, Joana] Univ Coimbra FMUC, Fac Med, Coimbra, Portugal.
   [Lopes, Maria Celeste] Univ Coimbra, Polo Ciencias Saude, Fac Farm, Coimbra, Portugal.
   [Romao, Luciana] Univ Fed Rio Janeiro, Campus Duque Caxias, Duque De Caxias, Brazil.
   [Macharia, Lucy Wanjiku] Univ Fed Rio de Janeiro, Fac Med, Programa Posgrad Anat Patol, Rio de Janeiro, Brazil.
RP Moura-Neto, V (corresponding author), Inst Estadual Cerebro Paulo Niemeyer, Lab Biomed Cerebro, Secretaria Saude Estado Rio Janeiro, Rua Resende 156, BR-20231092 Rio De Janeiro, Brazil.
EM vivaldomouraneto@gmail.com
RI da Fonseca, Anna Carolina Carvalho/C-5825-2015; da Fonseca, Anna
   Carolina Carvalho/AAQ-7440-2020; Ferrer, Valeria Pereira/N-9890-2018;
   Matias, Diana/O-5110-2014; Moura-Neto, VIVALDO/V-9913-2019; Spohr,
   Tania/I-4299-2015; Abreu, Jose GR/G-6159-2010; Pontes,
   Bruno/L-5121-2015; Feijo Dubois, Luiz Gustavo/O-9904-2015
OI da Fonseca, Anna Carolina Carvalho/0000-0002-8366-3146; da Fonseca, Anna
   Carolina Carvalho/0000-0002-8366-3146; Ferrer, Valeria
   Pereira/0000-0002-5210-3445; Moura-Neto, VIVALDO/0000-0002-6266-043X;
   Spohr, Tania/0000-0001-8691-5962; Abreu, Jose GR/0000-0002-9875-7786;
   Feijo Dubois, Luiz Gustavo/0000-0002-9765-5315; Souza Lima, Flavia
   Regina/0000-0003-0799-9235; Matias, Diana/0000-0002-1327-6108; Macharia,
   Lucy Wanjiku/0000-0002-5356-9247
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); Pro-Saude Associacao Beneficente de
   Assistencia Social e Hospitalar; Ary Frauzino Foundation for Cancer
   Research
FX This study was supported by the Brazilian agencies Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo
   a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Pro-Saude Associacao
   Beneficente de Assistencia Social e Hospitalar, and Ary Frauzino
   Foundation for Cancer Research.
CR Abou-Antoun TJ, 2017, NEUROTHERAPEUTICS, V14, P372, DOI 10.1007/s13311-017-0524-0
   Ajmone-Cat MA, 2016, BRAIN BEHAV IMMUN, V55, P225, DOI 10.1016/j.bbi.2015.11.012
   Albini A, 2015, CONNECT TISSUE RES, V56, P414, DOI 10.3109/03008207.2015.1066780
   Amado NG, 2011, LIFE SCI, V89, P545, DOI 10.1016/j.lfs.2011.05.003
   Audia A, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00143
   Balca-Silva J, 2017, ONCOL REP, V38, P1341, DOI 10.3892/or.2017.5799
   da Fonseca ACC, 2016, ADV EXP MED BIOL, V949, P245, DOI 10.1007/978-3-319-40764-7_12
   da Fonseca ACC, 2014, J NEUROIMMUNOL, V274, P71, DOI 10.1016/j.jneuroim.2014.06.021
   Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102
   CONSTAM DB, 1992, J IMMUNOL, V148, P1404
   Crain JM, 2013, J NEUROSCI RES, V91, P1143, DOI 10.1002/jnr.23242
   da Fonseca ACC, 2012, NEUROSCIENCE, V200, P130, DOI 10.1016/j.neuroscience.2011.10.025
   Denysenko T, 2016, CANCER GENOM PROTEOM, V13, P31
   Dey N, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-537
   Dijksterhuis JP, 2015, EXP CELL RES, V339, P280, DOI 10.1016/j.yexcr.2015.10.022
   Faria J, 2006, DIFFERENTIATION, V74, P562, DOI 10.1111/j.1432-0436.2006.00090.x
   Friedmann-Morvinski Dinorah, 2014, Critical Reviews in Oncogenesis, V19, P327
   Garcia C, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-923
   Halleskog C, 2011, GLIA, V59, P119, DOI 10.1002/glia.21081
   Hambardzumyan D, 2016, NAT NEUROSCI, V19, P20, DOI 10.1038/nn.4185
   Holmes KC, 2009, NATURE, V457, P389, DOI 10.1038/457389a
   Hooper C, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-144
   Kahn SA, 2012, CURR TOP MED CHEM, V12, P2082
   Kaur N, 2013, MOL CELL NEUROSCI, V54, P44, DOI 10.1016/j.mcn.2013.01.001
   Liao D. Joshua, 2007, Critical Reviews in Oncogenesis, V13, P93
   Lima FRS, 2001, J NEUROSCI, V21, P2028, DOI 10.1523/JNEUROSCI.21-06-02028.2001
   Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4
   Markovic DS, 2005, J NEUROPATH EXP NEUR, V64, P754, DOI 10.1097/01.jnen.0000178445.33972.a9
   Matias D, 2017, BBA-REV CANCER, V1868, P333, DOI 10.1016/j.bbcan.2017.05.007
   Nawaz M, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00050
   O'Connor T, 2015, ENDOCR METAB IMMUNE, V15, P105, DOI 10.2174/1871530315666150316120920
   Olah M, 2012, GLIA, V60, P96, DOI 10.1002/glia.21251
   Oloumi A, 2006, ONCOGENE, V25, P7747, DOI 10.1038/sj.onc.1209752
   Pontes B, 2008, EUR BIOPHYS J BIOPHY, V37, P121, DOI 10.1007/s00249-007-0184-9
   Razavi SM, 2016, FRONT SURG, V3, DOI 10.3389/fsurg.2016.00011
   Roos A, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00120
   Shibamoto S, 1998, GENES CELLS, V3, P659
   Stupp R, 2007, J CLIN ONCOL, V25, P4127, DOI 10.1200/JCO.2007.11.8554
   Towbin H, 1992, Biotechnology, V24, P145
   VAN MEIR E, 1990, CANCER RES, V50, P6683
   Woiciechowsky C, 1997, ACTA NEUROCHIR, V139, P619, DOI 10.1007/BF01411996
   Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001
   Zhang I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165118
   Zhang ZM, 2015, ONCOL LETT, V10, P2442, DOI 10.3892/ol.2015.3533
   Zheng HH, 2017, J NEUROSCI, V37, P1772, DOI 10.1523/JNEUROSCI.2459-16.2017
NR 45
TC 13
Z9 13
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0893-7648
EI 1559-1182
J9 MOL NEUROBIOL
JI Mol. Neurobiol.
PD FEB
PY 2019
VL 56
IS 2
BP 1517
EP 1530
DI 10.1007/s12035-018-1150-5
PG 14
WC Neurosciences
SC Neurosciences & Neurology
GA HN8TY
UT WOS:000460470300053
PM 29948952
DA 2020-12-08
ER

PT J
AU Ibiapina, JC
   Fuzinatto, KAD
   Camacho, AHS
   Scaf, C
   Kasuki, L
   Wildemberg, LE
   Ventura, N
   Pereira, PJD
   Gadelha, M
   Chimelli, L
AF Ibiapina, Jaquelyne Cruz
   Fuzinatto, Karina A. D.
   Camacho, Aline H. S.
   Scaf, Cristiane
   Kasuki, Leandro
   Wildemberg, Luiz Eduardo
   Ventura, Nina
   da Mata Pereira, Paulo Jose
   Gadelha, Monica
   Chimelli, Leila
TI Agressive behavior of Spindle cell oncocytoma: a case report
SO BRAIN PATHOLOGY
LA English
DT Meeting Abstract
CT 19th International Congress of Neuropathology
CY SEP 23-27, 2018
CL Tokyo, JAPAN
C1 [Ibiapina, Jaquelyne Cruz; Fuzinatto, Karina A. D.; Camacho, Aline H. S.] Inst Nacl Canc, Div Anat Patol, Rio De Janeiro, Brazil.
   [Camacho, Aline H. S.; Scaf, Cristiane; Kasuki, Leandro; Wildemberg, Luiz Eduardo; Ventura, Nina; da Mata Pereira, Paulo Jose; Gadelha, Monica; Chimelli, Leila] Inst Estadual Cerebro Paulo Niemeyer, Lab Neuropatol & Genet, Rio De Janeiro, Brazil.
   [Scaf, Cristiane; Kasuki, Leandro; Wildemberg, Luiz Eduardo; Gadelha, Monica] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
RI Kasui, Leandro/R-8117-2019; wildemberg, luiz/S-4712-2017
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1015-6305
EI 1750-3639
J9 BRAIN PATHOL
JI Brain Pathol.
PD FEB
PY 2019
VL 29
SU 1
SI SI
MA P1-90
BP 42
EP 42
PG 1
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA HM9OP
UT WOS:000459814800125
DA 2020-12-08
ER

PT J
AU Chimelli, L
AF Chimelli, Leila
TI Neuropathology and neuropathogenesis of congenital Zika syndrome
SO BRAIN PATHOLOGY
LA English
DT Meeting Abstract
CT 19th International Congress of Neuropathology
CY SEP 23-27, 2018
CL Tokyo, JAPAN
C1 [Chimelli, Leila] State Inst Brain Paulo Niemeyer, Rio De Janeiro, Brazil.
   [Chimelli, Leila] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 1
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1015-6305
EI 1750-3639
J9 BRAIN PATHOL
JI Brain Pathol.
PD FEB
PY 2019
VL 29
SU 1
SI SI
MA S7-3
BP 51
EP 51
PG 1
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA HM9OP
UT WOS:000459814800154
DA 2020-12-08
ER

PT J
AU Camacho, AHS
   Silva, D
   Santos, DD
   Chimelli, L
AF Camacho, Aline H. S.
   Silva, Debora
   Santos, Diego De Araujo
   Chimelli, Leila
TI Do gemistocytic astrocytomas really exist? The longstanding debate about
   gemistocytes present in diffuse gliomas may be solved
SO BRAIN PATHOLOGY
LA English
DT Meeting Abstract
CT 19th International Congress of Neuropathology
CY SEP 23-27, 2018
CL Tokyo, JAPAN
C1 [Camacho, Aline H. S.; Silva, Debora; Santos, Diego De Araujo; Chimelli, Leila] Inst Estadual Cerebro Paulo Niemeyer, Lab Neuropatol & Genet, Rio De Janeiro, Brazil.
   [Camacho, Aline H. S.] Inst Nacl Canc, Div Anat Patol, Mexico City, DF, Mexico.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1015-6305
EI 1750-3639
J9 BRAIN PATHOL
JI Brain Pathol.
PD FEB
PY 2019
VL 29
SU 1
SI SI
MA P3-13
BP 143
EP 143
PG 1
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA HM9OP
UT WOS:000459814800447
DA 2020-12-08
ER

PT J
AU Chimelli, L
   Wiley, CA
   Vasconcelos, ZFM
   Moreira, MEL
   Pone, SM
   Pone, MVD
AF Chimelli, Leila
   Wiley, Clayton A.
   Meira Vasconcelos, Zilton Farias
   Lopes Moreira, Maria Elisabeth
   Pone, Sheila Moura
   da Silva Pone, Marcos Vinicius
TI Persistence of Zika Virus After Birth Response
SO JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
LA English
DT Letter
C1 [Chimelli, Leila] State Inst Brain, Neuropathol Lab, Rio De Janeiro, Brazil.
   [Chimelli, Leila] Univ Fed Rio de Janeiro, Rio de Janeiro, Brazil.
   [Wiley, Clayton A.] UPMC Presbyterian Hosp, Div Neuropathol, Pittsburgh, PA USA.
   [Meira Vasconcelos, Zilton Farias; Lopes Moreira, Maria Elisabeth] Oswaldo Cruz Fdn Fiocruz, Hlth Fernandes Figueira IFF, Natl Inst Women Children & Adolescents, Clin Res Unit, Rio De Janeiro, Brazil.
   [Pone, Sheila Moura; da Silva Pone, Marcos Vinicius] Oswaldo Cruz Fdn Fiocruz, Hlth Fernandes Figueira IFF, Natl Inst Women Children & Adolescents, Pediat Infect Dis Unit, Rio De Janeiro, Brazil.
RP Chimelli, L (corresponding author), State Inst Brain, Neuropathol Lab, Rio De Janeiro, Brazil.; Chimelli, L (corresponding author), Univ Fed Rio de Janeiro, Rio de Janeiro, Brazil.
EM chimelli@hucff.ufrj.br
RI da Silva Pone, Marcos Vinicius/N-1285-2019; Moreira, Maria Elisabeth
   Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Moura Pone,
   Sheila/0000-0002-6246-8915; Vasconcelos, Zilton/0000-0002-2193-2224; da
   Silva Pone, Marcos Vinicius/0000-0002-5152-2242
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Chimelli L, 2018, J NEUROPATH EXP NEUR, V77, P193, DOI 10.1093/jnen/nlx116
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
NR 7
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-3069
EI 1554-6578
J9 J NEUROPATH EXP NEUR
JI J. Neuropathol. Exp. Neurol.
PD JUL
PY 2018
VL 77
IS 7
BP 656
EP 657
PG 2
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA GO1KC
UT WOS:000439709000012
DA 2020-12-08
ER

PT J
AU Souza, IND
   Frost, PS
   Franca, JV
   Nascimento-Viana, JB
   Neris, RLS
   Freitas, L
   Pinheiro, DJLL
   Nogueira, CO
   Neves, G
   Chimelli, L
   De Felice, FG
   Cavalheiro, EA
   Ferreira, ST
   Assuncao-Miranda, I
   Figueiredo, CP
   Da Poian, AT
   Clarke, JR
AF de Oliveira Souza, Isis Nem
   Frost, Paula S.
   Franca, Julia V.
   Nascimento-Viana, Jessica B.
   Neris, Romulo L. S.
   Freitas, Leandro
   Pinheiro, Daniel J. L. L.
   Nogueira, Clara O.
   Neves, Gilda
   Chimelli, Leila
   De Felice, Fernanda G.
   Cavalheiro, Esper A.
   Ferreira, Sergio T.
   Assuncao-Miranda, Iranaia
   Figueiredo, Claudia P.
   Da Poian, Andrea T.
   Clarke, Julia R.
TI Acute and chronic neurological consequences of early-life Zika virus
   infection in mice
SO SCIENCE TRANSLATIONAL MEDICINE
LA English
DT Article
ID NEUROPSYCHIATRIC DISORDERS; OXIDATIVE STRESS; CASE SERIES; BRAZIL;
   BRAIN; SEIZURES; INFANTS; GROWTH; HIPPOCAMPUS; INDUCTION
AB Although congenital Zika virus (ZIKV) exposure has been associated with microcephaly and other neurodevelopmental disorders, long-term consequences of perinatal infection are largely unknown. We evaluated short-and long-term neuropathological and behavioral consequences of neonatal ZIKV infection in mice. ZIKV showed brain tropism, causing postnatal-onset microcephaly and several behavioral deficits in adulthood. During the acute phase of infection, mice developed frequent seizures, which were reduced by tumor necrosis factor-alpha (TNF-alpha) inhibition. During adulthood, ZIKV replication persisted in neonatally infected mice, and the animals showed increased susceptibility to chemically induced seizures, neurodegeneration, and brain calcifications. Altogether, the results show that neonatal ZIKV infection has long-term neuropathological and behavioral complications in mice and suggest that early inhibition of TNF-alpha-mediated neuroinflammation might be an effective therapeutic strategy to prevent the development of chronic neurological abnormalities.
C1 [de Oliveira Souza, Isis Nem; Frost, Paula S.; Nascimento-Viana, Jessica B.; Nogueira, Clara O.; Figueiredo, Claudia P.; Clarke, Julia R.] Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Frost, Paula S.; Franca, Julia V.; Neves, Gilda] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Neris, Romulo L. S.; Assuncao-Miranda, Iranaia] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Freitas, Leandro; Pinheiro, Daniel J. L. L.; Cavalheiro, Esper A.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Neurol & Neurosurg, BR-04023062 Sao Paulo, SP, Brazil.
   [Chimelli, Leila] State Inst Brain Paulo Niemeyer, Lab Neuropathol, Rio De Janeiro, Brazil.
   [De Felice, Fernanda G.; Ferreira, Sergio T.; Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [De Felice, Fernanda G.] Queens Univ, Dept Biomed & Mol Sci, Ctr Neurosci Studies, Kingston, ON, Canada.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.
RP Figueiredo, CP; Clarke, JR (corresponding author), Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, RJ, Brazil.; Assuncao-Miranda, I (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, BR-21944590 Rio De Janeiro, RJ, Brazil.; Da Poian, AT (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21944590 Rio De Janeiro, RJ, Brazil.
EM iranaiamiranda@micro.ufrj.br; claufig@gmail.com;
   dapoian@bioqmed.ufrj.br; juliaclarke@pharma.ufrj.br
RI Cavalheiro, Esper/N-3985-2019; Cavalheiro, Esper A/I-3084-2016; Da
   Poian, Andrea T./V-1699-2019; Neves, Gilda A./K-7573-2012; Figueiredo,
   Claudia P/F-8424-2012; de Oliveira Souza, Isis Nem/AAA-3423-2019;
   Ferreira, Sergio/AAZ-1576-2020; Neves, Gilda A./U-1622-2019; Clarke,
   Julia/AAF-9434-2019
OI Cavalheiro, Esper/0000-0002-0854-3582; Cavalheiro, Esper
   A/0000-0002-0854-3582; Neves, Gilda A./0000-0002-7027-3851; de Oliveira
   Souza, Isis Nem/0000-0002-0335-2541; Ferreira,
   Sergio/0000-0001-7160-9866; Figueiredo, Claudia/0000-0001-9467-9891;
   Neris, Romulo/0000-0002-7436-1680; Pinheiro, Daniel/0000-0003-0078-993X;
   da Silva Frost, Paula/0000-0002-3814-999X; Freitas,
   Leandro/0000-0002-0249-2948
FU Fundacao de Amparo a Pesquisa do Estado do Rio de JaneiroCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao
   de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Institutos
   Nacionais de Pesquisa-Instituto Nacional de Neurociencia Translacional;
   Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); Institutos
   Nacionais de Pesquisa-Inovacao em Medicamentos e Identificacao de Novos
   Alvos Terapeuticos; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   SuperiorCAPES; Financiadora de Estudos e ProjetosCiencia Tecnologia e
   Inovacao (FINEP)
FX Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (to F.G.D.F.,
   S.T.F., A.T.D.P., I.A.-M., C.P.F., and J.R.C.), Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (to E.A.C.), Institutos Nacionais de
   Pesquisa-Instituto Nacional de Neurociencia Translacional (to F.G.D.F.,
   E.A.C., and S.T.F.), Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (to P.S.F., G.N., F.G.D.F., E.A.C., S.T.F., A.T.D.P.,
   C.P.F., I.A.-M., and J.R.C.), Institutos Nacionais de Pesquisa-Inovacao
   em Medicamentos e Identificacao de Novos Alvos Terapeuticos (to C.P.F.),
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (to
   I.N.O.S., J.V.F., L.F., and D.J.L.L.P.), and Financiadora de Estudos e
   Projetos (to A.T.D.P.).
CR Coelho SVA, 2017, J VIROL METHODS, V246, P65, DOI 10.1016/j.jviromet.2017.04.011
   Assuncao-Miranda I, 2016, J APPL MICROBIOL, V120, P790, DOI 10.1111/jam.13038
   Balosso S, 2013, EXP NEUROL, V247, P267, DOI 10.1016/j.expneurol.2013.05.010
   Bao AM, 2010, NEUROSCIENTIST, V16, P550, DOI 10.1177/1073858410377005
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Chakrabarti B, 2009, AUTISM RES, V2, P157, DOI 10.1002/aur.80
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3
   Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004
   Dalman C, 2008, AM J PSYCHIAT, V165, P59, DOI 10.1176/appi.ajp.2007.07050740
   de Caires LC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02790-9
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Edwards MJJ, 2002, NEUROLOGY, V59, P1447, DOI 10.1212/WNL.59.9.1447
   Estes ML, 2016, SCIENCE, V353, P772, DOI 10.1126/science.aag3194
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gupta AK, 2016, SCI REP-UK, V6, DOI 10.1038/srep32713
   Ho YH, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0157-8
   Jiang PF, 2012, BRAIN RES, V1459, P1, DOI 10.1016/j.brainres.2012.03.058
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Kirkman NJ, 2010, EPILEPSIA, V51, P454, DOI 10.1111/j.1528-1167.2009.02390.x
   KOVAC S, 2016, REACT OXYGEN SPECIES, V1, P38, DOI DOI 10.20455/ROS.2016.807
   Kramer AH, 2008, CURR TREAT OPTION NE, V10, P201, DOI 10.1007/s11940-008-0022-0
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Libbey JE, 2008, EPILEPSIA, V49, P1066, DOI 10.1111/j.1528-1167.2008.01535.x
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mavigner M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6975
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Pauletti A, 2017, BRAIN, V140, P1885, DOI 10.1093/brain/awx117
   RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roze B, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.16.30205
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Smith R, 2006, PEDIATRICS, V117, P851, DOI 10.1542/peds.2005-0804
   Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Zhao K, 2010, BIOSCIENCE REP, V30, P233, DOI 10.1042/BSR20090048
NR 51
TC 32
Z9 32
U1 1
U2 15
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1946-6234
EI 1946-6242
J9 SCI TRANSL MED
JI Sci. Transl. Med.
PD JUN 6
PY 2018
VL 10
IS 444
AR eaar2749
DI 10.1126/scitranslmed.aar2749
PG 10
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA GI5IG
UT WOS:000434403600003
PM 29875203
OA Bronze
DA 2020-12-08
ER

PT J
AU Antunes, X
   Ventura, N
   Camilo, GB
   Wildemberg, LE
   Guasti, A
   Pereira, PJM
   Camacho, AHS
   Chimelli, L
   Niemeyer, P
   Gadelha, MR
   Kasuki, L
AF Antunes, Ximene
   Ventura, Nina
   Camilo, Gustavo Bittencourt
   Wildemberg, Luiz Eduardo
   Guasti, Andre
   Pereira, Paulo Jose M.
   Silva Camacho, Aline Helen
   Chimelli, Leila
   Niemeyer, Paulo
   Gadelha, Monica R.
   Kasuki, Leandro
TI Predictors of surgical outcome and early criteria of remission in
   acromegaly
SO ENDOCRINE
LA English
DT Article
DE Acromegaly; Surgery; Predictors of surgical outcome; Early criteria of
   remission
ID ENDOSCOPIC TRANSSPHENOIDAL SURGERY; SECRETING PITUITARY-ADENOMAS;
   GROWTH-HORMONE LEVELS; LONG-TERM REMISSION; SOMATOSTATIN ANALOGS;
   CLINICOPATHOLOGICAL FEATURES; MRI; CURE; INVASION; PATTERN
AB Transsphenoidal surgery (TSS) is the cornerstone of acromegaly treatment, however there are no robust predictors of surgical outcome and remission can only be defined three months after surgery.
   To analyze if biochemical, demographical, radiological, and immunohistochemical characteristics are predictors of surgical remission and investigate if immediate postoperative GH and IGF-I levels can help defining remission earlier.
   Consecutive acromegaly patients submitted to TSS between 2013-2016 were evaluated. Remission criteria was defined as normal IGF-I and GH < 1 mcg/L three months after surgery. Data of age, sex, GH and IGF-I levels, tumor volume, cavernous sinus invasion, T2-weighted signal, Ki-67, and granulation pattern were correlated with remission status. GH and IGF-I levels at 24, 48 h, and one week postoperative were evaluated as early criteria of remission.
   Sixty-nine patients were included (84% macroadenomas) and surgical remission was achieved in 45%. No difference between cured and not cured patients concerning age, gender, preoperative GH or IGF-I levels, tumor volume, T2-weighted signal, Ki-67 and tumor granularity was observed. Remission was obtained in 20 of 36 (56%) of the non-invasive tumors, and in 3 of 16 (19%) of the invasive tumors (p = 0.017). A GH < 1.57 mcg/L 48 h after surgery was able to predict remission with 93% sensitivity and 86% specificity and an IGF-I < 231% ULNR one week after surgery predicted remission with 86% sensitivity and 93% specificity.
   Cavernous sinus invasion is the only preoperative predictor of surgical remission. GH at 48 h and IGF-I one week after surgery can define earlier not cured patients.
C1 [Antunes, Ximene; Wildemberg, Luiz Eduardo; Gadelha, Monica R.; Kasuki, Leandro] Univ Fed Rio de Janeiro, Neuroendocrinol Res Ctr, Med Sch, Endocrinol Div, Rio De Janeiro, Brazil.
   [Antunes, Ximene; Wildemberg, Luiz Eduardo; Gadelha, Monica R.; Kasuki, Leandro] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil.
   [Ventura, Nina] Inst Estadual Cerebro Paulo Niemeyer, Radiol Div, Rio De Janeiro, Brazil.
   [Camilo, Gustavo Bittencourt] Inst Hosp & Maternidade Terezinha de Jesus, Radiol Div, Juiz De Fora, MG, Brazil.
   [Wildemberg, Luiz Eduardo; Gadelha, Monica R.; Kasuki, Leandro] Inst Estadual Cerebro Niemeyer, Neuroendocrinol Div, Rio De Janeiro, Brazil.
   [Guasti, Andre; Pereira, Paulo Jose M.; Niemeyer, Paulo] Inst Estadual Cerebro Niemeyer, Neurosurg Div, Rio De Janeiro, Brazil.
   [Silva Camacho, Aline Helen; Chimelli, Leila] Inst Estadual Cerebro Niemeyer, Neuropathol & Mol Genet Lab, Rio De Janeiro, Brazil.
   [Silva Camacho, Aline Helen] Inst Nacl Canc, Pathol Div, Rio De Janeiro, Brazil.
   [Kasuki, Leandro] Hosp Fed Bonsucesso, Endocrinol Div, Rio De Janeiro, Brazil.
RP Kasuki, L (corresponding author), Univ Fed Rio de Janeiro, Neuroendocrinol Res Ctr, Med Sch, Endocrinol Div, Rio De Janeiro, Brazil.; Kasuki, L (corresponding author), Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil.; Kasuki, L (corresponding author), Inst Estadual Cerebro Niemeyer, Neuroendocrinol Div, Rio De Janeiro, Brazil.; Kasuki, L (corresponding author), Hosp Fed Bonsucesso, Endocrinol Div, Rio De Janeiro, Brazil.
EM lkasuki@yahoo.com
RI wildemberg, luiz/S-4712-2017; Kasui, Leandro/R-8117-2019
CR Abosch A, 1998, J CLIN ENDOCR METAB, V83, P3411, DOI 10.1210/jc.83.10.3411
   Ahmed S, 1999, CLIN ENDOCRINOL, V50, P561
   Attanasio R, 2008, PITUITARY, V11, P1, DOI 10.1007/s11102-007-0059-1
   Babu H, 2017, NEUROSURGERY, V81, P357, DOI 10.1093/neuros/nyx020
   Bakhtiar Y, 2010, EUR J ENDOCRINOL, V163, P531, DOI 10.1530/EJE-10-0586
   Bourdelot A, 2004, EUR J ENDOCRINOL, V150, P763, DOI 10.1530/eje.0.1500763
   Briceno V, 2017, NEUROL RES, V39, P387, DOI 10.1080/01616412.2017.1296653
   Buchfelder M, 2017, PITUITARY, V20, P76, DOI 10.1007/s11102-016-0765-7
   Dutta P, 2016, NEUROL INDIA, V64, P252, DOI 10.4103/0028-3886.177622
   Feelders RA, 2005, J CLIN ENDOCR METAB, V90, P6480, DOI 10.1210/jc.2005-0901
   Gondim JA, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.7.FOCUS10167
   Hagiwara A, 2003, RADIOLOGY, V228, P533, DOI 10.1148/radiol.2282020695
   Hazer DB, 2013, J NEUROSURG, V119, P1467, DOI 10.3171/2013.8.JNS13224
   Heck A, 2016, ENDOCRINE, V52, P333, DOI 10.1007/s12020-015-0766-8
   Heck A, 2012, CLIN ENDOCRINOL, V77, P72, DOI 10.1111/j.1365-2265.2011.04286.x
   Jane JA, 2011, J CLIN ENDOCR METAB, V96, P2732, DOI 10.1210/jc.2011-0554
   Katznelson L, 2014, J CLIN ENDOCR METAB, V99, P3933, DOI 10.1210/jc.2014-2700
   Kim EH, 2012, NEUROSURGERY, V70, P1106, DOI 10.1227/NEU.0b013e31823f5c16
   Kim JH, 2017, WORLD NEUROSURG, V104, P272, DOI 10.1016/j.wneu.2017.04.141
   Kiseljak-Vassiliades K, 2015, ENDOCRINE, V49, P231, DOI 10.1007/s12020-014-0383-y
   Kreutzer J, 2001, J CLIN ENDOCR METAB, V86, P4072, DOI 10.1210/jc.86.9.4072
   Krieger MD, 2003, J NEUROSURG, V98, P719, DOI 10.3171/jns.2003.98.4.0719
   Mazal PR, 2001, CLIN NEUROPATHOL, V20, P163
   Micko ASG, 2015, J NEUROSURG, V122, P803, DOI 10.3171/2014.12.JNS141083
   Nishioka Hiroshi, 2014, J Neurosurg, V121, P505, DOI 10.3171/2014.3.JNS132214
   Nomikos P, 2005, EUR J ENDOCRINOL, V152, P379, DOI 10.1530/eje.1.01863
   Obari A, 2008, ENDOCR PATHOL, V19, P82, DOI 10.1007/s12022-008-9029-z
   Petrossians P, 2005, EUR J ENDOCRINOL, V152, P61, DOI 10.1530/eje.1.01824
   Potorac I, 2015, ENDOCR-RELAT CANCER, V22, P169, DOI 10.1530/ERC-14-0305
   Puig-Domingo M, 2010, J CLIN ENDOCR METAB, V95, P4973, DOI 10.1210/jc.2010-0573
   Sarkar S, 2014, ACTA NEUROCHIR, V156, P1379, DOI 10.1007/s00701-014-2098-5
   Shen M, 2016, NEURORADIOLOGY, V58, P1057, DOI 10.1007/s00234-016-1728-4
   Shirvani M, 2014, WORLD NEUROSURG, V81, P125, DOI 10.1016/j.wneu.2013.01.021
   Starke RM, 2013, J CLIN ENDOCR METAB, V98, P3190, DOI 10.1210/jc.2013-1036
   Sun H, 2014, J NEUROL SURG PART B, V75, P47, DOI 10.1055/s-0033-1354578
   Takahashi JA, 2004, CLIN ENDOCRINOL, V60, P366, DOI 10.1046/j.1365-2265.2003.01900.x
   Valdemarsson S, 2000, J INTERN MED, V247, P640, DOI 10.1046/j.1365-2796.2000.00667.x
   van Bunderen CC, 2013, PITUITARY, V16, P158, DOI 10.1007/s11102-012-0395-7
   Yildirim AE, 2014, TURK NEUROSURG, V24, P946, DOI 10.5137/1019-5149.JTN.12847-14.1
   Yu M, 2017, CLIN CHEM, V63, P486, DOI 10.1373/clinchem.2016.262592
NR 40
TC 19
Z9 20
U1 1
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-008X
EI 1559-0100
J9 ENDOCRINE
JI Endocrine
PD JUN
PY 2018
VL 60
IS 3
BP 415
EP 422
DI 10.1007/s12020-018-1590-8
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GE9LE
UT WOS:000431550400006
PM 29626274
DA 2020-12-08
ER

PT J
AU Faccion, RS
   Bernardo, PS
   de Lopes, GPF
   Bastos, LS
   Teixeira, CL
   de Oliveira, JA
   Fernandes, PV
   Dubois, LG
   Chimelli, L
   Maia, RC
AF Faccion, Roberta Soares
   Bernardo, Paula Sabbo
   Faria de Lopes, Giselle Pinto
   Bastos, Leonardo Soares
   Teixeira, Cristina Lordello
   de Oliveira, Jose Antonio
   Fernandes, Priscila Valverde
   Dubois, Luiz Gustavo
   Chimelli, Leila
   Maia, Raquel Ciuvalschi
TI p53 expression and subcellular survivin localization improve the
   diagnosis and prognosis of patients with diffuse astrocytic tumors
SO CELLULAR ONCOLOGY
LA English
DT Article
DE Astrocytic tumors; Survivin; p53; Subcellular localization; Diagnosis;
   Prognosis
ID CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR RECEPTOR; LOW-GRADE GLIOMAS; HUMAN
   GLIOBLASTOMA; DRUG-RESISTANCE; TP53 MUTATIONS; WILD-TYPE; NUCLEAR;
   CLASSIFICATION; PROTEINS
AB Diffuse astrocytic tumors are the most frequently occurring primary central nervous system (CNS) tumors. Their histological sub-classification into diffuse astrocytoma (DA), anaplastic astrocytoma (AA) and glioblastoma (GB) is challenging and the available prognostic factors are limited to age and tumor subtype. Biomarkers that may improve the histological sub-classification and/or serve as prognostic factors are, therefore, urgently needed. The relationship between survivin and p53 in diffuse astrocytic tumor progression and survival is currently unclear. Here, we aimed to assess the relevance of these proteins in the accuracy of the histological sub-classification of these tumors and their respective treatment responses.
   One hundred and thirty-three formalin-fixed paraffin-embedded diffuse astrocytic tumor samples were included. The tumor samples were histologically reviewed and subsequently assessed for p53 and survivin expression and the presence of the IDH R132H mutation by immunohistochemistry. p53 expression levels and survivin subcellular localization patterns were correlated with histological classification and clinical outcome.
   We found that age and histological subtype were the only features with a prognostic impact. In addition, we found that high p53 expression levels and a nuclear survivin localization correlated with the AA subtype, whereas cytoplasmic survivin localization correlated with the GB subtype. We also found that patients carrying tumors with a high cytoplasmic survivin expression, a high nuclear survivin expression or a high p53 expression, and who did not receive radiotherapy, exhibited poorer short-term and long-term overall survival rates.
   Our data suggest that subcellular survivin localization and p53 expression may be employed as valuable tools to improve the accuracy of the histological sub-classification of diffuse astrocytic tumors. Patients whose tumors overexpress these proteins may benefit from radiotherapy, irrespective age and/or histological classification.
C1 [Faccion, Roberta Soares; Bernardo, Paula Sabbo; Faria de Lopes, Giselle Pinto; Maia, Raquel Ciuvalschi] Inst Nacl Canc Jose Alencar Gomes da Silva INCA, Ctr Pesquisas, Lab Hematooncol Celular & Mol, Programa Hematooncol Mol,Hosp Canc 1, Praca Cruz Vermelha 23-6 Andar, BR-20230130 Rio De Janeiro, Brazil.
   [Faccion, Roberta Soares] Univ Fed Rio de Janeiro, Programa Posgrad Ciencias Biol Fisiol, Inst Biofis Carlos Chagas Filho, Ctr Ciencias Saude, Rio De Janeiro, Brazil.
   [Bernardo, Paula Sabbo] INCA, Programa Posgrad Stricto Sensu Oncol, Rio De Janeiro, Brazil.
   [Bastos, Leonardo Soares] Fundacao Oswaldo Cruz Fiocruz, Programa Comp Cient PROCC, Presidencia, Rio De Janeiro, Brazil.
   [Teixeira, Cristina Lordello] INCA, Hosp Canc 1, Serv Patol Clin, Rio De Janeiro, Brazil.
   [de Oliveira, Jose Antonio] INCA, Serv Neurocirurgia, Rio De Janeiro, Brazil.
   [Fernandes, Priscila Valverde] INCA, Div Patol, Rio De Janeiro, Brazil.
   [Dubois, Luiz Gustavo] IECPN, Lab Biomed Cerebro, Rio De Janeiro, Brazil.
   [Chimelli, Leila] IECPN, Lab Neuropatol & Genet Mol, Rio De Janeiro, Brazil.
RP Maia, RC (corresponding author), Inst Nacl Canc Jose Alencar Gomes da Silva INCA, Ctr Pesquisas, Lab Hematooncol Celular & Mol, Programa Hematooncol Mol,Hosp Canc 1, Praca Cruz Vermelha 23-6 Andar, BR-20230130 Rio De Janeiro, Brazil.
EM rcmaia@inca.gov.br
RI maia, raquel c/L-4869-2015; Bernardo, Paula Sabbo/D-7369-2018; Soares
   Faccion, Roberta/E-2090-2014; Bastos, Leonardo Soares/AAD-5335-2019;
   Feijo Dubois, Luiz Gustavo/O-9904-2015
OI maia, raquel c/0000-0003-0225-471X; Bernardo, Paula
   Sabbo/0000-0001-6478-8026; Soares Faccion, Roberta/0000-0002-9502-0324;
   Bastos, Leonardo Soares/0000-0002-1406-0122; Feijo Dubois, Luiz
   Gustavo/0000-0002-9765-5315
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao para Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ); Instituto Nacional de Ciencia e Tecnologia (INCT) para
   Controle do Cancer; Programa de Oncobiologia (Fundacao do Cancer);
   Programa de Oncobiologia (UFRJ); FAPERJCarlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ); Ministerio
   da Saude/Instituto Nacional de Cancer; CNPqNational Council for
   Scientific and Technological Development (CNPq); Instituto Nacional de
   Ciencia e Tecnologia para o Controle do Cancer [INCT-573806/2008-0
   (FAPERJ-E29/110.278/2010), INCT-573806/2008-0 (CNPq-306141/2010-8)];
   Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   JaneiroCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [E-26/103.140/2011]; Programa de Oncobiologia
   [Programa de Oncobiologia/2016UFRJ/FAF]
FX This work was supported by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), Fundacao para Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ), Instituto Nacional de Ciencia e
   Tecnologia (INCT) para Controle do Cancer and the Programa de
   Oncobiologia (Fundacao do Cancer and UFRJ). PSB was first supported by a
   PhD scholarship from FAPERJ and then by a post-doctoral fellowship from
   the Ministerio da Saude/Instituto Nacional de Cancer. RSF was first
   supported by a PhD scholarship from CNPq and then by a post-doctoral
   fellowship from the Ministerio da Saude/Instituto Nacional de Cancer. We
   would like to thank all patients enrolled in the study and the
   physicians from the Neurosurgery Service for their participation. We
   also acknowledge Dr. Mauricio G S Costa from Instituto Oswaldo Cruz
   (FIOCRUZ) for his help with the artwork.; This work was funded by the
   Instituto Nacional de Ciencia e Tecnologia para o Controle do Cancer
   [Award number: INCT-573806/2008-0 (FAPERJ-E29/110.278/2010,
   CNPq-306141/2010-8)], the Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro (Award number: E-26/103.140/2011)
   and the Programa de Oncobiologia (Award number: Programa de
   Oncobiologia/2016UFRJ/FAF).
CR Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917
   Angileri FF, 2008, CANCER-AM CANCER SOC, V112, P2258, DOI 10.1002/cncr.23407
   Ansari D, 2011, BRIT J SURG, V98, P1041, DOI 10.1002/bjs.7574
   Banks DP, 2000, BLOOD, V96, P4002, DOI 10.1182/blood.V96.12.4002.h8004000c_4002_4003
   Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121
   Calatozzolo C, 2005, J NEURO-ONCOL, V74, P113, DOI 10.1007/s11060-004-6152-7
   Chakravarti A, 2002, J CLIN ONCOL, V20, P1063, DOI 10.1200/JCO.20.4.1063
   Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385
   Chu JS, 2004, J FORMOS MED ASSOC, V103, P925
   Cohen AL, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0345-4
   COX DR, 1972, J R STAT SOC B, V34, P187
   Cykowski MD, 2013, J NEURO-ONCOL, V115, P477, DOI 10.1007/s11060-013-1249-5
   Das A, 2002, J CANCER RES CLIN, V128, P302, DOI 10.1007/s00432-002-0343-4
   de Faria GP, 2008, CANCER INVEST, V26, P883, DOI 10.1080/07357900801975264
   Del Gobbo A., 2017, GASTROENT RES PRACT, V2017
   Faccion RS, 2012, CANCER INVEST, V30, P404, DOI 10.3109/07357907.2012.672844
   Faccion RS, 2011, PATHOL ONCOL RES, V17, P899, DOI 10.1007/s12253-011-9401-z
   Fields AC, 2004, MODERN PATHOL, V17, P1378, DOI 10.1038/modpathol.3800203
   Gao YS, 2015, ONCOL LETT, V10, P301, DOI 10.3892/ol.2015.3180
   Gillet E, 2014, J NEURO-ONCOL, V118, P131, DOI 10.1007/s11060-014-1407-4
   Hui XH, 2013, ONCOL LETT, V6, P130, DOI 10.3892/ol.2013.1317
   Ichimura K, 2015, ACTA NEUROPATHOL, V129, P789, DOI 10.1007/s00401-015-1439-7
   Kajiwara Y, 2003, CANCER-AM CANCER SOC, V97, P1077, DOI 10.1002/cncr.11122
   Keime-Guibert F, 2007, NEW ENGL J MED, V356, P1527, DOI 10.1056/NEJMoa065901
   Kim YH, 2010, AM J PATHOL, V177, P2708, DOI 10.2353/ajpath.2010.100680
   Knauer SK, 2007, CELL CYCLE, V6, P518, DOI 10.4161/cc.6.5.3902
   Li FZ, 2005, INT J CANCER, V114, P509, DOI 10.1002/ijc.20768
   Li QL, 2017, ONCOTARGET, V8, P29458, DOI 10.18632/oncotarget.15297
   Lin H, 2012, MED ONCOL, V29, P1272, DOI 10.1007/s12032-011-9835-x
   Liu XY, 2012, ACTA NEUROPATHOL, V124, P615, DOI 10.1007/s00401-012-1031-3
   Lopez-Gines C, 2017, CELL ONCOL, V40, P389, DOI 10.1007/s13402-017-0329-5
   Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4
   Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1
   Louis DN, 2014, BRAIN PATHOL, V24, P429, DOI 10.1111/bpa.12171
   Lv SZ, 2015, MOL NEUROBIOL, V51, P1462, DOI 10.1007/s12035-014-8823-5
   Matias D, 2017, CELL ONCOL, V40, P247, DOI 10.1007/s13402-017-0320-1
   McCullagh P. N., 1989, GENERALIZED LINEAR M
   Mesti T, 2016, RADIOL ONCOL, V50, P129, DOI 10.1515/raon-2015-0003
   Mirza A, 2002, ONCOGENE, V21, P2613, DOI 10.1038/sj.onc.1205353
   O'Driscoll L, 2003, CURR CANCER DRUG TAR, V3, P131, DOI 10.2174/1568009033482038
   Ogura R, 2015, NEUROPATHOLOGY, V35, P324, DOI 10.1111/neup.12196
   Ohgaki H, 2013, CLIN CANCER RES, V19, P764, DOI 10.1158/1078-0432.CCR-12-3002
   Okamoto Y, 2004, ACTA NEUROPATHOL, V108, P49, DOI 10.1007/s00401-004-0861-z
   Ostrom QT, 2015, NEURO-ONCOLOGY, V17, P1, DOI 10.1093/neuonc/nov189
   Pardo FS, 2004, BRIT J CANCER, V91, P1678, DOI 10.1038/sj.bjc.6602161
   R. Core Team, 2015, R FDN STAT COMP
   Rathore R, 2017, APOPTOSIS, V22, P898, DOI 10.1007/s10495-017-1375-1
   Saito T, 2007, J NEURO-ONCOL, V82, P193, DOI 10.1007/s11060-006-9267-1
   Sasaki T, 2002, ACTA NEUROPATHOL, V104, P105, DOI 10.1007/s00401-002-0532-x
   Seifert M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1939-9
   Shirai K, 2009, J NEURO-ONCOL, V91, P353, DOI 10.1007/s11060-008-9720-4
   Soffietti R, 2010, EUR J NEUROL, V17, P1124, DOI 10.1111/j.1468-1331.2010.03151.x
   Staberg M, 2017, CELL ONCOL, V40, P21, DOI 10.1007/s13402-016-0301-9
   Stauber RH, 2007, CANCER RES, V67, P5999, DOI 10.1158/0008-5472.CAN-07-0494
   Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330
   Takami H, 2015, BRAIN PATHOL, V25, P256, DOI 10.1111/bpa.12173
   Takano S, 2016, BRAIN TUMOR PATHOL, V33, P107, DOI 10.1007/s10014-016-0260-x
   Tews DS, 2000, J NEURO-ONCOL, V50, P227, DOI 10.1023/A:1006491405010
   Varughese RK, 2016, ONCOL LETT, V12, P1679, DOI 10.3892/ol.2016.4867
   Vischioni B, 2004, ANN ONCOL, V15, P1654, DOI 10.1093/annonc/mdh436
   Waitkus MS, 2016, NEURO-ONCOLOGY, V18, P16, DOI 10.1093/neuonc/nov136
   Wakimoto H, 2014, CLIN CANCER RES, V20, P2898, DOI 10.1158/1078-0432.CCR-13-3052
   Wang K, 2014, ASIAN PAC J CANCER P, V15, P10893, DOI 10.7314/APJCP.2014.15.24.10893
   Weller M, 2014, LANCET ONCOL, V15, pE395, DOI 10.1016/S1470-2045(14)70011-7
   Xie D, 2006, BRIT J CANCER, V94, P108, DOI 10.1038/sj.bjc.6602904
NR 65
TC 4
Z9 5
U1 0
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 2211-3428
EI 2211-3436
J9 CELL ONCOL
JI Cell. Oncol.
PD APR
PY 2018
VL 41
IS 2
BP 141
EP 157
DI 10.1007/s13402-017-0361-5
PG 17
WC Oncology; Cell Biology; Pathology
SC Oncology; Cell Biology; Pathology
GA GA8IX
UT WOS:000428584600003
PM 29374392
DA 2020-12-08
ER

PT J
AU Coelho, MCA
   Vasquez, ML
   Wildemberg, LE
   Vazquez-Borrego, MC
   Bitana, L
   Camacho, AHD
   Silva, D
   Ogino, LL
   Ventura, N
   Chimelli, L
   Luque, RM
   Kasuki, L
   Gadelha, MR
AF Alves Coelho, Maria Caroline
   Vasquez, Marina Lipkin
   Wildemberg, Luiz Eduardo
   Vazquez-Borrego, Mari C.
   Bitana, Luciana
   da Silva Camacho, Aline Helen
   Silva, Debora
   Ogino, Liana Lumi
   Ventura, Nina
   Chimelli, Leila
   Luque, Raul M.
   Kasuki, Leandro
   Gadelha, Monica R.
TI Molecular evidence and clinical importance of beta-arrestins expression
   in patients with acromegaly
SO JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
LA English
DT Article
DE acromegaly; beta-arrestins; somatostatin receptors; dopamine receptor;
   somatostatin receptor ligands
ID SOMATOSTATIN RECEPTOR SUBTYPES; PITUITARY-ADENOMAS;
   QUANTITATIVE-ANALYSIS; BIOCHEMICAL RESPONSE; ANALOG TREATMENT; CONTROL
   GENES; IN-VITRO; CANCER; SOMATOTROPINOMAS; PHOSPHORYLATION
AB beta-arrestins seem to have a role in endocytosis and desensitization of somatostatin receptor subtype 2 (sst2) and could be associated with the responsiveness to somatostatin receptor ligands (SRL) in patients with acromegaly. To investigate the invivo correlation between beta-arrestins 1 and 2 with sst2, sst5 and dopamine receptor subtype 2 (D2) expressions, and the association of beta-arrestins with response to first-generation SRL and invasiveness in somatotropinomas. beta-arrestins 1 and 2, sst2, sst5 and D2 mRNA expressions were evaluated by quantitative real-time RT-PCR on tumoral tissue of 96 patients. Moreover, sst2 and sst5 protein expressions were also evaluated in 40 somatotropinomas by immunohistochemistry. Response to SRL, defined as GH <1 mu g/l and normal IGF-I levels, was assessed in 40 patients. The Knosp-Steiner criteria were used to define invasiveness. Median beta-arrestin 1, beta-arrestin 2, sst2, sst5 and D2 mRNA copy numbers were 478; 9375; 731; 156; and 3989, respectively. There was a positive correlation between beta-arrestins 1 and 2 (R = 0.444, P < 0.001). However, no correlation between beta-arrestins and sst2, sst5 (mRNA and protein levels) or D2 was found. No association was found between beta-arrestins expression and SRL responsiveness or tumour invasiveness. Although previous data suggest a putative correlation between beta-arrestins and sst2, our data clearly indicated that no association existed between beta-arrestins and sst2, sst5 or D2 expression, nor with response to SRL or tumour invasiveness. Therefore, further studies are required to clarify whether beta-arrestins have a role in the response to treatment with SRL in acromegaly.
C1 [Alves Coelho, Maria Caroline; Wildemberg, Luiz Eduardo; Kasuki, Leandro; Gadelha, Monica R.] Univ Fed Rio de Janeiro, Med Sch, Neuroendocrinol Res Ctr, Endocrinol Div, Rio De Janeiro, Brazil.
   [Alves Coelho, Maria Caroline; Wildemberg, Luiz Eduardo; Kasuki, Leandro; Gadelha, Monica R.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil.
   [Alves Coelho, Maria Caroline] Univ Estado Rio De Janeiro, Hosp Univ Pedro Ernesto, Endocrine Div, Rio De Janeiro, Brazil.
   [Alves Coelho, Maria Caroline] Inst Estadual Diabet & Endocrinol Luiz Capriglion, Endocrine Div, Rio De Janeiro, Brazil.
   [Vasquez, Marina Lipkin; Ogino, Liana Lumi; Gadelha, Monica R.] Inst Estadual Cerebro Paulo Niemeyer, Mol Genet Lab, Rio De Janeiro, Brazil.
   [Wildemberg, Luiz Eduardo; Kasuki, Leandro; Gadelha, Monica R.] Inst Estadual Cerebro Paulo Niemeyer, Neuroendocrinol Div, Rio De Janeiro, Brazil.
   [Vazquez-Borrego, Mari C.; Luque, Raul M.] Maimonides Inst Biomed Res Cordoba IMIBIC, Cordoba, Spain.
   [Vazquez-Borrego, Mari C.; Luque, Raul M.] Univ Cordoba, Dept Cell Biol Physiol & Immunol, Cordoba, Spain.
   [Vazquez-Borrego, Mari C.; Luque, Raul M.] Reina Sofia Univ Hosp, Cordoba, Spain.
   [Luque, Raul M.] CIBER Fisiopatol Obesidad & Nutr CIBERobn, Cordoba, Spain.
   [Bitana, Luciana; da Silva Camacho, Aline Helen; Silva, Debora; Chimelli, Leila] Inst Estadual Cerebro Paulo Niemeyer, Neuropathol Lab, Rio De Janeiro, Brazil.
   [da Silva Camacho, Aline Helen] Inst Nacl Canc, Pathol Div, Rio De Janeiro, Brazil.
   [Vazquez-Borrego, Mari C.; Ventura, Nina] Inst Estadual Cerebro Paulo Niemeyer, Radiol Div, Rio De Janeiro, Brazil.
   [Kasuki, Leandro] Hosp Fed Bonsucesso, Endocrine Div, Rio De Janeiro, Brazil.
RP Gadelha, MR (corresponding author), Univ Fed Rio de Janeiro, Med Sch, Neuroendocrinol Res Ctr, Endocrinol Div, Rio De Janeiro, Brazil.; Gadelha, MR (corresponding author), Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil.; Gadelha, MR (corresponding author), Inst Estadual Cerebro Paulo Niemeyer, Mol Genet Lab, Rio De Janeiro, Brazil.; Gadelha, MR (corresponding author), Inst Estadual Cerebro Paulo Niemeyer, Neuroendocrinol Div, Rio De Janeiro, Brazil.; Luque, RM (corresponding author), Maimonides Inst Biomed Res Cordoba IMIBIC, Cordoba, Spain.; Luque, RM (corresponding author), Univ Cordoba, Dept Cell Biol Physiol & Immunol, Cordoba, Spain.; Luque, RM (corresponding author), Reina Sofia Univ Hosp, Cordoba, Spain.; Luque, RM (corresponding author), CIBER Fisiopatol Obesidad & Nutr CIBERobn, Cordoba, Spain.
EM raul.luque@uco.es; mgadelha@hucff.ufrj.br
RI wildemberg, luiz/S-4712-2017; Kasui, Leandro/R-8117-2019
OI Luque, Raul M./0000-0002-7585-1913; Vazquez-Borrego, Mari
   C./0000-0001-7256-8111
FU Rio de Janeiro Research Foundation (FAPERJ)-BrazilCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   Instituto de Salud Carlos III - SpainInstituto de Salud Carlos III;
   CIBERobn - Spain grant [E-26/010.001840/2015]; Junta de AndaluciaJunta
   de Andalucia [BIO-0139, CTS-1406]; Instituto de Salud Carlos
   IIIInstituto de Salud Carlos III; European Union (ERDF/ESF, 'Investing
   in your future')European Union (EU) [PI16/00264]; CIBERobn
FX This study was supported by Rio de Janeiro Research Foundation
   (FAPERJ)-Brazil, Instituto de Salud Carlos III - Spain and CIBERobn -
   Spain grant E-26/010.001840/2015 (to MRG); Junta de Andalucia (BIO-0139,
   CTS-1406), Instituto de Salud Carlos III, co-funded by European Union
   (ERDF/ESF, 'Investing in your future' PI16/00264) and CIBERobn (to RML).
   CIBER is an initiative of Instituto de Salud Carlos III, Ministerio de
   Sanidad, Servicios Sociales e Igualdad, Spain.
CR ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882
   Colao A, 2011, ENDOCR REV, V32, P247, DOI 10.1210/er.2010-0002
   de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208
   Fereshteha M, 2012, P NATL ACAD SCI USA, V109, P12532, DOI 10.1073/pnas.1209815109
   Gadelha MR, 2015, CLIN ENDOCRINOL, V83, P1, DOI 10.1111/cen.12797
   Gadelha MR, 2013, TRENDS ENDOCRIN MET, V24, P238, DOI 10.1016/j.tem.2012.11.007
   Gatto F, 2017, J CLIN ENDOCR METAB, V102, P2009, DOI 10.1210/jc.2017-00135
   Gatto F, 2016, EUR J ENDOCRINOL, V174, P651, DOI 10.1530/EJE-15-0391
   Gatto F, 2013, ENDOCRINOLOGY, V154, P4715, DOI 10.1210/en.2013-1672
   Gatto F, 2013, J CLIN ENDOCR METAB, V98, pE66, DOI 10.1210/jc.2012-2609
   Gatto F, 2013, ENVIRON MANAGE, V51, P1137, DOI 10.1007/s00267-013-0042-8
   Kao YJ, 2011, MOL ENDOCRINOL, V25, P1040, DOI 10.1210/me.2010-0398
   Katznelson L, 2014, J CLIN ENDOCR METAB, V99, P2110
   Lesche S, 2009, J CLIN ENDOCR METAB, V94, P654, DOI 10.1210/jc.2008-1919
   Liu Q, 2008, MOL PHARMACOL, V73, P292, DOI 10.1124/mol.107.038570
   Luttrell LM, 2010, PHARMACOL REV, V62, P305, DOI 10.1124/pr.109.002436
   Micko ASG, 2015, J NEUROSURG, V122, P803, DOI 10.3171/2014.12.JNS141083
   Neill JD, 1998, ENDOCRINOLOGY, V139, P1781, DOI 10.1210/en.139.4.1781
   Peverelli E, 2014, HORM METAB RES, V46, P845, DOI 10.1055/s-0034-1384520
   Peverelli E, 2014, ENDOCRINOLOGY, V155, P2932, DOI 10.1210/en.2014-1063
   Qiu C, 2015, INT J CLIN EXP PATHO, V8, P3785
   REMMELE W, 1987, PATHOLOGE, V8, P138
   Rosano L, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0401-4
   Scott MGH, 2006, MOL CELL BIOL, V26, P3432, DOI 10.1128/MCB.26.9.3432-3445.2006
   Sobolesky PM, 2013, PROG MOL BIOL TRANSL, V118, P395, DOI 10.1016/B978-0-12-394440-5.00015-2
   Sturzenbaum SR, 2001, COMP BIOCHEM PHYS B, V130, P281, DOI 10.1016/S1096-4959(01)00440-7
   Taboada GF, 2008, EUR J ENDOCRINOL, V158, P295, DOI 10.1530/EJE-07-0562
   Taboada GF, 2007, EUR J ENDOCRINOL, V156, P65, DOI 10.1530/eje.1.02313
   Tocci P, 2016, LIFE SCI, V159, P49, DOI 10.1016/j.lfs.2016.01.008
   Tulipano G, 2004, J BIOL CHEM, V279, P21374, DOI 10.1074/jbc.M313522200
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Wildemberg LEA, 2013, J ENDOCRINOL INVEST, V36, P38, DOI 10.3275/8305
NR 32
TC 9
Z9 9
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
EI 1582-4934
J9 J CELL MOL MED
JI J. Cell. Mol. Med.
PD APR
PY 2018
VL 22
IS 4
BP 2110
EP 2116
DI 10.1111/jcmm.13427
PG 7
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA GA6BP
UT WOS:000428418200007
PM 29377493
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Chimelli, L
   Pone, SM
   Avvad-Portari, E
   Vasconcelos, ZFM
   Zin, AA
   Cunha, DP
   Thompson, NR
   Moreira, MEL
   Wiley, CA
   Pone, MVD
AF Chimelli, Leila
   Pone, Sheila Moura
   Avvad-Portari, Elyzabeth
   Meira Vasconcelos, Zilton Farias
   Zin, Andrea Araujo
   Cunha, Daniela Prado
   Thompson, Nathalia Raposo
   Lopes Moreira, Maria Elisabeth
   Wiley, Clayton A.
   da Silva Pone, Marcos Vinicius
TI Persistence of Zika Virus After Birth: Clinical, Virological,
   Neuroimaging, and Neuropathological Documentation in a 5-Month Infant
   With Congenital Zika Syndrome
SO JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
LA English
DT Article
DE Arthrogryposis; Calcification; Hydrocephalus; Microcephaly;
   Neuropathology; RT-qPCR; Zika virus
ID INFECTION; POSTMORTEM; BRAIN
AB During the Zika epidemic in Brazil, a baby was born at term with microcephaly and arthrogryposis. The mother had Zika symptoms at 10 weeks of gestation. At 17 weeks, ultrasound showed cerebral malformation and ventriculomegaly. At 24 weeks, the amniotic fluid contained ZIKV RNA and at birth, placenta and maternal blood were also positive using RT-qPCR. At birth the baby urine contained ZIKV RNA, whereas CSF at birth and urine at 17 days did not. Seizures started at 6 days. EEG was abnormal and CT scan showed cerebral atrophy, calcifications, lissencephaly, ventriculomegaly, and cerebellar hypoplasia. Bacterial sepsis at 2 months was treated. A sudden increase in head circumference occurred at 4 months necessitating ventricle-peritoneal shunt placement. At 5 months, the infant died with sepsis due to bacterial meningitis. Neuropathological findings were as severe as some of those found in neonates who died soon after birth, including hydrocephalus, destructive lesions/calcification, gliosis, abnormal neuronal migration, dysmaturation of nerve cells, hypomyelination, loss of descending axons, and spinal motor neurons. ZIKV RNA was detected only in frozen brain tissue using RT-qPCR, but infected cells were not detected by in situ hybridization. Progressive gliosis and microgliosis in the midbrain may have contributed to aqueduct compression and subsequent hydrocephalus. The etiology of progressive disease after in utero infection is not clear and requires investigation.
C1 [Chimelli, Leila] State Inst Brain, Neuropathol Lab, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.
   [Chimelli, Leila] Univ Fed Rio de Janeiro, Rio de Janeiro, Brazil.
   [Pone, Sheila Moura; Thompson, Nathalia Raposo; da Silva Pone, Marcos Vinicius] Oswaldo Cruz Fdn Fiocruz, Natl Inst Women Children & Adolescents Hlth Ferna, Pediat Infect Dis, Rio De Janeiro, Brazil.
   [Avvad-Portari, Elyzabeth] Oswaldo Cruz Fdn Fiocruz, Natl Inst Women Children & Adolescents Hlth Ferna, Pathol, Rio De Janeiro, Brazil.
   [Meira Vasconcelos, Zilton Farias; Zin, Andrea Araujo; Cunha, Daniela Prado; Lopes Moreira, Maria Elisabeth] Oswaldo Cruz Fdn Fiocruz, Natl Inst Women Children & Adolescents Hlth Ferna, Clin Res Unit, Rio De Janeiro, Brazil.
   [Wiley, Clayton A.] UPMC Presbiterian Hosp, Div Neuropathol, Pittsburgh, PA USA.
RP Chimelli, L (corresponding author), State Inst Brain, Neuropathol Lab, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.
EM chimelli@hucff.ufrj.br
RI Vasconcelos, Zilton/AAD-5784-2019; da Silva Pone, Marcos
   Vinicius/N-1285-2019; Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Vasconcelos, Zilton/0000-0002-2193-2224; Moreira, Maria Elisabeth
   Lopes/0000-0002-2034-0294; Cunha, Daniela/0000-0002-5954-6054; Moura
   Pone, Sheila/0000-0002-6246-8915; da Silva Pone, Marcos
   Vinicius/0000-0002-5152-2242
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Ochieng' N, 2015, J NEUROSURG-PEDIATR, V15, P150, DOI 10.3171/2014.10.PEDS14178
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Siebert JR, 2007, POTTERS PATHOLOGY FE, P695
   SNIJDERS RJM, 1994, ULTRASOUND OBST GYN, V4, P34, DOI 10.1046/j.1469-0705.1994.04010034.x
   Sousa AQ, 2017, EMERG INFECT DIS, V23, P1164, DOI 10.3201/eid2307.162019
NR 16
TC 18
Z9 18
U1 0
U2 8
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-3069
EI 1554-6578
J9 J NEUROPATH EXP NEUR
JI J. Neuropathol. Exp. Neurol.
PD MAR
PY 2018
VL 77
IS 3
BP 193
EP 198
DI 10.1093/jnen/nlx116
PG 6
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA GB3IH
UT WOS:000428949800002
PM 29346650
DA 2020-12-08
ER

PT J
AU De Girolami, U
   Chimelli, L
   Taratuto, AL
AF De Girolami, Umberto
   Chimelli, Leila
   Taratuto, Ana Lia
TI Catherine Daumas-Duport, MD, PhD February 13, 1944-October 1, 2017 IN
   MEMORIAM
SO JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
LA English
DT Biographical-Item
CR DAUMASDUPORT C, PUBLICATION LIST
NR 1
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-3069
EI 1554-6578
J9 J NEUROPATH EXP NEUR
JI J. Neuropathol. Exp. Neurol.
PD JAN
PY 2018
VL 77
IS 1
BP 84
EP 84
DI 10.1093/jnen/nlx103
PG 1
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA GB3IB
UT WOS:000428948900007
OA Bronze
DA 2020-12-08
ER

PT J
AU Chimelli, L
   Avvad-Portari, E
AF Chimelli, L.
   Avvad-Portari, E.
TI Congenital Zika virus infection: a neuropathological review
SO CHILDS NERVOUS SYSTEM
LA English
DT Article
DE Congenital Zika virus infection; Neuropathology; Microcephaly;
   Ventriculomegaly; Calcifications; Migration disturbances
AB Background A relationship between Zika virus (ZikV) infection in pregnancy and the occurrence of microcephaly was established during the Zika outbreak in Brazil (2015-2016). Neuropathological findings in congenital Zika syndrome helped to understand its pathogenetic mechanisms. Results The most relevant postmortem findings in the central nervous system (CNS) of fetuses and neonates infected with ZikV early in gestation are microcephaly with ex-vacuo ventriculomegaly and large head circumference associated with obstructive hydrocephalus due to severe midbrain and aqueduct distortion. Babies with severe brain lesions are born with arthrogryposis. Histologically, there is extensive destruction of the hemispheric parenchyma, calcifications, various disturbances of neuronal migration, reactive gliosis, microglial hyperplasia and occasional perivascular cuffs of lymphocytes, also in the meninges. Hypoplastic lesions secondary to the lack of descending nerve fibers include small basis pontis, pyramids and spinal corticospinal tracts. Cerebellar hypoplasia is also common. Severe nerve motor nerve cell loss is observed in the anterior horn of the spinal cord. Conclusion A spectrum of neuropathological changes, from severe microcephaly to obstructive hydrocephalus was observed. The severity of the lesions is directly related to the gestational age, the most severe occurring when the mother is infected in the first trimester. Infection of progenitor cells at the germinal matrix was demonstrated. The lack of spinal motor neurons is responsible for fetal acynesia and consequent arthrogryposis.
C1 [Chimelli, L.] State Inst Brain Paulo Niemeyer, Lab Neuropathol, Rio De Janeiro, Brazil.
   [Chimelli, L.] Fed Univ Rio De Janeiro UFRJ, Rio De Janeiro, Brazil.
   [Avvad-Portari, E.] Oswaldo Cruz Fdn Fiocruz, Fernandes Figueira Inst, Rio De Janeiro, Brazil.
   [Avvad-Portari, E.] State Univ Rio De Janeiro UERJ, Rio De Janeiro, Brazil.
RP Avvad-Portari, E (corresponding author), Oswaldo Cruz Fdn Fiocruz, Fernandes Figueira Inst, Rio De Janeiro, Brazil.; Avvad-Portari, E (corresponding author), State Univ Rio De Janeiro UERJ, Rio De Janeiro, Brazil.
EM bethavvad@gmail.com
CR Acosta-Reyes J, 2017, EMERG INFECT DIS, V23, P982, DOI 10.3201/eid2306.161702
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Sousa AQ, 2017, EMERG INFECT DIS, V23, P1164, DOI 10.3201/eid2307.162019
NR 9
TC 12
Z9 13
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0256-7040
EI 1433-0350
J9 CHILD NERV SYST
JI Childs Nerv. Syst.
PD JAN
PY 2018
VL 34
IS 1
BP 95
EP 99
DI 10.1007/s00381-017-3651-3
PG 5
WC Clinical Neurology; Pediatrics; Surgery
SC Neurosciences & Neurology; Pediatrics; Surgery
GA FS7GQ
UT WOS:000419966300018
PM 29167994
DA 2020-12-08
ER

PT J
AU Faccion, RS
   Bernardo, PS
   Lopes, GPD
   Bastos, LS
   Teixeira, CL
   de Oliveira, JA
   Fernades, PV
   Dubois, LG
   Chimelli, LM
   Maia, RC
AF Faccion, Roberta Soares
   Bernardo, Paula Sabbo
   de Faria Lopes, Giselle Pinto
   Bastos, Leonardo Soares
   Teixeira, Cristina Lordello
   de Oliveira, Jose Antonio
   Fernades, Priscila Valverde
   Dubois, Luiz Gustavo
   Chimelli, Leila Maria
   Maia, Raquel Ciuvalschi
TI P53 expression and survivin subcellular localization contribute to the
   diagnosis and prognosis of patients with astrocytomas.
SO CLINICAL CANCER RESEARCH
LA English
DT Meeting Abstract
CT AACR International Conference on Translational Cancer Medicine held in
   Cooperation with the Latin-American-Cooperative-Oncology-Group
CY MAY 04-06, 2017
CL Sao Paulo, BRAZIL
SP Amer Assoc Canc Res, Latin Amer Cooperat Oncol Grp
C1 [Faccion, Roberta Soares; Bernardo, Paula Sabbo; Teixeira, Cristina Lordello; de Oliveira, Jose Antonio; Fernades, Priscila Valverde; Maia, Raquel Ciuvalschi] Inst Nacl Canc Jose Alencar Gomes da Silva, Rio De Janeiro, RJ, Brazil.
   [de Faria Lopes, Giselle Pinto] Univ Fed Estado Rio de Janeiro, Rio De Janeiro, RJ, Brazil.
   [Bastos, Leonardo Soares] Fundacao Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.
   [Dubois, Luiz Gustavo; Chimelli, Leila Maria] Inst Estadual Cerebro Paulo Niemeyer, Rio De Janeiro, RJ, Brazil.
RI Bernardo, Paula Sabbo/D-7369-2018; de Faria Lopes,
   Giselle/ABE-3700-2020; maia, raquel c/L-4869-2015; Bastos, Leonardo
   Soares/AAD-5335-2019
OI Bernardo, Paula Sabbo/0000-0001-6478-8026; maia, raquel
   c/0000-0003-0225-471X; Bastos, Leonardo Soares/0000-0002-1406-0122
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 1078-0432
EI 1557-3265
J9 CLIN CANCER RES
JI Clin. Cancer Res.
PD JAN
PY 2018
VL 24
IS 1
SU S
MA B66
BP 97
EP 97
PG 1
WC Oncology
SC Oncology
GA FR6MK
UT WOS:000419180000167
DA 2020-12-08
ER

PT J
AU Araujo, PB
   Kasuki, L
   Lima, CHD
   Ogino, L
   Camacho, AHS
   Chimelli, L
   Korbonits, M
   Gadelha, MR
AF Araujo, Paula Bruna
   Kasuki, Leandro
   de Azeredo Lima, Carlos Henrique
   Ogino, Liana
   Camacho, Aline H. S.
   Chimelli, Leila
   Korbonits, Marta
   Gadelha, Monica R.
TI AIP mutations in Brazilian patients with sporadic pituitary adenomas: a
   single-center evaluation
SO ENDOCRINE CONNECTIONS
LA English
DT Article
DE AIP; germline mutations; sporadic pituitary adenomas; tumor suppressor
   gene
ID INTERACTING-PROTEIN GENE; MULTIPLE ENDOCRINE NEOPLASIA; YOUNG-PATIENTS;
   GERMLINE MUTATIONS; LARGE COHORT; PREDISPOSITION; MACROADENOMAS;
   PREVALENCE; DIAGNOSIS; FAMILIES
AB Aryl hydrocarbon receptor-interacting protein (AIP) gene mutations (AIPmut) are the most frequent germline mutations found in apparently sporadic pituitary adenomas (SPA). Our aim was to evaluate the frequency of AIPmut among young Brazilian patients with SPA. We performed an observational cohort study between 2013 and 2016 in a single referral center. AIPmut screening was carried out in 132 SPA patients with macroadenomas diagnosed up to 40 years or in adenomas of any size diagnosed until 18 years of age. Twelve tumor samples were also analyzed. Leukocyte DNA and tumor tissue DNA were sequenced for the entire AIP-coding region for evaluation of mutations. Eleven (8.3%) of the 132 patients had AIPmut, comprising 9/74 (12%) somatotropinomas, 1/38 (2.6%) prolactinoma, 1/10 (10%) corticotropinoma and no non-functioning adenomas. In pediatric patients (<= 18 years), AIPmut frequency was 13.3% (2/15). Out of the 5 patients with gigantism, two had AIPmut, both truncating mutations. The Y268* mutation was described in Brazilian patients and the K273Rfs*30 mutation is a novel mutation in our patient. No somatic AIP mutations were found in the 12 tumor samples. A tumor sample from an acromegaly patient harboring the A299V AIPmut showed loss of heterozygosity. In conclusion, AIPmut frequency in SPA Brazilian patients is similar to other populations. Our study identified two mutations exclusively found in Brazilians and also shows, for the first time, loss of heterozygosity in tumor DNA from an acromegaly patient harboring the A299V AIPmut. Our findings corroborate previous observations that AIPmut screening should be performed in young patients with SPA.
C1 [Araujo, Paula Bruna; Kasuki, Leandro; Gadelha, Monica R.] Univ Fed Rio de Janeiro, Dept Internal Med, Rio De Janeiro, RJ, Brazil.
   [Araujo, Paula Bruna; Kasuki, Leandro; Gadelha, Monica R.] Univ Fed Rio de Janeiro, Endocrine Unit, Sch Med, Rio De Janeiro, RJ, Brazil.
   [Araujo, Paula Bruna; Kasuki, Leandro; Gadelha, Monica R.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, RJ, Brazil.
   [Araujo, Paula Bruna] Diagnost Amer SA, Rio De Janeiro, RJ, Brazil.
   [Kasuki, Leandro; Gadelha, Monica R.] Inst Estadual Cerebro Paulo Niemeyer, Neuroendocrinol Unit, Rio De Janeiro, RJ, Brazil.
   [Kasuki, Leandro] Hosp Fed Bonsucesso, Endocrinol Unit, Rio De Janeiro, RJ, Brazil.
   [de Azeredo Lima, Carlos Henrique; Ogino, Liana; Gadelha, Monica R.] Inst Estadual Cerebro Paulo Niemeyer, Mol Genet Lab, Rio De Janeiro, RJ, Brazil.
   [Camacho, Aline H. S.; Chimelli, Leila] Inst Estadual Cerebro Paulo Niemeyer, Neuropathol Lab, Rio De Janeiro, RJ, Brazil.
   [Camacho, Aline H. S.] Natl Canc Inst, Rio De Janeiro, RJ, Brazil.
   [Korbonits, Marta] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, Ctr Endocrinol, Charterhouse Sq, London, England.
RP Araujo, PB; Gadelha, MR (corresponding author), Univ Fed Rio de Janeiro, Dept Internal Med, Rio De Janeiro, RJ, Brazil.; Araujo, PB; Gadelha, MR (corresponding author), Univ Fed Rio de Janeiro, Endocrine Unit, Sch Med, Rio De Janeiro, RJ, Brazil.; Araujo, PB; Gadelha, MR (corresponding author), Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, RJ, Brazil.; Araujo, PB (corresponding author), Diagnost Amer SA, Rio De Janeiro, RJ, Brazil.; Gadelha, MR (corresponding author), Inst Estadual Cerebro Paulo Niemeyer, Neuroendocrinol Unit, Rio De Janeiro, RJ, Brazil.; Gadelha, MR (corresponding author), Inst Estadual Cerebro Paulo Niemeyer, Mol Genet Lab, Rio De Janeiro, RJ, Brazil.
EM paulabruna@gmail.com; mgadelha@hucff.ufrj.br
RI Kasui, Leandro/R-8117-2019
OI Korbonits, Marta/0000-0002-4101-9432
FU Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [E-26/010.001967/2014]; NovartisNovartis; Ipsen;
   Diagnosticos da America SA
FX The laboratory work was funded by a grant from Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro - FAPERJ E-26/010.001967/2014 (to M
   R G) and from unrestricted research grants from Novartis and Ipsen (to M
   R G). The funder Diagnosticos da America SA provided support in the form
   of salaries for author P B A, but did not have any additional role in
   the study design, data collection and analysis, decision to publish or
   preparation of the manuscript.
CR Barlier A, 2007, J CLIN ENDOCR METAB, V92, P1952, DOI 10.1210/jc.2006-2702
   Beckers A, 2013, ENDOCR REV, V34, P239, DOI 10.1210/er.2012-1013
   Bolger GB, 2016, ENDOCR-RELAT CANCER, V23, P419, DOI 10.1530/ERC-15-0205
   Cai F, 2013, EUR J ENDOCRINOL, V169, P867, DOI 10.1530/EJE-13-0442
   Cazabat L, 2007, EUR J ENDOCRINOL, V157, P1, DOI 10.1530/EJE-07-0181
   Cazabat L, 2012, J CLIN ENDOCR METAB, V97, pE663, DOI 10.1210/jc.2011-2291
   Chahal HS, 2010, TRENDS ENDOCRIN MET, V21, P419, DOI 10.1016/j.tem.2010.02.007
   Cuny T, 2013, EUR J ENDOCRINOL, V168, P533, DOI 10.1530/EJE-12-0763
   Daly AF, 2007, J CLIN ENDOCR METAB, V92, P1891, DOI 10.1210/jc.2006-2513
   Daly AF, 2015, ENDOCRIN METAB CLIN, V44, P19, DOI 10.1016/j.ecl.2014.10.002
   Daly AF, 2010, J CLIN ENDOCR METAB, V95, pE373, DOI 10.1210/jc.2009-2556
   Denes J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117107
   Gadelha MR, 2013, FRONT HORM RES, V41, P111, DOI 10.1159/000345673
   Gadelha MR, 1999, J CLIN ENDOCR METAB, V84, P249, DOI 10.1210/jc.84.1.249
   Georgitsi M, 2008, J CLIN ENDOCR METAB, V93, P4146, DOI 10.1210/jc.2008-1003
   Georgitsi M, 2008, CLIN ENDOCRINOL, V69, P621, DOI 10.1111/j.1365-2265.2008.03266.x
   Georgitsi M, 2007, P NATL ACAD SCI USA, V104, P4101, DOI 10.1073/pnas.0700004104
   Hernandez-Ramirez LC, 2016, J CLIN ENDOCR METAB, V101, P3144, DOI 10.1210/jc.2016-1307
   Hernandez-Ramirez LC, 2015, J CLIN ENDOCR METAB, V100, pE1242, DOI 10.1210/jc.2015-1869
   Igreja S, 2010, HUM MUTAT, V31, P950, DOI 10.1002/humu.21292
   Iwata T, 2007, CLIN ENDOCRINOL, V66, P499, DOI 10.1111/j.1365-2265.2007.02758.x
   Jaffrain-Rea ML, 2009, ENDOCR-RELAT CANCER, V16, P1029, DOI 10.1677/ERC-09-0094
   de Pinho LKJ, 2010, ARQ BRAS ENDOCRINOL, V54, P698, DOI 10.1590/S0004-27302010000800006
   KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820
   Korbonits M, 2012, CLIN ENDOCRINOL, V77, P351, DOI 10.1111/j.1365-2265.2012.04445.x
   Laenger A, 2009, FEBS LETT, V583, P1493, DOI 10.1016/j.febslet.2009.03.072
   Lecoq AL, 2016, EUR J ENDOCRINOL, V174, P523, DOI 10.1530/EJE-15-1044
   Lecoq AL, 2015, NAT REV ENDOCRINOL, V11, P43, DOI 10.1038/nrendo.2014.181
   Leontiou CA, 2008, J CLIN ENDOCR METAB, V93, P2390, DOI 10.1210/jc.2007-2611
   Luzi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039767
   Melmed S, 2011, NAT REV ENDOCRINOL, V7, P257, DOI 10.1038/nrendo.2011.40
   Minnetti M, 2016, BEST PRACT RES CL EN, V30, P115, DOI 10.1016/j.beem.2015.09.007
   Occhi G, 2010, EUR J ENDOCRINOL, V163, P369, DOI 10.1530/EJE-10-0327
   Oriola J, 2013, EUR J ENDOCRINOL, V168, P9, DOI 10.1530/EJE-12-0457
   Ozfirat Z, 2010, MOL CELL ENDOCRINOL, V326, P71, DOI 10.1016/j.mce.2010.05.001
   Perez-Rivas LG, 2015, J CLIN ENDOCR METAB, V100, pE997, DOI 10.1210/jc.2015-1453
   Preda V, 2014, EUR J ENDOCRINOL, V171, P659, DOI 10.1530/EJE-14-0426
   Ramalho-Carvalho J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058206
   Ramirez-Renteria C, 2016, ENDOCRINE, V53, P402, DOI 10.1007/s12020-016-0930-9
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Rowlands JC, 2011, DRUG METAB PHARMACOK, V26, P431, DOI 10.2133/dmpk.DMPK-11-SC-013
   Schofl C, 2014, J CLIN ENDOCR METAB, V99, pE2789, DOI 10.1210/jc.2014-2094
   Stratakis CA, 2010, CLIN GENET, V78, P457, DOI 10.1111/j.1399-0004.2010.01406.x
   Swedenborg E, 2010, TOXICOLOGY, V268, P132, DOI 10.1016/j.tox.2009.09.007
   Tichomirowa MA, 2011, EUR J ENDOCRINOL, V165, P509, DOI 10.1530/EJE-11-0304
   Toledo RA, 2007, J CLIN ENDOCR METAB, V92, P1934, DOI 10.1210/jc.2006-2394
   Trivellin G, 2012, AM J PHYSIOL-ENDOC M, V303, pE708, DOI 10.1152/ajpendo.00546.2011
   Trivellin G, 2011, J ENDOCRINOL, V210, P137, DOI 10.1530/JOE-11-0054
   Tuominen I, 2015, ONCOGENE, V34, P1174, DOI 10.1038/onc.2014.50
   Vierimaa O, 2006, SCIENCE, V312, P1228, DOI 10.1126/science.1126100
   Zatelli MC, 2013, PITUITARY, V16, P238, DOI 10.1007/s11102-012-0409-5
NR 51
TC 4
Z9 4
U1 1
U2 2
PU BIOSCIENTIFICA LTD
PI BRISTOL
PA EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT,
   ENGLAND
SN 2049-3614
J9 ENDOCR CONNECT
JI Endocr. Connect.
PD NOV 1
PY 2017
VL 6
IS 8
BP 914
EP 925
DI 10.1530/EC-17-0237
PG 12
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FQ6TS
UT WOS:000418497500043
PM 29074612
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Wiley, CA
   Chimelli, L
AF Wiley, Clayton A.
   Chimelli, Leila
TI Human Zika and West Nile virus neurological infections: What is the
   difference?
SO NEUROPATHOLOGY
LA English
DT Review
ID ENCEPHALITIS; RISK; TRANSMISSION; PERSISTENCE; EPIDEMIC; VIREMIA;
   BRAZIL; WOMEN
AB The recent epidemic of West Nile Virus (WNV) infection in the United States was associated with severe neurological disease in immunocompromised hosts, while the emergence of Zika virus infection in the Americas has been notable for an association with increased microcephaly in the fetuses of infected mothers. Rare autopsies of WNV infected humans have shown multiple organ involvement with a clear neurotropism. We have recently had the opportunity to examine the distribution of Zika virus in autopsies of newborns from infected pregnancies. While both viruses infect multiple organs, Zika appears to cause neurological disease in the fetus through two different mechanisms. Infection during the first trimester showed the potential to infect neural progenitor cells causing severe developmental abnormalities, while infection later in gestation was associated with meningeal infection and destructive ischemic lesions of the brain. Both viruses infect kidney tubules but Zika shares a prominent hepatotropism characteristic of other flaviviruses (e.g., Dengue). Limited transplacental Zika infection would be consistent with restriction to primary maternal infections with high viremia. In the absence of a vaccine, restriction of travel by immunosuppressed and pregnant non-immune individuals to endemic regions seems prudent.
C1 [Wiley, Clayton A.] Univ Pittsburgh, Sch Med, Dept Pathol, 200 Lothrop St,Scaife Hall S-701, Pittsburgh, PA 15238 USA.
   [Chimelli, Leila] State Inst Brain Paulo Niemeyer, Neuropathol Lab, Rio De Janeiro, Brazil.
RP Wiley, CA (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, 200 Lothrop St,Scaife Hall S-701, Pittsburgh, PA 15238 USA.
EM wileyca@upmc.edu
RI amsalu, ribka/G-8780-2019
CR Armah HB, 2007, BRAIN PATHOL, V17, P354, DOI 10.1111/j.1750-3639.2007.00080.x
   Barzon L, 2014, J CLIN MICROBIOL, V52, P3411, DOI 10.1128/JCM.01328-14
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   Bharucha T, 2016, NEUROPATH APPL NEURO, V42, P317, DOI 10.1111/nan.12326
   Bidet K, 2014, BIOCHEM J, V462, P215, DOI 10.1042/BJ20140456
   Bissel SJ, 2015, J NEUROPATH EXP NEUR, V74, P767, DOI 10.1097/NEN.0000000000000215
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1135
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Chimelli L, 2017, ACTA NEUROPATHOL
   DeSalvo D, 2004, TRANSPLANTATION, V77, P466, DOI 10.1097/01.TP.0000101434.98873.CB
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Garcia MN, 2015, MICROBES INFECT, V17, P163, DOI 10.1016/j.micinf.2014.12.003
   Gold CA, 2016, JAMA NEUROL, V73, P905, DOI 10.1001/jamaneurol.2016.1268
   Guarner J, 2004, HUM PATHOL, V35, P983, DOI 10.1016/j.humpath.2004.04.008
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kleinschmidt-DeMasters BK, 2004, ARCH NEUROL-CHICAGO, V61, P1210, DOI 10.1001/archneur.61.8.1210
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lopez M, 2010, FETAL DIAGN THER, V28, P1, DOI 10.1159/000309155
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Michielsen PP, 1999, ACTA GASTRO-ENT BELG, V62, P21
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Novak CM, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12615
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Petrovsky N, 2013, J VIROL, V87, P10324, DOI 10.1128/JVI.00480-13
   POGODINA VV, 1983, ARCH VIROL, V75, P71, DOI 10.1007/BF01314128
   Ratterree MS, 2004, J INFECT DIS, V189, P669, DOI 10.1086/381461
   Samuel CE, 2002, P NATL ACAD SCI USA, V99, P11555, DOI 10.1073/pnas.202448899
   Smith RD, 2004, HUM PATHOL, V35, P254, DOI 10.1016/j.humpath.2003.09.007
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522
NR 39
TC 3
Z9 3
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0919-6544
EI 1440-1789
J9 NEUROPATHOLOGY
JI Neuropathology
PD OCT
PY 2017
VL 37
IS 5
BP 393
EP 397
DI 10.1111/neup.12385
PG 5
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA FI6HY
UT WOS:000412096400002
PM 28493351
OA Bronze
DA 2020-12-08
ER

PT J
AU Landemberger, MC
   Machado, CF
   Smid, J
   Gomes, HR
   Chimelli, L
   Canedo, NH
   Rosemberg, S
   Nitrini, R
   Martins, VR
AF Landemberger, M. C.
   Machado, C. F.
   Smid, J.
   Gomes, H. R.
   Chimelli, L.
   Canedo, N. H.
   Rosemberg, S.
   Nitrini, R.
   Martins, V. R.
TI Surveillance of human prion diseases in Brazil data from 2005 to 2017
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
CT ISN-ESN Meeting
CY AUG 20-24, 2017
CL Paris, FRANCE
SP Int Soc Neurochemistry, Amer Soc Neurochemistry, ESN
C1 [Landemberger, M. C.; Machado, C. F.; Martins, V. R.] AC Camargo Canc Ctr, Int Res Ctr, Sao Paulo, Brazil.
   [Smid, J.; Gomes, H. R.; Rosemberg, S.; Nitrini, R.] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   [Chimelli, L.; Canedo, N. H.] Univ Fed Rio de Janeiro, Fac Med, Rio de Janeiro, Brazil.
RI Martins, Vilma/N-5446-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD AUG
PY 2017
VL 142
SU 1
SI SI
MA WTH07-27
BP 222
EP 222
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA FD3HY
UT WOS:000407425300538
DA 2020-12-08
ER

PT J
AU Balca-Silva, J
   Matias, D
   Dubois, LG
   Carneiro, B
   do Carmo, A
   Girao, H
   Ferreira, F
   Ferrer, VP
   Chimelli, L
   Niemeyer, P
   Tao, HN
   Rebelo, O
   Barbosa, M
   Sarmento-Ribeiro, AB
   Lopes, MC
   Moura-Neto, V
AF Balca-Silva, Joana
   Matias, Diana
   Dubois, Luiz Gustavo
   Carneiro, Brenno
   do Carmo, Analia
   Girao, Henrique
   Ferreira, Fernanda
   Ferrer, Valeria Pereira
   Chimelli, Leila
   Niemeyer Filho, Paulo
   Tao, Herm-Nio
   Rebelo, Olinda
   Barbosa, Marcos
   Sarmento-Ribeiro, Ana Bela
   Lopes, Maria Celeste
   Moura-Neto, Vivaldo
TI The Expression of Connexins and SOX2 Reflects the Plasticity of Glioma
   Stem-Like Cells
SO TRANSLATIONAL ONCOLOGY
LA English
DT Article
ID MESENCHYMAL TRANSITION; ADJUVANT TEMOZOLOMIDE; TUMOR HETEROGENEITY;
   CLONAL EVOLUTION; DRUG-RESISTANCE; GLIOBLASTOMA; CANCER; RADIOTHERAPY;
   ORGANIZATION; EPIGENETICS
AB Glioblastoma (GBM) is the most malignant primary brain tumor, with an average survival rate of 15 months. GBM is highly refractory to therapy, and such unresponsiveness is due, primarily, but not exclusively, to the glioma stem-like cells (GSCs). This subpopulation express stem-like cell markers and is responsible for the heterogeneity of GBM, generating multiple differentiated cell phenotypes. However, how GBMs maintain the balance between stem and non-stem populations is still poorly understood. We investigated the GBM ability to interconvert between stem and non-stem states through the evaluation of the expression of specific stem cell markers as well as cell communication proteins. We evaluated the molecular and phenotypic characteristics of GSCs derived from differentiated GBM cell lines by comparing their stem-like cell properties and expression of connexins. We showed that non-GSCs as well as GSCs can undergo successive cycles of gain and loss of stem properties, demonstrating a bidirectional cellular plasticity model that is accompanied by changes on connexins expression. Our findings indicate that the interconversion between non-GSCs and GSCs can be modulated by extracellular factors culminating on differential expression of stem-like cell markers and cell-cell communication proteins. Ultimately, we observed that stem markers are mostly expressed on GBMs rather than on low-grade astrocytomas, suggesting that the presence of GSCs is a feature of high-grade gliomas. Together, our data demonstrate the utmost importance of the understanding of stem cell plasticity properties in a way to a step closer to new strategic approaches to potentially eliminate GSCs and, hopefully, prevent tumor recurrence.
C1 [Balca-Silva, Joana; do Carmo, Analia; Girao, Henrique; Sarmento-Ribeiro, Ana Bela; Lopes, Maria Celeste] Ctr Neurosci & Cell Biol, Coimbra, Portugal.
   [Balca-Silva, Joana; do Carmo, Analia; Girao, Henrique; Sarmento-Ribeiro, Ana Bela; Lopes, Maria Celeste] Inst Biomed Imaging & Life Sci CNC IBILI, Coimbra, Portugal.
   [Balca-Silva, Joana; Girao, Henrique; Barbosa, Marcos; Sarmento-Ribeiro, Ana Bela] Univ Coimbra FMUC, Fac Med, Coimbra, Portugal.
   [Balca-Silva, Joana; Matias, Diana; Dubois, Luiz Gustavo; Ferrer, Valeria Pereira; Chimelli, Leila; Niemeyer Filho, Paulo] IECPN, Secretaria Estado Saude, 156 Ctr, BR-20231092 Rio De Janeiro, RJ, Brazil.
   [Matias, Diana; Carneiro, Brenno; Ferreira, Fernanda] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [do Carmo, Analia] CHUC, Clin Pathol Dept, Coimbra, Portugal.
   [Tao, Herm-Nio] CHUC, Neurosurg Serv, Coimbra, Portugal.
   [Lopes, Maria Celeste] CHUC, Neurol Serv, Neuropathol Lab, Coimbra, Portugal.
   [Rebelo, Olinda; Sarmento-Ribeiro, Ana Bela] Univ Coimbra, Fac Med, CIMAGO, Coimbra, Portugal.
   [Rebelo, Olinda; Sarmento-Ribeiro, Ana Bela] Univ Coimbra, Lab Oncobiol & Hematol, Coimbra, Portugal.
   [Sarmento-Ribeiro, Ana Bela] CHUC, Hematol Dept, Coimbra, Portugal.
   [do Carmo, Analia] Univ Coimbra, Fac Pharm, FFUC, Coimbra, Portugal.
RP Balca-Silva, J (corresponding author), IECPN, Secretaria Estado Saude, 156 Ctr, BR-20231092 Rio De Janeiro, RJ, Brazil.
EM joanabalca.silva@gmail.com
RI Sarmento Ribeiro, Ana Bela/U-9773-2017; Matias, Diana/O-5110-2014;
   Moura-Neto, VIVALDO/V-9913-2019; Ferrer, Valeria Pereira/N-9890-2018;
   Girao, H/I-7591-2012; Barbosa, Marcos/C-6884-2018; Carmo,
   Analia/ABE-3713-2020; Feijo Dubois, Luiz Gustavo/O-9904-2015
OI Sarmento Ribeiro, Ana Bela/0000-0002-4142-4841; Moura-Neto,
   VIVALDO/0000-0002-6266-043X; Ferrer, Valeria
   Pereira/0000-0002-5210-3445; Barbosa, Marcos/0000-0003-3704-4499; Carmo,
   Analia/0000-0002-7704-4736; Girao, Henrique/0000-0002-5786-8447; Matias,
   Diana/0000-0002-1327-6108; Feijo Dubois, Luiz
   Gustavo/0000-0002-9765-5315
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); Pro-Saude Associacao Beneficente de
   Assistencia Social e Hospitalar; Ary Frauzino Foundation for Cancer
   Research; FEDER through Operational Programme Factors
   Competitiveness-COMPETE; FCT-Foundation for Science and Technology
   within FCT-Fundacao para a Ciencia e Tecnologia [SFRH/BD/51993/2012]; 
   [FEDER/COMPETE/FCTPTDC/EBB-EBI/120634/2010]; 
   [PDTC/QUI-BIQ/120652/2010];  [QREN: CENTRO-01-0762-FEDER-00204]; 
   [PEst-C/SAU/LA0001/2013-2014]
FX We are grateful to Dr. Herve Chneiweiss for providing the OB1 cell line.
   We are also grateful to Tania Spohr for providing the SOX2 Syber green
   primer for qPCR. This study was supported by the Brazilian agencies
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES),
   Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ), Pro-Saude
   Associacao Beneficente de Assistencia Social e Hospitalar, and Ary
   Frauzino Foundation for Cancer Research. Also, this study was also
   supported by FEDER funds through the Operational Programme Factors
   Competitiveness-COMPETE and National Funds through the FCT-Foundation
   for Science and Technology within the project "National funds from
   FCT-Fundacao para a Ciencia e Tecnologia" under a Ph.D. fellowship to
   Joana Balca Pinheiro da Costa e Silva (SFRH/BD/51993/2012) and by the
   project PEst-C/SAU/LA0001/2013-2014. Additional funding was granted by
   FEDER/COMPETE/FCTPTDC/EBB-EBI/120634/2010 and PDTC/QUI-BIQ/120652/2010
   and by QREN: CENTRO-01-0762-FEDER-00204.
CR Altaner C, 2012, NEOPLASMA, V59, P756, DOI 10.4149/neo_2012_95
   Balca-Silva J, 2015, BBA-GEN SUBJECTS, V1850, P722, DOI 10.1016/j.bbagen.2014.12.022
   BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510
   Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108
   Deheeger M., 2014, CANC CELL MICROENVIR, V1
   Diaz Arlhee, 2011, Cancers (Basel), V3, P3331, DOI 10.3390/cancers3033331
   Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738
   Dubois LG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00418
   Easwaran H, 2014, MOL CELL, V54, P716, DOI 10.1016/j.molcel.2014.05.015
   Evans WH, 2002, MOL MEMBR BIOL, V19, P121, DOI 10.1080/09687680210139839
   Faria J, 2006, DIFFERENTIATION, V74, P562, DOI 10.1111/j.1432-0436.2006.00090.x
   Garcia C, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-923
   Grossman SA, 2010, CLIN CANCER RES, V16, P2443, DOI 10.1158/1078-0432.CCR-09-3106
   Hitomi M, 2015, CELL REP, V11, P1031, DOI 10.1016/j.celrep.2015.04.021
   Huse JT, 2013, ANNU REV MED, V64, P59, DOI 10.1146/annurev-med-100711-143028
   Jackson M, 2015, CARCINOGENESIS, V36, P177, DOI 10.1093/carcin/bgu243
   Kahn SA, 2012, CURR TOP MED CHEM, V12, P2082
   Lima FRS, 2012, BBA-REV CANCER, V1826, P338, DOI 10.1016/j.bbcan.2012.05.004
   Liu Y, 2012, EXPERT OPIN DRUG DEL, V9, P671, DOI 10.1517/17425247.2012.682726
   Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1
   Mallini P, 2014, CANCER TREAT REV, V40, P341, DOI 10.1016/j.ctrv.2013.09.008
   Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624
   Naus CC, 2010, NAT REV CANCER, V10, P435, DOI 10.1038/nrc2841
   Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023
   Oliveira-Nunes MC, 2016, CANCER CELL INT, V16, DOI 10.1186/s12935-016-0324-3
   Orellana JA, 2012, REV NEUROSCIENCE, V23, P163, DOI 10.1515/revneuro-2011-0065
   Ortensi B, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt166
   Patru C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-66
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Reference JE, 1985, BOTTENSTEIN PRODUCT
   Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003
   Safa AR, 2015, GENES DIS, V2, P152, DOI 10.1016/j.gendis.2015.02.001
   Schuh A, 2012, BLOOD, V120, P4191, DOI 10.1182/blood-2012-05-433540
   Seymour T, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00159
   Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933
   Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128
   Soares AR, 2015, SCI REP-UK, V5, DOI 10.1038/srep13243
   Soroceanu L, 2001, GLIA, V33, P107, DOI 10.1002/1098-1136(200102)33:2<107::AID-GLIA1010>3.0.CO;2-4
   Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330
   Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7
   Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336
   Tania M, 2014, TUMOR BIOL, V35, P7335, DOI 10.1007/s13277-014-2163-y
   Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777
   Thirant C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016375
   Todorova MG, 2008, J CELL PHYSIOL, V214, P354, DOI 10.1002/jcp.21203
   TOWBIN H, 1989, J CLIN CHEM CLIN BIO, V27, P495
   Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007
   Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309
   Wurth R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/126586
NR 49
TC 11
Z9 12
U1 1
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1936-5233
J9 TRANSL ONCOL
JI Transl. Oncol.
PD AUG
PY 2017
VL 10
IS 4
BP 555
EP 569
DI 10.1016/j.tranon.2017.04.005
PG 15
WC Oncology
SC Oncology
GA FD7LN
UT WOS:000407707700011
PM 28654819
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Correa, DG
   de Souza, SR
   Ventura, N
   Camacho, AH
   Chimelli, L
   Gasparetto, EL
AF Correa, Diogo Goulart
   de Souza, Simone Rachid
   Ventura, Nina
   Camacho, Aline Helen
   Chimelli, Leila
   Gasparetto, Emerson Leandro
TI Suprasellar atypical teratoid/rhabdoid tumor
SO JOURNAL OF NEURORADIOLOGY
LA English
DT Letter
ID FEATURES
C1 [Correa, Diogo Goulart; Ventura, Nina; Gasparetto, Emerson Leandro] State Inst Brain, Dept Radiol, Rua Rezende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.
   [de Souza, Simone Rachid; Camacho, Aline Helen; Chimelli, Leila] State Inst Brain, Neuropathol Lab, Rua Rezende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.
RP Correa, DG (corresponding author), State Inst Brain, Dept Radiol, Rua Rezende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.
EM diogogoulartcorrea@yahoo.com.br
RI Correa, Diogo/AAZ-1590-2020
CR Biswas A, 2016, CANCER MANAG RES, V8, P115, DOI 10.2147/CMAR.S83472
   Plaza MJ, 2013, AM J ROENTGENOL, V200, P1115, DOI 10.2214/AJR.12.9725
   Tez S, 2008, TURK NEUROSURG, V18, P30
   Warmuth-Metz M, 2008, NEURORADIOLOGY, V50, P447, DOI 10.1007/s00234-008-0369-7
   Yildiz AE, 2016, J NEURORADIOLOGY, V43, P246, DOI 10.1016/j.neurad.2016.03.009
NR 5
TC 0
Z9 0
U1 0
U2 1
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 0150-9861
EI 1773-0406
J9 J NEURORADIOLOGY
JI J. Neuroradiol.
PD JUL
PY 2017
VL 44
IS 4
BP 288
EP 290
DI 10.1016/j.neurad.2017.03.002
PG 3
WC Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical
   Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA FD6VV
UT WOS:000407666900010
PM 28454722
DA 2020-12-08
ER

PT J
AU Andreiuolo, F
   Le Teuff, G
   Bayar, MA
   Kilday, JP
   Pietsch, T
   von Bueren, AO
   Witt, H
   Korshunov, A
   Modena, P
   Pfister, SM
   Pages, M
   Castel, D
   Giangaspero, F
   Chimelli, L
   Varlet, P
   Rutkowski, S
   Frappaz, D
   Massimino, M
   Grundy, R
   Grill, J
AF Andreiuolo, Felipe
   Le Teuff, Gwenael
   Bayar, Mohamed Amine
   Kilday, John-Paul
   Pietsch, Torsten
   von Bueren, Andre O.
   Witt, Hendrik
   Korshunov, Andrey
   Modena, Piergiorgio
   Pfister, Stefan M.
   Pages, Melanie
   Castel, David
   Giangaspero, Felice
   Chimelli, Leila
   Varlet, Pascale
   Rutkowski, Stefan
   Frappaz, Didier
   Massimino, Maura
   Grundy, Richard
   Grill, Jacques
CA SIOP Ependymoma Biology Working
TI Integrating Tenascin-C protein expression and 1q25 copy number status in
   pediatric intracranial ependymoma prognostication: A new model for risk
   stratification
SO PLOS ONE
LA English
DT Article
ID POSTOPERATIVE CHEMOTHERAPY; CHILDHOOD; SUPRATENTORIAL; CHILDREN;
   MARKERS; TRIAL; CLASSIFICATION; IRRADIATION; PROGRESSION; VALIDATION
AB Purpose
   Despite multimodal therapy, prognosis of pediatric intracranial ependymomas remains poor with a 5-year survival rate below 70% and frequent late deaths.
   Experimental design
   This multicentric European study evaluated putative prognostic biomarkers. Tenascin-C (TNC) immunohistochemical expression and copy number status of 1q25 were retained for a pooled analysis of 5 independent cohorts. The prognostic value of TNC and 1q25 on the overall survival (OS) was assessed using a Cox model adjusted to age at diagnosis, tumor location, WHO grade, extent of resection, radiotherapy and stratified by cohort. Stratification on a predictor that did not satisfy the proportional hazards assumption was considered. Model performance was evaluated and an internal-external cross validation was performed.
   Results
   Among complete cases with 5-year median follow-up (n = 470; 131 deaths), TNC and 1q25 gain were significantly associated with age at diagnosis and posterior fossa tumor location. 1q25 status added independent prognostic value for death beyond the classical variables with a hazard ratio (HR) = 2.19 95%CI = [1.29; 3.76] (p = 0.004), while TNC prognostic relation was tumor location-dependent with HR = 2.19 95%CI = [1.29; 3.76] (p = 0.004) in posterior fossa and HR = 0.64 [0.28; 1.48] (p = 0.295) in supratentorial (interaction p value = 0.015). The derived prognostic score identified 3 different robust risk groups. The omission of upfront RT was not associated with OS for good and intermediate prognostic groups while the absence of upfront RT was negatively associated with OS in the poor risk group.
   Conclusion
   Integrated TNC expression and 1q25 status are useful to better stratify patients and to eventually adapt treatment regimens in pediatric intracranial ependymoma.
C1 [Andreiuolo, Felipe; Castel, David; Grill, Jacques] Univ Paris Sud, Gustave Roussy, CNRS, UMR Vectorol & Therapeut Anticanc 8203, Villejuif, France.
   [Andreiuolo, Felipe; Pages, Melanie; Varlet, Pascale] Hop St Anne, Dept Neuropathol, Paris, France.
   [Andreiuolo, Felipe; Chimelli, Leila] Univ Fed Rio de Janeiro, Dept Patol, Rio De Janeiro, Brazil.
   [Le Teuff, Gwenael; Bayar, Mohamed Amine] Gustave Roussy, Dept Biostat & Epidemiol, Canc Campus, Villejuif, France.
   [Le Teuff, Gwenael; Bayar, Mohamed Amine] Paris Sud Univ, U1018, INSERM, CESP Ctr Res Epidemiol & Populat Hlth, Villejuif, France.
   [Kilday, John-Paul] Royal Manchester Childrens Hosp, Childrens Brain Tumour Res Network, Manchester, Lancs, England.
   [Kilday, John-Paul] Univ Manchester, Inst Canc Sci, Ctr Paediat Teenage & Young Adult Canc, Manchester, Lancs, England.
   [Pietsch, Torsten] Univ Bonn, Med Ctr, Inst Neuropathol, Bonn, Germany.
   [von Bueren, Andre O.; Rutkowski, Stefan] Univ Med Ctr Hamburg Eppendorf, Dept Paediat Hematol & Oncol, Hamburg, Germany.
   [von Bueren, Andre O.] Univ Med Ctr Goettingen, Dept Pediat & Adolescent Med, Div Pediat Hematol & Oncol, Gottingen, Germany.
   [Witt, Hendrik; Pfister, Stefan M.] German Canc Res Ctr, Div Paediat Neurooncol, Heidelberg, Germany.
   [Witt, Hendrik; Pfister, Stefan M.] Heidelberg Univ Hosp, Dept Paediat Oncol, Heidelberg, Germany.
   [Korshunov, Andrey] German Canc Res Ctr, Clin Cooperat Unit Neuropathol, Heidelberg, Germany.
   [Modena, Piergiorgio] Osped S Anna Como, Dept Pathol, Genet Unit, Como, Italy.
   [Pages, Melanie; Varlet, Pascale] Univ Sorbonne Paris Cite, Paris, France.
   [Castel, David; Grill, Jacques] Gustave Roussy, Dept Cancerol Enfant & Adolescent, Villejuif, France.
   [Giangaspero, Felice] Sapienza Univ, Dept Radiol Oncol & Anatomopathol, Rome, Italy.
   [Giangaspero, Felice] IRCCS Neuromed, Pozzilli, Isernia, Italy.
   [Frappaz, Didier] Inst Hematol Oncol Pediat, Lyon, France.
   [Massimino, Maura] Fdn Ist Ricovero & Cura Carattere Sci, Paediat Unit, Ist Nazl Tumori, Milan, Italy.
   [Grundy, Richard] Univ Nottingham, Childrens Brain Tumour Res Ctr, Nottingham, England.
RP Grill, J (corresponding author), Univ Paris Sud, Gustave Roussy, CNRS, UMR Vectorol & Therapeut Anticanc 8203, Villejuif, France.; Grill, J (corresponding author), Gustave Roussy, Dept Cancerol Enfant & Adolescent, Villejuif, France.
EM jacques.grill@gustaveroussy.fr
RI GIANGASPERO, FELICE/Z-4961-2019; Castel, David/D-5353-2018; Pfister,
   Stefan M/F-6860-2013; Grill, Jacques/R-8093-2019; Giangaspero,
   Felice/AAH-9253-2020; von Bueren, Andre/AAF-2065-2020; Pages,
   Melanie/S-1875-2019; Massimino, Maura/K-7310-2016
OI Castel, David/0000-0003-0247-080X; Pfister, Stefan
   M/0000-0002-5447-5322; Giangaspero, Felice/0000-0001-5382-2380; VARLET,
   pascale/0000-0002-8164-1517; Korshunov, Andrey/0000-0002-5257-3623;
   BAYAR, Mohamed Amine/0000-0002-9513-900X; Grundy,
   Richard/0000-0002-2585-2539; Massimino, Maura/0000-0002-5506-2001;
   Andreiuolo, Felipe/0000-0002-2568-6155
FU INCa/Canceropole Ile de FranceInstitut National du Cancer (INCA) France;
   Societe Francaise des Cancers de l'Enfant/Enfants et Sante; L'Etoile de
   Martin; Mecenat Carrefour; German Childrens Cancer Aid (DKKS); James
   Tudor Foundation; Joseph Foote Foundation;  [Cancer Research-UK]
FX This study had financial support from INCa/Canceropole Ile de France
   (FA), Societe Francaise des Cancers de l'Enfant/Enfants et Sante (JG),
   Cancer Research-UK (in support of Childrens Cancer and Leukemia Group)
   (JPK and RG) and the following charities: L'Etoile de Martin, Lea
   Princesse Eternelle, Sarah Petite Princesse, Mecenat Carrefour (JG),
   German Childrens Cancer Aid (DKKS) (TP), the James Tudor and Joseph
   Foote Foundations (RG). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Altman DG, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-51
   Andreiuolo F, 2013, FUTURE ONCOL, V9, P183, DOI [10.2217/fon.12.174, 10.2217/FON.12.174]
   Andreiuolo F, 2010, NEURO-ONCOLOGY, V12, P1126, DOI 10.1093/neuonc/noq074
   Araki A, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0349-9
   Carter M, 2002, BRIT J CANCER, V86, P929, DOI 10.1038/sj.bjc.6600180
   Dyer S, 2002, AM J PATHOL, V161, P2133, DOI 10.1016/S0002-9440(10)64491-4
   Ellison DW, 2011, J NEGAT RESULTS BIOM, V10, DOI 10.1186/1477-5751-10-7
   Godfraind C, 2012, ACTA NEUROPATHOL, V124, P247, DOI 10.1007/s00401-012-0981-9
   Grill J, 2001, J CLIN ONCOL, V19, P1288, DOI 10.1200/JCO.2001.19.5.1288
   Grundy RG, 2007, LANCET ONCOL, V8, P696, DOI 10.1016/S1470-2045(07)70208-5
   Gupta RK, 2014, J NEURO-ONCOL, V116, P267, DOI 10.1007/s11060-013-1287-z
   Kattan MW, 2004, CLIN CANCER RES, V10, P822, DOI 10.1158/1078-0432.CCR-03-0061
   Kilday JP, 2012, CLIN CANCER RES, V18, P2001, DOI 10.1158/1078-0432.CCR-11-2489
   Korshunov A, 2000, J NEUROL SCI, V177, P72, DOI 10.1016/S0022-510X(00)00347-6
   Korshunov A, 2010, J CLIN ONCOL, V28, P3182, DOI 10.1200/JCO.2009.27.3359
   Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1
   Massimino M, 2011, INT J RADIAT ONCOL, V80, P807, DOI 10.1016/j.ijrobp.2010.02.048
   Mendrzyk F, 2006, CLIN CANCER RES, V12, P2070, DOI 10.1158/1078-0432.CCR-05-2363
   Merchant TE, 2009, LANCET ONCOL, V10, P258, DOI 10.1016/S1470-2045(08)70342-5
   Orend G, 2006, CANCER LETT, V244, P143, DOI 10.1016/j.canlet.2006.02.017
   Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379
   Pajtler KW, 2015, CANCER CELL, V27, P728, DOI 10.1016/j.ccell.2015.04.002
   Parker M, 2014, NATURE, V506, P451, DOI 10.1038/nature13109
   Pietsch T, 2014, ACTA NEUROPATHOL, V127, P609, DOI 10.1007/s00401-014-1264-4
   Puget S, 2009, J CLIN ONCOL, V27, P1884, DOI 10.1200/JCO.2007.15.4195
   Royston P, 2004, STAT MED, V23, P907, DOI 10.1002/sim.1691
   Royston P, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-33
   Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001
   Timmermann B, 2000, INT J RADIAT ONCOL, V46, P287, DOI 10.1016/S0360-3016(99)00414-9
   Witt H, 2011, CANCER CELL, V20, P143, DOI 10.1016/j.ccr.2011.07.007
   Zamecnik J, 2004, NEOPLASMA, V51, P214
NR 31
TC 5
Z9 5
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 15
PY 2017
VL 12
IS 6
AR e0178351
DI 10.1371/journal.pone.0178351
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EX6PQ
UT WOS:000403364600009
PM 28617804
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Smid, J
   Neto, AS
   Landemberger, MC
   Machado, CF
   Nobrega, PR
   Canedo, NHS
   Schultz, RR
   Naslavsky, MS
   Rosemberg, S
   Kok, F
   Chimelli, L
   Martins, VR
   Nitrini, R
AF Smid, Jerusa
   Neto, Adalberto Studart
   Landemberger, Michele Christine
   Machado, Cleiton Fagundes
   Nobrega, Paulo Ribeiro
   Silva Canedo, Nathalie Henriques
   Schultz, Rodrigo Rizek
   Naslavsky, Michel Satya
   Rosemberg, Sergio
   Kok, Fernando
   Chimelli, Leila
   Martins, Vilma Regina
   Nitrini, Ricardo
TI High phenotypic variability in Gerstmann-Straussler-Scheinker disease
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE Gerstmann-Straussler-Scheinker disease; prion diseases; prions
ID CREUTZFELDT-JAKOB-DISEASE; INHERITED PRION DISEASE; PROTEIN; MUTATION;
   P102L; HETEROGENEITY; FAMILY; VARIANT; COMMON
AB Gerstmann-Straussler-Scheinker is a genetic prion disease and the most common mutation is p.Pro102Leu. We report clinical, molecular and neuropathological data of seven individuals, belonging to two unrelated Brazilian kindreds, carrying the p.Pro102Leu. Marked differences among patients were observed regarding age at onset, disease duration and clinical presentation. In the first kindred, two patients had rapidly progressive dementia and three exhibited predominantly ataxic phenotypes with variable ages of onset and disease duration. In this family, age at disease onset in the mother and daughter differed by 39 years. In the second kindred, different phenotypes were also reported and earlier ages of onset were associated with 129 heterozygosis. No differences were associated with apoE genotype. In these kindreds, the codon 129 polymorphism could not explain the clinical variability and 129 heterozygosis was associated with earlier disease onset. Neuropathological examination in two patients confirmed the presence of typical plaques and PrPsc immunopositivity.
C1 [Smid, Jerusa; Neto, Adalberto Studart; Kok, Fernando; Nitrini, Ricardo] Univ Sao Paulo, Dept Neurol, Fac Med, Sao Paulo, SP, Brazil.
   [Neto, Adalberto Studart; Landemberger, Michele Christine; Martins, Vilma Regina] AC Camargo Canc Ctr, Sao Paulo, SP, Brazil.
   [Nobrega, Paulo Ribeiro] Univ Fed Ceara, Fac Med, Dept Neurol, Fortaleza, Ceara, Brazil.
   [Silva Canedo, Nathalie Henriques; Chimelli, Leila] Univ Fed Rio de Janeiro, Dept Patol, Rio De Janeiro, RJ, Brazil.
   [Schultz, Rodrigo Rizek] Univ Fed Sao Paulo, Secao Neurol Comportamental, Sao Paulo, SP, Brazil.
   [Naslavsky, Michel Satya] Univ Sao Paulo, Inst Biociencias, Ctr Estudos Genoma Humano, Sao Paulo, SP, Brazil.
   [Rosemberg, Sergio] Univ Sao Paulo, Dept Patol, Div Neuropatol, Sao Paulo, SP, Brazil.
RP Smid, J (corresponding author), Rua Itapeva,538 Conjunto 132, BR-01332000 Sao Paulo, SP, Brazil.
EM jsmid77@hotmail.com
RI Martins, Vilma/N-5446-2019; Martins, Vilma R/E-2547-2012; Naslavsky,
   Michel/L-1772-2015; Nitrini, Ricardo/B-8703-2013; Naslavsky,
   Michel/U-6595-2019; Landemberger, Michele Christine/P-3014-2014
OI Martins, Vilma R/0000-0002-2909-8502; Naslavsky,
   Michel/0000-0002-9068-1713; Nitrini, Ricardo/0000-0002-5721-1525;
   Landemberger, Michele Christine/0000-0002-3513-3554
CR Arata H, 2006, NEUROLOGY, V66, P1672, DOI 10.1212/01.wnl.0000218211.85675.18
   Barbanti P, 1996, NEUROLOGY, V47, P734, DOI 10.1212/WNL.47.3.734
   Calero O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022090
   Calero O, 2009, J NEUROSCI METH, V183, P238, DOI 10.1016/j.jneumeth.2009.06.033
   Castro RMRPS, 2004, J NEUROSCI METH, V139, P263, DOI 10.1016/j.jneumeth.2004.05.001
   Chapman J, 1998, NEUROLOGY, V51, P548, DOI 10.1212/WNL.51.2.548
   Chi NF, 2010, J NEUROL, V257, P191, DOI 10.1007/s00415-009-5290-4
   Collins S, 2001, J CLIN NEUROSCI, V8, P387, DOI 10.1054/jocn.2001.0919
   DOHURA K, 1989, BIOCHEM BIOPH RES CO, V163, P974, DOI 10.1016/0006-291X(89)92317-6
   Ellison D, 2013, NEUROPATHOLOGY REFER
   Gerstmann J, 1936, Z NEUROL, V154, P736
   Giovagnoli A, 2008, NEUROL SCI, V29, P405, DOI 10.1007/s10072-008-1025-z
   HAINFELLNER JA, 1995, BRAIN PATHOL, V5, P201, DOI 10.1111/j.1750-3639.1995.tb00596.x
   Holman RC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008521
   HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0
   Irisawa Momoko, 2007, Magn Reson Med Sci, V6, P53, DOI 10.2463/mrms.6.53
   Ishizawa K, 2002, ACTA NEUROPATHOL, V104, P342, DOI 10.1007/s00401-002-0547-3
   Iwasaki Y, 2014, CLIN NEUROPATHOL, V33, P344, DOI 10.5414/NP300733
   Jansen C, 2009, NEUROPATH APPL NEURO, V35, P272, DOI 10.1111/j.1365-2990.2008.01004a.x
   Kovacs GG, 2005, HUM GENET, V118, P166, DOI 10.1007/s00439-005-0020-1
   KRETZSCHMAR HA, 1991, LANCET, V337, P1160, DOI 10.1016/0140-6736(91)92826-N
   Ladogana A, 2005, NEUROLOGY, V64, P1586, DOI 10.1212/01.WNL.0000160117.56690.B2
   Majtenyi C, 2000, NEUROLOGY, V54, P2133, DOI 10.1212/WNL.54.11.2133
   Mead S, 2006, EUR J HUM GENET, V14, P273, DOI 10.1038/sj.ejhg.5201544
   Minikel EV, 2014, AM J HUM GENET, V95, P371, DOI 10.1016/j.ajhg.2014.09.003
   Piccardo P, 1998, J NEUROPATH EXP NEUR, V57, P979, DOI 10.1097/00005072-199810000-00010
   Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363
   Puoti G, 2012, LANCET NEUROL, V11, P618, DOI 10.1016/S1474-4422(12)70063-7
   Riudavets MA, 2014, BRAIN PATHOL, V24, P142, DOI 10.1111/bpa.12083
   Wadsworth JD, 2003, BRIT MED BULL, V66, P241, DOI 10.1093/bmb/66.1.241
   Wadsworth JDF, 2006, BRAIN, V129, P1557, DOI 10.1093/brain/awl076
   Webb TEF, 2008, BRAIN, V131, P2632, DOI 10.1093/brain/awn202
NR 32
TC 2
Z9 2
U1 0
U2 9
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD JUN
PY 2017
VL 75
IS 6
BP 331
EP 338
DI 10.1590/0004-282X20170049
PG 8
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA EZ1MZ
UT WOS:000404476400002
PM 28658400
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Chimelli, L
   Melo, ASO
   Avvad-Portari, E
   Wiley, CA
   Camacho, AHS
   Lopes, VS
   Machado, HN
   Andrade, CV
   Dock, DCA
   Moreira, ME
   Tovar-Moll, F
   Oliveira-Szejnfeld, PS
   Carvalho, ACG
   Ugarte, ON
   Batista, AGM
   Amorim, MMR
   Melo, FO
   Ferreira, TA
   Marinho, JRL
   Azevedo, GS
   Leal, JIBF
   da Costa, RFM
   Rehen, S
   Arruda, MB
   Brindeiro, RM
   Delvechio, R
   Aguiar, RS
   Tanuri, A
AF Chimelli, Leila
   Melo, Adriana S. O.
   Avvad-Portari, Elyzabeth
   Wiley, Clayton A.
   Camacho, Aline H. S.
   Lopes, Vania S.
   Machado, Heloisa N.
   Andrade, Cecilia V.
   Dock, Dione C. A.
   Moreira, Maria Elisabeth
   Tovar-Moll, Fernanda
   Oliveira-Szejnfeld, Patricia S.
   Carvalho, Angela C. G.
   Ugarte, Odile N.
   Batista, Alba G. M.
   Amorim, Melania M. R.
   Melo, Fabiana O.
   Ferreira, Thales A.
   Marinho, Jacqueline R. L.
   Azevedo, Girlene S.
   Leal, Jeime I. B. F.
   Madeiro da Costa, Rodrigo F.
   Rehen, Stevens
   Arruda, Monica B.
   Brindeiro, Rodrigo M.
   Delvechio, Rodrigo
   Aguiar, Renato S.
   Tanuri, Amilcar
TI The spectrum of neuropathological changes associated with congenital
   Zika virus infection
SO ACTA NEUROPATHOLOGICA
LA English
DT Article
DE Zika virus; Congenital ZIKV infection; Microcephaly; Calcification; In
   situ hybridization; Neuropathology
ID TRANSMISSION; OUTBREAK; BRAZIL
AB A major concern associated with ZIKV infection is the increased incidence of microcephaly with frequent calcifications in infants born from infected mothers. To date, postmortem analysis of the central nervous system (CNS) in congenital infection is limited to individual reports or small series. We report a comprehensive neuropathological study in ten newborn babies infected with ZIKV during pregnancy, including the spinal cords and dorsal root ganglia (DRG), and also muscle, pituitaries, eye, systemic organs, and placentas. Using in situ hybridization (ISH) and electron microscopy, we investigated the role of direct viral infection in the pathogenesis of the lesions. Nine women had Zika symptoms between the 4th and 18th and one in the 28th gestational week. Two babies were born at 32, one at 34 and 36 weeks each and six at term. The cephalic perimeter was reduced in four, and normal or enlarged in six patients, although the brain weights were lower than expected. All had arthrogryposis, except the patient infected at 28 weeks gestation. We defined three patterns of CNS lesions, with different patterns of destructive, calcification, hypoplasia, and migration disturbances. Ventriculomegaly was severe in the first pattern due to midbrain damage with aqueduct stenosis/distortion. The second pattern had small brains and mild/moderate (ex-vacuo) ventriculomegaly. The third pattern, a well-formed brain with mild calcification, coincided with late infection. The absence of descending fibres resulted in hypoplastic basis pontis, pyramids, and cortico-spinal tracts. Spinal motor cell loss explained the intrauterine akinesia, arthrogryposis, and neurogenic muscle atrophy. DRG, dorsal nerve roots, and columns were normal. Lymphohistiocytic inflammation was mild. ISH showed meningeal, germinal matrix, and neocortical infection, consistent with neural progenitors death leading to proliferation and migration disorders. A secondary ischemic process may explain the destructive lesions. In conclusion, we characterized the destructive and malformative consequences of ZIKV in the nervous system, as reflected in the topography and severity of lesions, anatomic localization of the virus, and timing of infection during gestation. Our findings indicate a developmental vulnerability of the immature CNS, and shed light on possible mechanisms of brain injury of this newly recognized public health threat.
C1 [Chimelli, Leila; Camacho, Aline H. S.] State Inst Brain Paulo Niemeyer, Neuropathol Lab, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.
   [Chimelli, Leila; Camacho, Aline H. S.] Univ Fed Rio de Janeiro, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.
   [Melo, Adriana S. O.; Amorim, Melania M. R.; Melo, Fabiana O.; Ferreira, Thales A.; Azevedo, Girlene S.] Res Inst Prof Amorim Neto, Rua Duque Caxias 330, BR-58400506 Campina Grande, PB, Brazil.
   [Melo, Adriana S. O.; Batista, Alba G. M.; Marinho, Jacqueline R. L.; Leal, Jeime I. B. F.] Hlth Secretary Campina Grande, Rua Duque Caxias 330, BR-58400506 Campina Grande, PB, Brazil.
   [Avvad-Portari, Elyzabeth; Machado, Heloisa N.; Andrade, Cecilia V.; Dock, Dione C. A.; Moreira, Maria Elisabeth] Fiocruz MS, Fernandes Figueira Inst, Ave Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
   [Wiley, Clayton A.] UPMC Presbiterian Hosp, Div Neuropathol, S701 Scaife Hall 200 Lothrop St, Pittsburgh, PA 15213 USA.
   [Lopes, Vania S.; Carvalho, Angela C. G.; Ugarte, Odile N.] Univ Fed Fluminense, Antonio Pedro Univ Hosp, Dept Pathol, Rua Marques Parana 303, BR-24033900 Niteroi, RJ, Brazil.
   [Tovar-Moll, Fernanda; Madeiro da Costa, Rodrigo F.; Rehen, Stevens] DOr Inst Res & Educ IDOR, Rua Diniz Cordeiro 30, BR-22281100 Rio De Janeiro, RJ, Brazil.
   [Tovar-Moll, Fernanda; Madeiro da Costa, Rodrigo F.; Rehen, Stevens] Univ Fed Rio de Janeiro, Rua Diniz Cordeiro 30, BR-22281100 Rio de Janeiro, RJ, Brazil.
   [Oliveira-Szejnfeld, Patricia S.] Fdn Inst Educ & Res Diagnost Imaging FIDI, Fetal Med Res, Rua Napoleao Barros 800, BR-04024002 Sao Paulo, SP, Brazil.
   [Arruda, Monica B.; Brindeiro, Rodrigo M.; Delvechio, Rodrigo; Aguiar, Renato S.; Tanuri, Amilcar] Univ Fed Rio de Janeiro, CCS, Inst Biol, Lab Med Virol,Dept Genet, Bloco A,Sala 121, BR-21941902 Rio de Janeiro, RJ, Brazil.
RP Chimelli, L (corresponding author), State Inst Brain Paulo Niemeyer, Neuropathol Lab, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.; Chimelli, L (corresponding author), Univ Fed Rio de Janeiro, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.
EM chimelli@hucff.ufrj.br
RI Melo, Adriana S O/H-5650-2016; Amorim, Melania M/C-5807-2013; Moll,
   Fernanda Tovar/N-3320-2018; Ferreira, Thales Araujo/AAA-6252-2019;
   Aguiar, Renato S/G-3542-2015; Rehen, Stevens K/J-5874-2012; ANDRADE,
   CECILIA/B-5916-2017
OI Amorim, Melania M/0000-0003-1047-2514; Moll, Fernanda
   Tovar/0000-0002-0292-5985; Aguiar, Renato S/0000-0001-5180-3717; Rehen,
   Stevens K/0000-0003-4216-9501; Soares de Oliveira Szejnfeld,
   Patricia/0000-0002-3780-5182; FERREIRA, THALES/0000-0002-6699-5886;
   ANDRADE, CECILIA/0000-0001-7980-4367
FU National Institute of Health (NIH) IH NIAID grant [U01 AI 111598];
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   [CNPq]National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Rio de Janeiro [FAPERJ]Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ); Medical Research CouncilMedical Research Council UK
   (MRC) [MC_PC_15102] Funding Source: researchfish; NATIONAL INSTITUTE OF
   ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [U01AI111598,
   U01AI111598, U01AI111598, U01AI111598, U01AI111598, U01AI111598] Funding
   Source: NIH RePORTER
FX We thank DEbora Silva, Diego Santos, and Luciana Bitana for technical
   assistance in histological and immunohistochemical preparations, and
   Centro Nacional de Biologia Estrutural e Bioimagem (CENABIO) for
   technical assistance in transmission electron microscopy. These studies
   received partial support from the National Institute of Health (NIH) IH
   NIAID grant U01 AI 111598 (C.A.W.) and from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico [CNPq] and Fundacao de Amparo a
   Pesquisa do Rio de Janeiro [FAPERJ] (A.T).
CR Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brien JD, 2009, J EXP MED, V206, P2735, DOI 10.1084/jem.20090222
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   da Silva SR, 2016, J MED VIROL, V88, P1291, DOI 10.1002/jmv.24563
   Dasti JI, 2016, ASIAN PAC J TROP MED, V9, P601, DOI 10.1016/j.apjtm.2016.05.010
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ellison D, 2012, NEUROPATHOLOGY REFER
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larroche J-C, 1977, DEV PATHOLOGY NEONAT, P1
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Love S, 2015, GREENFIELD'S NEUROPATHOLOGY, 9TH EDITION, VOLS 1AND 2, P1087
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Mecharles S, 2016, LANCET, V8, P6736, DOI DOI 10.1136/BCR-2012-007094.4
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   SNIJDERS RJM, 1994, ULTRASOUND OBST GYN, V4, P34, DOI 10.1046/j.1469-0705.1994.04010034.x
   Solomon IH, 2016, J NEUROINFECT DIS, V7, P220
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Strafela P, 2017, ARCH PATHOL LAB MED, V141, P73, DOI 10.5858/arpa.2016-0341-SA
   Tadros MA, 2015, J NEUROPHYSIOL, V114, P2661, DOI 10.1152/jn.00682.2015
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI 10.1097/NEN.0000000000000038
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 49
TC 73
Z9 76
U1 1
U2 30
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0001-6322
EI 1432-0533
J9 ACTA NEUROPATHOL
JI Acta Neuropathol.
PD JUN
PY 2017
VL 133
IS 6
BP 983
EP 999
DI 10.1007/s00401-017-1699-5
PG 17
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA EU6HB
UT WOS:000401134000008
PM 28332092
DA 2020-12-08
ER

PT J
AU Melo, ASD
   Chimelli, L
   Tanuri, A
AF de Oliveira Melo, Adriana Suely
   Chimelli, Leila
   Tanuri, Amilcar
TI Congenital Zika Virus Infection: Beyond Neonatal Microcephaly Reply
SO JAMA NEUROLOGY
LA English
DT Letter
ID CASE SERIES
C1 [de Oliveira Melo, Adriana Suely] Inst Pesquisa Prof Amorim Neto IPESQ, Campina Grande, Paraiba, Brazil.
   [de Oliveira Melo, Adriana Suely] Inst Saude Elpidio Almeida, Campina Grande, Paraiba, Brazil.
   [de Oliveira Melo, Adriana Suely] Fac Ciencias Med Campina Grande, Campina Grande, Paraiba, Brazil.
   [de Oliveira Melo, Adriana Suely] Hosp Municipal Pedro I, Campina Grande, Paraiba, Brazil.
   [Chimelli, Leila] Inst Estadual Cerebro Paulo Niemeyer, Lab Neuropatol, Rio De Janeiro, Brazil.
   [Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, RJ, Brazil.
RP Tanuri, A (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Lab Virol Mol, CCS Bloco A Sala 121, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM atanuri1@gmail.com
RI Melo, Adriana S O/H-5650-2016
CR Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Leyser M, 2017, J NEUROL SCI, V372, P73, DOI 10.1016/j.jns.2016.11.030
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
NR 5
TC 5
Z9 6
U1 0
U2 2
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6149
EI 2168-6157
J9 JAMA NEUROL
JI JAMA Neurol.
PD MAY
PY 2017
VL 74
IS 5
BP 610
EP 611
DI 10.1001/jamaneurol.2017.0051
PG 6
WC Clinical Neurology
SC Neurosciences & Neurology
GA EU2EE
UT WOS:000400838900028
PM 28319244
DA 2020-12-08
ER

PT J
AU Melo, ASD
   Aguiar, RS
   Amorim, MMR
   Arruda, MB
   Melo, FD
   Ribeiro, STC
   Batista, AGM
   Ferreira, T
   dos Santos, MP
   Sampaio, VV
   Moura, SRM
   Rabello, LP
   Gonzaga, CE
   Malinger, G
   Ximenes, R
   de Oliveira-Szejnfeld, PS
   Tovar-Moll, F
   Chimelli, L
   Silveira, PP
   Delvechio, R
   Higa, L
   Campanati, L
   Nogueira, RMR
   Filippis, AMB
   Szejnfeld, J
   Voloch, CM
   Ferreira, OC
   Brindeiro, RM
   Tanuri, A
AF de Oliveira Melo, Adriana Suely
   Aguiar, Renato Santana
   Ramos Amorim, Melania Maria
   Arruda, Monica B.
   Melo, Fabiana de Oliveira
   Clementino Ribeiro, Suelem Tais
   Medeiros Batista, Alba Gean
   Ferreira, Thales
   dos Santos, Mayra Pereira
   Sampaio, Virginia Vilar
   Martins Moura, Sarah Rogeria
   Rabello, Luciana Portela
   Gonzaga, Clarissa Emanuelle
   Malinger, Gustavo
   Ximenes, Renato
   de Oliveira-Szejnfeld, Patricia Soares
   Tovar-Moll, Fernanda
   Chimelli, Leila
   Silveira, Paola Paz
   Delvechio, Rodrigo
   Higa, Luiza
   Campanati, Loraine
   Nogueira, Rita M. R.
   Bispo Filippis, Ana Maria
   Szejnfeld, Jacob
   Voloch, Carolina Moreira
   Ferreira, Orlando C., Jr.
   Brindeiro, Rodrigo M.
   Tanuri, Amilcar
TI Congenital Zika Virus Infection Beyond Neonatal Microcephaly
SO JAMA NEUROLOGY
LA English
DT Article
ID CYTOMEGALOVIRUS-INFECTION; DIAGNOSTIC-APPROACH; TRANSMISSION; CHILDREN
AB IMPORTANCE Recent studies have reported an increase in the number of fetuses and neonates with microcephaly whose mothers were infected with the Zika virus (ZIKV) during pregnancy. To our knowledge, most reports to date have focused on select aspects of the maternal or fetal infection and fetal effects.
   OBJECTIVE To describe the prenatal evolution and perinatal outcomes of 11 neonates who had developmental abnormalities and neurological damage associated with ZIKV infection in Brazil.
   DESIGN, SETTING, AND PARTICIPANTS We observed 11 infants with congenital ZIKV infection from gestation to 6 monthus in the state of Paraba, Brazil. Ten of 11 women included in this study presented with symptoms of ZIKV infection during the first half of pregnancy, and all 11 had laboratory evidence of the infection in several tissues by serology or polymerase chain reaction. Brain damage was confirmed through intrauterine ultrasonography and was complemented by magnetic resonance imaging. Histopathological analysis was performed on the placenta and brain tissue from infants who died. The ZIKV genome was investigated in several tissues and sequenced for further phylogenetic analysis.
   MAIN OUTCOMES AND MEASURES Description of the major lesions caused by ZIKV congenital infection.
   RESULTS Of the 11 infants, 7 (63.6%) were female, and the median (SD) maternal age at delivery was 25 (6) years. Three of 11 neonates died, giving a perinatal mortality rate of 27.3%. The median (SD) cephalic perimeter at birth was 31 (3) cm, a value lower than the limit to consider a microcephaly case. In all patients, neurological impairments were identified, including microcephaly, a reduction in cerebral volume, ventriculomegaly, cerebellar hypoplasia, lissencephaly with hydrocephalus, and fetal akinesia deformation sequence (ie, arthrogryposis). Results of limited testing for other causes of microcephaly, such as genetic disorders and viral and bacterial infections, were negative, and the ZIKV genome was found in both maternal and neonatal tissues (eg, amniotic fluid, cord blood, placenta, and brain). Phylogenetic analyses showed an intrahost virus variation with some polymorphisms in envelope genes associated with different tissues.
   CONCLUSIONS AND RELEVANCE Combined findings from clinical, laboratory, imaging, and pathological examinations provided a more complete picture of the severe damage and developmental abnormalities caused by ZIKV infection than has been previously reported. The term congenital Zika syndrome is preferable to refer to these cases, as microcephaly is just one of the clinical signs of this congenital malformation disorder.
C1 [de Oliveira Melo, Adriana Suely; Ramos Amorim, Melania Maria; Melo, Fabiana de Oliveira] Inst Pesquisa Prof Amorim Neto IPESQ, Campina Grande, Paraiba, Brazil.
   [de Oliveira Melo, Adriana Suely; Ramos Amorim, Melania Maria; Melo, Fabiana de Oliveira; Clementino Ribeiro, Suelem Tais; dos Santos, Mayra Pereira] Inst Saude Elpidio de Almeida, Campina Grande, Paraiba, Brazil.
   [de Oliveira Melo, Adriana Suely; Ramos Amorim, Melania Maria; Clementino Ribeiro, Suelem Tais; Sampaio, Virginia Vilar; Martins Moura, Sarah Rogeria; Rabello, Luciana Portela] Fac Ciencias Med Campina Grande, Campina Grande, Paraiba, Brazil.
   [de Oliveira Melo, Adriana Suely; Medeiros Batista, Alba Gean; Sampaio, Virginia Vilar; Martins Moura, Sarah Rogeria; Rabello, Luciana Portela; Gonzaga, Clarissa Emanuelle] Hosp Municipal Pedro I, Campina Grande, Paraiba, Brazil.
   [Aguiar, Renato Santana; Arruda, Monica B.; Silveira, Paola Paz; Delvechio, Rodrigo; Higa, Luiza; Voloch, Carolina Moreira; Ferreira, Orlando C., Jr.; Brindeiro, Rodrigo M.; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [Ramos Amorim, Melania Maria; Ferreira, Thales] Univ Fed Campina Grande, Campina Grande, Paraiba, Brazil.
   [Malinger, Gustavo] Tel Aviv Univ, Div Ultrasound Obstet & Gynecol, Lis Matern Hosp, Tel Aviv Sourasky Med Ctr,Sackler Fac Med, Tel Aviv, Israel.
   [Ximenes, Renato] Fundacao Med Fetal Latino Amer, Sao Paulo, Brazil.
   [de Oliveira-Szejnfeld, Patricia Soares] Univ Fed Sao Paulo, Fundacao Inst Pesquisa & Ensino Diagnost Imagem, Sao Paulo, Brazil.
   [Tovar-Moll, Fernanda; Campanati, Loraine] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] Inst DOr Pesquisa & Ensino, Rio De Janeiro, Brazil.
   [Chimelli, Leila] Inst Estadual Cerebro Paulo Niemeyer, Lab Neuropatol, Rio De Janeiro, Brazil.
   [Nogueira, Rita M. R.; Bispo Filippis, Ana Maria] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Szejnfeld, Jacob] Univ Fed Sao Paulo, Dept Diagnost Imagem, Sao Paulo, Brazil.
RP Tanuri, A (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Lab Virol Mol, CCS Bloco Sala 121, BR-21941902 Rio De Janeiro, Brazil.
EM atanuri1@gmail.com
RI Moll, Fernanda Tovar/N-3320-2018; Amorim, Melania M/C-5807-2013;
   Ferreira, Thales Araujo/AAA-6252-2019; Aguiar, Renato S/G-3542-2015;
   Campanati, Loraine/V-2632-2018; Voloch, Carolina M/F-8874-2013; Melo,
   Adriana S O/H-5650-2016; Higa, Luiza/W-2698-2019
OI Moll, Fernanda Tovar/0000-0002-0292-5985; Amorim, Melania
   M/0000-0003-1047-2514; Aguiar, Renato S/0000-0001-5180-3717; Campanati,
   Loraine/0000-0001-9172-1951; Voloch, Carolina M/0000-0001-5182-4366;
   Malinger, Gustavo/0000-0003-0864-206X
FU Consellho Nacional de Desenvolvimento e Pesquisa; Fundacao de Amparo a
   Pesquisa do Estado do Rio de JaneiroCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel SuperiorCAPES; Prefeitura Municipal
   de Campina Grande; Medical Research CouncilMedical Research Council UK
   (MRC) [MC_PC_15102] Funding Source: researchfish
FX This study was supported by Consellho Nacional de Desenvolvimento e
   Pesquisa, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro,
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, and
   Prefeitura Municipal de Campina Grande.
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Besnard M, 2014, EURO SURVEILL, V19
   Bosnjak VM, 2011, COLLEGIUM ANTROPOL, V35, P229
   Brasil P, 2016, N ENGL J MED
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Corey L, 2009, NEW ENGL J MED, V361, P1376, DOI 10.1056/NEJMra0807633
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Hall JG, 1997, J PEDIATR ORTHOP B, V6, P159, DOI 10.1097/01202412-199707000-00002
   Jaglin XH, 2009, TRENDS GENET, V25, P555, DOI 10.1016/j.tig.2009.10.003
   Kouame N, 2013, Diagn Interv Imaging, V94, P433, DOI 10.1016/j.diii.2013.01.002
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muller-Oehring EM, 2010, NEUROPSYCHOLOGIA, V48, P1133, DOI 10.1016/j.neuropsychologia.2009.12.015
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Romaniello R, 2015, BRAIN DEV-JPN, V37, P273, DOI 10.1016/j.braindev.2014.06.002
   Stadlbauer A, 2012, EUR RADIOL, V22, P232, DOI 10.1007/s00330-011-2247-7
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zucca C, 2003, NEUROLOGY, V61, P710, DOI 10.1212/WNL.61.5.710
NR 33
TC 185
Z9 185
U1 0
U2 47
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6149
EI 2168-6157
J9 JAMA NEUROL
JI JAMA Neurol.
PD DEC 1
PY 2016
VL 73
IS 12
BP 1407
EP 1416
DI 10.1001/jamaneurol.2016.3720
PG 10
WC Clinical Neurology
SC Neurosciences & Neurology
GA EG5ZB
UT WOS:000391122200011
PM 27695855
OA Bronze
DA 2020-12-08
ER

PT J
AU de Oliveira-Szejnfeld, PS
   Levine, D
   Melo, ASD
   Amorim, MMR
   Batista, AGM
   Chimelli, L
   Tanuri, A
   Aguiar, RS
   Malinger, G
   Ximenes, R
   Robertson, R
   Szejnfeld, J
   Tovar-Moll, F
AF de Oliveira-Szejnfeld, Patricia Soares
   Levine, Deborah
   de Oliveira Melo, Adriana Suely
   Ramos Amorim, Melania Maria
   Batista, Alba Gean M.
   Chimelli, Leila
   Tanuri, Amilcar
   Aguiar, Renato Santana
   Malinger, Gustavo
   Ximenes, Renato
   Robertson, Richard
   Szejnfeld, Jacob
   Tovar-Moll, Fernanda
TI Congenital Brain Abnormalities and Zika Virus: What the Radiologist Can
   Expect to See Prenatally and Postnatally
SO RADIOLOGY
LA English
DT Article
ID INFECTION; ULTRASOUND; OUTBREAK; GROWTH; BRAZIL
AB Purpose: To document the imaging findings associated with congenital Zika virus infection as found in the Instituto de Pesquisa in Campina Grande State Paraiba (IPESQ) in northeastern Brazil, where the congenital infection has been particularly severe.
   Materials and Methods: From June 2015 to May 2016, 438 patients were referred to the IPESQ for rash occurring during pregnancy or for suspected fetal central nervous system abnormality. Patients who underwent imaging at IPESQ were included, as well as those with documented Zika virus infection in fluid or tissue (n = 17, confirmed infection cohort) or those with brain findings suspicious for Zika virus infection, with intracranial calcifications (n = 28, presumed infection cohort). Imaging examinations included 12 fetal magnetic resonance (MR) examinations, 42 postnatal brain computed tomographic examinations, and 11 postnatal brain MR examinations. Images were reviewed by four radiologists, with final opinion achieved by means of consensus.
   Results: Brain abnormalities seen in confirmed (n = 17) and presumed (n = 28) congenital Zika virus infections were similar, with ventriculomegaly in 16 of 17 (94%) and 27 of 28 (96%) infections, respectively; abnormalities of the corpus callosum in 16 of 17 (94%) and 22 of 28 (78%) infections, respectively; and cortical migrational abnormalities in 16 of 17 (94%) and 28 of 28 (100%) infections, respectively. Although most fetuses underwent at least one examination that showed head circumference below the 5th percentile, head circumference could be normal in the presence of severe ventriculomegaly (seen in three fetuses). Intracranial calcifications were most commonly seen at the gray matter-white matter junction, in 15 of 17 (88%) and 28 of 28 (100%) confirmed and presumed infections, respectively. The basal ganglia and/or thalamus were also commonly involved with calcifications in 11 of 17 (65%) and 18 of 28 (64%) infections, respectively. The skull frequently had a collapsed appearance with overlapping sutures and redundant skin folds and, occasionally, intracranial herniation of orbital fat and clot in the confluence of sinuses.
   Conclusion: The spectrum of findings associated with congenital Zika virus infection in the IPESQ in northeastern Brazil is illustrated to aid the radiologist in identifying Zika virus infection at imaging. (C) RSNA, 2016
C1 [de Oliveira-Szejnfeld, Patricia Soares; Ximenes, Renato; Szejnfeld, Jacob] Univ Fed Sao Paulo, Dept Diagnost Imaging, Sao Paulo, Brazil.
   [de Oliveira-Szejnfeld, Patricia Soares; Szejnfeld, Jacob] Univ Fed Sao Paulo, Dept Diagnost Imaging, Fdn Inst Educ & Res Diagnost Imaging, Sao Paulo, Brazil.
   [Levine, Deborah] Harvard Med Sch, Dept Radiol, Beth Israel Deaconess Med Ctr, Boston, MA USA.
   [de Oliveira Melo, Adriana Suely; Ramos Amorim, Melania Maria] Inst Pesquisa Prof Amorim Neto, Campina Grande, PB, Brazil.
   [de Oliveira Melo, Adriana Suely; Ramos Amorim, Melania Maria] Inst Saude Elpidio Almeida, Campina Grande, PB, Brazil.
   [de Oliveira Melo, Adriana Suely] Fac Ciencias Med Campina Grande, Campina Grande, PB, Brazil.
   [de Oliveira Melo, Adriana Suely; Batista, Alba Gean M.] Hosp Municipal Pedro I, Serv Municipal Atendimento Transdisciplinar Gesta, Campina Grande, PB, Brazil.
   [Ramos Amorim, Melania Maria] Univ Fed Campina Grande, Campina Grande, PB, Brazil.
   [Chimelli, Leila] State Inst Brain, Neuropathol Lab, Rio De Janeiro, Brazil.
   [Tanuri, Amilcar; Aguiar, Renato Santana] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [Malinger, Gustavo] Tel Aviv Univ, Sackler Fac Med, Div Ultrasound Obstet & Gynecol, Tel Aviv Sourasky Med Ctr,Lis Matern Hosp, Tel Aviv, Israel.
   [Ximenes, Renato] Fetal Med Fdn Latinamerica FMFLA, Centrus Fetal Med, Campinas, SP, Brazil.
   [Robertson, Richard] Boston Childrens Hosp, Boston, MA USA.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] DOr Inst Res & Educ, Rua Diniz Cordeiro 30, BR-22881100 Rio De Janeiro, RJ, Brazil.
RP Tovar-Moll, F (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.; Tovar-Moll, F (corresponding author), Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging, Rio De Janeiro, Brazil.; Tovar-Moll, F (corresponding author), DOr Inst Res & Educ, Rua Diniz Cordeiro 30, BR-22881100 Rio De Janeiro, RJ, Brazil.
EM Fernanda.tovarmoll@idor.org
RI Aguiar, Renato S/G-3542-2015; Moll, Fernanda Tovar/N-3320-2018; Amorim,
   Melania M/C-5807-2013; Melo, Adriana S O/H-5650-2016
OI Aguiar, Renato S/0000-0001-5180-3717; Moll, Fernanda
   Tovar/0000-0002-0292-5985; Amorim, Melania M/0000-0003-1047-2514;
   Malinger, Gustavo/0000-0003-0864-206X; Soares de Oliveira Szejnfeld,
   Patricia/0000-0002-3780-5182; Robertson, Richard/0000-0001-8811-4405
FU Medical Research CouncilMedical Research Council UK (MRC) [MC_PC_15102]
   Funding Source: Medline
CR [Anonymous], 2016, HEAD CIRC FOR AG
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Brasil P, 2016, N ENGL J MED
   Brazilian Ministry of Health, 2016, MIN SAUD CONF 1656 C
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Centers for Disease Control and Prevention, ALL COUNTR TERR ACT
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ESTROFF JA, 1992, J ULTRAS MED, V11, P686
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Franca GV, 2016, LANCET
   Freitas BP, 2016, JAMA OPHTHALMOL
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo A, JAMA NEUROL IN PRESS
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moinuddin A, 2003, PRENATAL DIAG, V23, P797, DOI 10.1002/pd.688
   Nonaka H, 2003, J NEUROPATH EXP NEUR, V62, P154, DOI 10.1093/jnen/62.2.154
   Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2
   Picone O, 2008, PRENATAL DIAG, V28, P753, DOI 10.1002/pd.2037
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI 10.1097/NEN.0000000000000038
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
NR 32
TC 127
Z9 133
U1 0
U2 13
PU RADIOLOGICAL SOC NORTH AMERICA
PI OAK BROOK
PA 820 JORIE BLVD, OAK BROOK, IL 60523 USA
SN 0033-8419
J9 RADIOLOGY
JI Radiology
PD OCT
PY 2016
VL 281
IS 1
BP 203
EP 218
DI 10.1148/radiol.2016161584
PG 16
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA EG8NJ
UT WOS:000391313600023
PM 27552432
OA Bronze
DA 2020-12-08
ER

PT J
AU Chimelli, L
   Melo, ASO
   Tovar-Moll, F
   Oliveira-Szejnfeld, PS
   Camacho, AHS
   Gomes, GC
   Melo, FO
   Batista, AGM
   Machado, HN
   Awad, E
   Ferreira, TA
   Andrade, RD
   Mello, RJV
   Arruda, MB
   Brindeiro, RM
   Delvechio, R
   Tanuri, A
AF Chimelli, Leila
   Melo, Adriana S. O.
   Tovar-Moll, Fernanda
   Oliveira-Szejnfeld, Patricia S.
   Camacho, Aline H. S.
   Gomes, Giovanna C.
   Melo, Fabiana O.
   Batista, Alba G. M.
   Machado, Heloisa N.
   Awad, Elizabeth
   Ferreira, Thales A.
   Andrade, Rodrigo D.
   Mello, Roberto J. V.
   Arruda, Monica B.
   Brindeiro, Rodrigo M.
   Delvechio, Rodrigo
   Tanuri, Amilcar
TI Neuropathological aspects of congenital Zika virus infection in Brazil
SO JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
LA English
DT Meeting Abstract
CT 92nd Annual Meeting of the American-Association-of-Neuropathologist-Inc
CY JUN 16-19, 2016
CL Baltimore, MD
SP Amer Assoc Neuropathologist Inc
C1 [Chimelli, Leila; Camacho, Aline H. S.; Gomes, Giovanna C.] State Inst Brain, Rio De Janeiro, RJ, Brazil.
   [Melo, Adriana S. O.; Melo, Fabiana O.] Res Inst Prof Amorim Neto, Campina Grande, PB, Brazil.
   [Melo, Adriana S. O.; Batista, Alba G. M.] Hlth Secretary Campina Grande, Campina Grande, PB, Brazil.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, DOr Inst Res & Educ IDOR, Rio De Janeiro, RJ, Brazil.
   [Oliveira-Szejnfeld, Patricia S.] Fdn Inst Educ & Res Diagnost Imaging FIDI, Fetal Med Res, Sao Paulo, SP, Brazil.
   [Machado, Heloisa N.; Awad, Elizabeth] Fiocruz MS, Fernandes Figueira Inst, BR-21045900 Rio De Janeiro, Brazil.
   [Ferreira, Thales A.] Univ Fed Pernambuco, Dept Pathol, Recife, PE, Brazil.
   [Andrade, Rodrigo D.] Univ Fed Campina Grande, Campina Grande, Paraiba, Brazil.
   [Mello, Roberto J. V.] Hlth Inst Elpidio de Almeida, Campina Grande, PB, Brazil.
   [Arruda, Monica B.; Brindeiro, Rodrigo M.; Delvechio, Rodrigo; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Mol Virol Lab, Rio De Janeiro, RJ, Brazil.
RI Moll, Fernanda Tovar/N-3320-2018; Ferreira, Thales Araujo/AAA-6252-2019;
   Melo, Adriana S O/H-5650-2016
OI Moll, Fernanda Tovar/0000-0002-0292-5985; 
NR 0
TC 0
Z9 0
U1 0
U2 55
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0022-3069
J9 J NEUROPATH EXP NEUR
JI J. Neuropathol. Exp. Neurol.
PD JUN
PY 2016
VL 75
IS 6
MA 2
BP 567
EP 567
PG 1
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA DO3FC
UT WOS:000377665000011
DA 2020-12-08
ER

PT J
AU Landemberger, MC
   Machado, C
   Smid, J
   Gomes, H
   Chimelli, L
   Canedo, N
   Rosemberg, S
   Nitrini, R
   Martins, V
AF Landemberger, M. C.
   Machado, C.
   Smid, J.
   Gomes, H.
   Chimelli, L.
   Canedo, N.
   Rosemberg, S.
   Nitrini, R.
   Martins, V.
TI Human prion diseases in brazil
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
CT 25th Biennial Meeting of the International-Society-for-Neurochemistry
   Jointly with the 13th Meeting of the
   Asian-Pacific-Society-for-Neurochemistry in Conjunction with the 35th
   Meeting of the Australasian-Neuroscience-Society
CY AUG 23-27, 2015
CL Cairns, AUSTRALIA
SP Int Soc Neurochemistry, Asian Pacific Soc Neurochemistry, Australasian Neuroscience Soc
C1 [Landemberger, M. C.; Martins, V.] AC Camargo Canc Ctr, Int Res Ctr, Sao Paulo, Brazil.
   [Machado, C.] Univ Sao Paulo, Inst Quim, Sao Paulo, Brazil.
   [Smid, J.; Gomes, H.; Rosemberg, S.; Nitrini, R.] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   [Chimelli, L.; Canedo, N.] Univ Fed Rio de Janeiro, Fac Med, Sao Paulo, Brazil.
RI Martins, Vilma/N-5446-2019; Nitrini, Ricardo/B-8703-2013; Martins, Vilma
   R/E-2547-2012
OI Nitrini, Ricardo/0000-0002-5721-1525; Martins, Vilma
   R/0000-0002-2909-8502
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD AUG
PY 2015
VL 134
SU 1
SI SI
MA MTU11-22
BP 201
EP 201
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA CP9IA
UT WOS:000360206300487
DA 2020-12-08
ER

PT J
AU Esperanca, JCP
   Miranda, WRR
   Netto, JB
   Lima, FS
   Baumworcel, L
   Chimelli, L
   Silva, R
   Urmenyi, TP
   Cabello, PH
   Rondinelli, E
   Faffe, DS
AF Esperanca, Jose Carlos P.
   Miranda, William R. R.
   Netto, Jose B.
   Lima, Fabiane S.
   Baumworcel, Leonardo
   Chimelli, Leila
   Silva, Rosane
   Uermenyi, Turan P.
   Cabello, Pedro H.
   Rondinelli, Edson
   Faffe, Debora S.
TI Polymorphisms in IL-10 and INF-gamma genes are associated with early
   atherosclerosis in coronary but not in carotid arteries: A study of 122
   autopsy cases of young adults
SO BBA CLINICAL
LA English
DT Article
DE Atherosclerosis; IL-10; INF-gamma; Polymorphisms; Coronary artery
   disease
ID HISTOLOGICAL CLASSIFICATION; MYOCARDIAL-INFARCTION; VASCULAR-LESIONS;
   DISEASE RISK; ARTERIOSCLEROSIS; PATHOBIOLOGY; DEFINITION; CYTOKINES;
   COMMITTEE; COUNCIL
AB Atherosclerosis is a complex disease, involving both genetic and environmental factors. However, the influence of genetic variations on its early development remains unclear. This study examined the association of 12 different polymorphisms with atherosclerosis severity in anterior descending coronary (DA, n = 103) and carotid arteries (CA, n = 66) of autopsied young adults (<30 years old). Histological sections (H-E) were classified according to the American Heart Association. Polymorphisms in ACE, TNF-alpha (-308G/A and -238 G/A), IFN-gamma (+874 A/T), MMP-9 (-1562 C/T), IL-10 (-1082 A/G and -819 C/T), NOS3 (894 G/T), ApoA1 (rs964184), ApoE (E2E3E4 isoforms), and TGF-beta (codons 25 and 10) genes were genotyped by gel electrophoresis or automatic DNA sequencing. Firearm projectile or car accident was the main cause of death, and no information about classical risk factors was available. Histological analysis showed high prevalence of type III atherosclerotic lesions in both DA (69%) and CA (39%) arteries, while severe type IV and V lesions were observed in 14% (DA) and 33% (CA). Allele frequencies and genotype distributions were determined. Among the polymorphisms studied, IFN-gamma and IL-10 (-1082 A/G) were related to atherosclerosis severity in DA artery. No association between genotypes and lesion severity was found in CA. In conclusion, we observed that the high prevalence of early atherosclerosis in young adults is associated with IFN-gamma (p < 0.001) and IL-10 (p = 0.013) genotypes. This association is blood vessel dependent. Our findings suggest that the vascular system presents site specialization, and specific genetic variations may provide future biomarkers for early disease identification. (C) 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Miranda, William R. R.; Netto, Jose B.; Lima, Fabiane S.; Baumworcel, Leonardo; Silva, Rosane; Uermenyi, Turan P.; Rondinelli, Edson; Faffe, Debora S.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Metab Macromol Firmino Torres Castro, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Esperanca, Jose Carlos P.; Chimelli, Leila] Univ Fed Rio de Janeiro, Dept Patol, Hosp Univ Clementino Fraga Filho, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Cabello, Pedro H.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Cabello, Pedro H.] Univ Fed Rio de Janeiro, Escola Ciencias Saude, Genet Lab, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Rondinelli, Edson] Univ Fed Rio de Janeiro, Fac Med, Dept Clin Med, BR-21941902 Rio De Janeiro, RJ, Brazil.
RP Faffe, DS (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Ctr Ciencias Saude, Ilha Fundao, Ave Carlos Chagas Filho 373,Rm G1-050, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM faffe@biof.ufrj.br
RI Silva, Rosane/U-6913-2019; Silva, Rosane/C-1427-2013
OI Silva, Rosane/0000-0002-2998-6999; Silva, Rosane/0000-0002-2998-6999
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado
   do Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); Instituto Nacional de
   Cardiologia (INC), Brazil
FX We would like to express our gratitude to Elizabeth Valentin, Cesar
   Felix Schmidt, Jorge Luiz Albuquerque Coutinho, and Claudio Nunes
   Pereira for their technical assistance. This study was supported by
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES),
   Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ), and Instituto Nacional de Cardiologia (INC), Brazil.
CR Abilleira S, 2006, J MED GENET, V43, P897, DOI 10.1136/jmg.2006.040808
   Ambrosius W, 2006, NEUROLOGY, V66, P1946, DOI 10.1212/01.wnl.0000219808.28678.48
   Angeline T, 2010, EXP MOL PATHOL, V89, P205, DOI 10.1016/j.yexmp.2010.08.009
   [Anonymous], 2010, INFLAMM ATHEROSCLER, P1
   [Anonymous], 2001, NEW POLYMORPHISMS IN, P1
   Caligiuri G, 2003, MOL MED, V9, P10, DOI 10.1007/BF03402102
   Chi JT, 2003, P NATL ACAD SCI USA, V100, P10623, DOI 10.1073/pnas.1434429100
   Edwards-Smith CJ, 1999, HEPATOLOGY, V30, P526, DOI 10.1002/hep.510300207
   Fausto N, 1998, AM J PATHOL, V153, P1021, DOI 10.1016/S0002-9440(10)65646-5
   Heiskanen M, 2010, ATHEROSCLEROSIS, V208, P190, DOI 10.1016/j.atherosclerosis.2009.06.032
   HIXSON JE, 1991, ARTERIOSCLER THROMB, V11, P1237, DOI 10.1161/01.ATV.11.5.1237
   Ianni M, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-14
   Incalcaterra E, 2010, CLIN HEMORHEOL MICRO, V46, P291, DOI 10.3233/CH-2010-1353
   Kaplan RC, 2008, ATHEROSCLEROSIS, V201, P130, DOI 10.1016/j.atherosclerosis.2008.01.003
   Knowles JW, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-23
   Visentainer JE, 2008, INT J IMMUNOGENET, V35, P287, DOI 10.1111/j.1744-313X.2008.00778.x
   Manolio TA, 2004, ARTERIOSCL THROM VAS, V24, P1567, DOI 10.1161/01.ATV.0000138789.11433.c1
   McGill HC, 2000, CIRCULATION, V102, P374
   Oda K, 2007, HUM MOL GENET, V16, P592, DOI 10.1093/hmg/ddl483
   Okser S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001146
   Pinheiro MB, 2015, CYTOKINE, V71, P232, DOI 10.1016/j.cyto.2014.10.021
   Pravica V, 2000, HUM IMMUNOL, V61, P863, DOI 10.1016/S0198-8859(00)00167-1
   Roy H, 2009, HUM GENET, V125, P467, DOI 10.1007/s00439-009-0654-5
   Sakakura K, 2013, HEART LUNG CIRC, V22, P399, DOI 10.1016/j.hlc.2013.03.001
   Sookoian SC, 2005, OBES RES, V13, P2122, DOI 10.1038/oby.2005.263
   STARY HC, 1994, CIRCULATION, V89, P2462, DOI 10.1161/01.CIR.89.5.2462
   Stary HC, 2000, ARTERIOSCL THROM VAS, V20, P1177, DOI 10.1161/01.ATV.20.5.1177
   STARY HC, 1995, ARTERIOSCL THROM VAS, V15, P1512, DOI 10.1161/01.ATV.15.9.1512
   Thej Mothakapalli Jagadish, 2012, J Cardiovasc Dis Res, V3, P265, DOI 10.4103/0975-3583.102692
   Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x
   Westendorp RGJ, 1997, LANCET, V349, P170, DOI 10.1016/S0140-6736(96)06413-6
   WISSLER RW, 1991, ANN NY ACAD SCI, V623, P26, DOI 10.1111/j.1749-6632.1991.tb43716.x
NR 32
TC 4
Z9 4
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2214-6474
J9 BBA CLIN
JI BBA Clin.
PD JUN
PY 2015
VL 3
BP 214
EP 220
DI 10.1016/j.bbacli.2015.02.005
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA CR1ZB
UT WOS:000361122900027
PM 26674973
OA Green Published, Bronze
DA 2020-12-08
ER

PT J
AU Medeiros, MF
   Rodrigues, MMJ
   Vital, RT
   Nery, JAD
   Sales, AM
   Hacker, MD
   Ferreira, H
   Chimelli, L
   Sarno, EN
   Antunes, SLG
AF Medeiros, Mildred F.
   Rodrigues, Marcia M. J.
   Vital, Robson T.
   da Costa Nery, Jose A.
   Sales, Anna M.
   Hacker, Mariana de Andrea
   Ferreira, Helen
   Chimelli, Leila
   Sarno, Euzenir N.
   Antunes, Sergio L. G.
TI CXCL10, MCP-1, and Other Immunologic Markers Involved in Neural Leprosy
SO APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
LA English
DT Article
DE pure neural leprosy; Mycobacterium leprae; inflammatory cells;
   immunohistochemistry; peripheral nerve; chemokine; CXCL10; CCL2
ID MONOCYTE CHEMOATTRACTANT PROTEIN-1; HUMAN SCHWANN-CELLS; MACROPHAGE
   RECRUITMENT; GRANULOMA-FORMATION; NERVE DAMAGE; TNF-ALPHA; EXPRESSION;
   GAMMA; METALLOPROTEINASES; INTERLEUKIN-6
AB Nerve damage in leprosy can be directly induced by Mycobacterium leprae in the early stages of infection, however, immunomediated mechanisms add gravity to the impairment of neural function in symptomatic periods of the disease. This study investigated the immunohistochemical expression of immunomarkers involved in the pathogenic mechanisms of leprosy nerve damage. These markers selected were CXCL10, CCL2 chemokines and immunomarkers as CD3, CD4, CD8, CD45RA, CD45RO, CD68, HLA-DR, and metalloproteinases 2 and 9 (MMP2 and MMP9) occurring in nerve biopsy specimens collected from leprosy (23) and nonleprosy patients (5) suffering peripheral neuropathy. CXCL10, CCL2, MMP2, and MMP9 immunoreactivities were found in the leprosy nerves but not in nonleprosy samples. Immunolabeling was predominantly found in recruited macrophages and Schwann cells composing the inflammatory cellular population in the leprosy-affected nerves. The immunohistochemical expression of all the markers, but CXCL10, was associated with fibrosis, however, only CCL2 was, independently from the others, associated with this excessive deposit of extracellular matrix. No difference in the frequency of the immunolabeling was detected between the AFB(+) and AFB(-) leprosy subgroups of nerve, exception made to some statistical trend to difference in regard to CD68(-) and HLA-DR+ cells in the AFB(-) nerves exhibiting epithelioid granuloma. MMP9 expression associated with fibrosis is consistent with previous results of research group. The findings conveys the idea that CCL2 and CXCL10 chemokines at least in advanced stages of leprosy nerve lesions are not determinant for the establishment of AFB(+) or AFB(-) leprosy lesions, however, CCL2 is associated with macrophage recruitment and fibrosis.
C1 [Medeiros, Mildred F.; Rodrigues, Marcia M. J.; Vital, Robson T.; da Costa Nery, Jose A.; Sales, Anna M.; Hacker, Mariana de Andrea; Ferreira, Helen; Sarno, Euzenir N.; Antunes, Sergio L. G.] Fiocruz MS, Lab Leprosy, Inst Oswaldo Cruz, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Medeiros, Mildred F.] State Univ PGCM UERJ, Postgrad Doctorate Program Med Sci, Rio De Janeiro, Brazil.
   [Chimelli, Leila] Natl Canc Inst, Pathol Div, Rio De Janeiro, Brazil.
RP Medeiros, MF (corresponding author), Fiocruz MS, Lab Leprosy, Inst Oswaldo Cruz, Av Brasil 4365, BR-21040900 Rio De Janeiro, RJ, Brazil.
EM mildred@ioc.fiocruz.br
OI Nunes Sarno, Euzenir/0000-0003-0129-2159
FU Plano de Objetivos e Metas of the Oswaldo Cruz Institute; FIOCRUZ; Rio
   de Janeiro, RJ, Brazil; CNPqNational Council for Scientific and
   Technological Development (CNPq); CAPESCAPES
FX Supported by Plano de Objetivos e Metas of the Oswaldo Cruz Institute,
   FIOCRUZ, Rio de Janeiro, RJ, Brazil, together with CNPq and CAPES.
CR Assassi S, 2005, CURR OPIN RHEUMATOL, V17, P761, DOI 10.1097/01.bor.0000179943.27777.b1
   Campana WM, 2007, BRAIN BEHAV IMMUN, V21, P522, DOI 10.1016/j.bbi.2006.12.008
   CARSON FL, 1973, AM J CLIN PATHOL, V59, P365
   de Leseleuc L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002015
   Ferreira AM, 2006, J INVEST DERMATOL, V126, P1900, DOI 10.1038/sj.jid.5700302
   Fischer S, 2008, GLIA, V56, P836, DOI 10.1002/glia.20657
   Antunes SLG, 2012, MEM I OSWALDO CRUZ, V107, P246, DOI 10.1590/S0074-02762012000200015
   Hasan Z, 2006, SCAND J IMMUNOL, V63, P241, DOI 10.1111/j.1365-3083.2006.01733.x
   Jardim MR, 2005, LEPROSY REV, V76, P232
   Jardim MR, 2003, J NEUROL, V250, P806, DOI 10.1007/s00415-003-1081-5
   KAPLAN G, 1986, J IMMUNOL, V137, P983
   Karrer S, 2005, J INVEST DERMATOL, V124, P92, DOI 10.1111/j.0022-202X.2004.23512.x
   KAUR G, 1991, INT J LEPROSY, V59, P385
   Kirkaldy AA, 2003, CLIN EXP IMMUNOL, V134, P447, DOI 10.1111/j.1365-2249.2003.02306.x
   Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001
   LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0
   Masaki Toshihiro, 2013, F1000Res, V2, P198, DOI 10.12688/f1000research.2-198.v2
   Mendonca VA, 2008, AN BRAS DERMATOL, V83, P343, DOI 10.1590/S0365-05962008000400010
   Oliveira AL, 2010, J NEUROPATH EXP NEUR, V69, P27, DOI 10.1097/NEN.0b013e3181c6515c
   Oliveira RB, 2003, INFECT IMMUN, V71, P1427, DOI 10.1128/IAI.71.3.1427-1433.2003
   Parham P, 1996, IMMUNOL REV, V154, P137, DOI 10.1111/j.1600-065X.1996.tb00932.x
   Penido C, 2003, J IMMUNOL, V171, P6788, DOI 10.4049/jimmunol.171.12.6788
   Petito RB, 2013, J NEUROPATH EXP NEUR, V72, P351, DOI 10.1097/NEN.0b013e31828bfc60
   Qiu BQ, 2001, AM J PATHOL, V158, P1503, DOI 10.1016/S0002-9440(10)64101-6
   Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255
   Roach DR, 2002, J IMMUNOL, V168, P4620, DOI 10.4049/jimmunol.168.9.4620
   Sakai N, 2006, J LEUKOCYTE BIOL, V79, P555, DOI 10.1189/jlb.0305127
   Save MP, 2004, NEUROPATH APPL NEURO, V30, P635, DOI 10.1111/j.1365-2990.2004.00578.x
   Shi Y, 2011, J NEUROSCI RES, V89, P544, DOI 10.1002/jnr.22576
   Shubayev VI, 2006, MOL CELL NEUROSCI, V31, P407, DOI 10.1016/j.mcn.2005.10.011
   Spierings E, 2001, J IMMUNOL, V166, P5883, DOI 10.4049/jimmunol.166.10.5883
   Stefani MM, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-75
   SUMMERS KL, 1994, CLIN EXP IMMUNOL, V97, P39
   Tapinos N, 2005, P NATL ACAD SCI USA, V102, P9188, DOI 10.1073/pnas.0501196102
   Teles RMB, 2007, J PERIPHER NERV SYST, V12, P195, DOI 10.1111/j.1529-8027.2007.00139.x
   Toews AD, 1998, J NEUROSCI RES, V53, P260, DOI 10.1002/(SICI)1097-4547(19980715)53:2<260::AID-JNR15>3.3.CO;2-V
   Tofaris GK, 2002, J NEUROSCI, V22, P6696
   Yamamoto T, 2008, FRONT BIOSCI-LANDMRK, V13, P2686, DOI 10.2741/2875
NR 38
TC 5
Z9 5
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1541-2016
EI 1533-4058
J9 APPL IMMUNOHISTO M M
JI Appl. Immunohistochem.
PD MAR
PY 2015
VL 23
IS 3
BP 220
EP 229
DI 10.1097/PAI.0000000000000074
PG 10
WC Anatomy & Morphology; Medical Laboratory Technology; Pathology
SC Anatomy & Morphology; Medical Laboratory Technology; Pathology
GA CD3OE
UT WOS:000350987300009
PM 25221954
DA 2020-12-08
ER

PT J
AU Andrade, RC
   Nevado, J
   de Lima, MADD
   Saad, T
   Moraes, L
   Chimelli, L
   Lapunzina, P
   Vargas, FR
AF Andrade, Raissa Coelho
   Nevado, Julian
   de Faria Domingues de Lima, Maria Angelica
   Saad, Tania
   Moraes, Lucia
   Chimelli, Leila
   Lapunzina, Pablo
   Vargas, Fernando Regla
TI Segmental Uniparental Isodisomy of Chromosome 6 Causing Transient
   Diabetes Mellitus and Merosin-Deficient Congenital Muscular Dystrophy
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART A
LA English
DT Article
DE LAMA2; MDC1A; TNDM; 6q24 segmental uniparental disomy
ID DISOMY; MUTATIONS; MACROGLOSSIA; DISORDER
AB Segmental uniparental isodisomy (iUPD) is a rare genetic event that may cause aberrant expression of imprinted genes, and reduction to homozygosity of a recessive mutation. Transient neonatal diabetes mellitus (TNDM) is typically caused by imprinting aberrations in chromosome 6q24 TNDM differentially-methylated region (DMR). Approximately, 15.12Mb upstream in 6q22-q23 is located LAMA2, the gene responsible of merosin-deficient congenital muscular dystrophy type 1A (MDC1A). We investigated a patient diagnosed both with TNDM and MDC1A, born from a twin dichorionic discordant pregnancy. Parents are first-degree cousins. Methylation sensitive-PCR of the imprinted 6q24 TNDM CpG island showed only the non-methylated (paternal) allele. Microsatellite markers and SNP array profiling disclosed normal biparental inheritance at 6p and a segmental paternal iUPD, between 6q22.33 and 6q27. Sequencing of LAMA2 exons showed a homozygous frameshift mutation, c.7490_7493dupAAGA, which predicts p.Asp2498GlufsX4, in exon 54. Her father, but not her mother, was a carrier of the mutation. While segmental paternal iUPD6 causing TNDM was reported twice, there are no previous reports of MDC1A caused by this event. This is a child with two genetic disorders, yet neither is caused by the parental consanguinity, which reinforces the importance of considering different etiological mechanisms in the genetic clinic. (c) 2014 Wiley Periodicals, Inc.
C1 [Andrade, Raissa Coelho; Vargas, Fernando Regla] Inst Nacl Canc, Div Genet, Rio De Janeiro, Brazil.
   [Nevado, Julian; Lapunzina, Pablo] Univ Autonoma Madrid, IdiPAZ CIBERER, INGEMM, Inst Genet Med & Mol, Madrid, Spain.
   [de Faria Domingues de Lima, Maria Angelica; Vargas, Fernando Regla] Univ Fed Estado Rio de Janeiro, Genet & Mol Biol Dept, Rio De Janeiro, Brazil.
   [de Faria Domingues de Lima, Maria Angelica] Univ UnigranRio, Programa Internato Genet, Rio De Janeiro, Brazil.
   [Saad, Tania] Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Neuropediat Serv, BR-21040900 Rio De Janeiro, Brazil.
   [Moraes, Lucia] Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Ctr Med Genet, BR-21040900 Rio De Janeiro, Brazil.
   [Chimelli, Leila] Univ Fed Rio de Janeiro, Sch Med, Dept Pathol, Rio De Janeiro, Brazil.
   [Vargas, Fernando Regla] Fundacao Oswaldo Cruz, Birth Defects Epidemiol Lab, BR-21040900 Rio De Janeiro, Brazil.
RP Vargas, FR (corresponding author), Fundacao Oswaldo Cruz, Birth Defects Epidemiol Lab, Sala 617,Av Brasil 4365, BR-21040900 Rio De Janeiro, Brazil.
EM fernando.vargas@ioc.fiocruz.br
RI Vargas, Fernando/V-1934-2019; Lapunzina, Pablo/L-7075-2014
OI Lapunzina, Pablo/0000-0002-6324-4825; Andrade,
   Raissa/0000-0001-6363-6215
FU INCA/MSInstitut National du Cancer (INCA) France; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq) [476808/2010-3];
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [E26/110.535/2012]
FX Grant sponsor: INCA/MS; Grant sponsor: Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq); Grant number:
   476808/2010-3; Grant sponsor: Fundacao de Amparo a Pesquisa do Estado do
   Rio de Janeiro (FAPERJ); Grant number: E26/110.535/2012.
CR Allamand V, 2002, EUR J HUM GENET, V10, P91, DOI 10.1038/sj.ejhg.5200743
   Bonnemann CG, 2014, NEUROMUSCULAR DISORD, V24, P289, DOI 10.1016/j.nmd.2013.12.011
   Das S, 2000, AM J HUM GENET, V67, P1586, DOI 10.1086/316897
   Docherty LE, 2010, DIABETOLOGIA, V53, P2347, DOI 10.1007/s00125-010-1853-2
   Flanagan SE, 2007, DIABETES, V56, P1930, DOI 10.2337/db07-0043
   Geranmayeh F, 2010, NEUROMUSCULAR DISORD, V20, P241, DOI 10.1016/j.nmd.2010.02.001
   Kotzot D, 2008, J MED GENET, V45, P545, DOI 10.1136/jmg.2008.058016
   Liehr T, 2010, MOL CYTOGENET, V3, DOI 10.1186/1755-8166-3-8
   Mackay DJG, 2008, NAT GENET, V40, P949, DOI 10.1038/ng.187
   Mackay DJG, 2005, HUM GENET, V116, P255, DOI 10.1007/s00439-004-1236-1
   Oliveira J, 2008, CLIN GENET, V74, P502, DOI 10.1111/j.1399-0004.2008.01068.x
   Quijano-Roy S., 2012, GENEREVIEWS
   Robinson WP, 2000, BIOESSAYS, V22, P452
   Suzuki S, 2010, CLIN GENET, V78, P580, DOI 10.1111/j.1399-0004.2010.01433.x
   Temple IK, 2000, DIABETES, V49, P1359, DOI 10.2337/diabetes.49.8.1359
   Temple IK, 2002, J MED GENET, V39, P872, DOI 10.1136/jmg.39.12.872
   Yamazawa K, 2010, AM J MED GENET C, V154C, P329, DOI 10.1002/ajmg.c.30270
NR 17
TC 4
Z9 5
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4825
EI 1552-4833
J9 AM J MED GENET A
JI Am. J. Med. Genet. A
PD NOV
PY 2014
VL 164
IS 11
BP 2908
EP 2913
DI 10.1002/ajmg.a.36716
PG 6
WC Genetics & Heredity
SC Genetics & Heredity
GA AS3OB
UT WOS:000344187200032
PM 25124546
DA 2020-12-08
ER

PT J
AU Vasconcellos, LFR
   Cunha, AM
   Marussi, VHR
   Canedo, NHS
   Chimelli, LMC
AF Vasconcellos, Luiz F. R.
   Cunha, Alexandre M.
   Marussi, Victor H. R.
   Canedo, Nathalie H. S.
   Chimelli, Leila M. C.
TI A 20-YEAR-OLD MAN WITH HEARING LOSS PROGRESSING TO TETRAPARESIS
SO BRAIN PATHOLOGY
LA English
DT Editorial Material
ID IDIOPATHIC HYPERTROPHIC PACHYMENINGITIS; CRANIAL PACHYMENINGITIS
C1 [Vasconcellos, Luiz F. R.; Chimelli, Leila M. C.] Univ Fed Rio de Janeiro, Inst Neurol Deolindo Couto, Div Neurol, Rio De Janeiro, Brazil.
   [Cunha, Alexandre M.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Dept Surg, Div Neurosurg, Rio De Janeiro, Brazil.
   [Canedo, Nathalie H. S.; Chimelli, Leila M. C.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Dept Pathol, Div Neuropathol, Rio De Janeiro, Brazil.
   [Cunha, Alexandre M.] Univ Estado Rio De Janeiro, Hosp Univ Pedro Ernesto, Dept Surg Specialties, Div Neurosurg, Rio De Janeiro, Brazil.
   [Marussi, Victor H. R.] Hosp Beneficencia Portuguesa, Div Neuroradiol, Medimagem, Sao Paulo, Brazil.
RP Vasconcellos, LFR (corresponding author), Univ Fed Rio de Janeiro, Inst Neurol Deolindo Couto, Div Neurol, Rio De Janeiro, Brazil.
OI Cunha, Alexandre/0000-0003-1014-975X; Vasconcellos, Luiz
   Felipe/0000-0001-9080-7833
CR Arismendi-Morillo GJ, 2004, REV NEUROLOGIA, V39, P830, DOI 10.33588/rn.3909.2004128
   Bosman T, 2008, RHEUMATOL INT, V28, P713, DOI 10.1007/s00296-007-0504-5
   Hosler MR, 2007, J NEURO-OPHTHALMOL, V27, P95, DOI 10.1097/WNO.0b013e318064c53a
   Rojana-Udomsart A, 2008, J CLIN NEUROSCI, V15, P465, DOI 10.1016/j.jocn.2006.11.020
   Vargas-Bellina V, 2009, REV NEUROLOGIA, V48, P300, DOI 10.33588/rn.4806.2008541
NR 5
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1015-6305
EI 1750-3639
J9 BRAIN PATHOL
JI Brain Pathol.
PD SEP
PY 2014
VL 24
IS 5
BP 551
EP 552
DI 10.1111/bpa.12203
PG 2
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA AR9UT
UT WOS:000343925000014
PM 25323672
DA 2020-12-08
ER

PT J
AU Antunes, SLG
   Jardim, M
   Vital, RT
   Chimelli, LMC
   Nery, JAD
   Sales, AM
   Sarno, EN
AF Antunes, S. L. G.
   Jardim, M.
   Vital, R. T.
   Chimelli, L. M. C.
   da Costa Nery, J. A.
   Sales, A. M.
   Sarno, E. N.
TI Diagnosis and pathogenesis of neural leprosy
SO BRAIN PATHOLOGY
LA English
DT Meeting Abstract
CT 18th International Congress of Neuropathology
CY SEP 14-18, 2014
CL Rio de Janeiro, BRAZIL
C1 Inst Oswaldo Cruz, Lab Leprosy, BR-20001 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, BR-21941 Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1015-6305
EI 1750-3639
J9 BRAIN PATHOL
JI Brain Pathol.
PD SEP
PY 2014
VL 24
SU 1
SI SI
BP 7
EP 7
PG 1
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA AP6CT
UT WOS:000342165800023
DA 2020-12-08
ER

PT J
AU Chimelli, L
AF Chimelli, L.
TI Toxic encephalopathies
SO BRAIN PATHOLOGY
LA English
DT Meeting Abstract
CT 18th International Congress of Neuropathology
CY SEP 14-18, 2014
CL Rio de Janeiro, BRAZIL
C1 [Chimelli, L.] Univ Fed Rio de Janeiro, Dept Pathol, BR-21941 Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1015-6305
EI 1750-3639
J9 BRAIN PATHOL
JI Brain Pathol.
PD SEP
PY 2014
VL 24
SU 1
SI SI
BP 36
EP 36
PG 1
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA AP6CT
UT WOS:000342165800136
DA 2020-12-08
ER

PT J
AU Santos, Z
   Chimelli, L
AF Santos, Z.
   Chimelli, L.
TI Partial characterization of the population of patients with
   medulloblastoma diagnosed at the Brazilian National Cancer Institute
   (INCA) from 2002 to 2012
SO BRAIN PATHOLOGY
LA English
DT Meeting Abstract
CT 18th International Congress of Neuropathology
CY SEP 14-18, 2014
CL Rio de Janeiro, BRAZIL
C1 [Santos, Z.; Chimelli, L.] Natl Canc Inst, Belo Horizonte, MG, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1015-6305
EI 1750-3639
J9 BRAIN PATHOL
JI Brain Pathol.
PD SEP
PY 2014
VL 24
SU 1
SI SI
MA P06-05
BP 47
EP 47
PG 1
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA AP6CT
UT WOS:000342165800176
DA 2020-12-08
ER

PT J
AU Madruga, M
   Vieira, TM
   Pereira, RCD
   Canedo, NHS
   Chimelli, L
AF Madruga, M.
   Vieira, T. M.
   da Silva Pereira, R. C.
   Canedo, N. H. S.
   Chimelli, L.
TI Encephalomyelopathies associated to HIV infection after an introduction
   of combined antiretroviral therapy (TARV): thirteen years of experience
   in a university hospital
SO BRAIN PATHOLOGY
LA English
DT Meeting Abstract
CT 18th International Congress of Neuropathology
CY SEP 14-18, 2014
CL Rio de Janeiro, BRAZIL
C1 [Madruga, M.; Vieira, T. M.] INCA, Rio De Janeiro, Brazil.
   [da Silva Pereira, R. C.; Canedo, N. H. S.; Chimelli, L.] Univ Fed Rio de Janeiro, BR-21941 Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1015-6305
EI 1750-3639
J9 BRAIN PATHOL
JI Brain Pathol.
PD SEP
PY 2014
VL 24
SU 1
SI SI
MA P10-03
BP 53
EP 53
PG 1
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA AP6CT
UT WOS:000342165800196
DA 2020-12-08
ER

PT J
AU Chimelli, J
   Raposo, M
   Maceira, JP
   Chimelli, L
AF Chimelli, J.
   Raposo, M.
   Maceira, J. P.
   Chimelli, L.
TI Dermal nerve analysis in resin embedded skin biopsy is a reliable method
   to diagnose small fiber neuropathies, reproducing morphological changes
   seen in nerve biopsies
SO BRAIN PATHOLOGY
LA English
DT Meeting Abstract
CT 18th International Congress of Neuropathology
CY SEP 14-18, 2014
CL Rio de Janeiro, BRAZIL
C1 [Chimelli, J.; Raposo, M.; Maceira, J. P.; Chimelli, L.] Univ Fed Rio de Janeiro, Univ Hosp, BR-21941 Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1015-6305
EI 1750-3639
J9 BRAIN PATHOL
JI Brain Pathol.
PD SEP
PY 2014
VL 24
SU 1
SI SI
MA P13-02
BP 57
EP 58
PG 2
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA AP6CT
UT WOS:000342165800212
DA 2020-12-08
ER

PT J
AU Canedo, NHS
   Corr, R
   Almeida, B
   Correa, AHP
   Chimelli, L
   Pires, ARC
AF Canedo, N. H. S.
   Corr, R.
   Almeida, B.
   Correa, A. H. P.
   Chimelli, L.
   Pires, A. R. C.
TI Tissue microarray technique: a valid method for immunohistochemical
   assessment of IDH1 mutation in gliomas
SO BRAIN PATHOLOGY
LA English
DT Meeting Abstract
CT 18th International Congress of Neuropathology
CY SEP 14-18, 2014
CL Rio de Janeiro, BRAZIL
C1 [Canedo, N. H. S.; Corr, R.; Almeida, B.; Correa, A. H. P.; Chimelli, L.] Univ Fed Rio de Janeiro, BR-21941 Rio De Janeiro, Brazil.
   [Pires, A. R. C.] Fonte Med Diagnost, Niteroi, RJ, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1015-6305
EI 1750-3639
J9 BRAIN PATHOL
JI Brain Pathol.
PD SEP
PY 2014
VL 24
SU 1
SI SI
MA P13-05
BP 58
EP 58
PG 1
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA AP6CT
UT WOS:000342165800215
DA 2020-12-08
ER

PT J
AU Landemberger, MC
   Machado, CF
   Smid, J
   Gomes, HR
   Chimelli, L
   Rosemberg, S
   Nitrini, R
   Martins, VR
AF Landemberger, M. C.
   Machado, C. F.
   Smid, J.
   Gomes, H. R.
   Chimelli, L.
   Rosemberg, S.
   Nitrini, R.
   Martins, V. R.
TI Human prion diseases in Brazil
SO BRAIN PATHOLOGY
LA English
DT Meeting Abstract
CT 18th International Congress of Neuropathology
CY SEP 14-18, 2014
CL Rio de Janeiro, BRAZIL
C1 [Landemberger, M. C.; Machado, C. F.; Smid, J.; Gomes, H. R.; Chimelli, L.; Rosemberg, S.; Nitrini, R.; Martins, V. R.] Univ Fed Rio de Janeiro, Univ Sao Paulo, AC Camargo Canc Ctr, BR-21941 Rio De Janeiro, Brazil.
RI Landemberger, Michele Christine/P-3014-2014; Martins, Vilma
   Regina/E-2547-2012
OI Landemberger, Michele Christine/0000-0002-3513-3554; Martins, Vilma
   Regina/0000-0002-2909-8502
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1015-6305
EI 1750-3639
J9 BRAIN PATHOL
JI Brain Pathol.
PD SEP
PY 2014
VL 24
SU 1
SI SI
MA P24-07
BP 81
EP 81
PG 1
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA AP6CT
UT WOS:000342165800292
DA 2020-12-08
ER

PT J
AU Faccion, RS
   de Faria, GP
   Bernardo, PS
   Teixeira, CL
   de Oliveira, JA
   Chimelli, L
   Maia, RC
AF Faccion, R. S.
   de Faria, G. P.
   Bernardo, P. S.
   Teixeira, C. L.
   de Oliveira, J. A.
   Chimelli, L.
   Maia, R. C.
TI Expression of the inhibitor of apoptosis protein survivin, but not of
   tumor suppressor protein p53, has a negative prognostic impact in
   glioblastoma
SO BRAIN PATHOLOGY
LA English
DT Meeting Abstract
CT 18th International Congress of Neuropathology
CY SEP 14-18, 2014
CL Rio de Janeiro, BRAZIL
C1 [Faccion, R. S.; Bernardo, P. S.; Maia, R. C.] Inst Nacl Canc INCA, Lab Hematooncol Celular & Mol, Programa Hematooncol Mol, Rio De Janeiro, Brazil.
   [Faccion, R. S.; de Faria, G. P.; Bernardo, P. S.] Inst Nacl Canc INCA, Programa Posgrad Strictu Sensu Oncol, Rio De Janeiro, Brazil.
   [Teixeira, C. L.] Inst Nacl Canc INCA, Lab Geral, Rio De Janeiro, Brazil.
   [de Oliveira, J. A.] Inst Nacl Canc INCA, Serv Neurocirurgia, Rio De Janeiro, Brazil.
   [Chimelli, L.] Inst Nacl Canc INCA, Div Patol, Rio De Janeiro, Brazil.
   [de Faria, G. P.] Univ Fed Bahia, Inst Ciencias Saude, Lab Neuroquim & Biol Celular, BR-41170290 Salvador, BA, Brazil.
RI maia, raquel c/L-4869-2015
OI maia, raquel c/0000-0003-0225-471X
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1015-6305
EI 1750-3639
J9 BRAIN PATHOL
JI Brain Pathol.
PD SEP
PY 2014
VL 24
SU 1
SI SI
MA P28-21
BP 90
EP 90
PG 1
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA AP6CT
UT WOS:000342165800323
DA 2020-12-08
ER

PT J
AU de Souza, ACS
   Chimelli, L
   Guedes, JF
AF de Souza, A. C. S.
   Chimelli, L.
   Guedes, J. F.
TI Hybrid peripheral nerve sheath tumor - case report
SO BRAIN PATHOLOGY
LA English
DT Meeting Abstract
CT 18th International Congress of Neuropathology
CY SEP 14-18, 2014
CL Rio de Janeiro, BRAZIL
C1 [de Souza, A. C. S.; Chimelli, L.; Guedes, J. F.] Univ Fed Rio de Janeiro, Inst Neurol, BR-21941 Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1015-6305
EI 1750-3639
J9 BRAIN PATHOL
JI Brain Pathol.
PD SEP
PY 2014
VL 24
SU 1
SI SI
MA P28-28
BP 92
EP 92
PG 1
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA AP6CT
UT WOS:000342165800330
DA 2020-12-08
ER

PT J
AU de Sousa, VPL
   Chaves, CBP
   Huguenin, JFL
   Moreira, FCD
   de Reis, BSB
   Chimelli, L
   Bergmann, A
   Simao, TD
   Pinto, LFR
AF Leite de Sousa, Vanessa Paiva
   Pereira Chaves, Claudia Bessa
   Loureiro Huguenin, Janina Ferreira
   de Barros Moreira, Fabio Carvalho
   Bianchi de Reis, Bruno Souza
   Chimelli, Leila
   Bergmann, Anke
   Simao, Tatiana de Almeida
   Ribeiro Pinto, Luis Felipe
TI ERM/ETV5 and RUNX1/AML1 expression in endometrioid adenocarcinomas of
   endometrium and association with neoplastic progression
SO CANCER BIOLOGY & THERAPY
LA English
DT Article
DE endometrioid endometrial carcinoma; myometrial invasion; ERM/ETV5;
   RUNX1/AML1; differential gene expression
ID ETS TRANSCRIPTION FACTORS; GENE-EXPRESSION; MYOMETRIAL INFILTRATION;
   UP-REGULATION; C-JUN; CANCER; CARCINOMA; INVASION; REVEALS; PATHWAY
AB The majority of endometrioid endometrial carcinomas (EEC) is diagnosed at stage I. Among these, 30% present myometrial invasion (stage IB), which is associated with tumor spread and relapse after primary treatment. Although an increased expression of RUNX1/AML1 and ERM/ETV5 in EEC have been suggested to be associated with early events of myometrial infiltration, there is no data regarding its expression along the evolution of EEC and possible associations with other clinicopathological parameters. Therefore, ERM/ETV5 and RUNX1/AML1 protein and gene expression profiles were assessed in different EEC stages to evaluate their role in endometrial carcinogenesis. RUNX1/AML1 and ERM/ETV5 proteins were analyzed by immunohistochemistry in 219 formalin fixed paraffin embedded endometrioid tumors and in 12 normal atrophic and proliferative endometrium samples. RUNX1/AML1 and ERM/ETV5 genes expression were analyzed by RT-qPCR. RUNX1/AML1 and ERM/ETV5 expression were decreased with increasing EEC stage, with a positive correlation between protein and gene expression for ERM/ETV5, but not for RUNX1/AML1. Both proteins were present in the nucleus of the tumor cells, whereas RUNX1/AML1, but not ERM/ETV5, was expressed in 7 out of 12 normal endometrial samples, with its expression being restricted to the cytoplasm of the positive cells. We concluded that there is a higher expression of ERM/ETV5 in early stages of EEC, whereas there seems to be a RUNX1/AML1 translocation from cytoplasm to nucleus in EEC neoplastic transformation.
C1 [Leite de Sousa, Vanessa Paiva; Pereira Chaves, Claudia Bessa; Simao, Tatiana de Almeida; Ribeiro Pinto, Luis Felipe] Inst Nacl Canc INCA, Ctr Pesquisa CPQ, Programa Carcinogenese Mol, Rio De Janeiro, Brazil.
   [Pereira Chaves, Claudia Bessa; Loureiro Huguenin, Janina Ferreira] Inst Nacl Canc INCA, Dept Ginecol Oncol, Rio De Janeiro, Brazil.
   [de Barros Moreira, Fabio Carvalho; Bianchi de Reis, Bruno Souza; Chimelli, Leila] Inst Nacl Canc INCA, Div Patol DIPAT, Rio De Janeiro, Brazil.
   [Bergmann, Anke] Inst Nacl Canc INCA, Rio De Janeiro, Brazil.
   [Simao, Tatiana de Almeida; Ribeiro Pinto, Luis Felipe] Univ Estado Rio de Janeiro, IBRAG, Dept Bioquim, Lab Toxicol & Biol Mol, BR-20550011 Rio De Janeiro, Brazil.
RP Pinto, LFR (corresponding author), Inst Nacl Canc INCA, Ctr Pesquisa CPQ, Programa Carcinogenese Mol, Rio De Janeiro, Brazil.
EM lfrpinto@inca.gov.br
RI Chaves, Claudia/AAJ-1914-2020; Bergmann, Anke/G-2684-2012
OI Chaves, Claudia/0000-0003-1919-5672; Ribeiro Pinto, Luis
   Felipe/0000-0001-5509-1008
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq,
   Brazil)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ, Brazil)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ)
FX This work was supported by grants from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil) and Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil).
CR Abal M, 2007, CLIN TRANSL ONCOL, V9, P272, DOI 10.1007/s12094-007-0054-z
   Bansal N, 2009, CANCER CONTROL, V16, P8, DOI 10.1177/107327480901600102
   Bertucci F, 2000, HUM MOL GENET, V9, P2981, DOI 10.1093/hmg/9.20.2981
   BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7
   Chotteau-Lelievre A, 2004, CLIN CANCER RES, V10, P7297, DOI 10.1158/1078-0432.CCR-04-0593
   Cibula D, 2010, HUM REPROD UPDATE, V16, P631, DOI 10.1093/humupd/dmq022
   Colas E, 2012, ONCOGENE, V31, P4778, DOI 10.1038/onc.2011.632
   Dedes KJ, 2011, NAT REV CLIN ONCOL, V8, P261, DOI 10.1038/nrclinonc.2010.216
   deLaunoit Y, 1997, BIOCHEM MOL MED, V61, P127, DOI 10.1006/bmme.1997.2605
   Dobrzycka B, 2010, FOLIA HISTOCHEM CYTO, V48, P319, DOI 10.2478/v10042-10-0061-8
   Doll A, 2009, INT J CANCER, V125, P257, DOI 10.1002/ijc.24330
   Dossus L, 2010, ENDOCR-RELAT CANCER, V17, P1007, DOI 10.1677/ERC-10-0053
   Engelsen IB, 2009, APMIS, V117, P693, DOI 10.1111/j.1600-0463.2009.02467.x
   Fader AN, 2009, GYNECOL ONCOL, V114, P121, DOI 10.1016/j.ygyno.2009.03.039
   Feng J, 2009, BRIT J HAEMATOL, V145, P412, DOI 10.1111/j.1365-2141.2009.07632.x
   Fujimoto J., 1995, European Journal of Gynaecological Oncology, V16, P138
   Huang G, 2001, EMBO J, V20, P723, DOI 10.1093/emboj/20.4.723
   Ito Y, 2004, ONCOGENE, V23, P4198, DOI 10.1038/sj.onc.1207755
   Jaakkola S, 2011, INT J CANCER, V128, P1644, DOI 10.1002/ijc.25762
   Keld R, 2011, BRIT J CANCER, V105, P124, DOI 10.1038/bjc.2011.187
   Lewin SN, 2011, CLIN OBSTET GYNECOL, V54, P215, DOI 10.1097/GRF.0b013e3182185baa
   Monge M, 2007, CANCER RES, V67, P6753, DOI 10.1158/0008-5472.CAN-06-4487
   Monge M, 2009, CARCINOGENESIS, V30, P1288, DOI 10.1093/carcin/bgp119
   Moreno-Bueno G, 2002, ONCOGENE, V21, P7981, DOI 10.1038/sj.onc.1205924
   NAKAE K, 1995, J BIOL CHEM, V270, P23795, DOI 10.1074/jbc.270.40.23795
   Peltomaki P, 2001, HUM MOL GENET, V10, P735, DOI 10.1093/hmg/10.7.735
   Planaguma J, 2004, CANCER RES, V64, P8846, DOI 10.1158/0008-5472.CAN-04-2066
   Planaguma J, 2005, J PATHOL, V207, P422, DOI 10.1002/path.1853
   Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013
   Shiozawa T, 2004, ONCOGENE, V23, P8603, DOI 10.1038/sj.onc.1207849
   Uharcek P, 2008, J OBSTET GYNAECOL RE, V34, P776, DOI 10.1111/j.1447-0756.2008.00796.x
   Wall EH, 2013, FASEB J, V27, P1874, DOI 10.1096/fj.12-213462
   Wang SQ, 2007, LEUKEMIA RES, V31, P839, DOI 10.1016/j.leukres.2006.08.016
   Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0
   Yamaguchi Y, 2004, J BIOL CHEM, V279, P15630, DOI 10.1074/jbc.M400355200
   Zighelboim I, 2007, J CLIN ONCOL, V25, P2042, DOI 10.1200/JCO.2006.08.2107
NR 36
TC 5
Z9 5
U1 0
U2 3
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1538-4047
EI 1555-8576
J9 CANCER BIOL THER
JI Cancer Biol. Ther.
PD JUL
PY 2014
VL 15
IS 7
BP 888
EP 894
DI 10.4161/cbt.28879
PG 7
WC Oncology
SC Oncology
GA AK0OH
UT WOS:000338112900008
PM 24756106
OA Green Published, Bronze
DA 2020-12-08
ER

PT J
AU Chimelli, L
AF Chimelli, Leila
TI Untitled
SO BRAIN PATHOLOGY
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1015-6305
EI 1750-3639
J9 BRAIN PATHOL
JI Brain Pathol.
PD JUL
PY 2014
VL 24
IS 4
DI 10.1111/bpa.12160
PG 2
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA AJ4SF
UT WOS:000337665400001
DA 2020-12-08
ER

PT J
AU Goncalves, CB
   Lima, GAB
   Nogueira, J
   do Souto, AAD
   Chimelli, L
   Taboada, GF
AF Goncalves, Cesar B.
   Lima, Giovanna A. B.
   Nogueira, Janio
   Dutra do Souto, Antonio Aversa
   Chimelli, Leila
   Taboada, Giselle F.
TI Subgaleal recurrence of craniopharyngioma of rapid growing pattern
SO PITUITARY
LA English
DT Article
DE Ectopic recurrence; Craniopharyngioma; Tumor seeding; Surgical route
ID TUMOR-CELL MIGRATION; ECTOPIC RECURRENCE
AB The purpose of the present clinical case is to remind clinicians that craniopharyngiomas, which are benign neoplasms with a high incidence of local recurrences, may also present ectopic recurrences which may at first go unsuspected. These tumors most commonly arise in the suprasellar region and despite their benign histology, they may infiltrate the surrounding neurovascular structures making total removal challenging. Ectopic recurrences of craniopharyngiomas are very rare. We describe an adult patient with ectopic recurrence of craniopharyngioma, emphasizing unique features of the case presentation and its physiopathological aspects. A 49-year-old male presented with headache and visual field defect and was diagnosed with a suprasellar tumor. He was submitted to neurosurgery and histological examination revealed an adamantinomatous craniopharyngioma. Postoperative magnetic resonance imaging (MRI) showed complete tumor resection. The patient remained asymptomatic with no imaging signs of local recurrence during follow up. Five years after surgery, the patient noticed a rapidly growing lump at the surgical incision site. He reported a mild to moderate local trauma 4 months before. A MRI showed a subgaleal cystic tumor arising in the pathway of the craniotomy. Surgical resection of that cystic lesion was performed and histological examination revealed an adamantinomatous craniopharyngioma. One year later no recurrences have been detected. The case reported has two particular features: the local trauma as a potential trigger for tumor progression and the rapidly growing pattern of the ectopic recurrent tumor. We emphasize that although ectopic recurrences of craniopharyngiomas are rare, they may occur away from the primary tumor and quite late in the follow up of the patient.
C1 [Goncalves, Cesar B.] Univ Fed Fluminense, Hosp Univ Antonio Pedro, Neurosurg Unit, Niteroi, RJ, Brazil.
   [Lima, Giovanna A. B.; Taboada, Giselle F.] Univ Fed Fluminense, Hosp Univ Antonio Pedro, Endocrinol Unit, Niteroi, RJ, Brazil.
   [Nogueira, Janio; Dutra do Souto, Antonio Aversa] Inst Nacl Canc, Neurosurg Unit, Rio De Janeiro, Brazil.
   [Dutra do Souto, Antonio Aversa] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Neurosurg Unit, Rio De Janeiro, Brazil.
   [Chimelli, Leila] Inst Nacl Canc, Div Pathol, Rio De Janeiro, Brazil.
   [Chimelli, Leila] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Div Pathol, Rio De Janeiro, Brazil.
RP Taboada, GF (corresponding author), Univ Fed Fluminense, Hosp Univ Antonio Pedro, Endocrinol Unit, Niteroi, RJ, Brazil.
EM giselle.taboada@terra.com.br
CR Anson M, 2012, J CLIN INVEST, V122, P586, DOI 10.1172/JCI43937
   Baba M, 1978, No Shinkei Geka, V6, P687
   Bianco AD, 2006, SURG NEUROL, V66, P437, DOI 10.1016/j.surneu.2005.12.027
   Bikmaz K, 2009, NEUROSURGERY, V64, P382, DOI [10.1227/01.NEU.0000337128.67045.70, 10.1227/01.NEU.0000337078.60998.98]
   de Blank PM, 2011, J PEDIAT HEMATOL ONC, V33, P392, DOI 10.1097/MPH.0b013e31820acfb2
   Du Qiang, 2010, For Immunopathol Dis Therap, V1, P155
   Elfving M, 2011, CHILD NERV SYST, V27, P845, DOI 10.1007/s00381-010-1375-8
   Elliott RE, 2009, J NEUROSURG-PEDIATR, V4, P105, DOI 10.3171/2009.3.PEDS0948
   Gupta DK, 2006, J CLIN NEUROSCI, V13, P405, DOI 10.1016/j.jocn.2006.01.012
   Haupt R, 2006, J PEDIATR ENDOCR MET, V19, P289
   Holsken A, 2011, CLIN CANCER RES, V17, P4367, DOI 10.1158/1078-0432.CCR-10-2811
   Holsken A, 2010, ACTA NEUROPATHOL, V119, P631, DOI 10.1007/s00401-010-0642-9
   Ishii K, 2004, PEDIATR NEUROSURG, V40, P230, DOI 10.1159/000082297
   Ito M, 2001, NEUROSURGERY, V48, P933
   Jeong IH, 2006, J NEURO-ONCOL, V79, P191, DOI 10.1007/s11060-006-9124-2
   Kawaguchi T, 2005, J CLIN NEUROSCI, V12, P307, DOI 10.1016/j.jocn.2004.01.009
   Lee CH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-64
   Lee DK, 2001, J NEUROSURG, V94, P617, DOI 10.3171/jns.2001.94.4.0617
   Lee JH, 1999, J NEUROSURG, V90, P796, DOI 10.3171/jns.1999.90.4.0796
   Lermen O, 2010, ACTA NEUROCHIR, V152, P309, DOI 10.1007/s00701-009-0537-5
   MALIK JM, 1992, J NEUROSURG, V77, P804, DOI 10.3171/jns.1992.77.5.0804
   Muller HL, 2008, HORM RES, V69, P193, DOI 10.1159/000113019
   Novegno F, 2002, CHILD NERV SYST, V18, P468, DOI 10.1007/s00381-002-0641-9
   Rengifo-Cam W, 2007, CANCER RES, V67, P7266, DOI 10.1158/0008-5472.CAN-07-1206
   Romani R, 2010, ACTA NEUROCHIR, V152, P297, DOI 10.1007/s00701-009-0415-1
   Schmalisch K, 2010, ACTA NEUROCHIR, V152, P313, DOI 10.1007/s00701-009-0538-4
   Wang XY, 2010, J INT MED RES, V38, P1876, DOI 10.1177/147323001003800536
   Zada G, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS09318
NR 28
TC 6
Z9 6
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1386-341X
EI 1573-7403
J9 PITUITARY
JI Pituitary
PD JUN
PY 2014
VL 17
IS 3
BP 214
EP 219
DI 10.1007/s11102-013-0490-4
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AG8MT
UT WOS:000335673400004
PM 23686436
DA 2020-12-08
ER

PT J
AU Gadelha, MR
   Neto, LV
   Giorgetta, JM
   Pereira, PJD
   Niemeyer, P
   Chimelli, L
AF Gadelha, Monica R.
   Neto, Leonardo Vieira
   Giorgetta, Juliana Malheiros
   da Mata Pereira, Paulo Jose
   Niemeyer Filho, Paulo
   Chimelli, Leila
TI A 21-YEAR-OLD FEMALE WITH GALACTORRHEA
SO BRAIN PATHOLOGY
LA English
DT Editorial Material
ID GIANT-CELL TUMORS; BONE; SERIES; SELLAR; MASSES
C1 [Gadelha, Monica R.; Neto, Leonardo Vieira; Giorgetta, Juliana Malheiros] Univ Fed Rio de Janeiro, Univ Hosp, Div Endocrinol, Rio De Janeiro, Brazil.
   [Chimelli, Leila] Univ Fed Rio de Janeiro, Univ Hosp, Div Pathol, Rio De Janeiro, Brazil.
   [Neto, Leonardo Vieira] Lagoa Fed Hosp, Div Endocrinol, Rio De Janeiro, Brazil.
   [da Mata Pereira, Paulo Jose; Niemeyer Filho, Paulo] Santa Casa Misericordia, Neurosurg Div, Rio De Janeiro, Brazil.
RP Gadelha, MR (corresponding author), Univ Fed Rio de Janeiro, Univ Hosp, Div Endocrinol, Rio De Janeiro, Brazil.
OI Vieira Neto, Leonardo/0000-0002-1595-3985
CR Famini P, 2011, J CLIN ENDOCR METAB, V96, P1633, DOI 10.1210/jc.2011-0168
   Freda PU, 1996, J CLIN ENDOCR METAB, V81, P3455, DOI 10.1210/jc.81.10.3455
   Klenke FM, 2011, CLIN ORTHOP RELAT R, V469, P591, DOI 10.1007/s11999-010-1501-7
   Saw S, 2009, PATHOL ONCOL RES, V15, P291, DOI 10.1007/s12253-008-9124-y
   Sharma RR, 2002, J CLIN NEUROSCI, V9, P41, DOI 10.1054/jocn.2001.0963
   VIALE GL, 1977, ACTA NEUROCHIR, V38, P259, DOI 10.1007/BF01401096
   Weber AL, 1997, SKULL BASE SURG, V7, P163, DOI 10.1055/s-2008-1058592
   Werner M, 2006, INT ORTHOP, V30, P484, DOI 10.1007/s00264-006-0215-7
   Wulling M, 2003, HUM PATHOL, V34, P983, DOI 10.1053/S0046-8177(03)00413-1
NR 9
TC 0
Z9 0
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1015-6305
EI 1750-3639
J9 BRAIN PATHOL
JI Brain Pathol.
PD APR
PY 2014
VL 24
IS 3
BP 299
EP 300
DI 10.1111/bpa.12139
PG 2
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA AE6RN
UT WOS:000334121900010
PM 24895692
DA 2020-12-08
ER

PT J
AU Medeiros, MF
   Jardim, MR
   Vital, RT
   Nery, JAD
   Sales, AM
   de Moraes, MO
   Chimelli, LM
   Pessolani, MCV
   Ferreira, H
   Sarno, EN
   Antunes, SLG
AF Medeiros, Mildred Ferreira
   Jardim, Marcia Rodrigues
   Vital, Robson Teixeira
   da Costa Nery, Jose Augusto
   Sales, Anna Maria
   de Moraes, Milton Ozorio
   Chimelli, Leila Maria
   Vidal Pessolani, Maria Cristina
   Ferreira, Helen
   Sarno, Euzenir Nunes
   Gomes Antunes, Sergio Luiz
TI An Attempt to Improve Pure Neural Leprosy Diagnosis Using
   Immunohistochemistry Tests in Peripheral Nerve Biopsy Specimens
SO APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
LA English
DT Article
DE pure neural leprosy; Mycobacterium leprae; diagnosis;
   immunohistochemistry; peripheral nerve
ID MYCOBACTERIUM-LEPRAE; SKIN-LESIONS; ANTIGENS; ASSOCIATION; IMPAIRMENT;
   SAMPLES; LAM
AB The diagnosis of pure neural leprosy (PNL) is based on clinical and laboratory data, including the histopathology of nerve biopsy specimens and detection of Mycobacterium leprae DNA by polymerase chain reaction (PCR). Given that histopathologic examination and PCR methods may not be sufficient to confirm the diagnosis, immunolabeling of lipoarabinomanan (LAM) and/or phenolic glycolipid 1 (PGL-1) M. leprae wall components was utilized in the present investigation in an attempt to detect any vestigial presence of M. leprae in acid-fast bacilli (AFB)(-) nerve samples. Twenty-three PNL nerve samples (6 AFB(+) and 17 AFB(-)PCR(+)) were cryosectioned and subjected to LAM and PGL-1 immunohistochemical staining by immunoperoxidase. Five nonleprosy nerve samples were used as controls. The 6 AFB(+) samples showed LAM/PGL-1 immunoreactivity. Among the 17 AFB(-) samples, 8 revealed LAM and/or PGL-1 immunoreactivity. In 17 AFB(-)PCR(+) patients, just 7 yielded LAM(+) and/or PGL-1(+) nerve results. In the PNL cases, the detection of immunolabeled LAM and PGL-1 in the nerve samples would have contributed to an enhanced diagnostic efficiency in the absence of molecular diagnostic facilities.
C1 [Medeiros, Mildred Ferreira; Jardim, Marcia Rodrigues; Vital, Robson Teixeira; da Costa Nery, Jose Augusto; Sales, Anna Maria; de Moraes, Milton Ozorio; Ferreira, Helen; Sarno, Euzenir Nunes; Gomes Antunes, Sergio Luiz] Inst Oswaldo Cruz, Leprosy Lab, BR-20001 Rio De Janeiro, RJ, Brazil.
   [Vidal Pessolani, Maria Cristina] Inst Oswaldo Cruz, Cellular Microbiol Lab, BR-20001 Rio De Janeiro, RJ, Brazil.
   [Chimelli, Leila Maria] Natl Canc Inst, Div Pathol, Rio De Janeiro, RJ, Brazil.
RP Medeiros, MF (corresponding author), Fundacao Oswaldo Cruz, Lab Hanseniase, Av Brasil 4365, BR-21040900 Rio De Janeiro, RJ, Brazil.
EM mildred@ioc.fiocruz.br
RI Moraes, Milton Ozorio/G-9753-2011
OI Moraes, Milton Ozorio/0000-0003-2653-0037; Nunes Sarno,
   Euzenir/0000-0003-0129-2159
FU Plano de Objetivos e Metas of the Oswaldo Cruz Institute, FIOCRUZ, Rio
   de Janeiro, RJ, Brazil; CNPqNational Council for Scientific and
   Technological Development (CNPq); CAPESCAPES
FX The authors thank Plano de Objetivos e Metas of the Oswaldo Cruz
   Institute, FIOCRUZ, Rio de Janeiro, RJ, Brazil, together with CNPq and
   CAPES for their support of this study and Judy Grevan for editing the
   text. The authors are also grateful to Dr Patrick Brennan, PhD (Colorado
   University, CO) for donating the antibodies (produced by BEI Resources,
   NIAID, and NIH) applied in the immunohistochemistry tests.
CR CHANG ZY, 1994, J BIOL CHEM, V269, P1956
   Chemouilli P, 1996, INT J LEPROSY, V64, P1
   Chimelli L, 1997, J NEUROL, V244, P318, DOI 10.1007/s004150050094
   Croft RP, 1999, LEPROSY REV, V70, P140
   Da Cunha FMB, 2006, MUSCLE NERVE, V33, P409, DOI 10.1002/mus.20465
   Garbino JA, 2004, HANSEN INT, V29, P130
   GAYLORD H, 1987, INFECT IMMUN, V55, P2860, DOI 10.1128/IAI.55.11.2860-2863.1987
   Girdhar B K, 1996, Indian J Lepr, V68, P35
   Antunes SLG, 2012, MEM I OSWALDO CRUZ, V107, P246, DOI 10.1590/S0074-02762012000200015
   Illarramendi X, 2005, EUR J CLIN INVEST, V35, P658, DOI 10.1111/j.1365-2362.2005.01554.x
   Jardim MR, 2009, ARQ NEURO-PSIQUIAT, V67, P726, DOI 10.1590/S0004-282X2009000400035
   Jardim MR, 2005, LEPROSY REV, V76, P232
   Jardim MR, 2003, J NEUROL, V250, P806, DOI 10.1007/s00415-003-1081-5
   KAUR G, 1991, INT J LEPROSY, V59, P385
   Lockwood DNJ, 2002, AM J TROP MED HYG, V66, P409, DOI 10.4269/ajtmh.2002.66.409
   Martinez AN, 2006, J CLIN MICROBIOL, V44, P3154, DOI 10.1128/JCM.02250-05
   Menicucci LA, 2005, J AM ACAD DERMATOL, V52, P648, DOI 10.1016/j.jaad.2004.11.068
   NARAYANAN RB, 1990, IMMUNOL LETT, V24, P179, DOI 10.1016/0165-2478(90)90045-R
   Nilsen R, 1986, Lepr Rev, V57 Suppl 2, P177
   RAMBUKKANA A, 1992, SCAND J IMMUNOL, V36, P35, DOI 10.1111/j.1365-3083.1992.tb02938.x
   RODRIGUEZ G, 1993, J AM ACAD DERMATOL, V29, P1050, DOI 10.1016/S0190-9622(08)82047-6
   STONER GL, 1979, LANCET, V2, P994
   Uplekar M W, 1986, Indian J Lepr, V58, P513
   Van den Bos IC, 1999, LEPROSY REV, V70, P272
   Verhagen C, 1999, AM J PATHOL, V154, P1793, DOI 10.1016/S0002-9440(10)65435-1
NR 25
TC 2
Z9 2
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1541-2016
EI 1533-4058
J9 APPL IMMUNOHISTO M M
JI Appl. Immunohistochem.
PD MAR
PY 2014
VL 22
IS 3
BP 222
EP 230
DI 10.1097/PAI.0b013e31828dc70c
PG 9
WC Anatomy & Morphology; Medical Laboratory Technology; Pathology
SC Anatomy & Morphology; Medical Laboratory Technology; Pathology
GA AD2IC
UT WOS:000333057100009
PM 23702646
DA 2020-12-08
ER

PT J
AU Fischer, JDD
   Canedo, NHS
   Goncalves, KMD
   Chimelli, LMC
   Franca, M
   Leprevost, FV
   Aquino, PF
   Carvalho, PC
   Carvalho, MDC
AF Fischer, Juliana de S. da G.
   Canedo, Nathalie H. S.
   Goncalves, Katia Maria da S.
   Cardao Chimelli, Leila Maria
   Franca, Monique
   Leprevost, Felipe V.
   Aquino, Priscila Ferreira
   Carvalho, Paulo C.
   Carvalho, Maria da Gloria C.
TI Proteome Analysis of Formalin-Fixed Paraffin-Embedded Tissues from a
   Primary Gastric Melanoma and its Meningeal Metastasis: A Case Report
SO CURRENT TOPICS IN MEDICINAL CHEMISTRY
LA English
DT Review
DE Gastric melanoma; proteomic; meningeal metastasis
ID FALSE-DISCOVERY RATE; PYRUVATE-KINASE; GENE-ONTOLOGY; EXPRESSION;
   IDENTIFICATION; TOOL; METABOLISM; MIGRATION; GLUTAMINE; SPECTRA
AB Melanoma is the third most common brain metastasis cause in the United States as it has a relatively high susceptibility to metastasize to the central nervous system. Among the different origins for brain metastasis, those originating from primary gastric melanomas are extremely rare. Here, we compare protein profiles obtained from formalin-fixed paraffin-embedded (FFPE) tissues of a primary gastric melanoma with its meningeal metastasis. For this, the contents of a microscope slide were scraped and ultimately analyzed by nano-chromatography coupled online with tandem mass spectrometry using an Orbitrap XL. Our results disclose 184 proteins uniquely identified in the primary gastric melanoma, 304 in the meningeal metastasis, and 177 in common. Notably, we indentified several enzymes related to changes in the metabolism that are linked to producing energy by elevated rates of glycolysis in a process called the Warburg effect. Moreover, we show that our FFPE proteomic approach allowed identification of key biological markers such as the S100 protein that we further validated by immunohistochemistry for both, the primary and metastatic tumor samples. That said, we demonstrated a powerful strategy to retrospectively mine data for aiding in the understanding of metastasis, biomarker discovery, and ultimately, diseases. To our knowledge, these results disclose for the first time a comparison of the proteomic profiles of gastric melanoma and its corresponding meningeal metastasis.
C1 [Fischer, Juliana de S. da G.; Leprevost, Felipe V.; Carvalho, Paulo C.] Fiocruz MS, Carlos Chagas Inst, Maringa, Parana, Brazil.
   [Canedo, Nathalie H. S.; Goncalves, Katia Maria da S.; Cardao Chimelli, Leila Maria; Franca, Monique; Carvalho, Maria da Gloria C.] Univ Fed Rio de Janeiro, Sch Med, Dept Anat Pathol, BR-21941 Rio De Janeiro, Brazil.
   [Aquino, Priscila Ferreira] Univ Fed Rio de Janeiro, Inst Chem, BR-21941 Rio De Janeiro, Brazil.
RP Carvalho, MDC (corresponding author), Rua Nascimento Silva 241-501, BR-22421020 Rio De Janeiro, RJ, Brazil.
EM gloria@gcarvalho.com
RI Aquino, Priscila/AAJ-3019-2020; da Gloria da Costa Carvalho,
   Maria/H-1644-2012; da Veiga Leprevost, Felipe/D-6905-2013
OI Aquino, Priscila/0000-0002-2344-0493; da Gloria da Costa Carvalho,
   Maria/0000-0001-5890-8095; da Veiga Leprevost,
   Felipe/0000-0002-8228-5374
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPES-FiocruzCAPES [30/2006]; FAPERJCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   PDTIS; Fundacao do Cancer
FX The authors thank CNPq, CAPES-Fiocruz 30/2006, FAPERJ, PDTIS, and
   Fundacao do Cancer for financial support. The authors thank the
   Fiocruz-PR proteomics core facility for generating the data.
CR Alazmi WM, 2003, GASTROINTEST ENDOSC, V57, P431, DOI 10.1067/mge.2003.120
   ALBERTI J E, 1984, Acta Gastroenterologica Latinoamericana, V14, P139
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Azimzadeh O, 2010, J PROTEOME RES, V9, P4710, DOI 10.1021/pr1004168
   Barboza R, 2011, PROTEOMICS, V11, P4105, DOI 10.1002/pmic.201100297
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Carvalho PC, 2008, GENET MOL RES, V7, P342, DOI 10.4238/vol7-2gmr426
   Carvalho PC, 2012, BIOINFORMATICS, V28, P1652, DOI 10.1093/bioinformatics/bts247
   Carvalho PC, 2012, PROTEOMICS, V12, P944, DOI 10.1002/pmic.201100529
   Carvalho PC, 2011, BIOINFORMATICS, V27, P275, DOI 10.1093/bioinformatics/btq632
   Carvalho PC, 2010, BIOINFORMATICS, V26, P847, DOI 10.1093/bioinformatics/btq031
   Carvalho PC, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-6
   Carvalho PC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-316
   Carvalho PC, 2010, CURR PROTOC BIOINFOR, V13, P1
   CHANDLER A B, 1951, Am Surg, V17, P719
   Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734
   Cui XN, 2009, WORLD J GASTROENTERO, V15, P6117, DOI 10.3748/wjg.15.6117
   Donadio E, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-29
   Gaglio D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.56
   HENNIPMAN A, 1988, TUMOR BIOL, V9, P241, DOI 10.1159/000217568
   Jiang BH, 1997, CANCER RES, V57, P5328
   Kanamori H, 2011, ONCOLOGY-BASEL, V80, P406, DOI 10.1159/000330734
   Kanthan R, 2009, WORLD J SURG ONCOL, V7, DOI 10.1186/1477-7819-7-62
   Lagoudianakis EE, 2006, WORLD J GASTROENTERO, V12, P4425, DOI 10.3748/wjg.v12.i27.4425
   Lee EK, 2010, J PROTEOME RES, V9, P5108, DOI 10.1021/pr100378z
   Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009
   McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603
   Medina MA, 2001, J NUTR, V131, p2539S, DOI 10.1093/jn/131.9.2539S
   Murphy D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-14
   Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200
   Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910
   Ralton LD, 2011, J CLIN PATHOL, V64, P297, DOI 10.1136/jcp.2010.086835
   Sprung RW, 2009, MOL CELL PROTEOMICS, V8, P1988, DOI 10.1074/mcp.M800518-MCP200
   Venable JD, 2004, NAT METHODS, V1, P39, DOI 10.1038/NMETH705
   WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309
   Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686
   Xu T, 2006, MOL CELL PROTEOMICS, V5, pS174
   Yang CD, 2009, CANCER RES, V69, P7986, DOI 10.1158/0008-5472.CAN-09-2266
   Zeltz C, 2010, EXP CELL RES, V316, P2922, DOI 10.1016/j.yexcr.2010.08.002
NR 39
TC 1
Z9 1
U1 0
U2 3
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1568-0266
EI 1873-5294
J9 CURR TOP MED CHEM
JI Curr. Top. Med. Chem.
PD FEB
PY 2014
VL 14
IS 3
BP 382
EP 387
DI 10.2174/1568026613666131204114218
PG 6
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA AA8XY
UT WOS:000331379500014
PM 24304316
DA 2020-12-08
ER

PT J
AU Neto, LV
   Chimelli, L
   Pereira, PJD
   Gasparetto, EL
   Bines, J
   Wildemberg, LEA
   Gadelha, MR
AF Vieira Neto, Leonardo
   Chimelli, Leila
   Pereira, Paulo Jose da M.
   Gasparetto, Emerson L.
   Bines, Jose
   Wildemberg, Luiz Eduardo A.
   Gadelha, Monica R.
TI THE ROLE OF TEMOZOLOMIDE IN THE TREATMENT OF A PATIENT WITH A PURE
   SILENT PITUITARY SOMATOTROPH CARCINOMA
SO ENDOCRINE PRACTICE
LA English
DT Article
ID MALIGNANT GROWTH; TUMORS; INVASIVENESS; METASTASIS
AB Objective: To describe a case of a pure silent somatotroph pituitary carcinoma.
   Methods: We describe a 54-year-old female with a clinically nonfunctioning pituitary macroadenoma diagnosed 15 years earlier.
   Results: The patient underwent transsphenoidal surgery and no visible tumor remnant was observed for 6 years. A magnetic resonance imaging (MRI) detected the recurrence of a 1.2 x 1.5 cm macroadenoma. The patient was submitted to conventional radiotherapy (4500 cGy), and the tumor volume remained stable for 7 years. Then, an MRI revealed a slight increase in tumor size, and 2 years later, a subsequent MRI detected a very large, invasive pituitary mass. The patient was resubmitted to transsphenoidal surgery, and the histopathological examination showed diffuse positivity for growth hormone (GH). The nadir GH level during an oral glucose tolerance test was 0.06 ng/mL, and the pre- and postoperative insulin like growth factor type I (IGF-I) levels were within the normal range. Abdominal, chest, brain, and spine MRI showed multiple small and hypervascular liver and bone lesions suggestive of metastases. Liver biopsy confirmed metastasis of GH-producing pituitary carcinoma. The patient has been treated with temozolomide and zoledronic acid for 7 months and with octreotide long-acting release (LAR) for 4 months. The primary tumor and metastases are stable.
   Conclusion: Despite being an extremely rare event, pituitary carcinoma may develop several years after the successful treatment of even a silent GH-producing pituitary adenoma, which suggests that close long-term follow-up is necessary.
C1 [Vieira Neto, Leonardo; Wildemberg, Luiz Eduardo A.; Gadelha, Monica R.] Univ Fed Rio de Janeiro, Dept Internal Med, Rio De Janeiro, Brazil.
   [Vieira Neto, Leonardo; Wildemberg, Luiz Eduardo A.; Gadelha, Monica R.] Univ Fed Rio de Janeiro, Sch Med, Endocrine Unit, Rio De Janeiro, Brazil.
   [Vieira Neto, Leonardo; Wildemberg, Luiz Eduardo A.; Gadelha, Monica R.] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Rio De Janeiro, Brazil.
   [Vieira Neto, Leonardo] Fed Hosp Lagoa, Endocrinol Sect, Rio De Janeiro, Brazil.
   [Chimelli, Leila] Natl Canc Inst, Div Pathol, Rio De Janeiro, Brazil.
   [Pereira, Paulo Jose da M.] Hosp Santa Casa de Misericordia, Neurosurg Sect, Rio De Janeiro, Brazil.
   [Gasparetto, Emerson L.] CDPI, Rio De Janeiro, Brazil.
   [Gasparetto, Emerson L.] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Sch Med, Radiol Unit, Rio De Janeiro, Brazil.
   [Bines, Jose] Natl Canc Inst, Div Oncol, Rio De Janeiro, Brazil.
RP Gadelha, MR (corresponding author), Ilha Fundao, Rua Prof Rodolpho Paulo Rocco,255 9th Floor, BR-21941913 Rio De Janeiro, Brazil.
EM mgadelha@hucff.ufrj.br
RI wildemberg, luiz/S-4712-2017
OI Vieira Neto, Leonardo/0000-0002-1595-3985
FU Ipsen; NovartisNovartis; PfizerPfizer
FX This case was presented by Prof. M. Gadelha at ENDO 2012, the annual
   Endocrine Society meeting, during the Master Clinician Session -
   Difficult Pituitary Cases. MRG: Lecture fees from Ipsen, Novartis and
   Pfizer. Research grants from Novartis and Pfizer. Advisory board:
   Novartis.
CR Annamalai AK, 2012, PITUITARY, V15, P276, DOI 10.1007/s11102-011-0363-7
   ASAI A, 1988, NEUROSURGERY, V22, P1091, DOI 10.1227/00006123-198806010-00023
   Bush ZM, 2010, J CLIN ENDOCR METAB, V95, pE280, DOI 10.1210/jc.2010-0441
   Dayan C, 1996, CLIN ENDOCRINOL, V44, P597, DOI 10.1046/j.1365-2265.1996.685507.x
   Dudziak K, 2011, J CLIN ENDOCR METAB, V96, P2665, DOI 10.1210/jc.2011-1166
   Green J, 2010, CANCER INVEST, V28, P944, DOI 10.3109/07357907.2010.512598
   Greenman Y, 1996, J CLIN ENDOCR METAB, V81, P1628, DOI 10.1210/jc.81.4.1628
   Hagen C, 2009, EUR J ENDOCRINOL, V161, P631, DOI 10.1530/EJE-09-0389
   HASHIMOTO N, 1986, J NEUROSURG, V64, P140, DOI 10.3171/jns.1986.64.1.0140
   Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331
   JAMJOOM A, 1994, BRIT J NEUROSURG, V8, P87, DOI 10.3109/02688699409002399
   de Pinho LKJ, 2011, NEUROENDOCRINOLOGY, V94, P39, DOI 10.1159/000322787
   Kaltsas GA, 2005, J CLIN ENDOCR METAB, V90, P3089, DOI 10.1210/jc.2004-2231
   Lau Q, 2010, PITUITARY, V13, P367, DOI 10.1007/s11102-010-0249-0
   le Roux CW, 2001, NEW ENGL J MED, V345, P1645, DOI 10.1056/NEJM200111293452216
   Lim S, 2006, LANCET ONCOL, V7, P518, DOI 10.1016/S1470-2045(06)70728-8
   Lloyd RV, 2004, WHO CLASSIFICATION T, P10
   Lopes M Beatriz S, 2005, Endocrine, V28, P115, DOI 10.1385/ENDO:28:1:115
   McCormack AI, 2011, EUR J CLIN INVEST, V41, P1133, DOI 10.1111/j.1365-2362.2011.02520.x
   MOUNTCASTLE RB, 1989, AM J MED SCI, V298, P109, DOI 10.1097/00000441-198908000-00007
   Raverot G, 2012, CLIN ENDOCRINOL, V76, P769, DOI 10.1111/j.1365-2265.2012.04381.x
   Scheithauer BW, 2001, ULTRASTRUCT PATHOL, V25, P227, DOI 10.1080/019131201300343865
   STEWART PM, 1992, CLIN ENDOCRINOL, V37, P189, DOI 10.1111/j.1365-2265.1992.tb02306.x
   Thapar K, 1996, NEUROSURGERY, V38, P99, DOI 10.1097/00006123-199601000-00024
   YAMASHITA S, 1992, ANN INTERN MED, V117, P1057, DOI 10.7326/0003-4819-117-12-1057
   Zahedi A, 2001, CLIN ENDOCRINOL, V55, P549, DOI 10.1046/j.1365-2265.2001.01322.x
NR 26
TC 17
Z9 17
U1 0
U2 0
PU AMER ASSOC CLINICAL ENDOCRINOLOGISTS
PI JACKSONVILLE
PA 245 RIVERSIDE AVENUE, STE 200, JACKSONVILLE, FL 32202 USA
SN 1530-891X
EI 1934-2403
J9 ENDOCR PRACT
JI Endocr. Pract.
PD NOV-DEC
PY 2013
VL 19
IS 6
BP E145
EP E149
DI 10.4158/EP12400.CR
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 261EB
UT WOS:000327645900004
PM 23807517
DA 2020-12-08
ER

PT J
AU Gomes, MD
   Engelhardt, E
   Chimelli, L
AF Gomes, Marleide da Mota
   Engelhardt, Eliasz
   Chimelli, Leila
TI The first Brazilian neuropsychiatrist, Jose Martins da Cruz Jobim,
   tuberculous meningitis and mental disease
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE Brazilian Neurology; Neuropsychiatry; tuberculous; meningitis; history
   of Neurosciences
AB The intersection between infectious diseases, poverty and mental disease was an important subject to the Brazilian Neuropsychiatry in the early 19th century. Jose Martins da Cruz Jobim (1802-1878) was engaged in a hygienist approach based on symptomatological and anatomo-pathological studies. He wrote "Insania loquaz" (Loquacious insanity), 1831, the first written text about mental illness in Brazil, founded on clinical and pathological data, compatible with tuberculous meningitis. Thus, Jobim deserves the title of the first neuropsychiatrist in Brazil. The authors critically studied the clinical history and the autopsy findings of his cases, and the main health policies at the time.
C1 [Gomes, Marleide da Mota] Univ Fed Rio de Janeiro UFRJ, Inst Neurol, Sch Med, BR-22290140 Rio De Janeiro, RJ, Brazil.
   [Engelhardt, Eliasz] Univ Fed Rio de Janeiro, Cognit & Behav Neurol Unit, Inst Neurol, Inst Psychiat, Rio de Janeiro, RJ, Brazil.
   [Chimelli, Leila] Univ Fed Rio de Janeiro, Inst Neurol, Sch Med, Rio de Janeiro, RJ, Brazil.
RP Gomes, MD (corresponding author), Univ Fed Rio de Janeiro UFRJ, Inst Neurol Deolindo Couto, Ave Venceslau Braz 95, BR-22290140 Rio De Janeiro, RJ, Brazil.
EM mmotagomes@acd.ufrj.br
CR Edler Flavio Coelho, 2002, Hist. cienc. saude-Manguinhos, V9, P357, DOI 10.1590/S0104-59702002000200007
   Fernandes R, 1982, CONSELHEIRO JOBIM ES
   Gomes MDM, 2007, ARQ NEURO-PSIQUIAT, V65, P710, DOI 10.1590/S0004-282X2007000400033
   Gomes MD, 2011, ARQ NEURO-PSIQUIAT, V69, P559, DOI 10.1590/S0004-282X2011000400028
   Jobim José Martins da Cruz, 2005, Rev. latinoam. psicopatol. fundam., V8, P557, DOI 10.1590/1415-47142005003013
   Jobim Jose Martins da Cruz, DICIONARIO HIST BIOG
   Oda Ana Maria Galdini Raimundo, 2005, Rev. latinoam. psicopatol. fundam., V8, P554, DOI 10.1590/1415-47142005003012
   Ruhrah J, 1904, Med Library Hist J, V2, P160
   SANTOS FILHO L, 1991, HIST GERAL MED BRASI
   WILLIAMS M, 1954, J NEUROL NEUROSUR PS, V17, P173, DOI 10.1136/jnnp.17.3.173
NR 10
TC 3
Z9 3
U1 0
U2 1
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD MAR
PY 2013
VL 71
IS 3
BP 191
EP 193
PG 3
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 122JY
UT WOS:000317315600012
PM 23563721
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Souza, CCR
   Dombroski, TCD
   Machado, HR
   Oliveira, RS
   Rocha, LB
   Rodrigues, ARA
   Neder, L
   Chimelli, L
   Correa, VMA
   Larson, RE
   Martins, AR
AF Souza, C. C. R.
   Dombroski, T. C. D.
   Machado, H. R.
   Oliveira, R. S.
   Rocha, L. B.
   Rodrigues, A. R. A.
   Neder, L.
   Chimelli, L.
   Correa, V. M. A.
   Larson, R. E.
   Martins, A. R.
TI Myosin Va is developmentally regulated and expressed in the human
   cerebellum from birth to old age
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE Myosin Va; Human cerebellum; Postnatal development; Aging;
   Immunohistochemical expression
ID GRISCELLI-SYNDROME; CELL-MIGRATION; DENDRITIC SPINES; MOTOR PROTEIN;
   BRAIN; LOCALIZATION; COMPLEX; RAT; MUTATIONS; TRANSPORT
AB Myosin Va functions as a processive, actin-based motor molecule highly enriched in the nervous system, which transports and/or tethers organelles, vesicles, and mRNA and protein translation machinery. Mutation of myosin Va leads to Griscelli disease that is associated with severe neurological deficits and a short life span. Despite playing a critical role in development, the expression of myosin Va in the central nervous system throughout the human life span has not been reported. To address this issue, the cerebellar expression of myosin Va from newborns to elderly humans was studied by immunohistochemistry using an affinity-purified anti-myosin Va antibody. Myosin Va was expressed at all ages from the 10th postnatal day to the 98th year of life, in molecular, Purkinje and granular cerebellar layers. Cerebellar myosin Va expression did not differ essentially in localization or intensity from childhood to old age, except during the postnatal developmental period. Structures resembling granules and climbing fibers in Purkinje cells were deeply stained. In dentate neurons, long processes were deeply stained by anti-myosin Va, as were punctate nuclear structures. During the first postnatal year, myosin Va was differentially expressed in the external granular layer (EGL). In the EGL, proliferating prospective granule cells were not stained by anti-myosin Va antibody. In contrast, premigratory granule cells in the EGL stained moderately. Granule cells exhibiting a migratory profile in the molecular layer were also moderately stained. In conclusion, neuronal myosin Va is developmentally regulated, and appears to be required for cerebellar function from early postnatal life to senescence.
C1 [Souza, C. C. R.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurol, BR-14049 Ribeirao Preto, SP, Brazil.
   [Dombroski, T. C. D.; Martins, A. R.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Farmacol, BR-14049 Ribeirao Preto, SP, Brazil.
   [Dombroski, T. C. D.; Rocha, L. B.; Rodrigues, A. R. A.; Martins, A. R.] Univ Fed Triangulo Mineiro, Inst Ciencias Nat & Biol, BR-38025015 Uberaba, MG, Brazil.
   [Machado, H. R.; Oliveira, R. S.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Cirurgia, Div Neurocirurgia Pediat, BR-14049 Ribeirao Preto, SP, Brazil.
   [Neder, L.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Patol, BR-14049 Ribeirao Preto, SP, Brazil.
   [Chimelli, L.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Dept Patol, Rio De Janeiro, RJ, Brazil.
   [Correa, V. M. A.; Larson, R. E.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol, BR-14049 Ribeirao Preto, SP, Brazil.
RP Martins, AR (corresponding author), Univ Fed Triangulo Mineiro, Inst Ciencias Nat & Biol, Praca Manoel Terra 330, BR-38025015 Uberaba, MG, Brazil.
EM armartin@fmrp.usp.br
RI de Oliveira, Ricardo S/A-2039-2010; de Oliveira, Ricardo
   Santos/AAW-7714-2020; de Oliveira, Ricardo Santos/AAY-1993-2020;
   Machado, Helio R/I-6602-2012; Rocha, Lenaldo B/D-2382-2011
OI de Oliveira, Ricardo S/0000-0003-0390-5553; de Oliveira, Ricardo
   Santos/0000-0003-0390-5553; Rocha, Lenaldo B/0000-0002-4345-6994;
   Machado, Helio/0000-0002-1069-7804
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   FAEPA; CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX Research supported by FAPESP, FAEPA, CAPES, and CNPq.
CR Abu-Hamdah R, 2006, ULTRAMICROSCOPY, V106, P670, DOI 10.1016/j.ultramic.2006.01.013
   Cheney RE, 1998, METHOD ENZYMOL, V298, P3, DOI 10.1016/S0076-6879(98)98003-X
   Cohen DL, 2001, BRAIN RES, V890, P233, DOI 10.1016/S0006-8993(00)03165-6
   Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063
   Costa MCR, 1999, J BIOL CHEM, V274, P15811, DOI 10.1074/jbc.274.22.15811
   de Azevedo A, 2004, ANAT EMBRIOL, V208, P395
   DekkerOhno K, 1996, BRAIN RES, V714, P226, DOI 10.1016/0006-8993(95)01560-4
   Desnos C, 2007, BIOL CELL, V99, P411, DOI 10.1042/BC20070021
   ESPINDOLA FS, 1992, J CELL BIOL, V118, P359, DOI 10.1083/jcb.118.2.359
   ESPREAFICO EM, 1992, J CELL BIOL, V119, P1541, DOI 10.1083/jcb.119.6.1541
   Evans LL, 1998, J CELL SCI, V111, P2055
   Goodson HV, 2006, P NATL ACAD SCI USA, V103, P3498, DOI 10.1073/pnas.0600045103
   KOMURO H, 1995, J NEUROSCI, V15, P1110
   Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2
   Komuro H, 2001, J NEUROSCI, V21, P527, DOI 10.1523/JNEUROSCI.21-02-00527.2001
   LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8
   Larson RE, 2004, ENCY BIOL CHEM, V2, P778
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Martins AR, 2011, J NEUROSCI METH, V198, P16, DOI 10.1016/j.jneumeth.2011.02.024
   Martins AR, 1999, J NEUROSCI METH, V92, P25, DOI 10.1016/S0165-0270(99)00090-4
   Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024
   Menasche G, 2003, J CLIN INVEST, V112, P450, DOI 10.1172/JCI200318264
   MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0
   Nascimento AAC, 1997, MOL BIOL CELL, V8, P1971, DOI 10.1091/mbc.8.10.1971
   Pastural E, 2000, GENOMICS, V63, P299, DOI 10.1006/geno.1999.6081
   Pastural E, 1997, NAT GENET, V16, P289, DOI 10.1038/ng0797-289
   Prekeris R, 1997, J CELL BIOL, V137, P1589, DOI 10.1083/jcb.137.7.1589
   RAKIC P, 1970, J COMP NEUROL, V139, P473, DOI 10.1002/cne.901390407
   RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380
   RIVAS RJ, 1995, J NEUROSCI, V15, P981
   Rodriguez OC, 2002, J CELL SCI, V115, P991
   Sellers JR, 2006, CURR OPIN CELL BIOL, V18, P68, DOI 10.1016/j.ceb.2005.12.014
   Tilelli CQ, 2003, NEUROSCIENCE, V121, P573, DOI 10.1016/S0306-4522(03)00546-3
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Trybus KM, 2008, CELL MOL LIFE SCI, V65, P1378, DOI 10.1007/s00018-008-7507-6
   Wang FS, 1996, SCIENCE, V273, P660, DOI 10.1126/science.273.5275.660
   Wu XF, 1997, J CELL SCI, V110, P847
   Yoshimura A, 2006, CURR BIOL, V16, P2345, DOI 10.1016/j.cub.2006.10.024
NR 38
TC 1
Z9 1
U1 0
U2 6
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, 00, BRAZIL
SN 0100-879X
EI 1678-4510
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD FEB
PY 2013
VL 46
IS 2
BP 164
EP 170
DI 10.1590/1414-431X20122627
PG 7
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA 120BI
UT WOS:000317144100009
PM 23558932
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Mendonca, DMF
   Pizzati, L
   Mostacada, K
   Martins, SCD
   Higashi, R
   Sa, LA
   Neto, VM
   Chimelli, L
   Martinez, AMB
AF Mendonca, D. M. F.
   Pizzati, L.
   Mostacada, K.
   Martins, S. C. de S.
   Higashi, R.
   Ayres Sa, L.
   Moura Neto, V.
   Chimelli, L.
   Martinez, A. M. B.
TI Neuroproteomics: an insight into ALS
SO NEUROLOGICAL RESEARCH
LA English
DT Article
DE Amyotrophic lateral sclerosis; Cerebrospinal fluid; MALDI-TOF;
   Proteomics
ID AMYOTROPHIC-LATERAL-SCLEROSIS; MATRIN 3; MOTOR-NEURONS; PROTEIN;
   DEGRADATION; ACTIVATION; PROTEASOME; EXPRESSION; BIOMARKERS; PROTEOMICS
AB Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease of unknown aetiology. Diagnosis is made through physical examination, electrophysiological findings, and by excluding other conditions. There is not a single biomarker that concludes the diagnosis. The aim of this study was to investigate differentially expressed proteins in cerebrospinal fluid (CSF) of ALS patients compared to control subjects, with the purpose to identify a panel of possible biomarkers for the disease. The differentially expressed spots/proteins were submitted to two-dimensional (2D) electrophoresis and recognized with matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometry. Parkin-like and many iron and zinc binding were some of the proteins found in ALS CSF. Parkin is a ligase involved in ubiquitin-proteasome pathway and mutations in the parkin gene are the most common cause of recessive familial Parkinson's disease. Iron and zinc are involved with many important metabolic processes and are related to neurodegenerative disease. Common features of ALS comprise failure of the ubiquitin-proteasome system and increased levels of metal ions in the brain. Therefore, the identification of these proteins can be a significant step in ALS research. These and other identified proteins are discussed in this study.
C1 [Mendonca, D. M. F.] Univ Fed Sergipe, Dept Biociencias, BR-49500000 Sergipe, SE, Brazil.
   [Pizzati, L.] Univ Fed Rio de Janeiro, Inst Nacl Canc, Ctr Estudos Medula Ossea, Rio De Janeiro, Brazil.
   [Pizzati, L.; Ayres Sa, L.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, ICB, Ctr Ciencias Saude, Rio De Janeiro, Brazil.
   [Mostacada, K.; Chimelli, L.] Univ Fed Rio de Janeiro, Dept Patol, Fac Med, Ctr Ciencias Saude, Rio De Janeiro, Brazil.
   [Mostacada, K.; Martinez, A. M. B.] Univ Fed Rio de Janeiro, Programa Neurociencia Basica & Clin, Dept Histol, Inst Ciencias Biol,Ctr Ciencias Saude, Rio De Janeiro, Brazil.
   [Martins, S. C. de S.; Moura Neto, V.] Univ Fed Rio de Janeiro, Dept Anat, Inst Ciencias Biomed, Ctr Ciencias Saude, Rio De Janeiro, Brazil.
   [Martins, S. C. de S.; Moura Neto, V.] INCT Minist Sci & Technol MCT, Natl Inst Translat Neurosci, Rio De Janeiro, Brazil.
RP Mendonca, DMF (corresponding author), Univ Fed Sergipe, Dept Biociencias, Av Vereador Olimpio Grande,Campus Prof Alberto Ca, BR-49500000 Sergipe, SE, Brazil.
EM deise_mendonca@ufs.br
RI Pizzatti, Luciana/AAW-2480-2020; Neurociencia, Inct/I-1011-2013;
   Moura-Neto, VIVALDO/V-9913-2019; Martinez, Ana/C-6318-2014
OI Pizzatti, Luciana/0000-0001-5513-782X; Moura-Neto,
   VIVALDO/0000-0002-6266-043X; 
FU FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); CNPqNational Council for Scientific and
   Technological Development (CNPq); CAPESCAPES; FUJB
FX We are especially grateful to Mario Ary Pires Neto, Jose Mauro Braz de
   Lima, Marli Pernes da Silva Loureiro, and Marzia Puccioni Sohler for
   their excellent and indispensable assistance. We also thank the
   Proteomic Unit of Biophysics Institute Carlos Chagas Filho, Federal
   University of Rio de Janeiro, Brazil. This study was supported by
   FAPERJ, CNPq, CAPES, and FUJB.
CR BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536
   Freed EF, 2010, MOL BIOSYST, V6, P481, DOI 10.1039/b919670f
   Gil OD, 1998, J NEUROSCI, V18, P9312
   Giordano G, 2005, J NEUROCHEM, V94, P808, DOI 10.1111/j.1471-4159.2005.03235.x
   Glatt H, 2001, MUTAT RES-FUND MOL M, V482, P27, DOI 10.1016/S0027-5107(01)00207-X
   Goulet I, 2008, HUM MOL GENET, V17, P3055, DOI 10.1093/hmg/ddn203
   Hadari YR, 2000, J CELL SCI, V113, P2385
   Hines RM, 2010, J BIOL CHEM, V285, P4621, DOI 10.1074/jbc.M109.069849
   Hrycay EG, 2009, CURR DRUG METAB, V10, P1151, DOI 10.2174/138920009790820138
   Kimata Y, 2008, MOL CELL, V32, P576, DOI 10.1016/j.molcel.2008.09.023
   Lee DH, 2005, J BIOL CHEM, V280, P39448, DOI 10.1074/jbc.M509881200
   McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9
   Mendonca DMF, 2006, NEUROSCI LETT, V404, P315, DOI 10.1016/j.neulet.2006.06.009
   Mendonca DMF, 2011, AMYOTROPH LATERAL SC, V12, P144, DOI 10.3109/17482968.2010.542002
   MURPHY MG, 1982, J NEUROCHEM, V38, P675, DOI 10.1111/j.1471-4159.1982.tb08684.x
   Nakamizo T, 2000, NEUROREPORT, V11, P3493, DOI 10.1097/00001756-200011090-00019
   Oveland E, 2009, LEUKEMIA RES, V33, P276, DOI 10.1016/j.leukres.2008.06.029
   Pasinetti GM, 2006, NEUROLOGY, V66, P1218, DOI 10.1212/01.wnl.0000203129.82104.07
   Pei JJ, 2008, J ALZHEIMERS DIS, V14, P385
   Przygodzka P, 2011, EXP CELL RES, V317, P802, DOI 10.1016/j.yexcr.2010.12.009
   Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543
   Ryberg H, 2010, MUSCLE NERVE, V42, P104, DOI 10.1002/mus.21683
   Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X
   Senderek J, 2009, AM J HUM GENET, V84, P511, DOI 10.1016/j.ajhg.2009.03.006
   Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h
   Suzuki T, 2008, BIOCHEM J, V411, P581, DOI 10.1042/BJ20071312
   Valencia CA, 2007, BIOCHEM BIOPH RES CO, V361, P281, DOI 10.1016/j.bbrc.2007.06.156
   White HE, 2007, CLIN CHEM, V53, P1960, DOI 10.1373/clinchem.2007.093351
   Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3
   Wilson ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015133
   Zeitz MJ, 2009, J CELL BIOCHEM, V108, P125, DOI 10.1002/jcb.22234
   Zhou JY, 2010, J PROTEOME RES, V9, P5133, DOI 10.1021/pr100409r
NR 33
TC 13
Z9 13
U1 0
U2 9
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0161-6412
EI 1743-1328
J9 NEUROL RES
JI Neurol. Res.
PD DEC
PY 2012
VL 34
IS 10
BP 937
EP 943
DI 10.1179/1743132812Y.0000000092
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 036ME
UT WOS:000311029600004
PM 23146297
DA 2020-12-08
ER

PT J
AU Dozza, DC
   Rodrigues, FF
   Chimelli, L
AF Dozza, Diego Cassol
   Rodrigues, Flavio Freinkel
   Chimelli, Leila
TI Dysembryoplastic neuroepithelial tumor originally diagnosed as
   astrocytoma and oligodendroglioma
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE dysembryoplastic neuroepithelial tumor; low-grade gliomas; epilepsy
ID SINGLE-INSTITUTION; CHRONIC EPILEPSY; CHILDREN; MR; CHILDHOOD; SURGERY;
   SERIES; CT
AB Dysembryoplastic neuroepithelial tumor (DNT), described in 1988 and introduced in the WHO classification in 1993, affects predominantly children or young adults causing intractable complex partial seizures. Since it is benign and treated with surgical resection, its recognition is important. It has similarities with low-grade gliomas and gangliogliomas, which may recur and become malignant. Objectives: To investigate whether DNT was previously diagnosed as astrocytoma, oligodendroglioma, or ganglioglioma and to determine its frequency in a series of low-grade glial/glio-neuronal tumors. Methods: Clinical, radiological, and histological aspects of 58 tumors operated from 1978 to 2008, classified as astrocytomas (32, including 8 pilocytic), oligodendrogliomas (12), gangliogliomas (7), and DNT (7), were reviewed. Results: Four new DNT, one operated before 1993, previously classified as astrocytoma (3) and oligodendroglioma (1), were identified. One DNT diagnosed in 2002 was classified once more as angiocentric glioma. Therefore, 10 DNT (17.2%) were identified. Conclusions: Clinical-radiological and histopathological correlations have contributed to diagnose the DNT.
C1 [Rodrigues, Flavio Freinkel] Univ Fed Rio de Janeiro, Dept Surg, Rio De Janeiro, RJ, Brazil.
   [Chimelli, Leila] Univ Fed Rio de Janeiro, Sch Med, Natl Canc Inst, Dept Pathol,Div Pathol, Rio de Janeiro, RJ, Brazil.
RP Chimelli, L (corresponding author), DIPAT, Div Patol INCA, Rua Cordeiro Graca 156, BR-20220400 Rio De Janeiro, RJ, Brazil.
EM lchimelli@inca.gov.br
RI Dozza, Diego Cassol/E-7084-2014
OI Cassol Dozza, Diego/0000-0002-4364-8224
CR BECKER AJ, 2007, WHO CLASSIFICATION T, P103
   Burger PC, 2007, WHO CLASSIFICATION T, P92
   Campos AR, 2009, NEURORADIOLOGY, V51, P433, DOI 10.1007/s00234-009-0511-1
   Chan CH, 2006, J NEUROSURG, V104, P62, DOI 10.3171/jns.2006.104.1.62
   Cosson RS, 2001, J NEURORADIOLOGY, V28, P230
   DAUMASDUPORT C, 1988, NEUROSURGERY, V23, P545, DOI 10.1227/00006123-198811000-00002
   DAUMASDUPORT C, 2007, WHO CLASSIFICATION T, P99
   Fernandez C, 2003, AM J NEURORADIOL, V24, P829
   Giulioni M, 2005, J NEUROSURG, V102, P288, DOI 10.3171/ped.2005.102.3.0288
   KLEIHUES P, 1993, BRAIN PATHOL, V3, P255, DOI 10.1111/j.1750-3639.1993.tb00752.x
   Lee DY, 2000, J NEURO-ONCOL, V47, P167, DOI 10.1023/A:1006401305247
   Minkin K, 2008, J NEUROS-PEDIATR, V1, P206, DOI 10.3171/PED/2008/1/3/206
   Nolan MA, 2004, NEUROLOGY, V62, P2270, DOI 10.1212/01.WNL.0000130495.69512.6F
   Ostertun B, 1996, AM J NEURORADIOL, V17, P419
   Pasquier B, 2002, EPILEPTIC DISORD, V4, P99
   Prayson RA, 2010, PATHOLOGY, V42, P426, DOI 10.3109/00313025.2010.493870
   Rickert CH, 2001, CHILD NERV SYST, V17, P503, DOI 10.1007/s003810100496
   Rosemberg S, 1998, ARQ NEURO-PSIQUIAT, V56, P232, DOI 10.1590/S0004-282X1998000200011
   Ruban D, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.5.FOCUS0998
   Spalice A, 2010, PEDIATR NEUROL, V43, P395, DOI 10.1016/j.pediatrneurol.2010.06.017
   Thom M, 2011, J NEUROPATH EXP NEUR, V70, P859, DOI 10.1097/NEN.0b013e3182302475
   Tian AG, 2011, J NEUROSURG-PEDIATR, V7, P229, DOI 10.3171/2010.12.PEDS10293
   Yu AH, 2009, CHINESE MED J-PEKING, V122, P2433, DOI 10.3760/cma.j.issn.0366-6999.2009.20.007
NR 23
TC 6
Z9 6
U1 0
U2 2
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD SEP
PY 2012
VL 70
IS 9
BP 710
EP 714
DI 10.1590/S0004-282X2012000900012
PG 5
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 008LX
UT WOS:000308959600012
PM 22990729
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Chimelli, L
   Moreira, VG
   Canedo, N
AF Chimelli, L.
   Moreira, V. G.
   Canedo, N.
TI Ganglion Cells in Low-Grade Circumscribed/Cystic Astrocytic Tumors:
   Possible Implication in Classification and Prognosis
SO JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
LA English
DT Meeting Abstract
CT 88th Annual Meeting of the American-Association-of-Neuropathologists
CY JUN 21-24, 2012
CL Chicago, IL
SP Amer Assoc Neuropathol
C1 [Chimelli, L.; Moreira, V. G.; Canedo, N.] Univ Fed Rio de Janeiro, BR-21941 Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-3069
J9 J NEUROPATH EXP NEUR
JI J. Neuropathol. Exp. Neurol.
PD JUN
PY 2012
VL 71
IS 6
MA 80
BP 569
EP 569
PG 1
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA 949QB
UT WOS:000304589600087
DA 2020-12-08
ER

PT J
AU Gadelha, M
   Neto, LV
   Giorgetta, JM
   Pereira, PJD
   Niemeyer, P
   Chimelli, L
AF Gadelha, Monica
   Vieira Neto, Leonardo
   Giorgetta, Juliana Malheiros
   da Mata Pereira, Paulo Jose
   Niemeyer Filho, Paulo
   Chimelli, Leila
TI Giant Cells Tumor Presenting as a Sellar Mass Mimicking a Pituitary
   Macroadenoma
SO JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
LA English
DT Meeting Abstract
CT 88th Annual Meeting of the American-Association-of-Neuropathologists
CY JUN 21-24, 2012
CL Chicago, IL
SP Amer Assoc Neuropathol
C1 [Gadelha, Monica; Vieira Neto, Leonardo; Giorgetta, Juliana Malheiros; da Mata Pereira, Paulo Jose; Niemeyer Filho, Paulo; Chimelli, Leila] Univ Fed Rio de Janeiro, BR-21941 Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-3069
J9 J NEUROPATH EXP NEUR
JI J. Neuropathol. Exp. Neurol.
PD JUN
PY 2012
VL 71
IS 6
MA 175
BP 595
EP 595
PG 1
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA 949QB
UT WOS:000304589600182
DA 2020-12-08
ER

PT J
AU Chimelli, L
AF Chimelli, L.
TI Co-infection of HIV and tropical infectious agents that affect the
   nervous system
SO REVUE NEUROLOGIQUE
LA English
DT Article
DE Tropical infections; HIV; AIDS; Central nervous system
ID IMMUNE RECONSTITUTION DISEASE; STRONGYLOIDES-STERCORALIS; HIGH
   PREVALENCE; VIRUS TYPE-1; MALARIA; AIDS; SCHISTOSOMIASIS; FUNGAL;
   ACTIVATION; PATIENT
AB Tropical infections refer to a group of diseases usually located in regions with a warm climate, particularly affecting developing countries, partly because of the conditions that allow them to thrive. However, due to the increased international travel, infectious agents that were previously limited to tropical regions pose an increasing threat to populations at risk for opportunistic infection (OI), especially those infected with the HIV. Tropical infections can facilitate HIV transmission and accelerate the progression of asymptomatic HIV infection to AIDS. Some have the potential to alter the epidemiology, natural history, and/or response to treatment of the other. The introduction of highly active antiretroviral therapy has provided a huge benefit for the vast majority of patients infected with the HIV, by allowing the immune system to recover, improving the clinical and radiological results and reducing the number of OI. On the other hand, some patients have developed various disorders of immune reconstitution, resulting in either hyper-immune inflammatory response to an exogenous antigen or autoimmunity. A significant proportion of these cases have been reported in immigrants from tropical countries to high-income countries, therefore awareness of these phenomena is needed since clinical presentations are often atypical and pose diagnostic challenges. This article reviews some of the key diagnostic aspects of tropical infections associated with HIV infection. (C) 2012 Elsevier Masson SAS. All rights reserved.
C1 Natl Canc Inst, Div Pathol, BR-20220400 Rio De Janeiro, RJ, Brazil.
RP Chimelli, L (corresponding author), Natl Canc Inst, Div Pathol, Rua Cordeiro Graca 156, BR-20220400 Rio De Janeiro, RJ, Brazil.
EM lchimelli@inca.gov.br
CR AdleBiassette H, 1996, ACTA NEUROPATHOL, V92, P415, DOI 10.1007/s004010050538
   Anthony IC, 2008, INT REV PSYCHIATR, V20, P15, DOI 10.1080/09540260701862037
   Benard G, 2000, CLIN INFECT DIS, V31, P1032, DOI 10.1086/318146
   Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511
   Brown M, 2006, INT J STD AIDS, V17, P560, DOI 10.1258/095646206778145712
   Cabral R F, 2010, AJNR Am J Neuroradiol, V31, pE65, DOI 10.3174/ajnr.A2158
   Casseb J, 2008, J MED VIROL, V80, P392, DOI 10.1002/jmv.21111
   Cetron Martin S, 2002, MMWR Recomm Rep, V51, P1
   Chacko G, 2010, SEMIN DIAGN PATHOL, V27, P167, DOI 10.1053/j.semdp.2010.05.003
   Chimelli B, 2011, PATHOL RES INT, P15, DOI 10.14061/2011/290853
   CHIMELLI L, 1992, NEUROPATH APPL NEURO, V18, P478, DOI 10.1111/j.1365-2990.1992.tb00815.x
   Chimelli L, 1997, BRAIN PATHOL, V7, P613, DOI 10.1111/j.1750-3639.1997.tb01078.x
   Cohen C, 2005, CLIN INFECT DIS, V41, P1631, DOI 10.1086/498023
   Davis JA, 2009, TRANSPL INFECT DIS, V11, P432, DOI 10.1111/j.1399-3062.2009.00424.x
   DeJonckheere JF, 1997, CLIN INFECT DIS, V25, P943, DOI 10.1086/597677
   Delobel P, 2004, EUR J NEUROL, V11, P55, DOI 10.1046/j.1351-5101.2003.00696.x
   Ellison D, 2004, NEUROPATHOLOGY REFER, P755
   Gallagher M, 2005, AIDS, V19, P1849, DOI 10.1097/01.aids.0000189846.90946.5d
   Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970
   GOLDANI LZ, 1995, CLIN INFECT DIS, V21, P1275, DOI 10.1093/clinids/21.5.1275
   Gonzalez D, 2009, J INFECT DEV COUNTR, V3, P318
   Gray F, 2005, J NEUROVIROL, V11, P16, DOI 10.1080/13550280500511741
   Gray F, 2003, J NEUROPATH EXP NEUR, V62, P429, DOI 10.1093/jnen/62.5.429
   Haddow LJ, 2009, AIDS, V23, P1609, DOI 10.1097/QAD.0b013e32832c41f4
   Harries AD, 2001, LANCET, V357, P1519, DOI 10.1016/S0140-6736(00)04639-0
   Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006
   Hewitt K, 2006, AIDS, V20, P1993, DOI 10.1097/01.aids.0000247572.95880.92
   Pittella JEH, 2009, T ROY SOC TROP MED H, V103, P973, DOI 10.1016/j.trstmh.2009.04.012
   Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000300
   Kallestrup P, 2006, CLIN INFECT DIS, V42, P1781, DOI 10.1086/504380
   Karanja DMS, 1997, AM J TROP MED HYG, V56, P515, DOI 10.4269/ajtmh.1997.56.515
   Karp CL, 2007, CLIN INFECT DIS, V45, P1214, DOI 10.1086/522180
   Karp CL, 2007, CLIN INFECT DIS, V45, P1208, DOI 10.1086/522181
   Karp CL, 1999, CLIN INFECT DIS, V28, P947, DOI 10.1086/514745
   Karp CL, 2006, TROPICAL INFECT DIS, V2, P1642
   Keiser PB, 2004, CLIN MICROBIOL REV, V17, P208, DOI 10.1128/CMR.17.1.208-217.2004
   Kjetland EF, 2006, AIDS, V20, P593, DOI 10.1097/01.aids.0000210614.45212.0a
   Laufer Miriam K, 2007, Curr Infect Dis Rep, V9, P47, DOI 10.1007/s11908-007-0022-3
   Lawn SD, 2007, CURR OPIN INFECT DIS, V20, P482, DOI 10.1097/QCO.0b013e3282a6463d
   Lederman MM, 2000, AIDS, V14, P951, DOI 10.1097/00002030-200005260-00006
   Lucas S, 2008, GREENFIELDS NEUROPAT, V1, P1447
   Marcos LA, 2008, T ROY SOC TROP MED H, V102, P314, DOI 10.1016/j.trstmh.2008.01.020
   Martinez AJ, 1997, BRAIN PATHOL, V7, P583, DOI 10.1111/j.1750-3639.1997.tb01076.x
   Meshnick SR, 2006, J INFECT DIS, V194, P273, DOI 10.1086/505087
   Miller RF, 2004, ACTA NEUROPATHOL, V108, P17, DOI 10.1007/s00401-004-0852-0
   Montoya JG, 2005, PRINCIPLES PRATICE I, P3170
   Moss WJ, 2002, CLIN INFECT DIS, V35, P189, DOI 10.1086/341248
   Oshitani H, 1996, LANCET, V348, P415, DOI 10.1016/S0140-6736(05)65044-1
   Pittella JEH, 1997, BRAIN PATHOL, V7, P681, DOI 10.1111/j.1750-3639.1997.tb01083.x
   Pittella JEH, 1997, BRAIN PATHOL, V7, P649, DOI 10.1111/j.1750-3639.1997.tb01080.x
   Rauchway AC, 2010, NEUROL CLIN, V28, P293, DOI 10.1016/j.ncl.2009.09.013
   Sartori AMC, 2007, ANN TROP MED PARASIT, V101, P31, DOI 10.1179/136485907X154629
   Scaravilli F, 2007, BRAIN PATHOL, V17, P197, DOI 10.1111/j.1750-3639.2007.00047.x
   Secor WE, 2006, PARASITE IMMUNOL, V28, P597, DOI 10.1111/j.1365-3024.2006.00887.x
   Shankar SK, 2007, NEUROL INDIA, V55, P198, DOI 10.4103/0028-3886.35680
   Silva MT, 2009, AIDS REV, V11, P71
   Sinha S, 2009, J CLIN NEUROSCI, V16, P867, DOI 10.1016/j.jocn.2008.10.030
   Siong Wong Chia, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P260
   SISON JP, 1995, CLIN INFECT DIS, V20, P1207, DOI 10.1093/clinids/20.5.1207
   Slutsker L, 2007, CURR OPIN INFECT DIS, V20, P3, DOI 10.1097/QCO.0b013e328012c5cd
   Steketee RW, 1996, AM J TROP MED HYG, V55, P42, DOI 10.4269/ajtmh.1996.55.42
   Toro C, 2007, CLIN INFECT DIS, V45, pE118, DOI 10.1086/522172
   Tremont-Lukats IW, 2009, ANN INTERN MED, V150, P656, DOI 10.7326/0003-4819-150-9-200905050-00025
   Ustianowski AP, 2006, LANCET INFECT DIS, V6, P350, DOI 10.1016/S1473-3099(06)70493-5
   Vaidian Anil K, 2004, Kinetoplastid Biol Dis, V3, P2, DOI 10.1186/1475-9292-3-2
   Viriyavejakul P, 2009, SE ASIAN J TROP MED, V40, P223
   Walker M, 2006, CLIN INFECT DIS, V42, P115, DOI 10.1086/498510
   Watt G, 2003, CLIN INFECT DIS, V36, P1067, DOI 10.1086/374600
   Weiss LM, 2005, MANDELL DOUGLAS BENN, P3237
NR 69
TC 0
Z9 0
U1 0
U2 5
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 0035-3787
EI 2213-0004
J9 REV NEUROL-FRANCE
JI Rev. Neurol.
PD MAR
PY 2012
VL 168
IS 3
BP 270
EP 282
DI 10.1016/j.neurol.2012.02.001
PG 13
WC Clinical Neurology
SC Neurosciences & Neurology
GA 932BJ
UT WOS:000303264600010
PM 22405463
DA 2020-12-08
ER

PT J
AU Antunes, SLG
   Chimelli, L
   Jardim, MR
   Vital, RT
   Nery, JAD
   Corte-Real, S
   Hacker, MAVB
   Sarno, EN
AF Gomes Antunes, Sergio Luiz
   Chimelli, Leila
   Jardim, Marcia Rodrigues
   Vital, Robson Teixeira
   da Costa Nery, Jose Augusto
   Corte-Real, Suzana
   Vilas Boas Hacker, Mariana Andrea
   Sarno, Euzenir Nunes
TI Histopathological examination of nerve samples from pure neural leprosy
   patients: obtaining maximum information to improve diagnostic efficiency
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE leprosy; pure neural form; diagnosis
ID DAMAGE
AB Nerve biopsy examination is an important auxiliary procedure for diagnosing pure neural leprosy (PNL). When acid-fast bacilli (AFB) are not detected in the nerve sample, the value of other nonspecific histological alterations should be considered along with pertinent clinical, electroneuromyographical and laboratory data (the detection of Mycobacterium leprae DNA with polymerase chain reaction and the detection of serum anti-phenolic glycolipid 1 antibodies) to support a possible or probable PNL diagnosis. Three hundred forty nerve samples [ 144 from PNL patients and 196 from patients with non-leprosy peripheral neuropathies (NLN)] were examined. Both AFB-negative and AFB-positive PNL samples had more frequent histopathological alterations (epithelioid granulomas, mononuclear infiltrates, fibrosis, perineurial and subperineurial oedema and decreased numbers of myelinated fibres) than the NLN group. Multivariate analysis revealed that independently, mononuclear infiltrate and perineurial fibrosis were more common in the PNL group and were able to correctly classify AFB-negative PNL samples. These results indicate that even in the absence of AFB, these histopathological nerve alterations may justify a PNL diagnosis when observed in conjunction with pertinent clinical, epidemiological and laboratory data.
C1 [Gomes Antunes, Sergio Luiz; Jardim, Marcia Rodrigues; Vital, Robson Teixeira; da Costa Nery, Jose Augusto; Vilas Boas Hacker, Mariana Andrea; Sarno, Euzenir Nunes] Inst Oswaldo Cruz Fiocruz, Lab Hanseniase, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [Corte-Real, Suzana] Inst Oswaldo Cruz Fiocruz, Lab Biol Estrut, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [Chimelli, Leila] Univ Fed Rio de Janeiro, Dept Patol, Rio De Janeiro, RJ, Brazil.
RP Antunes, SLG (corresponding author), Inst Oswaldo Cruz Fiocruz, Lab Hanseniase, Av Brasil 4365, BR-21045900 Rio De Janeiro, RJ, Brazil.
EM santunes@ioc.fiocruz.br
OI Nunes Sarno, Euzenir/0000-0003-0129-2159
FU IOC-FIOCRUZ
FX Financial support: IOC-FIOCRUZ
CR [Anonymous], 2010, Wkly Epidemiol Rec, V85, P337
   Antia N H, 1970, Int J Lepr Other Mycobact Dis, V38, P12
   Antunes SLG, 2011, HISTOPATHOLOGY, V58, P304, DOI 10.1111/j.1365-2559.2011.03749.x
   Chimelli L, 1997, J NEUROL, V244, P318, DOI 10.1007/s004150050094
   Dastur D K, 1970, Int J Lepr Other Mycobact Dis, V38, P30
   Garbino J. A., 2004, Hansenologia Internationalis, V29, P124
   Girdhar B K, 1996, Indian J Lepr, V68, P35
   Jardim MR, 2005, LEPROSY REV, V76, P232
   Jardim MR, 2003, J NEUROL, V250, P806, DOI 10.1007/s00415-003-1081-5
   JOB CK, 1989, INT J LEPROSY, V57, P532
   JUNQUEIRA LCU, 1980, INT J LEPROSY, V48, P291
   MODLIN RL, 1994, J INVEST DERMATOL, V102, P828, DOI 10.1111/1523-1747.ep12381958
   Pannikar V K, 1983, Lepr India, V55, P212
   Said G, 2002, BRAIN, V125, P264, DOI 10.1093/brain/awf027
   Shetty VP, 1997, PERIPHERAL NERVE LEP, P79
   Singh N, 1998, LEPROSY REV, V69, P246
   SRINIVASAN H, 1990, TROP MED PARASITOL, V41, P347
   VALLAT JM, 1991, ACTA NEUROPATHOL, V81, P336, DOI 10.1007/BF00305877
NR 18
TC 26
Z9 26
U1 0
U2 1
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD MAR
PY 2012
VL 107
IS 2
BP 246
EP 253
DI 10.1590/S0074-02762012000200015
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 908AV
UT WOS:000301463500015
PM 22415265
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Wildemberg, LEA
   Neto, LV
   Taboada, GF
   Moraes, AB
   Marcondes, J
   Conceicao, FL
   Chimelli, L
   Gadelha, MR
AF Armondi Wildemberg, Luiz Eduardo
   Vieira Neto, Leonardo
   Taboada, Giselle Fernandes
   Moraes, Aline Barbosa
   Marcondes, Jorge
   Conceicao, Flavia Lucia
   Chimelli, Leila
   Gadelha, Monica Roberto
TI Sellar and suprasellar mixed germ cell tumor mimicking a pituitary
   adenoma
SO PITUITARY
LA English
DT Article
DE Mixed germ cell tumors; Intrasellar; Pituitary adenoma; Central diabetes
   insipidus; beta-Human chorionic gonadotrophin
ID PRIMARY INTRASELLAR GERMINOMA; INTRACRANIAL GERMINOMA;
   CEREBROSPINAL-FLUID; PINEAL; HYPERPROLACTINEMIA; CHEMOTHERAPY;
   RADIATION; TERATOMA; LESIONS; REGION
AB Germ cell tumors (GCT) are a heterogeneous group of lesions whose origin is not well established. Several cases of primary intrasellar germinomas have been reported, however non-germinomatous GCT have rarely been described. We report the case of a young adult male patient with a mixed GCT that presented with a sellar tumor with suprasellar extension. The patient seeked medical attention because of seizures and magnetic resonance imaging evidenced a tumor of the sellar region. Hyperprolactinemia was also present and dopamine agonist therapy was started. As there was a rapid tumor growth and the patient had concomitant central diabetes insipidus and elevated testosterone levels, a GCT was suspected and confirmed by elevated serum concentration of beta-human chorionic gonadotrophin. Patient underwent surgical resection of the tumor and histopathological examination confirmed the diagnosis of a mixed GCT. Chemotherapy was initiated, followed by conventional radiotherapy. In conclusion, although pituitary adenomas respond for the vast majority of sellar tumors, concomitant symptoms such as central diabetes insipidus and rapid tumor growth should raise the suspicion of a diverse diagnosis. The present report intend not only to show a rare case of sellar and suprasellar mixed GCT but also to remind clinicians that if laboratory findings do not fit into patient's diagnosis (such as high testosterone levels in our patient), then the diagnosis should be reviewed.
C1 [Armondi Wildemberg, Luiz Eduardo; Vieira Neto, Leonardo; Taboada, Giselle Fernandes; Moraes, Aline Barbosa; Conceicao, Flavia Lucia; Gadelha, Monica Roberto] Univ Fed Rio de Janeiro, Endocrinol Unit, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil.
   [Moraes, Aline Barbosa; Gadelha, Monica Roberto] Inst Estadual Diabet & Endocrinol Luiz Capriglion, Endocrinol Unit, Rio De Janeiro, Brazil.
   [Marcondes, Jorge] Univ Fed Rio de Janeiro, Neurosurg Unit, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil.
   [Chimelli, Leila] Univ Fed Rio de Janeiro, Pathol Unit, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil.
RP Gadelha, MR (corresponding author), Univ Fed Rio de Janeiro, Endocrinol Unit, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil.
EM lwildemberg@hotmail.com; mgadelha@hucff.ufrj.br
RI wildemberg, luiz/S-4712-2017
OI Vieira Neto, Leonardo/0000-0002-1595-3985
CR ANDREW J, 1985, J NEUROL NEUROSUR PS, V48, P589, DOI 10.1136/jnnp.48.6.589
   Ballesteros MD, 1997, NEURORADIOLOGY, V39, P860, DOI 10.1007/s002340050521
   Cho DY, 1997, CHILD NERV SYST, V13, P42, DOI 10.1007/s003810050038
   Choi JU, 1998, CHILD NERV SYST, V14, P41, DOI 10.1007/s003810050173
   DEGIROLAMI U, 1999, PATHOLOGIC BASIS DIS, P1293
   Fonseca ALV, 2001, ARQ NEURO-PSIQUIAT, V59, P905, DOI 10.1590/S0004-282X2001000600013
   FRANK G, 1992, NEUROSURGERY, V30, P786
   GIUFFRE R, 1975, J NEUROSURG, V42, P602, DOI 10.3171/jns.1975.42.5.0602
   HOROWITZ MB, 1991, ARCH NEUROL-CHICAGO, V48, P652, DOI 10.1001/archneur.1991.00530180110026
   JENNINGS MT, 1985, J NEUROSURG, V63, P155, DOI 10.3171/jns.1985.63.2.0155
   KAGEYAMA N, 1961, NEUROLOGY, V11, P318
   Kellie SJ, 2004, J CLIN ONCOL, V22, P846, DOI 10.1200/JCO.2004.07.006
   Kidooka Minoru, 1995, Neurologia Medico-Chirurgica, V35, P96, DOI 10.2176/nmc.35.96
   Li CS, 2006, ACTA NEUROCHIR, V148, P795, DOI 10.1007/s00701-006-0776-7
   Lim S K, 1986, Korean J Intern Med, V1, P266
   Lin Chih-Lung, 1997, Kaohsiung Journal of Medical Sciences, V13, P462
   MARCOVITZ S, 1984, SURG NEUROL, V22, P387, DOI 10.1016/0090-3019(84)90145-9
   Matsutani M, 1998, CHILD NERV SYST, V14, P59, DOI 10.1007/s003810050176
   Melmed S, 2003, WILLIAMS TXB ENDOCRI, P177
   Nishizaki T, 2001, J CLIN NEUROSCI, V8, P27, DOI 10.1054/jocn.2000.0750
   OISHI M, 1989, NEUROSURGERY, V25, P458, DOI 10.1227/00006123-198909000-00024
   Oishi M, 2001, SURG NEUROL, V56, P236, DOI 10.1016/S0090-3019(01)00575-4
   Ozbey Nese, 2006, Hormones (Athens), V5, P67
   Packer R J, 2000, Oncologist, V5, P312
   PAGE RB, 1983, J NEUROSURG, V58, P766, DOI 10.3171/jns.1983.58.5.0766
   POON W, 1988, SURG NEUROL, V30, P402, DOI 10.1016/0090-3019(88)90205-4
   Rogers SJ, 2005, LANCET ONCOL, V6, P509, DOI 10.1016/S1470-2045(05)70245-X
   Russell DS, 1944, J PATHOL BACTERIOL, V56, P145, DOI 10.1002/path.1700560202
   Saeki N, 2000, ENDOCR J, V47, P83, DOI 10.1507/endocrj.47.83
   Santos-Calle FJ, 2005, INT J CLIN PHARM TH, V43, P436
   SHEN DY, 1984, NEUROSURGERY, V15, P417, DOI 10.1227/00006123-198409000-00020
   Smith AA, 2004, J NEURO-ONCOL, V68, P153, DOI 10.1023/B:NEON.0000027670.96412.36
   SUGIYAMA K, 1992, SURG NEUROL, V38, P114, DOI 10.1016/0090-3019(92)90088-5
   Utsuki S, 2002, ACTA NEUROCHIR, V144, P1151, DOI 10.1007/s00701-002-1008-4
   Yuki K, 1988, Gan No Rinsho, V34, P2091
NR 35
TC 7
Z9 10
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1386-341X
EI 1573-7403
J9 PITUITARY
JI Pituitary
PD DEC
PY 2011
VL 14
IS 4
BP 345
EP 350
DI 10.1007/s11102-008-0161-z
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 893IO
UT WOS:000300349800009
PM 19116786
DA 2020-12-08
ER

PT J
AU Martins, AR
   Zanella, CAB
   Zucchi, FCR
   Dombroski, TCD
   Costa, ET
   Guethe, LM
   Oliveira, AO
   Donatti, ALF
   Neder, L
   Chimelli, L
   De Nucci, G
   Lee-Ho, P
   Murad, F
AF Martins, Antonio R.
   Zanella, Cesar A. B.
   Zucchi, Fabiola C. R.
   Dombroski, Thais C. D.
   Costa, Edmar T.
   Guethe, Liliane M.
   Oliveira, Alina O.
   Donatti, Ana L. F.
   Neder, Luciano
   Chimelli, Leila
   De Nucci, Gilberto
   Lee-Ho, Paulo
   Murad, Ferid
TI Immunolocalization of nitric oxide synthase isoforms in human archival
   and rat tissues, and cultured cells
SO JOURNAL OF NEUROSCIENCE METHODS
LA English
DT Article
DE Nitric oxide synthases; Immunohistochemistry; Cerebellum; Lung; Human
   and rat nervous system; Cell culture
ID CENTRAL-NERVOUS-SYSTEM; NEUTROPHIL HAPTOTAXIS; ANTIGEN RETRIEVAL;
   EXPRESSION; IMMUNOREACTIVITY; MODULATION; ANTIBODIES; MIGRATION;
   NEURONS; BINDING
AB Nitric oxide (NO) exerts important physiological and pathological roles in humans. The study of NO requires the immunolocalization of its synthesizing enzymes, neuronal, endothelial and inducible NO synthases (NOS). NOS are labile to formalin-fixation and paraffin-embedding, which are used to prepare human archival tissues. This lability has made NOS immunohistochemical studies difficult, and a detailed protocol is not yet available. We describe here a protocol for the immunolocalization of NOS isoforms in human archival cerebellum and non-nervous tissues, and in rat tissues and cultured cells. Neuronal NOS antigenicity in human archival and rat nervous tissue sections was microwave-retrieved in 50 mM Tris-HCl buffer, pH 9.5, for 20 min at 900W. Neuronal NOS was expressed in stellate, basket, Purkinje and granule cells in human and rat cerebellum. Archival and frozen human cerebellar sections showed the same neuronal NOS staining pattern. Archival cerebellar sections not subjected to antigen retrieval stained weakly. Antigenicity of inducible NOS in human lung was best retrieved in 10 mM sodium citrate buffer, pH 6.0, for 15 min at 900W. Inflammatory cells in a human lung tuberculoma were strongly stained by anti-inducible NOS antibody. Anti-endothelial NOS strongly stained kidney glomeruli. Cultured PC12 cells were strongly stained by anti-neuronal NOS without antigen retrieving. The present immunohistochemistry protocol is easy to perform, timeless, and suitable for the localization of NOS isoforms in nervous and non-nervous tissues, in human archival and rat tissues. It has been extensively used in our laboratory, and is also appropriate for other antigens. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Martins, Antonio R.; Dombroski, Thais C. D.] Univ Fed Triangulo Mineiro, Inst Biol Sci, BR-38025015 Uberaba, MG, Brazil.
   [Martins, Antonio R.] Univ Sao Paulo, Postgrad Program Neurosci, Ribeirao Preto Sch Med, BR-14049 Ribeirao Preto, SP, Brazil.
   [Zanella, Cesar A. B.; Zucchi, Fabiola C. R.; Dombroski, Thais C. D.] Univ Sao Paulo, Dept Neurol, Ribeirao Preto Sch Med, BR-14049 Ribeirao Preto, SP, Brazil.
   [Costa, Edmar T.; De Nucci, Gilberto] Univ Estadual Campinas, Dept Pharmacol, Fac Ciencias Med, Campinas, SP, Brazil.
   [Guethe, Liliane M.; Oliveira, Alina O.; Donatti, Ana L. F.] Univ Sao Paulo, Dept Psychol & Educ, FFCLRP, BR-14049 Ribeirao Preto, SP, Brazil.
   [Neder, Luciano] Univ Sao Paulo, Dept Pathol, Ribeirao Preto Sch Med, BR-14049 Ribeirao Preto, SP, Brazil.
   [Chimelli, Leila] Univ Fed Rio de Janeiro, Dept Pathol, Rio de Janeiro, Brazil.
   [Lee-Ho, Paulo] Butantan Inst, Ctr Biotechnol, Sao Paulo, Brazil.
   [Murad, Ferid] Univ Texas Hlth Sci Ctr, Inst Mol Med, Houston, TX USA.
RP Martins, AR (corresponding author), Univ Fed Triangulo Mineiro, Inst Biol Sci, Praca Manoel Terra 330, BR-38025015 Uberaba, MG, Brazil.
EM armartin@fmrp.usp.br
RI De Nucci, Gilberto/J-5990-2012; Donatti, Ana Luiza/Y-4553-2018
OI De Nucci, Gilberto/0000-0002-4346-7941; 
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   FAEPA; CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES
FX We thank Mr. Hildeberto Caldo, Ms. Vani A. Correa and Ms. Marcia S.Z.
   Graeff for skillful technical assistance. Supported by FAPESP, FAEPA,
   CNPq and CAPES.
CR BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0
   Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214
   Chimelli L, 2002, J NeuroAIDS, V2, P67, DOI 10.1300/J128v02n03_05
   COBBS CS, 1995, CANCER RES, V55, P727
   Coers W, 1998, J HISTOCHEM CYTOCHEM, V46, P1385, DOI 10.1177/002215549804601207
   EGBERONGBE YI, 1994, NEUROSCIENCE, V59, P561, DOI 10.1016/0306-4522(94)90177-5
   Elfering SL, 2002, J BIOL CHEM, V277, P38079, DOI 10.1074/jbc.M205256200
   Ferreira HHA, 2002, EUR J PHARMACOL, V442, P155, DOI 10.1016/S0014-2999(02)01507-8
   Ferreira HHD, 2004, BIOCHEM PHARMACOL, V68, P631, DOI 10.1016/j.bcp.2004.05.025
   Ganiko L, 2005, BBA-GEN SUBJECTS, V1721, P152, DOI 10.1016/j.bbagen.2004.10.012
   Ganiko L, 1998, GLYCOCONJUGATE J, V15, P527
   Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x
   Guix FX, 2005, PROG NEUROBIOL, V76, P126, DOI 10.1016/j.pneurobio.2005.06.001
   Han KH, 2005, AM J PHYSIOL-RENAL, V288, pF694, DOI 10.1152/ajprenal.00085.2004
   Hara MR, 2007, ANNU REV PHARMACOL, V47, P117, DOI 10.1146/annurev.pharmtox.47.120505.105311
   HEITZMAN.H, 1974, P NATL ACAD SCI USA, V71, P3537, DOI 10.1073/pnas.71.9.3537
   HO PL, 1992, J CELL PHYSIOL, V150, P647, DOI 10.1002/jcp.1041500326
   Leite JP, 2002, EPILEPSIA, V43, P235, DOI 10.1046/j.1528-1157.43.s.5.29.x
   Martins AR, 1999, J NEUROSCI METH, V92, P25, DOI 10.1016/S0165-0270(99)00090-4
   Mendes RV, 2001, HISTOPATHOLOGY, V39, P172, DOI 10.1046/j.1365-2559.2001.01189.x
   Moncada S, 2006, BRIT J PHARMACOL, V147, pS193, DOI 10.1038/sj.bjp.0706458
   Ohyu J, 1998, DEV BRAIN RES, V110, P193, DOI 10.1016/S0165-3806(98)00107-2
   Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006
   Pelegrini-Da-Silva A, 2005, NEUROSCIENCE, V132, P453, DOI 10.1016/j.neuroscience.2004.12.046
   POOL CW, 1983, IBRO HDB SERIES METH, V3, P1
   SCHMIDT HHHW, 1992, J HISTOCHEM CYTOCHEM, V40, P1439, DOI 10.1177/40.10.1382087
   SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656
   Shi SR, 2001, APPL IMMUNOHISTO M M, V9, P107, DOI 10.1097/00022744-200106000-00002
   Soares TJ, 1999, P NATL ACAD SCI USA, V96, P278, DOI 10.1073/pnas.96.1.278
   SPRINGALL DR, 1992, HISTOCHEMISTRY, V98, P259, DOI 10.1007/BF00271040
   Teixeira SA, 2003, GLYCOCONJUGATE J, V20, P501, DOI 10.1023/B:GLYC.0000038296.79574.c8
   WOOD GS, 1981, J HISTOCHEM CYTOCHEM, V29, P1196, DOI 10.1177/29.10.7028859
   Zanardo RCO, 1997, P NATL ACAD SCI USA, V94, P14111, DOI 10.1073/pnas.94.25.14111
   Zhao HX, 1998, BLOOD, V92, P1031
NR 34
TC 14
Z9 14
U1 0
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0165-0270
EI 1872-678X
J9 J NEUROSCI METH
JI J. Neurosci. Methods
PD MAY 15
PY 2011
VL 198
IS 1
BP 16
EP 22
DI 10.1016/j.jneumeth.2011.02.024
PG 7
WC Biochemical Research Methods; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 771FM
UT WOS:000291142600003
PM 21420432
DA 2020-12-08
ER

PT J
AU Smid, J
   Landemberger, MC
   Martins, VR
   Schultz, R
   Rosemberg, S
   Chimelli, L
   Nitrini, R
AF Smid, Jerusa
   Landemberger, Michele C.
   Martins, Vilma R.
   Schultz, Rodrigo
   Rosemberg, Sergio
   Chimelli, Leila
   Nitrini, Ricardo
TI Phenotypic Heterogeneity in a Brazilian Family with Mutation in the
   Codon 102 of the Prion Protein Gene
SO PRION
LA English
DT Meeting Abstract
C1 [Landemberger, Michele C.; Martins, Vilma R.] AC Camargo Hosp, Sao Paulo, Brazil.
   [Smid, Jerusa; Schultz, Rodrigo; Nitrini, Ricardo] Univ Sao Paulo, Sch Med, Hosp Clin, Cognit & Behav Neurol Unit, Sao Paulo, Brazil.
   [Rosemberg, Sergio] Univ Sao Paulo, Sch Med, Dept Pathol, Sao Paulo, Brazil.
   [Chimelli, Leila] Univ Fed Rio de Janeiro, Sch Med, Dept Pathol, Rio De Janeiro, RJ, Brazil.
EM vmartins@cipe.accamargo.org.br
RI Martins, Vilma R/E-2547-2012; Landemberger, Michele
   Christine/P-3014-2014; Nitrini, Ricardo/B-8703-2013; Martins,
   Vilma/N-5446-2019
OI Martins, Vilma R/0000-0002-2909-8502; Landemberger, Michele
   Christine/0000-0002-3513-3554; Nitrini, Ricardo/0000-0002-5721-1525; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LANDES BIOSCIENCE
PI AUSTIN
PA 1806 RIO GRANDE ST, AUSTIN, TX 78702 USA
SN 1933-6896
EI 1933-690X
J9 PRION
JI Prion
PD APR-JUN
PY 2011
VL 5
SU S
MA Bio.104
BP 65
EP 65
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA V34DE
UT WOS:000209066300146
DA 2020-12-08
ER

PT J
AU Landemberger, MC
   Machado, CF
   Gomes, HR
   Chimelli, L
   Rosemberg, S
   Nitrini, R
   Martins, VR
AF Landemberger, Michele C.
   Machado, Cleiton F.
   Gomes, Helio R.
   Chimelli, Leila
   Rosemberg, Sergio
   Nitrini, Ricardo
   Martins, Vilma R.
TI Genetic Analysis of Human Prion Diseases in Brazil from 2005 to 2011
SO PRION
LA English
DT Meeting Abstract
C1 [Landemberger, Michele C.; Machado, Cleiton F.; Martins, Vilma R.] Hosp AC Camargo Fund Antonio Prudente, Int Ctr Res & Educ, Sao Paulo, Brazil.
   [Gomes, Helio R.; Rosemberg, Sergio; Nitrini, Ricardo] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   [Chimelli, Leila] Univ Fed Rio de Janeiro, Fac Med, Rio De Janeiro, RJ, Brazil.
EM mlandemberger@yahoo.com
RI Martins, Vilma R/E-2547-2012; Nitrini, Ricardo/B-8703-2013; Martins,
   Vilma/N-5446-2019; Landemberger, Michele Christine/P-3014-2014
OI Martins, Vilma R/0000-0002-2909-8502; Nitrini,
   Ricardo/0000-0002-5721-1525; Landemberger, Michele
   Christine/0000-0002-3513-3554
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LANDES BIOSCIENCE
PI AUSTIN
PA 1806 RIO GRANDE ST, AUSTIN, TX 78702 USA
SN 1933-6896
EI 1933-690X
J9 PRION
JI Prion
PD APR-JUN
PY 2011
VL 5
SU S
MA Risk.25
BP 132
EP 132
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA V34DE
UT WOS:000209066300300
DA 2020-12-08
ER

PT J
AU Mendonca, DMF
   Martins, SCS
   Higashi, R
   Muscara, MN
   Neto, VM
   Chimelli, L
   Martinez, AMB
AF Mendonca, Deise M. F.
   Martins, Sheila C. S.
   Higashi, Rafael
   Muscara, Marcelo N.
   Moura Neto, Vivaldo
   Chimelli, Leila
   Martinez, Ana Maria B.
TI Neurofilament heavy subunit in cerebrospinal fluid: A biomarker of
   amyotrophic lateral sclerosis?
SO AMYOTROPHIC LATERAL SCLEROSIS
LA English
DT Article
DE Amyotrophic Lateral Sclerosis; cerebrospinal fluid; proteinopathy;
   protein aggregation and neurofilament
ID MOTOR-NEURONS; SPINAL-CORDS; PROTEASOME; UBIQUITIN; ALS
AB The objectives of this study were to investigate the presence of the three neurofilament subunits, ubiquitin, proteasome and 3-nitrotyrosine, in CSF samples of ALS patients. CSF samples were obtained by lumbar puncture from 10 ALS patients and six controls. All samples were analysed by Western blotting. Results revealed that neurofilament heavy subunit was identified in 70% of ALS cases and we conclude that this subunit may be a promising biomarker for clinical diagnosis of ALS.
C1 [Martinez, Ana Maria B.] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Ciencias Biomed, Ilha Fundao,Dept Histol & Embriol,Programa Histol, BR-21941540 Rio De Janeiro, Brazil.
   [Mendonca, Deise M. F.] Univ Fed Sergipe, Dept Biociencias, Sergipe, Brazil.
   [Martins, Sheila C. S.; Moura Neto, Vivaldo] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Programa Anat, Inst Ciencias Biomed, BR-21941540 Rio De Janeiro, Brazil.
   [Muscara, Marcelo N.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Farmacol, BR-05508 Sao Paulo, Brazil.
   [Chimelli, Leila] Hosp Univ Clementino Fraga Filho, Serv Anat Patol, Rio De Janeiro, Brazil.
RP Martinez, AMB (corresponding author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Ciencias Biomed, Ilha Fundao,Dept Histol & Embriol,Programa Histol, Av Brig Trompowsky S-N,Cidade Univ,Bloco F,Sala F, BR-21941540 Rio De Janeiro, Brazil.
EM deise_mendonca@ufs.br
RI Muscara, Marcelo N/F-3250-2012; Neurociencia, Inct/I-1011-2013
OI Muscara, Marcelo N/0000-0002-8342-5586; 
FU FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); CNPqNational Council for Scientific and
   Technological Development (CNPq); CAPESCAPES; FUJB
FX We thank Mario Ary Pires Neto, Jose Mauro Braz de Lima, Marly Pernes da
   Silva Loureiro and Marzia Puccioni Sohler for their support, and Lilian
   Ayres Sa, Heliomar Pereira Marcos and Suely Menezes da Cunha for their
   excellent technical assistance. This study was supported by FAPERJ,
   CNPq, CAPES, and FUJB.
CR Alves-Rodrigues A, 1998, TRENDS NEUROSCI, V21, P516, DOI 10.1016/S0166-2236(98)01276-4
   Basso M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008130
   Boylan K, 2009, J NEUROCHEM, V111, P1182, DOI 10.1111/j.1471-4159.2009.06386.x
   Brettschneider J, 2006, NEUROLOGY, V66, P852, DOI 10.1212/01.wnl.0000203120.85850.54
   Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536
   DeMartino GN, 1999, J BIOL CHEM, V274, P22123, DOI 10.1074/jbc.274.32.22123
   Liu D, 2007, NEUROSCIENCE, V146, P255, DOI 10.1016/j.neuroscience.2007.01.028
   Mendonca DMF, 2006, NEUROSCI LETT, V404, P315, DOI 10.1016/j.neulet.2006.06.009
   Mendonca DMF, 2005, BRAZ J MED BIOL RES, V38, P925, DOI 10.1590/S0100-879X2005000600015
   Norgren N, 2003, BRAIN RES, V987, P25, DOI 10.1016/S0006-8993(03)03219-0
   Pradat PF, 2009, REV NEUROL-FRANCE, V165, P532, DOI 10.1016/j.neurol.2009.01.038
   Ryberg H, 2004, NEUROCHEM INT, V45, P57, DOI 10.1016/j.neuint.2003.12.012
   Shibata Noriyuki, 2008, Brain and Nerve (Tokyo), V60, P157
   Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3
   Zetterberg H, 2007, EUR J NEUROL, V14, P1329, DOI 10.1111/j.1468-1331.2007.01972.x
NR 15
TC 12
Z9 12
U1 0
U2 1
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1748-2968
EI 1471-180X
J9 AMYOTROPH LATERAL SC
JI Amyotroph. Lateral. Scler.
PD MAR
PY 2011
VL 12
IS 2
BP 144
EP 147
DI 10.3109/17482968.2010.542002
PG 4
WC Clinical Neurology
SC Neurosciences & Neurology
GA 722AU
UT WOS:000287402100012
PM 21198418
DA 2020-12-08
ER

PT J
AU Cavalcanti, GM
   Oliveira, ADB
   Assis, TD
   Chimelli, LMC
   de Medeiros, PL
   da Mota, DL
AF Cavalcanti, George Maciel
   Braga Oliveira, Andre de Sa
   Assis, Thiago de Oliveira
   Cardao Chimelli, Leila Maria
   de Medeiros, Paloma Lys
   da Mota, Diogenes Luis
TI Histochemistry and Morphometric Analysis of Muscle Fibers from Patients
   with Duchenne Muscular Dystrophy (DMD)
SO INTERNATIONAL JOURNAL OF MORPHOLOGY
LA English
DT Article
DE Histochemistry analysis; Morphometric analysis; Vastus lateralis muscle;
   Duchenne muscular dystrophy
ID DISEASES; GENE
AB The aim of the study was to analyze the muscle fibers by histochemistry and morphometric methods from patients with Duchenne muscular dystrophy (DMD). Muscle biopsies were taken from the vastus lateralis muscle of five boys between 13 and 15-years of age, with clinical diagnosis of DMD. The histochemistry was performed using myofibrillar ATPases (9.6, 4.6 and 4.3). To morphometrical analysis a computerized semiautomatic system and software Image-Lab was used. ATPase staining showed atrophy of muscle fibers. Fibrosis and adipose deposition occurred in variable degree depending of muscular involvement. The morphometrical analysis showed an increase of size (percentage) to type I fiber than other types in all patients. Furthermore, the type I fiber had a larger cross-sectional area and mean diameter than type IIa and IIb fibers. Both histochemistry and morphometric analysis could be important tools for qualitative and quantitative diagnostics of muscle fibers attacked in this type of disease.
C1 [Cavalcanti, George Maciel; Braga Oliveira, Andre de Sa; Assis, Thiago de Oliveira] Univ Fed Pernambuco, Dept Morfol, Recife, PE, Brazil.
   [Cardao Chimelli, Leila Maria] Univ Fed Rio de Janeiro, Setor Neuropatol, Hosp Clin, Rio De Janeiro, RJ, Brazil.
   [de Medeiros, Paloma Lys] Univ Fed Pernambuco, Dept Histol & Embriol, Ctr Ciencias Biol, Recife, PE, Brazil.
   [da Mota, Diogenes Luis] Univ Fed Pernambuco, Programa Posgrad Nutr, Recife, PE, Brazil.
RP Assis, TD (corresponding author), Univ Fed Paraiba UFPB, Dept Morfol, Cidade Univ S-N, BR-58051900 Joao Pessoa, Paraiba, Brazil.
EM Thiago.oa@hotmail.com
CR Adams R. D., 1997, DISTROFIAS MUSCULARE
   BROOKE MH, 1969, NEUROLOGY, V19, P591, DOI 10.1212/WNL.19.6.591
   BROOKE MH, 1970, ARCH NEUROL-CHICAGO, V23, P369, DOI 10.1001/archneur.1970.00480280083010
   Day JW, 2005, NEUROMUSCULAR DISORD, V15, P5, DOI 10.1016/j.nmd.2004.09.012
   Dubowitz V, 1985, MUSCLE BIOPSY PRACTI
   El-Harouni AA, 2003, ACTA NEUROL SCAND, V107, P400, DOI 10.1034/j.1600-0404.2003.00072.x
   Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U
   Emery AEH, 1993, DUCHENNE MUSCULAR DY
   Jay V, 2001, LANCET, V357, P550, DOI 10.1016/S0140-6736(00)04052-6
   Kapsa R, 2003, LANCET NEUROL, V2, P299, DOI 10.1016/S1474-4422(03)00382-X
   KOENIG M, 1989, AM J HUM GENET, V45, P498
   Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4
   Piccininni M, 2004, ACTA NEUROL SCAND, V109, P113, DOI 10.1046/j.1600-0404.2003.00185.x
   SIMONEAU JA, 1989, AM J PHYSIOL, V257, pE567
   TOOP J, 1974, CLIN GENET, V5, P230
   WORTON R, 1995, SCIENCE, V270, P755, DOI 10.1126/science.270.5237.755
   Zats M, 2002, CIENC SAUDE COLETIVA, V7, P85
   ZATZ M, 1976, J GENET HUM, V24, P153
NR 18
TC 3
Z9 3
U1 0
U2 3
PU SOC CHILENA ANATOMIA
PI TEMUCO
PA CASILLA 54-D, TEMUCO, 00000, CHILE
SN 0717-9502
EI 0717-9367
J9 INT J MORPHOL
JI Int. J. Morphol.
PY 2011
VL 29
IS 3
BP 934
EP 938
DI 10.4067/S0717-95022011000300046
PG 5
WC Anatomy & Morphology
SC Anatomy & Morphology
GA 883QA
UT WOS:000299647600046
OA Other Gold
DA 2020-12-08
ER

PT J
AU Chimelli, L
   Pereira, BS
   Canedo, N
   Correa, AHP
AF Chimelli, L.
   Pereira, B. S.
   Canedo, N.
   Correa, A. H. P.
TI Low grade diffuse astrocytomas recurring as oligodendrogliomas: a reflex
   of peripheral sampling in the first specimen or of subjectivity in
   classifying diffuse low grade gliomas?
SO BRAIN PATHOLOGY
LA English
DT Meeting Abstract
CT 17th International Congress of Neuropathology (ICN 2010)
CY SEP 11-15, 2010
CL Salzburg, AUSTRIA
C1 [Chimelli, L.; Pereira, B. S.; Canedo, N.; Correa, A. H. P.] Univ Fed Rio de Janeiro, Univ Hosp, BR-21941 Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1015-6305
J9 BRAIN PATHOL
JI Brain Pathol.
PD SEP
PY 2010
VL 20
SU 1
BP 66
EP 67
PG 2
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA 649TZ
UT WOS:000281798100237
DA 2020-12-08
ER

PT J
AU Chimelli, L
   Raposo, M
   Maceira, JP
AF Chimelli, L.
   Raposo, M.
   Maceira, J. P.
TI Morphological and morphometric analysis of dermal nerves in resin
   embedded semi-thin sections. An alternative method to diagnose small
   fibre neuropathies such as leprosy
SO BRAIN PATHOLOGY
LA English
DT Meeting Abstract
CT 17th International Congress of Neuropathology (ICN 2010)
CY SEP 11-15, 2010
CL Salzburg, AUSTRIA
C1 [Chimelli, L.; Raposo, M.; Maceira, J. P.] Univ Fed Rio de Janeiro, Univ Hosp, BR-21941 Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1015-6305
J9 BRAIN PATHOL
JI Brain Pathol.
PD SEP
PY 2010
VL 20
SU 1
BP 92
EP 93
PG 2
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA 649TZ
UT WOS:000281798100327
DA 2020-12-08
ER

PT J
AU Landemberger, MC
   Machado, CF
   Gomes, HR
   Chimelli, L
   Rosemberg, S
   Nitrini, R
   Martins, VR
AF Landemberger, Michele C.
   Machado, Cleiton F.
   Gomes, Helio R.
   Chimelli, Leila
   Rosemberg, Sergio
   Nitrini, Ricardo
   Martins, Vilma Regina
TI The Notification of Human Prion Diseases in Brazil from 2005-2010
SO PRION
LA English
DT Meeting Abstract
DE prion; prion diseases in brazil; Creutzfeldt-Jakob disease; E200K
   mutation; polymorphism
C1 [Landemberger, Michele C.; Martins, Vilma Regina] Ludwig Inst Canc Res, Sao Paulo, Brazil.
   [Martins, Vilma Regina] Ensino Hosp, Ac Camargo, SP, Brazil.
   [Gomes, Helio R.; Rosemberg, Sergio; Nitrini, Ricardo] Univ Sao Paulo, Fac Med, BR-05508 Sao Paulo, Brazil.
   [Chimelli, Leila] Univ Fed Rio de Janeiro, Fac Med, BR-21941 Rio De Janeiro, RJ, Brazil.
RI Martins, Vilma/N-5446-2019; Machado, Cleiton/I-5907-2014; Martins, Vilma
   R/E-2547-2012; Nitrini, Ricardo/B-8703-2013; Landemberger, Michele
   Christine/P-3014-2014; Rosemberg, Sergio/F-4464-2012
OI Machado, Cleiton/0000-0002-3313-3868; Martins, Vilma
   R/0000-0002-2909-8502; Nitrini, Ricardo/0000-0002-5721-1525;
   Landemberger, Michele Christine/0000-0002-3513-3554; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LANDES BIOSCIENCE
PI AUSTIN
PA 1806 RIO GRANDE ST, AUSTIN, TX 78702 USA
SN 1933-6896
J9 PRION
JI Prion
PD JUL-SEP
PY 2010
VL 4
IS 3
BP 160
EP 161
PG 2
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 702CN
UT WOS:000285872300129
DA 2020-12-08
ER

PT J
AU Brito, CCB
   Lopes, FCR
   Chimelli, L
   Gasparetto, EL
AF Branco Brito, Cecilia Castelo
   Rueda Lopes, Fernanda Cristina
   Chimelli, Leila
   Gasparetto, Emerson L.
TI Intracranial cell plasma granuloma
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Letter
C1 UFRJ, Dept Radiol, BR-21941913 Rio De Janeiro, Brazil.
   UFRJ, Dept Pathol, BR-21941913 Rio De Janeiro, Brazil.
RP Gasparetto, EL (corresponding author), UFRJ, Hosp Univ Clementino Fraga Filho, Rua Prof Rodolpho Paulo Rocco 255, BR-21941913 Rio De Janeiro, Brazil.
EM egasparetto@gmail.com
CR Brandsma D, 2003, J NEUROL, V250, P1302, DOI 10.1007/s00415-003-0200-7
   BREIDAHL WH, 2006, NEURORADIOLOGY S, V38, pS86
   Dwarakanath S, 2004, J CLIN NEUROSCI, V11, P552, DOI 10.1016/j.jocn.2003.05.012
   MAKINO K, 1995, SURG NEUROL, V43, P374, DOI 10.1016/0090-3019(95)80067-Q
   McCall T, 2006, NEUROSURG REV, V29, P194, DOI 10.1007/s10143-006-0017-9
   Murakami M, 2003, ACTA NEUROCHIR, V145, P221, DOI 10.1007/s00701-002-1040-4
   Provenzale JM, 1997, AM J NEURORADIOL, V18, P389
   Tekkok I H, 2000, Brain Tumor Pathol, V17, P97, DOI 10.1007/BF02484280
NR 8
TC 4
Z9 4
U1 0
U2 0
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD FEB
PY 2010
VL 68
IS 1
BP 127
EP 129
DI 10.1590/S0004-282X2010000100026
PG 3
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 565XL
UT WOS:000275330100026
PM 20339667
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Becker, AP
   de Oliveira, RS
   Saggioro, FP
   Neder, L
   Chimelli, LMC
   Machado, HR
AF Becker, Aline Paixao
   de Oliveira, Ricardo Santos
   Saggioro, Fabiano Pinto
   Neder, Luciano
   Cardao Chimelli, Leila Maria
   Machado, Helio Rubens
TI In pursuit of prognostic factors in children with pilocytic astrocytomas
SO CHILDS NERVOUS SYSTEM
LA English
DT Article
DE Brain tumor; Pediatric neurosurgery; Pilocytic astrocytoma; Prognostic
   factors; Galectin-3
ID BENIGN CEREBELLAR ASTROCYTOMAS; MIB-1 LABELING INDEX; LOW-GRADE
   ASTROCYTOMAS; DIFFUSE ASTROCYTOMAS; TUMOR RESECTION; BRAIN-TUMORS;
   CHILDHOOD; EXPRESSION; GALECTIN-3; ADULTS
AB This study described a 23-year experience in the treatment of children with pilocytic astrocytomas (piloA) with the aim of identifying putative clinical, histopathological, and/or immunohistochemical features that could be related to the outcome of these patients.
   Clinical data of 31 patients under 18 years of age with piloA were obtained from 1984 to 2006.
   The mean age at the time of surgery was 7.8 +/- 4.2 years (1 to 17 years), and the mean follow-up was 5.7 +/- 5.4 years (1 to 20 years). The most common site of tumor formation was the cerebellum (17), followed by brainstem (4), optic chiasmatic hypothalamic region (4), cerebral hemisphere (3), cervical spinal cord (2), and optic nerve (1). Gross total resection (GTR) was achieved in 23 (74.1%), mainly in those with tumors located in the cerebellum and cerebral hemispheres (P = 0.02). The global mortality rate was 6.4%. Nine patients were reoperated. Rosenthal fibers, eosinophilic granular bodies, microvascular proliferation, and lymphocytic infiltration were observed in most cases. The mean Ki-67LI was 4.4 +/- 4.5%. In all cases, Gal-3 expression in tumor cells was observed with variable staining pattern.
   Aside from GTR, no other clinical, histopathological, or immunohistochemical features were found to be related to the prognosis. We postulate that strict follow-up is recommended if piloA is associated with high mitotic activity/Ki67-LI, or if GTR cannot be achieved at surgery. Tumor recurrence or progression of the residual lesion should be strictly observed. In some aspects, childhood piloA remains an enigmatic tumor.
C1 [de Oliveira, Ricardo Santos; Machado, Helio Rubens] Univ Sao Paulo, Div Pediat Neurosurg, Dept Surg & Anat, Ribeirao Preto Sch Med, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Becker, Aline Paixao; Saggioro, Fabiano Pinto; Neder, Luciano] Univ Sao Paulo, Dept Pathol, Ribeirao Preto Sch Med, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Cardao Chimelli, Leila Maria] Univ Fed Rio de Janeiro, Dept Pathol, Rio De Janeiro, Brazil.
RP de Oliveira, RS (corresponding author), Univ Sao Paulo, Div Pediat Neurosurg, Dept Surg & Anat, Ribeirao Preto Sch Med, Campus Univ, BR-14049900 Ribeirao Preto, SP, Brazil.
EM rsoliveira@hcrp.fmrp.usp.br
RI de Oliveira, Ricardo S/A-2039-2010; de Oliveira, Ricardo
   Santos/AAY-1993-2020; Machado, Helio R/I-6602-2012; de Oliveira, Ricardo
   Santos/AAW-7714-2020
OI de Oliveira, Ricardo S/0000-0003-0390-5553; de Oliveira, Ricardo
   Santos/0000-0003-0390-5553; Machado, Helio/0000-0002-1069-7804
FU CNPQ (Conselho Nacional de Desenvolvimento Cientifico e
   TecnologicoNational Council for Scientific and Technological Development
   (CNPq); FAEPA (Fundacao de Assistencia de Ensino e Pesquisa)
FX The authors thank the CNPQ (Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico and FAEPA (Fundacao de Assistencia de Ensino e
   Pesquisa) for grant support. The authors are also grateful to Deise
   Simoes and Ana Maria Anselmi for their expert technical assistance.
CR ABDOLLAHZADEH M, 1994, CHILD NERV SYST, V10, P380, DOI 10.1007/BF00335126
   Abdulrauf SI, 1998, J NEUROSURG, V88, P513, DOI 10.3171/jns.1998.88.3.0513
   AUSTIN EJ, 1988, J NEUROSURG, V68, P41, DOI 10.3171/jns.1988.68.1.0041
   Benesch M, 2006, PEDIATR NEUROSURG, V42, P159, DOI 10.1159/000091859
   Bowers DC, 2003, J CLIN ONCOL, V21, P2968, DOI 10.1200/JCO.2003.01.017
   Buschmann U, 2003, CHILD NERV SYST, V19, P298, DOI 10.1007/s00381-003-0746-9
   Camby I, 2001, BRAIN PATHOL, V11, P12
   Ceppa EP, 2007, J NEURO-ONCOL, V81, P191, DOI 10.1007/s11060-006-9216-z
   CIVITELLO LA, 1988, NEUROLOGY, V38, P509
   CUSHING H, 1931, SURG GYNECOL OBSTET, V52, P129
   Desai KI, 2001, PEDIATR NEUROSURG, V35, P311, DOI 10.1159/000050443
   Dirven CMF, 1997, CHILD NERV SYST, V13, P17, DOI 10.1007/s003810050033
   Due-Tonnessen BJ, 2002, PEDIATR NEUROSURG, V37, P71, DOI 10.1159/000065108
   Faria MHG, 2006, NEUROPATHOLOGY, V26, P519, DOI 10.1111/j.1440-1789.2006.00724.x
   Fernandez C, 2003, NEUROSURGERY, V53, P544, DOI 10.1227/01.NEU.0000079330.01541.6E
   Fisher PG, 2008, PEDIATR BLOOD CANCER, V51, P245, DOI 10.1002/pbc.21563
   Giannini C, 1999, J NEUROPATH EXP NEUR, V58, P46, DOI 10.1097/00005072-199901000-00006
   Gordower L, 1999, NEUROPATH APPL NEURO, V25, P319
   Gunny RS, 2005, PEDIATR RADIOL, V35, P1086, DOI 10.1007/s00247-005-1546-z
   Johannessen AL, 2006, PATHOL ONCOL RES, V12, P143, DOI 10.1007/BF02893360
   KEPES JJ, 1980, J NEUROSURG, V52, P414, DOI 10.3171/jns.1980.52.3.0414
   LAPRAS C, 1986, CHILD NERV SYST, V2, P55
   Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4
   Malik A, 2006, PATHOL ONCOL RES, V12, P164, DOI 10.1007/BF02893364
   MAMELAK AN, 1994, J NEUROSURG, V81, P24, DOI 10.3171/jns.1994.81.1.0024
   Mirone G, 2009, CHILD NERV SYST, V25, P247, DOI 10.1007/s00381-008-0690-9
   Neder L, 2004, CLIN NEUROPATHOL, V23, P262
   Neder L, 2004, BRAIN PATHOL, V14, P399
   Ohki M, 2003, NEUROSURG REV, V26, P262, DOI 10.1007/s10143-003-0280-y
   Park SH, 2008, NEUROPATHOLOGY, V28, P497, DOI 10.1111/j.1440-1789.2008.00909.x
   Parsa CF, 2008, BRIT J OPHTHALMOL, V92, P40, DOI 10.1136/bjo.2007.125567
   Pencalet P, 1999, J NEUROSURG, V90, P265, DOI 10.3171/jns.1999.90.2.0265
   Prados MD, 1997, J NEURO-ONCOL, V32, P235, DOI 10.1023/A:1005736104205
   Preusser M, 2006, HISTOPATHOLOGY, V48, P438, DOI 10.1111/j.1365-2559.2006.02359.x
   Rodriguez FJ, 2006, ACTA NEUROPATHOL, V112, P727, DOI 10.1007/s00401-006-0129-x
   Roessler K, 2002, J NEURO-ONCOL, V58, P141, DOI 10.1023/A:1016053229688
   Rollins NK, 1998, AM J NEURORADIOL, V19, P151
   SCHNEIDER JH, 1992, NEUROSURGERY, V30, P58, DOI 10.1227/00006123-199201000-00011
   SGOUROS S, 1995, CHILD NERV SYST, V11, P89, DOI 10.1007/BF00303812
   Sobel EL, 1996, NEUROSURGERY, V39, P45, DOI 10.1097/00006123-199607000-00010
   STRONG JA, 1993, AM J ROENTGENOL, V161, P369, DOI 10.2214/ajr.161.2.8333380
   Stuer C, 2007, CANCER-AM CANCER SOC, V110, P2799, DOI 10.1002/cncr.23148
   Sutton LN, 1996, J NEUROSURG, V84, P721, DOI 10.3171/jns.1996.84.5.0721
   TOMLINSON FH, 1994, J CHILD NEUROL, V9, P301, DOI 10.1177/088307389400900317
   Torp SH, 2002, PATHOL RES PRACT, V198, P261
   Villarejo F, 2008, CHILD NERV SYST, V24, P203, DOI 10.1007/s00381-007-0449-8
NR 46
TC 16
Z9 16
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0256-7040
EI 1433-0350
J9 CHILD NERV SYST
JI Childs Nerv. Syst.
PD JAN
PY 2010
VL 26
IS 1
BP 19
EP 28
DI 10.1007/s00381-009-0990-8
PG 10
WC Clinical Neurology; Pediatrics; Surgery
SC Neurosciences & Neurology; Pediatrics; Surgery
GA 518UZ
UT WOS:000271721700006
PM 19823847
DA 2020-12-08
ER

PT J
AU De Pinho, LKJ
   Neto, LV
   Chimelli, LMC
   Gasparetto, EL
   Warszawski, L
   Do Souto, AAD
   Gadelha, MR
AF Jomori De Pinho, Leandro Kasuki
   Neto, Leonardo Vieira
   Cardao Chimelli, Leila Maria
   Gasparetto, Emerson Leandro
   Warszawski, Leila
   Dutra Do Souto, Antonio Aversa
   Gadelha, Monica R.
TI Germ cell tumor presenting as sellar mass with suprasellar extension and
   long history of hypopituitarism
SO NEUROENDOCRINOLOGY LETTERS
LA English
DT Article
DE Germ cell tumor; sellar mass; diabetes insipidus; hypopituitarism
ID CENTRAL-NERVOUS-SYSTEM; PITUITARY; DIAGNOSIS
AB OBJECTIVE: Primary central nervous system germ cell tumors are rare neoplasms usually located in the pineal and/or suprasellar region. Pure germinomas do not usually secrete beta-human chorionic gonadotropin hormone (beta-HCG) or alpha-fetoprotein (AFP) and diagnosis is made a few weeks or months after beginning of symptoms.
   CASE: Here we report a case of a pure germinoma in a 20 year-old woman presenting as a sellar mass with suprasellar extension, abnormal serum beta-HCG and a long history of polyuria and polydipsia (4 years), that was initially diagnosed as a pituitary macroadenoma.
   CONCLUSION: This presentation highlights the importance of thinking in alternative diagnosis to pituitary adenoma when diabetes insipidus is the initial symptom.
C1 [Jomori De Pinho, Leandro Kasuki; Neto, Leonardo Vieira; Gadelha, Monica R.] Univ Fed Rio de Janeiro, Endocrinol Unit, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil.
   [Cardao Chimelli, Leila Maria] Univ Fed Rio de Janeiro, Pathol Unit, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil.
   [Gasparetto, Emerson Leandro] Univ Fed Rio de Janeiro, Radiol Unit, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil.
   [Jomori De Pinho, Leandro Kasuki; Warszawski, Leila; Gadelha, Monica R.] Inst Estadual Diabet & Endocrinol Luiz Capriglion, Rio De Janeiro, Brazil.
   [Dutra Do Souto, Antonio Aversa] Univ Fed Rio de Janeiro, Neurosurg Unit, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil.
RP Gadelha, MR (corresponding author), Ilha Fundao, Ctr Pesquisa Neuroendocrinol, Rua Prof Rodolpho Paulo Rocco,255 Bloco 9F,Cidade, BR-21941913 Rio De Janeiro, Brazil.
EM mgadelha@hucff.ufrj.br
RI warszawski, leila/X-8707-2018
OI Vieira Neto, Leonardo/0000-0002-1595-3985
CR Balmaceda Casilda, 2004, Curr Neurol Neurosci Rep, V4, P253, DOI 10.1007/s11910-004-0046-0
   Chahal J, 2008, PITUITARY, V11, P141, DOI 10.1007/s11102-008-0107-5
   Crawford JR, 2007, NEUROLOGY, V68, P1668, DOI 10.1212/01.wnl.0000261908.36803.ac
   Silva CMD, 2008, ARQ NEURO-PSIQUIAT, V66, P415, DOI 10.1590/S0004-282X2008000300028
   Echevarria ME, 2008, ONCOLOGIST, V13, P690, DOI 10.1634/theoncologist.2008-0037
   Kaltsas GA, 2008, ENDOCR-RELAT CANCER, V15, P885, DOI 10.1677/ERC-08-0170
   MELMED S, 2008, WILLIAMS TXB ENDOCRI, P155
   Rondinelli PIP, 2005, ARQ NEURO-PSIQUIAT, V63, P832, DOI 10.1590/S0004-282X2005000500021
   Sawamura Y, 1998, EUR J CANCER, V34, P104, DOI 10.1016/S0959-8049(97)10045-4
   WILDEMBERG LE, 2008, PITUITARY       1231
NR 10
TC 4
Z9 4
U1 0
U2 1
PU MAGHIRA & MAAS PUBLICATIONS
PI STOCKHOLM
PA PO BOX 26132, S-100 41 STOCKHOLM, SWEDEN
SN 0172-780X
J9 NEUROENDOCRINOL LETT
JI Neuroendocrinol. Lett.
PY 2010
VL 31
IS 3
BP 306
EP 309
PG 4
WC Endocrinology & Metabolism; Neurosciences
SC Endocrinology & Metabolism; Neurosciences & Neurology
GA 632XG
UT WOS:000280462300006
PM 20588244
DA 2020-12-08
ER

PT J
AU Chimelli, L
AF Chimelli, Leila
TI "New ISN effort to raise interest in Neuropathology: Conference in
   Sofia, Bulgaria"
SO BRAIN PATHOLOGY
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1015-6305
J9 BRAIN PATHOL
JI Brain Pathol.
PD OCT
PY 2009
VL 19
IS 4
BP 747
EP 751
DI 10.1111/j.1750-3639.2009.00329.x
PG 5
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA 491JT
UT WOS:000269575600024
DA 2020-12-08
ER

PT J
AU Alves-Leon, S
   Meira, ID
   Coelho, SR
   Pereira, V
   Chimelli, L
   Gaspareto, E
   De Souza, JPBM
AF Alves-Leon, S.
   Meira, I. D'Andrea
   Coelho, S. R.
   Pereira, V.
   Chimelli, L.
   Gaspareto, E.
   Barreto Marcondes De Souza, J. Paes
TI CYSTICERCUS INSIDE OF A HIPPOCAMPUS WITH SCLEROSIS MESIAL: DUAL
   PATHOLOGY OR AN INDIRECT INFLAMMATORY RESPONSE?
SO EPILEPSIA
LA English
DT Meeting Abstract
CT 28th International Epilespy Congress
CY JUN 28-JUL 01, 2009
CL Budapest, HUNGARY
SP Int League Epilepsy, Int Bureau Epilepsy
C1 [Alves-Leon, S.; Meira, I. D'Andrea; Pereira, V.; Chimelli, L.; Gaspareto, E.; Barreto Marcondes De Souza, J. Paes] Univ Fed Estado Rio de Janeiro, Univ Hosp Clementino Fraga Filho, Rio De Janeiro, Brazil.
RI DAndrea-Meira, Isabella/B-5341-2013; Leon, Soniza V Alves/J-7786-2012
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0013-9580
J9 EPILEPSIA
JI Epilepsia
PD OCT
PY 2009
VL 50
BP 55
EP 55
PG 1
WC Clinical Neurology
SC Neurosciences & Neurology
GA 502DB
UT WOS:000270433800196
DA 2020-12-08
ER

PT J
AU Neto, LV
   Machado, ED
   Luque, RM
   Taboada, GF
   Marcondes, JB
   Chimelli, LMC
   Quintella, LP
   Niemeyer, P
   de Carvalho, DP
   Kineman, RD
   Gadelha, MR
AF Vieira Neto, Leonardo
   Machado, Evelyn de O.
   Luque, Raul M.
   Taboada, Giselle F.
   Marcondes, Jorge B.
   Chimelli, Leila M. C.
   Quintella, Leonardo Pereira
   Niemeyer, Paulo, Jr.
   de Carvalho, Denise P.
   Kineman, Rhonda D.
   Gadelha, Monica R.
TI Expression Analysis of Dopamine Receptor Subtypes in Normal Human
   Pituitaries, Nonfunctioning Pituitary Adenomas and Somatotropinomas, and
   the Association between Dopamine and Somatostatin Receptors with
   Clinical Response to Octreotide-LAR in Acromegaly
SO JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
LA English
DT Article
ID MESSENGER-RIBONUCLEIC-ACID; GENE-EXPRESSION; QUANTITATIVE-ANALYSIS; D2
   RECEPTOR; IN-VIVO; PROLACTIN; RAT; ANALOGS; CABERGOLINE; HALOPERIDOL
AB Context: Dopamine receptor (DR) and somatostatin receptor subtype expression in pituitary adenomas may predict the response to postsurgical therapies.
   Objectives: Our objectives were to assess and compare the mRNA levels of DR1-5 and somatostatin receptors 1-5 in normal pituitaries (NPs), nonfunctioning pituitary adenomas (NFPAs), and somatotropinomas. In addition, we determined whether the level of DR expression correlates with the in vivo response to octreotide-LAR in acromegalic patients.
   Design and Patients: Eight NPs, 30 NFPAs, and 39 somatotropinomas were analyzed for receptor mRNA levels by real-time RT-PCR. The DR2 short variant was estimated as the DR2 long/DR2 total (DR2T). The relationship between DR expression and the postsurgical response to octreotide-LAR was assessed in 19 of the acromegalic patients.
   Results: DR3 was not detected. The relationship between expression levels of DR subtypes in NPs and ;somatotropinomas was DR2T >>> DR4 >> DR5 > DR1, whereas in NFPAs, DR2T >>> DR4 >> DR1 > DR5. The DR2 short variant was the predominant DR2 variant in the majority of samples. In acromegalics treated with octreotide-LAR, DR1 was negatively correlated with percent GH reduction (3 months: r = -0.67, P = 0.002; and 6 months: r = -0.58, P = 0.009), and DR5 was positively correlated with percent IGF-I reduction (3 months: r = 0.55, P = 0.01; and 6 months: r = 0.47, P = 0.04).
   Conclusions: DR2 is the predominant DR subtype in NPs, NFPAs, and somatotropinomas. The fact that DR1, DR4, and DR5 are also expressed in many adenomas tested suggests that these receptors might also play a role in the therapeutic impact of postsurgical medical therapies in patients with NFPA and acromegaly. This was supported by the finding that the in vivo response to octreotide-LAR was negatively associated with DR1 and positively associated with DR5. (J Clin Endocrinol Metab 94: 1931-1937, 2009)
C1 [Vieira Neto, Leonardo; Machado, Evelyn de O.; Taboada, Giselle F.; Gadelha, Monica R.] Univ Fed Rio de Janeiro, Endocrinol Sect, BR-21941913 Rio De Janeiro, Brazil.
   [Marcondes, Jorge B.] Univ Fed Rio de Janeiro, Neurosurg Sect, BR-21941913 Rio De Janeiro, Brazil.
   [Chimelli, Leila M. C.] Univ Fed Rio de Janeiro, Pathol Sect, BR-21941913 Rio De Janeiro, Brazil.
   [de Carvalho, Denise P.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Inst Biofis Carlos Chagas Filho, BR-21941913 Rio De Janeiro, Brazil.
   [Quintella, Leonardo Pereira] Fiocruz MS, Pathol Sect, Inst Pesquisa Clin Evandro Chagas, BR-21040360 Rio De Janeiro, Brazil.
   [Niemeyer, Paulo, Jr.] Hosp Santa Casa Misericordia Rio Janeiro, Neurosurg Sect, BR-20021230 Rio De Janeiro, Brazil.
   [Gadelha, Monica R.] Inst Estadual Diabet & Endocrinol Luis Caprigl, BR-20211340 Rio De Janeiro, Brazil.
   [Luque, Raul M.] Univ Cordoba, Dept Cell Biol Physiol & Immunol, E-14004 Cordoba, Spain.
   [Luque, Raul M.; Kineman, Rhonda D.] Univ Illinois, Dept Med, Sect Endocrinol Diabet & Metab, Chicago, IL 60612 USA.
   [Luque, Raul M.; Kineman, Rhonda D.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA.
RP Gadelha, MR (corresponding author), Rua Nascimento Silva 555-101, BR-22421020 Ipanema, RJ, Brazil.
EM mgadelha@hucff.ufrj.br
RI Kineman, Rhonda/H-2221-2011; Carvalho, Denise P/H-6306-2012
OI Kineman, Rhonda/0000-0001-7322-1152; Carvalho, Denise
   P/0000-0001-6933-6424; Luque, Raul M./0000-0002-7585-1913; Vieira Neto,
   Leonardo/0000-0002-1595-3985
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES;
   Programa Ramon y Cajal del Ministerio de Educacion y CienciaSpanish
   Government [RYC-2007-00186]; Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro; National Institute of Diabetes and
   Digestive and Kidney DiseasesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Diabetes & Digestive & Kidney Diseases (NIDDK) [30677]; Veteran
   Affairs Merit (to R. D. K.) and Novartis Pharmaceuticals
FX This work was supported by grants from Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (to L.V.N.), Programa Ramon y Cajal del
   Ministerio de Educacion y Ciencia (RYC-2007-00186), Spain (to R. M. L.),
   and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio
   de Janeiro (to M. R. G.), National Institute of Diabetes and Digestive
   and Kidney Diseases Grant 30677, and Veteran Affairs Merit (to R. D. K.)
   and Novartis Pharmaceuticals (to G. F. T. and M. R. G.).
CR Abs R, 1998, J CLIN ENDOCR METAB, V83, P374, DOI 10.1210/jc.83.2.374
   ARNAULD E, 1991, NEUROSCI LETT, V130, P12, DOI 10.1016/0304-3940(91)90216-G
   ASGHARI V, 1995, J NEUROCHEM, V65, P1157, DOI 10.1046/j.1471-4159.1995.65031157.x
   Baragli A, 2007, CELL SIGNAL, V19, P2304, DOI 10.1016/j.cellsig.2007.07.007
   Byrnes EM, 2007, J NEUROENDOCRINOL, V19, P773, DOI 10.1111/j.1365-2826.2007.01586.x
   CACCAVELLI L, 1994, NEUROENDOCRINOLOGY, V60, P314, DOI 10.1159/000126764
   CARON MG, 1978, J BIOL CHEM, V253, P2244
   Choi EY, 1999, BIOCHEM BIOPH RES CO, V256, P33, DOI 10.1006/bbrc.1999.0286
   CIVELLI O, 1993, ANNU REV PHARMACOL, V33, P281, DOI 10.1146/annurev.pa.33.040193.001433
   Colao A, 2007, EUR J ENDOCRINOL, V156, pS57, DOI 10.1530/eje.1.02348
   CRONIN MJ, 1984, P SOC EXP BIOL MED, V175, P191
   DALTOSO R, 1989, EMBO J, V8, P4025, DOI 10.1002/j.1460-2075.1989.tb08585.x
   DEKEYSER J, 1988, BRAIN RES, V443, P77, DOI 10.1016/0006-8993(88)91600-9
   DUTTON MD, 1995, ANAL BIOCHEM, V230, P353, DOI 10.1006/abio.1995.1488
   Ferone D, 2001, CLIN ENDOCRINOL, V54, P469, DOI 10.1046/j.1365-2265.2001.01080.x
   Ferone D, 2008, J CLIN ENDOCR METAB, V93, P1412, DOI 10.1210/jc.2007-1358
   Ferone D, 2007, EUR J ENDOCRINOL, V156, pS37, DOI 10.1530/eje.1.02351
   Ferone D, 2007, EUR J ENDOCRINOL, V156, pS23, DOI 10.1530/eje.1.02356
   FOORD SM, 1983, ENDOCRINOLOGY, V112, P1567, DOI 10.1210/endo-112-5-1567
   GANDELMAN KY, 1991, J NEUROCHEM, V56, P1024, DOI 10.1111/j.1471-4159.1991.tb02024.x
   GIROS B, 1989, NATURE, V342, P923, DOI 10.1038/342923a0
   GOLDSMITH PC, 1979, J HISTOCHEM CYTOCHEM, V27, P1205, DOI 10.1177/27.8.383827
   Guivarc'H D, 1998, ENDOCRINOLOGY, V139, P4213, DOI 10.1210/en.139.10.4213
   HAYES G, 1992, MOL ENDOCRINOL, V6, P920, DOI 10.1210/me.6.6.920
   Inoue A, 1998, MOL BRAIN RES, V55, P285, DOI 10.1016/S0169-328X(98)00009-6
   Kostenis E, 2005, TRENDS PHARMACOL SCI, V26, P595, DOI 10.1016/j.tips.2005.09.007
   Lezcano N, 2002, J NEUROPHYSIOL, V87, P2167, DOI 10.1152/jn.00541.2001
   LIU YF, 1992, MOL ENDOCRINOL, V6, P1815, DOI 10.1210/me.6.11.1815
   MACK KJ, 1991, J NEUROCHEM, V57, P795, DOI 10.1111/j.1471-4159.1991.tb08221.x
   Missale C, 1998, PHYSIOL REV, V78, P189
   OMALLEY KL, 1990, BIOCHEMISTRY-US, V29, P1367, DOI 10.1021/bi00458a003
   Pivonello R, 2004, J CLIN ENDOCR METAB, V89, P1674, DOI 10.1210/jc.2003-030859
   Pivonello R, 2007, EUR J ENDOCRINOL, V156, pS13, DOI 10.1530/eje.1.02353
   RAO DD, 1990, FEBS LETT, V263, P18, DOI 10.1016/0014-5793(90)80695-F
   Renner U, 1998, J CLIN ENDOCR METAB, V83, P1368, DOI 10.1210/jc.83.4.1368
   Rocheville M, 2000, SCIENCE, V288, P154, DOI 10.1126/science.288.5463.154
   Sanyal S, 1997, ENDOCRINOLOGY, V138, P1871, DOI 10.1210/en.138.5.1871
   Saveanu A, 2006, NEUROENDOCRINOLOGY, V83, P258, DOI 10.1159/000095536
   Saveanu A, 2009, REV ENDOCR METAB DIS, V10, P83, DOI 10.1007/s11154-008-9086-0
   Senogles SE, 2000, MOL PHARMACOL, V58, P455
   Stefaneanu L, 2001, ENDOCRINE, V14, P329, DOI 10.1385/ENDO:14:3:329
   Taboada GF, 2008, EUR J ENDOCRINOL, V158, P295, DOI 10.1530/EJE-07-0562
   Taboada GF, 2007, EUR J ENDOCRINOL, V156, P65, DOI 10.1530/eje.1.02313
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   VANTOL HHM, 1992, NATURE, V358, P149
   Zatelli C, 2005, J MOL ENDOCRINOL, V35, P333, DOI 10.1677/jme.1.01876
NR 46
TC 85
Z9 89
U1 0
U2 6
PU ENDOCRINE SOC
PI WASHINGTON
PA 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA
SN 0021-972X
EI 1945-7197
J9 J CLIN ENDOCR METAB
JI J. Clin. Endocrinol. Metab.
PD JUN
PY 2009
VL 94
IS 6
BP 1931
EP 1937
DI 10.1210/jc.2008-1826
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 453CM
UT WOS:000266587800015
PM 19293270
OA Green Published, Bronze
DA 2020-12-08
ER

PT J
AU Andreiuolo, F
   Junier, MP
   Hol, EM
   Miquel, C
   Chimelli, L
   Leonard, N
   Chneiweiss, H
   Daumas-Duport, C
   Varlet, P
AF Andreiuolo, Felipe
   Junier, Marie-Pierre
   Hol, Elly M.
   Miquel, Catherine
   Chimelli, Leila
   Leonard, Nadine
   Chneiweiss, Herve
   Daumas-Duport, Catherine
   Varlet, Pascale
TI GFAP delta immunostaining improves visualization of normal and
   pathologic astrocytic heterogeneity
SO NEUROPATHOLOGY
LA English
DT Article
DE GFAP delta; glia limitans; gliomas; gliosis; intermediate filaments
ID FIBRILLARY ACIDIC PROTEIN; REACTIVE ASTROCYTES; EXPRESSION; BRAIN;
   IDENTIFICATION; NESTIN; CELLS; OLIGODENDROGLIOMAS; ISOFORM; GROWTH
AB Neuropathological analysis of cellular mechanisms underlying gliosis and brain tumors is slowed by the lack of markers allowing to distinguish glial subpopulations in normal or pathological human brains. We therefore evaluated GFAP delta immunostaining in a wide panel of astrogliosis and gliomas, and compared these with GFAP and vimentin. In normal tissue, gliosis and gliomas, GFAP delta immunostaining was observed in astrocytes with relatively high GFAP levels. GFAP delta immunostaining was most conspicuous in glia limitans astrocytes. In Chaslin's gliosis accompanying chronic epilepsy, GFAP delta immunostaining evidenced the glia limitans reactive astrocytes as the source of the dense fibrillary meshwork typical of Chaslin's gliosis. Interestingly GFAP delta and vimentin immunostainings coincided in normal tissues and gliosis, but not in gliomas. Altogether these results show that combined GFAP, GFAP delta and vimentin labelling reveals fine gliofilament regulation in normal and pathological brain.
C1 [Varlet, Pascale] Univ Paris 05, Ctr Hosp Sainte Anne, Serv Anat Pathol, Dept Pathol, F-75674 Paris 14, France.
   [Junier, Marie-Pierre; Miquel, Catherine; Leonard, Nadine; Chneiweiss, Herve; Daumas-Duport, Catherine; Varlet, Pascale] INSERM, U834, Paris, France.
   [Hol, Elly M.] Inst Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands.
   [Andreiuolo, Felipe; Chimelli, Leila] Univ Fed Rio de Janeiro, Sch Med, Dept Pathol, Rio De Janeiro, Brazil.
RP Varlet, P (corresponding author), Univ Paris 05, Ctr Hosp Sainte Anne, Serv Anat Pathol, Dept Pathol, 1 Rue Cabanis, F-75674 Paris 14, France.
EM p.varlet@ch-sainte-anne.fr
RI miquel, catherine/B-5536-2013; Hol, Elly M/F-1891-2013; Hol,
   Elly/J-2025-2019; herve, chneiweiss/Q-6818-2019
OI Hol, Elly M/0000-0001-5604-2603; Hol, Elly/0000-0001-5604-2603; VARLET,
   pascale/0000-0002-8164-1517; Chneiweiss, Herve/0000-0001-7675-5061;
   Andreiuolo, Felipe/0000-0002-2568-6155
CR BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8
   Blechingberg J, 2007, GLIA, V55, P497, DOI 10.1002/glia.20475
   BRAAK E, 1975, CELL TISSUE RES, V157, P367
   Chaslin P., 1889, CR HEBD ACAD SCI, V1, P169
   CLARKE SR, 1994, NEUROREPORT, V5, P1885, DOI 10.1097/00001756-199410000-00011
   Condorelli DF, 1999, J NEUROSCI RES, V56, P219, DOI 10.1002/(SICI)1097-4547(19990501)56:3<219::AID-JNR1>3.0.CO;2-2
   DAPSON RW, 1993, BIOTECH HISTOCHEM, V68, P75, DOI 10.3109/10520299309104670
   Daumas-Duport C, 2000, ANN PATHOL, V20, P413
   DaumasDuport C, 1997, J NEURO-ONCOL, V34, P37, DOI 10.1023/A:1005707203596
   DaumasDuport C, 1997, J NEURO-ONCOL, V34, P61, DOI 10.1023/A:1005759220434
   Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7
   Duggal N, 1997, BRAIN RES, V768, P1, DOI 10.1016/S0006-8993(97)00588-X
   Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996
   Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387
   ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8
   FEINSTEIN DL, 1992, J NEUROSCI RES, V32, P1, DOI 10.1002/jnr.490320102
   GALEA E, 1995, J NEUROSCI RES, V41, P452, DOI 10.1002/jnr.490410404
   Hol EM, 2003, MOL PSYCHIATR, V8, P786, DOI 10.1038/sj.mp.4001379
   Korolainen MA, 2005, NEUROBIOL DIS, V20, P858, DOI 10.1016/j.nbd.2005.05.021
   Krum JM, 1999, EXP NEUROL, V160, P348, DOI 10.1006/exnr.1999.7222
   MCLENDON RE, 1994, BRAIN PATHOL, V4, P221, DOI 10.1111/j.1750-3639.1994.tb00837.x
   Nielsen AL, 2004, J BIOL CHEM, V279, P41537, DOI 10.1074/jbc.M406601200
   Nielsen AL, 2002, J BIOL CHEM, V277, P29983, DOI 10.1074/jbc.M112121200
   Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207
   PETERS A, 1970, FINE STRUCTURE NERVO
   Roelofs RF, 2005, GLIA, V52, P289, DOI 10.1002/glia.20243
   Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103
   YAMADA T, 1992, ACTA NEUROPATHOL, V84, P157, DOI 10.1007/BF00311389
   ZELENIKA D, 1995, MOL BRAIN RES, V30, P251, DOI 10.1016/0169-328X(95)00010-P
NR 29
TC 15
Z9 16
U1 0
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0919-6544
EI 1440-1789
J9 NEUROPATHOLOGY
JI Neuropathology
PD FEB
PY 2009
VL 29
IS 1
BP 31
EP 39
DI 10.1111/j.1440-1789.2008.00936.x
PG 9
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA 394VN
UT WOS:000262479600006
PM 18564099
DA 2020-12-08
ER

PT J
AU Chimelli, L
AF Chimelli, Leila
TI SOCIETY NEWS
SO BRAIN PATHOLOGY
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1015-6305
J9 BRAIN PATHOL
JI Brain Pathol.
PD JAN
PY 2009
VL 19
IS 1
BP 171
EP 174
DI 10.1111/j.1750-3639.2008.00251.x
PG 4
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA 379KN
UT WOS:000261395200022
DA 2020-12-08
ER

PT J
AU de Souza, JM
   Domingues, FS
   Chimelli, L
   Gault, J
AF de Souza, Jorge Marcondes
   Domingues, Flavio S.
   Chimelli, Leila
   Gault, Judith
TI Spinal root arteriovenous malformations and same-segment cord cavernous
   malformation in familial cerebral cavernous malformation
SO JOURNAL OF NEUROSURGERY-SPINE
LA English
DT Article
DE cavernous angioma; familial cavernous malformations; genetics; mutation;
   spinal arteriovenous malformations
ID VASCULAR MALFORMATIONS; NATURAL-HISTORY; CLASSIFICATION
AB Spinal vascular malformations are uncommon lesions, and controversy persists regarding optimal investigation, classification, and treatment strategies. The authors report on a patient with a spinal root arteriovenous malformation (AVM) associated with a parenchymal cavernous malformation (CM) in the same spinal cord segment and describe a complete familial and molecular investigation. This 35-year-old woman presented with symptoms of progressive clinical spastic paraparesis. Magnetic resonance imaging results were suggestive of a spinal cord cavernoma associated with cerebral CMs. Her family history included 2 sisters treated for epilepsy. At surgery an intraspinal root AVM was found at the same level of the cord CM, and both lesions were completely removed. Cerebral gradient echo MR imaging disclosed multiple cavernomas in her relatives, which prompted the molecular diagnosis. On sequence analysis, a novel mutation on the cerebral CM1 (CCM1) gene (c796insA) was found. The authors report on a unique case of familial cerebral CM in which a spinal root AVM was situated next to a cord CM, and discuss the concomitant occurrence of altered nervous system angiogenesis and vasculogenesis.
C1 [de Souza, Jorge Marcondes] Hosp Univ Clementino Fraga Filho, Serv Neurocirurg, Dept Surg, Div Neurosurg, BR-21941913 Rio De Janeiro, Brazil.
   [Chimelli, Leila] Hosp Univ Clementino Fraga Filho, Dept Pathol, BR-21941913 Rio De Janeiro, Brazil.
   [Gault, Judith] Univ Colorado, Dept Neurosurg & Psychiat, Denver, CO 80202 USA.
RP de Souza, JM (corresponding author), Hosp Univ Clementino Fraga Filho, Serv Neurocirurg, Dept Surg, Div Neurosurg, R Rodolpho Rocco 255,Cidade Univ, BR-21941913 Rio De Janeiro, Brazil.
EM jmarcondes@hucff.ufrj.br
CR AWAD IA, 1993, NEUROSURGERY, V33, P179, DOI 10.1227/00006123-199308000-00001
   Cohen-Gadol AA, 2006, J NEUROSURG, V104, P376, DOI 10.3171/jns.2006.104.3.376
   Gault J, 2004, NEUROSURGERY, V55, P1, DOI 10.1227/01.NEU.0000126872.23715.E5
   GENNUSO R, 1989, SPINE, V14, P543, DOI 10.1097/00007632-198905000-00016
   Hasegawa S, 1999, ACTA NEUROCHIR, V141, P315, DOI 10.1007/s007010050303
   Jabbour P, 2004, NEUROSURGERY, V55, P1431, DOI 10.1227/01.NEU.0000143618.88015.DD
   Jallo George I, 2006, Neurosurg Focus, V21, pe10
   Kharkar S, 2007, NEUROSURGERY, V60, P865, DOI 10.1227/01.NEU.0000255437.36742.15
   Labouge P, 2007, LANCET NEUROL, V6, P237, DOI 10.1016/S1474-4422(07)70053-4
   Parsch D, 1999, SPINAL CORD, V37, P62, DOI 10.1038/sj.sc.3100787
   RIGAMONTI D, 1987, J NEUROSURG, V67, P518, DOI 10.3171/jns.1987.67.4.0518
   Rodesch G, 2002, NEUROSURGERY, V51, P374, DOI 10.1097/00006123-200208000-00013
   Rothbart D, 1996, NEUROSURGERY, V38, P915, DOI 10.1097/00006123-199605000-00011
   Spetzler RF, 2002, J NEUROSURG, V96, P145, DOI 10.3171/spi.2002.96.2.0145
NR 14
TC 1
Z9 1
U1 0
U2 1
PU AMER ASSOC NEUROLOGICAL SURGEONS
PI ROLLING MEADOWS
PA 5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA
SN 1547-5654
EI 1547-5646
J9 J NEUROSURG-SPINE
JI J. Neurosurg.-Spine
PD SEP
PY 2008
VL 9
IS 3
BP 249
EP 252
DI 10.3171/SPI/2008/9/9/249
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA 344CT
UT WOS:000258903900003
PM 18928219
DA 2020-12-08
ER

PT J
AU de Freitas, MRG
   Neves, MAO
   Nascimento, OJM
   de Mello, MP
   Botelho, JP
   Chimelli, L
AF de Freitas, Marcos R. Gomes
   Neves, Marco A. O.
   Nascimento, Osvaldo J. M.
   de Mello, Mariana P.
   Botelho, John P.
   Chimelli, Leila
TI Inclusion body myositis and HIV infection
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
ID MUSCLE; MANIFESTATIONS; MYOPATHY; THERAPY; DISEASE; IMMUNE; AIDS
C1 [de Freitas, Marcos R. Gomes; Neves, Marco A. O.; Nascimento, Osvaldo J. M.] Univ Fed Fluminense, Dept Neurol, Niteroi, RJ, Brazil.
   [Chimelli, Leila] Univ Fed Rio de Janeiro, Dept Neuropathol, Rio De Janeiro, Brazil.
   [Neves, Marco A. O.; de Mello, Mariana P.; Botelho, John P.] Serra Orgaos Univ, Rio De Janeiro, Brazil.
RP de Freitas, MRG (corresponding author), Rua Gastao Ruch 16-1402, BR-24220100 Niteroi, RJ, Brazil.
EM mgdefreitas@hotmail.com
OI Nascimento, Osvaldo/0000-0003-3516-485X; de Freitas,
   Marcos/0000-0001-7747-0287
CR Alexanderson H, 2005, CURR OPIN RHEUMATOL, V17, P164, DOI 10.1097/01.bor.0000152665.41493.49
   ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5
   Authier FJ, 2005, MUSCLE NERVE, V32, P247, DOI 10.1002/mus.20338
   Cupler EJ, 1996, BRAIN, V119, P1887, DOI 10.1093/brain/119.6.1887
   Dalakas MC, 2006, NAT CLIN PRACT NEURO, V2, P437, DOI 10.1038/ncpneuro0261
   Dalakas MC, 2006, NEUROLOGY, V66, pS33, DOI 10.1212/01.wnl.0000192129.65677.87
   Dalakas MC, 1997, NEUROLOGY, V48, P712, DOI 10.1212/WNL.48.3.712
   DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602
   LEVY RM, 1985, J NEUROSURG, V62, P475, DOI 10.3171/jns.1985.62.4.0475
   Ozden S, 2004, J VIROL, V78, P10320, DOI 10.1128/JVI.78.19.10320-10327.2004
   Peng A, 2000, NEUROLOGY, V55, P296, DOI 10.1212/WNL.55.2.296
   Roedling S, 2004, SEX TRANSM INFECT, V80, P315, DOI 10.1136/sti.2003.008474
   Scola RH, 1998, ARQ NEURO-PSIQUIAT, V56, P388, DOI 10.1590/S0004-282X1998000300007
   SIMPSON DM, 1994, ANN INTERN MED, V121, P769, DOI 10.7326/0003-4819-121-10-199411150-00008
   Wulff EA, 1999, SEMIN NEUROL, V19, P157, DOI 10.1055/s-2008-1040833
NR 15
TC 6
Z9 6
U1 0
U2 0
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD JUN
PY 2008
VL 66
IS 2B
BP 428
EP 430
DI 10.1590/S0004-282X2008000300033
PG 3
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 327WV
UT WOS:000257760100033
PM 18641890
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Pinto, LW
   Araujo, MBM
   Vettore, AL
   Wernersbach, L
   Leite, ACC
   Chimelli, LMC
   Soares, FA
AF Pinto, Luciana Wernersbach
   Araujo, Maria Betania Mahler
   Vettore, Andre L.
   Wernersbach, Liana
   Leite, Andre Campana C.
   Chimelli, Leila Maria C.
   Soares, Fernando Augusto
TI Glioblastomas: correlation between oligodendroglial components, genetic
   abnormalities, and prognosis
SO VIRCHOWS ARCHIV
LA English
DT Article
DE glioblastoma; oligodendroglial component; 1p loss; 19q loss; prognostic
   factors
ID MOLECULAR-GENETICS; GLIOMAS; CLASSIFICATION; EXPRESSION; GENOTYPE;
   SURVIVAL; TUMORS; 1P; OLIGOASTROCYTOMAS; PATHOLOGY
AB It has been demonstrated that a small percentage (approximately 15%) of glioblastomas (GBM) presents an oligodendroglial component with a variable frequency of chromosome 1p and 19q deletions, the genetic alteration related to chemotherapy response and longer survival in oligodendrogliomas. There is a growing interest in investigating 1p and 19q losses in hybrid gliomas and their impact on prognosis. A series of 88 GBMs was investigated regarding 1p and/or 19q losses, 24 with oligodendroglioma-like areas, using quantitative microsatellite analysis and/or fluorescent in situ hybridization. When present, the oligodendroglial and astrocytic components were independently investigated. Clinical data, histology, and 1p/19q status were correlated. Tumors with oligodendroglial components showed three cases each of 1p or 19q loss and one with combined 1p/19q loss. No difference in 1p or 19q status was observed between the oligodendroglial and astrocytic components. Conventional GBM demonstrated isolated 1p loss in four cases and 19q loss in five. No association was seen between 1p/19q status and histology. Deletions at 1p and/or 19q were infrequent in GBMs with oligodendroglial components. Despite the hybrid phenotype, the pattern of genetic changes at 1p and 19q was not different from that usually observed in conventional GBMs, nor did it show any correlation with survival.
C1 [Pinto, Luciana Wernersbach] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Pathol Lab, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Chimelli, Leila Maria C.] Univ Fed Rio de Janeiro, Sch Med, Dept Pathol, Rio De Janeiro, RJ, Brazil.
   [Leite, Andre Campana C.] Hosp AC Camargo Fund Antonio Prudente, Dept Radiotherapy, Sao Paulo, SP, Brazil.
   [Wernersbach, Liana] Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Rio De Janeiro, RJ, Brazil.
   [Vettore, Andre L.] Ludwig Inst Canc Res, Sao Paulo, SP, Brazil.
   [Pinto, Luciana Wernersbach; Araujo, Maria Betania Mahler; Soares, Fernando Augusto] Hosp AC Camargo Fund Antonio Prudente, Dept Anat Pathol, Sao Paulo, SP, Brazil.
RP Pinto, LW (corresponding author), Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Pathol Lab, Av Brasil 4365, BR-21040900 Rio De Janeiro, RJ, Brazil.
EM luciana.wernersbach@ipec.fiocruz.br
RI Vettore, Andre L/J-5168-2012
OI Vettore, Andre L/0000-0001-8526-5478; Soares,
   Fernando/0000-0002-1212-9093; Soares, Fernando
   Augusto/0000-0003-1647-7842
CR Aldape K, 2007, ARCH PATHOL LAB MED, V131, P242
   Barbashina V, 2005, CLIN CANCER RES, V11, P1119
   Cairncross JG, 1998, J NATL CANCER I, V90, P1473, DOI 10.1093/jnci/90.19.1473
   Caskey LS, 2000, HISTOL HISTOPATHOL, V15, P971, DOI 10.14670/HH-15.971
   Fuller CE, 2003, J NEUROPATH EXP NEUR, V62, P1118, DOI 10.1093/jnen/62.11.1118
   He J, 2001, J NEUROPATH EXP NEUR, V60, P863, DOI 10.1093/jnen/60.9.863
   Hilton DA, 2004, HISTOPATHOLOGY, V44, P555, DOI 10.1111/j.1365-2559.2004.01887.x
   Homma T, 2006, J NEUROPATH EXP NEUR, V65, P846, DOI 10.1097/01.jnen.0000235118.75182.94
   Idbaih A, 2005, ANN NEUROL, V58, P483, DOI 10.1002/ana.20607
   Ino Y, 2000, J NEUROSURG, V92, P983, DOI 10.3171/jns.2000.92.6.0983
   Kleihues P, 2007, WHO CLASSIFICATION T, P33
   Kraus JA, 2001, ACTA NEUROPATHOL, V101, P311
   Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4
   McDonald JM, 2005, CANCER-AM CANCER SOC, V104, P1468, DOI 10.1002/cncr.21338
   Miller CR, 2007, ARCH PATHOL LAB MED, V131, P397
   Mueller W, 2002, AM J PATHOL, V161, P313, DOI 10.1016/S0002-9440(10)64183-1
   Nigro JM, 2001, AM J PATHOL, V158, P1253, DOI 10.1016/S0002-9440(10)64076-X
   Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337
   Qu MQ, 2007, ACTA NEUROPATHOL, V113, P129, DOI 10.1007/s00401-006-0142-0
   Reifenberger G, 2004, J MOL MED, V82, P656, DOI 10.1007/s00109-004-0564-x
   REIFENBERGER J, 1994, AM J PATHOL, V145, P1175
   Schmidt MC, 2002, J NEUROPATH EXP NEUR, V61, P321, DOI 10.1093/jnen/61.4.321
   Tews B, 2006, INT J CANCER, V119, P792, DOI 10.1002/ijc.21901
   Walker C, 2003, CLIN CANCER RES, V9, P4841
NR 24
TC 42
Z9 43
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0945-6317
EI 1432-2307
J9 VIRCHOWS ARCH
JI Virchows Arch.
PD MAY
PY 2008
VL 452
IS 5
BP 481
EP 490
DI 10.1007/s00428-007-0562-9
PG 10
WC Pathology
SC Pathology
GA 292IF
UT WOS:000255259000002
PM 18351387
DA 2020-12-08
ER

PT J
AU Paschoal, J
   Caroli-Bottino, A
   Silva, NH
   Chimelli, L
   Pannain, VL
AF Paschoal, Juliana
   Caroli-Bottino, Adriana
   Silva, Nathalie Henriques
   Chimelli, Leila
   Pannain, Vera Lucia
TI Angiogenesis in hepatocellular carcinoma and cirrhosis:
   Immunohistochemical study with endothelial markers
SO VIRCHOWS ARCHIV
LA English
DT Meeting Abstract
C1 [Paschoal, Juliana; Caroli-Bottino, Adriana; Silva, Nathalie Henriques; Chimelli, Leila; Pannain, Vera Lucia] Univ Fed Rio de Janeiro, Dept Pathol, BR-21941 Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0945-6317
J9 VIRCHOWS ARCH
JI Virchows Arch.
PD MAY
PY 2008
VL 452
SU 1
BP S130
EP S130
PG 1
WC Pathology
SC Pathology
GA 305QJ
UT WOS:000256192600304
DA 2020-12-08
ER

PT J
AU Gasparetto, EL
   da Cruz, LCH
   Doring, TM
   Araujo, B
   Dantas, MA
   Chimelli, L
   Domingues, RC
AF Gasparetto, Emerson L.
   da Cruz, L. Celso Hygino, Jr.
   Doring, Thomas M.
   Araujo, Bertha
   Dantas, Mario Alberto
   Chimelli, Leila
   Domingues, Rolrleu C.
TI Diffusion-weighted MR images and pineoblastoma: Diagnosis and follow-up
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE pineoblastoma; magnetic resonance imaging; diffusion-weighted imaging
ID TUMORS; MASSES
AB Pineoblastomas are uncommon pineal tumors, which demonstrate rapid growing and poor prognosis. We report the case of a 43-year-old man with an enhancing pineal region mass, which showed restriction of the diffusion on diffusion-weighted (DW) MR images. The surgical biopsy defined the diagnosis of pineoblastoma and the therapy was initiated with radiation and chemotherapy. Three months later, the follow-up MR imaging showed areas suggestive of necrosis and the DW images demonstrate no significant areas of restricted diffusion. The differential diagnosis of pineal region masses that could show restriction of diffusion is discussed.
C1 [Gasparetto, Emerson L.; da Cruz, L. Celso Hygino, Jr.; Doring, Thomas M.; Domingues, Rolrleu C.] Univ Fed Rio de Janeiro, Clin Multi Imagen, Rio De Janeiro, Brazil.
   [Chimelli, Leila] Univ Fed Rio de Janeiro, Pathol Lab, Rio De Janeiro, Brazil.
   [Gasparetto, Emerson L.] Univ Fed Rio de Janeiro, Dept Radiol, Rio De Janeiro, Brazil.
   [Chimelli, Leila] Univ Fed Rio de Janeiro, Dept Pathol, Rio De Janeiro, Brazil.
   [Gasparetto, Emerson L.; da Cruz, L. Celso Hygino, Jr.; Doring, Thomas M.; Domingues, Rolrleu C.] Univ Fed Rio de Janeiro, CDPI, Rio De Janeiro, Brazil.
RP Gasparetto, EL (corresponding author), Rua Lopes Trovao 88-1702B, BR-24220071 Niteroi, RJ, Brazil.
EM egasparetto@gmail.com
RI Gasparetto, Emerson/B-9129-2008
CR Ashburner J, 1997, NEUROIMAGE, V6, P209, DOI 10.1006/nimg.1997.0290
   Hagmann P, 2006, RADIOGRAPHICS, V26, pS205, DOI 10.1148/rg.26si065510
   Hein PA, 2004, AM J NEURORADIOL, V25, P201
   Kono K, 2001, AM J NEURORADIOL, V22, P1081
   Krabbe K, 1997, NEURORADIOLOGY, V39, P483, DOI 10.1007/s002340050450
   Mardor Y, 2003, J CLIN ONCOL, V21, P1094, DOI 10.1200/JCO.2003.05.069
   Nakamura M, 2000, NEURORADIOLOGY, V42, P509, DOI 10.1007/s002349900243
   Provenzale JM, 2006, RADIOLOGY, V239, P632, DOI 10.1148/radiol.2393042031
   Reis F, 2006, J NEUROIMAGING, V16, P52, DOI 10.1177/1051228405001514
   SMIRNIOTOPOULOS JG, 1992, RADIOGRAPHICS, V12, P577, DOI 10.1148/radiographics.12.3.1609147
   Song K, 2004, ARCH PATHOL LAB MED, V128, P707
   Stadnik TW, 2001, AM J NEURORADIOL, V22, P969
   Yamasaki F, 2005, RADIOLOGY, V235, P985, DOI 10.1148/radiol.2353031338
NR 13
TC 10
Z9 11
U1 0
U2 0
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD MAR
PY 2008
VL 66
IS 1
BP 64
EP 68
DI 10.1590/S0004-282X2008000100015
PG 5
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 282PQ
UT WOS:000254580100015
PM 18392417
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Taboada, GF
   Luque, RM
   Vieira, L
   Machado, ED
   Sbaffi, BC
   Domingues, RC
   Marcondes, JB
   Chimelli, LMC
   Fontes, R
   Niemeyer, P
   de Carvalho, DP
   Kineman, RD
   Gadelha, MR
AF Taboada, Giselle F.
   Luque, Raul M.
   Vieira Neto, Leonardo
   Machado, Evelyn de O.
   Sbaffi, Bruna C.
   Domingues, Romeu C.
   Marcondes, Jorge B.
   Chimelli, Leila M. C.
   Fontes, Rosita
   Niemeyer, Paulo
   de Carvalho, Denise P.
   Kineman, Rhonda D.
   Gadelha, Monica R.
TI Quantitative analysis of somatostatin receptor subtypes (1-5) gene
   expression levels in somatotropinomas and correlation to in vivo
   hormonal and tumor volume responses to treatment with octreotide LAR
SO EUROPEAN JOURNAL OF ENDOCRINOLOGY
LA English
DT Article
ID SECRETING PITUITARY-ADENOMAS; SUPPRESSING GROWTH-HORMONE;
   PREDICTIVE-VALUE; ACROMEGALIC PATIENTS; ANALOG THERAPY; GH; SURGERY;
   CELLS; NORMALIZATION; SCINTIGRAPHY
AB Objective: To determine whether the somatostatin receptor subtype (SSTR) expression profile correlates with hormonal and tumor volume responses to postsurgical octreotide long acting repeatable (OCT LAR) treatment.
   Design and methods: Quantitative real-time RT-PCR was used to evaluate the absolute mRNA copy numbers for all five SSTR subtypes in 22 somatotropinomas. Response to OCT LAR was studied by hormone levels (GH and IGF-I) and tumor volume (sella turcica magnetic resonance imaging).
   Results: SSTR5 was present at the highest level followed by SSTR2, SSTR3, SSTR1, and SSTR4 (2327 (1046-5555), 2098 (194-23 954), 97 (0-460), 14 (0-29 480), and 0 (0-652) copies respectively). Positive correlations were found between SSTR2 levels and the percentage decrease of GH and lGF-I after 3 (r=0.49, P < 0.027 and r=0.49, P < 0.029 respectively) and 6 (r=0.59, P < 0.006 and r=0.58, P < 0.008 respectively) months of OCT LAR. A negative correlation was found between SSTR5 mRNA levels and the percentage decrease of GH after 3 months of OCT LAR (r=-0.52, P=0.016, n=21). A higher SSTR2/SSTR5 ratio was observed among patients who obtained hormonal control with OCT LAR, when compared with those uncontrolled (2.4 (0.7-10) vs 0.3 (0.1-7.7), P = 0.001). A ROC curve analysis showed a SSTR2/SSTR5 ratio of 1.3 as the best predictor of disease control, with a sensitivity of 88%, and a specificity of 92% - area under curve, 0.9. A positive correlation was also found between SSTR2 mRNA levels and the percentage decrease in tumor volume after 6 months of OCT LAR (r=0.79, P = 0.002, n = 12).
   Conclusions: Somatostatin receptor subtype 2 mRNA expression levels in somatotropinomas correlate positively with in vivo hormonal and tumor volume responses to OCT LAR.
C1 [Taboada, Giselle F.; Vieira Neto, Leonardo; Machado, Evelyn de O.; Gadelha, Monica R.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Endocrinol Sect, BR-21941913 Rio De Janeiro, Brazil.
   [Sbaffi, Bruna C.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Radiol Sect, BR-21941913 Rio De Janeiro, Brazil.
   [Marcondes, Jorge B.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Neurosurg Sect, BR-21941913 Rio De Janeiro, Brazil.
   [Chimelli, Leila M. C.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Pathol Sect, BR-21941913 Rio De Janeiro, Brazil.
   [de Carvalho, Denise P.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Hosp Univ Clementino Fraga Filho, BR-21941913 Rio De Janeiro, Brazil.
   [Niemeyer, Paulo] Pontificia Univ Catolica Rio de Janeiro, Hosp Santa Casa Misericordia, Neurosurg Sect, Rio De Janeiro, Brazil.
   [Fontes, Rosita; Gadelha, Monica R.] Inst Estadual & Endocrinol Luis Capriglione, BR-20211340 Rio De Janeiro, Brazil.
   [Luque, Raul M.; Kineman, Rhonda D.] Univ Illinois, Sect Endocrinol Diabet & Metab, Dept Med, Chicago, IL USA.
   [Luque, Raul M.; Kineman, Rhonda D.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL USA.
RP Gadelha, MR (corresponding author), Rua Nascimento Silva 555-101, BR-22421020 Rio De Janeiro, Brazil.
EM mgadelha@hucff.ufri.br
RI Carvalho, Denise P/H-6306-2012; Kineman, Rhonda/H-2221-2011
OI Carvalho, Denise P/0000-0001-6933-6424; Kineman,
   Rhonda/0000-0001-7322-1152; Luque, Raul M./0000-0002-7585-1913; Vieira
   Neto, Leonardo/0000-0002-1595-3985
FU PHS HHSUnited States Public Health Service [NIDDK 30677] Funding Source:
   Medline
CR Ahmed S, 1999, CLIN ENDOCRINOL, V50, P561
   Barlier A, 1998, J CLIN ENDOCR METAB, V83, P1604, DOI 10.1210/jc.83.5.1604
   Bevan JS, 2005, J CLIN ENDOCR METAB, V90, P1856, DOI 10.1210/jc.2004-1093
   Biermasz NR, 2005, GROWTH HORM IGF RES, V15, P200, DOI 10.1016/j.ghir.2005.02.007
   Casarini APM, 2006, J ENDOCRINOL INVEST, V29, P826, DOI 10.1007/BF03347378
   Colao A, 1996, J CLIN ENDOCR METAB, V81, P2356, DOI 10.1210/jc.81.6.2356
   Corbetta S, 2001, EUR J CLIN INVEST, V31, P208, DOI 10.1046/j.1365-2362.2001.00786.x
   Cozzi R, 2003, J CLIN ENDOCR METAB, V88, P3090, DOI 10.1210/jc.2003-030110
   Danila DC, 2001, J CLIN ENDOCR METAB, V86, P2976, DOI 10.1210/jc.86.7.2976
   de Herder WW, 2005, EUR J ENDOCRINOL, V153, P67, DOI 10.1530/eje.1.01935
   Drange MR, 2000, J CLIN ENDOCR METAB, V85, P168, DOI 10.1210/jc.85.1.168
   Florio T, 2003, CLIN ENDOCRINOL, V59, P115, DOI 10.1046/j.1365-2265.2003.01811.x
   Freda PU, 2005, J CLIN ENDOCR METAB, V90, P4465, DOI 10.1210/jc.2005-0260
   Gittoes NJL, 1999, QJM-MON J ASSOC PHYS, V92, P741, DOI 10.1093/qjmed/92.12.741
   Halah Fernanda P.B., 2004, Arq Bras Endocrinol Metab, V48, P245, DOI 10.1590/S0004-27302004000200007
   Hofland LJ, 2004, J CLIN ENDOCR METAB, V89, P1577, DOI 10.1210/jc.2003-031344
   Jaquet P, 2000, J CLIN ENDOCR METAB, V85, P781, DOI 10.1210/jc.85.2.781
   JIANG H, 2007, 89 ANN M END SOC CHI, P745
   Karavitaki N, 2005, CLIN ENDOCRINOL, V62, P282, DOI 10.1111/j.1365-2265.2004.02191.x
   LAMBERTS SWJ, 1988, CLIN ENDOCRINOL, V29, P411, DOI 10.1111/j.1365-2265.1988.tb02890.x
   Legovini P, 1997, J ENDOCRINOL INVEST, V20, P424, DOI 10.1007/BF03347995
   Lindsay J R, 2004, Pituitary, V7, P139, DOI 10.1007/s11102-005-1756-2
   LUNDIN P, 1992, J COMPUT ASSIST TOMO, V16, P518
   Olias G, 2004, J NEUROCHEM, V89, P1057, DOI 10.1111/j.1471-4159.2004.02402.x
   Park CY, 2004, ENDOCR J, V51, P227, DOI 10.1507/endocrj.51.227
   Patel RC, 2002, P NATL ACAD SCI USA, V99, P3294, DOI 10.1073/pnas.042705099
   Plockinger U, 1997, EUR J ENDOCRINOL, V136, P369, DOI 10.1530/eje.0.1360369
   RAYNOR K, 1993, MOL PHARMACOL, V44, P385
   RAYNOR K, 1993, MOL PHARMACOL, V43, P838
   Resmini E, 2007, J CLIN ENDOCR METAB, V92, P1592, DOI 10.1210/jc.2006-2084
   Rocheville M, 2000, J BIOL CHEM, V275, P7862, DOI 10.1074/jbc.275.11.7862
   Saveanu A, 2001, J CLIN ENDOCR METAB, V86, P140, DOI 10.1210/jc.86.1.140
   Saveanu A, 2002, J CLIN ENDOCR METAB, V87, P5545, DOI 10.1210/jc.2002-020934
   Swearingen B, 1998, J CLIN ENDOCR METAB, V83, P3419, DOI 10.1210/jc.83.10.3419
   Taboada Giselle F., 2005, Arq Bras Endocrinol Metab, V49, P390, DOI 10.1590/S0004-27302005000300010
   Taboada GF, 2007, EUR J ENDOCRINOL, V156, P65, DOI 10.1530/eje.1.02313
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Zatelli MC, 2003, J CLIN ENDOCR METAB, V88, P2797, DOI 10.1210/jc.2002-021825
NR 38
TC 119
Z9 125
U1 0
U2 1
PU BIOSCIENTIFICA LTD
PI BRISTOL
PA EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT,
   ENGLAND
SN 0804-4643
EI 1479-683X
J9 EUR J ENDOCRINOL
JI Eur. J. Endocrinol.
PD MAR
PY 2008
VL 158
IS 3
BP 295
EP 303
DI 10.1530/EJE-07-0562
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 272JB
UT WOS:000253854600003
PM 18299461
OA Bronze
DA 2020-12-08
ER

PT J
AU Colli, BO
   Carlotti, CG
   Assirati, JA
   Lopes, LD
   Marques, W
   Chimelli, L
   Neder, L
   Barreira, AA
AF Colli, Benedicto Oscar
   Carlotti, Carlos Gilberto, Jr.
   Assirati, Joao Alberto, Jr.
   Lopes, Luiza da Silva
   Marques, Wilson, Jr.
   Chimelli, Leila
   Neder, Luciano
   Barreira, Amilton Antunes
TI Dorsal root ganglionectomy for the diagnosis of sensory neuropathies.
   Surgical technique and results
SO SURGICAL NEUROLOGY
LA English
DT Article
DE dorsal root ganglionectomy; sensory neuronopathy; surgical technique;
   diagnosis
ID PRIMARY SJOGRENS-SYNDROME; SICCA SYNDROME; NEURONOPATHY; GANGLIONITIS;
   NERVE; PAIN
AB Background: Inflammatory diseases stand out among sensory neuronopathies because, in their active phase, they can be treated with immunosuppressive agents. Immunosuppressive therapy may present severe adverse effects and requires previous inflammatory activity confirmation. Sensory neuronopathies are diagnosed based on clinical and EMG findings. Diagnostic confirmation and identification of inflammatory activity are based on sensory ganglion histopathological examination. We describe the surgical technique used for dorsal root ganglionectomy in patients with clinical/EMG diagnosis of sensory neuronopathies.
   Methods: The sensory ganglion was obtained from 15 patients through a small T7-T8 hemilaminectomy and foraminotomy to expose the C7 root from its origin to the spinal nerve bifurcation. In 6 patients, the dural cuff supposed to contain the ganglion was resected en bloc; and in 9 patients, the ganglion was obtained through a longitudinal incision of the dural cuff and microsurgical dissection from the ventral and dorsal roots and radicular arteries. All ganglia were histopathologically examined.
   Results: No ganglion was found in the dural cuff in 2 patients submitted to en bloc removal, and the ganglion was removed in all patients who underwent microsurgical dissection. All but 2 patients that had ganglion examination presented a neuronopathy of nerve cell loss, 3 with mononuclear inflammatory infiltrate. These patients underwent immunosuppressive therapy, and 2 of them presented clinical improvement. No surgical complications were observed.
   Conclusions: Microsurgical dorsal root ganglionectomy for diagnosing inflammatory sensory ganglionopathies was effective and safe. Although safe, en bloc resection of the proximal dural cuff was not effective for this purpose. (c) 2008 Published by Elsevier Inc.
C1 [Colli, Benedicto Oscar; Carlotti, Carlos Gilberto, Jr.; Assirati, Joao Alberto, Jr.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Surg, Div Neurosurg, BR-05508 Sao Paulo, Brazil.
   [Colli, Benedicto Oscar; Carlotti, Carlos Gilberto, Jr.; Assirati, Joao Alberto, Jr.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Anat, Div Neurosurg, BR-05508 Sao Paulo, Brazil.
   [Lopes, Luiza da Silva] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Anat, Div Anat, BR-05508 Sao Paulo, Brazil.
   [Lopes, Luiza da Silva] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Surg, Div Anat, BR-05508 Sao Paulo, Brazil.
   [Neder, Luciano] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pathol, BR-05508 Sao Paulo, Brazil.
   [Marques, Wilson, Jr.; Barreira, Amilton Antunes] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Neurol Psychiat & Med Psychol, BR-05508 Sao Paulo, Brazil.
   [Chimelli, Leila] Univ Fed Rio de Janeiro, Dept Pathol, Rio De Janeiro, Brazil.
RP Colli, BO (corresponding author), Campus Univ USP, Dept Cirugia HCFMRP, BR-14048900 Ribeirao Preto, SP, Brazil.
EM bocolli.@fmrp.usp.br
RI Carlotti, Carlos G/C-1608-2012; Lopes, Luiza S/H-2253-2012; Marques,
   Wilson/G-4240-2012; Colli, Benedicto/A-2833-2016; Barreira,
   Amilton/A-1159-2008
OI Carlotti, Carlos G/0000-0002-7055-0564; Lopes, Luiza
   S/0000-0001-6229-4196; Marques, Wilson/0000-0002-4589-2749; Colli,
   Benedicto/0000-0002-0222-6770; Barreira, Amilton/0000-0002-4791-223X
CR BAKCHINE S, 1987, REV NEUROL, V143, P839
   Bolton B, 1939, J NEUROL PSYCHIATRY, V2, P137, DOI 10.1136/jnnp.2.2.137
   CARPENTER MB, 1978, NEUROANATOMIA HUMANA, P567
   DALAKAS MC, 1986, ANN NEUROL, V19, P545, DOI 10.1002/ana.410190605
   DENNYBROWN D, 1948, J NEUROL NEUROSUR PS, V11, P73, DOI 10.1136/jnnp.11.2.73
   DJINDJIAN R, 1973, ENCY MED CIR PARIS
   ERHART EB, 1964, NEURANATOMIA, P313
   GRAUS F, 1988, NEUROLOGY, V38, P1637, DOI 10.1212/WNL.38.10.1637
   GRIFFIN JW, 1990, ANN NEUROL, V27, P304, DOI 10.1002/ana.410270313
   HANKEY GJ, 1987, J NEUROL NEUROSUR PS, V50, P1085, DOI 10.1136/jnnp.50.8.1085
   Houdart R, 1965, Rev Neurol (Paris), V112, P472
   HULL RG, 1984, BRIT J RHEUMATOL, V23, P301
   KENNETT RP, 1986, J NEUROL NEUROSUR PS, V49, P90, DOI 10.1136/jnnp.49.1.90
   LALOUX P, 1988, J NEUROL, V235, P352, DOI 10.1007/BF00314231
   LAZORTHES G., 1962, REV NEUROL [PARIS], V106, P535
   LOW P A, 1988, Neurology, V38, P104
   MALINOW K, 1986, ANN NEUROL, V20, P535, DOI 10.1002/ana.410200416
   MCCABE JS, 1969, ANAT REC, V164, P15, DOI 10.1002/ar.1091640102
   OSGOOD CP, 1976, J NEUROSURG, V45, P113, DOI 10.3171/jns.1976.45.1.0113
   SAH TH, 1939, ARCH NEUROL PSYCHIAT, V41, P659
   SCOVILLE WB, 1966, J NEUROSURG, V25, P94, DOI 10.3171/jns.1966.25.1.0094
   SMITH BE, 1992, PERIPHERAL NEUROPATH, P1525
   SMITH FP, 1970, J NEUROSURG, V32, P574, DOI 10.3171/jns.1970.32.5.0574
   WARWICK R, 1979, GRAY ANATOINIA, P707
   WILKINSO.PC, 1965, BRAIN, V88, P529, DOI 10.1093/brain/88.3.529
   ZULCH K J, 1954, Dtsch Z Nervenheilkd, V172, P81
   ZULCH K. J., 1962, REV NEUROL [PARIS], V106, P632
NR 27
TC 15
Z9 16
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0090-3019
J9 SURG NEUROL
JI Surg. Neurol.
PD MAR
PY 2008
VL 69
IS 3
BP 266
EP 273
DI 10.1016/j.surneu.2007.01.057
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA 275SJ
UT WOS:000254091600012
PM 17597195
DA 2020-12-08
ER

PT J
AU Peres, LC
   Saggioro, FP
   Dias, LB
   Alves, VNAF
   Brasil, RA
   Luiz, VEDD
   Neder, L
   Rosman, FC
   Fleury, RN
   Ura, S
   Orsi, AT
   Talhari, C
   Ferreira, LCDL
   Ramos, SG
   Rey, LC
   Martinez-Espinosa, FE
   Satana, FSE
   Duarte, MIS
   Lambertucci, JR
   Chimelli, LMCO
   Rosa, PS
   Belone, ADFF
AF Peres, Luiz Cesar
   Saggioro, Fabiano Pinto
   Dias, Leonidas Braga, Jr.
   Ferreira Alves, Vena Ncio Avancini
   Brasil, Roosecelis Araujo
   Dias De Barros Luiz, Veridiana Ester
   Neder, Luciano
   Rosman, Fernando Colonna
   Fleury, Raul Negrao
   Ura, Somei
   Orsi, Ana Tereza
   Talhari, Carolina
   De Lima Ferreira, Luiz Carlos
   Ramos, Simone Gusmao
   Rey, Luis Carlos
   Martinez-Espinosa, Flor E.
   De Satana Filho, Franklin Simo Es
   Duarte, Maria Irma Seixas
   Lambertucci, Jose Roberto
   Chimelli, Leila M. Cardao
   Rosa, Patricia Sammarco
   Belone, Andrea De Faria Fernandes
TI Infectious diseases in paediatric pathology: experience from a
   developing country
SO PATHOLOGY
LA English
DT Article
DE infection; tropical diseases; parasitic diseases; viral diseases; fungal
   diseases; bacterial diseases
ID CONGENITAL CHAGAS-DISEASE; HUMAN-IMMUNODEFICIENCY-VIRUS; VISCERAL
   LEISHMANIASIS; YELLOW-FEVER; CRYPTOCOCCUS-NEOFORMANS; DENGUE VIRUS;
   HUMAN-LIVER; VERTICAL TRANSMISSION; MYCOBACTERIUM-LEPRAE;
   TRYPANOSOMA-CRUZI
AB Infectious and parasitic diseases have always challenged man. Although many of them are typically seen in some areas of the world and can be adequately managed by just improving socioeconomic status and sanitary conditions, they are still quite prevalent and may sometimes be seen outside their original geographical areas. Human migration due to different reasons, tourism, blood transfusion and solid organ transplantation has created new concerns for health professionals all over the world. If not for diagnostic purposes, at least these tropical and infectious diseases should be largely known because their epidemiology, pathogenesis, host/parasite interaction, inflammatory and reparative responses are quite interesting and teach us about human biology. Curiosity is inherent to pathology practice and so we are compelled to look for things other than tumours or degenerative diseases. This review focuses on infectious and parasitic diseases found in a developing country and brings up-to-date information on diseases caused by viruses (dengue, yellow fever), bacteria (typhoid fever, leprosy), parasites (Chagas' disease, cutaneous and visceral leishmaniasis, amoebiasis, Capillaria hepatica, schistosomiasis, cysticercosis) and caused by fungi (paracoccidioidomycosis, cryptococcosis, histoplasmosis) that may be useful for pathologists when facing somewhat strange cases from developing countries.
C1 [Peres, Luiz Cesar; Ramos, Simone Gusmao] Univ Sao Paulo, Ribeirao Preto Med Sch, Sao Paulo, Brazil.
   [Saggioro, Fabiano Pinto] HCFMRP USP, Serv Death Verificat Interior, Sao Paulo, Brazil.
   [Saggioro, Fabiano Pinto] HCFMRP USP, Serv Pathol, Sao Paulo, Brazil.
   [Fleury, Raul Negrao] Para Univ, Sch Med, Dept Pathol, Belem, Para, Brazil.
   [Ferreira Alves, Vena Ncio Avancini] Univ Sao Paulo, Sch Med, Dept Pathol, Sao Paulo, Brazil.
   [Brasil, Roosecelis Araujo; Duarte, Maria Irma Seixas] Univ Sao Paulo, Sch Med, Dept Pathol, Lab Transmissible Dis, Sao Paulo, Brazil.
   [Dias De Barros Luiz, Veridiana Ester] Univ Sao Paulo, Ribeirao Preto Sch Med, Ctr Res Virol, Sao Paulo, Brazil.
   [Rosman, Fernando Colonna] Univ Fed Rio de Janeiro, Sch Med, Dept Pathol, BR-21941 Rio De Janeiro, Brazil.
   [Fleury, Raul Negrao] Univ Sao Paulo, Lauro Souza Lima Inst, Bauru, Brazil.
   [Fleury, Raul Negrao] Univ Sao Paulo, Bauru Dent Sch, Bauru, Brazil.
   [Ura, Somei] Lauro Souza Lima Inst, Div Res & Teaching, Bauru, Brazil.
   [Rey, Luis Carlos] Univ Fed Ceara, Inst Biomed, Clin Res Unit, Fortaleza, Ceara, Brazil.
   [Lambertucci, Jose Roberto] Univ Fed Minas Gerais, Trop Med, Fac Med, Belo Horizonte, MG, Brazil.
   [Chimelli, Leila M. Cardao] Univ Fed Rio de Janeiro, Dept Pathol, BR-21941 Rio De Janeiro, Brazil.
   [Rosa, Patricia Sammarco; Belone, Andrea De Faria Fernandes] Lauro Souza Lima Inst, BR-21941 Rio De Janeiro, Brazil.
RP Peres, LC (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Sao Paulo, Brazil.
RI Ramos, Simone G./C-4720-2012
OI Ramos, Simone G./0000-0002-1981-5248
CR Aguilar-Diaz H, 2006, PARASITOL INT, V55, pS127, DOI 10.1016/j.parint.2005.11.020
   Akogbeto M C, 2005, Bull Soc Pathol Exot, V98, P400
   ALJURAYYAN NAM, 1995, J TROP PEDIATRICS, V41, P143, DOI 10.1093/tropej/41.3.143
   Altcheh J, 2005, REV SOC BRAS MED TRO, V38, P41
   ANDRADE TM, 1990, J INFECT DIS, V162, P1354, DOI 10.1093/infdis/162.6.1354
   Angelis M, 2003, LIVER TRANSPLANT, V9, P451, DOI 10.1053/jlts.2003.50094
   Assis BCA, 2004, MEM I OSWALDO CRUZ, V99, P173, DOI 10.1590/S0074-02762004000200010
   BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639
   Berman JD, 1997, CLIN INFECT DIS, V24, P684, DOI 10.1093/clind/24.4.684
   BINFORD CH, 1976, PATHOLOGY TROPICAL E, P567
   BITTENCOURT AL, 1992, REV I MED TROP, V34, P403, DOI 10.1590/S0036-46651992000500006
   BITTENCOURT AL, 1976, AM J DIS CHILD, V130, P97, DOI 10.1001/archpedi.1976.02120020099020
   BITTENCOURT AL, 1995, DERMATOL TROPICA, P23
   Brochero HHL, 2007, AM J TROP MED HYG, V76, P1113, DOI 10.4269/ajtmh.2007.76.1113
   Campbell G, 2006, PARASITOL INT, V55, pS121, DOI 10.1016/j.parint.2005.11.019
   Cardoso Adriana V.N., 2006, Rev. Inst. Med. trop. S. Paulo, V48, P287, DOI 10.1590/S0036-46652006000500009
   Castro G, 2006, REV SOC BRAS MED TRO, V39, P501, DOI 10.1590/S0037-86822006000500016
   CERF BJ, 1987, J INFECT DIS, V156, P1030, DOI 10.1093/infdis/156.6.1030
   Chagas C., 1909, MEM I OSWALDO CRUZ, V1, P159, DOI DOI 10.1590/S0074-02761909000200008
   CHIMELLI L, 1992, NEUROPATH APPL NEURO, V18, P478, DOI 10.1111/j.1365-2990.1992.tb00815.x
   Claveria Florencia G, 2005, Southeast Asian J Trop Med Public Health, V36 Suppl 4, P146
   Connor D. H., 1976, Pathology of tropical and extraordinary diseases - an atlas. Volume 1., P308
   Convit Jacinto, 1997, P553
   Das CJ, 2006, PEDIATR RADIOL, V36, P877, DOI 10.1007/s00247-006-0197-z
   de Carvalho LP, 2003, MICROBES INFECT, V5, P7, DOI 10.1016/S1286-4579(02)00051-5
   DEBRITO T, 1992, PATHOL RES PRACT, V188, P177, DOI 10.1016/S0344-0338(11)81176-3
   DIAS JC, 2000, CAD SAUDE PUBLICA, V254, P3058
   Dias LB, 2007, T ROY SOC TROP MED H, V101, P831, DOI 10.1016/j.trstmh.2006.10.007
   ELHAG IA, 1994, J CLIN PATHOL, V47, P547, DOI 10.1136/jcp.47.6.547
   ELTON NW, 1955, AM J CLIN PATHOL, V25, P135
   Figueiredo LTM, 1998, AM J TROP MED HYG, V59, P357, DOI 10.4269/ajtmh.1998.59.357
   FILHO GB, 2006, BOGLIOLO PATOLOGIA, P1472
   FLEURY RN, 1997, HANSENIASE, P77
   GOUBLER DJ, 2002, TRENDS MICROBIOL, V10, P100
   Granados DP, 2005, MICROB ECOL, V49, P282, DOI 10.1007/s00248-004-0236-y
   GRAYSON W, 2005, PATHOLOGY SKIN, P929
   Groen J, 2000, CLIN DIAGN LAB IMMUN, V7, P867, DOI 10.1128/CDLI.7.6.867-871.2000
   Guzman MG, 1996, CLIN DIAGN LAB IMMUN, V3, P621
   Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2
   HALL WC, 1991, AM J TROP MED HYG, V45, P408, DOI 10.4269/ajtmh.1991.45.408
   Halstead SB, 2006, REV PANAM SALUD PUBL, V20, P407, DOI 10.1590/S1020-49892006001100007
   Harboe M, 1994, LEPROSY, P87
   Hayden RT, 2000, PEDIATR INFECT DIS J, V19, P290, DOI 10.1097/00006454-200004000-00005
   Houng HSH, 2001, J VIROL METHODS, V95, P19, DOI 10.1016/S0166-0934(01)00280-4
   Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043
   JOPLING WH, 1978, HDB LEPROSY, P66
   KAUFFMAN C, 2007, ACP MED
   Kaur R, 2002, SCAND J INFECT DIS, V34, P542, DOI 10.1080/00365540110080782
   Khasnis AA, 2005, ARCH MED RES, V36, P689, DOI 10.1016/j.arcmed.2005.03.041
   KOBERLE F, 1970, B WORLD HEALTH ORGAN, V42, P739
   KUMAR V, 2004, PATHOLOGIC BASIS DIS, pCH8
   Kwon-Chung K.J., 1992, MED MYCOL, P866
   Lambertucci JR, 2000, ACTA TROP, V77, P101, DOI 10.1016/S0001-706X(00)00124-8
   Lin XR, 2006, ANNU REV MICROBIOL, V60, P69, DOI 10.1146/annurev.micro.60.080805.142102
   LONDERO A T, 1962, Mycopathol Mycol Appl, V18, P293, DOI 10.1007/BF02051452
   Marin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296
   MARK EJ, 1984, LUNG BIOPSY INTERPRE, P50
   MARQUES A C, 1986, Memorias do Instituto Oswaldo Cruz, V81, P17, DOI 10.1590/S0074-02761986000600004
   Martens P, 2000, EMERG INFECT DIS, V6, P103, DOI 10.3201/eid0602.000202
   MEHRA V, 1984, NATURE, V308, P194, DOI 10.1038/308194a0
   Mendes EC, 2005, ARQ NEURO-PSIQUIAT, V63, P1058, DOI 10.1590/S0004-282X2005000600027
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Moncayo A, 2006, ANN TROP MED PARASIT, V100, P663, DOI 10.1179/136485906X112248
   Moreno JE, 2005, MED VET ENTOMOL, V19, P329, DOI 10.1111/j.1365-2915.2005.00572.x
   MOSER SA, 1988, DIAGNOSTIC PROCEDURE, P173
   Neafie R. C., 1976, Pathology of tropical and extraordinary diseases - an atlas. Volume 2., P402
   Newman RD, 2004, ANN INTERN MED, V141, P547, DOI 10.7326/0003-4819-141-7-200410050-00012
   Othman Norlijah, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P930
   Pappalardo Mara C.S.M., 2003, Rev. Inst. Med. trop. S. Paulo, V45, P299, DOI 10.1590/S0036-46652003000600001
   Peres LC, 2006, ARCH PATHOL LAB MED, V130, P62
   Pittella JEH, 1997, BRAIN PATHOL, V7, P681, DOI 10.1111/j.1750-3639.1997.tb01083.x
   Quaresma JAS, 2005, ACTA TROP, V94, P116, DOI 10.1016/j.actatropica.2005.03.003
   Queiroz Márcia J. A., 2004, J. Pediatr. (Rio J.), V80, P141, DOI 10.1590/S0021-75572004000200012
   REES RJW, 1985, LEPROSY, P31
   Rey Luís C., 2005, J. Pediatr. (Rio J.), V81, P73, DOI 10.1590/S0021-75572005000100014
   RIDLEY D. S., 1962, LEPROSY REV, V33, P119
   RIDLEY DS, 1989, J PATHOL, V159, P293, DOI 10.1002/path.1711590406
   RIDLEY DS, 1987, SKIN BIOPSY LEPROSY
   Rossi MA, 2003, FRONT BIOSCI-LANDMRK, V8, pE94, DOI 10.2741/948
   Sawamura R, 1999, AM J TROP MED HYG, V61, P642, DOI 10.4269/ajtmh.1999.61.642
   Schmunis GA, 2005, CLIN MICROBIOL REV, V18, P12, DOI 10.1128/CMR.18.1.12-29.2005
   Scott JX, 2005, J TROP PEDIATRICS, V51, P254, DOI 10.1093/tropej/fmi004
   SILVA CL, 1993, INT J LEPROSY, V61, P107
   Silva LCS, 2004, CLIN INFECT DIS, V39, P1618, DOI 10.1086/425611
   Sorvillo FJ, 2007, EMERG INFECT DIS, V13, P230, DOI 10.3201/eid1302.060527
   STRANO AJ, 1976, PATHOLOGY TROPICAL E, P1
   Sundar S, 2002, CLIN INFECT DIS, V35, P581, DOI 10.1086/342057
   Takayanagui OM, 2006, PARASITOL INT, V55, pS111, DOI 10.1016/j.parint.2005.11.016
   Talhari S, 1995, DERMATOL TROPICA, P23
   Teixeira ARL, 2006, POSTGRAD MED J, V82, P788, DOI 10.1136/pgmj.2006.047357
   Torrico MC, 2005, REV SOC BRAS MED TRO, V38, P58
   Velasco TR, 2006, J NEUROL NEUROSUR PS, V77, P485, DOI 10.1136/jnnp.2005.078675
   VIEIRA WT, 1983, HISTOPATHOLOGY, V7, P195, DOI 10.1111/j.1365-2559.1983.tb02235.x
   VOORHIS WCV, 2007, ACP MED
   WHO, 2002, WHO TECH REP SER, V905, P1
   *WHO, 2002, WEEKLY EPIDEMIOL REC, V77, P210
   WILCOX RA, 2007, J EUR NEUROL, V14, P350
   World Health Organization, 2003, BACKGR DOC DIAGN TRE, P38
   World Health Organization, 1997, DENG HEM FEV DIAGN T
   2006, MMWR WEEKLY, V55, P798
NR 100
TC 4
Z9 4
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0031-3025
EI 1465-3931
J9 PATHOLOGY
JI Pathology
PY 2008
VL 40
IS 2
BP 161
EP 175
DI 10.1080/00313020701816357
PG 15
WC Pathology
SC Pathology
GA 252OF
UT WOS:000252455100007
PM 18203038
DA 2020-12-08
ER

PT J
AU Dozza, DC
   Chimelli, L
   Andraus, CF
   de Oliveira, CR
   Rodrigues, FF
AF Dozza, Diego Cassol
   Chimelli, Leila
   Andraus, Cesar Fantezia
   de Oliveira, Claudio Russio
   Rodrigues, Flavio Freinkel
TI Dysembryoplastic neuroepithelial tumor clinical and diagnostic aspects
SO NEUROSURGERY QUARTERLY
LA English
DT Article
DE dysembryoplastic neuroepithelial tumor; seizures; specific glioneural
   element; cortical dysplasia
ID CORTICAL DYSPLASIA; APPEARANCE; CEREBELLUM; SEIZURES; FEATURES; MR
AB The medical charts of 162 patients who had been subjected to brain tumor surgery between 1997 and 2005 in the Institute of Neurology Deolindo Couto were reviewed. Of the 162 patients subjected to cranial intervention, 5 (3.8%) had presented criteria for the dysembryoplastic neuroepithelial tumor. Two patients had tumor in the frontal lobe, 2 in the parietal lobe, and I in the temporal area. The age at seizure onset ranged from 2 to 17 years. The average duration of active epilepsy preoperatively was 4 to 22 years. A review of the literature was carried out and the histologic and radiologic aspects were commented upon. Correct histologic diagnosis is important, because dysembryoplastic neuroepithelial tumor presents an excellent prognosis, and they can be confused with other tumors.
C1 Univ Fed Rio de Janeiro, Inst Neurol Deolindo Couto, BR-21941 Rio De Janeiro, Brazil.
RP Rodrigues, FF (corresponding author), Rua Buarque Macedo, Rio De Janeiro, Brazil.
EM dcdozza@yahoo.com.br
RI Dozza, Diego Cassol/E-7084-2014
OI Cassol Dozza, Diego/0000-0002-4364-8224
CR Cabiol J, 1999, CRIT REV NEUROSURG, V9, P116, DOI 10.1007/s003290050118
   CerveraPierot P, 1997, NEUROSURGERY, V40, P1065, DOI 10.1097/00006123-199705000-00035
   Daumas-Duport C, 1999, J NEURO-ONCOL, V41, P267, DOI 10.1023/A:1006193018140
   Daumas-Duport C, 2003, REV NEUROL-FRANCE, V159, P622
   DAUMASDUPORT C, 1993, BRAIN PATHOL, V3, P283, DOI 10.1111/j.1750-3639.1993.tb00755.x
   DAUMASDUPORT C, 1988, NEUROSURGERY, V23, P545, DOI 10.1227/00006123-198811000-00002
   Fujimoto K, 2000, J NEUROSURG, V93, P487, DOI 10.3171/jns.2000.93.3.0487
   Hammond RR, 2000, J NEUROSURG, V92, P722, DOI 10.3171/jns.2000.92.4.0722
   Hirose T, 1998, ACTA NEUROPATHOL, V95, P649, DOI 10.1007/s004010050852
   KIRKPATRICK PJ, 1993, J NEUROSURG, V78, P19, DOI 10.3171/jns.1993.78.1.0019
   KLEIHUES P, 1993, BRAIN PATHOL, V3, P255, DOI 10.1111/j.1750-3639.1993.tb00752.x
   KOELLER KK, 1992, AM J NEURORADIOL, V13, P1319
   KUCHELMEISTER K, 1995, ACTA NEUROPATHOL, V89, P385
   KUROIWA T, 1995, RADIOLOGY, V197, P233, DOI 10.1148/radiology.197.1.7568829
   Kurtkaya-Yapicier Ozlem, 2002, Brain Tumor Pathol, V19, P97, DOI 10.1007/BF02478934
   Nolan MA, 2004, NEUROLOGY, V62, P2270, DOI 10.1212/01.WNL.0000130495.69512.6F
   Ostertun B, 1996, AM J NEURORADIOL, V17, P419
   Park JY, 2003, ACTA CYTOL, V47, P624, DOI 10.1159/000326579
   Reis JJ, 2000, REV NEUROLOGIA, V30, P436
   Rushing Elisabeth J, 2003, Ann Diagn Pathol, V7, P240, DOI 10.1016/S1092-9134(03)00070-4
   Sakuta R, 2005, J CHILD NEUROL, V20, P377, DOI 10.1177/08830738050200041801
   Seo DW, 2003, J KOREAN MED SCI, V18, P559, DOI 10.3346/jkms.2003.18.4.559
   Takahashi A, 2005, SURG NEUROL, V64, P419, DOI 10.1016/j.surneu.2005.02.005
   TARATUTO AL, 1995, NEUROSURGERY, V36, P474, DOI 10.1227/00006123-199503000-00005
   Tatke M, 1998, CHILD NERV SYST, V14, P293, DOI 10.1007/s003810050229
   Whittle IR, 1999, BRIT J NEUROSURG, V13, P508, DOI 10.1080/0268869998540629
NR 26
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1050-6438
EI 1534-4916
J9 NEUROSURG QUART
JI Neurosurg. Q.
PD DEC
PY 2007
VL 17
IS 4
BP 287
EP 290
DI 10.1097/WNQ.0b013e318154b5e0
PG 4
WC Neurosciences; Surgery
SC Neurosciences & Neurology; Surgery
GA 234WR
UT WOS:000251195500006
DA 2020-12-08
ER

PT J
AU Sell, K
   Yamamoto, L
   Velloso, F
   Cerqueira, A
   Zanoteli, E
   Chimelli, L
   Kashiwagi, F
   Zatz, M
   Vainzof, M
AF Sell, K.
   Yamamoto, L.
   Velloso, F.
   Cerqueira, A.
   Zanoteli, E.
   Chimelli, L.
   Kashiwagi, F.
   Zatz, M.
   Vainzof, M.
TI Screening for mutations in the dynamin 2 gene in Brazilian patients with
   centronuclear myopathy and Charcot-Marie-Tooth neuropathy
SO NEUROMUSCULAR DISORDERS
LA English
DT Meeting Abstract
CT 12th International Congress of the World-Muscle-Society
CY OCT 17-20, 2007
CL Giardini Naxos, ITALY
SP World Muscle Soc
C1 [Sell, K.; Yamamoto, L.; Velloso, F.; Cerqueira, A.; Zatz, M.; Vainzof, M.] Univ Sao Paulo, Human Genome Res Ctr, IBUSP, Sao Paulo, Brazil.
   [Zanoteli, E.] Univ Fed Sao Paulo, Sao Paulo, Brazil.
   [Chimelli, L.] Univ Fed Rio de Janeiro, Univ Hosp, Rio De Janeiro, Brazil.
   [Kashiwagi, F.] UNESP, Sch Med, Botucatu, SP, Brazil.
RI Vainzof, Mariz/J-7150-2012; Vainzof, Mariz/Q-4787-2019; Zatz,
   Mayana/M-5338-2015; Velloso, Fernando/AAA-5262-2020
OI Vainzof, Mariz/0000-0002-2797-0782; Vainzof, Mariz/0000-0002-2797-0782;
   Zatz, Mayana/0000-0003-3970-8025; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD OCT
PY 2007
VL 17
IS 9-10
BP 880
EP 881
DI 10.1016/j.nmd.2007.06.398
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 221WL
UT WOS:000250258000399
DA 2020-12-08
ER

PT J
AU Neto, LV
   Taboada, GF
   Correa, LL
   Polo, J
   Nascimento, AF
   Chimelli, L
   Rumilla, K
   Gadelha, MR
AF Neto, L. Vieira
   Taboada, G. F.
   Correa, L. L.
   Polo, J.
   Nascimento, A. F.
   Chimelli, L.
   Rumilla, K.
   Gadelha, M. R.
TI Acromegaly secondary to growth hormone-releasing hormone secreted by an
   incidentally discovered pheochromocytoma
SO ENDOCRINE PATHOLOGY
LA English
DT Article
DE acromegaly; GHRH; pheochromocytoma
ID ISLET-CELL TUMOR; MULTIPLE ENDOCRINE NEOPLASIA; BRONCHIAL
   CARCINOID-TUMOR; SOMATOTROPH HYPERPLASIA; PITUITARY-ADENOMAS; PATIENT;
   PEPTIDE; SOMATOSTATIN; PANCREAS; MICE
AB Ectopic growth hormone-releasing hormone (GHRH)-secreting tumors are rare and cause acromegaly with somatotroph hyperplasia. We report a case of acromegaly secondary to GHRH secretion by an incidentally discovered pheochromocytoma in a normotensive patient. A 23-year-old man presented with signs and symptoms of acromegaly. Laboratory evaluation confirmed the diagnosis and magnetic resonance imaging (MRI) revealed a sellar mass which was thought to be a macro-adenoma and surgically resected. The patient was not cured and medical treatment was indicated. An abdominal ultrasound performed before initiation of medical treatment showed a solid/cystic lesion superiorly to the right kidney. An abdominal MRI confirmed an adrenal tumor. Hormonal workup of the adrenal incidentaloma revealed elevated urinary cathecolamine and total metanephrines findings strongly suggestive of a pheochromocytoma. Acromegaly was then suspected to be due to ectopic secretion of GHRH by the tumor. Patient underwent surgical resection and histopathologic examination confirmed a pheochromocytoma which stained positively for GHRH. Also, review of the pituitary specimen confirmed somatotrophic hyperplasia. Genetic analysis of the ret proto-oncogene showed no mutation. Pituitary MRI was repeated 10 months after pheochromocytoma resection and revealed a slightly enlarged pituitary and partial empty sella. The diagnosis of acromegaly caused by ectopic production of GHRH is a challenging task. A careful histopatological examination of the surgically excised pituitary tissue has a key role to arouse the suspicion and guide the investigation of a secondary cause of acromegaly.
C1 Univ Fed Rio de Janeiro, Hosp Clementino Fraga, Endocrinol Sect, BR-21941 Rio De Janeiro, Brazil.
   Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Boston, MA 02115 USA.
   Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Boston, MA 02115 USA.
   Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Dept Pathol, BR-21941 Rio De Janeiro, Brazil.
   Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA.
RP Gadelha, MR (corresponding author), R Nascimento Silva 555-101, BR-22421020 Rio De Janeiro, Brazil.
EM mgadelha@hucff.ufrj.br
CR ANDERSON RJ, 1981, CLIN ENDOCRINOL, V14, P605, DOI 10.1111/j.1365-2265.1981.tb02971.x
   ASA SL, 1984, J CLIN ENDOCR METAB, V58, P796, DOI 10.1210/jcem-58-5-796
   ASA SL, 1992, ENDOCRINOLOGY, V131, P2083, DOI 10.1210/en.131.5.2083
   BARKAN AL, 1986, J CLIN ENDOCR METAB, V63, P1057, DOI 10.1210/jcem-63-5-1057
   Baughan J, 2001, AM J SURG, V182, P185, DOI 10.1016/S0002-9610(01)00678-X
   BERGER G, 1984, CANCER, V54, P2097, DOI 10.1002/1097-0142(19841115)54:10<2097::AID-CNCR2820541009>3.0.CO;2-X
   Beuschlein F, 2000, NEW ENGL J MED, V342, P1871, DOI 10.1056/NEJM200006223422504
   Breckenridge Suzanne M, 2003, Pituitary, V6, P221, DOI 10.1023/B:PITU.0000023429.89644.7b
   CARON P, 1992, ANN ENDOCRINOL-PARIS, V53, P158
   CHNG JLC, 1985, AM J MED, V79, P135, DOI 10.1016/0002-9343(85)90559-5
   EZZAT S, 1994, J CLIN ENDOCR METAB, V78, P555, DOI 10.1210/jc.78.3.555
   FAGLIA G, 1992, ENDOCRIN METAB CLIN, V21, P575, DOI 10.1016/S0889-8529(18)30203-2
   FARHI F, 1976, ARCH PATHOL LAB MED, V100, P495
   FROHMAN LA, 1980, J CLIN INVEST, V65, P43, DOI 10.1172/JCI109658
   GERMAN W J, 1964, Clin Neurosurg, V10, P72
   Horvath E, 1999, Pituitary, V1, P169, DOI 10.1023/A:1009952930425
   IVERSEN K, 1952, ACTA MED SCAND, V142, P1, DOI 10.1111/j.0954-6820.1952.tb13837.x
   KAHN MT, 1964, JAMA-J AM MED ASSOC, V188, P74
   KODOWAKI S, 1976, SAISHIN IGAKU, V31, P1402
   LLOYD RV, 1992, AM J PATHOL, V141, P895
   Losa M, 1997, CLIN ENDOCRINOL, V47, P123, DOI 10.1046/j.1365-2265.1997.2311048.x
   Manger WM, 1977, PHEOCHROMOCYTOMA, P284
   MELMED S, 1985, NEW ENGL J MED, V312, P9, DOI 10.1056/NEJM198501033120103
   MILLER GL, 1971, ARCH INTERN MED, V127, P299, DOI 10.1001/archinte.127.2.299
   Morel O, 2004, CLIN NUCL MED, V29, P841, DOI 10.1097/00003072-200412000-00025
   MYERS JH, 1981, ARCH INTERN MED, V141, P1521, DOI 10.1001/archinte.141.11.1521
   O'Higgins N J, 1967, J Ir Med Assoc, V60, P213
   POPOVIC V, 1990, Endocrinologia Experimentalis, V24, P167
   REICHLIN S, 1991, FUNCTIONAL ENDOCRINE, P898
   Reuters VS, 2003, ENDOCRINOLOGIST, V13, P376, DOI 10.1097/01.ten.0000089860.69958.83
   ROTH KA, 1986, J CLIN ENDOCR METAB, V63, P1421, DOI 10.1210/jcem-63-6-1421
   SAITO H, 1993, ACTA ENDOCRINOL-COP, V129, P246, DOI 10.1530/acta.0.1290246
   Sanno N, 1997, J CLIN ENDOCR METAB, V82, P2731, DOI 10.1210/jc.82.8.2731
   SANO T, 1988, ENDOCR REV, V9, P357, DOI 10.1210/edrv-9-3-357
   SASAKI A, 1990, J CLIN ENDOCR METAB, V70, P996, DOI 10.1210/jcem-70-4-996
   SCHEITHAUER BW, 1984, AM J MED, V76, P605, DOI 10.1016/0002-9343(84)90284-5
   SHINTANI Y, 1995, ENDOCR J, V42, P331, DOI 10.1507/endocrj.42.331
   Sleilati Gina G, 2002, Endocr Pract, V8, P54
   Taboada Giselle F., 2005, Arq Bras Endocrinol Metab, V49, P626, DOI 10.1590/S0004-27302005000500004
   Teh BT, 1996, BRIT J SURG, V83, P1132, DOI 10.1002/bjs.1800830832
   THOMER MO, 1984, J CLIN ENDOCRINO MET, V59, P846
   THORNER MO, 1982, J CLIN INVEST, V70, P965, DOI 10.1172/JCI110708
   VANCE ML, 1985, J CLIN INVEST, V75, P1584, DOI 10.1172/JCI111864
   WILSON DM, 1984, J CLIN ENDOCR METAB, V59, P1002, DOI 10.1210/jcem-59-5-1002
   Wimalawansa SJ, 1997, CRIT REV NEUROBIOL, V11, P167, DOI 10.1615/CritRevNeurobiol.v11.i2-3.40
   ZIMMERMAN D, 1993, J CLIN ENDOCR METAB, V76, P216, DOI 10.1210/jcem.76.1.8421089
NR 46
TC 18
Z9 19
U1 0
U2 0
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1046-3976
EI 1559-0097
J9 ENDOCR PATHOL
JI Endocr. Pathol.
PD SPR
PY 2007
VL 18
IS 1
BP 46
EP 52
DI 10.1007/s12022-007-0006-8
PG 7
WC Endocrinology & Metabolism; Pathology
SC Endocrinology & Metabolism; Pathology
GA 186TV
UT WOS:000247802000008
PM 17652801
DA 2020-12-08
ER

PT J
AU Dozza, DC
   Chimelli, L
   Andraus, CF
   de Oliveira, CR
   Rodrigues, FF
AF Dozza, Diego Cassol
   Chimelli, Leila
   Andraus, Cesar Fantezia
   de Oliveira, Claudio Russia
   Rodrigues, Flavio Freinkel
TI Dysembryoplastic neuroepithelial tumors - Clinical and diagnostic
   aspects
SO NEUROSURGERY QUARTERLY
LA English
DT Article
DE dysembryoplastic neuroepithelial tumor; partial seizures; specific
   glioneural element; cortical dysplasia
ID CORTICAL DYSPLASIA; APPEARANCE; CEREBELLUM; SEIZURES; FEATURES; MR
AB The medical charts of 162 patients who had submitted to brain tumor surgery between 1997 and 2005 in the Institute of Neurology Deolindo Couto were reviewed. Of the 162 patients who had submitted to cranial intervention, 5 (3.8%) had presented criteria for the dysembryoplastic neuroepithelial tumors. Two patients had tumors in the frontal lobe, 2 in the parietal lobe, and I in the temporal area. All the patients had experienced seizures, the onset of which ranged from age 2 to 17 years. A review of the literature was carried out and the histologic and radiologic aspects were reviewed. The correct histologic diagnosis is important, because the dysembryoplastic neuroepithelial tumor has an excellent prognosis and it can be easily confused with other tumors.
C1 Univ Fed Rio de Janeiro, INDC, Rio De Janeiro, Brazil.
RP Rodrigues, FF (corresponding author), Buarque de Macedo St 14-606, BR-22220030 Rio De Janeiro, Brazil.
EM dcdozza@yahoo.com.br
RI Dozza, Diego Cassol/E-7084-2014
OI Cassol Dozza, Diego/0000-0002-4364-8224
CR Cabiol J, 1999, CRIT REV NEUROSURG, V9, P116, DOI 10.1007/s003290050118
   CerveraPierot P, 1997, NEUROSURGERY, V40, P1065, DOI 10.1097/00006123-199705000-00035
   Daumas-Duport C, 1999, J NEURO-ONCOL, V41, P267, DOI 10.1023/A:1006193018140
   Daumas-Duport C, 2003, REV NEUROL-FRANCE, V159, P622
   DAUMASDUPORT C, 1993, BRAIN PATHOL, V3, P283, DOI 10.1111/j.1750-3639.1993.tb00755.x
   DAUMASDUPORT C, 1988, NEUROSURGERY, V23, P545, DOI 10.1227/00006123-198811000-00002
   Fujimoto K, 2000, J NEUROSURG, V93, P487, DOI 10.3171/jns.2000.93.3.0487
   Hammond RR, 2000, J NEUROSURG, V92, P722, DOI 10.3171/jns.2000.92.4.0722
   Hirose T, 1998, ACTA NEUROPATHOL, V95, P649, DOI 10.1007/s004010050852
   KIRKPATRICK PJ, 1993, J NEUROSURG, V78, P19, DOI 10.3171/jns.1993.78.1.0019
   KLEIHUES P, 1993, BRAIN PATHOL, V3, P255, DOI 10.1111/j.1750-3639.1993.tb00752.x
   KOELLER KK, 1992, AM J NEURORADIOL, V13, P1319
   KUCHELMEISTER K, 1995, ACTA NEUROPATHOL, V89, P385
   KUROIWA T, 1995, RADIOLOGY, V197, P233, DOI 10.1148/radiology.197.1.7568829
   Kurtkaya-Yapicier Ozlem, 2002, Brain Tumor Pathol, V19, P97, DOI 10.1007/BF02478934
   Nolan MA, 2004, NEUROLOGY, V62, P2270, DOI 10.1212/01.WNL.0000130495.69512.6F
   Ostertun B, 1996, AM J NEURORADIOL, V17, P419
   Park JY, 2003, ACTA CYTOL, V47, P624, DOI 10.1159/000326579
   Reis JJ, 2000, REV NEUROLOGIA, V30, P436
   Rushing Elisabeth J, 2003, Ann Diagn Pathol, V7, P240, DOI 10.1016/S1092-9134(03)00070-4
   Sakuta R, 2005, J CHILD NEUROL, V20, P377, DOI 10.1177/08830738050200041801
   Seo DW, 2003, J KOREAN MED SCI, V18, P559, DOI 10.3346/jkms.2003.18.4.559
   Takahashi A, 2005, SURG NEUROL, V64, P419, DOI 10.1016/j.surneu.2005.02.005
   TARATUTO AL, 1995, NEUROSURGERY, V36, P474, DOI 10.1227/00006123-199503000-00005
   Tatke M, 1998, CHILD NERV SYST, V14, P293, DOI 10.1007/s003810050229
   Whittle IR, 1999, BRIT J NEUROSURG, V13, P508, DOI 10.1080/0268869998540629
NR 26
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1050-6438
J9 NEUROSURG QUART
JI Neurosurg. Q.
PD MAR
PY 2007
VL 17
IS 1
BP 56
EP 59
DI 10.1097/WNQ.0b013e31803299a0
PG 4
WC Neurosciences; Surgery
SC Neurosciences & Neurology; Surgery
GA 144JY
UT WOS:000244793500010
DA 2020-12-08
ER

PT J
AU Taboada, GF
   Luque, RM
   Bastos, W
   Guimares, RFC
   Marcondes, JB
   Chimelli, LMC
   Fontes, R
   Mata, PJP
   Niemeyer, P
   Carvalho, DP
   Kineman, RD
   Gadelha, MR
AF Taboada, Giselle F.
   Luque, Raul M.
   Bastos, Wildebranham
   Guimares, Renata F. C.
   Marcondes, Jorge B.
   Chimelli, Leila M. C.
   Fontes, Rosita
   Mata, Paulo J. P.
   Niemeyer Filho, Paulo
   Carvalho, Denise P.
   Kineman, Rhonda D.
   Gadelha, Monica R.
TI Quantitative analysis of somatostatin receptor subtype (SSTR1-5) gene
   expression levels in somatotropinomas and non-functioning pituitary
   adenomas
SO EUROPEAN JOURNAL OF ENDOCRINOLOGY
LA English
DT Article
ID GROWTH-HORMONE-SECRETION; CELLS IN-VITRO; TRANSSPHENOIDAL SURGERY;
   MESSENGER-RNA; ANALOGS; TUMORS; PROLACTIN; GH; THERAPY; PROLIFERATION
AB Objective: It is believed that the variable effectiveness of somatostatin analogs in post-surgical management of somatotropinomas and non-functioning pituitary adenomas (NFPA) may be due in part to variable expression of somatostatin receptor isoforms (SSTR1-5), within and between pituitary tumor types.
   Design and methods: Quantitative real-time RT-PCR was used to compare absolute mRNA copy numbers for all five SSTR isoforms in 23 somatotropinomas and 19 NFPA.
   Results: Somatostatin receptor subtype 5 mRNA was present at the highest level in somatotropinomas, followed by SSTR2 > SSTR3 >> SSTR1 >>> SSTR4. In contrast, SSTR3 mRNA was present at the highest level in NEPA, followed by SSTR2. while SSTR1, SSTR4, and SSTR5 transcripts were only detectable in select tumors. Among somatotropinomas, a positive correlation was found between SSTR2 mRNA levels and the percent decrease of GH (%GH) after 3 and 6 months of therapy with octreotide long acting repeatable (LAR) (r=0.51 and r=0.66: P=0.05 and P=0.008). Also the percent decrease of IGF-I (%IGF-I) after 3 months of octreotide LAR was negatively correlated with SSTR5 and %IGF-I after 6 months of octreotide LAR was positively correlated with SSTR2.
   Conclusions: The present report is a large series examining SSTR mRNA levels in somatotropinomas and NFPA. These initial findings suggest that detailed knowledge of the SSTR mRNA expression profile in somatotropinomas can help to predict the hormonal response to therapy with LAR. Also, it appears that SSTR3 in NFPA may be a potential target for SSTR3 preferential or universal ligands such as pasireotide.
C1 Hosp Univ Clementino Fraga Filho, Serv Endocrinol, Rio De Janeiro, Brazil.
   Hosp Univ Clementino Fraga Filho, Serv Neurochirurg, Rio De Janeiro, Brazil.
   Hosp Univ Clementino Fraga Filho, Serv Anat Patol, Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil.
   Pontificia Univ Catolica Rio de Janeiro, Serv Neurochirurg, Hosp Santa Casa Misericordia Rio De Janeiro, Rio de Janeiro, Brazil.
   Lab Diagnost Amer, Rio De Janeiro, Brazil.
   Inst Estadual Diabet & Endocrinol Luis Capriglion, Rio De Janeiro, Brazil.
   Univ Illinois, Dept Med, Sect Endocrinol & Metab, Chicago, IL USA.
   Jesse Brown VA Med Ctr, Chicago, IL USA.
RP Gadelha, MR (corresponding author), Rua Nascimento Silva,555-101, BR-22421020 Rio De Janeiro, Brazil.
EM mgadelha@hucff.ufrj.br
RI Carvalho, Denise P/H-6306-2012; Kineman, Rhonda/H-2221-2011
OI Carvalho, Denise P/0000-0001-6933-6424; Kineman,
   Rhonda/0000-0001-7322-1152; Luque, Raul M./0000-0002-7585-1913
FU NIDDK NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [DK 30677] Funding Source: Medline
CR Ahmed S, 1999, CLIN ENDOCRINOL, V50, P561
   Bevan JS, 2005, J CLIN ENDOCR METAB, V90, P1856, DOI 10.1210/jc.2004-1093
   Boerlin V, 2003, J Endocrinol Invest, V26, P14
   COMTOIS R, 1991, CANCER, V68, P860, DOI 10.1002/1097-0142(19910815)68:4<860::AID-CNCR2820680431>3.0.CO;2-4
   Corbetta S, 2001, EUR J CLIN INVEST, V31, P208, DOI 10.1046/j.1365-2362.2001.00786.x
   Cozzi R, 2003, J CLIN ENDOCR METAB, V88, P3090, DOI 10.1210/jc.2003-030110
   Danila DC, 2001, J CLIN ENDOCR METAB, V86, P2976, DOI 10.1210/jc.86.7.2976
   DEBRUIN TWA, 1992, J CLIN ENDOCR METAB, V75, P1310, DOI 10.1210/jc.75.5.1310
   Florio T, 1999, EUR J ENDOCRINOL, V141, P396, DOI 10.1530/eje.0.1410396
   Florio T, 2003, CLIN ENDOCRINOL, V59, P115, DOI 10.1046/j.1365-2265.2003.01811.x
   Freda PU, 2002, J CLIN ENDOCR METAB, V87, P3013, DOI 10.1210/jc.87.7.3013
   Gittoes NJL, 1999, QJM-MON J ASSOC PHYS, V92, P741, DOI 10.1093/qjmed/92.12.741
   Gittoes NJL, 1998, CLIN ENDOCRINOL, V48, P331
   Giustina A, 2000, J CLIN ENDOCR METAB, V85, P526, DOI 10.1210/jc.85.2.526
   GREENMAN Y, 1994, J CLIN ENDOCR METAB, V78, P398, DOI 10.1210/jc.78.2.398
   GREENMAN Y, 1994, J CLIN ENDOCR METAB, V79, P724, DOI 10.1210/jc.79.3.724
   Hannon JP, 2002, J MOL NEUROSCI, V18, P15, DOI 10.1385/JMN:18:1-2:15
   Hofland LJ, 2004, FRONT HORM RES, V32, P235
   Hofland LJ, 2004, J CLIN ENDOCR METAB, V89, P1577, DOI 10.1210/jc.2003-031344
   Jaquet P, 2000, J CLIN ENDOCR METAB, V85, P781, DOI 10.1210/jc.85.2.781
   KATZNELSON L, 1992, J CLIN ENDOCR METAB, V75, P1318, DOI 10.1210/jc.75.5.1318
   Matrone C, 2004, NEUROENDOCRINOLOGY, V79, P142, DOI 10.1159/000077272
   MILLER GM, 1995, J CLIN ENDOCR METAB, V80, P1386, DOI 10.1210/jc.80.4.1386
   Mortini P, 2005, NEUROSURGERY, V56, P1222, DOI 10.1227/01.NEU.0000159647.64275.9D
   Murabe H, 1996, J NEUROENDOCRINOL, V8, P605, DOI 10.1111/j.1365-2826.1996.tb00695.x
   Nielsen S, 2001, J ENDOCRINOL INVEST, V24, P430, DOI 10.1007/BF03351043
   Nielsen S, 1998, J CLIN ENDOCR METAB, V83, P2997, DOI 10.1210/jc.83.8.2997
   Olias G, 2004, J NEUROCHEM, V89, P1057, DOI 10.1111/j.1471-4159.2004.02402.x
   Panetta Rosemarie, 1995, Life Sciences, V56, P333
   Park WB, 2005, DIAGN MICR INFEC DIS, V51, P227, DOI 10.1016/j.diagmicrobio.2004.11.014
   Patel YC, 1999, FRONT NEUROENDOCRIN, V20, P157, DOI 10.1006/frne.1999.0183
   PLOCKINGER U, 1994, J CLIN ENDOCR METAB, V79, P1416, DOI 10.1210/jc.79.5.1416
   RAYNOR K, 1993, MOL PHARMACOL, V44, P385
   RAYNOR K, 1993, MOL PHARMACOL, V43, P838
   Ren SG, 2003, J CLIN ENDOCR METAB, V88, P4239, DOI 10.1210/jc.2003-030303
   Saveanu A, 2001, J CLIN ENDOCR METAB, V86, P140, DOI 10.1210/jc.86.1.140
   Saveanu A, 2001, EUR J ENDOCRINOL, V145, P35, DOI 10.1530/eje.0.1450035
   Sharma K, 1996, MOL ENDOCRINOL, V10, P1688, DOI 10.1210/me.10.12.1688
   Sheaves R, 1996, CLIN ENDOCRINOL, V45, P407, DOI 10.1046/j.1365-2265.1996.8370847.x
   Shimon I, 1997, J CLIN INVEST, V100, P2386, DOI 10.1172/JCI119779
   Turner HE, 1999, CLIN ENDOCRINOL, V51, P281
   van der Hoek J, 2005, CURR PHARM DESIGN, V11, P1573
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Zatelli MC, 2003, J CLIN ENDOCR METAB, V88, P2797, DOI 10.1210/jc.2002-021825
NR 44
TC 159
Z9 168
U1 1
U2 8
PU BIOSCIENTIFICA LTD
PI BRISTOL
PA EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT,
   ENGLAND
SN 0804-4643
EI 1479-683X
J9 EUR J ENDOCRINOL
JI Eur. J. Endocrinol.
PD JAN
PY 2007
VL 156
IS 1
BP 65
EP 74
DI 10.1530/eje.1.02313
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 152JK
UT WOS:000245358100008
PM 17218727
OA Bronze
DA 2020-12-08
ER

PT J
AU Faria, J
   Romao, L
   Martins, S
   Alves, T
   Mendes, FA
   de Faria, GP
   Hollanda, R
   Takiya, C
   Chimelli, L
   Morandi, V
   de Souza, JM
   Abreu, JG
   Moura, V
AF Faria, Jane
   Romao, Luciana
   Martins, Sheila
   Alves, Tercia
   Mendes, Fabio A.
   de Faria, Giselle Pinto
   Hollanda, Rosenilde
   Takiya, Christina
   Chimelli, Leila
   Morandi, Veronica
   de Souza, Jorge Marcondes
   Abreu, Jose Garcia
   Moura Neto, Vivaldo
TI Interactive properties of human glioblastoma cells with brain neurons in
   culture and neuronal modulation of glial laminin organization
SO DIFFERENTIATION
LA English
DT Article
DE glioma; neuron-glia interactions; extracellular matrix; brain tumors
ID FIBRILLARY ACIDIC PROTEIN; CENTRAL-NERVOUS-SYSTEM; HUMAN
   ASTROCYTOMA-CELLS; EXTRACELLULAR-MATRIX MOLECULES; GAP-JUNCTIONAL
   COMMUNICATION; HEPARAN-SULFATE; STEM-CELLS; REACTIVE ASTROCYTES; GENE
   PROMOTER; HUMAN GLIOMA
AB The harmonious development of the central nervous system depends on the interactions of the neuronal and glial cells. Extracellular matrix elements play important roles in these interactions, especially laminin produced by astrocytes, which has been shown to be a good substrate for neuron growth and axonal guidance. Glioblastomas are the most common subtypes of primary brain tumors and may be astrocytes in origin. As normal laminin-producing glial cells are the preferential substrate for neurons, and glial tumors have been shown to produce laminin, we questioned whether glioblastoma retained the same normal glial neuron interactive properties with respect to neuronal growth and differentiation. Then, rat neurons were co-cultured onto rat normal astrocytes or onto three human glioblastoma cell lines obtained from neurosurgery. The co-culture confirmed that human glioblastoma cells as well as astrocytes maintained the ability to support neuritogenesis, but non- neural normal or tumoral cells failed to do so. However, glioblastoma cells did not distinguish embryonic from post-natal neurons in relation to neurite pattern in the co-cultures, as normal astrocytes did. Further, the laminin organization on both normal and tumoral glial cells was altered from a. lamentous arrangement to a mixed punctuate/filamentous pattern when in co-culture with neurons. Together, these results suggest that glioblastoma cells could identify neuronal cells as partners, to support their growth and induce complex neurites, but they lost the normal glia property to distinguish neuronal age. In addition, our results show for the first time that neurons modulate the organization of astrocytes and glioblastoma laminin on the extracellular matrix.
C1 Univ Fed Rio de Janeiro, Dept Anat, BR-21949590 Rio De Janeiro, Brazil.
   Univ Estado Rio De Janeiro, Dept Biol Celular & Genet, BR-21949590 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Histol & Embriol, BR-21949590 Rio De Janeiro, Brazil.
   Univ Estado Rio De Janeiro, Hosp Clementino Fraga Filho, Serv Anat Patol, BR-21949590 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Serv Neurocirurgia, BR-21949590 Rio De Janeiro, Brazil.
RP Moura, V (corresponding author), Univ Fed Rio de Janeiro, Dept Anat, Bloco F,Sala 20, BR-21949590 Rio De Janeiro, Brazil.
EM vivaldo@anato.ufrj.br
RI Mendes, Fabio/J-6911-2015; Moura-Neto, VIVALDO/V-9913-2019; Abreu, Jose
   GR/G-6159-2010; Morandi, Veronica/C-5837-2013; Romao,
   Luciana/I-4291-2015
OI Moura-Neto, VIVALDO/0000-0002-6266-043X; Abreu, Jose
   GR/0000-0002-9875-7786; 
CR Andressen C, 2005, EUR J CELL BIOL, V84, P973, DOI 10.1016/j.ejcb.2005.09.017
   Berger F, 2004, LANCET ONCOL, V5, P511, DOI 10.1016/S1470-2045(04)01531-1
   Cavalcante LA, 2002, AN ACAD BRAS CIENC, V74, P691, DOI 10.1590/S0001-37652002000400010
   CHAMAK B, 1989, DEVELOPMENT, V106, P483
   Chintala SK, 1996, CANCER LETT, V101, P107, DOI 10.1016/0304-3835(96)04124-9
   Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R
   DECK JHN, 1978, ACTA NEUROPATHOL, V42, P183, DOI 10.1007/BF00690355
   DENISDONINI S, 1984, NATURE, V307, P641, DOI 10.1038/307641a0
   do Outeiro-Bernstein MAF, 2002, MATRIX BIOL, V21, P311, DOI 10.1016/S0945-053X(02)00010-0
   DUFFY PE, 1982, EXP CELL RES, V139, P145, DOI 10.1016/0014-4827(82)90328-7
   Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6
   ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8
   Forster E, 2002, P NATL ACAD SCI USA, V99, P13178, DOI 10.1073/pnas.202035899
   Freire E, 2004, J CELL SCI, V117, P4067, DOI 10.1242/jcs.01276
   Freire E, 2002, J CELL SCI, V115, P4867, DOI 10.1242/jcs.00173
   Freire E, 2000, J BIOL CHEM, V275, P817, DOI 10.1074/jbc.275.2.817
   FRISA PS, 1994, J NEUROSCI RES, V39, P47, DOI 10.1002/jnr.490390107
   Froes MM, 1999, P NATL ACAD SCI USA, V96, P7541, DOI 10.1073/pnas.96.13.7541
   Garcia-Abreu J, 2000, GLIA, V29, P260, DOI 10.1002/(SICI)1098-1136(20000201)29:3<260::AID-GLIA7>3.0.CO;2-I
   GARCIAABREU J, 1995, J NEUROSCI RES, V40, P471, DOI 10.1002/jnr.490400406
   GARCIAABREU J, 1995, NEUROREPORT, V6, P761, DOI 10.1097/00001756-199503270-00014
   GarciaAbreu J, 1996, GLIA, V17, P339, DOI 10.1002/(SICI)1098-1136(199608)17:4<339::AID-GLIA8>3.0.CO;2-U
   GIESE A, 1995, GLIA, V13, P64, DOI 10.1002/glia.440130108
   GIFTOCHRISTOS N, 1988, J NEUROCYTOL, V17, P385, DOI 10.1007/BF01187860
   Gomes D, 1997, ACTA NEUROPATHOL, V94, P376, DOI 10.1007/s004010050722
   Gomes FCA, 1999, GLIA, V26, P97
   Gomes FCA, 1999, BRAZ J MED BIOL RES, V32, P619, DOI 10.1590/S0100-879X1999000500016
   HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384
   HATTEN ME, 1987, J CELL BIOL, V104, P1353, DOI 10.1083/jcb.104.5.1353
   Hunter DD, 1997, MOL CELL NEUROSCI, V10, P7, DOI 10.1006/mcne.1997.0632
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   Kleihues P., 2000, PATHOLOGY GENETICS T
   LIESI P, 1990, EXPERIENTIA, V46, P900, DOI 10.1007/BF01939382
   LIESI P, 1985, EMBO J, V4, P1163, DOI 10.1002/j.1460-2075.1985.tb03755.x
   Lim DA, 1999, P NATL ACAD SCI USA, V96, P7526, DOI 10.1073/pnas.96.13.7526
   LIN RCS, 1995, NEUROBIOL DIS, V2, P79, DOI 10.1006/nbdi.1995.0008
   Ljubimova JY, 2006, FRONT BIOSCI, V11, P81, DOI 10.2741/1781
   Ljubimova JY, 2004, CANCER-AM CANCER SOC, V101, P604, DOI 10.1002/cncr.20397
   Lopes UG, 1997, J BIOL CHEM, V272, P12893, DOI 10.1074/jbc.272.20.12893
   Mallat M, 1986, Brain Res, V391, P23
   MCKEON RJ, 1991, J NEUROSCI, V11, P3398
   Mittaud P, 2002, GLIA, V37, P169, DOI 10.1002/glia.10029
   Nakayama T, 2003, NEUROSCI RES, V46, P241, DOI 10.1016/S0168-0102(03)00063-4
   NEDERGAARD M, 1994, SCIENCE, V263, P1768, DOI 10.1126/science.8134839
   NETO VM, 1983, EMBO J, V2, P1243, DOI 10.1002/j.1460-2075.1983.tb01576.x
   NETO VM, 1986, BRAIN RES, V391, P11
   NOBLE M, 1984, J NEUROSCI, V4, P1892
   PINDZOLA RR, 1993, DEV BIOL, V156, P34, DOI 10.1006/dbio.1993.1057
   Pires-Neto MA, 1998, J COMP NEUROL, V399, P176, DOI 10.1002/(SICI)1096-9861(19980921)399:2<176::AID-CNE3>3.0.CO;2-Y
   Powell SK, 1997, INT J BIOCHEM CELL B, V29, P401, DOI 10.1016/S1357-2725(96)00110-0
   RAKIC P, 1981, TRENDS NEUROSCI, V4, P184, DOI 10.1016/0166-2236(81)90060-6
   RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105
   Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167
   Rouach N, 2002, P NATL ACAD SCI USA, V99, P1023, DOI 10.1073/pnas.022257499
   Rouach N, 2000, J CELL BIOL, V149, P1513, DOI 10.1083/jcb.149.7.1513
   Russell DS, 1989, PATHOLOGY TUMORS NER
   Rutka JT, 1999, INT J DEV NEUROSCI, V17, P503, DOI 10.1016/S0736-5748(99)00049-0
   SCHIFFER D, 1997, BIOL PATHOLOGY CLIN, P155
   Siegel S., 1956, NONPARAMETRIC STAT B
   Singh SK, 2003, CANCER RES, V63, P5821
   SNOW DM, 1990, DEV BIOL, V138, P359, DOI 10.1016/0012-1606(90)90203-U
   Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a
   Sousa VD, 2004, EUR J NEUROSCI, V19, P1721, DOI 10.1111/j.1460.9568.2004.03249.x
   Spohr TCLDE, 2002, EUR J NEUROSCI, V16, P2059, DOI 10.1046/j.1460-9568.2002.02283.x
   TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123
   TRENTIN AG, 1995, NEUROREPORT, V6, P293, DOI 10.1097/00001756-199501000-00017
   ZHOU FC, 1990, DEV BRAIN RES, V55, P191, DOI 10.1016/0165-3806(90)90200-I
NR 67
TC 41
Z9 41
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0301-4681
EI 1432-0436
J9 DIFFERENTIATION
JI Differentiation
PD DEC
PY 2006
VL 74
IS 9-10
BP 562
EP 572
DI 10.1111/j.1432-0436.2006.00090.x
PG 11
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA 114HL
UT WOS:000242657200009
PM 17177853
DA 2020-12-08
ER

PT J
AU Mendonca, DMF
   Chimelli, L
   Martinez, AMB
AF Mendonca, D. M. F.
   Chimelli, L.
   Martinez, A. M. B.
TI Expression of ubiquitin and proteasome in motorneurons and astrocytes of
   spinal cords from patients with amyotrophic lateral sclerosis
SO NEUROSCIENCE LETTERS
LA English
DT Article
DE arryotrophic lateral sclerosis; neurofilament; ubiquitin; proteasome;
   immunohistochemistry
ID PROTEIN; INCLUSIONS; AGGREGATION; INHIBITION; BODIES; ALS
AB Proteasome, ubiquitin, GRAP and neurofilament were evaluated in motorneurons and astrocytes of spinal cords of ALS and control cases. ALS neurons exhibited ubiquitin positive inclusions and areas of strong immunoreaction for proteasome. Areas of proteasome stain were observed close to neurofilament positive proximal process enlargement. The percentage of neurons strongly immunoreacted, for proteasome was higher in ALS cases than in controls. Many astrocytes were positive for ubiquitin and proteasome. These results suggest that the ubiquitin-proteasome pathway is involved in the ALS pathogenesis and agree with the view that ALS is a disorder of protein aggregation that affects neurons and nonneuronal cells. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
C1 Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Histol & Embriol, Ctr Ciencias Saude, BR-21941540 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Serv Anat Patol, Hosp Univ Clementino Fraga Filho, Ctr Ciencias Saude, Rio De Janeiro, Brazil.
RP Martinez, AMB (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Histol & Embriol, Ctr Ciencias Saude, Av Brig Trompowsky S-N,Bl F, BR-21941540 Rio De Janeiro, Brazil.
EM martinez@histo.ufrj.br
RI Martinez, Ana/C-6318-2014
CR Alves-Rodrigues A, 1998, TRENDS NEUROSCI, V21, P516, DOI 10.1016/S0166-2236(98)01276-4
   Anderson CM, 2000, GLIA, V32, P1
   Barbeito LH, 2004, BRAIN RES REV, V47, P263, DOI 10.1016/j.brainresrev.2004.05.003
   BENARROCH EE, 2005, MAYO CLIN P, V80, P1238
   Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X
   Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244
   Calingasan NY, 2005, NEUROBIOL DIS, V19, P340, DOI 10.1016/j.nbd.2005.01.012
   Chung KKK, 2001, TRENDS NEUROSCI, V24, pS7, DOI 10.1016/S0166-2236(00)01998-6
   Ding QX, 2001, FREE RADICAL BIO MED, V31, P574, DOI 10.1016/S0891-5849(01)00635-9
   Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742
   Glickman MH, 2005, FEBS LETT, V579, P3214, DOI 10.1016/j.febslet.2005.04.048
   Lam YA, 2000, P NATL ACAD SCI USA, V97, P9902, DOI 10.1073/pnas.170173897
   Layfield R, 2001, NEUROPATH APPL NEURO, V27, P171, DOI 10.1046/j.1365-2990.2001.00335.x
   MATHER K, 1993, NEUROSCI LETT, V160, P13, DOI 10.1016/0304-3940(93)90905-Z
   Mendonca DMF, 2005, BRAZ J MED BIOL RES, V38, P925, DOI 10.1590/S0100-879X2005000600015
   Rao SD, 2004, TRENDS NEUROSCI, V27, P17, DOI 10.1016/j.tins.2003.11.001
   Sasaki S, 1999, ACTA NEUROPATHOL, V97, P463, DOI 10.1007/s004010051015
   SCHIFFER D, 1991, J NEUROPATH EXP NEUR, V50, P463, DOI 10.1097/00005072-199107000-00007
   SCHIFFER D, 1994, NEUROSCI LETT, V180, P21, DOI 10.1016/0304-3940(94)90904-0
   Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870
   Seilhean D, 2004, ACTA NEUROPATHOL, V108, P81, DOI 10.1007/s00401-004-0855-x
   Strong MJ, 2004, EXPERT OPIN INV DRUG, V13, P1593, DOI 10.1517/13543784.13.12.1593
   STRONG MJ, 2005, J NEUROPATHOL EXP NE, V64, P1
   van Welsem ME, 2002, ACTA NEUROPATHOL, V103, P583, DOI 10.1007/s00401-001-0507-3
   Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443
   Yang WC, 2003, NEUROLOGY, V61, P1766, DOI 10.1212/01.WNL.0000099372.75786.F8
   Zwickl P, 2002, CURR TOP MICROBIOL, V268, P23
NR 27
TC 29
Z9 29
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0304-3940
EI 1872-7972
J9 NEUROSCI LETT
JI Neurosci. Lett.
PD SEP 1
PY 2006
VL 404
IS 3
BP 315
EP 319
DI 10.1016/j.neulet.2006.06.009
PG 5
WC Neurosciences
SC Neurosciences & Neurology
GA 079GM
UT WOS:000240163800014
PM 16806703
DA 2020-12-08
ER

PT J
AU Antunes, SLG
   Chimelli, LM
   Rabello, ET
   Valentim, VC
   Corte-Real, S
   Sarno, EN
   Jardim, MR
AF Antunes, S. L. G.
   Chimelli, L. M.
   Rabello, E. T.
   Valentim, V. C.
   Corte-Real, S.
   Sarno, E. N.
   Jardim, M. R.
TI An immunohistochemical, clinical and electroneuromyographic correlative
   study of the neural markers in the neuritic form of leprosy
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE neurofilament protein; nerve growth factor receptor; S-100 protein;
   myelin basic protein; gene product 9.5; neuritic leprosy; peripheral
   neuropathy
ID HUMAN SCHWANN-CELLS; MYCOBACTERIUM-LEPRAE; CUTANEOUS LESIONS; NERVE
   DAMAGE; PGP 9.5; EXPRESSION; DIAGNOSIS; NEUROPATHY; MECHANISM; FIBER
AB The nerve biopsies of 11 patients with pure neuritic leprosy were submitted to routine diagnostic procedures and immunoperoxidase staining with antibodies against axonal (neurofilament, nerve growth factor receptor (NGFr), and protein gene product (PGP) 9.5) and Schwann cell (myelin basic protein, S-100 protein, and NGFr) markers. Two pairs of non-adjacent histological cross-sections of the peripheral nerve were removed for quantification. All the fascicles of the nerve were examined with a 10X-ocular and 40X-objective lens. The immunohistochemistry results were compared to the results of semithin section analysis and clinical and electroneuromyographic data. Neurofilament staining was reduced in 100% of the neuritic biopsies. NGFr positivity was also reduced in 81.8%, PGP staining in 100% of the affected nerves, S100 positivity in 90.9%, and myelin basic protein immunoreactivity in 90.9%. Hypoesthesia was associated with decreased NGFr (81.8%) and PGP staining (90.9%). Reduced potential amplitudes (electroneuromyographic data) were found to be associated with reduced PGP 9.5 (63.6%) and nerve fiber neurofilament staining (45.4%) by immunohistochemistry and with loss of myelinated fibers (100%) by semithin section analysis. On the other hand, the small fibers (immunoreactive dots) seen amid inflammatory cells continued to be present even after 40% of the larger myelinated fibers had disappeared. The present study shows an in-depth view of the destructive effects of leprosy upon the expression of neural markers and the integrity of nerve fiber. The association of these structural changes with the clinical and electroneuromyographic manifestations of leprosy peripheral neuropathy was also discussed.
C1 Fiocruz MS, Lab Hanseniase, BR-21045900 Rio De Janeiro, Brazil.
   Fiocruz MS, Dept Ultraestrutura & Biol Celular, BR-21045900 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Dept Pathol, Rio De Janeiro, Brazil.
RP Antunes, SLG (corresponding author), Fiocruz MS, Lab Hanseniase, Av Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
EM santunes@fiocruz.br
OI Nunes Sarno, Euzenir/0000-0003-0129-2159
CR Anand P, 2004, PROG BRAIN RES, V146, P477
   Antunes SLG, 1997, INT J LEPROSY, V65, P357
   Antunes SLG, 2003, ARQ NEURO-PSIQUIAT, V61, P346, DOI 10.1590/S0004-282X2003000300005
   BRYCESON A, 1990, LEPROSY MED TROPICS
   CARSON FL, 1973, AM J CLIN PATHOL, V59, P365
   CHESA PG, 1988, J HISTOCHEM CYTOCHEM, V36, P383, DOI 10.1177/36.4.2831267
   Chimelli L, 1997, J NEUROL, V244, P318, DOI 10.1007/s004150050094
   Dastur D K, 1970, Int J Lepr Other Mycobact Dis, V38, P30
   DEIBLER GE, 1972, PREP BIOCHEM, V2, P139, DOI 10.1080/00327487208061467
   FITE GL, 1951, ANN NY ACAD SCI, V54, P28, DOI 10.1111/j.1749-6632.1951.tb45828.x
   FRANKE FE, 1991, AM J PATHOL, V139, P67
   Girdhar B K, 1996, Indian J Lepr, V68, P35
   Hayat M.A, 1981, PRINCIPLES TECHNIQUE, V1
   JACOBS JM, 1987, J NEUROL SCI, V79, P301, DOI 10.1016/0022-510X(87)90237-1
   Jardim MR, 2005, LEPROSY REV, V76, P232
   Jardim MR, 2003, J NEUROL, V250, P806, DOI 10.1007/s00415-003-1081-5
   Kumar V, 2003, INT J LEPROSY, V71, P328, DOI 10.1489/1544-581X(2003)071&lt;0328:USOSCA&gt;2.0.CO;2
   LOWE J, 1990, J PATHOL, V161, P153, DOI 10.1002/path.1711610210
   MIKO TL, 1993, LEPROSY REV, V64, P330
   Oliveira RB, 2003, INFECT IMMUN, V71, P1427, DOI 10.1128/IAI.71.3.1427-1433.2003
   Pannikar V K, 1983, Lepr India, V55, P212
   Rambukkana A, 2002, SCIENCE, V296, P927, DOI 10.1126/science.1067631
   SANTOS AR, 1993, J MED MICROBIOL, V39, P298, DOI 10.1099/00222615-39-4-298
   Shetty VP, 1997, PERIPHERAL NERVE LEP, P79
   Spierings E, 2001, J IMMUNOL, V166, P5883, DOI 10.4049/jimmunol.166.10.5883
   STALWAR, 1992, LEPROSY REV, V63, P263
   Ustianowski AP, 2003, CURR OPIN INFECT DIS, V16, P421, DOI 10.1097/00001432-200310000-00008
   Vardhini D, 2004, INFECT GENET EVOL, V4, P21, DOI 10.1016/j.meegid.2003.11.001
NR 28
TC 21
Z9 22
U1 0
U2 2
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, 00, BRAZIL
SN 0100-879X
EI 1678-4510
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD AUG
PY 2006
VL 39
IS 8
BP 1071
EP 1081
DI 10.1590/S0100-879X2006000800010
PG 11
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA 076DJ
UT WOS:000239936900010
PM 16906282
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Mendonca, DMF
   Chimelli, L
   Martinez, AMB
AF Mendonca, DMF
   Chimelli, L
   Martinez, AMB
TI Quantitative evidence for neurofilament heavy subunit aggregation in
   motor neurons of spinal cords of patients with amyotrophic lateral
   sclerosis
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE amyotrophic lateral sclerosis; spheroids; neurofilament proteins;
   immunohistochemistry
ID PHOSPHORYLATION SITES; AXONAL SWELLINGS; PROTEINS; ACCUMULATION;
   EPITOPES; SEQUENCE; INVITRO; HEALTH; GENE
AB Amyotrophic lateral sclerosis (ALS), a neurodegenerative disease of unknown etiology, affects motor neurons leading to atrophy of skeletal muscles, paralysis and death. There is evidence for the accumulation of neurofilaments (NF) in motor neurons of the spinal cord in ALS cases. NF are major structural elements of the neuronal cytoskeleton. They play an important role in cell architecture and differentiation and in the determination and maintenance of fiber caliber. They are composed of three different polypeptides: light (NF-L), medium (NF-M) and heavy (NF-H) subunits. In the present study, we performed a morphological and quantitative immunohistochemical analysis to evaluate the accumulation of NF and the presence of each subunit in control and ALS cases. Spinal cords from patients without neurological disease and from ALS patients were obtained at autopsy. In all ALS cases there was a marked loss of motor neurons, besides atrophic neurons and preserved neurons with cytoplasmic inclusions, and extensive gliosis. In control cases, the immunoreaction in the cytoplasm of neurons was weak for phosphorylated NF-H, strong for NF-M and weak for NF-L. In ALS cases, anterior horn neurons showed intense immunoreactivity in focal regions of neuronal perikarya for all subunits, although the difference in the integrated optical density was statistically significant only for NF-H. Furthermore, we also observed dilated axons (spheroids), which were immunopositive for NF-H but negative for NF-M and NF-L. In conclusion, we present qualitative and quantitative evidence of NF-H subunit accumulation in neuronal perikarya and spheroids, which suggests a possible role of this subunit in the pathogenesis of ALS.
C1 Univ Fed Rio de Janeiro, CCS, ICB, Dept Histol & Embriol, BR-21941540 Rio de Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Ctr Ciencias Saude, Serv Anat Patol, BR-21941540 Rio de Janeiro, Brazil.
RP Martinez, AMB (corresponding author), Univ Fed Rio de Janeiro, CCS, ICB, Dept Histol & Embriol, Av Brig Trompowsky S-N,Bl F, BR-21941540 Rio de Janeiro, Brazil.
EM martinez@ufrj.br
RI Martinez, Ana/C-6318-2014
CR Ackerley S, 2000, J CELL BIOL, V150, P165, DOI 10.1083/jcb.150.1.165
   Alves-Rodrigues A, 1998, TRENDS NEUROSCI, V21, P516, DOI 10.1016/S0166-2236(98)01276-4
   Bajaj NPS, 1999, PROG NEURO-PSYCHOPH, V23, P833, DOI 10.1016/S0278-5846(99)00044-5
   Betts JC, 1997, J BIOL CHEM, V272, P12922, DOI 10.1074/jbc.272.20.12922
   Bredesen DE, 1996, NEUROLOGY, V47, pS36, DOI 10.1212/WNL.47.4_Suppl_2.36S
   CARDEN MJ, 1985, J BIOL CHEM, V260, P9805
   CARPENTER S, 1968, NEUROLOGY, V18, P841, DOI 10.1212/WNL.18.9.841
   Chen JG, 2000, J CELL SCI, V113, P3861
   Chung KKK, 2001, TRENDS NEUROSCI, V24, pS7, DOI 10.1016/S0166-2236(00)01998-6
   DELISLE MB, 1984, J NEUROL SCI, V63, P241, DOI 10.1016/0022-510X(84)90199-0
   Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514
   GEISLER N, 1981, J MOL BIOL, V151, P565, DOI 10.1016/0022-2836(81)90011-5
   GEISLER N, 1987, FEBS LETT, V221, P403, DOI 10.1016/0014-5793(87)80964-X
   HEDREEN JC, 1994, J NEUROPATH EXP NEUR, V53, P663, DOI 10.1097/00005072-199411000-00013
   Hirano A, 1996, NEUROLOGY, V47, pS63, DOI 10.1212/WNL.47.4_Suppl_2.63S
   HIROKAWA N, 1984, J CELL BIOL, V66, P351
   HOFFMAN PN, 1984, J CELL BIOL, V99, P705, DOI 10.1083/jcb.99.2.705
   INOUE S, 1997, VIDEPO MICROSCOPY
   Julien JP, 1999, CURR OPIN NEUROBIOL, V9, P554, DOI 10.1016/S0959-4388(99)00004-5
   JULIEN JP, 1982, J BIOL CHEM, V257, P467
   Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6
   Kriz J, 2000, EXP NEUROL, V163, P414, DOI 10.1006/exnr.2000.7378
   Lee MK, 1996, ANNU REV NEUROSCI, V19, P187, DOI 10.1146/annurev.ne.19.030196.001155
   Louvel E, 1997, TRENDS PHARMACOL SCI, V18, P196, DOI 10.1016/S0165-6147(97)01062-6
   Marques SA, 2003, BRAIN RES, V969, P1, DOI 10.1016/S0006-8993(02)03834-9
   MIGHELI A, 1993, LAB INVEST, V68, P185
   NAPOLITANO EW, 1987, J NEUROSCI, V7, P2590
   NIXON RA, 1994, J CELL BIOL, V126, P1031, DOI 10.1083/jcb.126.4.1031
   ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0
   Rouleau GA, 1996, ANN NEUROL, V39, P128, DOI 10.1002/ana.410390119
   Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207
   SCHLAEPFER WW, 1978, J CELL BIOL, V78, P653, DOI 10.1083/jcb.78.3.653
   SCHMIDT ML, 1987, LAB INVEST, V56, P282
   Talbot K, 2002, POSTGRAD MED J, V78, P513, DOI 10.1136/pmj.78.923.513
   TOYOSHIMA I, 1989, J NEUROL SCI, V89, P269, DOI 10.1016/0022-510X(89)90028-2
   Tsang YM, 2000, BRAIN RES, V861, P45, DOI 10.1016/S0006-8993(00)01954-5
   Xu ZS, 1996, J CELL BIOL, V133, P1061, DOI 10.1083/jcb.133.5.1061
NR 37
TC 32
Z9 34
U1 0
U2 4
PU ASSOC BRAS DIVULG CIENTIFICA
PI RIBEIRAO PRETO
PA FACULDADE MEDICINA, CASA 10, 14049 RIBEIRAO PRETO, RIBEIRAO PRETO, SP
   14049, BRAZIL
SN 0100-879X
EI 1414-431X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD JUN
PY 2005
VL 38
IS 6
BP 925
EP 933
DI 10.1590/S0100-879X2005000600015
PG 9
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA 940EA
UT WOS:000230125300015
PM 15933787
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Donangelo, I
   Marcos, HP
   Araujo, PB
   Marcondes, J
   Niemeyer, P
   Gadelha, M
   Chimelli, L
AF Donangelo, Ines
   Marcos, Heliomar Pereira
   Araujo, Paula Bruna
   Marcondes, Jorge
   Niemeyer Filho, Paulo
   Gadelha, Monica
   Chimelli, Leila
TI Expression of retinoblastoma protein in human growth hormone-secreting
   pituitary adenomas
SO ENDOCRINE PATHOLOGY
LA English
DT Article
DE acromegaly; pituitary adenoma; retinoblastoma protein; RB1 gene;
   pathogenesis
AB The retinoblastoma gene (RB1) is a tumor-suppressor gene in chromosomal region 13q14.2. Its role in the pathogenesis of pituitary tumors has not been fully clarified. Some studies have shown that losses in this chromosomal region are related to aggressive tumor behavior, although the retinoblastoma protein (pRB) is still expressed. Conversely, lack of expression of pRB was observed in one fourth of GH-secreting pituitary adenomas (GH-tumors). In order to further study the expression of pRB in GH-tumors, we evaluated this protein in 49 tumors from patients with acromegaly (20 noninvasive, 25 invasive, and 4 with no information) and 8 normal pituitaries using immunohistochemistry (IHC). Nuclear staining for pRB ranged from 0 to 90% (median 40%) in the tumors and from 40 to 80% (median 58%) in normal pituitaries. In 10 tumors (20% of total) the adenomatous cells were negative (5 cases) or had very low labeling (5 cases) for pRB. Sixty three percent (31/49) of the tumors showed staining in 10-80% of the cells and in 16% (8/49) of the cases > 80% of the adenomatous cells were positive for pRB. The expression of pRB was not different in invasive and noninvasive tumors. In conclusion, pRB is underexpressed in a subgroup of GH-tumors, and this may represent an early event in the pathogenesis of this tumor subtype.
C1 Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Endocrine Unit, BR-21941 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Pathol Unit, BR-21941 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Neurosurg Unit, BR-21941 Rio De Janeiro, Brazil.
RP Gadelha, M (corresponding author), Rua Nascimento Silva,555 Apt 101, BR-22421020 Rio De Janeiro, Brazil.
EM mgadelha@hucff.ufrj.br
CR Asa SL, 1998, J CLIN ENDOCR METAB, V83, P3210, DOI 10.1210/jc.83.9.3210
   Bai YQ, 2003, ONCOGENE, V22, P7942, DOI 10.1038/sj.onc.1206634
   Bamberger CM, 1999, EUR J ENDOCRINOL, V140, P250, DOI 10.1530/eje.0.1400250
   Bates AS, 1997, J CLIN ENDOCR METAB, V82, P818, DOI 10.1210/jc.82.3.818
   BOGGILD MD, 1994, J CLIN ENDOCR METAB, V78, P387, DOI 10.1210/jc.78.2.387
   Chen C, 2002, ONCOGENE, V21, P6567, DOI 10.1038/sj.onc.1205817
   Ching YP, 2003, J BIOL CHEM, V278, P10824, DOI 10.1074/jbc.M208310200
   CRYNS VL, 1993, J CLIN ENDOCR METAB, V77, P644, DOI 10.1210/jc.77.3.644
   Daniel DC, 2002, MICROSC RES TECHNIQ, V59, P68, DOI 10.1002/jemt.10178
   Evans CO, 2000, J ENDOCRINOL INVEST, V23, P304, DOI 10.1007/BF03343727
   Farrell WE, 1999, BRIT J CANCER, V80, P44, DOI 10.1038/sj.bjc.6690319
   Fukino K, 1999, CANCER LETT, V144, P85, DOI 10.1016/S0304-3835(99)00201-3
   GREGER V, 1994, HUM GENET, V94, P491
   Hardy J., 1979, RECENT ADV DIAGNOSIS, P375
   Herwig S, 1997, EUR J BIOCHEM, V246, P581, DOI 10.1111/j.1432-1033.1997.t01-2-00581.x
   Hinoi T, 2001, AM J PATHOL, V159, P2239, DOI 10.1016/S0002-9440(10)63074-X
   Hinton DR, 1998, CANCER LETT, V126, P209, DOI 10.1016/S0304-3835(98)00013-5
   HOSOI E, 1993, ACTA ENDOCRINOL-COP, V129, P301, DOI 10.1530/acta.0.1290301
   HU NP, 1994, ONCOGENE, V9, P1021
   IKEDA H, 1995, ENDOCR PATHOL, V6, P189, DOI 10.1007/BF02739882
   JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0
   Jin L, 1997, AM J PATHOL, V151, P509
   Johnson MC, 1999, J PEDIATR ENDOCR MET, V12, P381
   Kan Beki, 2003, Pituitary, V6, P75, DOI 10.1023/B:PITU.0000004797.89592.5e
   Kapanadze B, 1998, FEBS LETT, V426, P266, DOI 10.1016/S0014-5793(98)00357-3
   Li YF, 2003, ONCOGENE, V22, P4398, DOI 10.1038/sj.onc.1206603
   Liu Y, 1997, ONCOGENE, V15, P2463, DOI 10.1038/sj.onc.1201643
   Lloyd RV, 1997, AM J PATHOL, V150, P401
   LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665
   McCabe CJ, 2003, CLIN ENDOCRINOL, V58, P141, DOI 10.1046/j.1365-2265.2003.01598.x
   OHTANIFUJITA N, 1993, ONCOGENE, V8, P1063
   PEI L, 1995, CANCER RES, V55, P1613
   Poncin J, 1999, EUR J ENDOCRINOL, V140, P573, DOI 10.1530/eje.0.1400573
   Prezant TR, 1998, J CLIN ENDOCR METAB, V83, P1388, DOI 10.1210/jc.83.4.1388
   SAKAI T, 1991, AM J HUM GENET, V48, P880
   Schmidt MC, 1999, J PATHOL, V188, P168, DOI 10.1002/(SICI)1096-9896(199906)188:2<168::AID-PATH342>3.0.CO;2-4
   Simpson DJ, 1999, CANCER RES, V59, P1562
   Simpson DJ, 2000, CANCER RES, V60, P1211
   Sossey-Alaoui K, 2002, GENOMICS, V80, P5, DOI 10.1006/geno.2002.6792
   SPADA A, 1990, J CLIN ENDOCR METAB, V71, P1421, DOI 10.1210/jcem-71-6-1421
   Takeuchi S, 1998, J ENDOCRINOL, V157, P337, DOI 10.1677/joe.0.1570337
   Tanaka C, 1997, J CLIN ENDOCR METAB, V82, P3141, DOI 10.1210/jc.82.9.3141
   Tanaka C, 1998, J CLIN ENDOCR METAB, V83, P2631, DOI 10.1210/jc.83.8.2631
   THAKKER RV, 1993, J CLIN INVEST, V91, P2815, DOI 10.1172/JCI116524
   Wieland I, 2001, ONCOL RES, V12, P491, DOI 10.3727/096504001108747503
   Wolf S, 2001, HUM MOL GENET, V10, P1275, DOI 10.1093/hmg/10.12.1275
   WOLOSCHAK M, 1994, CANCER, V74, P693, DOI 10.1002/1097-0142(19940715)74:2<693::AID-CNCR2820740223>3.0.CO;2-P
   Yang I, 1996, EUR J ENDOCRINOL, V134, P720, DOI 10.1530/eje.0.1340720
   YOSHIMOTO K, 1993, CANCER, V72, P1386, DOI 10.1002/1097-0142(19930815)72:4<1386::AID-CNCR2820720439>3.0.CO;2-J
   Zhang X, 1999, J CLIN ENDOCR METAB, V84, P761, DOI 10.1210/jc.84.2.761
   ZHU JG, 1994, J CLIN ENDOCR METAB, V78, P922, DOI 10.1210/jc.78.4.922
   Zhuang ZP, 1997, CANCER RES, V57, P5446
NR 52
TC 14
Z9 14
U1 0
U2 0
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1046-3976
J9 ENDOCR PATHOL
JI Endocr. Pathol.
PD MAR
PY 2005
VL 16
IS 1
BP 53
EP 62
DI 10.1385/EP:16:1:053
PG 10
WC Endocrinology & Metabolism; Pathology
SC Endocrinology & Metabolism; Pathology
GA V44HF
UT WOS:000202993100008
PM 16000847
DA 2020-12-08
ER

PT J
AU Mattiello-Sverzut, AC
   Chimelli, L
   Teixeira, S
   Pierre, M
   Oliveira, L
AF Mattiello-Sverzut, AC
   Chimelli, L
   Teixeira, S
   Pierre, M
   Oliveira, L
TI Effects of chronic heart disease on skeletal muscle fiber size
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE morphometry brachial biceps; chronic heart disease; post mortem muscle;
   type 1 fiber hypertrophy; type 2 fiber hypertrophy
ID IDIOPATHIC CARDIOMYOPATHY; INHERITED DISEASE; FAILURE; ABNORMALITIES;
   BIOCHEMISTRY; HISTOLOGY; BIOPSIES; MYOPATHY; FAMILY
AB Size changes in muscle fibers of subjects with chronic heart disease (CHD) have been reported, although a consensus has not been achieved. The aims of the present study were to investigate a possible association between CHD and fiber size changes in the brachial biceps compared to subjects without heart disease. Forty-six muscle samples were obtained in autopsies of individuals (13 to 84 years) without neuromuscular disorders, 19 (10 mates and 9 females) with, and 27 (14 males and 13 females) without CHD. In all cases muscle sections were stained with hematoxylin and eosin and processed for the visualization of myofibrillar AT]Pase activity. The lesser diameter of type I and type 2 fibers was obtained tracing their outlines (at least 150 fibers of each type per sample) onto an image analyzer connected to a computer. The results were analyzed statistically comparing males and females with and without CHID. Type I fiber mean lesser diameters were 51.51 and 54.52 mum in males (normal range 34-71 mum) and 45.65 and 55.42 mum in females (normal range 34-65 mum) without and with CHID, respectively; type 2 fibers measured 54.31, 58.23, 41.15, and 49.57 mum, respectively (normal range 36-79 mum for males and 32-59 mum for females). No significant difference in fiber size was detected in 24 males with and without CHD, while in 22 females there was a significant increase in size in those with cardiomyopathy. We concluded that CHD does not determine significant changes in fiber size. However, in females, there is some hypertrophy which, despite within normal range, may reflect morphologic heterogeneity of the sample, or the daily life activities in the upper limbs as a compensatory mechanism to fatigability that affect predominantly the lower limbs in subjects with CHD.
C1 Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biomecan Med & Reabilitacao Aparelho Locomot, Ribeirao Preto, Brazil.
   Univ Fed Rio de Janeiro, Fac Med, Dept Pathol, Rio De Janeiro, Brazil.
   Univ Fed Sao Carlos, Dept Estatist, BR-13560 Sao Carlos, SP, Brazil.
RP Chimelli, L (corresponding author), UFRJ, Univ Hosp, Serv Anat Patol, BR-21941590 Rio De Janeiro, Brazil.
EM chimelli@hucff.ufrj.br
RI Teixeira, Silvia A/F-3228-2014; Teixeira, Silvia/C-7181-2017;
   Mattiello-Sverzut, Ana Claudia/F-5955-2013
OI Teixeira, Silvia A/0000-0002-2462-8535; Teixeira,
   Silvia/0000-0002-2462-8535; Mattiello-Sverzut, Ana
   Claudia/0000-0002-4181-0718
CR BROOKE MH, 1969, NEUROLOGY, V19, P221, DOI 10.1212/WNL.19.3.221
   BRUNOTTE F, 1995, ACTA PHYSIOL SCAND, V154, P439, DOI 10.1111/j.1748-1716.1995.tb09929.x
   BULLER NP, 1991, BRIT HEART J, V65, P20
   CAFORIO ALP, 1989, J AM COLL CARDIOL, V14, P1464, DOI 10.1016/0735-1097(89)90383-5
   Delp MD, 1997, J APPL PHYSIOL, V83, P1291
   DUNNIGAN A, 1987, J AM COLL CARDIOL, V10, P608, DOI 10.1016/S0735-1097(87)80204-8
   DUNNIGAN A, 1984, AM J CARDIOL, V53, P731, DOI 10.1016/0002-9149(84)90395-3
   HOOTSMANS WJ, 1971, NEUROLOGY, V21, P810, DOI 10.1212/WNL.21.8.810
   HOWELL S, 1995, J APPL PHYSIOL, V79, P389
   ISAACS H, 1975, AM HEART J, V90, P767, DOI 10.1016/0002-8703(75)90467-6
   JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3
   LOCHNER A, 1981, S AFR MED J, V59, P453
   MANCINI DM, 1989, CIRCULATION, V80, P1338, DOI 10.1161/01.CIR.80.5.1338
   Mattiello-Sverzut AC, 2003, ARQ NEURO-PSIQUIAT, V61, P555, DOI 10.1590/S0004-282X2003000400006
   PRZYBOJEWSKI JZ, 1981, S AFR MED J, V59, P363
   SABBAH HN, 1993, CIRCULATION, V87, P1729, DOI 10.1161/01.CIR.87.5.1729
   SHAFIQ SA, 1972, J NEUROL SCI, V15, P303, DOI 10.1016/0022-510X(72)90072-X
   SHOREY CD, 1988, ACTA ANAT, V131, P30
   SMITH ER, 1976, ANN INTERN MED, V85, P566, DOI 10.7326/0003-4819-85-5-566
   SULLIVAN MJ, 1990, CIRCULATION, V81, P518, DOI 10.1161/01.CIR.81.2.518
NR 20
TC 1
Z9 2
U1 0
U2 2
PU ASSOC BRAS DIVULG CIENTIFICA
PI RIBEIRAO PRETO
PA FACULDADE MEDICINA, CASA 10, 14049 RIBEIRAO PRETO, RIBEIRAO PRETO, SP
   14049, BRAZIL
SN 0100-879X
EI 1414-431X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD FEB
PY 2005
VL 38
IS 2
BP 303
EP 307
DI 10.1590/S0100-879X2005000200019
PG 5
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA 904FG
UT WOS:000227480900019
PM 15785842
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Elias, J
   dos Santos, AC
   Carlotti, CG
   Colli, BO
   Canheu, A
   Matias, C
   Furlanetti, L
   Martinez, R
   Takayanagui, OM
   Sakamoto, AC
   Serafini, LN
   Chimelli, L
AF Elias, J
   dos Santos, AC
   Carlotti, CG
   Colli, BO
   Canheu, A
   Matias, C
   Furlanetti, L
   Martinez, R
   Takayanagui, OM
   Sakamoto, AC
   Serafini, LN
   Chimelli, L
TI Central nervous system paracoccidioidomycosis: diagnosis and treatment
SO SURGICAL NEUROLOGY
LA English
DT Article
DE paracoccidioidomycosis; imported mycosis; central nervous system;
   anti-fungal treatment; Paracoccidioides brasiliensis
ID SOUTH-AMERICAN BLASTOMYCOSIS; IMPORTED PARACOCCIDIOIDOMYCOSIS;
   INVOLVEMENT
AB Background: Paracoccidioidomycosis (PCM) is a systemic mycosis caused by Paracoccidioides brasiliensis. The involvement of the central nervous system (CNS) in paracoccidioidomycosis is higher than previously thought and 2 clinical presentations have been reported, meningitis and pseudotumoral.
   Methods: Twenty medical records of patients with CNS paracoccidioidomycosis treated from 1986 to 2003 were analyzed. The follow-up ranged from 1 to 18 years (mean = 8.9 +/- 4.2).
   Results: Besides CNS paracoccidioidomycosis, all patients but one had the chronic systemic form and the pseudotumoral clinical presentation was the most frequent. Based on computed tomography scan findings, 4 image patterns were identified: low-density lesion with ring enhancement, lesion with calcification and ring enhancement, multiloculated low-density lesion with ring enhancement, and diffuse subarachnoid enhancement. The magnetic resonance imaging was performed in 3 patients and showed subarachnoid enhancement in I patient and heterogeneous lesion with ring enhancement in 2 patients. Eleven patients were submitted to medical treatment and 9 needed neurosurgical treatment; ventriculoperitoneal shunts in 4 patients, brain lesions resection in 3 patients, and partial resection of spinal cord lesions in 2 patients. Eleven patients had excellent outcome, 4 patients died, 3 are in good clinical condition with residual pulmonary dysfunction, and 1 patient was lost to follow-up.
   Conclusions: The diagnosis of paracoccidioidomycosis with involvement of the CNS is difficult and clinical suspicion is a key point to achieve the correct diagnosis. Patients with early diagnosis have a favorable outcome with clinical or surgical treatment.
C1 Univ Sao Paulo, Ribeirao Preto Med Sch, Hosp Clin, Dept Internal Med,Div Imaging, BR-14048900 Ribeirao Preto, SP, Brazil.
   Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Surg, Hosp Clin,Div Neurosurg, BR-14048900 Ribeirao Preto, SP, Brazil.
   Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Internal Med, Div Infect Dis, BR-14048900 Ribeirao Preto, SP, Brazil.
   Univ Sao Paulo, Ribeirao Preto Med Sch, Hosp Clin, Dept Neurol Psychol & Psychiat,Div Neurol, BR-14048900 Ribeirao Preto, SP, Brazil.
   Univ Sao Paulo, Ribeirao Preto Med Sch, Hosp Clin, Dept Pathol, BR-14048900 Ribeirao Preto, SP, Brazil.
   Univ Fed Rio de Janeiro, Sch Med, Dept Pathol, BR-21941590 Rio De Janeiro, RJ, Brazil.
RP Carlotti, CG (corresponding author), Univ Sao Paulo, Dept Cirurgia, Campus Univ, BR-14048900 Ribeirao Preto, SP, Brazil.
EM carlotti@fmrp.usp.br
RI Sakamoto, Americo C/H-5311-2012; Junior, Jorge Elias/A-6683-2008;
   Furlanetti, Luciano/AAC-7039-2019; Colli, Benedicto/A-2833-2016;
   Carlotti, Carlos G/C-1608-2012; Takayanagui, Osvaldo M/C-8159-2013;
   Santos, Antonio/F-5419-2012
OI Junior, Jorge Elias/0000-0002-1158-1045; Furlanetti,
   Luciano/0000-0003-0981-1179; Colli, Benedicto/0000-0002-0222-6770;
   Carlotti, Carlos G/0000-0002-7055-0564; Takayanagui, Osvaldo
   M/0000-0002-8190-0275; 
CR Ajello L, 1985, Eur J Epidemiol, V1, P160, DOI 10.1007/BF00234089
   ARAUJO JC, 1978, J NEUROSURG, V49, P425, DOI 10.3171/jns.1978.49.3.0425
   ARGOLLO A, 1978, T ROY SOC TROP MED H, V72, P37, DOI 10.1016/0035-9203(78)90296-1
   Benoldi D, 1985, Eur J Epidemiol, V1, P150, DOI 10.1007/BF00141809
   Borges-Walmsley MI, 2002, TRENDS MICROBIOL, V10, P80, DOI 10.1016/S0966-842X(01)02292-2
   BRAUNINGER W, 1985, HAUTARZT, V36, P408
   Colli BO, 1996, ARQ NEURO-PSIQUIAT, V54, P466, DOI 10.1590/S0004-282X1996000300017
   DANTAS AM, 1990, AM J TROP MED HYG, V43, P386, DOI 10.4269/ajtmh.1990.43.386
   de Almeida SM, 2002, AM J CLIN PATHOL, V118, P864, DOI 10.1092/UB6VWQKDFJKQKW14
   de Almeida SM, 2004, J INFECTION, V48, P193, DOI 10.1016/j.jinf.2003.08.012
   Duarte A L, 1999, Rev Soc Bras Med Trop, V32, P439, DOI 10.1590/S0037-86821999000400015
   Finamor LP, 2002, AM J OPHTHALMOL, V134, P456, DOI 10.1016/S0002-9394(02)01574-X
   Franco M, 1987, Rev Soc Bras Med Trop, V20, P129, DOI 10.1590/S0037-86821987000200012
   Fujio J, 1999, Nihon Ishinkin Gakkai Zasshi, V40, P103
   Gasparetto EL, 2003, J COMPUT ASSIST TOMO, V27, P12, DOI 10.1097/00004728-200301000-00003
   Ginarte M, 2003, MYCOSES, V46, P407, DOI 10.1046/j.0933-7407.2003.00914.x
   Horre R, 2002, MED MYCOL, V40, P213, DOI 10.1080/mmy.40.2.213.216
   Hutzler R U, 1985, Rev Paul Med, V103, P243
   Kamei Katsuhiko, 2003, Journal of Infection and Chemotherapy, V9, P16, DOI 10.1007/s10156-002-0217-3
   KRIVOY S, 1978, J NEUROSURG, V49, P429, DOI 10.3171/jns.1978.49.3.0429
   Lambertucci J R, 2001, Rev Soc Bras Med Trop, V34, P395, DOI 10.1590/S0037-86822001000400016
   Lorenzoni PJ, 2002, ARQ NEURO-PSIQUIAT, V60, P1015, DOI 10.1590/S0004-282X2002000600025
   Magalhaes A C, 1993, Rev Hosp Clin Fac Med Sao Paulo, V48, P94
   Magalhaes A C, 1993, J Neuroimaging, V3, P216
   Maluf Márcia Luzia Ferrarezi, 2003, Rev. Soc. Bras. Med. Trop., V36, P11, DOI 10.1590/S0037-86822003000100003
   Marchiori E, 1989, Arq Neuropsiquiatr, V47, P224
   MINGUETTI G, 1983, ARCH NEUROL-CHICAGO, V40, P100, DOI 10.1001/archneur.1983.04050020062013
   Miyaji Makoto, 2003, Journal of Infection and Chemotherapy, V9, P107
   MORATO-FERNANDEZ R N, 1991, Arquivos de Neuro-Psiquiatria, V49, P192
   MOURA LP, 1984, ARQ NEURO-PSIQUIAT, V52, P82
   PEDRO R D J, 1980, Revista do Instituto de Medicina Tropical de Sao Paulo, V22, P269
   PLA MDP, 1994, MYCOPATHOLOGIA, V127, P139, DOI 10.1007/BF01102913
   Rodacki MA, 1995, NEURORADIOLOGY, V37, P636, DOI 10.1007/BF00593377
   San-Blas G, 2002, MED MYCOL, V40, P225, DOI 10.1080/mmy.40.3.225.242
   Sano A, 2001, Nihon Ishinkin Gakkai Zasshi, V42, P23
   SILVA CEA, 2000, ARQ NEURO-PSIQUIAT, V58, P741
   Teive H, 2000, ARQ NEURO-PSIQUIAT, V58, P1160
   TEIVE HAG, 1991, J ROY SOC MED, V84, P562
   Villa Luis A., 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P231, DOI 10.1590/S0036-46652000000400009
NR 39
TC 27
Z9 29
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0090-3019
J9 SURG NEUROL
JI Surg. Neurol.
PY 2005
VL 63
SU 1
BP 13
EP 21
DI 10.1016/j.surneu.2004.09.019
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA 898FB
UT WOS:000227060500003
DA 2020-12-08
ER

PT J
AU Pinto, LW
   Chimelli, L
AF Pinto, LW
   Chimelli, L
TI Oligodendroglial and neuronal component in glioblastomas: possible
   relation with prognosis
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Portuguese
DT Article
DE glioblastomas; oligodendroglial component; glioneuronal tumors;
   prognosis
ID PLEOMORPHIC XANTHOASTROCYTOMA; BRAIN-TUMORS; GLIOMAS; CLASSIFICATION;
   EXPRESSION; SURVIVAL; MULTIFORME; ANTIGENS
AB Glioblastomas are high grade astrocytic tumors and current histology criteria does not explain the longer survival in some cases. Presence of oligodendroglial component has been suggested as possible marker for better outcome by the international WHO Working Group of experts and by the proponents of the Sainte-Anne Hospital Classification (2000). The latter also states that a neuronal component is associated with better survival. The aim of this study was to analyze a series of 40 patients with tumors classified as glioblastomas based on the WHO criteria, in order to identify: the presence of an oligodendroglial component, using morphologic criteria; the presence of a neuronal component, using immunohistochemical markers (antibodies anti-neurofilament and synaptofisin). The histological and immunohistochemical findings were correlated with patients' survival and other variables of possible prognostic significance were also studied. Oligodendroglial component was identified in 11 cases and neuronal component in 7. Despite the small number of patients studied, this review detected a longer survival in patients with oligodendroglial component. The significance of expression of neuronal markers in malignant gliomas is still to be confirmed, with the evaluation of larger series.
C1 UFRJ, Fac Med, Dept Patol, BR-21941590 Rio De Janeiro, Brazil.
RP Chimelli, L (corresponding author), UFRJ, Univ Hosp, Serv Anat Patol, Ilha Fundao, BR-21941590 Rio De Janeiro, Brazil.
EM chimelli@hucff.ufrj.br
CR Azzarelli B, 2004, J NEUROPATH EXP NEUR, V63, P170, DOI 10.1093/jnen/63.2.170
   Boiardi A, 1997, J NEURO-ONCOL, V34, P179, DOI 10.1023/A:1005705624858
   BURGER PC, 1980, CANCER, V46, P1179, DOI 10.1002/1097-0142(19800901)46:5<1179::AID-CNCR2820460517>3.0.CO;2-0
   BURGER PC, 1987, CANCER, V59, P1617, DOI 10.1002/1097-0142(19870501)59:9<1617::AID-CNCR2820590916>3.0.CO;2-X
   Coons SW, 1997, CANCER, V79, P1381, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W
   COSGROVE M, 1989, AM J SURG PATHOL, V13, P141, DOI 10.1097/00000478-198902000-00007
   Daumas-Duport C, 2000, ANN PATHOL, V20, P413
   FRANKE FE, 1991, AM J PATHOL, V139, P67
   Giannini C, 2002, AM J SURG PATHOL, V26, P479, DOI 10.1097/00000478-200204000-00010
   He J, 2001, J NEUROPATH EXP NEUR, V60, P863, DOI 10.1093/jnen/60.9.863
   HIRATO J, 1994, CLIN NEUROPATHOL, V13, P1
   Ino Y, 2000, J NEUROSURG, V92, P983, DOI 10.3171/jns.2000.92.6.0983
   Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215
   KLEIHUES P, 2000, PATHOLOGY GENETICS T, P29
   Kraus JA, 2001, ACTA NEUROPATHOL, V101, P311
   Martinez-Diaz H, 2003, ARCH PATHOL LAB MED, V127, P1187
   WEIR B, 1973, J NEUROSURG, V38, P448, DOI 10.3171/jns.1973.38.4.0448
   Wharton SB, 1998, NEUROPATH APPL NEURO, V24, P302
   Wolf HK, 1997, ACTA NEUROPATHOL, V94, P436, DOI 10.1007/s004010050730
   YOKOO H, 2003, 15 INT C NEUR TOR LI, P145
NR 20
TC 4
Z9 4
U1 0
U2 0
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD DEC
PY 2004
VL 62
IS 4
BP 1074
EP 1078
DI 10.1590/S0004-282X2004000600026
PG 5
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 879GQ
UT WOS:000225704800026
PM 15608972
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Neder, L
   Colli, BO
   Machado, HR
   Carlotti, CG
   Santos, AC
   Chimelli, L
AF Neder, L
   Colli, BO
   Machado, HR
   Carlotti, CG
   Santos, AC
   Chimelli, L
TI MIB-1 labeling index in astrocytic tumors a clinicopathologic study
SO CLINICAL NEUROPATHOLOGY
LA English
DT Article
DE astrocytic tumors; MIB-1; survival; proliferative potential
ID MONOCLONAL-ANTIBODY KI-67; GROWTH-FACTOR RECEPTOR; LOW-GRADE
   ASTROCYTOMAS; CELL NUCLEAR ANTIGEN; BRAIN-TUMORS; PROGNOSTIC FACTORS;
   SURGICAL RESECTION; RADIATION-THERAPY; SUPRATENTORIAL ASTROCYTOMAS;
   GLIOBLASTOMA-MULTIFORME
AB Background: Although neuroimage and surgical techniques have improved substantially, the prognosis of patients with astrocytic tumors remains unchanged. The purpose of this study was to evaluate the proliferative activity in astrocytic tumors in different grades of malignancy and correlate it to other clinical features. Patients and methods: From archival paraffin-embedded surgical specimens of 40 patients of the Ribeirao Preto Medical School with World Health Organization grade II (n = 10), grade III (n = 5) and grade IV astrocytomas (n = 25), the MIB-1 labeling index (LI) was determined using at least a half of the blocks per case. The results were correlated to the biological behavior of the tumors. The aims of this study were to determine the level of MIB-1 LI values (cut-off) that reflect differences in biological behavior of these tumors, the impact on survival of clinical features such as age, tumor location or extension of surgical removal as well as the adjuvant therapy. Results and conclusions: As expected, a wide range of MIB-1 LI values was disclosed (mean of 2.35% in grade II astrocytomas to 12.28% in glioblastomas). A close relationship was found between MIB-1 LI and survival of patients with astrocytomas according to the histological grade. All but I recurrent tumor presented higher MIB-1 LI in the second biopsy, and the mean MIB-1 LI of the patients who died in the immediate postoperative period (n = 7) was higher in comparison to the MIB-1 LI of the respective grade. Postoperative radiation therapy was an important factor that affected the survival of patients with high-grade astrocytomas (p = 0.006). MIB-1 LI cut-off of 3% divided the astrocytomas in 2 groups with significantly different survival (p < 0.001): median survival time of 12 months (low-grade) versus 45 months (high-grade). On the other hand, univariate analysis did not show any correlation between survival and extension of surgical resection (radical versus partial), tumor's location or patient's age at surgery.
C1 Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pathol, BR-05508 Sao Paulo, Brazil.
   Fac Med Ribeirao Preto, Dept Patol, BR-14049900 Ribeirao Preto, Brazil.
   Univ Sao Paulo, Clin Hosp, Ribeirao Preto Med Sch, Div Neurosurg, Ribeirao Preto, Brazil.
   Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Internal Med, Div Image, BR-14049 Ribeirao Preto, SP, Brazil.
   Univ Fed Rio de Janeiro, Dept Pathol, Rio De Janeiro, Brazil.
RP Neder, L (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pathol, BR-05508 Sao Paulo, Brazil.
EM neder@fmrp.usp.br
RI Carlotti, Carlos G/C-1608-2012; Santos, Antonio/F-5419-2012; Machado,
   Helio R/I-6602-2012; Colli, Benedicto/A-2833-2016
OI Carlotti, Carlos G/0000-0002-7055-0564; Colli,
   Benedicto/0000-0002-0222-6770; Machado, Helio/0000-0002-1069-7804
CR Buckner JC, 2001, CANCER-AM CANCER SOC, V92, P420, DOI 10.1002/1097-0142(20010715)92:2<420::AID-CNCR1338>3.0.CO;2-3
   BURGER PC, 1988, MODERN PATHOL, V1, P493
   Coons SW, 1997, NEUROSURGERY, V41, P878, DOI 10.1097/00006123-199710000-00021
   COONS SW, 1993, J NEUROPATH EXP NEUR, V52, P609, DOI 10.1097/00005072-199311000-00008
   Croteau D, 2001, Curr Treat Options Oncol, V2, P507, DOI 10.1007/s11864-001-0072-y
   Cunningham JM, 1997, J NEUROSURG, V86, P121, DOI 10.3171/jns.1997.86.1.0121
   DECKERT M, 1989, J CANCER RES CLIN, V115, P179, DOI 10.1007/BF00397921
   Di X, 1997, J EXP CLIN CANC RES, V16, P153
   Dirven CMF, 1998, J NEURO-ONCOL, V37, P9, DOI 10.1023/A:1005905009449
   GANJU V, 1994, CANCER-AM CANCER SOC, V74, P920, DOI 10.1002/1097-0142(19940801)74:3<920::AID-CNCR2820740320>3.0.CO;2-4
   GERDES J, 1992, J PATHOL, V168, P85, DOI 10.1002/path.1711680114
   GERDES J, 1991, AM J PATHOL, V138, P867
   GIANGASPERO F, 1987, ACTA NEUROPATHOL, V74, P179, DOI 10.1007/BF00692849
   Giannini C, 1999, J NEUROPATH EXP NEUR, V58, P46, DOI 10.1097/00005072-199901000-00006
   Herfarth KK, 2001, SEMIN SURG ONCOL, V20, P13, DOI 10.1002/ssu.1012
   Ho DM, 1998, CANCER, V82, P2459, DOI 10.1002/(SICI)1097-0142(19980615)82:12<2459::AID-CNCR21>3.0.CO;2-N
   Hsu DW, 1997, J NEUROPATH EXP NEUR, V56, P857, DOI 10.1097/00005072-199708000-00003
   JAROS E, 1992, BRIT J CANCER, V66, P373, DOI 10.1038/bjc.1992.273
   Khalid H, 1997, CANCER, V80, P2133, DOI 10.1002/(SICI)1097-0142(19971201)80:11<2133::AID-CNCR13>3.0.CO;2-#
   Kleihues P, 2000, PATHOLOGY GENETICS T, P6
   Kowalczuk A, 1997, NEUROSURGERY, V41, P1028, DOI 10.1097/00006123-199711000-00004
   KRETH FW, 1993, J NEUROSURG, V78, P762, DOI 10.3171/jns.1993.78.5.0762
   Lote K, 1997, J CLIN ONCOL, V15, P3129, DOI 10.1200/JCO.1997.15.9.3129
   LOUIS DN, 1991, ACTA NEUROPATHOL, V81, P675, DOI 10.1007/BF00296379
   MARUNO M, 1991, J NEUROSURG, V75, P97, DOI 10.3171/jns.1991.75.1.0097
   McKeever PE, 1997, J NEUROPATH EXP NEUR, V56, P798
   McKeever PE, 1998, J NEUROPATH EXP NEUR, V57, P931, DOI 10.1097/00005072-199810000-00005
   MONTINE TJ, 1994, NEUROSURGERY, V34, P674, DOI 10.1227/00006123-199404000-00016
   MORIMURA T, 1991, J NEURO-ONCOL, V10, P1, DOI 10.1007/BF00151242
   Nakamura M, 2000, ONCOLOGY-BASEL, V58, P108, DOI 10.1159/000012087
   Nicolato A, 1995, SURG NEUROL, V44, P208, DOI 10.1016/0090-3019(95)00184-0
   ONDA K, 1994, CANCER, V74, P1921, DOI 10.1002/1097-0142(19941001)74:7<1921::AID-CNCR2820740716>3.0.CO;2-9
   OSTERTAG CB, 1987, ACTA NEUROCHIR, V89, P117, DOI 10.1007/BF01560376
   PIGOTT T J D, 1991, British Journal of Neurosurgery, V5, P61, DOI 10.3109/02688699108998448
   SALLINEN PK, 1994, J PATHOL, V174, P275, DOI 10.1002/path.1711740407
   SALMON I, 1994, J NEUROSURG, V80, P877, DOI 10.3171/jns.1994.80.5.0877
   Salvati M, 1998, J NEURO-ONCOL, V36, P61, DOI 10.1023/A:1017926603341
   SCHONK DM, 1989, HUM GENET, V83, P297, DOI 10.1007/BF00285178
   Schuurman PR, 1997, ACTA NEUROCHIR, V139, P2, DOI 10.1007/BF01850860
   SIMPSON JR, 1993, INT J RADIAT ONCOL, V26, P239, DOI 10.1016/0360-3016(93)90203-8
   SNEED PK, 1995, NEUROSURGERY, V36, P898, DOI 10.1227/00006123-199505000-00002
   Tihan T, 2000, ARCH PATHOL LAB MED, V124, P108
   TORP SH, 1992, ACTA NEUROCHIR, V117, P182, DOI 10.1007/BF01400618
   Torp SH, 2002, PATHOL RES PRACT, V198, P261
   Torp SH, 2002, CLIN NEUROPATHOL, V21, P252
   Torp SH, 1997, J CLIN PATHOL-MOL PA, V50, P198, DOI 10.1136/mp.50.4.198
   VECHT CJ, 1990, J NEUROL NEUROSUR PS, V53, P466, DOI 10.1136/jnnp.53.6.466
   Wakimoto H, 1996, CANCER-AM CANCER SOC, V77, P373, DOI 10.1002/(SICI)1097-0142(19960115)77:2<373::AID-CNCR21>3.0.CO;2-Y
   ZUBER P, 1988, NEUROSURGERY, V22, P364, DOI 10.1227/00006123-198802000-00015
NR 49
TC 32
Z9 37
U1 0
U2 0
PU DUSTRI-VERLAG DR KARL FEISTLE
PI DEISENHOFEN-MUENCHEN
PA BAHNHOFSTRASSE 9 POSTFACH 49, D-82032 DEISENHOFEN-MUENCHEN, GERMANY
SN 0722-5091
J9 CLIN NEUROPATHOL
JI Clin. Neuropathol.
PD NOV-DEC
PY 2004
VL 23
IS 6
BP 262
EP 270
PG 9
WC Clinical Neurology; Pathology
SC Neurosciences & Neurology; Pathology
GA 875FM
UT WOS:000225405700002
PM 15584210
DA 2020-12-08
ER

PT J
AU Guerreiro, NE
   Colli, BO
   Carlotti, CG
   Chimelli, L
AF Guerreiro, NE
   Colli, BO
   Carlotti, CG
   Chimelli, L
TI Experimental microaneurysms in rats: I. Model for induction
SO SURGICAL NEUROLOGY
LA English
DT Article
DE experimental microaneurysms; mechanical trauma; aorta bifurcation; rats
ID INDUCED CEREBRAL ANEURYSMS; SACCULAR ANEURYSMS; SUBARACHNOID HEMORRHAGE;
   INTRACRANIAL ANEURYSMS; ANIMAL-MODEL; DISEASE; RUPTURE; GROWTH
AB BACKGROUND Small aneurysms (lesser than 2 mm) in humans called sessile, baby aneurysms, or microaneurysms, generally are not able to be clipped or to be coil-packed through endovascular route. Among the modalities of treatment that have been used for treating microaneurysms, bipolar coagulation and wrapping of the lesion are outstanding. Nevertheless, demonstration of the efficacy of these treatments is difficult because most reported experimental models for inducting aneurysms are complex and difficult to be reproduced. This study aimed to develop a simple and reproducible model for inducing microaneurysms.
   METHODS Microaneurysms were induced using a mechanical lesion of the bifurcation of the aorta in 72 rats. Three groups of 10 animals were sacrificed 7, 14, and 21 days after the lesion and 2 groups (35 and 7 animals) after 30 days. The aortic bifurcation was macro/microscopically analyzed in the first 4 groups and a resistance test was applied in the fifth group.
   RESULTS Microaneurysms occurred in 77.8% of cases. Microscopically, degenerative changes were observed in the intima, media, and adventitia and in the internal elastic lamina. The bursting pressure ranged from 368 to 1,472 mm Hg during the resistance test in the fifth group.
   CONCLUSIONS The presented model of experimental microaneurysm induction is simple, reproducible and gives a high rate of positivity. (C) 2004 Elsevier Inc. All rights reserved.
C1 USP, Dept Cirurgia, HCFMRP, Dept Surg,Div Neurosurg,Ribeirao Preto Med Sch, BR-14048900 Sao Paulo, Brazil.
   Marilia Sch Med, Dept Surg, Div Neurosurg, Sao Paulo, Brazil.
   Univ Fed Rio de Janeiro, Dept Pathol, Sch Med, Rio De Janeiro, Brazil.
RP Colli, BO (corresponding author), USP, Dept Cirurgia, HCFMRP, Dept Surg,Div Neurosurg,Ribeirao Preto Med Sch, Campus Univ, BR-14048900 Sao Paulo, Brazil.
RI Colli, Benedicto/A-2833-2016; Carlotti, Carlos G/C-1608-2012
OI Colli, Benedicto/0000-0002-0222-6770; Carlotti, Carlos
   G/0000-0002-7055-0564
CR AMMIRATI M, 1988, Microsurgery, V9, P78, DOI 10.1002/micr.1920090204
   CANHAM PB, 1985, NEUROSURGERY, V17, P291, DOI 10.1227/00006123-198508000-00007
   CARLOTTI CG, 2001, ARG NEUROPSIGUIATR, P365
   DIAS LAA, 1995, J BRAS NEUROC, V6, P25
   EBINA K, 1984, ACTA NEUROCHIR, V72, P61, DOI 10.1007/BF01406814
   FERGUSON GG, 1972, J NEUROSURG, V37, P666, DOI 10.3171/jns.1972.37.6.0666
   HANDA H, 1983, STROKE, V14, P857, DOI 10.1161/01.STR.14.6.857
   Hashimoto H, 2000, J NEUROSURG, V92, P278, DOI 10.3171/jns.2000.92.2.0278
   HASHIMOTO N, 1983, AM J PATHOL, V110, P397
   HASSLER O, 1961, Acta Psychiatr Scand Suppl, V154, P1
   HAZAMA F, 1986, AM J PATHOL, V124, P399
   Herrera O, 1999, NEUROL MED-CHIR, V39, P134, DOI 10.2176/nmc.39.134
   KAMPHORST W, 1991, NEUROL RES, V13, P256
   KIM C, 1988, STROKE, V19, P507, DOI 10.1161/01.STR.19.4.507
   Kirollos RW, 1997, ACTA NEUROCHIR, V139, P411, DOI 10.1007/BF01808876
   KOJIMA M, 1986, STROKE, V17, P835, DOI 10.1161/01.STR.17.5.835
   MAXWELL GP, 1979, PLAST RECONSTR SURG, V63, P824
   Nishikawa M, 1976, Surg Neurol, V5, P15
   Nussbaum ES, 1999, NEUROSURGERY, V45, P1172, DOI 10.1097/00006123-199911000-00031
   QUIGLEY MR, 1986, NEUROSURGERY, V18, P292, DOI 10.1227/00006123-198603000-00006
   REDEKOP G, 1995, NEUROVASCULAR SURG, P625
   SADASIVAN B, 1990, SURG NEUROL, V43, P3
   SEKHAR LN, 1981, NEUROSURGERY, V8, P248, DOI 10.1227/00006123-198102000-00020
   STEHBENS WE, 1989, J NEUROSURG, V70, P823, DOI 10.3171/jns.1989.70.6.0823
   TATTER SB, 1995, NEUROSURGERY, V37, P48, DOI 10.1227/00006123-199507000-00007
   TODD EM, 1962, JAMA-J AM MED ASSOC, V179, P935, DOI 10.1001/jama.1962.03050120013003
   van Alphen H A, 1990, Neurol Res, V12, P256
   WHITE JC, 1961, J NEUROSURG, V18, P741, DOI 10.3171/jns.1961.18.6.0741
   YASARGIL MG, 1984, MICRONEUROSURGERY, V2, P305
   YOUNG P, 1987, MICROSURG, V8, P194
NR 30
TC 6
Z9 7
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0090-3019
J9 SURG NEUROL
JI Surg. Neurol.
PD NOV
PY 2004
VL 62
IS 5
BP 406
EP 412
DI 10.1016/j.surneu.2004.01.023
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA 867CP
UT WOS:000224820000009
PM 15518846
DA 2020-12-08
ER

PT J
AU Jardim, MR
   Chimelli, L
   Faria, SCR
   Fernandes, PV
   Neri, JAD
AF Jardim, MR
   Chimelli, L
   Faria, SCR
   Fernandes, PV
   Neri, JAD
TI Clinical, electroneuromyographic and morphological studies of pure
   neural leprosy in a Brazilian referral centre
SO LEPROSY REVIEW
LA English
DT Article
ID EXTRACELLULAR-MATRIX; NERVE BIOPSY; NEUROPATHY; DIAGNOSIS; LESIONS
AB Nineteen patients with pure neural leprosy were analysed with clinical examination, electroneuromyography and histopathology of nerve biopsies. Clinical examination showed sensory loss (78.9%), paresis (78.9%), nerve enlargement (68.4%) and nerve pain (42.1%). Electroneuromyographic study revealed an axonal pattern in 18 patients (94.7%) and a demyelinating pattern in one (0.5%). Mononeuropathy multiplex was the most frequent presentation (78.9%), followed by mononeuropathy simplex (10.5%) and polyneuropathy (10.5%). The histopathological study showed the presence of inflammatory infiltrate composed of epithelioid granuloma (42.1%), mononuclear infiltrate (36.8%) or macrophages positive for bacilli (21%). Fibrosis was present in 78.9% of the biopsies. Examination of semithin sections revealed, besides inflammatory infiltrate, myelinated fibre loss (94.7%), remyelination (42%), axonal degeneration (10%) as well as regeneration (31.5%). Based on these results, the pathogenesis of leprosy neuropathy in this group of patients is briefly discussed.
C1 Oswaldo Cruz Fdn, Inst Oswaldo Cruz, Dept Trop Med, Dept Ultrastruct & Cell Biol,Lab Hanseniase, BR-21045900 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Dept Pathol, Rio De Janeiro, Brazil.
RP Jardim, MR (corresponding author), Oswaldo Cruz Fdn, Inst Oswaldo Cruz, Dept Trop Med, Dept Ultrastruct & Cell Biol,Lab Hanseniase, Av Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
EM santunes@fiocruz.br
OI Nunes Sarno, Euzenir/0000-0003-0129-2159
CR ANTIA NH, 1999, PERIPHERAL NERVE LEP, P79
   Antunes SLG, 1999, INT J LEPROSY, V67, P24
   BJORN F, 1995, J CLIN NEUROPHYSIOL, V12, P254
   Chimelli L, 1997, J NEUROL, V244, P318, DOI 10.1007/s004150050094
   Dastur D K, 1970, Int J Lepr Other Mycobact Dis, V38, P30
   DELISA J, 1994, MANUAL NERVE CONDUCT
   FITE GL, 1951, ANN NY ACAD SCI, V54, P28, DOI 10.1111/j.1749-6632.1951.tb45828.x
   Girdhar B K, 1996, Indian J Lepr, V68, P35
   JACOB M, 1988, INT J LEPROSY, V56, P56
   JACOBS JM, 1987, J NEUROL SCI, V79, P301, DOI 10.1016/0022-510X(87)90237-1
   JAMES WA, 1993, J CLIN NEUROPHYSIOL, V10, P149
   Jardim MR, 2003, J NEUROL, V250, P806, DOI 10.1007/s00415-003-1081-5
   Job C K, 1968, Int J Lepr Other Mycobact Dis, V36, P257
   JUNQUEIRA LCU, 1980, INT J LEPROSY, V48, P291
   Kajihara Hiroki, 2000, Hiroshima Journal of Medical Sciences, V49, P83
   MIKO TL, 1993, LANCET, V342, P1060
   Ramu G., 1997, PERIPHERAL NERVE LEP, P37
   RIDLEY DS, 1997, PERIPHERAL NERVE LEP, P138
   Santos A R, 1999, Indian J Lepr, V71, P101
   Singh N, 1998, LEPROSY REV, V69, P246
   Spierings E, 2001, J IMMUNOL, V166, P5883, DOI 10.4049/jimmunol.166.10.5883
   SRIDHARAN R, 2001, EMEDICINE
   TZOURIO C, 1992, J NEUROL, V239, P367
   Uplekar M W, 1986, Indian J Lepr, V58, P513
   VANBRAKEL WH, 1994, LEPROSY REV, V65, P350
   Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8
NR 26
TC 26
Z9 27
U1 0
U2 1
PU LEPRA
PI COLCHESTER
PA 28 MIDDLEBOROUGH, COLCHESTER CO1 1TG, ESSEX, ENGLAND
SN 0305-7518
EI 2162-8807
J9 LEPROSY REV
JI Lepr. Rev.
PD SEP
PY 2004
VL 75
IS 3
BP 242
EP 253
PG 12
WC Dermatology; Infectious Diseases; Pathology; Tropical Medicine
SC Dermatology; Infectious Diseases; Pathology; Tropical Medicine
GA 867FB
UT WOS:000224826600007
PM 15508901
DA 2020-12-08
ER

PT J
AU Kovacs, GG
   Lindeck-Pozza, E
   Chimelli, L
   Araujo, AQC
   Gabbai, AA
   Strobel, T
   Glatzel, M
   Aguzzi, A
   Budka, H
AF Kovacs, GG
   Lindeck-Pozza, E
   Chimelli, L
   Araujo, AQC
   Gabbai, AA
   Strobel, T
   Glatzel, M
   Aguzzi, A
   Budka, H
TI Creutzfeldt-Jakob disease and inclusion body myositis: Abundant
   disease-associated prion protein in muscle
SO ANNALS OF NEUROLOGY
LA English
DT Article
ID CLASSIFICATION; HOMOZYGOSITY; STRAINS
AB Pathological prion protein (PrPSc) is the hallmark of prion diseases affecting primarily the central nervous system. Using immunohistochemistry, paraffin-embedded tissue blot, and Western blot, we demonstrated abundant PrPSc in the muscle of a patient with sporadic Creutzfeldt-Jakob disease and inclusion body myositis. Extraneural PrPC-PrPSc conversion in Creutzfeldt-Jakob disease appears to become prominent when PrPC is abundantly available as substrate, as in inclusion body myositis muscle.
C1 Univ Vienna, Inst Neurol, A-1097 Vienna, Austria.
   Austrian Reference Ctr Human Prion Dis, Vienna, Austria.
   Natl Inst Psychiat & Neurol, Budapest, Hungary.
   Univ Fed Rio de Janeiro, Sch Med, Dept Pathol, BR-21941 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Sch Med, Dept Neurol, BR-21941 Rio De Janeiro, Brazil.
   Univ Fed Sao Paulo, Sch Med, Dept Neurol, Sao Paulo, Brazil.
   Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland.
RP Budka, H (corresponding author), Univ Vienna, Inst Neurol, AKH 4J,Wuhringer Gurtel 18-20,POB 48, A-1097 Vienna, Austria.
EM h.budka@akh-wien.ac.at
RI Kovacs, Gabor G/A-7468-2013; Aguzzi, Adriano/A-3351-2008; de
   Queiroz-Campos Araujo, Abelardo/N-3637-2013; Budka, Herbert/I-3486-2019;
   Glatzel, Markus/G-3356-2011; Glatzel, Markus/V-8844-2019
OI Kovacs, Gabor G/0000-0003-3841-5511; de Queiroz-Campos Araujo,
   Abelardo/0000-0001-7694-7223; Budka, Herbert/0000-0002-1933-1577;
   Glatzel, Markus/0000-0002-7720-8817; Glatzel,
   Markus/0000-0002-7720-8817; Aguzzi, Adriano/0000-0002-0344-6708
CR Asante EA, 2002, EMBO J, V21, P6358, DOI 10.1093/emboj/cdf653
   Askanas V, 2001, J NEUROPATH EXP NEUR, V60, P1
   Bosque PJ, 2002, P NATL ACAD SCI USA, V99, P3812, DOI 10.1073/pnas.052707499
   Budka H, 2000, ARCH VIROL, P135
   Hill AF, 1997, LANCET, V349, P99, DOI 10.1016/S0140-6736(97)24002-X
   Hill AF, 2003, BRAIN, V126, P1333, DOI 10.1093/brain/awg125
   Koperek O, 2002, AM J PATHOL, V161, P1979, DOI 10.1016/S0002-9440(10)64474-4
   Kovacs GG, 2002, BRAIN PATHOL, V12, P1
   Lampe J, 2001, NEUROLOGY, V57, P368
   Orth M, 2000, NEUROLOGY, V55, P1235, DOI 10.1212/WNL.55.8.1235
   Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W
   Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245
   Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654
   SAILER A, 1994, CELL, V77, P967, DOI 10.1016/0092-8674(94)90436-7
   Schulz-Schaeffer WJ, 2000, AM J PATHOL, V156, P51, DOI 10.1016/S0002-9440(10)64705-0
   Thomzig A, 2003, EMBO REP, V4, P530, DOI 10.1038/sj.embor.embor827
   *WHO, WHO EMC ZDI 1998 GEN
   Zanusso G, 2001, BRAIN PATHOL, V11, P182
NR 18
TC 44
Z9 44
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD JAN
PY 2004
VL 55
IS 1
BP 121
EP 125
DI 10.1002/ana.10813
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 762AW
UT WOS:000187948500018
PM 14705121
DA 2020-12-08
ER

PT J
AU do Souto, AA
   Fonseca, ALV
   Gadelha, M
   Donangelo, LS
   Chimelli, L
   Domingues, FS
AF do Souto, AA
   Fonseca, ALV
   Gadelha, M
   Donangelo, LS
   Chimelli, L
   Domingues, FS
TI Optic pathways tuberculoma mimicking glioma: Case report
SO SURGICAL NEUROLOGY
LA English
DT Article
DE tuberculosis; optic pathway glioma; magnetic resonance imaging
ID NERVOUS-SYSTEM TUBERCULOSIS; INTRASELLAR TUBERCULOMA; HYPOPHYSEAL
   TUBERCULOMA; PITUITARY-STALK; HYPOPITUITARISM; SELLAR
AB BACKGROUND Optochiasmatic tuberculomas are very rare lesions. They can occur with concomitant tuberculous meningitis, and pulmonary tuberculosis or as the only manifestation of the disease. The authors present a case of optic pathways tuberculoma with radiologic appearance simulating an optic pathways glioma.
   CASE DESCRIPTION We report a case of a 20-year-old man with mental retardation due to anoxic encephalopathy who developed a sudden bilateral amaurosis. He also presented with diabetes insipidus, panhypopituitarism, right proptosis, and chemosis. Computed tomography (CT) and magnetic resonance imaging (MRI) showed an enhancing lesion in the optochiasmatic region extending to both optic nerves, with a mass in the right orbit, mimicking an optic pathways glioma. There was no other evidence of systemic involvement of the tuberculosis. The lesion was explored through a right pterional transylvian approach with opening of the optic canal and orbital roof, and a biopsy and an internal decompression were performed. Histopathological studies demonstrated a granulomatous lesion with central caseous necrosis with acid-fast bacilli. The patient improved after treatment with tuberculostatic drugs, but vision recovery could not be achieved.
   CONCLUSION Visual compromise in tuberculosis is associated with hydrocephalus, optical neuritis or tuberculomas involving the optic pathways. Reviewing the literature on tuberculomas of the optochiasmatic area, we could not find any other case with such extensive involvement of the optic pathways that was radiologically suggestive of an infiltrating glioma. Histopathological studies remain crucial in the diagnosis of intrinsic expansive processes of the optochiasmatic region. (C) 2003 Elsevier Inc. All rights reserved.
C1 Univ Fed Rio de Janeiro, Univ Hosp, Div Neurosurg, Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Univ Hosp, Div Endocrinol, Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Univ Hosp, Dept Pathol, Rio De Janeiro, Brazil.
RP do Souto, AA (corresponding author), Serv Neurocirurgia, S-N HUCFF UFRJ 10 Andar,Av Brigadeiro Trompowski, Rio De Janeiro, Brazil.
CR Ashkan K, 1997, ACTA NEUROCHIR, V139, P523, DOI 10.1007/BF02750994
   BROOKS MH, 1973, AM J MED, V54, P777, DOI 10.1016/0002-9343(73)90065-X
   DEANGELIS LM, 1981, NEUROLOGY, V31, P1133, DOI 10.1212/WNL.31.9.1133
   FitzPatrick M, 1999, RADIOL CLIN N AM, V37, P101, DOI 10.1016/S0033-8389(05)70081-6
   FLANNERY MT, 1993, AM J MED SCI, V306, P101, DOI 10.1097/00000441-199308000-00007
   Garcia-Monco JC, 1999, NEUROL CLIN, V17, P737, DOI 10.1016/S0733-8619(05)70164-X
   GUPTA RK, 1990, CLIN RADIOL, V41, P120, DOI 10.1016/S0009-9260(05)80143-6
   Indira B, 1996, SURG NEUROL, V45, P347, DOI 10.1016/0090-3019(95)00431-9
   IRACI G, 1980, J NEUROSURG, V52, P129, DOI 10.3171/jns.1980.52.1.0129
   Jain R, 2001, NEUROL INDIA, V49, P314
   LANAPEIXOTO MA, 1980, ARCH NEUROL-CHICAGO, V37, P186, DOI 10.1001/archneur.1980.00500520084020
   LESOIN F, 1984, SEM HOP PARIS, V60, P1185
   Patankar T, 2000, CLIN IMAG, V24, P89, DOI 10.1016/S0899-7071(00)00181-9
   PEREIRA J, 1995, NEUROSURGERY, V36, P1013, DOI 10.1227/00006123-199505000-00019
   POON WS, 1993, POSTGRAD MED J, V69, P147, DOI 10.1136/pgmj.69.808.147
   RANJAN A, 1994, BRIT J NEUROSURG, V8, P179, DOI 10.3109/02688699409027964
   Sharma MC, 2000, CLIN NEUROL NEUROSUR, V102, P72, DOI 10.1016/S0303-8467(00)00063-9
   Sinha S, 2000, NEUROSURGERY, V46, P735, DOI 10.1097/00006123-200003000-00041
   WHITEMAN M, 1995, AM J NEURORADIOL, V16, P1319
NR 19
TC 9
Z9 9
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0090-3019
J9 SURG NEUROL
JI Surg. Neurol.
PD OCT
PY 2003
VL 60
IS 4
BP 349
EP 353
DI 10.1016/S0090-3019(03)00133-1
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA 724DT
UT WOS:000185472400015
PM 14505863
DA 2020-12-08
ER

PT J
AU Mattiello-Sverzut, AC
   Chimelli, L
   Moura, MSD
   Teixeira, S
   de Oliveira, JAM
AF Mattiello-Sverzut, AC
   Chimelli, L
   Moura, MSD
   Teixeira, S
   de Oliveira, JAM
TI The effects of aging on biceps brachii muscle fibers - A morphometrical
   study from biopsies and autopsies
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE biceps brachii; morphometry; aging; autopsy; muscle biopsy
ID HUMAN SKELETAL-MUSCLE; VASTUS LATERALIS MUSCLE; HISTOGRAPHIC ANALYSIS;
   QUADRICEPS MUSCLE; MEN; AGE; HYPERTROPHY; VARIABILITY; ATROPHY; SAMPLES
AB Objectives: In order to study the morphology and size of muscle fibers, cross sections of biceps brachii samples from autopsies, up to 9 hours after death, and biopsies of 72 subjects were compared. The subjects aged 13 to 84 years in both sexes. Methods: The samples obtained from autopsies (n=47) were from subjects with sudden death, or who died after acute disease without evidence of neuromuscular involvement. The biopsies (n=25) were from patients with symptoms suggestive of inflammatory or metabolic myopathy, not confirmed morphologically. The lesser diameter of muscle fibers was measured using the ATPase reaction. Results: Morphological analysis showed that aging changes were present from the sixth decade in autopsies, and consisted of atrophy and/or type-grouping. The statistical models adjusted for females in both autopsies and biopsies were linear straight with no variation in fiber size with increasing age. The models adjusted for males in both groups were quadratic, indicating that age influenced the size of different type fibers. In males type 2 were larger than type 1 fibers, and than fibers in females. Conclusions: These values might be useful as controls, helping interpretation of changes in fiber size in samples obtained from biopsies and autopsies.
C1 Univ Fed Rio de Janeiro, Univ Hosp, Serv Anat Patol, Div Pathol, BR-21941590 Rio De Janeiro, Brazil.
   Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Pathol, BR-14049 Ribeirao Preto, SP, Brazil.
   Univ Fed Sao Carlos, Dept Stat, BR-13560 Sao Carlos, SP, Brazil.
   USP, FMRP, MS, Sao Paulo, Brazil.
RP Chimelli, L (corresponding author), Univ Fed Rio de Janeiro, Univ Hosp, Serv Anat Patol, Div Pathol, BR-21941590 Rio De Janeiro, Brazil.
RI Mattiello-Sverzut, Ana Claudia/F-5955-2013; Teixeira, Silvia
   A/F-3228-2014
OI Mattiello-Sverzut, Ana Claudia/0000-0002-4181-0718; Teixeira, Silvia
   A/0000-0002-2462-8535
CR BANKER BQ, 1994, MYOLOGY, P832
   BLOMSTRAND E, 1984, ACTA PHYSIOL SCAND, V122, P545, DOI 10.1111/j.1748-1716.1984.tb07543.x
   BRAUND KG, 1988, VET PATHOL, V25, P77, DOI 10.1177/030098588802500111
   BROOKE MH, 1969, NEUROLOGY, V19, P378, DOI 10.1212/WNL.19.4.378
   BROOKE MH, 1969, NEUROLOGY, V19, P221, DOI 10.1212/WNL.19.3.221
   BROOKE MH, 1969, NEUROLOGY, V19, P469, DOI 10.1212/WNL.19.5.469
   ERIKSSON PO, 1980, HISTOCHEMISTRY, V65, P193, DOI 10.1007/BF00493169
   ESSENGUSTAVSSON B, 1986, ACTA PHYSIOL SCAND, V126, P107, DOI 10.1111/j.1748-1716.1986.tb07793.x
   FRONTERA WR, 1988, J APPL PHYSIOL, V64, P1038
   GLENMARK B, 1992, ACTA PHYSIOL SCAND, V146, P251, DOI 10.1111/j.1748-1716.1992.tb09414.x
   GOLDSPINK G, 1973, J ANAT, V114, P1
   GRIMBY G, 1982, ACTA PHYSIOL SCAND, V115, P125, DOI 10.1111/j.1748-1716.1982.tb07054.x
   HEGARTY PVJ, 1971, J ANAT, V110, P249
   Kirkeby S, 2000, HISTOL HISTOPATHOL, V15, P61, DOI 10.14670/HH-15.61
   LARSSON L, 1983, ACTA PHYSIOL SCAND, V117, P469, DOI 10.1111/j.1748-1716.1983.tb00024.x
   LARSSON L, 1978, ACTA PHYSIOL SCAND, V103, P31, DOI 10.1111/j.1748-1716.1978.tb06187.x
   LEXELL J, 1991, J ANAT, V174, P239
   LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3
   MAHON M, 1984, J NEUROL SCI, V63, P85, DOI 10.1016/0022-510X(84)90111-4
   MANFA P, 1996, CLIN NEUROPATHOL, V15, P116
   NETER J, 1989, APPL LINEAR REGRESSI, P3349
   NYGAARD E, 1982, ANAT RECORD, V203, P451, DOI 10.1002/ar.1092030404
   PERNUS F, 1994, J NEUROL SCI, V121, P194, DOI 10.1016/0022-510X(94)90352-2
   POGGI P, 1987, ANAT RECORD, V217, P30, DOI 10.1002/ar.1092170106
   SCARPELLI M, 1992, PATHOL RES PRACT, V188, P603, DOI 10.1016/S0344-0338(11)80064-6
   SHOREY CD, 1988, ACTA ANAT, V131, P30
NR 26
TC 11
Z9 11
U1 0
U2 2
PU ASSOC ARQUIVOS DE NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD SEP
PY 2003
VL 61
IS 3A
BP 555
EP 560
DI 10.1590/S0004-282X2003000400006
PG 6
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 736RE
UT WOS:000186186300006
PM 14513157
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Jardim, MR
   Antunes, SLG
   Santos, AR
   Nascimento, OJM
   Nery, JAC
   Sales, AM
   Illarramendi, X
   Duppre, N
   Chimelli, L
   Sampaio, EP
   Sarno, EN
AF Jardim, MR
   Antunes, SLG
   Santos, AR
   Nascimento, OJM
   Nery, JAC
   Sales, AM
   Illarramendi, X
   Duppre, N
   Chimelli, L
   Sampaio, EP
   Sarno, EN
TI Criteria for diagnosis of pure neural leprosy
SO JOURNAL OF NEUROLOGY
LA English
DT Article
DE pure neural leprosy (PNL); leprosy neuropathy; histopathology;
   polymerase chain reaction (PCR)
ID POLYMERASE-CHAIN-REACTION; MYCOBACTERIUM-LEPRAE; LESIONS
AB The clinical diagnosis of pure neural leprosy (PNL) remains a public health care problem mainly because skin lesions-the cardinal features of leprosy-are always absent. Moreover, the identification of the leprosy bacillus is not easily achieved even when a nerve biopsy can be performed. In an attempt to reach a reliable PNL diagnosis in patients referred to our Leprosy Outpatient Clinic, this study employed a variety of criteria. The nerve biopsies performed on the 67 individuals whose clinical, neurological, and electrophysiological examination findings strongly suggested peripheral neuropathy were submitted to M. leprae identification via a polymerase chain reaction (PCR). Mononeuropathy multiplex was the most frequent clinical and electrophysiological pattern of nerve dysfunction, while sensory impairment occurred in 89% of all cases and motor dysfunction in 81%. Axonal neuropathy was the predominant electrophysiological finding, while the histopathological nerve study showed epithelioid granuloma in 14% of the patients, acid fast bacilli in 16%, and nonspecific inflammatory infiltrate and/or fibrosis in 39%. PCR for M. leprae was positive in 47% of the nerve biopsy samples (n=23). PCR, in conjunction with clinical and neurological examination results, can be a powerful tool in attempting to identify and confirm a PNL diagnosis.
C1 Fiocruz MS, Inst Oswaldo Cruz, Leprosy Lab, BR-21045900 Rio De Janeiro, Brazil.
   Univ Fed Fluminense, Hosp Univ Antonio Pedro, Dept Neurol, Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Dept Pathol, BR-21941 Rio De Janeiro, Brazil.
RP Sarno, EN (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Leprosy Lab, Av Brasil,4365 Manguinhos, BR-21045900 Rio De Janeiro, Brazil.
EM euzenir@fiocruz.br
RI Illarramendi, Ximena/G-2592-2019
OI Illarramendi, Ximena/0000-0003-1504-1553; Nunes Sarno,
   Euzenir/0000-0003-0129-2159
CR Chemouilli P, 1996, INT J LEPROSY, V64, P1
   *COMM CLASS, 1953, INT J LEPROSY, V21, P504
   FREITAS MRG, 1998, ARQ NEURO-PSIQUIAT, V56, P585
   Girdhar B K, 1996, Indian J Lepr, V68, P35
   Indian association of leprologists, 1955, LEPROSY INDIA, V27, P93
   JENKINS D, 1990, J AM ACAD DERMATOL, V23, P1023, DOI 10.1016/0190-9622(90)70328-F
   Job CK, 1997, INT J LEPROSY, V65, P461
   KAUR G, 1991, INT J LEPROSY, V59, P385
   Mahajan P M, 1996, Indian J Lepr, V68, P137
   *MED RES COUNC, 1962, AIDS INV PER NERV IN
   RODRIGUEZ G, 1993, J AM ACAD DERMATOL, V29, P1050, DOI 10.1016/S0190-9622(08)82047-6
   SANTOS AR, 1993, J MED MICROBIOL, V39, P298, DOI 10.1099/00222615-39-4-298
   Scollard DM, 1998, AM J CLIN PATHOL, V109, P642, DOI 10.1093/ajcp/109.5.642
   STALWAR, 1992, LEPROSY REV, V63, P263
   TZOURIO C, 1992, J NEUROL, V239, P367
   Uplekar M W, 1986, Indian J Lepr, V58, P513
   WADE H W, 1952, Int J Lepr, V20, P429
   *WHO, 1980, GUID LEPR CONTR, P78
NR 18
TC 73
Z9 76
U1 0
U2 3
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 1432-1459
J9 J NEUROL
JI J. Neurol.
PD JUL
PY 2003
VL 250
IS 7
BP 806
EP 809
DI 10.1007/s00415-003-1081-5
PG 4
WC Clinical Neurology
SC Neurosciences & Neurology
GA 707YK
UT WOS:000184537400005
PM 12883921
DA 2020-12-08
ER

PT J
AU Souto, AA
   Domingues, FS
   Chimelli, L
   Lemos, AM
AF Souto, AA
   Domingues, FS
   Chimelli, L
   Lemos, AM
TI Lumbosacral angiolipoma: Case report
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE angiolipoma; spinal tumors; sacral tumors
ID SPINAL EXTRADURAL ANGIOLIPOMA; INFILTRATING ANGIOLIPOMA; EPIDURAL
   ANGIOLIPOMA; LIPOMA; ANGIOMYOLIPOMA; COMPRESSION; CORD
AB We present a case of a 46-year old woman with a ventral epidural angiolipoma at the lumbosacral level with erosion of the sacrum. About ninety cases of spinal angiolipomas have been previously described in the literature, most of them situated on the thoracic region, dorsal to the dural sac. Angiolipomas can be radically excised with a good prognosis even in the presence of bone erosion. We did not find any other angiolipoma at the sacral level surgically explored in the review of the literature.
C1 Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Serv Neurochirurg, Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Dept Pathol, Rio De Janeiro, Brazil.
EM aversa@hucff.ufrj.br
RI Souto, Andre A/E-6737-2011
OI Souto, Andre A/0000-0002-2437-8767
CR Aguiar PH, 1996, ARQ BRAS NEUROCIRURG, V15, P103
   BALBO RJ, 1995, ARQ NEURO-PSIQUIAT, V53, P659, DOI 10.1590/S0004-282X1995000400019
   BENDER JL, 1974, J NEUROSURG, V41, P100, DOI 10.3171/jns.1974.41.1.0100
   Boockvar JA, 1997, SPINE, V22, P2304, DOI 10.1097/00007632-199710010-00022
   BOURAMAS D, 1995, J SPINAL DISORD, V8, P324, DOI 10.1097/00002517-199508040-00011
   COSTA FA, 1998, ARQ BRAS NEUROCIRURG, V17, P48
   GONZALEZ.F, 1966, J BONE JOINT SURG AM, VA 48, P1111, DOI 10.2106/00004623-196648060-00009
   HADDAD FS, 1986, SURG NEUROL, V26, P473, DOI 10.1016/0090-3019(86)90261-2
   Kasper JA, 1929, ARCH PATHOL, V8, P800
   KURODA S, 1990, NEUROSURGERY, V27, P315, DOI 10.1227/00006123-199008000-00027
   Labram EK, 1999, BRIT J NEUROSURG, V13, P25, DOI 10.1080/02688699944140
   LIN JJ, 1974, CANCER-AM CANCER SOC, V34, P720, DOI 10.1002/1097-0142(197409)34:3<720::AID-CNCR2820340331>3.0.CO;2-K
   Machado Filho JA, 1993, ARQ BRAS NEUROCIRURG, V12, P141
   MICHILLI R, 1993, NEUROCHIRURGIA, V36, P63
   NISHIURA I, 1986, NEUROCHIRURGIA, V29, P63
   OBRADOR S, 1977, REV CLIN ESP, V146, P395
   PADOVANI R, 1982, NEUROSURGERY, V11, P674, DOI 10.1227/00006123-198211000-00010
   PAGNI CA, 1992, NEUROSURGERY, V31, P758
   PALKOVIC S, 1988, SURG NEUROL, V29, P243, DOI 10.1016/0090-3019(88)90014-6
   PEARSON J, 1993, J NEUROSURG, V78, P280
   PREUL MC, 1993, J NEUROSURG, V78, P280, DOI 10.3171/jns.1993.78.2.0280
   Provenzale JM, 1996, AM J NEURORADIOL, V17, P713
   RIVKIND A, 1986, SPINE, V11, P623, DOI 10.1097/00007632-198607000-00016
   RUBIN G, 1992, SPINE, V17, P719, DOI 10.1097/00007632-199206000-00013
   Sakaida H, 1998, SPINE, V23, P391, DOI 10.1097/00007632-199802010-00022
   Stookey B, 1927, ARCH NEURO PSYCHIATR, V18, P16, DOI 10.1001/archneurpsyc.1927.02210010019002
   Trabulo A, 1996, ACTA NEUROCHIR, V138, P1311, DOI 10.1007/BF01411061
   Turgut M, 1999, BRIT J NEUROSURG, V13, P30, DOI 10.1080/02688699944159
   VONHANWEHR R, 1985, NEUROSURGERY, V16, P406, DOI 10.1227/00006123-198503000-00023
NR 29
TC 8
Z9 8
U1 0
U2 0
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD JUN
PY 2003
VL 61
IS 2A
BP 269
EP 273
DI 10.1590/S0004-282X2003000200021
PG 5
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 688QR
UT WOS:000183447700021
PM 12806510
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Fonseca, ALV
   Chimelli, L
   Santos, MJCF
   dos Santos, AASMD
   Violante, AHD
AF Fonseca, ALV
   Chimelli, L
   Santos, MJCF
   dos Santos, AASMD
   Violante, AHD
TI Influence of hyperprolactinemia and tumoral size in the postoperative
   pituitary function in clinically nonfuncioning pituitary macroadenomas
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Portuguese
DT Article
DE pituitary gland; adenomas; hyperprolactinemia; hypopituitarism
ID PROLACTIN SECRETION; STALK COMPRESSION; HYPOPITUITARISM; INTRASELLAR;
   MANAGEMENT; PRESSURE
AB Objective: To study the influence of hyperprolactinemia and tumoral size in the pituitary function in clinically nonfuncioning pituitary macroadenomas. Methods: Twenty three patients with clinically nonfuncioning pituitary macroadenomas were evaluated by image studies (computed tomography or magnetic resonance) and basal hormonal level; 16 had preoperative hypothalamus-hypophysial function tests (megatests). All tumors had histological diagnosis and in seventeen immunohistochemical study for adenohypophysial hormones was also performed. Student's t test, chi square test, exact test of Fisher and Mc Neman test were used for the statistics analysis. The level of significance adopted was 5% (p<0.05). Results: Tumoral diameter varied of 1.1 to 4.7 cm (average=2.99 cm +/- 1.04). In the preoperative, 5 (21.7%) patients did not show laboratorial hormonal deficit, 9 (39.1%) developed hyperprolactinemia, 13 (56,5%) normal levels of prolactin (PRL and 1 (4.3%) subnormal; 18 (78.3%) patients developed hypopituitarism (4 pan-hypopituitarism). Nineteen patients (82.6%) underwent transsfenoidal approach, 3 (13%) craniotomy and 1 (4.4%) combined access. Only 6 patients had total tumoral resection. Of the 17 immunohistochemical studies, 5 tumours were immunonegatives, 1 compound, 1 LH+, 1 FSH +, 1 alpha sub-unit and 8 focal or isolated immunorreactivity for one of the pituitary hormones or sub-units; of the other six turnours, 5 were chromophobe and 1 chromophobe/aciclophile. No significanct statistic difference was noted between tumoral size and preoperative PRL levels (p=0.82), nor between tumoral size and postoperative hormonal state, except in the GH and gonadal axis. Significant statistic was noted: between tumoral size and preoperative hormonal state (except in the gonadal axis); between normal PRL levels, associated to none or little preoperative hypophysial disfunction, and recovery of postoperative pituitary function. Conclusion: Isolated preoperative hyperprolactinemia and tumoral size have not been predictible for the recovery of postoperative pituitary function.
C1 Univ Fed Rio de Janeiro, HUCFF, Serv Neurocirurgia, Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Dept Patol, Fac Med, Rio De Janeiro, Brazil.
   HUCFF, Lab Hormonios, Rio De Janeiro, Brazil.
   Univ Fed Fluminense, Dept Radiol, Niteroi, RJ, Brazil.
   Univ Fed Rio de Janeiro, FM, Disciplina Endocrinol, Rio de Janeiro, Brazil.
RI Violante, Alice/M-6798-2019
CR Albuquerque FC, 1998, J NEUROSURG, V89, P1043, DOI 10.3171/jns.1998.89.6.1043
   ARAFAH BM, 1995, J CLIN ENDOCR METAB, V80, P3507, DOI 10.1210/jc.80.12.3507
   ARAFAH BM, 1994, J CLIN ENDOCR METAB, V79, P348, DOI 10.1210/jc.79.2.348
   Arafah BM, 2000, J CLIN ENDOCR METAB, V85, P1789, DOI 10.1210/jc.85.5.1789
   Arafah BM, 2000, TECH NEUROSURG, V6, P248
   ARAFAH BM, 1990, J CLIN ENDOCR METAB, V71, P323, DOI 10.1210/jcem-71-2-323
   ARAFAH PM, 1986, J CLIN ENDOCR METAB, V62, P1173, DOI 10.1210/jcem-62-6-1173
   Aron DC, 2000, ENDOCRIN METAB CLIN, V29, P205, DOI 10.1016/S0889-8529(05)70124-9
   CAVACO B, 1995, J CLIN ENDOCR METAB, V80, P2342, DOI 10.1210/jc.80.8.2342
   DIEFENBACH WP, 1976, J CLIN ENDOCR METAB, V43, P638, DOI 10.1210/jcem-43-3-638
   Drange MR, 2000, J CLIN ENDOCR METAB, V85, P168, DOI 10.1210/jc.85.1.168
   FIELD RA, 1961, NEW ENGL J MED, V264, P689, DOI 10.1056/NEJM196104062641404
   Goel A, 1996, ACTA NEUROCHIR, V138, P1042, DOI 10.1007/BF01412306
   GREENMAN Y, 1995, J CLIN ENDOCR METAB, V80, P1577, DOI 10.1210/jc.80.5.1577
   GREENSPAN FS, 1997, HYPOTHALAMUS PITUITA, P95
   Henriques JGD, 2000, ARQ NEURO-PSIQUIAT, V58, P485
   Herzog AG, 2000, NEUROLOGY, V55, P148, DOI 10.1212/WNL.55.1.148
   KLIJN JGM, 1980, CLIN ENDOCRINOL, V12, P341, DOI 10.1111/j.1365-2265.1980.tb02719.x
   KRISHT AF, 1999, PITUITARY DISORDERS, P99
   LANDEIRO JA, 1996, ARQ BR NEUROCIR, V15, P181
   LEES PD, 1987, J NEUROSURG, V67, P192, DOI 10.3171/jns.1987.67.2.0192
   Molitch ME, 2001, ENDOCRIN METAB CLIN, V30, P585, DOI 10.1016/S0889-8529(05)70203-6
   SMITH MV, 1994, NEUROSURGERY, V34, P834, DOI 10.1227/00006123-199405000-00007
   TINDALL GT, 1996, PRACTICE NEUROSURGER, P1021
   Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X
   Tosaka M, 2000, J NEUROSURG, V92, P361, DOI 10.3171/jns.2000.92.2.0361
   Tritos NA, 1998, EUR J ENDOCRINOL, V138, P82, DOI 10.1530/eje.0.1380082
   VANCE ML, 1994, NEW ENGL J MED, V330, P1651, DOI 10.1056/NEJM199406093302306
   WEIR B, 1992, NEUROSURGERY, V30, P585
NR 29
TC 3
Z9 3
U1 0
U2 0
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD SEP
PY 2002
VL 60
IS 3A
BP 590
EP 596
DI 10.1590/S0004-282X2002000400014
PG 7
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 589NW
UT WOS:000177767200014
PM 12244397
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU do Souto, AA
   Chimelli, L
   Takya, CM
   de Souza, JM
   Fonseca, ALV
   da Silva, LF
AF do Souto, AA
   Chimelli, L
   Takya, CM
   de Souza, JM
   Fonseca, ALV
   da Silva, LF
TI Brain edema in meningiomas: radiological and histological factors
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Spanish
DT Article
DE brain edema; immunohistochemistry; computerized tomography; magnetic
   resonance imaging
ID ENDOTHELIAL GROWTH-FACTOR; VASCULAR-PERMEABILITY FACTOR; CEREBRAL EDEMA;
   INTRACRANIAL MENINGIOMAS; PERITUMORAL EDEMA; TUMOR INTERFACES;
   ANGIOGENESIS; EXPRESSION; CELLS; INHIBITION
AB Many factors have been associated to the development of peritumoral edema in meningiomas. We studied the radiological and pathological features of 51 intracranial meningiomas surgically treated in the University Hospital of the Federal University of Rio de Janeiro. Two thirds of the meningiomas in our series had peritumoral edema. The size of the meningioma was probably related to the development of edema. Peritumoral edema was found frequently in the large meningiomas. The location of the meningioma was also associated with the frequency of peritumoral edema. Sphenoid wing meningiomas had significantly more peritumoral edema. In contrast, tuberculum sellae meningiomas were almost never associated with cerebral edema. There is growing evidence in the literature that vascular endothelial growth factor (VEGF) is a key factor in the pathogenesis of peritumoral edema. We studied by immunohistochemical techniques the expression of VEGF and its receptor flk-1 in meningiomas.
C1 Univ Fed Rio de Janeiro, HUCFF, Setor Cirurgia Base Cranio, Serv Neurocirurgia, BR-21941590 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, HUCFF, Dept Patol, BR-21941590 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, HUCFF, Dept Cirurgia, BR-21941590 Rio De Janeiro, Brazil.
RI Souto, Andre A/E-6737-2011
OI Souto, Andre A/0000-0002-2437-8767
CR ABE T, 1994, SURG NEUROL, V42, P471, DOI 10.1016/0090-3019(94)90075-2
   BENZEL EC, 1988, NEUROSURGERY, V23, P169, DOI 10.1227/00006123-198808000-00007
   BERKMAN RA, 1993, J CLIN INVEST, V91, P153, DOI 10.1172/JCI116165
   Bitzer M, 1998, NEUROSURGERY, V42, P730, DOI 10.1097/00006123-199804000-00026
   Bitzer M, 1997, J NEUROSURG, V87, P368, DOI 10.3171/jns.1997.87.3.0368
   BRUCE JN, 1987, J NEUROSURG, V67, P880, DOI 10.3171/jns.1987.67.6.0880
   CHEN TC, 1992, NEUROSURGERY, V31, P1015, DOI 10.1227/00006123-199212000-00005
   CONSTANTINI S, 1993, NEUROSURGERY, V33, P204, DOI 10.1097/00006123-199308000-00004
   GILBERT JJ, 1983, NEUROSURGERY, V12, P599, DOI 10.1227/00006123-198306000-00001
   GO KG, 1988, NEUROSURGERY, V23, P175
   GOLDMAN CK, 1997, NEUROSURGERY, V40
   GOSPODAROWICZ D, 1989, P NATL ACAD SCI USA, V86, P7311, DOI 10.1073/pnas.86.19.7311
   Ildan F, 1999, J NEUROSURG, V91, P384, DOI 10.3171/jns.1999.91.3.0384
   Kalkanis SN, 1996, J NEUROSURG, V85, P1095, DOI 10.3171/jns.1996.85.6.1095
   KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001
   Lamszus K, 2000, NEUROSURGERY, V46, P938
   MAIURI F, 1987, Surgical Neurology, V27, P64, DOI 10.1016/0090-3019(87)90109-1
   Mantle RE, 1999, J NEUROSURG, V91, P375, DOI 10.3171/jns.1999.91.3.0375
   OHNO K, 1992, CLIN NEUROL NEUROSUR, V94, P291, DOI 10.1016/0303-8467(92)90176-4
   PHILIPPON J, 1984, NEUROSURGERY, V14, P295, DOI 10.1227/00006123-198403000-00006
   Provias J, 1997, NEUROSURGERY, V40, P1016, DOI 10.1097/00006123-199705000-00027
   SALPIETRO FM, 1994, NEUROSURGERY, V35, P638, DOI 10.1227/00006123-199410000-00009
   SCHRELL UMH, 1995, J NEUROSURG, V82, P600, DOI 10.3171/jns.1995.82.4.0600
   SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562
   SMITH HP, 1981, NEUROSURGERY, V8, P428, DOI 10.1227/00006123-198104000-00004
   TAKAGI H, 1981, J NEUROSURG, V54, P797, DOI 10.3171/jns.1981.54.6.0797
   Tamiya T, 2001, NEUROSURGERY, V49, P1046, DOI 10.1097/00006123-200111000-00003
   TATAGIBA M, 1991, NEUROSURGERY, V28, P400, DOI 10.1227/00006123-199103000-00010
   Uranishi R, 2001, NEUROSURGERY, V48, P359, DOI 10.1097/00006123-200102000-00024
   Xie B, 1999, BRIT J CANCER, V81, P1335, DOI 10.1038/sj.bjc.6692206
NR 30
TC 8
Z9 10
U1 0
U2 0
PU ASSOC ARQUIVOS DE NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD SEP
PY 2002
VL 60
IS 3B
BP 807
EP 817
DI 10.1590/S0004-282X2002000500023
PG 11
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 595JU
UT WOS:000178106200023
PM 12364953
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Vasconcellos, LFR
   Correa, RB
   Chimelli, L
   Nascimento, F
   Fonseca, AB
   Nagel, J
   Novis, SAP
   Vincent, M
AF Vasconcellos, LFR
   Correa, RB
   Chimelli, L
   Nascimento, F
   Fonseca, AB
   Nagel, J
   Novis, SAP
   Vincent, M
TI Myelopathy due to vitamin B12 deficiency presenting as transverse
   myelitis (vol 60, pg 150, 2002)
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Portuguese
DT Correction
DE transverse myelitis; vitamin B12; pernicious anemia
ID SUBACUTE COMBINED DEGENERATION; ANEMIA
AB Vitamin B12 deficiency may induce neuropathy, myelopathy, dementia and optic neuropathy. The diagnosis is established by vitamin B12, homocysteine and methylmalonic acid measurements. Myelin and axon destruction in the white matter of the spinal cord are observed. The posterior column of the cervical and thoracic level is the most common involved area. The involvement of the anterior column is restricted to advanced and relatively severe cases. Treatment is based on vitamin B12 injections, and the prognosis depends on the stage of vitamin deficiency and deterioration at treatment onset. We report a case with transverse myelitis due to vitamin B12 deficiency. This picture is relatively uncommon, however, we believe patients with transverse myelitis should have vitamin B12 studies as part of the diagnosis work up.
C1 Univ Fed Rio de Janeiro, INDC, Rio De Janeiro, RJ, Brazil.
   Univ Fed Rio de Janeiro, HUCFF, Serv Neurol, Rio De Janeiro, RJ, Brazil.
   Univ Fed Rio de Janeiro, HUCFF, IFF, Rio De Janeiro, RJ, Brazil.
   Univ Fed Rio de Janeiro, Fac Med, Rio De Janeiro, RJ, Brazil.
RI Vincent, Maurice/B-1415-2009
CR Adams R, 1997, PRINCIPLES NEUROLOGY, P1138
   ASSIS JL, 1968, ARQ NEURO-PSIQUIAT, V26, P160
   BRADLEY WG, 2000, NEUROLOGY CLIN PRACT, P1495
   CANELAS H. M., 1960, ARQ NEURO PSIQUIAT, V18, P105
   Capdevila AM, 2000, REV NEUROLOGIA, V30, P797, DOI 10.33588/rn.3008.99497
   Da Silva MTT, 2000, ARQ NEURO-PSIQUIAT, V58, P752, DOI 10.1590/S0004-282X2000000400026
   HEALTON EB, 1991, MEDICINE, V70, P229, DOI 10.1097/00005792-199107000-00001
   Hemmer B, 1998, J NEUROL NEUROSUR PS, V65, P822, DOI 10.1136/jnnp.65.6.822
   KOSIK KS, 1980, ARCH NEUROL-CHICAGO, V37, P590, DOI 10.1001/archneur.1980.00500580086019
   Marie RM, 2000, ARCH NEUROL-CHICAGO, V57, P380, DOI 10.1001/archneur.57.3.380
   REYNOLDS EH, 1993, ARCH NEUROL-CHICAGO, V50, P739, DOI 10.1001/archneur.1993.00540070055015
   REYNOLDS EH, 1992, ARCH NEUROL-CHICAGO, V49, P649, DOI 10.1001/archneur.1992.00530300089014
   SAVAGE DG, 1994, AM J MED, V96, P239, DOI 10.1016/0002-9343(94)90149-X
   Stabler SP, 1997, AM J CLIN NUTR, V66, P741
   Toh BH, 1997, NEW ENGL J MED, V337, P1441, DOI 10.1056/NEJM199711133372007
   Vasconcellos LFR, 2002, ARQ NEURO-PSIQUIAT, V60, P150, DOI 10.1590/S0004-282X2002000100028
NR 16
TC 0
Z9 0
U1 0
U2 1
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD JUN
PY 2002
VL 60
IS 2A
PG 7
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 557CV
UT WOS:000175890500001
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Vasconcellos, LFR
   Correa, RB
   Chimelli, L
   Nascimento, F
   Fonseca, AB
   Nagel, J
   Novis, SAP
   Vincent, M
AF Vasconcellos, LFR
   Correa, RB
   Chimelli, L
   Nascimento, F
   Fonseca, AB
   Nagel, J
   Novis, SAP
   Vincent, M
TI Myelopathy due to vitamin B12 deficiency presenting as transverse
   myelitis
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Portuguese
DT Article
DE transverse myelitis; vitamin B12; pernicious anemia
ID SUBACUTE COMBINED DEGENERATION; ANEMIA
AB Vitamin B12 deficiency may induce neuropathy, myelopathy, dementia and optic neuropathy. The diagnosis is established by vitamin B12, homocysteine and methylmalonic acid measurements. Myelin and axon destruction in the white matter of the spinal cord are observed. The posterior column of the cervical and thoracic level is the most common involved area. The involvement of the anterior column is restricted to advanced and relatively severe cases. Treatment is based on vitamin B12 injections, and the prognosis depends on the stage of vitamin deficiency and deterioration at treatment onset, We report a case with transverse myelitis due to vitamin B12 deficiency. This picture is relatively uncommon, however, we believe patients with transverse myelitis should have vitamin B12 studies as part of the diagnosis work up.
C1 Univ Fed Rio de Janeiro, Inst Neurl Deolindo Couto, Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Neurol Serv, Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Fac Med, Rio De Janeiro, Brazil.
EM luizfrv@ig.com.br
RI Vincent, Maurice/B-1415-2009
OI Vincent, Maurice/0000-0001-5855-6069; Vasconcellos, Luiz
   Felipe/0000-0001-9080-7833
CR Adams R, 1997, PRINCIPLES NEUROLOGY, P1138
   ASSIS JL, 1968, ARQ NEURO-PSIQUIAT, V26, P160
   BRADLEY WG, 2000, NEUROLOGY CLIN PRACT, P1495
   CANELAS H. M., 1960, ARQ NEURO PSIQUIAT, V18, P105
   Capdevila AM, 2000, REV NEUROLOGIA, V30, P797, DOI 10.33588/rn.3008.99497
   Da Silva MTT, 2000, ARQ NEURO-PSIQUIAT, V58, P752, DOI 10.1590/S0004-282X2000000400026
   HEALTON EB, 1991, MEDICINE, V70, P229, DOI 10.1097/00005792-199107000-00001
   Hemmer B, 1998, J NEUROL NEUROSUR PS, V65, P822, DOI 10.1136/jnnp.65.6.822
   KOSIK KS, 1980, ARCH NEUROL-CHICAGO, V37, P590, DOI 10.1001/archneur.1980.00500580086019
   Marie RM, 2000, ARCH NEUROL-CHICAGO, V57, P380, DOI 10.1001/archneur.57.3.380
   REYNOLDS EH, 1993, ARCH NEUROL-CHICAGO, V50, P739, DOI 10.1001/archneur.1993.00540070055015
   REYNOLDS EH, 1992, ARCH NEUROL-CHICAGO, V49, P649, DOI 10.1001/archneur.1992.00530300089014
   SAVAGE DG, 1994, AM J MED, V96, P239, DOI 10.1016/0002-9343(94)90149-X
   Stabler SP, 1997, AM J CLIN NUTR, V66, P741
   Toh BH, 1997, NEW ENGL J MED, V337, P1441, DOI 10.1056/NEJM199711133372007
NR 15
TC 3
Z9 4
U1 0
U2 2
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD MAR
PY 2002
VL 60
IS 1
BP 150
EP 154
DI 10.1590/S0004-282X2002000100028
PG 5
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 535ZZ
UT WOS:000174677400028
PM 11965427
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Leite, JP
   Chimelli, L
   Terra-Bustamante, VC
   Costa, ET
   Assirati, JA
   de Nucci, G
   Martins, AR
AF Leite, JP
   Chimelli, L
   Terra-Bustamante, VC
   Costa, ET
   Assirati, JA
   de Nucci, G
   Martins, AR
TI Loss and sprouting of nitric oxide synthase neurons in the human
   epileptic hippocampus
SO EPILEPSIA
LA English
DT Article; Proceedings Paper
CT 6th Workshop on the Neurology of Epilepsy (WONOEP VI)
CY MAY 08-12, 2001
CL FOZ DO IGUACU, BRAZIL
DE hippocampal sclerosis; nitric oxide; plasticity; sprouting; neuronal
   vulnerability
ID TEMPORAL-LOBE EPILEPSY; METHYL-D-ASPARTATE; FASCIA-DENTATA; GUANYLYL
   CYCLASE; CYCLIC-GMP; EXPRESSION; SEIZURES; CHANNELS; RAT;
   IMMUNOREACTIVITY
AB Purpose: Nitric oxide (NO) has been implicated in a variety of functions, including the control of synaptic plasticity and sensory signaling. Current evidence suggests that this unconventional neurotransmitter mediates N-methyl-D-aspartate (NMDA) receptor-linked excitotoxicity. This study describes the expression of neuronal NO synthase (nNOS) immunoreactivity (IR) in hippocampi from patients with temporal lobe epilepsy (TLE).
   Methods: Hippocampi from patients with clinical symptoms, neuroimaging, and EEG typical of hippocampal sclerosis (HS; n = 22) were compared with those from patients with neocortical temporal lesions (NONHS; n = 4) and autopsy (AUT; n = 18) patients for total cells, and nNOS-IR neuron and puncta densities.
   Results: Compared with AUT, HS hippocampi had significantly less nNOS-IR neuron densities in the. fascia dentata (FD); hilus, and CA4, CA3, CA2, and CA1 subfields. HS hippocampi had significantly greater nNOS-IR puncta densities in the FD, as compared with AUT and NONHS.
   Conclusions: Our results show that hippocampi from TLE patients exhibit a loss of nNOS-IR neurons and an abnormal FD innervation. The release of NO can influence the dynamics of ionic channels and neurotransmitter release, thus affecting neuronal membrane potential. Because the NOergic transmission does not obey the topographic constraints imposed on conventional transmitters, target cells can be stimulated even in regions with severe deafferentation, The plastic changes described here may contribute to abnormal hippocampal excitability.
C1 Univ Sao Paulo, Sch Med, Dept Neurol, BR-14049900 Ribeirao Preto, Brazil.
   Univ Sao Paulo, Sch Med, Dept Pathol, BR-14049900 Ribeirao Preto, Brazil.
   Univ Sao Paulo, Sch Med, Dept Neurosurg, BR-14049900 Ribeirao Preto, Brazil.
   Univ Sao Paulo, Sch Med, Dept Pharmacol, BR-14049900 Ribeirao Preto, Brazil.
   Univ Sao Paulo, Inst Biol Sci, Sao Paulo, Brazil.
RP Leite, JP (corresponding author), Univ Sao Paulo, Sch Med, Dept Neurol, Campus Univ, BR-14049900 Ribeirao Preto, Brazil.
RI Leite, Joao/B-9070-2012; De Nucci, Gilberto/J-5990-2012
OI Leite, Joao/0000-0003-0558-3519; De Nucci, Gilberto/0000-0002-4346-7941;
   Terra, Vera/0000-0002-4246-970X
CR ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210
   BABB TL, 1984, EPILEPSIA, V25, P721, DOI 10.1111/j.1528-1157.1984.tb03483.x
   BABB TL, 1991, NEUROSCIENCE, V42, P351, DOI 10.1016/0306-4522(91)90380-7
   BABB TL, 1989, J NEUROSCI, V9, P2562
   Black SM, 1995, NEUROBIOL DIS, V2, P145, DOI 10.1006/nbdi.1995.0016
   Boda B, 1996, NEUROSCI LETT, V209, P37, DOI 10.1016/0304-3940(96)12590-8
   CETINER M, 1993, BRIT J PHARMACOL, V110, P995, DOI 10.1111/j.1476-5381.1993.tb13912.x
   Dawson VL, 1998, PROG BRAIN RES, V118, P215
   Dawson VL, 1996, J CHEM NEUROANAT, V10, P179, DOI 10.1016/0891-0618(96)00148-2
   DELANEROLLE NC, 1989, BRAIN RES, V495, P387, DOI 10.1016/0006-8993(89)90234-5
   DelBel EA, 1997, BRAZ J MED BIOL RES, V30, P971, DOI 10.1590/S0100-879X1997000800010
   DENO RL, 1933, J PSYCHOL NEUROL, V45, P113
   DESARRO GB, 1991, FUNDAM CLIN PHARM, V5, P503
   FAGNI L, 1995, MOL PHARMACOL, V47, P1239
   Fagni L, 1996, J CHEM NEUROANAT, V10, P231, DOI 10.1016/0891-0618(95)00140-9
   FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0
   Gonzalez-Hernandez T, 2000, EPILEPSIA, V41, P1259, DOI 10.1111/j.1528-1157.2000.tb04603.x
   GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423
   Kiss JP, 2001, TRENDS NEUROSCI, V24, P211, DOI 10.1016/S0166-2236(00)01745-8
   Kotsonis P, 2000, BIOCHEM J, V346, P767, DOI 10.1042/0264-6021:3460767
   KURENNY DE, 1994, NEURON, V13, P315, DOI 10.1016/0896-6273(94)90349-2
   LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8
   Lee YC, 2000, P NATL ACAD SCI USA, V97, P10763, DOI 10.1073/pnas.190333697
   Leite JP, 2000, NEUROLOGY, V55, P1485, DOI 10.1212/WNL.55.10.1485
   Liu LM, 1999, CELL DEATH DIFFER, V6, P937, DOI 10.1038/sj.cdd.4400578
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Lucas KA, 2000, PHARMACOL REV, V52, P375
   MARANGOZ C, 1994, NEUROREPORT, V5, P2454, DOI 10.1097/00001756-199412000-00012
   Martins AR, 1999, J NEUROSCI METH, V92, P25, DOI 10.1016/S0165-0270(99)00090-4
   Mathern GW, 1997, NEUROSCIENCE, V77, P1003, DOI 10.1016/S0306-4522(96)00516-7
   MATHERN GW, 1995, J NEUROSCI, V15, P3990
   MCNAMARA JO, 1994, J NEUROSCI, V14, P3413
   Murad F, 1994, Adv Pharmacol, V26, P19, DOI 10.1016/S1054-3589(08)60049-6
   NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6
   Proctor MR, 1997, NEUROSCIENCE, V76, P1231, DOI 10.1016/S0306-4522(96)00390-9
   SUHASINI M, 1995, CELL GROWTH DIFFER, V6, P1559
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   WU W, 1994, NEUROSCIENCE, V61, P719, DOI 10.1016/0306-4522(94)90394-8
   Zanardo RCO, 1997, P NATL ACAD SCI USA, V94, P14111, DOI 10.1073/pnas.94.25.14111
NR 39
TC 16
Z9 16
U1 0
U2 0
PU BLACKWELL PUBLISHING INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0013-9580
J9 EPILEPSIA
JI Epilepsia
PY 2002
VL 43
SU 5
BP 235
EP 242
DI 10.1046/j.1528-1157.43.s.5.29.x
PG 8
WC Clinical Neurology
SC Neurosciences & Neurology
GA 584AW
UT WOS:000177445900044
PM 12121328
OA Bronze
DA 2020-12-08
ER

PT J
AU Fonseca, ALV
   Souto, AAD
   Domingues, F
   Vaisman, M
   Gadelha, MR
   Chimelli, L
   Santos, MJCF
   Violante, AHD
AF Fonseca, ALV
   Souto, AAD
   Domingues, F
   Vaisman, M
   Gadelha, MR
   Chimelli, L
   Santos, MJCF
   Violante, AHD
TI Hormonal dysfunction of nonpituitary lesions from midline and perisellar
   area
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Portuguese
DT Article
DE intracranial tumor; sellar and juxtasellar lesions; hormonal dysfunction
ID PITUITARY-STALK COMPRESSION; INTRASELLAR; SELLAR; GLAND; SECONDARY;
   HYPERPROLACTINEMIA; HYPOPITUITARISM; PRESSURE; MASSES; TUMORS
AB Objective: To analyse clinical and/or laboratorial preoperative hormonal dysfunction, of the nonpituitary intracranial lesions from midline and parasellar area. Method: Forty-four patients were evaluated with nonpituitary intracranial lesions, who had images studies (computed tomography or magnetic resonance) and preoperative basal hormonal level; 16 had preoperative hypothalamus-hypophysial function tests (megatests). These patients were divided in two groups, Group I - 34 lesions from midline: 11 craniopharyngiomas, 8 meningiomas, 3 germinomas, 3 tumors of sphenoid sinus, 2 empty sella syndrome, 2 pylocitic astrocytomas, 1 giant aneurysm, 2 mucoceles, 1 III ventricle diverticulum and 1 Rathke's cleft cyst; Group II - 10 lesions from parasellar area: 9 meningiomas and 1 giant aneurysm. Results: In group 1, 25/34 (73.5%) patients showed laboratorial hormonal deficit (14 without clinical manifestations) 18/34 (52.9%) hyperprolactinemia (5 with galactorreia) and 8 (53.3%) showed growth hormone deficiency in 15 megatests avaliable In this group; 3 (8.8 %) patients presented central diabetes insipidus (CDI). In group II, 6/10 (60%) patients showed laboratorial hormonal deficit (5 without clinical manifestations), 1 (10%) hyperprolactinemia and 1 growth hormone deficiency (single megatest realized in this group); no patient had preoperative CID. Conclusions: The presence of nonspecific or poorly valorized clinical manifestations, does not indicate absence of hormonal dysfunction; in this present serie, 19/38 (50%) patients with laboratorial abnormalities, didn't show clinical manifestations. Hormonal dysfunction is frequent in sellar and perisellar nonpituitary lesions, specially involving midline.
C1 Univ Fed Rio de Janeiro, Serv Neurocirurgia, HUCFF, FM, BR-21941590 Rio de Janeiro, Brazil.
RI Violante, Alice/M-6798-2019; Souto, Andre A/E-6737-2011
OI Souto, Andre A/0000-0002-2437-8767
CR Abe T, 1999, SURG NEUROL, V52, P274, DOI 10.1016/S0090-3019(99)00081-6
   Arafah BM, 2000, J CLIN ENDOCR METAB, V85, P1789, DOI 10.1210/jc.85.5.1789
   Ashkan K, 1997, ACTA NEUROCHIR, V139, P523, DOI 10.1007/BF02750994
   Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353
   Cho DY, 1997, CHILD NERV SYST, V13, P42, DOI 10.1007/s003810050038
   Civit T, 1997, ACTA NEUROCHIR, V139, P160, DOI 10.1007/BF02747200
   CUSIMANO MD, 1988, J NEUROSURG, V69, P620, DOI 10.3171/jns.1988.69.4.0620
   Donovan JL, 1996, AM J ROENTGENOL, V167, P597, DOI 10.2214/ajr.167.3.8751659
   FitzPatrick M, 1999, RADIOL CLIN N AM, V37, P101, DOI 10.1016/S0033-8389(05)70081-6
   Freda PU, 1996, J CLIN ENDOCR METAB, V81, P3455, DOI 10.1210/jc.81.10.3455
   Freda PU, 1999, ENDOCRIN METAB CLIN, V28, P81, DOI 10.1016/S0889-8529(05)70058-X
   GLASS GE, 1995, AM J NEURORADIOL, V16, P179
   Gottfredsson M, 1996, AM J MED, V101, P563, DOI 10.1016/S0002-9343(96)00257-4
   Hampton TA, 1997, AM J SURG PATHOL, V21, P424, DOI 10.1097/00000478-199704000-00008
   Khawali C, 1999, ENDOCRINOLOGIST, V9, P61, DOI 10.1097/00019616-199901000-00012
   KRISHT AF, 1999, PITUITARY DISORDERS, P99
   LEES PD, 1987, J NEUROSURG, V67, P192, DOI 10.3171/jns.1987.67.2.0192
   Nagatani T, 1997, ACTA NEUROCHIR, V139, P94, DOI 10.1007/BF01850878
   Nishioka H, 1999, NEUROSURGERY, V44, P644, DOI 10.1097/00006123-199903000-00115
   Nomikos P, 1999, Pituitary, V2, P123, DOI 10.1023/A:1009983414014
   OSBORN AG, 1996, HDB NEURORADIOLGY BR, P604
   Petrossians P, 1998, J CLIN ENDOCR METAB, V83, P3454, DOI 10.1210/jc.83.10.3454
   Sahjpaul RL, 1999, NEUROSURGERY, V44, P864, DOI 10.1097/00006123-199904000-00101
   Sato N, 1997, RADIOLOGY, V203, P263, DOI 10.1148/radiology.203.1.9122405
   Scheithauer BW, 1996, NEUROSURGERY, V38, P395, DOI 10.1097/00006123-199602000-00034
   SMITH MV, 1994, NEUROSURGERY, V34, P834, DOI 10.1227/00006123-199405000-00007
   TAKAHATA T, 1995, J NEUROSURG, V83, P1092, DOI 10.3171/jns.1995.83.6.1092
   Thodou E, 2000, J NEUROSURG, V92, P976, DOI 10.3171/jns.2000.92.6.0976
   Tsetis D, 1996, BRIT J RADIOL, V69, P269, DOI 10.1259/0007-1285-69-819-269
   VANCE ML, 1994, NEW ENGL J MED, V330, P1651, DOI 10.1056/NEJM199406093302306
NR 30
TC 4
Z9 4
U1 0
U2 0
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD DEC
PY 2001
VL 59
IS 4
BP 905
EP 912
DI 10.1590/S0004-282X2001000600013
PG 8
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 500JM
UT WOS:000172623600013
PM 11733836
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Falavigna, A
   dos Santos, JAN
   Chimelli, L
   Ferraz, FAP
   Bonatelli, ADF
AF Falavigna, A
   dos Santos, JAN
   Chimelli, L
   Ferraz, FAP
   Bonatelli, ADF
TI Anaplastic meningioma - Case report
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE papillary meningioma; pathology; radiotherapy; chemotherapy
ID MALIGNANT MENINGIOMAS; INTRACRANIAL MENINGIOMAS; RECURRENT MENINGIOMAS;
   FEATURES; RADIOTHERAPY; RADIATION; THERAPY; SURGERY
AB Intracranial meningiomas continue to challenge our best clinical efforts to eliminate them once discovered and deemed appropriate for treatment. Malignant meningiomas constitute 10% to 15% of all meningiomas and limited information exists regarding adjuvant treatment. The external whole brain irradiation is recommended, Traditional chemotherapy has proven ineffective; thus, new chemotherapeutic agents and new methods of delivery should be developed. Immunotherapy may be considered for patients with malignant meningiomas when all others previous treatment have failed. We report a case of anaplastic papillary meningioma. A 67-year-old man presented with partial complex seizures, headache and aggressiveness. A computerized tomography and magnetic resonance image demonstrated a large left temporo-occipital mass with difuse contrast enhancement and extensive surrounding edema. A left temporo-occipital flap was performed. The tumor and the infiltrated dura were radically removed. Postoperatively, the patient remained neurologically intact. The treatment was complemented by external whole brain radiation.
C1 Univ Fed Sao Paulo, EPM, Postgrad Neurosurg, BR-04023062 Sao Paulo, Brazil.
   Hosp Procardiaco & Estereolife Neurocirurgia Este, Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
RI Falavigna, Asdrubal/H-5123-2012
OI Falavigna, Asdrubal/0000-0002-0016-3198
CR Akeyson E W, 1996, Oncology (Williston Park), V10, P747
   ALVAREZ F, 1987, NEUROSURGERY, V20, P688, DOI 10.1227/00006123-198705000-00003
   Chamberlain MC, 1996, J NEUROSURG, V84, P733, DOI 10.3171/jns.1996.84.5.0733
   CHEN WYK, 1990, CLIN NEUROPATHOL, V9, P74
   CHO KG, 1986, J NEUROSURG, V65, P790, DOI 10.3171/jns.1986.65.6.0790
   Dziuk TW, 1998, J NEURO-ONCOL, V37, P177, DOI 10.1023/A:1005853720926
   ELSTER AD, 1989, RADIOLOGY, V170, P857, DOI 10.1148/radiology.170.3.2916043
   GOLDSMITH BJ, 1994, J NEUROSURG, V80, P195, DOI 10.3171/jns.1994.80.2.0195
   GRUNBERG SM, 1991, J NEUROSURG, V74, P861, DOI 10.3171/jns.1991.74.6.0861
   INOUE H, 1984, ACTA NEUROCHIR, V73, P179, DOI 10.1007/BF01400851
   JAASKELAINEN J, 1986, SURG NEUROL, V25, P233, DOI 10.1016/0090-3019(86)90233-8
   JAASKELAINEN J, 1985, SURG NEUROL, V24, P165, DOI 10.1016/0090-3019(85)90180-6
   Kaba SE, 1997, NEUROSURGERY, V40, P271, DOI 10.1097/00006123-199702000-00007
   KONDZIOLKA D, 1991, J NEUROSURG, V74, P552, DOI 10.3171/jns.1991.74.4.0552
   KUMAR PP, 1991, NEUROSURGERY, V29, P676, DOI 10.1227/00006123-199111000-00006
   Kyritsis AP, 1996, J NEURO-ONCOL, V29, P269, DOI 10.1007/BF00165657
   MAHMOOD A, 1993, NEUROSURGERY, V33, P955, DOI 10.1227/00006123-199312000-00001
   MAIER H, 1992, J NEUROSURG, V77, P616, DOI 10.3171/jns.1992.77.4.0616
   MAIRE JP, 1995, INT J RADIAT ONCOL, V33, P315, DOI 10.1016/0360-3016(94)00661-4
   Milosevic MF, 1996, INT J RADIAT ONCOL, V34, P817, DOI 10.1016/0360-3016(95)02166-3
   Palma L, 1997, J NEUROSURG, V86, P793, DOI 10.3171/jns.1997.86.5.0793
   RODRIGUEZ LA, 1989, J NEUROSURG, V70, P318
   ROGANO LA, 1995, P C NEUR SURG 45 ANN, P382
   SERVO A, 1990, NEURORADIOLOGY, V32, P94, DOI 10.1007/BF00588556
   STEWART DJ, 1995, J NEURO-ONCOL, V24, P189, DOI 10.1007/BF01078489
   THOMAS HG, 1981, J NEUROSURG, V55, P929, DOI 10.3171/jns.1981.55.6.0929
   WILSON CB, 1994, J NEUROSURG, V81, P666, DOI 10.3171/jns.1994.81.5.0666
   YOUNIS GA, 1995, J NEUROSURG, V82, P17, DOI 10.3171/jns.1995.82.1.0017
NR 28
TC 4
Z9 5
U1 0
U2 0
PU ASSOC ARQUIVOS DE NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD DEC
PY 2001
VL 59
IS 4
BP 939
EP 943
DI 10.1590/S0004-282X2001000600019
PG 5
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 500JM
UT WOS:000172623600019
PM 11733842
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU de Azevedo, MFA
   Nascimento, F
   Quintella, L
   de Rosso, ALZ
   Maranhao, PA
   Correa, RB
   Chimelli, L
   Vincent, M
   Novis, SAP
AF de Azevedo, MFA
   Nascimento, F
   Quintella, L
   de Rosso, ALZ
   Maranhao, PA
   Correa, RB
   Chimelli, L
   Vincent, M
   Novis, SAP
TI Creutzfeldt-Jakob disease: case report with spinal cord involvement
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Spanish
DT Article
DE Creutzfeldt-Jakob disease; prion; spinal cord
ID PRION PROTEIN GENE; SHARP WAVE COMPLEXES; CEREBROSPINAL-FLUID;
   DIAGNOSIS; MUTATION; ENCEPHALITIS; MRI
AB Creutzfeldt-Jakob disease (CJD) is. the most common subacute transmissible spongiform encephalopathy. Approximately 85% of the cases are sporadic. The remaining 15% consist of genetic and iatrogenic forms. We report a sporadic form of CJD with spinal cord involvement and a clinical manifestation characterized by dementia and cerebellar syndrome, myofasciculation with absent reflexes and seizures. The two last manifestations are rare.-The clinical hypothesis was probable CJD which was confirmed with autopsy and immunohistochemistry, We conclude that OD should always be suspected when rapidly progressive dementia occurs and the absence of pyramidal or extrapyramidal signs suggest a spinal cord and/or peripheral nerve involvement.
C1 Univ Fed Rio de Janeiro, INDC, Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, HUCFF, Rio De Janeiro, Brazil.
EM mfaa@openlink.com.br
RI Vincent, Maurice/B-1415-2009
OI Vincent, Maurice/0000-0001-5855-6069
CR Bahn MM, 1999, ARCH NEUROL-CHICAGO, V56, P577, DOI 10.1001/archneur.56.5.577
   Brandel JP, 2000, NEUROLOGY, V54, P1095, DOI 10.1212/WNL.54.5.1095
   Brecher K, 1998, J NEUROL NEUROSUR PS, V64, P418, DOI 10.1136/jnnp.64.3.418a
   BROWN P, 2000, NEUROLOGY CLIN PRACT, V2, P1423
   Collins S, 2000, ARCH NEUROL-CHICAGO, V57, P1058, DOI 10.1001/archneur.57.7.1058
   Demaerel P, 1999, NEUROLOGY, V52, P205, DOI 10.1212/WNL.52.1.205
   Dickson DW, 1999, NEUROLOGY, V53, P1903, DOI 10.1212/WNL.53.9.1903
   Echebarria LEH, 2000, NEUROLOGY, V54, P1539, DOI 10.1212/WNL.54.7.1539
   Hansel P A, 1999, AORN J, V70, P224, DOI 10.1016/S0001-2092(06)62237-0
   Hansen HC, 1998, ACTA NEUROL SCAND, V97, P99
   Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5
   Johnson RT, 1998, NEW ENGL J MED, V339, P1994, DOI 10.1056/NEJM199812313392707
   Na DL, 1999, ARCH NEUROL-CHICAGO, V56, P951, DOI 10.1001/archneur.56.8.951
   NICHOLL D, 1995, J NEUROL NEUROSUR PS, V58, P65, DOI 10.1136/jnnp.58.1.65
   Nitrini R, 1997, ANN NEUROL, V42, P138, DOI 10.1002/ana.410420203
   Samman I, 1999, J NEUROL NEUROSUR PS, V67, P678, DOI 10.1136/jnnp.67.5.678
   Seipelt M, 1999, J NEUROL NEUROSUR PS, V66, P172, DOI 10.1136/jnnp.66.2.172
   Simon ES, 2000, ANN NEUROL, V47, P257, DOI 10.1002/1531-8249(200002)47:2<257::AID-ANA20>3.3.CO;2-L
   Steinhoff BJ, 1996, ARCH NEUROL-CHICAGO, V53, P162, DOI 10.1001/archneur.1996.00550020074017
   Taniwaki Y, 2000, J NEUROL NEUROSUR PS, V68, P388, DOI 10.1136/jnnp.68.3.388
   Wiltfang J, 1999, J NEUROCHEM, V73, P2485, DOI 10.1046/j.1471-4159.1999.0732485.x
   Zerr I, 1998, ANN NEUROL, V43, P32, DOI 10.1002/ana.410430109
NR 22
TC 0
Z9 0
U1 0
U2 2
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD DEC
PY 2001
VL 59
IS 4
BP 964
EP 967
DI 10.1590/S0004-282X2001000600024
PG 4
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 500JM
UT WOS:000172623600024
PM 11733847
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Leite, JP
   Terra-Bustamante, VC
   Fernandes, RMF
   Santos, AC
   Chimelli, L
   Sakamoto, AC
   Assirati, JA
   Takayanagui, OM
AF Leite, JP
   Terra-Bustamante, VC
   Fernandes, RMF
   Santos, AC
   Chimelli, L
   Sakamoto, AC
   Assirati, JA
   Takayanagui, OM
TI Calcified neurocysticercotic lesions and postsurgery seizure control in
   temporal lobe epilepsy
SO NEUROLOGY
LA English
DT Article
ID FASCIA-DENTATA; DUAL PATHOLOGY; CYSTICERCOSIS; ASSOCIATION; MANAGEMENT;
   DENSITIES; FREQUENCY; LOBECTOMY; SURGERY; SINGLE
AB Background: Several studies suggest that neurocysticercosis is the main cause of symptomatic epilepsy in developing countries. In such areas, calcified cysticercotic lesions (CCL) are frequently found in patients with complex partial seizures associated with hippocampal sclerosis (HS). The authors studied whether there are clinical and pathologic differences between HS patients with and without CCL. Methods: The authors determined the clinical and pathologic findings of 30 patients with HS and compared them with 32 patients with HS + CCL. Hippocampi from both groups were measured for fascia dentata Timm staining and cell density in hippocampal subfields. Results: In the HS + CCL group, single or multiple CCL were found in all lobes with no lobar predominance. An initial precipitating event occurred in 83.3% of HS and in 62.5% of HS + CCL. First complex partial seizure occurred at 10.1 years in HS and at 11.9 years in HS + CCL. No significant differences were found for fascia dentata Timm staining and hippocampal cell densities. Good postsurgery outcome (Engel I classification) did not differ between groups, with this result occurring in 76.6% of patients with HS and 81.2% of patients with HS + CCL. Conclusions: The presence of CCL does not influence the clinical and pathologic profile of patients with hippocampal atrophy. Clinical histories and postsurgical outcomes were similar to those of patients with classic HS, suggesting that the CCL is probably, in this set of patients, a coincidental pathology and does not have a role in epileptogenesis.
C1 Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Neurol, BR-14049900 Sao Paulo, Brazil.
   Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Surg, BR-14049900 Sao Paulo, Brazil.
   Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Pathol, BR-14049900 Sao Paulo, Brazil.
   Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Clin Med, BR-14049900 Sao Paulo, Brazil.
RP Leite, JP (corresponding author), Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Neurol, Campus Univ, BR-14049900 Sao Paulo, Brazil.
RI Takayanagui, Osvaldo M/C-8159-2013; Santos, Antonio/F-5419-2012; Leite,
   Joao/B-9070-2012; Sakamoto, Americo C/H-5311-2012
OI Takayanagui, Osvaldo M/0000-0002-8190-0275; Leite,
   Joao/0000-0003-0558-3519; Terra, Vera/0000-0002-4246-970X
CR ALMEIDAPINTO J, 1988, ACTA RADIOL, V29, P625
   BABB TL, 1984, EPILEPSIA, V25, P729, DOI 10.1111/j.1528-1157.1984.tb03484.x
   BABB TL, 1991, NEUROSCIENCE, V42, P351, DOI 10.1016/0306-4522(91)90380-7
   Bern C, 1999, CLIN INFECT DIS, V29, P1203, DOI 10.1086/313470
   BRATZ E, 1899, ARCH PSYCHIAT, V31, P820
   CARPIO A, 1994, CAN J NEUROL SCI, V21, P43, DOI 10.1017/S0317167100048757
   Carpio A, 1998, EPILEPSIA, V39, P1025, DOI 10.1111/j.1528-1157.1998.tb01287.x
   CENDES F, 1995, NEUROLOGY, V45, P2058, DOI 10.1212/WNL.45.11.2058
   Chimelli L, 1998, ARQ NEURO-PSIQUIAT, V56, P577, DOI 10.1590/S0004-282X1998000400010
   Chung C K, 1998, J Korean Med Sci, V13, P445
   de No RL, 1934, J PSYCHOL NEUROL, V46, P113
   Engel J, 1996, NEW ENGL J MED, V334, P647, DOI 10.1056/NEJM199603073341008
   ENGEL J, 1991, PRINCIPLES NEUROSURG, P319
   Engel Jerome Jr., 1993, P609
   FISH D, 1991, NEUROLOGY, V41, P1781, DOI 10.1212/WNL.41.11.1781
   GARCIA HH, 1993, LANCET, V341, P197, DOI 10.1016/0140-6736(93)90064-N
   Garg RK, 1998, SEIZURE-EUR J EPILEP, V7, P497, DOI 10.1016/S1059-1311(98)80009-5
   Gilliam F, 1997, EPILEPSIA, V38, P1315, DOI 10.1111/j.1528-1157.1997.tb00069.x
   HARDIMAN O, 1988, NEUROLOGY, V38, P1041, DOI 10.1212/WNL.38.7.1041
   KALE R, 1994, BRIT MED J, V309, P939, DOI 10.1136/bmj.309.6959.939
   Leite JP, 1996, EPILEPSY RES, V26, P219, DOI 10.1016/S0920-1211(96)00055-1
   Li LM, 1997, NEUROLOGY, V48, P437, DOI 10.1212/WNL.48.2.437
   LUDERS H, 1994, EPILEPSIA, V35, P1174, DOI 10.1111/j.1528-1157.1994.tb01785.x
   MATHERN GW, 1994, DEV BRAIN RES, V78, P70, DOI 10.1016/0165-3806(94)90011-6
   Mathern GW, 1996, NEUROREPORT, V7, P1029, DOI 10.1097/00001756-199604100-00015
   MATHERN GW, 1995, J NEUROSCI, V15, P3990
   MATHERN GW, 1997, EPILEPSY COMPREHENSI, P133
   MEDINA MT, 1990, ARCH INTERN MED, V150, P325, DOI 10.1001/archinte.150.2.325
   MEDINA MT, 1993, EPILEPSIA, V34, P1024, DOI 10.1111/j.1528-1157.1993.tb02128.x
   MONTEIRO L, 1992, INFECTION, V20, P61, DOI 10.1007/BF01711064
   Nieto D., 1982, CYSTICERCOSIS PRESEN, P179
   ODONOGHUE M, 1993, LANCET, V341, P568, DOI 10.1016/0140-6736(93)90338-H
   Pal DK, 2000, J NEUROL NEUROSUR PS, V68, P137, DOI 10.1136/jnnp.68.2.137
   Pataraia E, 1998, EPILEPSIA, V39, P608, DOI 10.1111/j.1528-1157.1998.tb01429.x
   Radhakrishnan K, 1998, NEUROLOGY, V51, P465, DOI 10.1212/WNL.51.2.465
   RAJSHEKHAR V, 1991, ACTA NEUROL SCAND, V84, P465, DOI 10.1111/j.1600-0404.1991.tb04996.x
   RAYMOND AA, 1994, NEUROLOGY, V44, P1841, DOI 10.1212/WNL.44.10.1841
   SCHANTZ PM, 1992, NEW ENGL J MED, V327, P692, DOI 10.1056/NEJM199209033271004
   TAKAYANAGUI OM, 1992, ARCH NEUROL-CHICAGO, V49, P290, DOI 10.1001/archneur.1992.00530270106026
   Vinters Harry V., 1993, P593
NR 40
TC 58
Z9 59
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0028-3878
J9 NEUROLOGY
JI Neurology
PD NOV 28
PY 2000
VL 55
IS 10
BP 1485
EP 1491
DI 10.1212/WNL.55.10.1485
PG 7
WC Clinical Neurology
SC Neurosciences & Neurology
GA 376DR
UT WOS:000165443400011
PM 11094102
DA 2020-12-08
ER

PT J
AU Puga, ACS
   Jardim, LB
   Chimelli, L
   De Souza, CFM
   Clivati, M
AF Puga, ACS
   Jardim, LB
   Chimelli, L
   De Souza, CFM
   Clivati, M
TI Neuronal ceroid lipofuscinoses - A clinical and morphologicial study of
   17 patients from southern Brazil
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE neuronal ceroid lipofuscinoses; lysosomal storage disease;
   Haltia-Santavuori disease; Jansky-Bielschowsky disease;
   Batten-Spielmeyer-Vogt disease
ID JANSKY-BIELSCHOWSKY DISEASE; BATTEN-DISEASE; FORMS; CHILDHOOD; VARIANT
AB The neuronal ceroid lipofuscinoses (NCL) are a group of inherited progressive neurodegenerative disorders with presentation from infancy to adulthood. Three main childhood forms can be established on the basis of age of onset, clinical course, and ultrastructural morphology; infantile (INCL), late infantile (LINCL), and juvenile (JNCL). Several variant subtypes have been described. Genetic and biochemical analysis are helping to better understand, diagnose and classify these disorders. We report on clinical, neurophysiological, neuroradiological, and morphological data from 17 patients with different forms (infantile, late infantile, and juvenile) of neuronal ceroid lipofuscinoses (NCL) evaluated at Hospital de Clinicas de Porto Alegro, Southern Brazil, during 6 years (1992-1997). Seven cases were infantile; 5 were late infantile; and 5 were juvenile NCL. Gender ratio was male:female, 11:6. Age at presentation varied from 2-24 months for INCL; 2,5 to 5 years for LINCL; and 4-10 years for the JNCL cases. Seizures (6 patients) and psychomotor retardation (1 patient) were the initial symptoms in the INCL group. All the patients in the group of LINCL had the usual findings. JNCL patients manifested different initial symptoms, although tending to follow a similar clinical picture within familial cases. Epidemiological data on the prevalence of NCLs in Brazil are not available, we expect this series of cases to contribute to further research in our population.
C1 Hosp Clin Porto Alegre, Serv Genet Med, Porto Alegre, RS, Brazil.
   Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Patol, Sao Paulo, Brazil.
   Harvard Univ, Childrens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA.
RI de Souza, Carolina Fischinger Moura/V-9921-2019; Jardim, Laura
   B/B-6149-2013
CR Bennett MJ, 1999, J INHERIT METAB DIS, V22, P535, DOI 10.1023/A:1005564509027
   BERKOVIC SF, 1988, BRAIN, V111, P27, DOI 10.1093/brain/111.1.27
   CARDONA F, 1995, AM J MED GENET, V57, P142, DOI 10.1002/ajmg.1320570206
   CARPENTER S, 1973, J NEUROL SCI, V18, P67, DOI 10.1016/0022-510X(73)90021-X
   CLAUSSEN M, 1992, AM J MED GENET, V42, P536, DOI 10.1002/ajmg.1320420422
   DYKEN P, 1995, AM J MED GENET, V57, P150, DOI 10.1002/ajmg.1320570208
   Dyken P R, 1988, Am J Med Genet Suppl, V5, P69
   Goebel H H, 1996, Semin Pediatr Neurol, V3, P270, DOI 10.1016/S1071-9091(96)80031-3
   GOEBEL HH, 1993, J INHERIT METAB DIS, V16, P233, DOI 10.1007/BF00710252
   Goebel HH, 1997, NEUROPEDIATRICS, V28, P67, DOI 10.1055/s-2007-973672
   Goebel HH, 1998, BRAIN PATHOL, V8, P151
   GOEBEL HH, 1995, J CHILD NEUROL, V10, P424, DOI 10.1177/088307389501000602
   HAGBERG B, 1968, ACTA PAEDIATR SCAND, V57, P495, DOI 10.1111/j.1651-2227.1968.tb06968.x
   HALTIA M, 1973, ACTA NEUROPATHOL, V26, P157, DOI 10.1007/BF00697751
   HELLSTEN E, 1993, GENOMICS, V16, P720, DOI 10.1006/geno.1993.1253
   KOHLSCHUTTER A, 1993, J INHERIT METAB DIS, V16, P241, DOI 10.1007/BF00710254
   LAKE BD, 1978, J NEUROL SCI, V36, P265, DOI 10.1016/0022-510X(78)90087-4
   LAKE BD, 1998, EUR J PAED NEUROL, V2, P2
   LYON G, 1996, NEUROLOGY HEREDITARY, P146
   LYON G, 1996, CHILDHOOD ADOLESCENT, P241
   MacLeod P M, 1976, Birth Defects Orig Artic Ser, V12, P289
   MARTIN JJ, 1993, J INHERIT METAB DIS, V16, P237, DOI 10.1007/BF00710253
   MITCHISON HM, 1993, J INHERIT METAB DIS, V16, P339, DOI 10.1007/BF00710278
   MOLE S, 1998, EUR J PEDIAT NEUROL, V2, P2
   Mole SE, 1996, J INHERIT METAB DIS, V19, P269, DOI 10.1007/BF01799253
   NARDOCCI N, 1995, AM J MED GENET, V57, P137, DOI 10.1002/ajmg.1320570205
   Sainio K, 1997, NEUROPEDIATRICS, V28, P70, DOI 10.1055/s-2007-973673
   SANTAVUORI P, 1988, BRAIN DEV-JPN, V10, P80, DOI 10.1016/S0387-7604(88)80075-5
   SANTAVUORI P, 1991, NEUROPEDIATRICS, V22, P92, DOI 10.1055/s-2008-1071423
   SANTAVUORI P, 1982, NEUROPEDIATRICS, V13, P135, DOI 10.1055/s-2008-1059612
   SHARP JD, 1995, EUR J HUM GENET, V3, P326
   Sharp JD, 1997, HUM MOL GENET, V6, P591, DOI 10.1093/hmg/6.4.591
   TARATUTO AL, 1995, AM J MED GENET, V57, P144, DOI 10.1002/ajmg.1320570207
   WILLIAM RE, 1998, EUR J PAED NEUROL, V2, P2
   WISNIEWSKI KE, 1992, AM J MED GENET, V42, P525, DOI 10.1002/ajmg.1320420420
NR 35
TC 10
Z9 10
U1 0
U2 0
PU ASSOC ARQUIVOS DE NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD SEP
PY 2000
VL 58
IS 3A
BP 597
EP 606
DI 10.1590/S0004-282X2000000400001
PG 10
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 349AR
UT WOS:000089022100001
PM 10973097
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Mahler-Araujo, MB
   Chimelli, L
AF Mahler-Araujo, MB
   Chimelli, L
TI Autonomic dysfunction in Chagas disease: lack of participation of the
   vagus nerve
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE Chagas disease; autonomic nervous system; vagus nerve; histology; light
   microscopy; electron microscopy
ID CARDIOMYOPATHY; DEATH
AB To evaluate the possible role of the vagus nerve in the development of the dysautonomia in Chagas disease, we examined 18 nerves from chagasic patients and 8 from non-chagasic patients, autopsied at the Department of Pathology, Ribeirao Preto School of Medicine, Brazil. Histological analysis showed mild inflammatory infiltrate composed predominantly of T lymphocytes, in epi-, peri- and endoneurium. No parasites were observed. Semithin sections showed swollen unmyelinated fibres, occasional thinly myelinated fibres, degenerated and atrophic axons, related to myelinated fibres. These findings were confirmed by electron microscopy, and in teased fibres. The changes were observed both in chagasic and in non-chagasic patients. Statistical analysis of the morphometric findings (myelinated fibre density, axonal and fibre diameters) failed to show significant differences between the 2 groups. The frequency of myelinated fibres of various diameters was also similar in the 2 groups. The morphological and morphometrical findings in chagasic patients are mild, non-specific, and could be related to the age of the patients, or with artefacts, since they have also been observed in non-chagasic patients. Retrograde changes due to the ganglionic lesions in the innervated organs cannot be completely ruled out. Our results do not allow us to implicate the vagus nerve in the dysautonomia in Chagas disease.
C1 UFRJ, Univ Hosp, Serv Anat Patol, BR-21941590 Rio De Janeiro, Brazil.
   Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Pathol, Sao Paulo, Brazil.
RP Chimelli, L (corresponding author), UFRJ, Univ Hosp, Serv Anat Patol, Ilha Fdn, BR-21941590 Rio De Janeiro, Brazil.
CR ALMEIDA HO, 1988, ARQ BRAS CARDIOL, V50, P159
   ANDRADE Z, 1987, Arquivos Brasileiros de Cardiologia, V48, P5
   ATKINSON JB, 1984, ARCH PATHOL LAB MED, V108, P341
   BECKER LE, 1993, ACTA NEUROPATHOL, V86, P617, DOI 10.1007/BF00294301
   Chapadeiro E, 1999, Rev Soc Bras Med Trop, V32, P35, DOI 10.1590/S0037-86821999000100007
   COWAN WM, 1970, CONT RES METHODS NEU, P217
   Davila DF, 1998, INT J CARDIOL, V66, P123, DOI 10.1016/S0167-5273(98)00212-5
   DEOLIVEIRA JAM, 1972, ARQ BRAS CARDIOL, V25, P17
   Fazan VPS, 1997, AM J TROP MED HYG, V57, P672, DOI 10.4269/ajtmh.1997.57.672
   GUO YP, 1987, J NEUROL NEUROSUR PS, V50, P1449, DOI 10.1136/jnnp.50.11.1449
   Johnson Robert David, 1994, CELL CYCLE PRACTICAL, P1
   JUNQUEIRA JF, 1991, REV INST MED TROP SP, V33, P337
   JUNQUEIRA LF, 1992, CARDIOVASC RES, V26, P324, DOI 10.1093/cvr/26.4.324
   Koberle F., 1968, Advances in Parasitology, V6, P63, DOI 10.1016/S0065-308X(08)60472-8
   KRISTENSSON K, 1971, ACTA PATH MICRO IM A, VA 79, P684
   Lopes E R, 1969, Rev Inst Med Trop Sao Paulo, V11, P123
   OCHOA J, 1969, ACTA NEUROPATHOL, V13, P197, DOI 10.1007/BF00690642
   Ramos SG, 1996, AM HEART J, V131, P417, DOI 10.1016/S0002-8703(96)90381-6
   RICH V, 1995, PHYS WORLD, V8, P8
   ROSSI MA, 1995, CARDIOLOGY, V86, P1, DOI 10.1159/000176822
   Thomas P., 1984, PERIPHERAL NEUROPATH, P39
   TURNBULL DM, 1980, LANCET, V20, P1381
NR 22
TC 3
Z9 3
U1 0
U2 2
PU ROYAL SOC TROPICAL MEDICINE
PI LONDON
PA MANSON HOUSE 26 PORTLAND PLACE, LONDON W1N 4EY, ENGLAND
SN 0035-9203
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD JUL-AUG
PY 2000
VL 94
IS 4
BP 405
EP 408
DI 10.1016/S0035-9203(00)90122-6
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 351ME
UT WOS:000089161600015
PM 11127245
DA 2020-12-08
ER

PT J
AU Chimelli, L
   Serafini, LN
   Baptista, DB
AF Chimelli, L
   Serafini, LN
   Baptista, DB
TI Investigation of encephalomyeloneuropathy in chronic Chagas' disease
SO JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
LA English
DT Meeting Abstract
C1 Univ Sao Paulo, Sch Med Ribeirao Preto, Sao Paulo, Brazil.
   Fed Univ Rio De Janeiro, Sch Med, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSN NEUROPATHOLOGISTS INC
PI LAWRENCE
PA 1041 NEW HAMPSHIRE ST, LAWRENCE, KS 66044 USA
SN 0022-3069
J9 J NEUROPATH EXP NEUR
JI J. Neuropathol. Exp. Neurol.
PD MAY
PY 2000
VL 59
IS 5
MA 68
BP 436
EP 436
PG 1
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA 311EE
UT WOS:000086871100078
DA 2020-12-08
ER

PT J
AU Martins, AR
   Dias, MM
   Vasconcelos, TM
   Caldo, H
   Costa, MCR
   Chimelli, L
   Larson, RE
AF Martins, AR
   Dias, MM
   Vasconcelos, TM
   Caldo, H
   Costa, MCR
   Chimelli, L
   Larson, RE
TI Microwave-stimulated recovery of myosin-V immunoreactivity from
   formalin-fixed, paraffin-embedded human CNS
SO JOURNAL OF NEUROSCIENCE METHODS
LA English
DT Article
DE myosin-V; human nervous system; immunohistochemistry; antigen retrieval;
   microwave; cerebellum; Purkinje cell; granule cell
ID UNCONVENTIONAL MYOSINS; ANTIGEN RETRIEVAL; GROWTH CONES; LOCALIZATION;
   PROTEINS; BRAIN; NITROCELLULOSE; SECTIONS; COMPLEX; MOTOR
AB The lability of brain myosin-V (BM-V) to aldehyde-fixation has hindered immunohistochemical (IH) studies of this actin-based motor. We show here that BM-V immunoreactivity (IR) can be retrieved from formalin-fixed, paraffin-embedded human tissue. BM-V IR was optimally retrieved by boiling 5 mu m cerebellar tissue sections in 10 mM sodium citrate buffer, pH 6, for 15 min, using a microwave oven set at 900 W and 2.45 GHz. A polyclonal, affinity purified anti-BM-V antibody, raised in rabbits against the tail domain of chicken BM-V, was shown here to recognize a single band in Western blots of human cortical homogenates. The combined use of this monospecific antibody and of the antigen retrieval (AR) method above allowed us to verify that BM-V IR is strongly expressed in human Purkinje cell bodies and dendrites, and in granule cells. The same pattern of BM-V IR expression was consistently and maximally detected in tissues stored in 10% formalin from 1 week to 2.5 months. The AR protocol for BM-V described here permits its IH study in formaldehyde-fixed tissues. It is a valuable tool to study BM-V in well fixed tissues, as occurs with the large collection of human archival tissue available. (C) 1999 Elsevier Science B.V. All rights reserved.
C1 Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Pharmacol, BR-14049900 Ribeirao Preto, SP, Brazil.
   Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biochem, BR-14049900 Ribeirao Preto, SP, Brazil.
   Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Pathol, BR-14049900 Ribeirao Preto, SP, Brazil.
RP Martins, AR (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Pharmacol, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
RI Romano, Minna/A-7538-2013; Romano, Minna Moreira Dias/K-1820-2013
OI Romano, Minna Moreira Dias/0000-0002-2526-0656
CR BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4
   DECAMILLI P, 1983, J CELL BIOL, V96, P1337, DOI 10.1083/jcb.96.5.1337
   ENGLE LJ, 1994, GENOMICS, V19, P407, DOI 10.1006/geno.1994.1088
   ESPINDOLA FS, 1992, J CELL BIOL, V118, P359, DOI 10.1083/jcb.118.2.359
   ESPREAFICO EM, 1992, J CELL BIOL, V119, P1541, DOI 10.1083/jcb.119.6.1541
   Evans LL, 1997, J CELL SCI, V110, P439
   LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8
   Larson RE, 1996, BRAZ J MED BIOL RES, V29, P309
   LEARY JJ, 1983, P NATL ACAD SCI-BIOL, V80, P4045, DOI 10.1073/pnas.80.13.4045
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MANI F, 1994, BRAZ J MED BIOL RES, V27, P2639
   MERCER JA, 1991, NATURE, V352, P547, DOI 10.1038/352547b0
   MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0
   Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527
   Mooseker MS, 1995, ANNU REV CELL DEV BI, V11, P633, DOI 10.1146/annurev.cb.11.110195.003221
   Pastural E, 1997, NAT GENET, V16, P289, DOI 10.1038/ng0797-289
   Prekeris R, 1997, J CELL BIOL, V137, P1589, DOI 10.1083/jcb.137.7.1589
   SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656
   Shi SR, 1997, J HISTOCHEM CYTOCHEM, V45, P327, DOI 10.1177/002215549704500301
   Titus MA, 1997, CURR BIOL, V7, pR301, DOI 10.1016/S0960-9822(06)00143-6
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Wang FS, 1996, SCIENCE, V273, P660, DOI 10.1126/science.273.5275.660
NR 22
TC 26
Z9 26
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-0270
J9 J NEUROSCI METH
JI J. Neurosci. Methods
PD OCT 15
PY 1999
VL 92
IS 1-2
BP 25
EP 29
DI 10.1016/S0165-0270(99)00090-4
PG 5
WC Biochemical Research Methods; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 262AD
UT WOS:000084042800004
PM 10595700
DA 2020-12-08
ER

PT J
AU Mathern, GW
   Pretorius, JK
   Mendoza, D
   Leite, JP
   Chimelli, L
   Born, DE
   Fried, I
   Assirati, JA
   Ojemann, GA
   Adelson, PD
   Cahan, LD
   Kornblum, HI
AF Mathern, GW
   Pretorius, JK
   Mendoza, D
   Leite, JP
   Chimelli, L
   Born, DE
   Fried, I
   Assirati, JA
   Ojemann, GA
   Adelson, PD
   Cahan, LD
   Kornblum, HI
TI Hippocampal N-methyl-D-aspartate receptor subunit mRNA levels in
   temporal lobe epilepsy patients
SO ANNALS OF NEUROLOGY
LA English
DT Article
ID DENTATE GRANULE CELLS; AMINO-ACID RECEPTORS; MESSENGER-RNA LEVELS; NMDA
   RECEPTOR; NEURON LOSS; FUNCTIONAL-PROPERTIES; ALTERED DISTRIBUTION;
   GLUTAMATE-RECEPTORS; ZINC INHIBITION; GROWTH-FACTOR
AB Changes in the subunit stoichiometry of the N-methyl-D-aspartate (NMDA) receptor (NMDAR) alters its channel properties, and may enhance or reduce neuronal excitability in temporal lobe epilepsy patients. This study determined whether hippocampal NMDA receptor subunit mRNA levels were increased or decreased in temporal lobe epilepsy patients compared with nonseizure autopsy cases. Hippocampal sclerosis (HS; n = 16), non-HS (n = 10), and autopsy hippocampi (n = 9) were studied for NMDAR1 (NR1) and NR2A-D mRNA levels by using semiquantitative in situ hybridization techniques, along with neuron densities. Compared with autopsy hippocampi, non-HS and HS patients showed increased NR2A and NR2B hybridization densities per dentate granule cell. Furthermore, non-HS hippocampi showed increased NR1 and NR2B mRNA levels per CA2/3 pyramidal neuron compared with autopsy cases. HS patients, by contrast, showed decreased NR2A hybridization densities per CA2/3 pyramidal neuron compared with non-HS and autopsy cases. These findings indicate that chronic temporal lobe seizures are associated with differential changes in hippocampal NR1 and NR2A-D hybridization densities that vary by subfield and clinical-pathological category. In temporal lobe epilepsy patients, these findings support the hypothesis that in dentate granule cells NMDA receptors are increased, and excitatory postsynaptic potentials should be strongly NMDA mediated compared with nonseizure autopsies. HS patients, by comparison, showed decreased pyramidal neuron NR2A mRNA levels, and this suggests that NMDA-mediated pyramidal neuron responses should be reduced in MS patients compared with non-HS cases.
C1 Univ Calif Los Angeles, Med Ctr, Div Neurosurg, Reed Neurol Res Ctr, Los Angeles, CA 90095 USA.
   Univ Calif Los Angeles, Div Pediat Neurol, Los Angeles, CA 90095 USA.
   Univ Calif Los Angeles, Div Mol & Med Pharmacol, Los Angeles, CA 90095 USA.
   Univ Calif Los Angeles, Mental Retardat Res Ctr, Los Angeles, CA 90095 USA.
   Univ Calif Los Angeles, Inst Brain Res, Los Angeles, CA 90095 USA.
   So Calif Permanente Med Grp, Div Neurosurg, Los Angeles, CA 90027 USA.
   Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Pathol, BR-14049 Ribeirao Preto, Brazil.
   Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Neurol, BR-14049 Ribeirao Preto, Brazil.
   Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Neurosurg, BR-14049 Ribeirao Preto, Brazil.
   Univ Washington, Sch Med, Dept Pathol Neuropathol, Seattle, WA 98195 USA.
   Univ Washington, Sch Med, Dept Neurosurg, Seattle, WA 98195 USA.
   Univ Pittsburgh, Sch Med, Dept Neurosurg, Pittsburgh, PA 15261 USA.
RP Mathern, GW (corresponding author), Univ Calif Los Angeles, Med Ctr, Div Neurosurg, Reed Neurol Res Ctr, Los Angeles, CA 90095 USA.
RI Leite, Joao/B-9070-2012; Adelson, David/W-2083-2019; Mathern, Gary
   W./J-2483-2016
OI Leite, Joao/0000-0003-0558-3519; 
FU NINDS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [K08 NS 01603, P01 NS 02808, R55 NS 36536]
   Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS
   AND STROKEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, K08NS001603, K08NS001603, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   K08NS001603, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, K08NS001603, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   K08NS001603, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, R55NS036536, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808] Funding Source: NIH
   RePORTER
CR ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210
   AMARAL DG, 1986, HUM NEUROBIOL, V5, P169
   Babb T. L., 1987, SURGICAL TREATMENT E, P511
   BABB TL, 1984, EPILEPSIA, V25, P721, DOI 10.1111/j.1528-1157.1984.tb03483.x
   BABB TL, 1984, EPILEPSIA, V25, P729, DOI 10.1111/j.1528-1157.1984.tb03484.x
   BAYER TA, 1995, ACTA NEUROPATHOL, V89, P446
   Blumcke I, 1996, ACTA NEUROPATHOL, V92, P576, DOI 10.1007/s004010050564
   BOCHET P, 1994, NEURON, V12, P383, DOI 10.1016/0896-6273(94)90279-8
   BULLER AL, 1994, J NEUROSCI, V14, P5471
   Chen NS, 1997, MOL PHARMACOL, V51, P1015
   CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6
   Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9
   COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143
   COLLINGRIDGE GL, 1990, TRENDS PHARMACOL SCI, V11, P290, DOI 10.1016/0165-6147(90)90011-V
   COX KH, 1984, DEV BIOL, V101, P485, DOI 10.1016/0012-1606(84)90162-3
   CRANDALL PH, 1999, EPILEPSY SURGERY
   CRUZORIVE LM, 1990, AM J PHYSIOL, V258, pL148
   DAM AM, 1980, EPILEPSIA, V21, P617, DOI 10.1111/j.1528-1157.1980.tb04315.x
   de No RL, 1934, J PSYCHOL NEUROL, V46, P113
   DINGLEDINE R, 1990, TRENDS PHARMACOL SCI, V11, P334, DOI 10.1016/0165-6147(90)90238-4
   ENGEL J, 1993, SURGICAL TREATMENT E
   ENGEL J, 1991, PRINCIPLES NEUROSURG, P319
   FRANCK JE, 1995, EPILEPSIA, V36, P543, DOI 10.1111/j.1528-1157.1995.tb02566.x
   GALL CM, 1989, SCIENCE, V245, P758, DOI 10.1126/science.2549634
   GEDDES JW, 1990, EXP NEUROL, V108, P214, DOI 10.1016/0014-4886(90)90125-C
   GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4
   Gold SJ, 1996, J COMP NEUROL, V365, P541
   HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335
   HOSFORD DA, 1991, J NEUROSCI, V11, P428
   IKEDA K, 1992, FEBS LETT, V313, P34, DOI 10.1016/0014-5793(92)81178-O
   Isokawa M, 1997, J NEUROPHYSIOL, V77, P3355
   ISOKAWA M, 1991, NEUROSCI LETT, V132, P212, DOI 10.1016/0304-3940(91)90304-C
   ISOKAWA M, 1991, NEUROSCI LETT, V129, P69, DOI 10.1016/0304-3940(91)90722-6
   Johnson M, 1996, NEUROBIOL AGING, V17, P639
   KOHR G, 1994, NEUROSCIENCE, V62, P975, DOI 10.1016/0306-4522(94)90336-0
   KOHR G, 1994, NEURON, V12, P1031, DOI 10.1016/0896-6273(94)90311-5
   Kohr G, 1996, J PHYSIOL-LONDON, V492, P445
   KORNBLUM HI, 1994, MOL BRAIN RES, V21, P107, DOI 10.1016/0169-328X(94)90383-2
   Krupp JJ, 1996, MOL PHARMACOL, V50, P1680
   KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0
   LAMBOLEZ B, 1992, NEURON, V9, P247, DOI 10.1016/0896-6273(92)90164-9
   MASUKAWA LM, 1991, BRAIN RES, V562, P176, DOI 10.1016/0006-8993(91)91205-F
   MASUKAWA LM, 1992, BRAIN RES, V579, P119, DOI 10.1016/0006-8993(92)90750-4
   Mathern GW, 1996, BRAIN, V119, P965, DOI 10.1093/brain/119.3.965
   Mathern GW, 1998, NEUROBIOL DIS, V5, P151, DOI 10.1006/nbdi.1998.0200
   MATHERN GW, 1995, BRAIN, V118, P105, DOI 10.1093/brain/118.1.105
   Mathern GW, 1997, J NEUROPATH EXP NEUR, V56, P199, DOI 10.1097/00005072-199702000-00011
   Mathern GW, 1996, NEUROREPORT, V7, P1029, DOI 10.1097/00001756-199604100-00015
   Mathern GW, 1998, J NEUROPATH EXP NEUR, V57, P615, DOI 10.1097/00005072-199806000-00008
   Mathern GW, 1997, BRAIN, V120, P1937, DOI 10.1093/brain/120.11.1937
   Mathern GW, 1998, EPILEPSY RES, V30, P133, DOI 10.1016/S0920-1211(97)00103-4
   MATHERN GW, 1995, EPILEPSY RES, V21, P133, DOI 10.1016/0920-1211(95)00014-2
   MATHERN GW, 1997, EPILEPSY COMPREHENSI, P133
   MAYHEW TM, 1992, J NEUROCYTOL, V21, P313, DOI 10.1007/BF01191700
   MCDONALD JW, 1991, ANN NEUROL, V29, P529, DOI 10.1002/ana.410290513
   MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0
   Michaelis EK, 1998, PROG NEUROBIOL, V54, P369, DOI 10.1016/S0301-0082(97)00055-5
   MODY I, 1987, NATURE, V326, P701, DOI 10.1038/326701a0
   MOLINOFF PB, 1994, PROG BRAIN RES, V100, P39
   MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0
   MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217
   MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0
   Paoletti P, 1997, J NEUROSCI, V17, P5711
   PRATT GD, 1993, NEUROSCIENCE, V57, P307, DOI 10.1016/0306-4522(93)90064-M
   SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0
   Scherzer CR, 1998, J COMP NEUROL, V390, P75, DOI 10.1002/(SICI)1096-9861(19980105)390:1<75::AID-CNE7>3.0.CO;2-N
   SOMMER B, 1992, TRENDS PHARMACOL SCI, V13, P291, DOI 10.1016/0165-6147(92)90088-N
   Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6
   URBAN L, 1990, BRAIN RES, V515, P319, DOI 10.1016/0006-8993(90)90615-I
   Weiss SW, 1998, J NEUROSCI, V18, P1725
   WEST MJ, 1990, PROG BRAIN RES, V83, P13
   Wieser Heinz-Gregor, 1993, P49
   Williams K, 1996, NEUROSCI LETT, V215, P9, DOI 10.1016/S0304-3940(96)12924-4
   WILLIAMSON A, 1994, HIPPOCAMPUS, V4, P226, DOI 10.1002/hipo.450040213
   WILLIAMSON A, 1993, BRAIN RES, V622, P194, DOI 10.1016/0006-8993(93)90819-9
   WILLIAMSON A, 1995, NEUROREPORT, V6, P1562, DOI 10.1097/00001756-199507310-00024
   WILLIAMSON A, 1990, EPILEPSIA, V31, P625
NR 77
TC 53
Z9 54
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD SEP
PY 1999
VL 46
IS 3
BP 343
EP 358
DI 10.1002/1531-8249(199909)46:3<343::AID-ANA10>3.0.CO;2-S
PG 16
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 232FJ
UT WOS:000082360000010
PM 10482265
DA 2020-12-08
ER

PT J
AU De-Carvalho, MCA
   Chimelli, LMC
   Quirico-Santos, T
AF De-Carvalho, MCA
   Chimelli, LMC
   Quirico-Santos, T
TI Modulation of fibronectin expression in the central nervous system of
   Lewis rats with experimental autoimmune encephalomyelitis
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article; Proceedings Paper
CT 5th Brazilian Symposium on Extracellular Matrix (SIMEC 98)
CY SEP 07-10, 1998
CL ANGRA DOS REIS, BRAZIL
DE experimental autoimmune encephalomyelitis (EAE); extracellular matrix;
   fibronectin; central nervous system
ID EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS LESIONS;
   EXTRACELLULAR-MATRIX; CELL-ADHESION; DISEASE; ICAM-1; VCAM-1
AB Fibronectin (FN), a large family of plasma and extracellular matrix (ECM) glycoproteins, plays an important role in leukocyte migration. In normal central nervous system (CNS), a fine and delicate mesh of FN is virtually restricted to the basal membrane of cerebral blood vessels and to the glial limitans externa. Experimental autoimmune encephalomyelitis (EAE), an inflammatory CNS demyelinating disease, was induced in Lewis rats with a spinal cord homogenate. During the preclinical phase and the onset of the disease, marked immunolabelling was observed on the endothelial luminal surface and basal lamina of spinal cord and brainstem microvasculature. In the paralytic phase, a discrete labelling was evident in blood vessels of spinal cord and brainstem associated or not with an inflammatory infiltrate. Conversely, intense immunolabelling was present in cerebral and cerebellar blood vessels, which were still free from inflammatory cuffs. Shortly after clinical recovery minimal labelling was observed in a few blood vessels. Brainstem and spinal cord returned to normal, but numerous inflammatory foci and demyelination were still evident near the ventricle walls, in the cerebral cortex and in the cerebellum. Intense expression of FN in brain vessels ascending from the spinal cord towards the encephalon preceded the appearance of inflammatory cells but faded away after the establishment of the inflammatory cuff. These results indicate an important role for FN in the pathogenesis of CNS inflammatory demyelinating events occurring during EAE.
C1 Univ Fed Fluminense, Lab Patol Celular, Dept Biol Celular & Mol, IB, BR-24020150 Niteroi, RJ, Brazil.
   Univ Rio de Janeiro, Dept Morfol, Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Dept Patol, Rio De Janeiro, Brazil.
   Inst Oswaldo Cruz, Dept Imunol, BR-20001 Rio De Janeiro, Brazil.
RP Quirico-Santos, T (corresponding author), Univ Fed Fluminense, Lab Patol Celular, Dept Biol Celular & Mol, IB, Outeiro Sao Joao Batista S-N, BR-24020150 Niteroi, RJ, Brazil.
CR Adams JC, 1997, TRENDS CELL BIOL, V7, P107, DOI 10.1016/S0962-8924(97)01001-5
   Berger T, 1997, LAB INVEST, V76, P355
   Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381
   CHOI BH, 1994, MICROSC RES TECHNIQ, V28, P193, DOI 10.1002/jemt.1070280304
   Clements JM, 1997, J NEUROIMMUNOL, V74, P85, DOI 10.1016/S0165-5728(96)00210-X
   GarciaAbreu J, 1996, BRAZ J MED BIOL RES, V29, P1179
   Goverman J, 1996, LAB ANIM SCI, V46, P482
   JOHNS TG, 1995, J IMMUNOL, V154, P5536
   JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577
   Kieseier BC, 1998, BRAIN, V121, P159, DOI 10.1093/brain/121.1.159
   KOH CS, 1993, J NEUROIMMUNOL, V47, P141, DOI 10.1016/0165-5728(93)90024-S
   LETOURNEAU PC, 1994, J NEUROSCI, V14, P915
   LINDSEY JW, 1993, J NEUROIMMUNOL, V48, P227, DOI 10.1016/0165-5728(93)90196-6
   Maeda A, 1996, J NEUROPATH EXP NEUR, V55, P300, DOI 10.1097/00005072-199603000-00005
   NAGANO N, 1993, GLIA, V8, P71, DOI 10.1002/glia.440080202
   OLSSON T, 1995, IMMUNOL REV, V144, P245, DOI 10.1111/j.1600-065X.1995.tb00072.x
   PATERSON PY, 1987, FED PROC, V46, P91
   Romanic AM, 1997, LAB INVEST, V76, P11
   SOBEL RA, 1988, AM J PATHOL, V131, P547
   Sobel RA, 1998, J NEUROPATH EXP NEUR, V57, P205, DOI 10.1097/00005072-199803000-00001
   STEFFEN BJ, 1994, AM J PATHOL, V145, P189
   STEPANIAK JA, 1995, J IMMUNOL, V155, P2762
   VENSTROM KA, 1993, FASEB J, V7, P996
   WEKERLE H, 1994, ANN NEUROL, V36, P47
   YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0
NR 25
TC 11
Z9 11
U1 0
U2 0
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, BRAZIL
SN 0100-879X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD MAY
PY 1999
VL 32
IS 5
BP 583
EP 592
DI 10.1590/S0100-879X1999000500012
PG 10
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA 199NY
UT WOS:000080489600012
PM 10412570
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Mathern, GW
   Mendoza, D
   Lozada, A
   Pretorius, JK
   Dehnes, Y
   Danbolt, NC
   Nelson, N
   Leite, JP
   Chimelli, L
AF Mathern, GW
   Mendoza, D
   Lozada, A
   Pretorius, JK
   Dehnes, Y
   Danbolt, NC
   Nelson, N
   Leite, JP
   Chimelli, L
TI Hippocampal GABA and glutamate transporter immunoreactivity in patients
   with temporal lobe epilepsy
SO NEUROLOGY
LA English
DT Article
ID GAMMA-AMINOBUTYRIC-ACID; EXTRACELLULAR AMINO-ACIDS; HUMAN
   FASCIA-DENTATA; RAT-BRAIN; NEURON DENSITIES; EXPRESSION; RELEASE;
   DECARBOXYLASE; LOCALIZATION; INTERNEURONS
AB Objective: Sodium-coupled transporters remove extracellular neurotransmitters and alterations in their function could enhance or suppress synaptic transmission and seizures. This study determined hippocampal gamma-aminobutyric acid (GABA) and glutamate transporter immunoreactivity (IR) in temporal lobe epilepsy (TLE) patients. Methods: Hippocampal sclerosis (HS) patients (n = 25) and non-HS cases (mass lesion and cryptogenic; n = 20) were compared with nonseizure autopsies (n = 8). Hippocampal sections were studied for neuron densities along with IR for glutamate decarboxylase (GAD; presynaptic GABA terminals), GABA transporter-1 (GAT-1; presynaptic GABA transporter), GAT-3 (astrocytic GABA transporter), excitatory amino acid transporter 3 (EAAT3; postsynaptic glutamate transporter), and EAAT2-1 (glial glutamate transporters). Results: Compared with autopsies, non-HS cases with similar neuron counts showed: 1) increased GAD IR gray values (GV) in the fascia dentata outer molecular layer (OML), hilus, and stratum radiatum; 2) increased GAT-I OML GVs; 3) increased astrocytic GAT-3 GVs in the hilus and Ammon's horn; and 4) no IR differences for EAAT3-1. HS patients with decreased neuron densities demonstrated: 1) increased OML and inner molecular layer GAD puncta; 2) decreased GAT-1 puncta relative to GAD in the stratum granulosum and pyramidale; 3) increased GAT-1 OML GVs; 4) decreased GAT-3 GVs; 5) increased EAAT3 IR on remaining granule cells and pyramids; 6) decreased glial EAAT2 GVs in the hilus and CA1 stratum radiatum associated with neuron loss; and 7) increased glial EAAT1 GVs in CA2/3 stratum radiatum. Conclusions: Hippocampal GABA and glutamate transporter IR differ in TLE patients compared with autopsies. These data support the hypothesis that excitatory and inhibitory neurotransmission and seizure susceptibility could be altered by neuronal and glial transporters in TLE patients.
C1 Univ Calif Los Angeles, Div Neurosurg, Los Angeles, CA 90095 USA.
   Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA.
   Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Pathol, Ribeirao Preto, Brazil.
   Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Neurol, Ribeirao Preto, Brazil.
   Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Neurosurg, Ribeirao Preto, Brazil.
   Univ Pittsburgh, Dept Neurosurg, Pittsburgh, PA USA.
   Univ Washington, Sch Med, Dept Pathol Neuropathol, Seattle, WA USA.
   Univ Washington, Sch Med, Dept Neurosurg, Seattle, WA USA.
   Univ Oslo, Inst Anat, N-0316 Oslo, Norway.
   Tel Aviv Univ, Dept Biochem, IL-69978 Tel Aviv, Israel.
RP Mathern, GW (corresponding author), Univ Calif Los Angeles, Med Ctr, Reed Neurol Res Ctr, Div Neurosurg, Los Angeles, CA 90095 USA.
EM gmathern@ucla.edu
RI Sakamoto, Americo C/H-5311-2012; Mathern, Gary W./J-2483-2016; Danbolt,
   Niels Christian/A-1907-2014; Leite, Joao/B-9070-2012
OI Danbolt, Niels Christian/0000-0003-4227-4520; Leite,
   Joao/0000-0003-0558-3519
FU NINDS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [P01 NS 02808, K08 NS 01910, K08 NS 01603]
   Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS
   AND STROKEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [P01NS002808, P01NS002808, P01NS002808,
   K08NS001603, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, K08NS001603, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, K08NS001910,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, K08NS001603, K08NS001603,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, K08NS001603, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, K08NS001910,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, K08NS001910, K08NS001910, P01NS002808,
   P01NS002808, P01NS002808, K08NS001910] Funding Source: NIH RePORTER
CR ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210
   Akbar MT, 1997, NEUROSCIENCE, V78, P351, DOI 10.1016/S0306-4522(96)00570-2
   AMARAL DG, 1986, HUM NEUROBIOL, V5, P169
   ARRIZA JL, 1994, J NEUROSCI, V14, P5559
   Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155
   Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8
   ATTWELL D, 1993, NEURON, V11, P401, DOI 10.1016/0896-6273(93)90145-H
   Babb T. L., 1987, SURGICAL TREATMENT E, P511
   BABB TL, 1984, EPILEPSIA, V25, P729, DOI 10.1111/j.1528-1157.1984.tb03484.x
   BABB TL, 1989, J NEUROSCI, V9, P2562
   Borden LA, 1996, NEUROCHEM INT, V29, P335, DOI 10.1016/0197-0186(95)00158-1
   BORDEN LA, 1994, RECEPTOR CHANNEL, V2, P207
   BRUHN T, 1992, ACTA NEUROL SCAND, V86, P455, DOI 10.1111/j.1600-0404.1992.tb05123.x
   CASADO M, 1993, J BIOL CHEM, V268, P27313
   CHAN PH, 1983, J NEUROCHEM, V40, P309, DOI 10.1111/j.1471-4159.1983.tb11284.x
   CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2
   DAM AM, 1980, EPILEPSIA, V21, P617, DOI 10.1111/j.1528-1157.1980.tb04315.x
   DANBOLT NC, 1994, PROG BRAIN RES, V100, P53
   de No RL, 1934, J PSYCHOL NEUROL, V46, P113
   DELLER T, 1995, J NEUROSCI, V15, P6868
   DESTEXHE A, 1995, P NATL ACAD SCI USA, V92, P9515, DOI 10.1073/pnas.92.21.9515
   DINGLEDINE R, 1985, J PHYSIOL-LONDON, V366, P387, DOI 10.1113/jphysiol.1985.sp015804
   DO KQ, 1991, FID RES FDN, V5, P677
   During M., 1991, MICRODIALYSIS NEUROS, P425
   DURING MJ, 1993, LANCET, V341, P1607
   DURING MJ, 1995, NATURE, V376, P174, DOI 10.1038/376174a0
   ENGEL J, 1991, PRINCIPLES NEUROSURG, P319
   FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0
   Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I
   Gibbs JW, 1997, J NEUROPHYSIOL, V77, P1924
   Ginsberg SD, 1996, J NEUROCHEM, V67, P1208
   Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715
   HAYCOCK JW, 1978, J NEUROCHEM, V30, P1113, DOI 10.1111/j.1471-4159.1978.tb12406.x
   ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E
   KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0
   Kanai Y, 1997, NEUROTRANSMITTER TRA, P171
   KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011
   Kiryu S, 1995, J NEUROSCI, V15, P7872
   LEHMANN A, 1985, BRAIN RES, V359, P147, DOI 10.1016/0006-8993(85)91422-2
   LEHRE KP, 1995, J NEUROSCI, V15, P1835
   LEVY LM, 1993, J NEUROCHEM, V61, pS208
   LIU QR, 1993, J BIOL CHEM, V268, P2106
   LOGAN WJ, 1971, NATURE, V234, P297, DOI 10.1038/234297b0
   Mathern GW, 1998, NEUROBIOL DIS, V5, P151, DOI 10.1006/nbdi.1998.0200
   MATHERN GW, 1995, BRAIN, V118, P105, DOI 10.1093/brain/118.1.105
   Mathern GW, 1997, J NEUROPATH EXP NEUR, V56, P199, DOI 10.1097/00005072-199702000-00011
   Mathern GW, 1996, NEUROREPORT, V7, P1029, DOI 10.1097/00001756-199604100-00015
   Mathern GW, 1998, J NEUROPATH EXP NEUR, V57, P615, DOI 10.1097/00005072-199806000-00008
   Mathern GW, 1997, BRAIN, V120, P1937, DOI 10.1093/brain/120.11.1937
   Mathern GW, 1997, NEUROSCIENCE, V77, P1003, DOI 10.1016/S0306-4522(96)00516-7
   MATHERN GW, 1995, J NEUROSCI, V15, P3990
   MATHERN GW, 1997, EPILEPSY COMPREHENSI, P133
   MATHERN GW, 1997, EPILEPSIA S3, V38, P231
   MAYHEW TM, 1992, J NEUROCYTOL, V21, P313, DOI 10.1007/BF01191700
   MILLAN MH, 1993, EPILEPSY RES, V14, P139, DOI 10.1016/0920-1211(93)90018-3
   MILLER JW, 1997, NEUROTRANSMITTER TRA, P101
   NADLER JV, 1977, BRAIN RES, V131, P241
   NADLER JV, 1974, EXP NEUROL, V45, P403, DOI 10.1016/0014-4886(74)90128-9
   NELSON H, 1990, FEBS LETT, V269, P181, DOI 10.1016/0014-5793(90)81149-I
   Obrenovitch TP, 1997, PROG NEUROBIOL, V51, P39, DOI 10.1016/S0301-0082(96)00049-4
   OERTEL WH, 1981, NEUROSCIENCE, V6, P2689, DOI 10.1016/0306-4522(81)90113-5
   Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996
   PIN JP, 1989, J NEUROSCI, V9, P648
   PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0
   RADIAN R, 1990, J NEUROSCI, V10, P1319
   Ribak CE, 1996, J COMP NEUROL, V367, P595, DOI 10.1002/(SICI)1096-9861(19960415)367:4<595::AID-CNE9>3.0.CO;2-#
   RONNEENGSTROM E, 1992, J CEREBR BLOOD F MET, V12, P873, DOI 10.1038/jcbfm.1992.119
   ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8
   Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0
   ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114
   SARANTIS M, 1993, NEURON, V11, P541, DOI 10.1016/0896-6273(93)90158-N
   SCHUNZEL G, 1992, NEUROSCIENCE, V49, P365, DOI 10.1016/0306-4522(92)90102-8
   STORMMATHISEN J, 1977, PROG NEUROBIOL, V8, P119, DOI 10.1016/0301-0082(77)90013-2
   TORP R, 1995, EXP BRAIN RES, V103, P51
   Trotti D, 1997, EUR J NEUROSCI, V9, P1236, DOI 10.1111/j.1460-9568.1997.tb01478.x
   UEDA Y, 1995, EPILEPSY RES, V20, P213, DOI 10.1016/0920-1211(94)00081-7
   VEZZANI A, 1985, J NEUROCHEM, V45, P335, DOI 10.1111/j.1471-4159.1985.tb03993.x
   WEST MJ, 1990, PROG BRAIN RES, V83, P13
   Wieser Heinz-Gregor, 1993, P49
   WILLIAMSON A, 1995, J NEUROPHYSIOL, V74, P378
   Yamada K, 1996, NEUROREPORT, V7, P2013, DOI 10.1097/00001756-199608120-00032
   ZHANG WQ, 1991, BRAIN RES, V540, P315, DOI 10.1016/0006-8993(91)90527-3
   Zhu ZQ, 1997, J NEUROPATH EXP NEUR, V56, P988, DOI 10.1097/00005072-199709000-00004
NR 83
TC 221
Z9 229
U1 0
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD FEB
PY 1999
VL 52
IS 3
BP 453
EP 472
DI 10.1212/WNL.52.3.453
PG 20
WC Clinical Neurology
SC Neurosciences & Neurology
GA 165GQ
UT WOS:000078512900007
PM 10025773
DA 2020-12-08
ER

PT J
AU Alexandre, V
   Bustamante, VCT
   Velasco, TR
   Garzon, E
   Wichert-Ana, L
   Bastos, A
   Chimelli, LMC
   Fernandes, RMF
   Santos, AC
   Assirati, JA
   Machado, HR
   Sakamoto, AC
AF Alexandre, V
   Bustamante, VCT
   Velasco, TR
   Garzon, E
   Wichert-Ana, L
   Bastos, A
   Chimelli, LMC
   Fernandes, RMF
   Santos, AC
   Assirati, JA
   Machado, HR
   Sakamoto, AC
TI Cortical dysplasia and surgically treated epilepsies: Clinical,
   pathological and follow-up data
SO EPILEPSIA
LA English
DT Meeting Abstract
C1 USP, Hosp Clin Ribeirao Preto, Ribeirao Preto, SP, Brazil.
RI Machado, Helio R/I-6602-2012; Sakamoto, Americo C/H-5311-2012; Velasco,
   Tonicarlo R/Q-2170-2016; Garzon, Eliana/O-2577-2016; Wichert-ana,
   Lauro/A-4756-2008; Wichert-Ana, Lauro/C-8373-2012; Velasco,
   Tonicarlo/A-2013-2008
OI Velasco, Tonicarlo R/0000-0001-7756-8882; Garzon,
   Eliana/0000-0002-6274-9207; Wichert-Ana, Lauro/0000-0003-2059-5120; 
NR 0
TC 0
Z9 0
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0013-9580
J9 EPILEPSIA
JI Epilepsia
PY 1999
VL 40
SU 7
BP 215
EP 215
PG 1
WC Clinical Neurology
SC Neurosciences & Neurology
GA 242NR
UT WOS:000082947600864
DA 2020-12-08
ER

PT J
AU Lage, JS
   Bustamante, VCT
   Garzon, E
   Velasco, TR
   Santos, AC
   Bastos, A
   Wichert-Ana, L
   Chimelli, LMC
   Leite, JP
   Assirati, JA
   Machado, HR
   Sakamoto, AC
AF Lage, JS
   Bustamante, VCT
   Garzon, E
   Velasco, TR
   Santos, AC
   Bastos, A
   Wichert-Ana, L
   Chimelli, LMC
   Leite, JP
   Assirati, JA
   Machado, HR
   Sakamoto, AC
TI Surgical treatment of medically intractable epilepsies in the pediatric
   group: Clinical and follow-up data
SO EPILEPSIA
LA English
DT Meeting Abstract
C1 USP, Hosp Clin Ribeirao Preto, Ribeirao Preto, SP, Brazil.
   Hosp Alemao Oswaldo Cruz, Sao Paulo, Brazil.
RI Wichert-Ana, Lauro/C-8373-2012; Velasco, Tonicarlo/A-2013-2008; Velasco,
   Tonicarlo R/Q-2170-2016; Machado, Helio R/I-6602-2012; Leite,
   Joao/B-9070-2012; Sakamoto, Americo C/H-5311-2012; Wichert-ana,
   Lauro/A-4756-2008; Garzon, Eliana/O-2577-2016
OI Wichert-Ana, Lauro/0000-0003-2059-5120; Velasco, Tonicarlo
   R/0000-0001-7756-8882; Leite, Joao/0000-0003-0558-3519; Garzon,
   Eliana/0000-0002-6274-9207
NR 0
TC 0
Z9 0
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0013-9580
J9 EPILEPSIA
JI Epilepsia
PY 1999
VL 40
SU 7
BP 215
EP 215
PG 1
WC Clinical Neurology
SC Neurosciences & Neurology
GA 242NR
UT WOS:000082947600865
DA 2020-12-08
ER

PT J
AU Takayanagui, OM
   Chimelli, L
AF Takayanagui, OM
   Chimelli, L
TI Disseminated muscular cysticercosis with myositis induced by
   praziquantel therapy
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID NEUROCYSTICERCOSIS
AB Cysticercosis, the infestation with the encysted larval stage of Taenia solium, is increasingly recognized as a major problem in most countries in Latin America, Asia, and Africa, involving mainly the central nervous system. Muscle involvement is also common, although it usually remains asymptomatic. We describe a case of disseminated muscular cysticercosis followed by myositis (fever, diffuse myalgia, weakness of the lower limbs, and inflammatory reaction around dying cysticerci) induced by praziquantel therapy, an event not described previously.
C1 Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurol, BR-14048900 Ribeirao Preto, SP, Brazil.
   Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Pathol, Ribeirao Preto, SP, Brazil.
RP Takayanagui, OM (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurol, BR-14048900 Ribeirao Preto, SP, Brazil.
RI Takayanagui, Osvaldo M/C-8159-2013
OI Takayanagui, Osvaldo M/0000-0002-8190-0275
CR Armbrust-Figueiredo J., 1970, ARQ NEURO-PSIQUIAT, V28, P385
   BITTENCOURT PRM, 1990, EUR NEUROL, V30, P229, DOI 10.1159/000117352
   CARPIO A, 1995, ARCH INTERN MED, V155, P1982, DOI 10.1001/archinte.155.18.1982
   CRUZ I, 1994, AM J TROP MED HYG, V51, P405, DOI 10.4269/ajtmh.1994.51.405
   JACOB JC, 1968, NEUROLOGY, V18, P767, DOI 10.1212/WNL.18.8.767
   LEOPOLD G, 1978, EUR J CLIN PHARMACOL, V14, P281, DOI 10.1007/BF00560463
   LIVRAMENTO JA, 1993, INT CONGR SER, V1033, P307
   MITCHELL WG, 1997, EUR NEUROL, V37, P124
   SAWHNEY BB, 1976, NEUROLOGY, V26, P270, DOI 10.1212/WNL.26.3.270
   Takayanagui OM, 1996, ARQ NEURO-PSIQUIAT, V54, P557, DOI 10.1590/S0004-282X1996000400002
   TAKAYANAGUI OM, 1992, ARCH NEUROL-CHICAGO, V49, P290, DOI 10.1001/archneur.1992.00530270106026
   TAKAYANAGUI OM, 1995, TAENIASIS CYSTICERCO
   VAZQUEZ V, 1992, NEW ENGL J MED, V327, P696, DOI 10.1056/NEJM199209033271005
   WADIA N, 1988, BRAIN, V111, P597, DOI 10.1093/brain/111.3.597
   White AC, 1997, CLIN INFECT DIS, V24, P101, DOI 10.1093/clinids/24.2.101
NR 15
TC 10
Z9 11
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD DEC
PY 1998
VL 59
IS 6
BP 1002
EP 1003
DI 10.4269/ajtmh.1998.59.1002
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 154RE
UT WOS:000077901900028
PM 9886213
OA Bronze
DA 2020-12-08
ER

PT J
AU Chimelli, L
   Lovalho, AF
   Takayanagui, OM
AF Chimelli, L
   Lovalho, AF
   Takayanagui, OM
TI Neurocysticercosis: contribution of autopsies to consolidation of the
   compulsory notification in Ribeirao Preto SP, Brazil
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Spanish
DT Article
DE cysticercosis; autopsy; Taenia solium; epidemiology; computed
   tomography; cerebrospinal fluid
ID CYSTICERCOSIS; PRAZIQUANTEL; DIAGNOSIS; SEROLOGY; THERAPY; BLOT
AB Neurocysticercosis is a serious public health problem in several countries of Asia, Africa and Latin America. The objective of the present study is to present autopsy findings of neurocysticercosis in the Pathology Division of the University Hospital, Medical School of Ribeirao Preto, University of Sao Paulo, from 1992 to 1997. Neurocysticercosis was detected in 38 (1.5%) of 2522 autopsies. In twenty two (57.9%) of these, the diagnosis was made post-mortem, while 16 (42.1%) had a previous diagnosis of cysticercosis based on laboratory and imaging studies. Reviewing the medical records, we found that 21 patients (55.2%) were neurologically asymptomatic, while the various clinical manifestations in the others were in accordance with the literature. The high frequency of asymptomatic individuals detected only post-mortem indicates the importance of autopsies as an additional source of data to consolidate the compulsory notification of cysticercosis. Considering the results of this study, the new coefficient of prevalence of cysticercosis in Ribeirao Preto is 67 cases/100000 inhabitants.
C1 Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Patol, BR-14048900 Ribeirao Preto, SP, Brazil.
   Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurol, BR-14048900 Ribeirao Preto, SP, Brazil.
RI Takayanagui, Osvaldo M/C-8159-2013
OI Takayanagui, Osvaldo M/0000-0002-8190-0275
CR AGAPEJEV S, 1994, THESIS U SAO PAULO
   Bang OY, 1997, STROKE, V28, P211, DOI 10.1161/01.STR.28.1.211
   BRICENO CARLOS E., 1961, PRENSA MED MEXICANA, V26, P193
   CAMACHO SD, 1990, T ROY SOC TROP MED H, V84, P563, DOI 10.1016/0035-9203(90)90041-C
   CANELAS H. M., 1962, ARQ NEURO PSIQUIAT, V20, P1
   Cantu C, 1996, ARCH NEUROL-CHICAGO, V53, P233, DOI 10.1001/archneur.1996.00550030039021
   *CDCP, 1992, MMWR-MORBID MORTAL W, V41, P691
   COSTACRUZ JM, 1995, ARQ NEURO-PSIQUIAT, V53, P227, DOI 10.1590/S0004-282X1995000200007
   DelBrutto OH, 1996, J NEUROL SCI, V142, P1, DOI 10.1016/0022-510X(96)00130-X
   DELBRUTTO OH, 1991, HUM BIOL, V63, P85
   DELBRUTTO OH, 1988, REV INFECT DIS, V10, P1075
   DELBRUTTO OH, 1988, ARCH INTERN MED, V66, P686
   Dixon HBF, 1961, MED RES COUNCIL SPEC, V299
   ESCOBAR A, 1983, CYSTICERCOSIS CENTRA, P7
   *FDN NAC SAUD, 1996, PROJ CONTR COMPL TEN
   FELDMAN M, 1990, T ROY SOC TROP MED H, V84, P559, DOI 10.1016/0035-9203(90)90040-L
   FISCHMANN A, 1994, EPIDEMIOLOGIA SAUDE, P421
   GARCIA HH, 1994, AM J TROP MED HYG, V50, P152, DOI 10.4269/ajtmh.1994.50.152
   GOBBI H., 1980, Revista de Patologia Tropical, V9, P51
   LIMA JGC, 1996, CISTICERCOSE ENCEFAL
   LIVRAMENTO JA, 1993, INT CONGR SER, V1033, P307
   *OPAS, 1994, EP CONTR TEN CIST AM
   Pittella JEH, 1997, BRAIN PATHOL, V7, P681, DOI 10.1111/j.1750-3639.1997.tb01083.x
   Pupo P.P., 1945, ARQ ASSIST PSICOP S, V10/11, P3
   QUEIROZ AC, 1979, ARQ NEURO-PSIQUIAT, V37, P34
   Rabiela-Cervantes M. T., 1982, Cysticercosis: present state of knowledge and perspectives. (Proc. Internat. workshop on cysticercosis, San Miguel de Allende, Guanajuato, Mexico, Nov. 16-18, 1981), P179
   RAMOSKURI M, 1992, ARCH NEUROL-CHICAGO, V49, P633, DOI 10.1001/archneur.1992.00530300069012
   Salgado P, 1997, ARCH INTERN MED, V157, P1991, DOI 10.1001/archinte.157.17.1991
   SCHARF D, 1988, ARCH NEUROL-CHICAGO, V45, P777, DOI 10.1001/archneur.1988.00520310087022
   Schenone H., 1982, P25
   SOTELO J, 1985, ARCH INTERN MED, V145, P442, DOI 10.1001/archinte.145.3.442
   Takayanagui O M, 1990, Arq Neuropsiquiatr, V48, P1
   Takayanagui O M, 1983, Arq Neuropsiquiatr, V41, P50
   Takayanagui O M, 1990, Arq Neuropsiquiatr, V48, P11
   Takayanagui OM, 1996, ARQ NEURO-PSIQUIAT, V54, P557, DOI 10.1590/S0004-282X1996000400002
   TAKAYANAGUI OM, 1992, ARCH NEUROL-CHICAGO, V49, P290, DOI 10.1001/archneur.1992.00530270106026
   TAVARES AR, 1994, THESIS ESCOLA PAULIS
   THORNTON CA, 1992, ARCH NEUROL-CHICAGO, V49, P963, DOI 10.1001/archneur.1992.00530330087021
   TRELLES J. O., 1940, Revista de Neuro-Psiquiatria, V3, P393
   TSANG VCW, 1989, J INFECT DIS, V159, P50, DOI 10.1093/infdis/159.1.50
   VIANNA LG, 1991, REV I MED TROP, V33, P129, DOI 10.1590/S0036-46651991000200007
   WILSON M, 1991, J INFECT DIS, V164, P1007, DOI 10.1093/infdis/164.5.1007
NR 42
TC 24
Z9 28
U1 0
U2 0
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD SEP
PY 1998
VL 56
IS 3B
BP 577
EP 584
DI 10.1590/S0004-282X1998000400010
PG 8
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 129FB
UT WOS:000076452200010
PM 9850753
OA Other Gold
DA 2020-12-08
ER

PT J
AU Carlotti, CG
   Colli, BO
   Chimelli, L
   Dos Santos, AC
   Junior, JE
AF Carlotti, CG
   Colli, BO
   Chimelli, L
   Dos Santos, AC
   Junior, JE
TI Lipoblastic meningioma - Case report
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE lipoblastic meningioma; metaplastic meningioma; computed tomography
ID LIPOMATOUS MENINGIOMA
AB We describe the case of a patient presenting a right parietal mass lesion with an heterogeneous aspect on computed tomography, with hyperdense contrast uptake areas and hypodense areas with fat density. The unusual aspect of the lesion prevented preoperative and intraoperative diagnosis. The final histopathological examination revealed a meningothelial neoplasia with adipose differentiation, characterizing a lipoblastic meningioma.
C1 Univ Sao Paulo, Ribeirao Preto Med Sch, Hosp Clin, Dept Surg,Div Neurosurg, BR-14048900 Ribeirao Preto, Brazil.
   Univ Sao Paulo, Ribeirao Preto Med Sch, Hosp Clin, Dept Pathol, BR-14048900 Ribeirao Preto, Brazil.
   Univ Sao Paulo, Ribeirao Preto Med Sch, Hosp Clin, Image Ctr, BR-14048900 Ribeirao Preto, Brazil.
EM cgcjunio@fmrp.usp.br
RI Colli, Benedicto/A-2833-2016; Carlotti, Carlos G/C-1608-2012; Junior,
   Jorge Elias/A-6683-2008; Santos, Antonio/F-5419-2012
OI Colli, Benedicto/0000-0002-0222-6770; Carlotti, Carlos
   G/0000-0002-7055-0564; Junior, Jorge Elias/0000-0002-1158-1045; 
CR BURGER PC, 1994, ARMED FORCES I PATHO, V9, P268
   KASANTIKUL V, 1984, J SURG ONCOL, V26, P35, DOI 10.1002/jso.2930260109
   KATAYAMA Y, 1993, NEURORADIOLOGY, V35, P187, DOI 10.1007/BF00588490
   KATAYAMA Y, 1986, SURG NEUROL, V25, P43, DOI 10.1016/0090-3019(86)90113-8
   KEPES JJ, 1994, J NEUROPATH EXP NEUR, V53, P384, DOI 10.1097/00005072-199407000-00010
   KEPES JJ, 1982, MENINGIOMA BIOL PATH
   KLEIHUES P, 1993, HISTOLOGICAL TYPING
   LATTES R, 1991, HUM PATHOL, V22, P164, DOI 10.1016/0046-8177(91)90038-Q
   LEROUX P, 1989, SURG NEUROL, V32, P360, DOI 10.1016/0090-3019(89)90140-7
   Osborn AG, 1994, DIAGNOSTIC NEURORADI, P579
   RUSSELL EJ, 1980, RADIOLOGY, V135, P673, DOI 10.1148/radiology.135.3.7384454
   SALIBI SS, 1989, NEUROSURGERY, V25, P122, DOI 10.1227/00006123-198907000-00024
NR 12
TC 3
Z9 3
U1 0
U2 0
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD SEP
PY 1998
VL 56
IS 3B
BP 661
EP 665
DI 10.1590/S0004-282X1998000400024
PG 5
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 129FB
UT WOS:000076452200024
PM 9850767
OA Other Gold
DA 2020-12-08
ER

PT J
AU Mathern, GW
   Pretorius, JK
   Kornblum, HI
   Mendoza, D
   Lozada, A
   Leite, JP
   Chimelli, L
   Born, DE
   Fried, I
   Sakamoto, AC
   Assirati, JA
   Peacock, WJ
   Ojemann, GA
   Adelson, PD
AF Mathern, GW
   Pretorius, JK
   Kornblum, HI
   Mendoza, D
   Lozada, A
   Leite, JP
   Chimelli, L
   Born, DE
   Fried, I
   Sakamoto, AC
   Assirati, JA
   Peacock, WJ
   Ojemann, GA
   Adelson, PD
TI Altered hippocampal kainate-receptor mRNA levels in temporal lobe
   epilepsy patients
SO NEUROBIOLOGY OF DISEASE
LA English
DT Review
DE glutamate neurotransmission; excitatory amino acid receptors; synaptic
   reorganization; complex partial seizures
ID ACID BINDING-SITES; HIGH-AFFINITY KAINATE; SUBUNIT MESSENGER-RNAS; HUMAN
   FASCIA-DENTATA; METHYL-D-ASPARTATE; GLUTAMATE-RECEPTOR; RAT-BRAIN;
   NEURON DENSITIES; GENE-EXPRESSION; NERVOUS-SYSTEM
AB This study determined whether hippocampal kainate (KA) receptor mRNA levels were increased or decreased in temporal lobe epilepsy patients compared with nonseizure autopsies, Hippocampal sclerosis (HS; n = 17), nonsclerosis (non-HS; n = 11), and autopsy hippocampi (n = 9) were studied for KA1-2 and GluR5-7 mRNA levels using semiquantitative in situ hybridization techniques, along with neuron densities. Compared with autopsy hippocampi, HS and non-HS cases showed decreased GluR5 and GluR6 hybridization densities per CA2 and/or CA3 pyramid. Furthermore, MS patients demonstrated increased KA2 and GluR5 hybridization densities per granule cell compared with autopsy hippocampi. These findings indicate that chronic temporal lobe seizures were associated with differential changes in hippocampal KA1-2 and GluR5-7 hybridization densities that vary by subfield and pathology group. In temporal robe epilepsy patients, these results support the hypothesis that pyramidal cell GluR5 and GluR6 mRNA levels are decreased as a consequence of seizures, and in Ms patients granule cell KA2 and GluR5 mRNA levels are increased in association with aberrant fascia dentata mossy fiber sprouting and/or hippocampal neuronal loss. (C) 1998 Academic Press.
C1 Univ Calif Los Angeles, Div Neurosurg, Los Angeles, CA 90095 USA.
   Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90095 USA.
   Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.
   Univ Calif Los Angeles, Mental Retardat Res Ctr, Los Angeles, CA 90095 USA.
   Univ Calif Los Angeles, Inst Brain Res, Los Angeles, CA 90095 USA.
   Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Neurol, BR-15213 Ribeirao Preto, SP, Brazil.
   Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Pathol, BR-15213 Ribeirao Preto, SP, Brazil.
   Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Neurosurg, BR-15213 Ribeirao Preto, SP, Brazil.
   Univ Pittsburgh, Dept Neurosurg, Pittsburgh, PA USA.
   Univ Washington, Sch Med, Dept Pathol Neuropathol, Seattle, WA 98195 USA.
   Univ Washington, Sch Med, Dept Neurosurg, Seattle, WA 98195 USA.
RP Mathern, GW (corresponding author), Univ Calif Los Angeles, Div Neurosurg, Los Angeles, CA 90095 USA.
RI Leite, Joao/B-9070-2012; Mathern, Gary W./J-2483-2016; Sakamoto, Americo
   C/H-5311-2012; Adelson, David/W-2083-2019
OI Leite, Joao/0000-0003-0558-3519; 
FU NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
   [P01NS002808, P01NS028383, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS028383,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   K08NS001603, P01NS002808, P01NS028383, P01NS002808, P01NS002808,
   P01NS028383, K08NS001603, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS028383, P01NS002808,
   P01NS028383, P01NS002808, P01NS002808, P01NS002808, P01NS028383,
   P01NS002808, P01NS002808, P01NS002808, P01NS028383, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS028383, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS028383, P01NS002808, K08NS001603, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS028383,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS028383, P01NS002808, P01NS002808, K08NS001603, P01NS002808,
   P01NS002808, K08NS001603, P01NS028383, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS028383, P01NS002808] Funding
   Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Neurological Disorders & Stroke (NINDS) [K08 NS 01603, P01
   NS 28383, P01 NS 02808] Funding Source: Medline
CR ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210
   AMARAL DG, 1986, HUM NEUROBIOL, V5, P169
   Babb T. L., 1987, SURGICAL TREATMENT E, P511
   Babb Thomas L., 1993, P55
   BABB TL, 1984, EPILEPSIA, V25, P721, DOI 10.1111/j.1528-1157.1984.tb03483.x
   BABB TL, 1984, EPILEPSIA, V25, P729, DOI 10.1111/j.1528-1157.1984.tb03484.x
   BABB TL, 1991, NEUROSCIENCE, V42, P351, DOI 10.1016/0306-4522(91)90380-7
   BAHN S, 1994, J NEUROSCI, V14, P5525
   BARTON AJL, 1993, J NEUROCHEM, V61, P1, DOI 10.1111/j.1471-4159.1993.tb03532.x
   BETTLER B, 1995, NEUROPHARMACOLOGY, V34, P123, DOI 10.1016/0028-3908(94)00141-E
   BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y
   BETTLER B, 1992, NEURON, V8, P257, DOI 10.1016/0896-6273(92)90292-L
   BOCHET P, 1994, NEURON, V12, P383, DOI 10.1016/0896-6273(94)90279-8
   Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645
   Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0
   Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315
   Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9
   COWBURN RF, 1989, J NEUROCHEM, V52, P140, DOI 10.1111/j.1471-4159.1989.tb10908.x
   COX KH, 1984, DEV BIOL, V101, P485, DOI 10.1016/0012-1606(84)90162-3
   CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U
   CRUZORIVE LM, 1990, AM J PHYSIOL, V258, pL148
   Cunha RA, 1997, EUR J PHARMACOL, V323, P167, DOI 10.1016/S0014-2999(97)00043-5
   DAM AM, 1980, EPILEPSIA, V21, P617, DOI 10.1111/j.1528-1157.1980.tb04315.x
   de No RL, 1934, J PSYCHOL NEUROL, V46, P113
   DEBONNEL G, 1989, CAN J PHYSIOL PHARM, V67, P904, DOI 10.1139/y89-142
   DEFELIPE J, 1994, BRAIN RES, V657, P150, DOI 10.1016/0006-8993(94)90962-8
   DELANEROLLE NC, 1989, BRAIN RES, V495, P387, DOI 10.1016/0006-8993(89)90234-5
   DOURNAUD P, 1994, NEUROSCIENCE, V61, P755, DOI 10.1016/0306-4522(94)90399-9
   EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0
   Engel J, 1993, SURG TREATMENT EPILE
   ENGEL J, 1991, PRINCIPLES NEUROSURG, P319
   Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I
   GAIARSA JL, 1994, J NEUROPHYSIOL, V71, P204
   GALL CM, 1989, SCIENCE, V245, P758, DOI 10.1126/science.2549634
   GarciaBarcina JM, 1996, EUR J NEUROSCI, V8, P2379, DOI 10.1111/j.1460-9568.1996.tb01201.x
   GEDDES J W, 1986, Neuroscience Research, V3, P672, DOI 10.1016/0168-0102(86)90062-3
   GEDDES JW, 1990, EXP NEUROL, V108, P214, DOI 10.1016/0014-4886(90)90125-C
   GEDDES JW, 1985, SCIENCE, V230, P1179, DOI 10.1126/science.4071042
   GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4
   Gold SJ, 1996, J COMP NEUROL, V365, P541
   GOOD PF, 1993, BRAIN RES, V624, P347, DOI 10.1016/0006-8993(93)90102-S
   HAMPSON DR, 1987, J NEUROCHEM, V49, P1209, DOI 10.1111/j.1471-4159.1987.tb10012.x
   Harrison PJ, 1995, NEUROSCI LETT, V200, P151, DOI 10.1016/0304-3940(95)12102-A
   HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X
   HIKIJI M, 1993, LIFE SCI, V53, P857, DOI 10.1016/0024-3205(93)90508-Z
   Hof PR, 1996, BRAIN RES, V723, P77, DOI 10.1016/0006-8993(96)00218-1
   HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335
   HOUSER CR, 1990, J NEUROSCI, V10, P267
   HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A
   HUETTNER JE, 1997, IONOTROPIC GLUTAMATE, P265
   HUNTER C, 1990, J NEUROCHEM, V54, P118, DOI 10.1111/j.1471-4159.1990.tb13290.x
   HUNTLEY CW, 1994, TRENDS NEUROSCI, V17, P536
   HUNTLEY GW, 1993, J NEUROSCI, V13, P2965
   JANSEN KLR, 1989, NEUROSCIENCE, V32, P587, DOI 10.1016/0306-4522(89)90282-0
   Johnson M, 1996, NEUROBIOL AGING, V17, P639
   KAMPHUIS W, 1995, NEUROSCIENCE, V67, P551, DOI 10.1016/0306-4522(95)00070-Y
   KORNBLUM HI, 1994, MOL BRAIN RES, V21, P107, DOI 10.1016/0169-328X(94)90383-2
   LAMBOLEZ B, 1992, NEURON, V9, P247, DOI 10.1016/0896-6273(92)90164-9
   LERMA J, 1993, P NATL ACAD SCI USA, V90, P11688, DOI 10.1073/pnas.90.24.11688
   LOMELI H, 1992, FEBS LETT, V307, P139, DOI 10.1016/0014-5793(92)80753-4
   Mathern GW, 1996, BRAIN, V119, P965, DOI 10.1093/brain/119.3.965
   MATHERN GW, 1995, BRAIN, V118, P105, DOI 10.1093/brain/118.1.105
   Mathern GW, 1997, J NEUROPATH EXP NEUR, V56, P199, DOI 10.1097/00005072-199702000-00011
   Mathern GW, 1996, NEUROREPORT, V7, P1029, DOI 10.1097/00001756-199604100-00015
   MATHERN GW, 1995, J NEUROSURG, V82, P211, DOI 10.3171/jns.1995.82.2.0211
   Mathern GW, 1998, J NEUROPATH EXP NEUR, V57, P615, DOI 10.1097/00005072-199806000-00008
   Mathern GW, 1997, BRAIN, V120, P1937, DOI 10.1093/brain/120.11.1937
   Mathern GW, 1997, NEUROSCIENCE, V77, P1003, DOI 10.1016/S0306-4522(96)00516-7
   MATHERN GW, 1995, EPILEPSY RES, V21, P133, DOI 10.1016/0920-1211(95)00014-2
   MATHERN GW, 1995, J NEUROSCI, V15, P3990
   MATHERN GW, 1997, EPILEPSY COMPREHENSI, P133
   MAYHEW TM, 1992, J NEUROCYTOL, V21, P313, DOI 10.1007/BF01191700
   MCBAIN CJ, 1993, J PHYSIOL-LONDON, V462, P373, DOI 10.1113/jphysiol.1993.sp019560
   MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053
   MONAGHAN DT, 1986, NEUROCHEM RES, V11, P1073, DOI 10.1007/BF00965595
   MONAGHAN DT, 1982, BRAIN RES, V252, P91, DOI 10.1016/0006-8993(82)90981-7
   NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X
   OKAZAKI MM, 1990, NEUROSCIENCE, V37, P135, DOI 10.1016/0306-4522(90)90198-D
   PETRALIA RS, 1994, J COMP NEUROL, V349, P85, DOI 10.1002/cne.903490107
   Porter RHP, 1997, BRAIN RES, V751, P217, DOI 10.1016/S0006-8993(96)01404-7
   REPRESA A, 1989, NEUROSCI LETT, V99, P351, DOI 10.1016/0304-3940(89)90472-2
   REPRESA A, 1987, NEUROSCIENCE, V20, P739, DOI 10.1016/0306-4522(87)90237-5
   REPRESA A, 1986, BRAIN RES, V384, P170, DOI 10.1016/0006-8993(86)91234-5
   ROBINSON JH, 1981, BRAIN RES, V221, P117, DOI 10.1016/0006-8993(81)91067-2
   Saper CB, 1996, J COMP NEUROL, V364, P5
   SAVAGE DD, 1984, BRAIN RES, V323, P128, DOI 10.1016/0006-8993(84)90274-9
   SIEGEL SJ, 1995, J NEUROSCI, V15, P2707
   SOMMER B, 1992, TRENDS PHARMACOL SCI, V13, P291, DOI 10.1016/0165-6147(92)90088-N
   SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521
   TREMBLAY E, 1985, BRAIN RES, V343, P378, DOI 10.1016/0006-8993(85)90761-9
   ULAS J, 1990, J NEUROSCI, V10, P2352
   UNNERSTALL JR, 1983, EUR J PHARMACOL, V86, P361, DOI 10.1016/0014-2999(83)90185-1
   VEZZANI A, 1990, BRAIN RES, V526, P113, DOI 10.1016/0006-8993(90)90256-B
   Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639
   WENTHOLD RJ, 1994, J BIOL CHEM, V269, P1332
   WERNER P, 1991, NATURE, V351, P742, DOI 10.1038/351742a0
   WEST MJ, 1990, PROG BRAIN RES, V83, P13
   WESTBROOK GL, 1983, BRAIN RES, V273, P97, DOI 10.1016/0006-8993(83)91098-3
   WETZEL DM, 1994, BRAIN RES, V649, P117, DOI 10.1016/0006-8993(94)91054-5
   Wieser Heinz-Gregor, 1993, P49
   Wilding TJ, 1997, J NEUROSCI, V17, P2713
   WISDEN W, 1993, J NEUROSCI, V13, P3582
NR 102
TC 48
Z9 49
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0969-9961
EI 1095-953X
J9 NEUROBIOL DIS
JI Neurobiol. Dis.
PD SEP
PY 1998
VL 5
IS 3
BP 151
EP 176
DI 10.1006/nbdi.1998.0200
PG 26
WC Neurosciences
SC Neurosciences & Neurology
GA 134XX
UT WOS:000076770000003
PM 9848088
DA 2020-12-08
ER

PT J
AU Malik, RA
   Walker, D
   Santos, LHC
   Chimelli, L
   Barriera, AA
   Boulton, AJM
AF Malik, RA
   Walker, D
   Santos, LHC
   Chimelli, L
   Barriera, AA
   Boulton, AJM
TI The primary pathology and pathogenesis of human diabetic neuropathy.
SO DIABETOLOGIA
LA English
DT Meeting Abstract
C1 Manchester Royal Infirm, Dept Med, Manchester, Lancs, England.
   Dept Neurol & Neuropathol, Curitiba, Parana, Brazil.
NR 0
TC 1
Z9 1
U1 0
U2 1
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0012-186X
J9 DIABETOLOGIA
JI Diabetologia
PD AUG
PY 1998
VL 41
SU 1
MA 192
BP A50
EP A50
PG 1
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 109ZG
UT WOS:000075353800197
DA 2020-12-08
ER

PT J
AU Mathern, GW
   Pretorius, JK
   Mendoza, D
   Lozada, A
   Leite, JP
   Chimelli, L
   Fried, I
   Sakamoto, AC
   Assirati, JA
   Adelson, PD
AF Mathern, GW
   Pretorius, JK
   Mendoza, D
   Lozada, A
   Leite, JP
   Chimelli, L
   Fried, I
   Sakamoto, AC
   Assirati, JA
   Adelson, PD
TI Increased hippocampal AMPA and NMDA receptor subunit immunoreactivity in
   temporal lobe epilepsy patients
SO JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
LA English
DT Article
DE complex partial seizures; excitatory amino acid receptors; NIH image
ID METHYL-D-ASPARTATE; AMINO-ACID RECEPTORS; IN-SITU HYBRIDIZATION; HUMAN
   FASCIA-DENTATA; GLUTAMATE-RECEPTOR; GENE-EXPRESSION; MESSENGER-RNA;
   KINDLED SEIZURES; RAT HIPPOCAMPUS; ALTERED DISTRIBUTION
AB This study determined if hippocampal AMPA and NMDA subunit immunoreactivity (IR) in temporal lobe epilepsy patients was increased compared with nonseizure autopsies. Hippocampi from hippocampal sclerosis patients (HS; n = 26) and nonsclerosis cases (non-HS; n = 12) were compared with autopsies (n = 6) and studied for GluR1, GluR2/3, NMDAR1, and NMDAR2 IR gray values (GV) along with fascia dentata and Ammon's horn neuron densities. Compared with autopsies, non-MS cases with similar neuron densities and HS patients with decreased neuron densities showed: (a) Increased GluR1 GVs in the fascia dentata molecular layer; (b) increased NMDAR1 GVs in the CA3-1 stratum radiatum and greater IR within pyramids; and (c) increased GluR2/3 and NMDAR2 GVs throughout all hippocampal subfields. Furthermore, HS patients showed that relative to the outer molecular layer: (a) GluR1 GV differences were decreased in the CA4/hilar region and CA1 stratum radiatum compared with autopsies; and (b) NMDAR2 GV differences were increased in the inner molecular layer compared with non-MS cases. In temporal lobe seizure patients, these results indicate that AMPA and NMDA receptor subunit LR was increased in HS and non-MS hippocampi compared with nonseizure autopsies. In humans, these findings support the hypothesis that glutamate receptor subunits are increased in association with chronic temporal lobe seizures, which may enhance excitatory neurotransmission and seizure susceptibility.
C1 Univ Calif Los Angeles, Ctr Med, Div Neurosurg, Reed Neurol Res Ctr, Los Angeles, CA 90095 USA.
   Univ Calif Los Angeles, Inst Brain Res, Los Angeles, CA 90095 USA.
   Univ Sao Paulo, Dept Pathol, Ribeirao Preto Sch Med, BR-14049 Ribeirao Preto, SP, Brazil.
   Univ Sao Paulo, Dept Neurol & Neurosurg, Ribeirao Preto Sch Med, BR-14049 Ribeirao Preto, SP, Brazil.
   Univ Pittsburgh, Dept Neurosurg, Pittsburgh, PA USA.
RP Mathern, GW (corresponding author), Univ Calif Los Angeles, Ctr Med, Div Neurosurg, Reed Neurol Res Ctr, Los Angeles, CA 90095 USA.
RI Mathern, Gary W./J-2483-2016; Adelson, David/W-2083-2019; Sakamoto,
   Americo C/H-5311-2012; Leite, Joao/B-9070-2012
OI Leite, Joao/0000-0003-0558-3519
FU NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
   [P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, K08NS001603, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, K08NS001603, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, K08NS001603, P01NS002808, P01NS002808,
   K08NS001603, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, K08NS001603, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
   [K08 NS 01603, P01 NS 02808] Funding Source: Medline
CR ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210
   AMARAL DG, 1986, HUM NEUROBIOL, V5, P169
   AVOLI M, 1987, NEUROSCI LETT, V76, P249, DOI 10.1016/0304-3940(87)90724-5
   Babb T. L., 1987, SURGICAL TREATMENT E, P511
   Babb Thomas L., 1993, P55
   BABB TL, 1984, EPILEPSIA, V25, P721, DOI 10.1111/j.1528-1157.1984.tb03483.x
   Babb TL, 1996, EPILEPSY RES, V26, P193, DOI 10.1016/S0920-1211(96)00053-8
   BABB TL, 1989, J NEUROSCI, V9, P2562
   BAYER TA, 1995, ACTA NEUROPATHOL, V89, P446
   BLUMCKE I, 1995, BRAIN RES, V682, P239, DOI 10.1016/0006-8993(95)00354-S
   Blumcke I, 1996, ACTA NEUROPATHOL, V92, P576, DOI 10.1007/s004010050564
   BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579
   BURNASHEV N, 1992, SCIENCE, V256, P1566, DOI 10.1126/science.1317970
   CALLAGHAN DA, 1980, NEUROPHARMACOLOGY, V19, P1131, DOI 10.1016/0028-3908(80)90113-6
   Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9
   CONDORELLI DF, 1994, NEUROCHEM INT, V25, P367, DOI 10.1016/0197-0186(94)90144-9
   COTMAN CW, 1987, TRENDS NEUROSCI, V10, P273, DOI 10.1016/0166-2236(87)90172-X
   CRUZORIVE LM, 1990, AM J PHYSIOL, V258, pL148
   DAY NC, 1995, MOL BRAIN RES, V31, P17, DOI 10.1016/0169-328X(95)00021-J
   de No RL, 1934, J PSYCHOL NEUROL, V46, P113
   During M., 1991, MICRODIALYSIS NEUROS, P425
   DURING MJ, 1993, LANCET, V341, P1607
   EASTWOOD SL, 1995, MOL BRAIN RES, V29, P211, DOI 10.1016/0169-328X(94)00247-C
   ENGEL J, 1991, PRINCIPLES NEUROSURG, P319
   FRIEDMAN LK, 1994, J NEUROSCI, V14, P2697
   GARCIALADONA FJ, 1994, MOL BRAIN RES, V21, P75, DOI 10.1016/0169-328X(94)90380-8
   GEDDES JW, 1990, EXP NEUROL, V108, P214, DOI 10.1016/0014-4886(90)90125-C
   Gold SJ, 1996, J COMP NEUROL, V365, P541
   HAMBERGER A, 1991, EPILEPSY RES, V9, P32, DOI 10.1016/0920-1211(91)90044-G
   HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335
   HOSFORD DA, 1991, J NEUROSCI, V11, P428
   HYMAN BT, 1994, ANN NEUROL, V35, P31, DOI 10.1002/ana.410350106
   IKONOMOVIC MD, 1995, J COMP NEUROL, V359, P239, DOI 10.1002/cne.903590205
   ISOKAWA M, 1991, NEUROSCI LETT, V132, P212, DOI 10.1016/0304-3940(91)90304-C
   Jensen PJ, 1997, MOL BRAIN RES, V44, P157, DOI 10.1016/S0169-328X(96)00262-8
   KAMPHUIS W, 1995, NEUROSCIENCE, V67, P551, DOI 10.1016/0306-4522(95)00070-Y
   KAMPHUIS W, 1994, EUR J NEUROSCI, V6, P1119, DOI 10.1111/j.1460-9568.1994.tb00609.x
   KAMPHUIS W, 1992, NEUROSCI LETT, V148, P51, DOI 10.1016/0304-3940(92)90802-E
   KOHR G, 1994, NEUROSCIENCE, V62, P975, DOI 10.1016/0306-4522(94)90336-0
   KRAUS JE, 1994, J NEUROSCI, V14, P4196
   LEE S, 1994, MOL BRAIN RES, V24, P34, DOI 10.1016/0169-328X(94)90115-5
   Leite JP, 1996, EPILEPSY RES, V26, P219, DOI 10.1016/S0920-1211(96)00055-1
   LyndBalta E, 1996, NEUROSCIENCE, V72, P15, DOI 10.1016/0306-4522(95)00554-4
   MARTIN LJ, 1993, NEUROSCIENCE, V53, P327, DOI 10.1016/0306-4522(93)90199-P
   Mathern GW, 1997, J NEUROPATH EXP NEUR, V56, P199, DOI 10.1097/00005072-199702000-00011
   Mathern GW, 1996, NEUROREPORT, V7, P1029, DOI 10.1097/00001756-199604100-00015
   Mathern GW, 1997, BRAIN, V120, P1937, DOI 10.1093/brain/120.11.1937
   Mathern GW, 1997, NEUROSCIENCE, V77, P1003, DOI 10.1016/S0306-4522(96)00516-7
   MATHERN GW, 1995, EPILEPSY RES, V21, P133, DOI 10.1016/0920-1211(95)00014-2
   MATHERN GW, 1995, J NEUROSCI, V15, P3990
   MATHERN GW, 1997, EPILEPSY COMPREHENSI, P133
   MAYHEW TM, 1992, J NEUROCYTOL, V21, P313, DOI 10.1007/BF01191700
   MCBAIN CJ, 1993, J PHYSIOL-LONDON, V462, P373, DOI 10.1113/jphysiol.1993.sp019560
   MCDONALD JW, 1991, ANN NEUROL, V29, P529, DOI 10.1002/ana.410290513
   MCNAMARA JO, 1988, NEUROPHARMACOLOGY, V27, P563, DOI 10.1016/0028-3908(88)90176-1
   MCNAMARA JO, 1990, EXCITATORY AMINO ACI, P451
   MOLINOFF PB, 1994, PROG BRAIN RES, V100, P39
   MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053
   MONAGHAN DT, 1997, IONOTROPHIC GLUTAMAT, P1
   MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0
   Naylor P, 1996, MOL BRAIN RES, V35, P349, DOI 10.1016/0169-328X(95)00264-S
   Ong WY, 1996, EXP BRAIN RES, V109, P251
   PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309
   POLLARD H, 1993, NEUROSCIENCE, V57, P545, DOI 10.1016/0306-4522(93)90004-Y
   Porter JT, 1996, J NEUROSCI, V16, P5073
   PRATT GD, 1993, NEUROSCIENCE, V57, P307, DOI 10.1016/0306-4522(93)90064-M
   PRINCE HK, 1995, J NEUROCHEM, V64, P462
   RONNEENGSTROM E, 1992, J CEREBR BLOOD F MET, V12, P873, DOI 10.1038/jcbfm.1992.119
   Saper CB, 1996, J COMP NEUROL, V364, P5
   Sloviter R S, 1991, Hippocampus, V1, P41, DOI 10.1002/hipo.450010106
   SOMMER B, 1992, TRENDS PHARMACOL SCI, V13, P291, DOI 10.1016/0165-6147(92)90088-N
   STEPHENS GJ, 1993, RECEPTOR CHANNEL, V1, P39
   Sutula T, 1996, J NEUROSCI, V16, P7398
   WEST MJ, 1990, PROG BRAIN RES, V83, P13
   Wieser Heinz-Gregor, 1993, P49
   WONG ML, 1993, EPILEPSY RES, V14, P221, DOI 10.1016/0920-1211(93)90046-A
NR 76
TC 54
Z9 57
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-3069
EI 1554-6578
J9 J NEUROPATH EXP NEUR
JI J. Neuropathol. Exp. Neurol.
PD JUN
PY 1998
VL 57
IS 6
BP 615
EP 634
DI 10.1097/00005072-199806000-00008
PG 20
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA 137DE
UT WOS:000076898900008
PM 9630240
OA Bronze
DA 2020-12-08
ER

PT J
AU Pereira, LAVD
   Tanaka, H
   Nagata, Y
   Sawada, K
   Mori, H
   Chimelli, LMC
   Nishimune, Y
AF Pereira, LAVD
   Tanaka, H
   Nagata, Y
   Sawada, K
   Mori, H
   Chimelli, LMC
   Nishimune, Y
TI Characterization and expression of a stage specific antigen by
   monoclonal antibody TRA 54 in testicular germ cells
SO INTERNATIONAL JOURNAL OF ANDROLOGY
LA English
DT Article
DE acrosome; chromatoid body; mAb; spermatid; testicular germ cell
ID EARLY MEIOTIC PROPHASE; MOUSE SPERMATOGENESIS; SPERM MATURATION;
   GOLGI-APPARATUS; ACROSOME BIOGENESIS; CHROMATOID BODY; RAT;
   SPERMIOGENESIS; IDENTIFICATION; EPIDIDYMIS
AB To study the mechanism of spermatogenesis, we have isolated many monoclonal antibodies (mAb) which recognize specific steps of mouse germ cell differentiation and then have evaluated the specific expression and characterization of antigenic molecules using immunohistochemistry and Western blotting. Monoclonal antibody TRA 54 recognized specific organelles in genu cell cytoplasm from spermatocytes to spermatids; that is, a large granule was stained in mid-late pachytene, diplotene and secondary spermatocytes and in round spermatids at stage I while the acrosome of spermatids at steps 2-3 to step 12 were also positive. Thereafter, the antigens disappeared from spermatids at more advanced stages of differentiation. Western blots using TRA 54 revealed broad bands with approximate molecular weights of >200, 190 and 85 kDa in the testis. The expression of these antigens during testicular germ cell development should be of interest in relation to the biogenesis of organelles such as the chromatoid body and acrosome and will be a useful stage-specific molecular marker for the study of spermatogenesis.
C1 Osaka Univ, Microbial Dis Res Inst, Dept Sci Lab Anim Experimantat, Suita, Osaka 565, Japan.
   State Univ Campinas, Dept Histol & Embryol, Campinas, SP, Brazil.
   Osaka Med Coll, Dept Pathol 2, Takatsuki, Osaka 569, Japan.
   Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Pathol, BR-14049 Ribeirao Preto, SP, Brazil.
RP Nishimune, Y (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Sci Lab Anim Experimantat, 3-1 Yamadaoka, Suita, Osaka 565, Japan.
RI Pereira, Luis Antonio Violin Dias/C-5570-2014; Pereira, Luis A V
   D/A-5263-2019
OI Pereira, Luis Antonio Violin Dias/0000-0002-9332-7285; 
CR ANAKWE OO, 1990, BIOL REPROD, V42, P317, DOI 10.1095/biolreprod42.2.317
   ARAKI S, 1991, ACTA HISTOCHEM CYTOC, V24, P477, DOI 10.1267/ahc.24.477
   BURGOS MH, 1955, J BIOPHYS BIOCHEM CY, V1, P287, DOI 10.1083/jcb.1.4.287
   CLERMONT Y, 1990, CELLULAR MOL EVENTS, P17
   ENDERS GC, 1994, DEV BIOL, V163, P331, DOI 10.1006/dbio.1994.1152
   ERICKSON RP, 1990, TRENDS GENET, V6, P264, DOI 10.1016/0168-9525(90)90209-O
   ESCALIER D, 1991, DEVELOPMENT, V113, P779
   FENDERSON BA, 1984, DEV BIOL, V103, P117, DOI 10.1016/0012-1606(84)90013-7
   HEAD JR, 1985, BIOL REPROD, V33, P1001, DOI 10.1095/biolreprod33.4.1001
   Ikawa M, 1997, NATURE, V387, P607, DOI 10.1038/42484
   KALLAJOKI M, 1986, BIOL REPROD, V35, P157, DOI 10.1095/biolreprod35.1.157
   KOSHIMIZU U, 1993, BIOL REPROD, V49, P875, DOI 10.1095/biolreprod49.5.875
   KOSHIMIZU U, 1995, MOL REPROD DEV, V49, P875
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MILLER C, 1979, RECEPTORS, V1, P1
   MILLETTE CF, 1981, J CELL SCI, V48, P367
   MILLETTE CF, 1977, J CELL BIOL, V74, P86, DOI 10.1083/jcb.74.1.86
   MONESI V, 1965, EXP CELL RES, V39, P197, DOI 10.1016/0014-4827(65)90023-6
   OBRIEN DA, 1984, DEV BIOL, V101, P307, DOI 10.1016/0012-1606(84)90144-1
   OBRIEN DA, 1988, BIOL REPROD, V38, P955, DOI 10.1095/biolreprod38.4.955
   OHSAKO S, 1991, J VET MED SCI, V53, P969, DOI 10.1292/jvms.53.969
   OHSAKO S, 1994, ANAT REC, V238, P335, DOI 10.1002/ar.1092380308
   ROMRELL LJ, 1982, GAMETE RES, V5, P35, DOI 10.1002/mrd.1120050105
   SUSI FR, 1971, AM J ANAT, V130, P251, DOI 10.1002/aja.1001300302
   TANAKA H, 1998, IN PRESS INT J ANDRO
   TANG XM, 1982, AM J ANAT, V163, P283, DOI 10.1002/aja.1001630402
   TANII I, 1992, CELL TISSUE RES, V267, P203, DOI 10.1007/BF00302956
   TANII I, 1994, CELL TISSUE RES, V277, P61, DOI 10.1007/BF00303081
   THORNETJOMSLAND G, 1988, ANAT REC, V221, P591, DOI 10.1002/ar.1092210205
   TOSHIMORI K, 1995, MOL REPROD DEV, V42, P72, DOI 10.1002/mrd.1080420110
   TOSHIMORI K, 1988, HISTOCHEMISTRY, V90, P195, DOI 10.1007/BF00492507
   WATANABE D, 1994, J BIOL CHEM, V269, P7744
   WATANABE D, 1992, MOL REPROD DEV, V33, P307, DOI 10.1002/mrd.1080330312
   WOODWARD MP, 1985, J IMMUNOL METHODS, V78, P143, DOI 10.1016/0022-1759(85)90337-0
NR 34
TC 19
Z9 19
U1 0
U2 2
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND
SN 0105-6263
J9 INT J ANDROL
JI Int. J. Androl.
PD FEB
PY 1998
VL 21
IS 1
BP 34
EP 40
PG 7
WC Andrology
SC Endocrinology & Metabolism
GA ZQ310
UT WOS:000073845400006
PM 9639150
DA 2020-12-08
ER

PT J
AU Mathern, GW
   Pretorius, JK
   Kornblum, HI
   Mendoza, D
   Lozada, A
   Leite, JP
   Chimelli, LMC
   Fried, I
   Sakamoto, AC
   Assirati, JA
   Levesque, MF
   Adelson, PD
   Peacock, WJ
AF Mathern, GW
   Pretorius, JK
   Kornblum, HI
   Mendoza, D
   Lozada, A
   Leite, JP
   Chimelli, LMC
   Fried, I
   Sakamoto, AC
   Assirati, JA
   Levesque, MF
   Adelson, PD
   Peacock, WJ
TI Human hippocampal AMPA and NMDA mRNA levels in temporal lobe epilepsy
   patients
SO BRAIN
LA English
DT Review
DE epilepsy; excitatory amino acid receptors; complex partial seizures;
   excitation
ID METHYL-D-ASPARTATE; GLUTAMATE-RECEPTOR SUBUNITS; CENTRAL-NERVOUS-SYSTEM;
   AMINO-ACID RECEPTORS; IN-SITU HYBRIDIZATION; MESSENGER-RNA; RAT
   HIPPOCAMPUS; GENE-EXPRESSION; DENTATE GYRUS; FASCIA-DENTATA
AB This study was designed to determine whether hippocampal neuronal AMPA (alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid) and NMDA (N-merhyl-o-aspartate) mRNA levels were differentially increased in temporal lobe epilepsy patients compared with those measured in control tissue from non-seizure autopsies. Hippocampi from hippocampal sclerosis patients (n = 28) and temporal mass lesion cases (n = 12) were compared with those from the autopsies (n = 4), and studied for AMPA GluR1-3 and NMDAR1-2 mRNAs using semi-quantitative in situ hybridization, along with fascia dentata and Ammon's horn neuron densities. Compared with the autopsies, and without correction for neuron counts, the mass lesion cases with neuron densities similar to autopsies showed: (i) significantly increased NMDAR2 hybridization densities for fascia dentata granule cells; (ii) increased AMPA GluR3 mRNA densities for Ammon's horn pyramids; and (iii) similar or numerically increased mRNAs for all other subunits and hippocampal subfields. Compared with the autopsies, hippocampal sclerosis cases with decreased neuron densities showed: (i) significantly decreased AMPA GluR1-2 and NMDAR1-2 hybridization densities for Ammon's horn pyramids and (ii) similar or numerically decreased mRNAs for all other subunits and subfields. However correcting for changes in neuron densities showed that hippocampal sclerosis patients had increased AMPA and NMDA mRNA levels per neuron: compared with autopsies, and in the CA2 resistant sector GluR2 mRNA levels were numerically greater than autopsies and mass lesion cases. Furthermore, relative to autopsies both sclerosis and mass lesion hippocampi showed that, in the stratum granulosum, the greatest mRNA increases were in AMPA GluR1 and NMDAR2 compared with the other mRNAs. In chronic temporal lobe seizure patients these results indicate that mass lesion and sclerosis cases show differential increases in hippocampal AMPA and NMDA mRNA levels per neuron compared with autopsies, especially for AMPA GluR1 and NMDAR2 in fascia dentata granule cells. These findings support the hypothesis that temporal lobe seizures are associated with increased ionotropic glutamate receptor mRNA levels and alterations in receptor subunit composition that probably contribute to neuronal hyperexcitability, synchronization and seizure generation.
C1 UNIV CALIF LOS ANGELES, DEPT NEUROL, LOS ANGELES, CA 90095 USA.
   UNIV CALIF LOS ANGELES, DEPT PEDIAT, LOS ANGELES, CA 90095 USA.
   UNIV CALIF LOS ANGELES, DEPT MOL & MED PHARMACOL, LOS ANGELES, CA 90095 USA.
   UNIV CALIF LOS ANGELES, BRAIN RES INST, LOS ANGELES, CA 90095 USA.
   EPILEPSY & BRAIN MAPPING CTR, LOS ANGELES, CA USA.
   UNIV PITTSBURGH, DEPT NEUROSURG, PITTSBURGH, PA 15260 USA.
   UNIV SAO PAULO, RIBEIRAO PRETO SCH MED, DEPT NEUROPATHOL, BR-14049 RIBEIRAO PRETO, BRAZIL.
   UNIV SAO PAULO, RIBEIRAO PRETO SCH MED, DEPT NEUROL, BR-14049 RIBEIRAO PRETO, BRAZIL.
   UNIV SAO PAULO, RIBEIRAO PRETO SCH MED, DEPT NEUROSURG, BR-14049 RIBEIRAO PRETO, BRAZIL.
RP Mathern, GW (corresponding author), UNIV CALIF LOS ANGELES, MED CTR, REED NEUROL RES CTR, DIV NEUROSURG, LOS ANGELES, CA 90095 USA.
RI Leite, Joao/B-9070-2012; Adelson, David/W-2083-2019; Sakamoto, Americo
   C/H-5311-2012; Mathern, Gary W./J-2483-2016
OI Leite, Joao/0000-0003-0558-3519; 
FU NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
   [P01NS002808, P01NS002808, P01NS002808, P50NS028383, P01NS002808,
   P01NS002808, P50NS028383, P01NS028383, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, K08NS001603, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, K08NS001603, P01NS002808,
   P01NS002808, P01NS028383, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS028383, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS028383, P01NS028383, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS028383,
   P50NS028383, P01NS002808, P01NS002808, P01NS002808, P01NS028383,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P50NS028383,
   P01NS002808, P01NS028383, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P50NS028383, K08NS001603, K08NS001603,
   P01NS002808, P50NS028383, P01NS002808, P01NS002808, P01NS002808,
   P01NS028383, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS028383, P01NS002808, P01NS002808, P01NS002808,
   P50NS028383, P01NS002808, P01NS002808, K08NS001603, P50NS028383,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS028383, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P50NS028383, P01NS028383, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS028383, P01NS028383,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808, P01NS002808,
   P01NS002808, P01NS002808, P01NS002808, P01NS002808] Funding Source: NIH
   RePORTER; NINDS NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Neurological Disorders & Stroke (NINDS) [NS 02808, NS 28383-03, K08
   NS 01603] Funding Source: Medline
CR ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210
   AMARAL DG, 1986, HUM NEUROBIOL, V5, P169
   Aniksztejn L, 1995, J NEUROPHYSIOL, V74, P2349
   AVOLI M, 1987, NEUROSCI LETT, V76, P249, DOI 10.1016/0304-3940(87)90724-5
   Babb T. L., 1987, SURGICAL TREATMENT E, P511
   Babb Thomas L., 1993, P55
   BABB TL, 1984, EPILEPSIA, V25, P721, DOI 10.1111/j.1528-1157.1984.tb03483.x
   Babb TL, 1996, EPILEPSY RES, V26, P193, DOI 10.1016/S0920-1211(96)00053-8
   BABB TL, 1984, EPILEPSIA, V25, P729, DOI 10.1111/j.1528-1157.1984.tb03484.x
   BABB TL, 1991, NEUROSCIENCE, V42, P351, DOI 10.1016/0306-4522(91)90380-7
   BAUDE A, 1995, NEUROSCIENCE, V69, P1031, DOI 10.1016/0306-4522(95)00350-R
   BAYER TA, 1995, ACTA NEUROPATHOL, V89, P446
   BEKENSTEIN JW, 1990, BRAIN RES, V514, P334, DOI 10.1016/0006-8993(90)91429-K
   BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0
   BERNARD C, 1995, EPILEPSY RES, V21, P95, DOI 10.1016/0920-1211(95)00017-5
   BETTLER B, 1995, NEUROPHARMACOLOGY, V34, P123, DOI 10.1016/0028-3908(94)00141-E
   BLUMCKE I, 1995, BRAIN RES, V682, P239, DOI 10.1016/0006-8993(95)00354-S
   BOCHET P, 1994, NEURON, V12, P383, DOI 10.1016/0896-6273(94)90279-8
   BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579
   BROSE N, 1993, J BIOL CHEM, V268, P22663
   BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677
   Burnashev N, 1996, CURR OPIN NEUROBIOL, V6, P311, DOI 10.1016/S0959-4388(96)80113-9
   BURNASHEV N, 1992, SCIENCE, V256, P1566, DOI 10.1126/science.1317970
   Chabot C, 1996, DEV BRAIN RES, V93, P70, DOI 10.1016/0165-3806(96)00021-1
   Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9
   Coggeshall RE, 1996, J COMP NEUROL, V369, P162
   CONDORELLI DF, 1994, NEUROCHEM INT, V25, P367, DOI 10.1016/0197-0186(94)90144-9
   COTMAN CW, 1987, TRENDS NEUROSCI, V10, P273, DOI 10.1016/0166-2236(87)90172-X
   COX KH, 1984, DEV BIOL, V101, P485, DOI 10.1016/0012-1606(84)90162-3
   CRUZORIVE LM, 1990, AM J PHYSIOL, V258, pL148
   DAM AM, 1980, EPILEPSIA, V21, P617, DOI 10.1111/j.1528-1157.1980.tb04315.x
   DAY NC, 1995, MOL BRAIN RES, V31, P17, DOI 10.1016/0169-328X(95)00021-J
   de No RL, 1934, J PSYCHOL NEUROL, V46, P113
   DELANEROLLE NC, 1989, BRAIN RES, V495, P387, DOI 10.1016/0006-8993(89)90234-5
   DINGLEDINE R, 1990, TRENDS PHARMACOL SCI, V11, P334, DOI 10.1016/0165-6147(90)90238-4
   DOURNAUD P, 1994, NEUROSCIENCE, V61, P755, DOI 10.1016/0306-4522(94)90399-9
   EASTWOOD SL, 1994, NEUROREPORT, V5, P1325, DOI 10.1097/00001756-199406000-00007
   ENGEL J, 1991, PRINCIPLES NEUROSURG, P319
   FRIEDMAN LK, 1994, J NEUROSCI, V14, P2697
   GALL C, 1990, P NATL ACAD SCI USA, V87, P7643, DOI 10.1073/pnas.87.19.7643
   GALL CM, 1989, SCIENCE, V245, P758, DOI 10.1126/science.2549634
   GARCIALADONA FJ, 1994, MOL BRAIN RES, V21, P75, DOI 10.1016/0169-328X(94)90380-8
   GEDDES JW, 1990, EXP NEUROL, V108, P214, DOI 10.1016/0014-4886(90)90125-C
   GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4
   Gold SJ, 1996, J COMP NEUROL, V365, P541
   GOULD E, 1994, J COMP NEUROL, V340, P551, DOI 10.1002/cne.903400408
   Gu JG, 1996, NATURE, V381, P793, DOI 10.1038/381793a0
   HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304
   HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335
   HOSFORD DA, 1991, J NEUROSCI, V11, P428
   HOUSER CR, 1990, J NEUROSCI, V10, P267
   HYMAN BT, 1994, ANN NEUROL, V35, P31, DOI 10.1002/ana.410350106
   IKONOMOVIC MD, 1995, J COMP NEUROL, V359, P239, DOI 10.1002/cne.903590205
   ISOKAWA M, 1991, NEUROSCI LETT, V132, P212, DOI 10.1016/0304-3940(91)90304-C
   KAMPHUIS W, 1995, NEUROSCIENCE, V67, P551, DOI 10.1016/0306-4522(95)00070-Y
   KAMPHUIS W, 1994, EUR J NEUROSCI, V6, P1119, DOI 10.1111/j.1460-9568.1994.tb00609.x
   KAMPHUIS W, 1992, NEUROSCI LETT, V148, P51, DOI 10.1016/0304-3940(92)90802-E
   KENNEDY MB, 1994, ANNU REV BIOCHEM, V63, P571, DOI 10.1146/annurev.bi.63.070194.003035
   KOH DS, 1995, J PHYSIOL-LONDON, V485, P383, DOI 10.1113/jphysiol.1995.sp020737
   KOHR G, 1994, NEUROSCIENCE, V62, P975, DOI 10.1016/0306-4522(94)90336-0
   KOHR G, 1993, J NEUROSCI, V13, P3612
   KORNBLUM HI, 1994, MOL BRAIN RES, V21, P107, DOI 10.1016/0169-328X(94)90383-2
   KRAUS JE, 1994, J NEUROSCI, V14, P4196
   LAMBOLEZ B, 1992, NEURON, V9, P247, DOI 10.1016/0896-6273(92)90164-9
   LEE S, 1994, MOL BRAIN RES, V24, P34, DOI 10.1016/0169-328X(94)90115-5
   Leranth C, 1996, NEUROSCIENCE, V70, P631, DOI 10.1016/S0306-4522(96)83003-X
   LyndBalta E, 1996, NEUROSCIENCE, V72, P15, DOI 10.1016/0306-4522(95)00554-4
   MARTIN D, 1992, J NEUROSCI, V12, P1928
   MARTIN LJ, 1993, NEUROSCIENCE, V53, P327, DOI 10.1016/0306-4522(93)90199-P
   Mathern G. W., 1996, Epilepsia, V37, P40
   Mathern GW, 1996, BRAIN, V119, P965, DOI 10.1093/brain/119.3.965
   MATHERN GW, 1995, BRAIN, V118, P105, DOI 10.1093/brain/118.1.105
   Mathern GW, 1997, J NEUROPATH EXP NEUR, V56, P199, DOI 10.1097/00005072-199702000-00011
   Mathern GW, 1996, NEUROREPORT, V7, P1029, DOI 10.1097/00001756-199604100-00015
   MATHERN GW, 1995, J NEUROSURG, V82, P211, DOI 10.3171/jns.1995.82.2.0211
   Mathern GW, 1997, NEUROSCIENCE, V77, P1003, DOI 10.1016/S0306-4522(96)00516-7
   MATHERN GW, 1995, J NEUROSURG, V82, P220, DOI 10.3171/jns.1995.82.2.0220
   MATHERN GW, 1995, EPILEPSY RES, V21, P133, DOI 10.1016/0920-1211(95)00014-2
   Mathern GW, 1997, MOL CHEM NEUROPATHOL, V30, P53, DOI 10.1007/BF02815150
   MATHERN GW, 1995, J NEUROSCI, V15, P3990
   MATHERN GW, 1997, IN PRESS EPILEPSY CO
   MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883
   MAYHEW TM, 1992, J NEUROCYTOL, V21, P313, DOI 10.1007/BF01191700
   MCBAIN CJ, 1993, J PHYSIOL-LONDON, V462, P373, DOI 10.1113/jphysiol.1993.sp019560
   MCDONALD JW, 1990, BRAIN RES REV, V15, P41, DOI 10.1016/0165-0173(90)90011-C
   MCDONALD JW, 1991, ANN NEUROL, V29, P529, DOI 10.1002/ana.410290513
   MCNAMARA JO, 1990, EXCITATORY AMINO ACI, P451
   MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0
   MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A
   MOLINOFF PB, 1994, PROG BRAIN RES, V100, P39
   MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053
   MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217
   MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0
   Naylor P, 1996, MOL BRAIN RES, V35, P349, DOI 10.1016/0169-328X(95)00264-S
   NICOLL RA, 1988, SCIENCE, V241, P545, DOI 10.1126/science.2456612
   PELLEGRINIGIAMPIETRO DE, 1992, NEUROSCI LETT, V144, P65, DOI 10.1016/0304-3940(92)90717-L
   PENNEFATHER P, 1982, MOL PHARMACOL, V22, P369
   PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309
   PETRALIA RS, 1994, J NEUROSCI, V14, P667
   POLLARD H, 1993, NEUROSCIENCE, V57, P545, DOI 10.1016/0306-4522(93)90004-Y
   PorteraCailliau C, 1996, J NEUROCHEM, V66, P692, DOI 10.1046/j.1471-4159.1996.66020692.x
   PRATT GD, 1993, NEUROSCIENCE, V57, P307, DOI 10.1016/0306-4522(93)90064-M
   PRINCE HK, 1995, J NEUROCHEM, V64, P462
   ROGERS SW, 1991, J NEUROSCI, V11, P2713
   Saper CB, 1996, J COMP NEUROL, V364, P5
   SIEGEL SJ, 1995, J NEUROSCI, V15, P2707
   Sloviter R S, 1991, Hippocampus, V1, P41, DOI 10.1002/hipo.450010106
   SLOVITER RS, 1994, ANN NEUROL, V35, P640, DOI 10.1002/ana.410350604
   SOLTESZ I, 1994, NEUROSCI LETT, V181, P5, DOI 10.1016/0304-3940(94)90547-9
   SOMMER B, 1992, TRENDS PHARMACOL SCI, V13, P291, DOI 10.1016/0165-6147(92)90088-N
   SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521
   STEPHENS GJ, 1993, RECEPTOR CHANNEL, V1, P39
   Wenthold RJ, 1996, J NEUROSCI, V16, P1982
   WEST MJ, 1990, PROG BRAIN RES, V83, P13
   WETZEL DM, 1994, BRAIN RES, V649, P117, DOI 10.1016/0006-8993(94)91054-5
   Wieser Heinz-Gregor, 1993, P49
   WONG ML, 1993, EPILEPSY RES, V14, P221, DOI 10.1016/0920-1211(93)90046-A
NR 117
TC 86
Z9 86
U1 0
U2 8
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD NOV
PY 1997
VL 120
BP 1937
EP 1959
DI 10.1093/brain/120.11.1937
PN 11
PG 23
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA YJ714
UT WOS:A1997YJ71400003
PM 9397013
OA Bronze
DA 2020-12-08
ER

PT J
AU Chimelli, L
   Freitas, M
   Nascimento, O
AF Chimelli, L
   Freitas, M
   Nascimento, O
TI Value of nerve biopsy in the diagnosis and follow-up of leprosy: The
   role of vascular lesions and usefulness of nerve studies in the
   detection of persistent bacilli
SO JOURNAL OF NEUROLOGY
LA English
DT Article
DE biopsy; leprosy; peripheral nerves
ID MYCOBACTERIUM-LEPRAE; LEPROMATOUS LEPROSY; ULTRASTRUCTURAL CHANGES;
   PERIPHERAL-NERVES; NEURITIC LEPROSY; BLOOD-VESSELS; NEUROPATHY;
   BORDERLINE; MANAGEMENT; SKIN
AB Nerve biopsy specimens from 53 patients with leprosy and neuropathy were taken from the sural, the dorsal branch of the ulnar, or the superficial radial nerves and processed for light and electron microscopy. There was inflammation in 40 cases (75%), 7 with a granulomatous reaction, various stages of fibrosis in 35 (66%), and endoneurial vascular neoformation in 7. In two cases, small focal infarcts were associated with marked endoneurial inflammation compressing the vessels, in addition to endoneurial lymphocytic vasculitis. Most had an axonal neuropathy of varying degree, some with total fibre loss, others with predominant small myelinated and unmyelinated fibre loss. Signs of demyelination and remyelination were the main findings in 9 cases (17%). Bacilli were present in endothelial, perineurial, Schwann cells and in macrophages. On two occasions, they lost their alcohol acid resistance, were suspected in semithin sections, and confirmed ultrastructurally. The biopsy was decisive for the diagnosis of leprosy in 15 cases (28%), most without skin lesions. We evaluated the effectiveness of the treatment in 20 (37.7%), 12 without and 8 with bacilli, despite negativity in the skin. The diagnosis of leprosy based on skin lesions was confirmed with the nerve biopsy in 9 cases, 6 had an inflammatory neuropathy suggestive of leprosy in the absence of bacilli, and 3 had nonspecific changes in the sural nerve since the neuropathy was in the upper limbs. We conclude that nerve biopsy is indicated for the diagnosis of leprosy in cases without clinically visible skin lesions and To evaluate the effectiveness of the treatment. In these cases the ultrastructural studies are important for recognition of the bacilli. Vascular lesions may play an important role in the progression of the nerve damage,including the occurrence of focal nerve infarcts which, to our knowledge, have not been previously reported in association with leprosy.
C1 UNIV FED FLUMINENSE,SCH MED,DEPT PATHOL,NITEROI,RJ,BRAZIL.
   UNIV FED FLUMINENSE,SCH MED,DIV NEUROL,NITEROI,RJ,BRAZIL.
RP Chimelli, L (corresponding author), UNIV SAO PAULO,SCH MED RIBEIRAO PRETO,DEPT PATHOL,BR-14049 RIBEIRAO PRET,BRAZIL.
CR ANTIA NH, 1985, IRCS MED SCI-BIOCHEM, V13, P914
   BODDINGIUS J, 1977, ACTA NEUROPATHOL, V40, P21, DOI 10.1007/BF00688570
   BODDINGIUS J, 1976, ACTA NEUROPATHOL, V35, P159, DOI 10.1007/BF00690562
   CARAYON A., 1977, Hansenologia Internationalis, V2, P15
   Chemouilli P, 1996, INT J LEPROSY, V64, P1
   DASTUR D K, 1973, International Journal of Leprosy and Other Mycobacterial Diseases, V41, P47
   Dastur D K, 1966, Int J Lepr Other Mycobact Dis, V34, P118
   DASTUR DK, 1991, INT J LEPROSY, V59, P122
   GIBBELS E, 1988, LEPROSY REV, V59, P153
   GIBBELS E, 1987, INT J LEPROSY, V55, P333
   GRUGNI A, 1990, INT J LEPROSY, V48, P19
   HAIMANOT RT, 1984, INT J LEPROSY, V52, P163
   JACOB M, 1988, INT J LEPROSY, V56, P56
   JOB CK, 1970, ARCH PATHOL, V89, P195
   JOB CK, 1989, INT J LEPROSY, V57, P532
   Job CK, 1996, INT J LEPROSY, V64, P44
   KAUR G, 1991, INT J LEPROSY, V59, P385
   KAUR S, 1993, LEPROSY REV, V64, P110
   Kumar SKA, 1996, LEPROSY REV, V67, P119
   Kumar V, 1992, Indian J Lepr, V64, P81
   Manghani D K, 1992, Indian J Lepr, V64, P67
   MOTTA CP, 1990, INT J LEPROSY, V58, P453
   NEGESSE Y, 1993, LEPROSY REV, V64, P104
   Nilsen R, 1986, Lepr Rev, V57 Suppl 2, P177
   NILSEN R, 1989, LEPROSY REV, V60, P28
   NOORDEEN SK, 1992, B WORLD HEALTH ORGAN, V70, P7
   Pearson J M, 1975, Lepr Rev, V46, P199
   Pearson J M, 1975, Lepr Rev, V46, P51
   PEREIRA JH, 1991, LEPROSY REV, V62, P134
   Rasouli I, 1992, Indian J Lepr, V64, P14
   RICHARDSON EP, 1995, MAJOR PROBLEMS PATHO, P4
   RIDLEY DS, 1989, LEPROSY REV, V60, P244
   RIDLEY MJ, 1987, INT J LEPROSY, V55, P99
   SABIN TD, 1993, PERIPHERAL NEUROPATH, V2, P1354
   SHETTY VP, 1988, J NEUROL SCI, V88, P115, DOI 10.1016/0022-510X(88)90210-9
   SHETTY VP, 1992, LEPROSY REV, V63, P329
   Srinivasan H, 1982, Lepr India, V54, P275
   STONER GL, 1979, LANCET, V2, P994
   TZOURIO C, 1992, J NEUROL, V239, P367
   VALLAT JM, 1991, ACTA NEUROPATHOL, V81, P336, DOI 10.1007/BF00305877
   Yajima M, 1991, Nihon Rai Gakkai Zasshi, V60, P121
NR 41
TC 42
Z9 43
U1 0
U2 0
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0340-5354
J9 J NEUROL
JI J. Neurol.
PD MAY
PY 1997
VL 244
IS 5
BP 318
EP 323
DI 10.1007/s004150050094
PG 6
WC Clinical Neurology
SC Neurosciences & Neurology
GA WZ006
UT WOS:A1997WZ00600008
PM 9178158
DA 2020-12-08
ER

PT J
AU Colli, BO
   Assirati, JA
   Machado, HR
   Figueiredo, JFEC
   Chimelli, L
   Salvarani, CP
   dosSantos, F
AF Colli, BO
   Assirati, JA
   Machado, HR
   Figueiredo, JFEC
   Chimelli, L
   Salvarani, CP
   dosSantos, F
TI Intramedullary spinal cord paracoccidioidomycosis
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Portuguese
DT Article
DE intramedullary paracoccidioidomycosis; granuloma intramedullar
   blastomycotic; spinal cord compression; surgical treatment; medical
   treatment
ID SOUTH-AMERICAN BLASTOMYCOSIS; POSTERIOR-FOSSA TUMOR; BRAIN
AB Two cases of intramedullary paracoccidioidomycosis are reported. Paracoccidioidomycosis is a systemic disease that involves the buccopharyngeal mucosa, lungs, lymph nodes and viscera and infrequently the central nervous system. Localization in the spinal cord is rare. Case 1: a 55-year old male admitted with crural pararesis, tactile/painful hypesthesia and sphincter disturbances of 15 days duration, Cutaneous-pulmonary blastomycosis was diagnosed 17 years ago. Myelotomography showed a blockade of T3-T4 (intramedullary lesion). The lesion surgically removed was a Paracoccidioides brasiliensis granuloma. Treatment with sulfadiazine was started after the surgery. Follow-up of 15 month showed an improvement of the clinical signs. Case 2: a 57-year old male was admitted elsewhere 6 months ago and, with a radiologic diagnosis of pulmonary paracoccidioidomycosis, was treated with amphotericin B. He progressively developed paresthesia and tactile/ pain anaesthesia on the left side, sphincter disturbances and tetraparesis with bilateral extensor plantar response and clonus of the feet. Myelotomography showed a blockade of C4-C6 (intramedullary lesion). The lesion was not found during surgical exploration and the patient deteriorated and died. Post-mortem examination revealed an intramedullary tumor above the site of the mielotomy (Paracoccidioides brasiliensis granuloma). The preoperative diagnosis of intermedullary paracoccidioidomycotic granulomas is difficult because the clinical and radiologic manifestations are uncharacteristic. Clinical suspicion was possible in our cases based on the history of previous systemic disease. Contrary to intracranial localizations, paracoccidioidomycotic granulomas causing progressive spinal cord compression may require early surgery because response to clinical treatment is slow and the reversibility of neurological deficits depends on the promptness of the decompression.
C1 UNIV SAO PAULO, RIBEIRAO PRETO MED SCH,HOSP CLIN,DIV NEUROSURG, DEPT SURG, RIBEIRAO PRETO, BRAZIL.
   UNIV SAO PAULO, RIBEIRAO PRETO MED SCH,HOSP CLIN,DIV NEUROSURG, DEPT INTERNAL MED, RIBEIRAO PRETO, BRAZIL.
   UNIV SAO PAULO, RIBEIRAO PRETO MED SCH,HOSP CLIN,DIV NEUROSURG, DEPT PATHOL, RIBEIRAO PRETO, BRAZIL.
RI Colli, Benedicto/A-2833-2016; Machado, Helio R/I-6602-2012
OI Colli, Benedicto/0000-0002-0222-6770; Machado, Helio/0000-0002-1069-7804
CR ANDRADE JJA, 1984, REV INST MED TROP, V26, P1
   ARAUJO JC, 1978, J NEUROSURG, V49, P425, DOI 10.3171/jns.1978.49.3.0425
   BARBOSA W, 1968, THESIS FEDERAL U GOI
   Braga FM, 1973, SEARA MED NEUROCIR S, V1, P435
   CAMPOS EC, 1963, NEUROBIOLOGIA, V26, P83
   CANELAS H M, 1951, Arq Neuropsiquiatr, V9, P203
   COLLI B O, 1986, Arquivos de Neuro-Psiquiatria, V44, P155
   COLLI BO, 1994, ARQ BRAS NEUROCIR, V4, P55
   Del Negro G, 1982, Rev Inst Med Trop Sao Paulo, V24, P27
   FILHO FM, 1977, ARQ NEURO-PSIQUIAT, V35, P151
   Hutzler R U, 1985, Rev Paul Med, V103, P243
   Lima N S, 1978, Rev Inst Med Trop Sao Paulo, V20, P347
   Maffei WE, 1943, AN FM S PAULO, V29, P297
   Marchiori E, 1989, Arq Neuropsiquiatr, V47, P224
   MARCONDES J, 1984, REV I MED TROP, V26, P113, DOI 10.1590/S0036-46651984000200008
   MINGUETTI G, 1983, REV INST MED TROP SP, V25, P99
   MINGUETTI G, 1983, ARCH NEUROL-CHICAGO, V40, P100, DOI 10.1001/archneur.1983.04050020062013
   MORATO-FERNANDEZ R N, 1991, Arquivos de Neuro-Psiquiatria, V49, P192
   MOURA LP, 1994, ARQ NEURO-PSIQUIAT, V52, P82
   Negroni R, 1988, Ann N Y Acad Sci, V544, P497, DOI 10.1111/j.1749-6632.1988.tb40447.x
   NEGRONI R, 1977, P ROY SOC MED, V70, P24, DOI 10.1177/00359157770700S108
   NOBREGA JPS, 1982, ARQ BRAS NEUROCIR, V1, P157
   PEDRO R D J, 1980, Revista do Instituto de Medicina Tropical de Sao Paulo, V22, P269
   PEREIRA JM, 1919, AN PAUL MED CIRURG, V10, P217
   Pereira W C, 1965, Arq Neuropsiquiatr, V23, P95
   Pereira W C, 1965, Arq Neuropsiquiatr, V23, P113
   PIMENTA AM, 1972, SEARA MED NEUROCIR, V1, P73
   RAPHAEL A, 1966, ARQ NEURO-PSIQUIAT, V24, P69
   RESTREPO A, 1983, AM J MED, V78, P53
   RITTER F H, 1948, Arq Neuropsiquiatr, V6, P352
   STEVENS DA, 1978, AM J TROP MED HYG, V27, P801, DOI 10.4269/ajtmh.1978.27.801
   TEIVE HAG, 1991, J ROY SOC MED, V84, P562
   VOELKER JL, 1989, J NEUROSURG, V70, P959, DOI 10.3171/jns.1989.70.6.0959
   WITTIG EO, 1968, ARQ NEURO-PSIQUIAT, V23, P73
NR 34
TC 20
Z9 25
U1 0
U2 0
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD SEP
PY 1996
VL 54
IS 3
BP 466
EP 473
DI 10.1590/S0004-282X1996000300017
PG 8
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA VE335
UT WOS:A1996VE33500017
PM 9109993
OA Other Gold
DA 2020-12-08
ER

PT J
AU Chimelli, L
AF Chimelli, L
TI Peripheral neuropathies in childhood: A neuropathological approach
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Portuguese
DT Article
DE peripheral neuropathies; childhood; nerve biopsy; morphology
ID GIANT AXONAL NEUROPATHY; GUILLAIN-BARRE-SYNDROME; HEREDITARY MOTOR; 2
   SIBLINGS; PATHOLOGY; DISEASE; MUSCLE; NERVES
AB Peripheral neuropathies affect children more often than the young and middle age adults, but less frequently than the elderly. They differ from those in the adults because of the high incidence of hereditary neuropathies, including those associated with metabolic and degenerative disorders of the central nervous system; the low incidence of toxic neuropathies and those associated with systemic disorders; and a lower incidence of chronic acquired polineuropathies. Nerve biopsies are indicated if the diagnosis has not been made with clinical and electrophysiologic studies and other methods, and should only be performed in laboratories with appropriate techniques for the study of the nerve. It is important to know the normal development of the nerve, the thickness of the myelin sheath and the distribution of small and large fibers, according to the age. The main morphological aspects of the most frequent neuropathies in children - acquired (inflammatory, demyelinating) and hereditary (sensory-motor, sensory-autonomic, ataxic, and those associated with metabolic and degenerative disorders), are reviewed.
C1 UNIV SAO PAULO,FAC MED RIBEIRAO PRETO,BR-05508 SAO PAULO,BRAZIL.
CR Dyck P.J., 1984, PERIPHERAL NEUROPATH, P1600
   DYCK PJ, 1993, NEUROLOGY, V43, P1277, DOI 10.1212/WNL.43.7.1277
   Dyck PJ, 1993, PERIPHERAL NEUROPATH, P1094
   DYCK PJ, 1993, PERIPHERAL NEUROPATH, P1065
   DYCK PJ, 1984, PERIPHERAL NEUROPATH, P1557
   FEASBY TE, 1993, J NEUROL SCI, V116, P185, DOI 10.1016/0022-510X(93)90324-R
   FREITAS MRG, 1995, ARQ NEURO-PSIQUIAT, V53, P545
   GABREELSFESTEN AAWM, 1994, NEUROMUSCULAR DISORD, V4, P63, DOI 10.1016/0960-8966(94)90049-3
   HAHN AF, 1994, ACTA NEUROPATHOL, V87, P149
   JACOBS JM, 1990, BRAIN, V113, P447, DOI 10.1093/brain/113.2.447
   JOHNSON MD, 1989, CLIN NEUROPATHOL, V8, P28
   KUMAR K, 1990, J CHILD NEUROL, V5, P229, DOI 10.1177/088307389000500316
   LUPSKI JR, 1992, BRAIN PATHOL, V2, P337, DOI 10.1111/j.1750-3639.1992.tb00710.x
   MALANDRINI A, 1992, CLIN NEUROPATHOL, V11, P318
   MCKHANN GM, 1993, ANN NEUROL, V33, P333, DOI 10.1002/ana.410330402
   Midroni G, 1995, BIOPSY DIAGNOSIS PER
   MIIKE T, 1986, ACTA NEUROPATHOL, V69, P117, DOI 10.1007/BF00687047
   NARA T, 1995, J NEUROL SCI, V129, P170, DOI 10.1016/0022-510X(94)00272-P
   OUVRIER RA, 1990, PERIPHERAL NEUROPATH
   RICHARDSON EP, 1995, PATHOL PERIPHERAL NE
   ROSEMBERG S, 1994, PEDIATR NEUROL, V11, P50, DOI 10.1016/0887-8994(94)90091-4
   SASAKI K, 1992, BRAIN DEV-JPN, V14, P114, DOI 10.1016/S0387-7604(12)80098-2
   SCHRODER JM, 1988, ACTA NEUROPATHOL, V76, P471, DOI 10.1007/BF00686386
   SNIPES GJ, 1995, BRAIN PATHOL, V5, P233, DOI 10.1111/j.1750-3639.1995.tb00600.x
   TARATUTO AL, 1990, ACTA NEUROPATHOL, V80, P680, DOI 10.1007/BF00307639
   VITAL A, 1992, ACTA NEUROPATHOL, V84, P433
   VITAL A, 1995, PEDIATRIC NEUROPATHO, P767
   WISNIEWSKI KE, 1988, J CHILD NEUROL, V3, P33, DOI 10.1177/088307388800300108
   YOKOTA T, 1992, MUSCLE NERVE, V15, P1211
NR 29
TC 2
Z9 2
U1 0
U2 1
PU ASSOC ARQUIVOS DE NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA C/O DR OSWALDO LANGE, CAIXA POSTAL 8877, 01065-970 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD SEP
PY 1996
VL 54
IS 3
BP 510
EP 518
DI 10.1590/S0004-282X1996000300025
PG 9
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA VE335
UT WOS:A1996VE33500025
PM 9110001
OA Other Gold, Bronze
DA 2020-12-08
ER

PT J
AU FREITAS, MRG
   NASCIMENTO, OJM
   CHIMELLI, L
   DEFREITAS, GR
AF FREITAS, MRG
   NASCIMENTO, OJM
   CHIMELLI, L
   DEFREITAS, GR
TI CHARCOT-MARIE-TOOTH-DISEASE - SURAL NERVE BIOPSY FINDINGS IN 41 PATIENTS
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Portuguese
DT Article
DE CHARCOT-MARIE-TOOTH DISEASE; SURAL NERVE BIOPSY; PATHOLOGICAL FINDINGS
ID PERONEAL MUSCULAR-ATROPHY; HMSN TYPE-I; SENSORY NEUROPATHY; HEREDITARY
   MOTOR; FEATURES
AB We studied the pathological findings of sural nerve biopsy in 41 patients with Charcot-Marie-Tooth (CMT) disease. They were previously classified by the median motor conduction velocity (MCV) in two types. Type I (demyelinating) with 9 patients and type II (axonal) with 32 cases. In type I we found loss of myelinated fibers (unimodal histogram), demyelinated and remyelinated axons with numerous onion bulb formations. In one case there was thickness of myelin with thin axons (axonal atrophy). In type II there were seven patients with normal sural nerve biopsy. In 25 cases there were mild to severe loss of myelinated fibers, In 5 patients the number of myelinated fibers was increased due to the great regeneration of the axons. The electron microscopic studies in type II showed in a few cases small onion bulbs and in one case axonal atrophy. In type I there was no correlation between clinical severity and the loss of myelinated fibres, but there was relationship between the low MCV and the intensity of myelinated fibers. In type II we did not round any correlation between clinical course, MCV and pathological findings.
C1 UNIV FED FLUMINENSE,HOSP ANTONIO PEDRO,SERV NEUROL,SETOR DOENCAS NEUROMUSCULARES,BR-24220100 NITEROI,RJ,BRAZIL.
   UNIV SAO PAULO,FAC MED RIBEIRAO PRETO,BR-05508 SAO PAULO,BRAZIL.
RI de Freitas, Gabriel R/B-1298-2013
CR BEHSE F, 1977, BRAIN, V100, P67, DOI 10.1093/brain/100.1.67
   CHIMELLI L, 1989, Arquivos de Neuro-Psiquiatria, V47, P413
   DAN A, 1990, J NEUROL SCI S, V98, P404
   Dyck P.J., 1984, PERIPHERAL NEUROPATH, P1600
   DYCK PJ, 1968, MAYO CLIN PROC, V43, P81
   DYCK PJ, 1968, ARCH NEUROL-CHICAGO, V18, P619, DOI 10.1001/archneur.1968.00470360041003
   DYCK PJ, 1971, MAYO CLIN PROC, V46, P432
   Dyck PJ, 1993, PERIPHERAL NEUROPATH, P1094
   DYCK PJ, 1966, P MAYO CLIN, V41, P742
   FREITAS MRG, 1995, ARQ NEURO-PSIQUIAT, V53, P545
   GABREELSFESTEN AAW, 1990, J NEUROL SCI S, V98, P365
   GABREELSFESTEN AAWM, 1992, J NEUROL SCI, V107, P145, DOI 10.1016/0022-510X(92)90282-P
   GHERARDI R, 1983, J NEUROL SCI, V61, P401, DOI 10.1016/0022-510X(83)90173-9
   HARDING AE, 1980, BRAIN, V103, P259, DOI 10.1093/brain/103.2.259
   LOW PA, 1978, J NEUROL SCI, V35, P93, DOI 10.1016/0022-510X(78)90104-1
   NUKADA H, 1984, ANN NEUROL, V16, P238, DOI 10.1002/ana.410160213
   NUKADA H, 1983, ANN NEUROL, V14, P648, DOI 10.1002/ana.410140608
   OUVRIER RA, 1987, BRAIN, V110, P121, DOI 10.1093/brain/110.1.121
   OUVRIER RA, 1990, PERIPHERAL NEUROPATH, P63
   THOMAS PK, 1974, ANN HUM GENET, V38, P111, DOI 10.1111/j.1469-1809.1974.tb01945.x
   VANWEERDEN TW, 1982, MUSCLE NERVE, V5, P185, DOI 10.1002/mus.880050303
   VITAL A, 1992, ACTA NEUROPATHOL, V84, P433
   VOGEL P, 1985, ANN NEUROL, V17, P455, DOI 10.1002/ana.410170507
NR 23
TC 2
Z9 2
U1 0
U2 2
PU ASSOC ARQUIVOS DE NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA C/O DR OSWALDO LANGE, CAIXA POSTAL 8877, 01065-970 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD SEP
PY 1995
VL 53
IS 3B
BP 560
EP 569
DI 10.1590/S0004-282X1995000400003
PG 10
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA TB699
UT WOS:A1995TB69900003
PM 8585811
OA Other Gold
DA 2020-12-08
ER

PT J
AU BUDKA, H
   CHIMELLI, L
AF BUDKA, H
   CHIMELLI, L
TI LIPOMATOUS MEDULLOBLASTOMA IN ADULTS - A NEW TUMOR TYPE WITH POSSIBLE
   FAVORABLE PROGNOSIS
SO HUMAN PATHOLOGY
LA English
DT Letter
C1 UNIV SAO PAULO,FAC MED RIBEIRAO PRETO,SAO PAULO,BRAZIL.
RP BUDKA, H (corresponding author), UNIV VIENNA,INST NEUROL,SCHWARZSPANIERSTR 17,VIENNA,AUSTRIA.
RI Budka, Herbert/I-3486-2019
OI Budka, Herbert/0000-0002-1933-1577
CR BUDKA H, 1974, ACTA NEUROPATHOL, V28, P205, DOI 10.1007/BF00719025
   CHIMELLI L, 1991, ACTA NEUROPATHOL, V81, P471, DOI 10.1007/BF00293470
   DAVIS DG, 1993, HUM PATHOL, V24, P990, DOI 10.1016/0046-8177(93)90113-U
   TOMITA T, 1988, CANCER, V61, P744, DOI 10.1002/1097-0142(19880215)61:4<744::AID-CNCR2820610418>3.0.CO;2-M
   ZERBINI C, 1993, J CLIN ONCOL, V11, P616, DOI 10.1200/JCO.1993.11.4.616
NR 5
TC 22
Z9 23
U1 0
U2 2
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399
SN 0046-8177
J9 HUM PATHOL
JI Hum. Pathol.
PD JUL
PY 1994
VL 25
IS 7
BP 730
EP 731
DI 10.1016/0046-8177(94)90309-3
PG 2
WC Pathology
SC Pathology
GA NX227
UT WOS:A1994NX22700017
PM 8026834
DA 2020-12-08
ER

PT J
AU CHIMELLI, L
   HAHN, MD
   SCARAVILLI, F
   WALLACE, S
   VISVESVARA, GS
AF CHIMELLI, L
   HAHN, MD
   SCARAVILLI, F
   WALLACE, S
   VISVESVARA, GS
TI GRANULOMATOUS AMEBIC ENCEPHALITIS DUE TO LEPTOMYXID AMEBAS - REPORT OF
   THE 1ST BRAZILIAN CASE
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Note
ID AMEBIC MENINGOENCEPHALITIS
C1 INST NEUROL,DEPT NEUROPATHOL,LONDON WC1N 3BG,ENGLAND.
   CTR DIS CONTROL,NATL CTR INFECT DIS,DIV PARASIT DIS,ATLANTA,GA 30333.
RP CHIMELLI, L (corresponding author), UNIV FED FLUMINENSE,HOSP UNIV ANTONIO PEDRO,DEPT PATOL,RUA MARQUES PARANA 303,BR-24030 NITEROI,RJ,BRAZIL.
CR ANZIL AP, 1991, ARCH PATHOL LAB MED, V115, P21
   MA P, 1990, REV INFECT DIS, V12, P490
   MARTINEZ AJ, 1980, NEUROLOGY, V30, P567, DOI 10.1212/WNL.30.6.567
   TARATUTO AL, 1991, T ROY SOC TROP MED H, V85, P77, DOI 10.1016/0035-9203(91)90164-T
   VISVESVARA GS, 1990, J CLIN MICROBIOL, V28, P2750, DOI 10.1128/JCM.28.12.2750-2756.1990
NR 5
TC 21
Z9 24
U1 0
U2 0
PU ROYAL SOC TROPICAL MEDICINE
PI LONDON
PA MANSON HOUSE 26 PORTLAND PLACE, LONDON, ENGLAND W1N 4EY
SN 0035-9203
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD NOV-DEC
PY 1992
VL 86
IS 6
BP 635
EP 635
DI 10.1016/0035-9203(92)90164-8
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KF358
UT WOS:A1992KF35800025
PM 1287925
DA 2020-12-08
ER

PT J
AU GRAY, F
   HAUG, H
   CHIMELLI, L
   GHERARDI, R
   SCARAVILLI, F
   BUDKA, H
AF GRAY, F
   HAUG, H
   CHIMELLI, L
   GHERARDI, R
   SCARAVILLI, F
   BUDKA, H
TI PROMINENT CORTICAL ATROPHY WITH NEURONAL LOSS AS CORRELATE OF HIV
   ENCEPHALOPATHY
SO JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
LA English
DT Meeting Abstract
C1 INST NEUROL,LONDON WC1N 3BG,ENGLAND.
   NEUROL INST,VIENNA,AUSTRIA.
   HOP HENRI MONDOR,F-94010 CRETEIL,FRANCE.
   INST ANAT,LUBECK,GERMANY.
   HOSP ANTONIO PEDRO,NITEROI,BRAZIL.
RI Budka, Herbert/I-3486-2019
OI Budka, Herbert/0000-0002-1933-1577
CR 1987, HUM PATHOL, V17, P271
   1986, ANN NEUROL, V19, P517
   1990, ACTA NEUROPATHOL, V80, P92
   1988, SCIENCE, V239, P586
   1986, ANN NEUROL, V19, P525
   J NEUROPATHOL EXP NE, V49, P350
   1987, NEUROLOGY, V37, P562
   1989, ACTA NEUROPATHOL, V77, P225
NR 8
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSN NEUROPATHOLOGISTS INC
PI LAWRENCE
PA 1041 NEW HAMPSHIRE ST, LAWRENCE, KS 66044
SN 0022-3069
J9 J NEUROPATH EXP NEUR
JI J. Neuropathol. Exp. Neurol.
PD MAY
PY 1991
VL 50
IS 3
BP 324
EP 324
PG 1
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA FK140
UT WOS:A1991FK14000113
DA 2020-12-08
ER

PT J
AU GRAY, F
   HAUG, H
   CHIMELLI, L
   GENY, C
   GASTON, A
   SCARAVILLI, F
   BUDKA, H
AF GRAY, F
   HAUG, H
   CHIMELLI, L
   GENY, C
   GASTON, A
   SCARAVILLI, F
   BUDKA, H
TI PROMINENT CORTICAL ATROPHY WITH NEURONAL LOSS AS CORRELATE OF
   HUMAN-IMMUNODEFICIENCY-VIRUS ENCEPHALOPATHY
SO ACTA NEUROPATHOLOGICA
LA English
DT Article
DE HUMAN IMMUNODEFICIENCY VIRUS; ACQUIRED IMMUNE DEFICIENCY SYNDROME
   (AIDS); ENCEPHALOPATHY; CORTICAL ATROPHY; MORPHOMETRY
ID AIDS DEMENTIA COMPLEX; IMMUNE-DEFICIENCY SYNDROME; CENTRAL
   NERVOUS-SYSTEM; CLINICAL-FEATURES; III INFECTION; HUMAN-BRAIN;
   NEUROPATHOLOGY; CELLS; ENCEPHALOMYELITIS; PATHOGENESIS
AB A 25-year-old homosexual AIDS patient presented with progressive cognitive, motor and behavioral disturbances consistent with HIV encephalopathy. CT scans demonstrated progressive diffuse brain atrophy. Neuropathology showed predominant cortical changes including severe neuronal loss corroborated by morphometry. Only minimal changes were found in the white matter and basal ganglia. Immunocytochemistry for HIV stained occasional microglial cells more markedly in the cerebral cortex. This suggests that HIV infection of the brain may cause predominant cortical nerve cell loss, and that HIV encephalopathy is not necessarily due to white matter lesions.
C1 UNIV PARIS 12,FAC MED CRETEIL,DEPT NEUROSCI MED,F-94010 CRETEIL,FRANCE.
   MED UNIV LUBECK,INST ANAT,LUBECK,GERMANY.
   HOSP ANTONIO PEDRO,DEPT PATOL,NITEROI,RJ,BRAZIL.
   INST NEUROL,DEPT NEUROPATHOL,LONDON WC1N 3BG,ENGLAND.
   UNIV VIENNA,INST NEUROL,A-1010 VIENNA,AUSTRIA.
RI Budka, Herbert/I-3486-2019
OI Budka, Herbert/0000-0002-1933-1577
CR BUDKA H, 1989, ACTA NEUROPATHOL, V77, P225, DOI 10.1007/BF00687573
   BUDKA H, 1987, ACTA NEUROPATHOL, V75, P184
   CIARDI A, 1990, ACTA NEUROPATHOL, V81, P51, DOI 10.1007/BF00662637
   CLAGUE CPT, 1988, J NEUROPATH EXP NEUR, V47, P346
   DALCANTO MC, 1989, HUM PATHOL, V20, P410, DOI 10.1016/0046-8177(89)90004-X
   DEGIROLAMI U, 1990, ARCH PATHOL LAB MED, V114, P643
   DELAMONTE SM, 1987, NEUROLOGY, V37, P562, DOI 10.1212/WNL.37.4.562
   FLODERUS S, 1944, ACTA PATHOL MICROB S, V53, P80
   GABUZDA DH, 1987, ANN INTERN MED, V107, P383, DOI 10.7326/0003-4819-107-2-383
   GIANGASPERO F, 1989, ACTA NEUROPATHOL, V78, P662, DOI 10.1007/BF00691293
   GRAY F, 1988, NEUROPATH APPL NEURO, V14, P365, DOI 10.1111/j.1365-2990.1988.tb01139.x
   HAUG H, 1984, J HIRNFORSCH, V25, P353
   HAUG H, 1967, QUANTITATIVE METHODS, P58
   KETZLER S, 1990, ACTA NEUROPATHOL, V80, P92, DOI 10.1007/BF00294228
   NAVIA BA, 1986, ANN NEUROL, V19, P525, DOI 10.1002/ana.410190603
   NAVIA BA, 1986, ANN NEUROL, V19, P517, DOI 10.1002/ana.410190602
   PETITO CK, 1986, J NEUROPATH EXP NEUR, V45, P635, DOI 10.1097/00005072-198611000-00003
   PETITO CK, 1985, NEW ENGL J MED, V312, P874, DOI 10.1056/NEJM198504043121402
   PRICE RW, 1988, ANN NEUROL, V23, pS27, DOI 10.1002/ana.410230711
   PRICE RW, 1988, SCIENCE, V239, P586, DOI 10.1126/science.3277272
   RUFF MR, 1987, FEBS LETT, V211, P17, DOI 10.1016/0014-5793(87)81265-6
   SCHWENK J, 1987, ACTA NEUROPATHOL, V74, P389, DOI 10.1007/BF00687217
   SHARER LR, 1986, HUM PATHOL, V17, P271, DOI 10.1016/S0046-8177(83)80220-2
   SNIDER WD, 1983, ANN NEUROL, V14, P403, DOI 10.1002/ana.410140404
   SOBEL RA, 1984, J IMMUNOL, V132, P2393
   VAZEUX R, 1987, AM J PATHOL, V126, P403
   WATKINS BA, 1990, SCIENCE, V249, P549, DOI 10.1126/science.2200125
   1986, ANN INTERN MED, V105, P234
   1987, JAMA-J AM MED ASSOC, V258, P1143
NR 29
TC 71
Z9 71
U1 0
U2 2
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0001-6322
J9 ACTA NEUROPATHOL
JI Acta Neuropathol.
PY 1991
VL 82
IS 3
BP 229
EP 233
DI 10.1007/BF00294450
PG 5
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA GA962
UT WOS:A1991GA96200011
PM 1927280
DA 2020-12-08
ER

PT J
AU CHIMELLI, L
   HAHN, MD
   BUDKA, H
AF CHIMELLI, L
   HAHN, MD
   BUDKA, H
TI LIPOMATOUS DIFFERENTIATION IN A MEDULLOBLASTOMA
SO ACTA NEUROPATHOLOGICA
LA English
DT Article
DE MEDULLOBLASTOMA; DIFFERENTIATION; METAPLASIA; FAT CELLS
ID FIBRILLARY ACIDIC PROTEIN; TUMORS
AB A surgically resected medulloblastoma of the left cerebellum in a 42-year-old man contained numerous mature fat cells; many of these adipocytes expressed glial fibrillary acidic protein (GFAP), S-100 protein, and vimentin as seen by immunocytochemistry.  The cellular parts of the tumor showed varying immunoreactivities for GFAP, S-100 protein, neuron-specific enolase, and synaptophysin.  It is concluded that this tumor exhibits a unique spectrum of differentiation along multiple lines, including transformation of neuroectodermal cells to fat cells.  The significance of this new type of differentiation in primitive neural tumors remains to be elucidated.
C1 UNIV FED FLUMINENSE,HOSP ANTONIO PEDRO,DEPT PATHOL,RUA MARQUES PARANA,BR-24030 NITEROI,RJ,BRAZIL.
   UNIV VIENNA,INST NEUROL,A-1090 VIENNA,AUSTRIA.
RI Budka, Herbert/I-3486-2019
OI Budka, Herbert/0000-0002-1933-1577
CR ANWER UE, 1989, ARCH PATHOL LAB MED, V113, P84
   BARNARD RO, 1980, J NEUROL NEUROSUR PS, V43, P1041, DOI 10.1136/jnnp.43.11.1041
   BUDKA K, 1974, ACTA NEUROPATHOL BER, V28, P205
   BURGER PC, 1987, ACTA NEUROPATHOL, V73, P115, DOI 10.1007/BF00693776
   DICKSON DW, 1983, J NEUROPATH EXP NEUR, V42, P639, DOI 10.1097/00005072-198311000-00004
   HERPERS MJHM, 1985, CLIN NEUROPATHOL, V4, P12
   KASANTIKUL V, 1986, SURG NEUROL, V26, P532, DOI 10.1016/0090-3019(86)90335-6
   KUMANISHI T, 1985, ACTA NEUROPATHOL, V67, P1, DOI 10.1007/BF00688118
   MANNOJI H, 1981, ACTA NEUROPATHOL, V55, P63, DOI 10.1007/BF00691533
   PALMER JO, 1981, J NEUROSURG, V55, P161, DOI 10.3171/jns.1981.55.2.0161
   RUBINSTEIN LJ, 1985, J NEUROSURG, V62, P795, DOI 10.3171/jns.1985.62.6.0795
   RUSSEL DS, 1989, PATHOL TUMOURS NER, P258
   SMITH TW, 1984, CANCER, V54, P323, DOI 10.1002/1097-0142(19840715)54:2<323::AID-CNCR2820540225>3.0.CO;2-5
   VELASCO ME, 1985, SURG NEUROL, V23, P177, DOI 10.1016/0090-3019(85)90340-4
NR 14
TC 51
Z9 52
U1 0
U2 0
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0001-6322
J9 ACTA NEUROPATHOL
JI Acta Neuropathol.
PY 1991
VL 81
IS 4
BP 471
EP 473
DI 10.1007/BF00293470
PG 3
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA FC060
UT WOS:A1991FC06000017
PM 2028751
DA 2020-12-08
ER

PT J
AU GRAY, F
   CHIMELLI, L
   MOHR, M
   CLAVELOU, P
   SCARAVILLI, F
   POIRIER, J
AF GRAY, F
   CHIMELLI, L
   MOHR, M
   CLAVELOU, P
   SCARAVILLI, F
   POIRIER, J
TI FULMINATING MULTIPLE SCLEROSIS-LIKE LEUKOENCEPHALOPATHY REVEALING
   HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
SO NEUROLOGY
LA English
DT Article
ID CENTRAL NERVOUS-SYSTEM; SYNDROME AIDS
C1 HOP FONTMAURE,SERV NEUROL,CHAMALIERES,FRANCE.
   HOSP ANTONIO PEDRO,DEPT PATOL,NITEROI,BRAZIL.
   INST NEUROL,DEPT NEUROPATHOL,LONDON WC1N 3BG,ENGLAND.
   UNIV PARIS 12,FAC MED CRETEIL,DEPT NEUROSCI MED,F-94010 CRETEIL,FRANCE.
   FAC MED STRASBOURG,INST PATHOL,STRASBOURG,FRANCE.
RP GRAY, F (corresponding author), HOP HENRI MONDOR,DEPT PATHOL NEUROPATHOL,F-94010 CRETEIL,FRANCE.
OI Clavelou, Pierre/0000-0003-2363-9352
CR Allen IV, 1984, GREENFIELDS NEUROPAT, P338
   BERGER JR, 1989, NEUROLOGY, V39, P324, DOI 10.1212/WNL.39.3.324
   BUDKA H, 1989, ACTA NEUROPATHOL, V77, P225, DOI 10.1007/BF00687573
   CARNE CA, 1985, LANCET, V2, P1206
   DENNING DW, 1987, BRIT MED J, V294, P143, DOI 10.1136/bmj.294.6565.143
   GRAY F, 1990, J NEUROPATH EXP NEUR, V49, P303, DOI 10.1097/00005072-199005000-00133
   GRAY F, 1988, BRAIN, V111, P245, DOI 10.1093/brain/111.2.245
   HO DD, 1985, ANN INTERN MED, V103, P880, DOI 10.7326/0003-4819-103-6-880
   JONES HR, 1988, ANN NEUROL, V23, P519, DOI 10.1002/ana.410230515
   KURTZKE JF, 1980, ACTA NEUROL SCAND, V62, P65, DOI 10.1111/j.1600-0404.1980.tb03006.x
   LEVY RM, 1988, J ACQ IMMUN DEF SYND, V1, P41
   MCARTHUR JC, 1987, MEDICINE, V66, P407, DOI 10.1097/00005792-198711000-00001
   PERSUY P, 1988, REV NEUROL-FRANCE, V144, P32
   POIRIER J, 1990, MANUAL NEUROPATHOLOG
   Sibley W, 1984, DIAGNOSIS MULTIPLE S, P14
   SOBEL RA, 1984, J IMMUNOL, V132, P2393
   THYGESEN P, 1949, ARCH NEURO PSYCHIATR, V61, P339, DOI 10.1001/archneurpsyc.1949.02310100003001
   TROTOT PM, 1988, CR ACAD SCI III-VIE, V307, P1
   VANBOGAERT L, 1950, J NEUROPATH EXP NEUR, V9, P219, DOI 10.1097/00005072-195007000-00001
   WELLER RO, 1985, MCALPINES MULTIPLE S, P301
   1989, NEUROLOGY, V39, P119
NR 21
TC 62
Z9 62
U1 0
U2 0
PU LITTLE BROWN CO
PI BOSTON
PA 34 BEACON STREET, BOSTON, MA 02108-1493
SN 0028-3878
J9 NEUROLOGY
JI Neurology
PD JAN
PY 1991
VL 41
IS 1
BP 105
EP 109
DI 10.1212/WNL.41.1.105
PG 5
WC Clinical Neurology
SC Neurosciences & Neurology
GA ER633
UT WOS:A1991ER63300021
PM 1985273
DA 2020-12-08
ER

PT J
AU GRAY, F
   MOHR, M
   CHIMELLI, L
   SCARAVILLI, F
   POIRIER, J
AF GRAY, F
   MOHR, M
   CHIMELLI, L
   SCARAVILLI, F
   POIRIER, J
TI HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION REVEALED BY FULMINATING
   MULTIPLE-SCLEROSIS (MS)-LIKE LEUKOENCEPHALOPATHY - REPORT OF 2 CASES
SO JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
LA English
DT Meeting Abstract
C1 HOP HENRI MONDOR,F-94010 CRETEIL,FRANCE.
CR 1989, NEUROLOGY, V39, P324
NR 1
TC 1
Z9 1
U1 0
U2 1
PU AMER ASSN NEUROPATHOLOGISTS INC
PI LAWRENCE
PA 1041 NEW HAMPSHIRE ST, LAWRENCE, KS 66044
SN 0022-3069
J9 J NEUROPATH EXP NEUR
JI J. Neuropathol. Exp. Neurol.
PD MAY
PY 1990
VL 49
IS 3
BP 303
EP 303
DI 10.1097/00005072-199005000-00133
PG 1
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA DC245
UT WOS:A1990DC24500133
DA 2020-12-08
ER

PT J
AU CHIMELLI, L
   HAHN, MD
   NETTO, MB
   BARTH, OM
   GRAY, F
AF CHIMELLI, L
   HAHN, MD
   NETTO, MB
   BARTH, OM
   GRAY, F
TI POSTINFECTIOUS LEUKOENCEPHALITIS ASSOCIATED WITH DENGUE - REPORT OF A
   BRAZILIAN CASE
SO JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
LA English
DT Meeting Abstract
C1 FLUMINENSE FED UNIV,NITEROI,RJ,BRAZIL.
   HOP HENRI MONDOR,F-94010 CRETEIL,FRANCE.
CR BARTH, 1988, MEM I O CRUZ, V83, P207
NR 1
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSN NEUROPATHOLOGISTS INC
PI LAWRENCE
PA 1041 NEW HAMPSHIRE ST, LAWRENCE, KS 66044
SN 0022-3069
J9 J NEUROPATH EXP NEUR
JI J. Neuropathol. Exp. Neurol.
PD MAY
PY 1990
VL 49
IS 3
BP 326
EP 326
DI 10.1097/00005072-199005000-00202
PG 1
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA DC245
UT WOS:A1990DC24500202
DA 2020-12-08
ER

PT J
AU CHIMELLI, L
   SYMON, L
   SCARAVILLI, F
AF CHIMELLI, L
   SYMON, L
   SCARAVILLI, F
TI GRANULAR-CELL TUMOR OF THE 5TH CRANIAL NERVE - FURTHER EVIDENCE FOR
   SCHWANN-CELL ORIGIN
SO JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
LA English
DT Article
C1 NATL HOSP, INST NEUROL, DEPT NEUROPATHOL, LONDON WC1N 3BG, ENGLAND.
   NATL HOSP, INST NEUROL, GOUGH COOPER DEPT NEUROL SURG, LONDON WC1N 3BG, ENGLAND.
CR Abrikossoff A, 1926, VIRCHOWS ARCH A, V260, P215, DOI 10.1007/BF02078314
   ALSARRAF M, 1971, ARCH PATHOL, V91, P550
   APARICIO SR, 1969, J PATHOL, V97, P339, DOI 10.1002/path.1710970221
   AZZOPARDI JG, 1956, J PATHOL BACTERIOL, V71, P85, DOI 10.1002/path.1700710113
   BANGLE R, 1952, CANCER, V5, P950, DOI 10.1002/1097-0142(195209)5:5<950::AID-CNCR2820050511>3.0.CO;2-K
   BANGLE R, 1953, CANCER, V6, P790, DOI 10.1002/1097-0142(195307)6:4<790::AID-CNCR2820060421>3.0.CO;2-O
   BEDETTI CD, 1983, VIRCHOWS ARCH A, V402, P175, DOI 10.1007/BF00695059
   BUDZILOVICH GN, 1968, ACTA NEUROPATHOL, V10, P162, DOI 10.1007/BF00691311
   BURSTON J, 1962, J PATHOL BACTERIOL, V83, P455, DOI 10.1002/path.1700830216
   CHOMETTE G, 1980, ARCH ANAT CYTOL PATH, V28, P365
   CHRIST ML, 1971, AM J CLIN PATHOL, V56, P736
   DORON Y, 1965, J NEUROSURG, V22, P95, DOI 10.3171/jns.1965.22.1.0095
   FARRIS KB, 1979, ARCH PATHOL LAB MED, V103, P510
   FISHER ER, 1962, CANCER, V15, P936, DOI 10.1002/1097-0142(196209/10)15:5<936::AID-CNCR2820150509>3.0.CO;2-F
   FUST JA, 1949, AM J CLIN PATHOL, V19, P522
   GLAZER N, 1956, AMER J ROENTGENOL RA, V76, P324
   HARLAND WA, 1953, CANCER, V6, P1134
   LIMA A, 1960, J NEUROSURG, V17, P778, DOI 10.3171/jns.1960.17.4.0778
   LISS L, 1958, J NEUROSURG, V15, P481, DOI 10.3171/jns.1958.15.5.0481
   MARKESBERY WR, 1973, J NEUROPATH EXP NEUR, V32, P92, DOI 10.1097/00005072-197301000-00006
   MEREDITH JM, 1958, J THORAC SURG, V35, P80
   MUKAI M, 1983, AM J PATHOL, V112, P139
   NAKAZATO Y, 1982, CANCER, V48, P1624, DOI 10.1002/1097-0142(19820415)49:8<1624::AID-CNCR2820490816>3.0.CO;2-H
   PEARSE AGE, 1950, J PATHOL BACTERIOL, V62, P351, DOI 10.1002/path.1700620306
   PFEIFFER SE, 1972, P NATL ACAD SCI USA, V69, P2885, DOI 10.1073/pnas.69.10.2885
   POLLARD JD, 1975, J NEUROL SCI, V24, P365, DOI 10.1016/0022-510X(75)90257-9
   SAKURAMA N, 1981, ACTA NEUROCHIR, V56, P81, DOI 10.1007/BF01400975
   SCHWIDDE JT, 1951, J NEUROPATH EXP NEUR, V10, P30
   SHIMAMURA K, 1984, CANCER-AM CANCER SOC, V53, P524, DOI 10.1002/1097-0142(19840201)53:3<524::AID-CNCR2820530326>3.0.CO;2-5
   SHOUSHA S, 1979, J CLIN PATHOL, V32, P219, DOI 10.1136/jcp.32.3.219
   SOBEL HJ, 1971, AM J PATHOL, V65, P59
   STEFANSSON K, 1982, AM J PATHOL, V106, P261
   STEFANSSON K, 1982, CANCER, V49, P1834, DOI 10.1002/1097-0142(19820501)49:9<1834::AID-CNCR2820490916>3.0.CO;2-G
   STERNBER.LA, 1970, J HISTOCHEM CYTOCHEM, V18, P315, DOI 10.1177/18.5.315
   SYMON L, 1971, J NEUROSURG, V35, P82, DOI 10.3171/jns.1971.35.1.0082
   USUI M, 1977, CANCER, V39, P1547, DOI 10.1002/1097-0142(197704)39:4<1547::AID-CNCR2820390428>3.0.CO;2-O
   WEISER G, 1978, VIRCHOWS ARCH A, V380, P49
   WEISMAN RA, 1980, ARCH OTOLARYNGOL, V106, P294
NR 38
TC 32
Z9 32
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-3069
EI 1554-6578
J9 J NEUROPATH EXP NEUR
JI J. Neuropathol. Exp. Neurol.
PY 1984
VL 43
IS 6
BP 634
EP 642
DI 10.1097/00005072-198411000-00007
PG 9
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA TS396
UT WOS:A1984TS39600007
PM 6094739
DA 2020-12-08
ER

EF